data_2b8a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2b8a _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 121.011 0.434 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 t -53.24 127.18 23.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.464 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.401 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 101.23 -14.84 58.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.096 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.07 138.8 54.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 0.0 111.115 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.7 mt -92.22 117.65 30.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.176 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.92 171.39 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.185 0.517 . . . . 0.0 111.956 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 32.5 m-85 -110.63 137.35 48.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.471 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.54 125.0 53.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.893 0.378 . . . . 0.0 111.586 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -90.37 134.37 34.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.906 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 mmm -129.8 151.85 49.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 122.62 18.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.81 -2.06 85.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.897 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -139.4 152.47 69.23 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.757 0.279 . . . . 0.0 110.674 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.87 163.8 13.85 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.6 2.2 . . . . 0.0 112.688 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 48.4 m80 -46.6 117.44 1.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.102 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.425 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.3 t-105 -101.13 128.04 30.42 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.584 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 9.5 Cg_endo -52.49 119.5 5.99 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.329 2.02 . . . . 0.0 111.073 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . -144.69 177.34 8.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.43 0.633 . . . . 0.0 112.67 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.459 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 4.3 ttp180 -143.2 156.66 44.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.84 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.459 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 24.1 mm -82.94 140.32 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.0 -19.38 6.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 111.001 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 1.1 mmpt? . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.907 0.384 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 2.6 m-85 -149.46 159.77 44.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.188 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 57' ' ' PHE . 11.5 mt-30 -93.04 105.32 17.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.076 0.465 . . . . 0.0 109.832 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 m -102.95 146.87 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.615 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 3.9 t80 -103.82 123.44 47.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.456 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -93.72 105.26 17.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.814 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 57.9 m-85 -56.47 178.53 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 111.389 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.39 -62.35 1.1 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.15 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.8 p -91.38 -21.96 20.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 110.932 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.6 m170 65.26 34.12 8.65 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.521 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -95.51 157.35 15.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.649 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 t -129.76 148.68 51.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.354 0.597 . . . . 0.0 111.833 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.53 170.77 21.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.606 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.3 m-85 -108.13 124.2 49.88 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.758 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.6 mt -138.65 161.73 36.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.975 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.11 176.27 42.06 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.248 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.45 -25.42 30.07 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.314 2.009 . . . . 0.0 111.865 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -68.96 -22.13 64.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.618 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.18 2.18 42.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.1 mt -110.99 139.35 46.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.291 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.2 m-85 -136.64 160.48 66.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 16.7 Cg_exo -67.59 112.62 2.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.646 2.231 . . . . 0.0 111.939 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.7 t80 -50.08 -61.41 2.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.242 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.83 -39.38 58.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.959 0.409 . . . . 0.0 111.638 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -71.37 -39.25 71.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.349 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 34.2 m -105.62 10.86 32.82 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 66' ' ' TYR . 14.6 tttt -54.76 -48.35 72.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.77 -29.77 68.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.934 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -83.77 -46.05 12.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.3 m-30 -98.13 -12.18 22.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.76 72.88 2.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.102 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.459 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.9 mttt -150.7 143.49 16.42 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.635 0.255 . . . . 0.0 110.592 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.26 158.59 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.468 2.112 . . . . 0.0 112.757 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.64 172.05 13.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.97 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -87.22 -16.85 34.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.393 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -13.96 61.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt 66.34 141.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.395 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -17.04 56.89 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.897 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 36.9 t80 -59.78 -53.76 54.17 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.944 0.402 . . . . 0.0 110.518 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.75 -47.08 71.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.72 -31.33 6.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.934 0.397 . . . . 0.0 110.367 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.14 -32.4 63.06 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.82 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.446 HD22 ' CE1' ' A' ' 82' ' ' PHE . 3.8 mm? -60.78 -43.66 97.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.985 0.421 . . . . 0.0 110.361 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -65.48 -44.17 87.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.237 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 24.3 mm-40 -63.56 -53.01 58.41 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.431 HG12 ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -52.77 -26.69 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.739 0.304 . . . . 0.0 111.775 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.71 -44.64 6.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -81.33 -32.63 32.93 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -156.72 90.95 2.54 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.715 0.293 . . . . 0.0 111.324 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -76.54 -11.02 18.83 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.48 2.12 . . . . 0.0 112.659 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.9 p -106.81 12.61 28.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.543 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.907 0.384 . . . . 0.0 111.542 -179.61 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 121.022 0.439 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.9 m -52.01 129.38 27.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.396 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.99 58.51 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.939 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.05 138.16 51.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.836 0.351 . . . . 0.0 111.263 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.4 mt -91.81 119.64 31.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 110.156 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.0 m -140.72 171.32 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.946 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 27' ' ' PRO . 10.0 m-85 -109.87 136.71 48.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.515 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -113.08 124.56 52.88 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.007 0.432 . . . . 0.0 111.775 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -92.09 131.69 37.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.75 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mtp -129.09 147.47 50.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.689 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 115.26 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.877 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.413 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 100.45 4.08 55.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.764 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -152.8 153.66 30.34 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.695 0.283 . . . . 0.0 110.653 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.83 167.6 18.3 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.562 2.174 . . . . 0.0 112.3 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.435 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 71.0 m80 -47.49 115.23 1.06 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.627 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.92 130.41 27.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.315 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 11.3 Cg_endo -54.89 120.89 8.89 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.206 1.937 . . . . 0.0 111.114 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.73 175.77 9.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.345 0.593 . . . . 0.0 112.252 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -142.84 155.7 44.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.455 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -78.85 135.28 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.98 -20.3 4.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -179.671 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.949 0.404 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -94.82 154.45 17.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.767 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -99.3 107.04 19.23 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 m -103.47 150.5 6.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-O 121.433 0.635 . . . . 0.0 112.342 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 49.0 t80 -105.43 124.51 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.024 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -93.28 108.96 20.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.718 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 47.8 m-85 -61.53 177.93 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.815 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.97 -63.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.001 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.1 p -91.52 -22.46 20.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.729 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 10.6 m-70 64.56 36.96 8.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -91.64 155.44 18.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.603 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.11 140.26 53.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.188 0.518 . . . . 0.0 111.356 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.26 178.1 10.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.363 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -119.92 127.21 52.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.853 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.2 mp -138.84 161.75 36.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.994 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.48 176.4 35.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.653 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.68 -25.06 54.43 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.583 2.189 . . . . 0.0 112.409 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -69.53 -27.07 64.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 0.0 110.894 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -100.25 6.95 44.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.312 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 22.3 mt -114.31 138.1 50.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.651 0.262 . . . . 0.0 110.35 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.6 m-85 -137.11 159.58 69.33 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.066 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.9 Cg_exo -70.24 113.86 3.59 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.674 2.25 . . . . 0.0 111.65 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 89.1 t80 -53.6 -59.51 4.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.737 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -49.04 -42.63 39.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.649 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.08 -39.53 72.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.57 -179.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -105.33 10.39 33.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.4 ptpt -56.38 -44.33 80.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.633 0.254 . . . . 0.0 111.676 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.43 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mm-40 -68.56 -32.86 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 13.1 ptpt -84.01 -43.34 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.436 ' CD1' ' HG3' ' A' ' 72' ' ' LYS . 18.2 m-30 -98.3 -8.6 26.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.24 75.38 2.04 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.999 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mmmm -148.61 159.26 38.86 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.609 0.242 . . . . 0.0 110.412 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.62 151.87 59.76 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.553 2.169 . . . . 0.0 112.573 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.05 170.27 15.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.148 0.499 . . . . 0.0 111.547 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -15.67 28.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.405 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -66.35 -14.82 62.65 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.009 0.433 . . . . 0.0 110.751 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt 63.37 144.15 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.111 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.44 -18.8 35.59 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.617 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 15.0 t80 -58.56 -55.65 32.36 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-O 121.04 0.448 . . . . 0.0 110.623 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -52.83 -45.67 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -48.72 -31.35 6.75 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.922 0.391 . . . . 0.0 110.441 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.09 -31.42 61.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.881 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.9 mt -60.97 -43.8 98.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 110.231 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -64.14 -44.9 90.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.069 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.476 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -63.38 -50.92 68.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -51.81 -27.6 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 111.82 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 89' ' ' ILE . 0.8 OUTLIER -99.44 -44.66 6.1 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.76 -32.92 41.05 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.3 87.43 3.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.751 0.31 . . . . 0.0 111.241 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.53 -13.75 18.19 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.986 2.457 . . . . 0.0 112.633 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 p -104.01 13.07 33.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.553 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 C--N 1.332 -0.194 0 CA-C-O 120.939 0.399 . . . . 0.0 111.491 -179.681 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.887 0.375 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 t -52.21 126.72 19.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.294 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.525 ' HA2' ' HE ' ' A' ' 29' ' ' ARG . . . 109.72 -18.46 29.44 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.195 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.47 144.56 48.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 111.859 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.54 123.73 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.105 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 m -141.9 173.01 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 112.193 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -111.84 135.88 51.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.746 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.75 122.24 47.09 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.003 0.43 . . . . 0.0 111.571 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.415 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 22.8 tptm -92.21 129.71 38.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 mtm -128.21 149.94 50.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.586 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 124.45 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.982 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 91.41 -0.75 75.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.049 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.1 m-85 -146.52 153.54 47.57 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.857 0.329 . . . . 0.0 110.813 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.41 165.31 16.47 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.771 2.314 . . . . 0.0 112.417 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.485 ' CE1' ' CZ ' ' A' ' 73' ' ' PHE . 70.1 m80 -47.94 115.42 1.17 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.489 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.429 ' CD1' ' HD2' ' A' ' 27' ' ' PRO . 2.5 t-105 -98.91 132.86 22.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.412 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 35.1 Cg_exo -54.54 120.05 7.42 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.04 1.827 . . . . 0.0 111.079 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.7 174.57 10.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.347 0.594 . . . . 0.0 112.373 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.525 ' HE ' ' HA2' ' A' ' 13' ' ' GLY . 43.1 ttt180 -141.53 154.8 45.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.607 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 mm -78.39 138.65 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -123.89 -23.21 4.7 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 120.979 0.419 . . . . 0.0 111.353 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 121.118 0.485 . . . . 0.0 111.543 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -94.37 158.3 15.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.128 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.9 106.37 18.66 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.9 t -103.7 142.72 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.494 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -106.77 123.3 47.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.774 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -95.11 108.69 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.311 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 54.3 m-85 -57.57 179.32 0.06 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.27 -64.12 0.56 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.311 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.5 p -92.0 -22.63 19.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.8 m170 64.62 36.01 8.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.224 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -90.41 153.84 20.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.602 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.72 141.35 52.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.212 0.529 . . . . 0.0 111.526 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.97 166.74 32.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.305 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -107.08 124.85 50.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.9 mt -138.71 160.22 40.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.925 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.13 177.26 38.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.63 -24.8 47.7 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.507 2.138 . . . . 0.0 112.388 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -69.17 -25.26 64.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.92 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.6 6.48 45.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.322 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 38.6 mt -115.02 138.82 50.43 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.723 0.297 . . . . 0.0 110.57 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.1 m-85 -136.34 159.99 68.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.701 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.602 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 8.1 Cg_exo -71.28 114.17 3.84 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.46 2.107 . . . . 0.0 111.479 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 70' ' ' LYS . 74.3 t80 -51.07 -59.57 4.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.117 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 1.1 mt-10 -48.09 -43.7 30.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.923 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 7.0 mt-10 -71.37 -39.63 71.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.524 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.44 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 63.7 m -103.04 9.69 38.45 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.3 ptpp? -55.62 -44.62 77.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.69 0.281 . . . . 0.0 111.669 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.463 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 1.4 mt-10 -68.39 -34.25 75.7 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.44 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -84.25 -44.15 14.16 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.485 ' CZ ' ' CE1' ' A' ' 25' ' ' HIS . 19.2 m-30 -95.95 -14.1 23.33 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.98 74.89 2.34 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.195 -1.002 . . . . 0.0 113.071 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -149.11 159.31 37.45 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.589 0.233 . . . . 0.0 110.548 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.69 152.72 79.17 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.559 2.172 . . . . 0.0 112.621 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.415 ' ND2' ' HB2' ' A' ' 79' ' ' ARG . 50.6 p-10 -138.52 -172.37 3.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.291 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -100.35 -12.09 19.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.154 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 13.7 mmm180 -65.91 -15.95 63.42 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.993 0.425 . . . . 0.0 110.676 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt 62.7 141.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.996 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.49 59.3 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.562 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 26.5 t80 -57.5 -58.09 9.82 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.979 0.419 . . . . 0.0 110.941 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.37 -45.23 62.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.086 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.21 -32.28 10.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.012 0.434 . . . . 0.0 110.324 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.9 -32.59 58.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.826 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.62 -43.51 97.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.098 0.475 . . . . 0.0 110.141 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 59.0 t90 -63.32 -44.51 94.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.1 mp0 -62.93 -51.91 65.1 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -51.97 -25.63 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -101.04 -44.74 5.62 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -81.98 -32.5 30.63 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.24 84.09 3.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.804 0.335 . . . . 0.0 110.733 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 91.4 Cg_endo -77.08 -9.99 17.9 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.559 2.173 . . . . 0.0 112.856 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.1 p -104.12 12.2 34.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.588 0.232 . . . . 0.0 111.445 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 111.549 -179.535 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.8 m -52.52 124.82 14.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.28 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 29' ' ' ARG . . . 105.58 -16.51 44.25 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.817 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.69 135.36 49.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.995 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.0 mt -92.07 117.26 29.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 110.286 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.5 m -139.1 171.38 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.995 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.568 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 28.6 m-85 -110.23 136.01 50.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.619 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -113.71 125.09 53.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.103 0.477 . . . . 0.0 111.781 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . 21.3 tptm -91.47 133.3 35.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.055 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -125.51 154.41 42.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.676 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.59 115.48 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.983 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.99 39.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.575 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -116.55 148.71 42.42 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-O 120.758 0.313 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.58 166.66 23.64 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.738 2.292 . . . . 0.0 112.731 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 69.6 m80 -51.64 115.13 1.48 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.373 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.469 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.6 t-105 -99.56 134.54 21.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 31.1 Cg_exo -54.44 120.89 8.77 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.164 1.909 . . . . 0.0 110.712 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.0 174.77 10.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.425 ' CZ ' ' HA2' ' A' ' 13' ' ' GLY . 5.1 ttp180 -141.59 156.85 45.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.745 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.414 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 27.0 mm -83.89 140.51 16.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.726 0.298 . . . . 0.0 110.574 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -124.55 -18.75 5.6 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.966 0.412 . . . . 0.0 111.214 -179.738 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.075 0.464 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -94.88 154.08 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.869 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -98.65 104.24 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.1 m -102.41 150.56 6.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.545 0.688 . . . . 0.0 112.432 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 36.4 t80 -105.4 124.81 50.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.967 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -91.47 108.1 19.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.494 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 45.0 m-85 -60.52 175.95 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.721 0.296 . . . . 0.0 110.955 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.58 -62.47 0.87 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.088 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 p -90.98 -22.52 20.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.841 0.353 . . . . 0.0 110.739 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 20.6 m170 63.83 35.51 11.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.499 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -91.3 155.38 18.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.64 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.79 140.6 52.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.326 0.584 . . . . 0.0 111.639 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.08 168.79 25.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.431 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -111.82 127.05 55.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.145 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 mp -138.36 160.23 40.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.58 177.33 37.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.77 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.89 -27.0 51.38 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.672 2.248 . . . . 0.0 112.363 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -69.25 -25.33 64.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -99.1 5.49 46.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.314 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 33.0 mt -113.17 138.71 49.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.814 0.34 . . . . 0.0 110.699 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 0.8 OUTLIER -134.74 154.01 79.18 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.83 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.464 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 15.0 Cg_exo -67.1 112.3 2.48 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.279 1.986 . . . . 0.0 111.157 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 77.2 t80 -51.49 -59.9 3.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.25 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -48.23 -43.0 31.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.012 0.434 . . . . 0.0 111.807 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 48.0 mt-10 -71.24 -39.69 71.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.466 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.0 8.49 38.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 66' ' ' TYR . 11.3 ptmt -55.35 -48.12 74.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.842 0.353 . . . . 0.0 111.38 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.01 -23.93 63.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.833 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -85.29 -47.51 9.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -105.58 -0.55 25.64 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.38 73.3 2.41 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.724 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.436 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 27.1 mmtt -148.53 159.11 39.44 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.588 0.232 . . . . 0.0 110.567 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.2 153.09 28.29 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.543 2.162 . . . . 0.0 112.374 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -131.96 165.57 23.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.113 0.483 . . . . 0.0 111.672 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -86.75 -17.27 34.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.009 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -14.47 62.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.049 0.452 . . . . 0.0 110.531 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm 63.65 144.56 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.131 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.59 -18.22 39.71 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.802 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 30.0 t80 -58.59 -54.4 47.44 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.037 0.446 . . . . 0.0 110.801 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -45.64 66.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.16 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -48.46 -31.7 6.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.43 . . . . 0.0 110.49 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.52 -31.89 60.31 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.054 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.57 -43.82 96.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 110.35 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 69.4 t90 -64.35 -45.48 87.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.125 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -62.55 -51.23 68.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.83 -27.73 8.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.317 . . . . 0.0 111.709 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.32 -44.58 6.17 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -80.69 -31.71 36.17 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -156.59 88.59 2.75 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 111.351 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 80.2 Cg_endo -77.81 -11.91 16.6 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.625 2.217 . . . . 0.0 112.646 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.3 p -101.71 10.55 39.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.605 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.0 111.266 -179.696 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.89 0.376 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.5 m -51.9 132.12 31.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.594 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.19 -12.25 68.37 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.937 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.73 139.18 51.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 0.0 111.006 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.2 mt -91.18 116.51 28.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.996 0.427 . . . . 0.0 110.4 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.69 170.34 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.552 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.521 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 18.0 m-85 -111.15 135.88 51.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.519 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.89 123.05 49.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.906 0.384 . . . . 0.0 111.397 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 23.8 tptp -92.08 130.94 37.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.134 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtm -127.03 147.86 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.47 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 113.48 4.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 111.013 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.96 -27.38 14.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.635 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.91 157.98 48.98 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.942 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.46 166.39 12.2 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.826 2.35 . . . . 0.0 112.372 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.505 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 59.0 m80 -47.23 113.99 0.78 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.516 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.466 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.49 130.7 27.49 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.642 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.55 119.03 5.75 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.376 2.051 . . . . 0.0 111.083 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.2 175.2 10.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 14.3 ttp180 -142.53 156.44 45.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.493 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.424 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 25.0 mm -79.91 138.76 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.21 -20.84 5.15 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.957 0.408 . . . . 0.0 111.227 -179.732 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.982 0.42 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -94.12 157.91 15.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.135 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.9 107.51 19.96 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.3 t -103.53 142.68 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 121.463 0.649 . . . . 0.0 112.56 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -105.61 121.89 44.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.507 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -94.16 106.62 18.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.049 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.443 ' HB3' ' HA2' ' A' ' 85' ' ' GLY . 49.4 m-85 -57.59 176.99 0.11 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.843 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.77 -63.55 0.67 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.418 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 81.0 p -90.19 -23.21 21.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.739 0.304 . . . . 0.0 110.738 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 52' ' ' THR . 4.0 m170 66.0 33.91 7.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.197 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.2 151.03 21.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.928 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.8 140.79 51.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.239 0.542 . . . . 0.0 111.307 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.88 168.11 28.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.289 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -109.31 125.45 52.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.995 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 mt -139.33 160.62 39.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.37 -179.85 40.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.23 -26.82 41.74 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.511 2.14 . . . . 0.0 112.189 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -69.55 -22.59 63.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.077 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -99.0 3.66 47.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.463 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.03 139.6 49.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.2 m-85 -136.59 166.3 28.65 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.845 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.414 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 4.8 Cg_exo -73.17 111.08 3.2 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.767 2.311 . . . . 0.0 111.69 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.2 t80 -49.95 -58.44 5.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.478 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -49.0 -41.09 33.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.611 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 4.9 mm-40 -71.02 -39.71 72.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.674 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.423 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . 3.6 m -103.39 13.87 32.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 66' ' ' TYR . 2.2 mtmp? -55.52 -44.95 77.15 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.413 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.75 -40.83 88.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.75 -43.88 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.9 m-30 -94.71 -19.77 20.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -86.73 74.08 2.39 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.042 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 12.1 mttt -149.32 153.57 37.62 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.95 155.5 8.42 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.616 2.211 . . . . 0.0 112.638 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -136.39 165.58 25.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.578 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -85.73 -16.07 40.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.304 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.58 -13.8 61.53 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.987 0.423 . . . . 0.0 110.713 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt 63.79 142.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.159 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.71 -16.87 55.52 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.517 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.466 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 31.4 t80 -59.0 -56.88 16.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.943 0.402 . . . . 0.0 110.882 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.41 -45.42 65.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.113 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.62 -30.13 5.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.017 0.437 . . . . 0.0 110.503 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.443 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.96 -31.86 57.43 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.161 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.4 -43.35 96.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.064 0.459 . . . . 0.0 110.34 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 62.9 t90 -63.73 -45.71 88.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.229 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.67 -50.63 70.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.428 HG21 ' N ' ' A' ' 90' ' ' GLU . 1.1 tt -52.92 -27.03 12.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.744 0.306 . . . . 0.0 111.692 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' N ' HG21 ' A' ' 89' ' ' ILE . 17.5 mt-10 -99.31 -44.83 6.08 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -79.64 -31.55 41.54 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.455 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . 1.0 OUTLIER -156.99 87.08 2.76 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.751 0.31 . . . . 0.0 111.282 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.01 -12.94 26.21 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.933 2.422 . . . . 0.0 112.61 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 p -107.05 14.66 26.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.53 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 92' ' ' ASN . 14.6 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.075 0.464 . . . . 0.0 111.702 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.905 0.383 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 98.8 m -52.01 125.36 15.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.409 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.34 -16.34 49.15 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.153 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.19 138.92 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.79 0.329 . . . . 0.0 111.323 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -91.43 120.75 32.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.191 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.6 m -141.62 174.05 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.369 0.604 . . . . 0.0 112.133 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.508 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 9.4 m-85 -111.97 136.34 51.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.419 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.65 125.53 54.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.022 0.439 . . . . 0.0 111.449 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.82 132.58 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.979 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.7 mtm -129.81 155.01 46.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.701 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.73 119.62 13.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.034 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.23 -13.03 66.12 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.813 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.54 149.21 64.23 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.759 0.279 . . . . 0.0 110.836 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.24 167.91 15.39 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.723 2.282 . . . . 0.0 112.448 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -47.18 112.38 0.52 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.581 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.6 t-105 -97.79 130.5 28.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.436 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.38 119.38 6.28 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.364 2.043 . . . . 0.0 111.004 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.62 175.54 10.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -142.45 157.18 45.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.464 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -80.13 138.84 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -125.45 -20.36 4.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 121.025 0.441 . . . . 0.0 111.519 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.109 0.48 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 84.6 m-85 -92.49 155.06 18.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.108 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -96.38 106.55 18.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.54 142.94 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.431 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -105.14 120.88 42.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.568 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -94.08 111.36 23.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.787 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 47.8 m-85 -60.67 177.54 0.29 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.954 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.22 -62.93 0.78 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.22 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.5 p -92.08 -23.24 19.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 0.0 110.679 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.4 m170 63.88 37.64 9.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.339 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.99 153.95 19.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.829 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 144.15 49.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.365 0.603 . . . . 0.0 111.764 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.93 164.79 38.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.099 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 36.8 m-85 -107.87 87.8 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.155 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.6 mt -99.21 158.67 15.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.059 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.29 171.78 32.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.319 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.87 -22.53 48.84 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.536 2.157 . . . . 0.0 112.464 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -67.87 -27.22 66.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.694 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -100.0 14.55 30.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.964 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.56 137.3 47.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.583 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.6 m-85 -136.18 157.85 74.83 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.958 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.5 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 9.5 Cg_exo -71.38 112.06 3.25 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.672 2.248 . . . . 0.0 111.525 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.4 t80 -51.37 -58.96 4.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.908 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.4 -40.28 49.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.081 0.467 . . . . 0.0 111.654 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.8 tt0 -71.66 -39.94 69.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.577 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -105.75 9.54 32.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.3 ptmm? -56.54 -47.51 79.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 0.0 111.435 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -23.27 62.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.75 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -85.06 -47.36 10.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -108.88 3.76 22.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 70' ' ' LYS . . . -83.77 16.84 29.38 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.684 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -94.07 157.91 36.99 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.39 0.595 . . . . 0.0 110.457 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.46 158.39 10.16 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.379 2.052 . . . . 0.0 112.246 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -132.23 169.07 16.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.625 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -89.18 -16.5 31.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.349 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -14.61 61.9 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 110.783 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt 63.35 141.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.084 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.8 -17.11 54.71 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.403 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 47.5 t80 -58.17 -54.88 41.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.03 0.443 . . . . 0.0 110.734 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.64 -46.37 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.306 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.34 -31.5 6.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.007 0.432 . . . . 0.0 110.619 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.42 -31.16 59.34 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.044 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.9 mt -60.88 -43.68 98.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.003 0.43 . . . . 0.0 110.415 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.1 t90 -63.74 -44.57 93.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.22 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -63.5 -50.5 69.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -51.72 -27.45 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.439 ' N ' HG23 ' A' ' 89' ' ' ILE . 55.4 mt-10 -100.29 -44.73 5.84 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -79.17 -33.71 43.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -156.37 90.2 2.68 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.317 . . . . 0.0 111.194 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.5 Cg_endo -77.27 -11.24 17.6 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.565 2.176 . . . . 0.0 112.748 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.2 p -103.09 12.54 35.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.507 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.944 0.402 . . . . 0.0 111.35 -179.731 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.907 0.384 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 t -52.28 124.61 13.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.83 -16.11 43.85 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.023 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.26 140.0 50.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 111.081 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 15' ' ' LEU . 56.1 mt -92.74 118.7 31.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.339 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.0 m -139.67 171.82 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.185 0.517 . . . . 0.0 111.743 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.6 m-85 -109.99 136.6 49.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.764 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' ASP . . . -113.49 126.44 55.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.012 0.434 . . . . 0.0 111.799 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.457 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 14.2 tptm -92.9 130.64 38.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.902 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.41 ' HE2' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.88 148.53 50.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.802 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -67.36 106.76 2.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.745 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.75 -7.07 27.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.78 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -141.06 156.58 68.14 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.781 0.324 . . . . 0.0 110.637 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.89 171.92 9.12 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.735 2.29 . . . . 0.0 112.212 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.457 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 74.7 m80 -47.76 111.8 0.47 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.392 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 1.5 t-105 -99.54 129.04 29.84 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.322 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HG3' HD22 ' A' ' 86' ' ' LEU . 12.5 Cg_endo -55.44 121.15 9.42 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.13 1.886 . . . . 0.0 110.98 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.59 175.73 9.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.308 0.575 . . . . 0.0 112.266 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -141.7 154.84 45.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 mm -82.27 114.25 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.87 -13.85 14.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 121.039 0.447 . . . . 0.0 111.318 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.973 0.416 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 62.9 m-85 -94.37 153.16 18.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.79 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -99.03 105.75 17.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -101.44 150.35 6.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.49 0.662 . . . . 0.0 112.214 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 33.0 t80 -105.82 124.51 49.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.04 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.446 ' HE2' ' HB1' ' A' ' 56' ' ' ALA . 32.7 m-85 -91.88 107.53 19.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.554 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 36.2 m-85 -58.46 174.99 0.27 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 0.0 111.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.57 -62.04 0.87 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.358 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.3 p -90.5 -21.57 21.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.606 0.241 . . . . 0.0 111.06 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 48.5 m170 64.02 34.94 10.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.912 0.386 . . . . 0.0 110.265 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -90.32 153.65 20.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.675 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.55 141.52 51.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.15 0.5 . . . . 0.0 111.69 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HB1' ' HE2' ' A' ' 49' ' ' PHE . . . -155.32 177.54 11.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.391 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 8.6 m-85 -120.62 127.29 51.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.886 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.93 163.93 31.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.13 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.94 177.07 35.18 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.616 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.07 -25.19 51.44 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.624 2.216 . . . . 0.0 112.552 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -69.9 -25.54 63.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 111.064 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 35.7 m-20 -98.3 4.84 48.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.436 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.7 mt -112.55 139.25 48.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.696 0.284 . . . . 0.0 110.488 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.3 m-85 -135.94 160.06 68.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.07 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 12.3 Cg_exo -69.77 110.91 2.67 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.672 2.248 . . . . 0.0 111.604 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.4 t80 -51.91 -59.16 4.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.593 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -50.49 -41.36 53.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.684 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 2.2 tm-20 -69.58 -39.77 77.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.545 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.1 m -108.09 13.74 25.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.5 ptpp? -56.08 -47.74 77.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.922 0.391 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.4 mt-10 -71.06 -21.41 62.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.307 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.424 ' HD3' ' CE1' ' A' ' 73' ' ' PHE . 4.2 tttt -85.46 -49.47 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 9.4 m-85 -102.94 -4.8 24.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.3 70.95 3.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.048 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 9.1 mtmt -149.21 153.69 38.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.88 158.23 14.53 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.587 2.192 . . . . 0.0 112.632 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -137.12 167.29 21.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.565 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.45 -15.51 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.109 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -14.06 61.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.958 0.408 . . . . 0.0 110.767 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp 63.84 142.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.276 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.05 -17.72 49.43 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.775 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 44.6 t80 -59.96 -54.23 48.53 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.904 0.383 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.05 -46.34 68.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.224 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -48.47 -29.75 4.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.986 0.422 . . . . 0.0 110.614 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.02 -31.48 59.77 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.206 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' A' ' 27' ' ' PRO . 3.8 mm? -61.09 -44.11 97.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.968 0.413 . . . . 0.0 110.535 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 64.0 t90 -65.08 -45.72 84.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.347 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.59 -50.85 69.65 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.44 -27.13 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.712 0.291 . . . . 0.0 111.734 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -99.58 -44.76 6.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.23 -31.98 38.47 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -155.55 88.04 3.09 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.725 0.298 . . . . 0.0 111.252 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.2 Cg_endo -75.78 -13.46 19.83 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.679 2.253 . . . . 0.0 112.739 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.3 p -105.69 12.4 31.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.532 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.938 0.399 . . . . 0.0 111.461 -179.675 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 mptt . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.4 t -52.21 129.15 27.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.49 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.75 -14.21 59.03 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.978 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.15 138.31 51.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 0.0 111.051 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -92.19 118.79 31.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.967 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.0 m -140.61 175.8 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.252 0.549 . . . . 0.0 112.152 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.487 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 16.4 m-85 -114.02 137.32 51.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.74 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.71 124.6 52.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 0.0 111.537 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -91.98 132.96 36.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.079 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 mmm -127.74 150.66 49.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.598 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 116.15 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.836 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.07 -16.07 58.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.859 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -130.06 151.93 79.17 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.715 0.293 . . . . 0.0 110.703 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.13 167.81 17.55 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.639 2.226 . . . . 0.0 112.409 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 51.0 m80 -46.38 114.77 0.87 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.871 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.447 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.3 t-105 -98.33 129.44 30.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.609 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.406 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 9.8 Cg_endo -52.56 119.11 5.41 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.398 2.065 . . . . 0.0 111.214 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.403 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.9 175.75 9.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 3.1 ttt180 -142.28 155.81 45.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.397 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.431 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 25.4 mm -79.03 137.35 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.28 -20.85 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.041 0.448 . . . . 0.0 111.284 -179.717 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.4 mttm . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.162 0.506 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 58.5 m-85 -94.2 154.51 17.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.99 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.03 108.06 20.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.403 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 60.5 t -103.2 142.46 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.576 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -104.14 120.3 40.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.807 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -93.66 108.36 20.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 47.5 m-85 -59.21 176.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.859 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 -63.34 0.84 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.287 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.2 p -90.79 -22.75 20.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.737 0.303 . . . . 0.0 110.742 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.2 m170 64.62 34.83 9.54 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.075 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -90.23 152.48 21.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.705 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.42 144.89 48.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.28 0.562 . . . . 0.0 111.549 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.37 165.01 37.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.161 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 74.1 m-85 -107.99 87.88 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.054 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mp -97.84 156.47 16.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.17 179.52 39.37 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.57 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.27 -30.11 45.92 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.635 2.224 . . . . 0.0 112.45 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -69.48 -21.69 63.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.098 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -99.49 2.6 45.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.474 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mt -110.16 139.34 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 0.0 110.653 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.8 m-85 -136.37 153.2 76.15 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.49 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 24.7 Cg_exo -63.49 112.4 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.469 2.113 . . . . 0.0 111.706 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' LYS . 60.0 t80 -53.39 -59.36 4.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.743 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.4 mt-10 -49.71 -41.76 44.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.106 0.479 . . . . 0.0 111.521 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -69.96 -39.76 75.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.42 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.9 m -105.9 12.2 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 66' ' ' TYR . 5.3 ptpp? -55.71 -48.42 75.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.953 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 16.6 pt-20 -71.65 -19.99 62.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.412 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.48 -49.99 8.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -103.36 -4.63 23.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.34 71.44 2.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.19 -1.005 . . . . 0.0 113.081 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.81 149.62 28.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.678 0.275 . . . . 0.0 110.303 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.54 155.61 2.2 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.588 2.192 . . . . 0.0 112.757 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.95 165.2 27.11 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.748 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -85.01 -16.44 40.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.123 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -65.68 -14.87 62.1 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.055 0.455 . . . . 0.0 110.619 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? 62.77 143.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.072 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.77 -18.0 41.82 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.337 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.447 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 43.7 t80 -58.46 -57.12 14.34 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -53.32 -45.69 69.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.989 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -48.86 -31.25 6.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.018 0.437 . . . . 0.0 110.525 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.39 -31.39 61.16 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.879 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.7 mt -60.56 -43.58 97.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.968 0.413 . . . . 0.0 110.359 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.1 t90 -63.21 -45.74 90.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.157 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -62.91 -50.91 69.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -52.23 -26.28 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.322 . . . . 0.0 111.851 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.424 ' N ' HG23 ' A' ' 89' ' ' ILE . 4.1 mm-40 -100.55 -44.75 5.76 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -79.45 -32.77 42.74 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -156.92 90.41 2.53 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.698 0.285 . . . . 0.0 111.152 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 82.3 Cg_endo -78.01 -11.31 16.49 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.544 2.163 . . . . 0.0 112.745 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.5 p -106.33 13.96 28.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.531 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.875 0.369 . . . . 0.0 111.568 -179.622 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.995 0.426 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.77 131.85 35.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.515 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.89 -11.57 67.81 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.101 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.84 138.31 50.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.249 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.4 mt -91.83 118.12 30.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.386 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 m -139.88 171.99 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.804 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 30.5 m-85 -112.88 137.05 51.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.492 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.43 126.6 55.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 111.248 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 12.3 tptp -90.27 136.01 33.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -130.21 151.88 50.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.547 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -67.62 118.22 10.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -8.62 74.48 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.968 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.422 ' CD1' ' HD3' ' A' ' 79' ' ' ARG . 1.9 m-85 -132.21 154.42 81.63 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-O 120.835 0.35 . . . . 0.0 111.03 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -84.23 167.15 12.36 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.832 2.355 . . . . 0.0 112.511 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.446 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 80.2 m80 -47.08 115.25 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.468 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.1 t-105 -99.02 129.98 28.42 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.503 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.77 119.46 6.29 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.374 2.049 . . . . 0.0 111.085 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.05 174.43 10.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.459 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -143.01 155.65 44.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.323 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.459 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 28.7 mm -78.13 138.4 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.73 -20.33 5.5 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.044 0.449 . . . . 0.0 111.239 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 121.066 0.46 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 79.8 m-85 -95.8 155.14 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.694 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.4 mt-30 -96.55 106.78 19.09 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.1 t -100.84 142.99 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.32 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.78 122.0 45.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.189 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -94.97 110.27 22.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.37 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.441 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 57.4 m-85 -58.83 -179.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.06 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.58 -63.66 0.63 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.146 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.9 p -91.07 -22.88 20.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 110.742 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.4 m170 64.57 36.52 8.48 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.598 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.32 157.04 16.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.44 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -131.79 149.97 52.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.313 0.578 . . . . 0.0 111.978 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.58 170.88 20.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.067 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 52.0 m-85 -105.94 86.58 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 0.0 110.875 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.23 156.84 16.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.126 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.98 169.46 32.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.295 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.54 -20.79 47.08 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.459 2.106 . . . . 0.0 112.375 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -27.83 67.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.969 0.414 . . . . 0.0 110.504 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -100.72 12.43 37.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.761 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.79 137.44 46.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.658 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.8 m-85 -136.17 158.16 74.22 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.558 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.6 Cg_exo -71.71 111.5 3.15 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.393 2.062 . . . . 0.0 111.235 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.5 t80 -45.63 -59.02 2.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.358 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -50.88 -39.55 54.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.9 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.1 mm-40 -70.6 -39.83 73.57 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.444 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 48.9 m -105.35 11.08 33.2 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.43 -49.46 74.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.797 0.332 . . . . 0.0 111.524 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.54 -26.12 64.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.649 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -84.99 -46.95 10.73 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 2.5 m-30 -99.77 -13.04 19.43 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -80.65 71.15 2.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.043 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.417 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.0 mttt -149.05 153.14 37.78 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.598 0.237 . . . . 0.0 110.39 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -51.17 153.31 9.57 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.501 2.134 . . . . 0.0 112.617 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -136.49 163.49 30.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.595 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -81.87 -16.47 50.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.196 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.422 ' HD3' ' CD1' ' A' ' 23' ' ' TYR . 17.9 mmm180 -64.54 -15.64 61.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.989 0.424 . . . . 0.0 110.809 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt 63.19 140.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.094 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.96 -17.0 53.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.399 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.468 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.6 t80 -58.54 -55.5 34.28 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.933 0.397 . . . . 0.0 110.658 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 m -53.58 -45.53 69.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.196 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.96 -31.69 7.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.997 0.427 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.02 -31.83 61.39 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.899 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.01 -43.74 98.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 0.0 110.318 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.8 t90 -63.51 -45.51 90.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.991 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.2 mp0 -62.31 -50.99 69.46 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.47 -26.02 8.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.731 0.3 . . . . 0.0 111.783 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.99 -44.79 5.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -80.42 -32.3 37.41 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.3 87.85 3.18 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 98.7 Cg_endo -79.47 -12.55 13.9 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.702 2.268 . . . . 0.0 113.029 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.0 p -103.78 12.67 34.3 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 111.33 -179.834 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.957 0.408 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.1 m -51.98 129.38 26.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.428 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.87 -14.91 58.61 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.91 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.04 138.16 51.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -91.79 119.66 31.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.246 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 m -140.77 171.27 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.133 0.492 . . . . 0.0 111.894 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 27' ' ' PRO . 10.0 m-85 -109.79 136.62 48.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.565 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -113.09 124.6 52.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.098 0.475 . . . . 0.0 111.841 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -91.99 131.58 37.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.82 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mtp -129.04 147.52 50.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.701 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 115.29 5.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 100.46 3.96 55.12 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.823 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -152.75 153.62 30.39 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.628 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.76 167.7 18.34 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.585 2.19 . . . . 0.0 112.382 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.433 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 71.2 m80 -47.57 115.23 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.588 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.93 130.51 27.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.245 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 11.4 Cg_endo -54.95 120.83 8.8 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.171 1.914 . . . . 0.0 111.179 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.67 175.7 9.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.277 0.56 . . . . 0.0 112.241 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -142.78 155.73 44.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.439 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.9 mm -78.88 135.2 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.92 -20.23 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.074 0.464 . . . . 0.0 111.73 -179.704 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.009 0.433 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.77 154.48 17.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.758 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -99.27 107.0 19.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 m -103.46 150.4 6.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.411 0.624 . . . . 0.0 112.339 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 49.3 t80 -105.44 124.56 49.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.992 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -93.31 108.94 20.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.648 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.477 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 48.2 m-85 -61.37 177.9 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.933 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.96 -63.48 0.93 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.96 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -91.42 -22.37 20.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.0 110.779 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 10.6 m-70 64.41 37.02 8.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.461 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -91.65 155.47 18.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 140.29 53.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.194 0.521 . . . . 0.0 111.393 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.36 178.11 10.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.428 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -119.97 127.18 52.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.2 mp -138.8 161.74 36.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.43 176.37 35.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.703 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.72 -24.98 54.22 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.622 2.214 . . . . 0.0 112.41 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -69.57 -27.14 64.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.857 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -100.22 6.9 44.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 22.4 mt -114.23 138.2 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.733 0.302 . . . . 0.0 110.32 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.7 m-85 -137.13 159.58 69.27 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.057 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.9 Cg_exo -70.21 113.91 3.6 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.674 2.25 . . . . 0.0 111.63 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 89.1 t80 -53.7 -59.5 4.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.683 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -49.0 -42.74 38.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.124 0.488 . . . . 0.0 111.648 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.94 -39.58 72.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.565 -179.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -105.29 10.23 33.64 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.4 ptpt -56.38 -44.28 80.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.659 0.266 . . . . 0.0 111.713 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mm-40 -68.55 -32.92 73.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.435 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 13.1 ptpt -83.99 -43.32 15.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 72' ' ' LYS . 18.2 m-30 -98.35 -8.52 26.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.24 75.27 2.05 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.039 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mmmm -148.55 159.32 38.87 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.613 0.206 . . . . 0.0 110.511 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.59 151.89 59.46 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.585 2.19 . . . . 0.0 112.516 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.11 170.29 15.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.616 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -15.68 28.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.356 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -66.34 -14.81 62.62 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.984 0.421 . . . . 0.0 110.716 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt 63.4 144.17 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.075 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.36 -18.7 35.78 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.594 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 15.1 t80 -58.61 -55.55 33.67 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.044 0.45 . . . . 0.0 110.692 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -52.89 -45.67 67.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.062 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -48.56 -31.39 6.49 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.985 0.421 . . . . 0.0 110.543 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.06 -31.55 61.63 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.85 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.94 -43.8 98.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.226 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -64.05 -44.91 91.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.477 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -63.51 -50.87 67.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -51.9 -27.5 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 111.828 -179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 89' ' ' ILE . 0.8 OUTLIER -99.44 -44.68 6.1 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.82 -32.96 40.67 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.23 87.46 3.24 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.817 0.342 . . . . 0.0 111.257 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.58 -13.73 18.11 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.038 2.492 . . . . 0.0 112.644 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.1 p -104.04 13.08 33.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.537 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.929 0.395 . . . . 0.0 111.447 -179.65 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.879 0.371 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.27 127.38 19.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.263 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.88 -13.45 60.68 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.729 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.49 137.18 50.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.84 0.352 . . . . 0.0 111.072 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 mt -90.18 115.36 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 110.3 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.2 m -138.65 170.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.581 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 27' ' ' PRO . 9.3 m-85 -109.69 136.7 48.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.79 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.87 121.4 44.93 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.473 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 2.4 tptt -93.51 129.15 39.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.011 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.8 mtp -126.55 147.98 49.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.693 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -59.53 119.59 7.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.04 -34.96 4.59 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.441 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -105.14 150.36 38.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.696 0.284 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.409 ' HG3' ' OD1' ' A' ' 77' ' ' ASN . 97.7 Cg_endo -82.49 170.16 13.29 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.593 2.195 . . . . 0.0 112.226 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.417 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 61.2 m80 -51.06 112.11 0.67 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.525 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.44 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.7 t-105 -99.6 131.07 25.4 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.237 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 11.8 Cg_endo -54.98 121.35 9.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.295 1.996 . . . . 0.0 111.183 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.12 178.44 8.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 112.328 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -143.66 157.76 44.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.489 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.08 116.12 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -110.93 -14.0 14.03 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--N 1.332 -0.193 0 CA-C-O 121.042 0.449 . . . . 0.0 111.474 -179.673 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 mttt . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.082 0.467 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 86.9 m-85 -95.43 155.29 16.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -99.59 105.05 16.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.7 m -99.94 149.39 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.369 0.604 . . . . 0.0 112.041 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -105.08 123.93 48.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.259 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -92.75 109.39 20.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.448 ' HB3' ' HA2' ' A' ' 85' ' ' GLY . 42.5 m-85 -61.49 176.12 0.52 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.746 0.307 . . . . 0.0 110.911 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.01 -62.48 0.96 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.083 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.2 p -91.7 -22.2 20.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 110.586 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.1 m80 63.4 36.89 11.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.416 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -90.85 154.74 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.5 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.41 144.25 49.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.311 0.577 . . . . 0.0 111.806 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.76 166.13 34.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.279 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 30.6 m-85 -108.94 88.61 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.233 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -97.92 158.32 15.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.09 172.05 33.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.352 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.1 -23.98 52.62 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.483 2.122 . . . . 0.0 112.38 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -27.93 66.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.973 0.416 . . . . 0.0 110.691 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -98.62 12.63 34.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.995 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.98 137.4 46.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.431 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.7 m-85 -134.79 157.64 76.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.765 0.317 . . . . 0.0 111.11 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.477 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.2 Cg_exo -71.02 110.93 2.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.731 2.287 . . . . 0.0 111.508 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 70' ' ' LYS . 93.2 t80 -55.29 -60.82 2.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.914 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -41.95 38.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.014 0.435 . . . . 0.0 111.48 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.31 -39.69 71.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.559 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 m -104.91 8.48 34.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.3 ptmt -56.55 -45.89 80.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.721 0.296 . . . . 0.0 111.337 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.44 -26.57 64.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.525 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.485 ' HG2' ' CE1' ' A' ' 73' ' ' PHE . 1.2 ttpm? -84.82 -45.7 12.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.485 ' CE1' ' HG2' ' A' ' 72' ' ' LYS . 18.8 m-30 -101.93 -6.15 23.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -86.44 75.39 2.25 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.284 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -151.91 153.09 31.11 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.523 0.201 . . . . 0.0 110.718 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.36 136.22 8.55 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.701 2.268 . . . . 0.0 112.504 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 0.7 OUTLIER -111.07 171.19 7.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.915 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.15 -21.61 18.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.748 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -67.34 -13.77 62.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.935 0.398 . . . . 0.0 110.585 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt 63.99 143.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.814 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.96 -17.23 54.36 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.931 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 13.0 t80 -59.13 -51.28 70.68 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.956 0.408 . . . . 0.0 110.322 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.45 -46.98 66.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.993 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -48.66 -32.76 8.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.979 0.418 . . . . 0.0 110.26 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.62 -31.76 60.26 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.788 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.3 mt -61.32 -43.79 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.168 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -64.78 -45.03 88.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.002 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.435 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -62.81 -50.9 69.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.42 HG21 ' N ' ' A' ' 90' ' ' GLU . 1.2 tt -52.32 -26.85 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.807 0.337 . . . . 0.0 111.768 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.42 ' N ' HG21 ' A' ' 89' ' ' ILE . 6.8 mm-40 -99.63 -44.75 6.02 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.74 -30.77 32.29 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -156.34 89.23 2.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 111.202 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 86.4 Cg_endo -78.46 -12.42 15.43 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.644 2.229 . . . . 0.0 112.72 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.1 p -102.34 10.98 38.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.586 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.819 0.343 . . . . 0.0 111.347 -179.712 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.918 0.389 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.0 m -51.81 132.07 31.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.544 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.13 -12.14 68.56 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.909 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.77 139.21 50.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -91.14 116.56 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.964 0.411 . . . . 0.0 110.398 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.76 170.29 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.622 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.522 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 17.9 m-85 -111.09 135.86 50.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.521 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.93 123.04 49.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.345 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 23.8 tptp -92.07 130.95 37.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.163 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtm -127.04 147.82 50.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.461 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 113.47 4.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 111.008 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.99 -27.37 14.65 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.689 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.91 157.97 49.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.787 0.327 . . . . 0.0 110.942 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.47 166.44 12.16 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.802 2.335 . . . . 0.0 112.346 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.505 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 59.0 m80 -47.17 114.02 0.78 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.497 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.466 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.66 130.63 27.45 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.611 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.51 119.1 5.85 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.337 2.024 . . . . 0.0 111.056 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.2 175.09 10.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 112.438 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 14.2 ttp180 -142.52 156.49 45.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.449 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.423 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 24.6 mm -79.9 138.8 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.26 -20.8 5.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.957 0.408 . . . . 0.0 111.237 -179.819 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.948 0.404 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -94.11 157.95 15.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.93 107.55 20.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.3 t -103.54 142.57 17.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.445 0.641 . . . . 0.0 112.567 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -105.55 121.87 44.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.528 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -94.03 106.51 18.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.087 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.443 ' HB3' ' HA2' ' A' ' 85' ' ' GLY . 49.7 m-85 -57.57 176.88 0.12 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.873 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.81 -63.57 0.68 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.384 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 80.9 p -90.16 -23.24 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.702 0.287 . . . . 0.0 110.712 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 52' ' ' THR . 3.9 m170 65.96 34.03 7.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.12 150.99 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.0 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.81 140.66 52.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.168 0.509 . . . . 0.0 111.329 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.78 168.22 27.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.333 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -109.32 125.48 52.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.027 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 mt -139.36 160.67 39.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.46 -179.78 40.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.28 -26.81 41.45 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.521 2.147 . . . . 0.0 112.206 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -69.63 -22.56 63.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.008 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.99 3.6 47.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.49 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 18.3 mt -115.0 139.65 49.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 110.578 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.2 m-85 -136.6 166.28 28.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.415 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.2 Cg_exo -73.21 111.15 3.21 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.732 2.288 . . . . 0.0 111.707 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.1 t80 -49.99 -58.44 5.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.484 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -49.04 -41.08 33.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.564 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 5.0 mm-40 -70.97 -39.75 72.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.659 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 3.6 m -103.41 13.89 32.63 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 66' ' ' TYR . 2.2 mtmp? -55.53 -44.99 77.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.364 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.71 -40.82 88.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.83 -43.77 16.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.9 m-30 -94.85 -19.65 20.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -86.68 73.84 2.43 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.041 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 12.1 mttt -149.22 153.57 37.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.92 155.51 8.33 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.623 2.215 . . . . 0.0 112.638 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -136.43 165.52 25.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.579 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -85.72 -16.1 40.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.256 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -13.82 61.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.975 0.417 . . . . 0.0 110.682 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt 63.76 142.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.203 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.55 -16.7 55.68 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.468 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.466 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 31.6 t80 -59.01 -56.82 17.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.003 0.43 . . . . 0.0 110.865 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -45.35 66.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.057 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.68 -30.06 5.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.048 0.451 . . . . 0.0 110.535 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.443 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.93 -31.89 57.45 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.162 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.43 -43.44 96.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.035 0.445 . . . . 0.0 110.254 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 62.9 t90 -63.59 -45.74 89.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.71 -50.58 70.58 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.428 HG21 ' N ' ' A' ' 90' ' ' GLU . 1.1 tt -52.9 -27.05 12.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 111.758 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' N ' HG21 ' A' ' 89' ' ' ILE . 17.6 mt-10 -99.29 -44.82 6.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -79.65 -31.54 41.52 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.455 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . 1.0 OUTLIER -157.06 86.9 2.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 111.302 -179.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.93 -12.93 26.39 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.93 2.42 . . . . 0.0 112.65 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.0 p -106.98 14.61 26.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.587 0.232 . . . . 0.0 111.605 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 92' ' ' ASN . 14.3 p . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 121.008 0.432 . . . . 0.0 111.69 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.931 0.396 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 m -52.87 130.72 34.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.277 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.76 68.54 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.086 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.65 140.76 48.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.915 0.388 . . . . 0.0 111.299 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.6 mt -91.79 119.16 31.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.079 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.84 171.91 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.224 0.535 . . . . 0.0 111.992 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 8.5 m-85 -111.08 134.81 52.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.656 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.36 124.3 52.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.006 0.431 . . . . 0.0 111.591 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -91.18 132.81 35.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.906 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -131.23 150.11 52.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.7 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' O ' ' CE2' ' A' ' 23' ' ' TYR . 1.2 mtpm? -62.46 121.8 14.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.104 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 81.82 15.93 74.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.897 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.427 ' CE2' ' O ' ' A' ' 21' ' ' LYS . 3.4 m-85 -151.4 147.96 21.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.63 0.252 . . . . 0.0 110.841 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.16 165.01 17.15 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.615 2.21 . . . . 0.0 112.221 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -47.51 115.42 1.12 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.571 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.76 130.13 28.44 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-O 120.527 0.203 . . . . 0.0 111.527 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.14 121.45 9.68 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.373 2.049 . . . . 0.0 111.155 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.61 176.09 9.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -141.43 154.63 45.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.492 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mm -81.8 140.12 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 0.0 110.541 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.17 -22.5 7.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.794 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.111 179.872 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.085 0.469 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 40.4 m-85 -93.77 154.71 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.122 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.65 98.82 10.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.84 148.92 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.358 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -105.96 125.1 50.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.252 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -91.39 113.16 25.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.699 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 44.0 m-85 -63.31 174.61 1.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.02 -61.75 0.75 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.3 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.8 p -90.36 -23.49 21.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.66 0.267 . . . . 0.0 110.723 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.8 m170 63.56 37.93 10.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.524 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -93.32 156.67 16.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.814 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 143.19 50.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.322 0.582 . . . . 0.0 111.926 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.65 168.2 27.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.5 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 75.6 m-85 -111.58 89.81 3.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.038 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 mp -97.72 157.45 16.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.251 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.76 171.77 34.92 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.409 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.18 -24.66 44.07 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.45 2.1 . . . . 0.0 112.316 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -27.73 67.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.423 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.63 14.7 31.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.858 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 mp -113.2 136.29 52.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.618 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.6 m-85 -135.93 155.47 77.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.636 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.8 Cg_exo -72.54 112.23 3.42 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.481 2.121 . . . . 0.0 111.2 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.7 t80 -48.34 -58.78 4.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.172 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -43.35 34.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.928 0.394 . . . . 0.0 112.033 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 5.8 mm-40 -70.28 -39.74 74.74 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 51.5 m -105.58 10.72 32.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.9 ptpt -55.97 -48.13 76.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.817 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.9 mm-40 -72.54 -19.91 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.586 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -84.92 -49.83 8.03 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 7.3 m-85 -104.41 -4.44 22.8 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.95 71.46 2.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.193 -1.004 . . . . 0.0 113.066 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -149.57 151.19 32.68 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.699 0.285 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.29 156.0 18.31 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.565 2.177 . . . . 0.0 112.7 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -138.77 -172.51 3.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.378 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -99.03 -13.81 19.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.058 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -67.87 -14.35 62.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt 62.88 142.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.175 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.55 -15.89 59.17 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.733 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 35.6 t80 -57.38 -58.7 7.1 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.061 0.458 . . . . 0.0 110.907 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -51.76 -46.17 64.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.281 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -48.79 -32.7 9.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.903 0.382 . . . . 0.0 110.501 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.45 -31.68 60.69 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.839 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.49 -43.63 96.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.012 0.434 . . . . 0.0 110.287 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.8 t90 -63.74 -43.0 97.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.926 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 39.6 mm-40 -62.84 -52.38 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -52.25 -25.71 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -44.75 5.73 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -81.05 -32.95 33.83 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -156.39 88.9 2.78 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.76 0.314 . . . . 0.0 111.152 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 72.2 Cg_endo -77.44 -12.05 17.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.662 2.242 . . . . 0.0 112.897 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.7 p -106.51 14.44 27.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.607 0.241 . . . . 0.0 111.587 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.874 0.369 . . . . 0.0 111.404 -179.521 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.96 0.409 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.8 m -52.4 129.92 29.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.572 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.26 -13.43 63.14 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.048 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.3 138.14 51.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 111.057 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.5 mt -91.59 117.45 29.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.357 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.2 m -139.99 172.1 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.851 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 13.4 m-85 -113.14 135.72 53.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.722 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.82 123.3 49.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 0.0 111.432 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 8.1 tptp -92.37 133.86 35.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.0 mtm -128.32 151.86 48.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.78 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.86 102.15 3.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.51 -1.21 23.53 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.818 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -146.91 149.71 36.77 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.706 0.289 . . . . 0.0 110.716 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.63 162.97 34.76 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.636 2.224 . . . . 0.0 112.387 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.416 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 80.1 m80 -47.72 116.78 1.58 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.62 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.452 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.5 t-105 -98.63 132.09 24.64 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.48 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 14.7 Cg_endo -56.34 120.98 9.2 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.37 2.047 . . . . 0.0 110.969 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 48' ' ' PHE . . . -145.16 176.39 9.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 0.0 112.28 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.43 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 1.8 ttt180 -142.23 155.72 45.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.453 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.43 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 23.6 mm -80.4 138.73 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.376 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -126.05 -21.58 4.29 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 120.907 0.384 . . . . 0.0 111.28 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.7 mttt . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -95.23 157.64 15.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.033 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -98.69 108.18 20.81 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 28' ' ' ALA . 45.4 t -104.31 141.4 19.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.397 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.446 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 25.8 t80 -106.57 122.22 45.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.897 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -94.34 109.42 21.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.156 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.47 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 73.9 m-85 -58.78 -178.97 0.06 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.998 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.61 -63.82 0.44 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.255 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.5 p -91.95 -22.52 19.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.843 0.354 . . . . 0.0 110.633 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.8 m170 64.81 35.44 8.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.973 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -89.8 153.12 20.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.683 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.12 141.6 50.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.318 0.58 . . . . 0.0 111.614 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.49 170.76 21.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -115.13 126.96 55.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 0.0 111.069 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.1 mt -139.62 162.03 36.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.0 176.62 36.21 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.364 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.96 -25.42 59.52 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.493 2.129 . . . . 0.0 112.269 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.71 -26.34 64.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.94 8.33 45.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.0 mt -117.06 139.07 51.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.694 0.283 . . . . 0.0 110.408 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.4 m-85 -137.39 157.89 73.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.576 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.576 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 13.4 Cg_exo -67.72 113.82 3.11 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.188 1.925 . . . . 0.0 111.395 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' LYS . 81.4 t80 -48.97 -57.15 6.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.031 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.429 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 15.7 mm-40 -51.46 -39.83 58.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.02 0.438 . . . . 0.0 111.984 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 15.8 mm-40 -70.08 -39.81 75.37 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.44 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 6.4 m -106.78 12.09 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.552 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 2.4 ptpp? -56.59 -48.74 76.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 0.0 111.024 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.552 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -72.33 -20.95 61.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.459 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.38 -49.34 8.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 8.3 m-85 -100.68 -13.56 18.47 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.82 73.05 1.96 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.972 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -149.75 147.98 24.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.663 0.268 . . . . 0.0 110.562 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.5 153.35 14.03 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.496 2.131 . . . . 0.0 112.769 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -139.08 -173.27 3.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.316 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -99.97 -13.31 19.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.971 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 79' ' ' ARG . 21.1 mmt180 -67.25 -14.5 62.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.927 0.394 . . . . 0.0 110.557 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp 63.06 141.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.261 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.21 -16.38 58.92 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.875 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.452 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 47.7 t80 -57.64 -57.07 14.31 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.928 0.394 . . . . 0.0 110.824 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -52.2 -46.22 65.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.138 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -48.86 -33.05 9.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.075 0.464 . . . . 0.0 110.289 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.92 -32.75 58.49 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.807 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.2 mt -60.49 -43.66 96.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.108 0.48 . . . . 0.0 109.956 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -64.09 -45.35 89.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.895 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -62.59 -51.89 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.23 -26.34 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.15 -44.83 6.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.57 -33.19 31.8 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -156.57 81.52 3.5 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.758 0.313 . . . . 0.0 110.974 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.0 Cg_endo -73.99 -8.94 21.78 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.627 2.218 . . . . 0.0 112.953 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.6 p -101.48 12.25 37.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.586 0.232 . . . . 0.0 111.515 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.812 0.339 . . . . 0.0 111.325 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.902 0.382 . . . . 0.0 110.786 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.4 t -53.67 131.85 39.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.083 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.71 -12.19 64.48 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.265 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -73.25 142.94 47.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 111.207 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.1 mt -91.79 119.6 31.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.391 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.3 m -140.77 170.1 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.661 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.402 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 8.4 m-85 -109.84 136.51 49.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.695 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 62' ' ' ASP . . . -113.95 122.72 47.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.007 0.432 . . . . 0.0 111.453 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -91.35 128.71 37.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.882 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.6 mtp -126.96 148.12 50.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.658 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.64 125.4 23.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.907 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.435 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 85.01 11.48 76.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.977 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -154.39 152.47 26.26 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 110.782 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.56 166.31 13.78 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.725 2.283 . . . . 0.0 112.233 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 66.7 m80 -47.19 114.82 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.601 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.2 130.34 28.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.514 0.197 . . . . 0.0 111.523 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.35 119.53 6.53 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.234 1.956 . . . . 0.0 111.065 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.19 175.44 10.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.29 0.567 . . . . 0.0 112.334 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -142.74 156.92 45.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.332 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.3 mm -78.26 136.26 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -125.5 -21.4 4.52 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.362 . . . . 0.0 111.002 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 mttt . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 121.108 0.48 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -95.12 159.91 14.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.033 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -99.16 107.51 19.88 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.7 t -103.59 143.85 14.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.335 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -106.19 122.73 46.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.829 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -94.9 110.02 21.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.922 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 58.9 m-85 -59.73 178.91 0.14 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.884 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.7 -63.91 0.65 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.117 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.2 p -91.35 -22.63 20.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.508 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.7 m80 63.71 36.58 10.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.346 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.75 155.07 19.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.695 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.68 141.8 51.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.226 0.536 . . . . 0.0 111.574 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.31 168.25 27.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.84 125.17 51.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.817 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.4 mt -139.55 162.29 35.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.63 177.79 40.72 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.72 -25.58 39.86 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.624 2.216 . . . . 0.0 112.362 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -69.04 -21.72 64.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.128 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.7 m-20 -99.47 4.76 46.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.556 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 25.9 mt -113.4 139.72 48.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.707 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.9 m-85 -137.22 163.8 46.45 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.816 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.435 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 3.0 Cg_exo -74.01 111.7 3.37 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.669 2.246 . . . . 0.0 111.75 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -50.77 -57.32 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.646 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.89 -40.79 57.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.995 0.426 . . . . 0.0 111.71 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 3.9 mm-40 -69.89 -39.93 75.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.59 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.444 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 4.3 m -108.43 13.58 25.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.3 ptpt -56.64 -47.02 80.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.849 0.357 . . . . 0.0 111.284 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -70.62 -24.89 62.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.744 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -84.73 -47.74 10.13 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 1.5 m-30 -101.02 -7.81 22.92 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.9 72.96 2.75 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.143 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.438 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.7 mtmt -148.98 155.68 40.49 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.554 0.216 . . . . 0.0 110.435 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.91 155.37 23.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.549 2.166 . . . . 0.0 112.687 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -136.78 172.93 12.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.485 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.93 -15.79 27.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.366 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.7 mmt-85 -66.05 -14.44 61.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.994 0.426 . . . . 0.0 110.769 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp 63.81 141.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.168 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.4 -17.12 53.94 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.653 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 23.0 t80 -58.96 -56.33 23.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.038 0.447 . . . . 0.0 110.724 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.81 -45.43 67.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.038 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.78 -30.95 6.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.956 0.407 . . . . 0.0 110.495 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.59 -31.9 60.15 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.992 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.9 mt -60.77 -43.77 97.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 110.3 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -64.06 -44.94 90.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -63.56 -51.53 65.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -51.44 -28.37 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.716 0.293 . . . . 0.0 111.685 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -98.86 -44.67 6.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -80.2 -32.56 38.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -157.05 91.24 2.44 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.678 0.275 . . . . 0.0 111.26 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.1 -10.78 16.48 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.503 2.135 . . . . 0.0 112.686 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.27 11.85 36.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.496 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 111.364 -179.724 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.908 0.385 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.2 m -51.87 130.62 29.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.36 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.01 -11.94 68.96 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.859 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -71.04 138.83 50.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.751 0.31 . . . . 0.0 110.985 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 15' ' ' LEU . 72.9 mt -91.1 116.38 28.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 110.318 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.3 m -139.4 170.78 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.698 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 36.5 m-85 -110.57 138.59 46.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.746 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.1 120.4 40.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.939 0.399 . . . . 0.0 111.195 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 129.3 39.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.243 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 mtm -119.22 161.12 20.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.611 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 119.72 13.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.108 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.63 -4.2 85.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.017 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.56 150.6 73.34 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.833 0.316 . . . . 0.0 110.756 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.81 160.74 18.79 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.742 2.294 . . . . 0.0 112.513 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 69.9 m80 -48.98 115.45 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.612 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.474 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 4.4 t-105 -98.67 133.5 22.48 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.0 119.26 6.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.384 2.056 . . . . 0.0 110.956 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.48 174.8 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.361 0.6 . . . . 0.0 112.394 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -142.98 156.75 44.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.477 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mm -78.85 135.79 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.6 -21.58 4.1 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 121.012 0.434 . . . . 0.0 111.593 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -93.42 160.56 14.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.877 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.17 109.72 22.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.5 t -104.03 141.51 19.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.249 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -105.12 121.32 43.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.702 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -93.52 106.74 18.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.482 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 49.4 m-85 -58.12 177.21 0.13 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.2 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.7 -63.02 0.88 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.034 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.1 p -91.45 -22.47 20.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.701 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.2 m170 63.81 35.31 11.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.303 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -89.92 153.71 20.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.545 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.34 141.71 51.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.31 0.576 . . . . 0.0 111.614 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.0 170.59 21.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.257 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -111.49 126.26 54.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.077 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.1 mt -138.82 160.79 38.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.26 179.86 39.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.512 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -65.99 -27.86 50.1 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.599 2.199 . . . . 0.0 112.221 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -69.3 -23.31 63.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.175 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -98.69 7.3 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.541 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.7 mt -116.21 140.01 49.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 110.697 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.9 m-85 -136.55 161.56 61.25 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.695 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 6.9 Cg_exo -71.43 109.91 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.437 2.092 . . . . 0.0 111.431 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 89.0 t80 -46.76 -58.72 3.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.223 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -38.41 59.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.082 0.468 . . . . 0.0 111.427 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 4.1 mm-40 -70.85 -39.8 72.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.444 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.463 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 1.2 m -104.67 11.62 33.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 66' ' ' TYR . 9.3 tttt -56.09 -49.43 73.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.795 0.331 . . . . 0.0 111.863 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -67.5 -35.19 78.65 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 2.7 ptpt -83.62 -43.83 15.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.429 ' CD1' ' HG3' ' A' ' 72' ' ' LYS . 18.9 m-30 -96.05 -17.77 20.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -83.37 73.51 2.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.02 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 74' ' ' GLY . 2.7 mttp -147.41 151.69 40.59 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.576 0.227 . . . . 0.0 110.409 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.52 152.03 9.47 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.495 2.13 . . . . 0.0 112.465 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.41 169.28 17.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.082 0.468 . . . . 0.0 111.718 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -15.19 36.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.366 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -14.93 62.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.958 0.409 . . . . 0.0 110.608 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm 63.37 140.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.142 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.85 -15.89 58.13 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.493 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 38.8 t80 -58.52 -58.29 9.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.916 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.82 -45.73 64.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.073 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.99 -32.59 9.45 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.974 0.416 . . . . 0.0 110.379 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.75 -31.95 61.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.751 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.72 -43.5 97.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.07 0.462 . . . . 0.0 110.179 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 59.1 t90 -64.04 -45.33 89.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.066 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 1.8 mp0 -62.86 -51.61 66.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -52.27 -27.21 10.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.777 0.322 . . . . 0.0 111.654 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.39 -44.84 6.36 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.48 -31.75 32.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -155.62 87.19 3.16 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.738 0.304 . . . . 0.0 111.104 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 76.0 Cg_endo -77.57 -12.17 16.88 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.687 2.258 . . . . 0.0 112.85 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 75.6 p -105.47 12.93 30.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 120.882 0.373 . . . . 0.0 111.421 -179.688 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 121.039 0.447 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 p -52.11 129.6 27.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.049 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.08 -10.49 71.77 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.911 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -72.95 141.83 47.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt -92.22 117.23 29.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.8 m -139.43 172.35 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.632 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.451 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 10.6 m-85 -113.13 136.94 52.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.992 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.73 121.82 45.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.89 0.376 . . . . 0.0 111.327 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -90.85 131.37 36.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.945 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.3 mtm -132.05 145.7 51.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.788 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 118.63 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.629 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 102.11 -0.51 51.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.61 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 0.5 OUTLIER -155.89 143.08 13.73 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.69 168.36 24.69 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.34 2.027 . . . . 0.0 112.366 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 39.1 m80 -45.66 115.9 1.06 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.043 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.432 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.6 t-105 -98.27 131.94 25.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.396 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.45 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 44.8 Cg_exo -53.64 119.0 5.51 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.244 1.963 . . . . 0.0 111.044 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.47 174.32 11.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.34 0.59 . . . . 0.0 112.389 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -142.72 156.23 44.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.434 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 30' ' ' ILE . 37.0 mm -77.56 135.22 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.3 -20.01 4.55 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.998 0.427 . . . . 0.0 111.019 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.907 0.384 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -94.17 158.68 15.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.946 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -98.85 109.83 22.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -104.18 143.02 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.279 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -107.0 123.1 47.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.945 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -94.93 111.69 23.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.78 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 59.5 m-85 -60.71 178.82 0.2 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.991 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.51 -63.45 0.62 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.268 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.6 p -91.43 -23.02 20.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.962 0.41 . . . . 0.0 110.618 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.9 m170 63.6 38.24 9.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.342 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -92.08 154.2 18.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.637 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.99 141.75 51.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.259 0.552 . . . . 0.0 111.576 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.41 167.12 31.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.314 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -108.03 125.23 51.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 mt -139.94 162.15 35.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.083 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.75 170.37 32.1 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.286 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.25 -19.04 50.74 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.428 2.085 . . . . 0.0 112.324 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -28.55 67.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.587 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -99.48 14.22 30.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.852 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.79 137.53 49.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.539 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.4 m-85 -137.51 155.13 75.54 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.912 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.568 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 14.5 Cg_exo -68.98 112.53 2.97 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.589 2.193 . . . . 0.0 111.6 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 70' ' ' LYS . 79.3 t80 -52.04 -58.92 5.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.056 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -49.36 -41.8 40.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.957 0.408 . . . . 0.0 112.022 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.07 -39.48 72.17 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -106.13 10.69 31.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -55.89 -45.83 78.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.755 0.312 . . . . 0.0 111.47 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -70.08 -24.88 63.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.925 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -84.69 -45.97 11.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 1.6 m-30 -101.82 -10.44 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.48 74.01 2.42 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.359 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -151.85 155.33 33.71 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.661 0.267 . . . . 0.0 110.666 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -47.14 139.52 15.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.744 2.296 . . . . 0.0 112.812 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 82' ' ' PHE . 9.6 t-20 -112.41 162.89 15.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.358 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -20.42 25.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.726 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? -69.34 -13.51 62.42 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.979 0.418 . . . . 0.0 110.711 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 0.3 OUTLIER 65.25 147.49 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.021 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.59 -19.59 35.87 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.68 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.45 ' CE2' ' HD3' ' A' ' 27' ' ' PRO . 11.9 t80 -57.88 -52.47 65.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.014 0.435 . . . . 0.0 110.545 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.51 -47.44 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.261 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -48.33 -32.45 7.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.036 0.446 . . . . 0.0 110.423 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.8 -31.81 57.81 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.436 -0.887 . . . . 0.0 111.928 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.8 mt -60.53 -43.69 96.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 0.0 110.285 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -64.06 -43.11 96.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.955 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.447 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 35.3 mm-40 -63.69 -51.88 63.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -51.88 -26.3 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.42 ' N ' HG23 ' A' ' 89' ' ' ILE . 8.2 mm-40 -101.48 -44.6 5.56 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.6 -32.81 41.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.47 89.05 2.74 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.76 0.314 . . . . 0.0 111.103 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.76 -12.53 16.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.635 2.224 . . . . 0.0 112.705 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -102.26 11.57 37.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.733 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 120.853 0.359 . . . . 0.0 111.29 -179.69 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.888 0.375 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 t -52.92 126.97 22.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.495 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.47 -13.61 62.7 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.309 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.01 142.46 49.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.971 0.386 . . . . 0.0 111.147 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 mt -91.39 118.03 30.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.382 . . . . 0.0 110.327 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.94 173.93 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.791 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.417 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.8 m-85 -113.38 137.67 51.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.716 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -113.59 122.49 47.37 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.892 0.377 . . . . 0.0 111.425 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HD3' ' CG ' ' A' ' 25' ' ' HIS . 21.1 tptp -91.18 131.46 36.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.927 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mmm -124.7 155.21 39.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.774 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.85 111.45 7.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.74 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 102.6 -1.21 49.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.845 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.1 m-85 -146.02 150.25 41.55 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.308 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.49 166.92 23.5 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.672 2.248 . . . . 0.0 112.517 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.42 ' CG ' ' HD3' ' A' ' 19' ' ' LYS . 79.7 m80 -47.48 115.67 1.2 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.056 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.8 t-105 -98.25 130.9 27.33 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.05 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 11.0 Cg_endo -54.0 119.01 5.59 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.302 2.001 . . . . 0.0 111.054 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.19 175.8 9.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.32 0.581 . . . . 0.0 112.305 -178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -143.13 156.96 44.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.379 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 30' ' ' ILE . 13.4 mm -81.69 136.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -123.93 -16.76 6.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.118 0.485 . . . . 0.0 111.669 -179.658 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.7 OUTLIER -99.52 165.52 11.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.692 179.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -100.95 113.63 26.79 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.5 t -103.45 142.48 17.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.866 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -104.87 121.29 43.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.962 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -94.43 108.71 20.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.643 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 50.0 m-85 -59.33 178.1 0.15 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.926 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.97 -63.62 0.71 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.097 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.8 p -91.29 -23.13 20.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.881 0.372 . . . . 0.0 110.502 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 m170 63.89 37.46 9.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.452 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -90.99 154.28 19.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.6 141.61 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.259 0.552 . . . . 0.0 111.509 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.29 167.36 30.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.361 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -107.17 124.83 50.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 mp -140.23 162.01 36.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.028 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.01 163.06 25.39 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.166 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.24 -17.98 49.48 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.448 2.099 . . . . 0.0 112.442 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -28.49 66.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.864 0.364 . . . . 0.0 110.656 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.54 12.23 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.88 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 6.5 mp -107.42 138.58 43.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.39 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.6 m-85 -137.38 147.96 59.98 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.109 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.504 ' HG2' ' HB2' ' A' ' 68' ' ' GLU . 20.8 Cg_endo -61.82 109.15 0.73 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.666 2.244 . . . . 0.0 111.568 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' A' ' 70' ' ' LYS . 86.2 t80 -50.74 -58.26 6.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.878 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -50.85 -39.62 54.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.164 0.507 . . . . 0.0 111.376 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.504 ' HB2' ' HG2' ' A' ' 65' ' ' PRO . 33.8 mt-10 -70.68 -40.02 73.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.507 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.78 11.36 30.25 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.6 ptpp? -56.4 -45.72 80.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.827 0.346 . . . . 0.0 111.382 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.463 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 18.8 mt-10 -70.51 -26.54 63.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.859 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -83.86 -46.4 12.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 2.6 m-30 -100.18 -11.2 20.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.19 74.4 2.49 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.296 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -152.15 154.55 32.53 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.616 0.246 . . . . 0.0 110.63 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -44.98 136.21 10.16 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.707 2.271 . . . . 0.0 112.596 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.438 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -109.77 175.03 5.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.817 -178.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -100.7 -22.52 14.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.621 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -13.22 61.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.684 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt 63.99 144.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.968 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.85 -18.01 49.75 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.714 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.47 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 12.0 t80 -59.53 -50.44 73.9 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.895 0.379 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -52.58 -47.48 66.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.233 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -48.3 -30.89 5.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.01 0.434 . . . . 0.0 110.45 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.44 -31.19 59.28 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.052 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.4 mt -60.64 -43.94 96.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 110.277 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.0 t90 -64.43 -45.24 88.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -62.61 -51.04 68.86 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -51.8 -26.99 7.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.784 0.325 . . . . 0.0 111.826 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 89' ' ' ILE . 1.9 mt-10 -99.7 -44.8 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.22 -32.33 38.5 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -156.71 89.36 2.66 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.738 0.304 . . . . 0.0 111.079 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 93.2 Cg_endo -79.08 -11.44 14.88 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.677 2.251 . . . . 0.0 112.983 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.6 p -103.95 13.27 33.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.614 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.894 0.378 . . . . 0.0 111.4 -179.684 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.782 0.325 . . . . 0.0 110.991 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.3 m -51.36 123.98 10.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.181 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.79 -13.87 56.24 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.238 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.44 140.46 50.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 111.211 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.8 mt -92.62 116.71 29.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.408 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.8 m -139.36 172.4 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.744 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.492 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 12.3 m-85 -111.71 136.18 51.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.801 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.94 123.63 50.77 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.889 0.376 . . . . 0.0 111.648 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -92.21 128.75 38.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.858 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.58 146.75 51.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.846 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -65.1 116.31 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.719 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 101.35 -0.91 53.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.726 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m-85 -148.78 151.28 34.98 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.683 0.278 . . . . 0.0 110.672 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.26 168.38 16.81 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.621 2.214 . . . . 0.0 112.193 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 74.3 m80 -47.27 113.52 0.7 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.654 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.446 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.2 t-105 -99.22 128.99 30.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.353 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 11.1 Cg_endo -53.99 119.81 6.91 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.268 1.979 . . . . 0.0 111.126 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . -143.76 176.45 9.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 3.2 ttt180 -144.69 157.59 44.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.456 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.49 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 27.8 mm -81.44 137.04 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.4 -18.91 4.77 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.349 . . . . 0.0 111.164 -179.707 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.917 0.389 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 40.9 m-85 -95.67 155.9 16.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.768 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.88 105.68 17.44 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.8 m -100.61 148.04 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.315 0.579 . . . . 0.0 112.03 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 4.9 t80 -105.39 124.5 49.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.482 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.05 108.06 19.92 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.112 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 60.6 m-85 -58.24 178.79 0.09 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.204 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.56 -62.07 0.87 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.378 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 46.4 p -91.28 -21.23 21.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.571 0.224 . . . . 0.0 110.934 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 52' ' ' THR . 26.3 m170 64.92 33.39 9.96 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.91 0.386 . . . . 0.0 110.432 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -94.93 158.49 15.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.46 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -132.85 149.26 52.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.31 0.576 . . . . 0.0 111.74 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.55 171.5 19.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.44 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 17.4 m-85 -107.78 124.52 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.923 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.9 mp -138.04 160.19 40.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.989 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.43 175.59 39.34 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.187 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.36 -24.92 49.54 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.405 2.07 . . . . 0.0 112.161 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -69.34 -25.74 64.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.086 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -97.97 7.7 45.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.31 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 71.8 mt -115.15 139.4 49.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.748 0.308 . . . . 0.0 110.37 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.7 m-85 -137.58 159.61 68.43 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.499 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 13.2 Cg_exo -69.48 111.88 2.88 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.685 2.256 . . . . 0.0 111.717 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 70' ' ' LYS . 78.1 t80 -51.97 -58.38 6.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.79 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.96 -41.73 47.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.08 0.467 . . . . 0.0 111.639 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.61 -39.72 73.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.477 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.23 12.19 30.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.6 ptpt -55.73 -46.38 77.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 0.0 111.49 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.461 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -70.1 -25.69 63.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.931 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -47.33 10.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 1.8 m-30 -101.02 -8.01 22.75 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.1 73.05 2.71 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.219 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.3 mtmt -149.09 158.19 39.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.592 0.234 . . . . 0.0 110.398 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.41 155.44 25.41 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.601 2.201 . . . . 0.0 112.555 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -136.36 168.74 18.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.545 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -89.42 -16.37 31.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.221 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -66.72 -14.51 62.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.004 0.431 . . . . 0.0 110.67 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt 63.6 143.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.124 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.67 -18.39 39.03 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.58 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 20.0 t80 -58.91 -56.08 26.86 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.976 0.417 . . . . 0.0 110.697 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.64 -45.33 66.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.82 -30.99 6.39 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.992 0.425 . . . . 0.0 110.52 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.88 -31.36 60.2 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.994 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.5 mt -60.9 -43.65 98.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.973 0.416 . . . . 0.0 110.471 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -64.26 -44.21 92.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.177 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.47 -50.91 69.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -52.09 -26.19 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.43 ' N ' HG23 ' A' ' 89' ' ' ILE . 2.2 mt-10 -100.92 -44.89 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.62 -33.34 41.54 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.9 87.1 3.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.848 0.356 . . . . 0.0 111.1 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -76.18 -12.01 19.31 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.638 2.225 . . . . 0.0 112.646 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.3 p -104.32 11.97 34.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.546 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.351 . . . . 0.0 111.466 -179.754 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.875 0.369 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 m -52.83 127.56 23.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.09 -14.15 57.18 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.163 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.01 141.0 47.69 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.798 0.333 . . . . 0.0 111.277 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -93.17 122.6 35.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.343 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.43 173.62 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.183 0.516 . . . . 0.0 111.93 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 9.4 m-85 -112.22 134.54 53.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.671 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.13 123.65 50.15 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.036 0.446 . . . . 0.0 111.659 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -91.72 127.39 37.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.787 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 ttm -127.02 152.29 47.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.582 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -67.14 126.93 30.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.92 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 91.54 -3.72 79.03 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.954 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 1.6 m-85 -148.72 149.7 31.41 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-N 116.808 0.304 . . . . 0.0 110.729 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.79 172.2 15.42 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.5 2.133 . . . . 0.0 112.508 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -49.15 114.52 1.03 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.772 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.86 132.46 23.7 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.293 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 32.5 Cg_exo -54.48 120.52 8.18 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.069 1.846 . . . . 0.0 110.953 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.16 175.04 10.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.394 0.616 . . . . 0.0 112.412 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -142.74 155.27 44.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.551 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -78.66 135.0 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.78 -20.1 4.34 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 121.034 0.445 . . . . 0.0 111.266 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.851 0.358 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.26 154.01 17.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.837 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.426 ' HG3' ' CE1' ' A' ' 57' ' ' PHE . 5.1 tt0 -100.39 106.09 17.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.3 m -101.95 150.91 5.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.499 0.666 . . . . 0.0 112.126 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 17.9 t80 -105.33 125.31 50.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.289 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.4 ' CE2' ' HB1' ' A' ' 56' ' ' ALA . 47.7 m-85 -91.37 106.97 18.89 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.422 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.429 ' HB3' ' HA2' ' A' ' 85' ' ' GLY . 41.0 m-85 -59.43 175.17 0.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.692 0.282 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.39 -61.66 0.84 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.31 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.7 p -90.33 -22.48 21.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.7 0.286 . . . . 0.0 110.986 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 44.3 m170 64.84 34.32 9.38 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.351 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -91.4 154.74 18.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.755 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.07 143.67 49.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.251 0.548 . . . . 0.0 111.617 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -155.35 172.18 18.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.511 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' A' ' 46' ' ' GLN . 15.3 m-85 -116.66 126.16 52.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.482 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mt -140.02 163.24 33.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.174 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.27 171.55 31.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.321 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.52 -19.48 54.68 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.474 2.116 . . . . 0.0 112.517 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -68.62 -29.48 68.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.936 0.398 . . . . 0.0 110.569 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.59 10.91 40.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.891 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -108.36 137.3 46.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.519 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.6 m-85 -137.03 157.03 75.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 6.7 Cg_exo -72.32 111.6 3.24 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.429 2.086 . . . . 0.0 111.327 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.2 t80 -48.46 -57.47 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.875 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.26 -40.52 48.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 111.348 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 17.3 mt-10 -71.24 -39.95 71.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.535 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.467 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -104.35 9.38 35.85 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.372 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -57.52 -46.43 83.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.758 0.314 . . . . 0.0 111.792 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.75 -35.56 78.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 13.4 ptpt -82.81 -41.52 18.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CD1' ' HG3' ' A' ' 72' ' ' LYS . 15.8 m-30 -97.92 -13.11 21.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -84.53 75.35 2.37 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.266 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -152.13 153.96 31.82 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.585 0.231 . . . . 0.0 110.586 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -45.31 136.14 11.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.717 2.278 . . . . 0.0 112.727 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.456 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 31.5 t30 -108.79 174.45 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.676 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 -22.4 15.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.851 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -12.94 61.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.8 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp 64.66 145.15 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.952 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.1 -18.25 46.05 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.753 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE2' ' HD3' ' A' ' 27' ' ' PRO . 11.3 t80 -58.88 -51.87 68.18 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 121.005 0.431 . . . . 0.0 110.559 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -46.66 66.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.409 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -48.11 -31.25 5.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.85 -31.22 60.44 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.063 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 mt -61.02 -43.8 98.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.971 0.415 . . . . 0.0 110.315 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -64.13 -45.15 89.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.097 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -63.09 -50.99 68.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -51.73 -27.4 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.758 0.313 . . . . 0.0 111.754 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -99.52 -44.73 6.06 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -80.98 -31.7 34.66 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.64 87.73 3.1 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.819 0.342 . . . . 0.0 111.132 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 75.4 Cg_endo -77.71 -12.93 16.44 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.58 2.187 . . . . 0.0 112.791 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.8 p -104.45 12.78 32.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.634 0.254 . . . . 0.0 111.577 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.845 0.355 . . . . 0.0 111.432 -179.752 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 121.006 0.432 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 t -52.3 135.82 31.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.372 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.85 -11.27 69.89 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.003 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.33 142.93 47.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 0.0 111.103 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.2 mt -90.77 118.53 30.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.205 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.28 167.44 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.834 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 8.2 m-85 -109.86 132.62 53.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.65 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.83 124.06 51.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 111.523 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.71 133.21 35.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.96 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.83 147.15 51.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.62 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 112.69 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.89 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 109.56 -5.79 31.41 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.911 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 1.4 m-85 -147.96 161.57 34.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.784 0.326 . . . . 0.0 110.886 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 95.1 Cg_endo -83.94 168.98 11.98 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.895 2.397 . . . . 0.0 112.503 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 73' ' ' PHE . 67.9 m80 -47.53 116.68 1.52 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.544 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.04 130.76 27.9 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.59 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.43 120.5 8.13 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.084 1.856 . . . . 0.0 111.044 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.74 175.06 10.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.352 0.596 . . . . 0.0 112.533 -178.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 2.0 ttt180 -142.89 156.07 44.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.527 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.421 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 21.1 mm -77.67 135.05 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.32 -21.66 4.18 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 111.272 -179.619 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 mttp . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.096 0.474 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -93.32 156.55 16.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.005 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.74 97.09 8.7 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.027 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -100.05 148.58 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.485 -177.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 33.0 t80 -106.33 125.6 51.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.293 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -93.39 110.65 22.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 50.3 m-85 -60.96 175.91 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.065 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.55 -62.94 0.85 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.132 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -90.63 -22.95 20.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 110.581 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 38.0 m80 63.93 37.05 9.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.013 0.435 . . . . 0.0 110.194 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -91.21 153.97 19.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.72 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.8 139.16 53.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.162 0.506 . . . . 0.0 111.137 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.35 169.6 23.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.634 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -112.07 126.41 55.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.773 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mp -139.21 162.53 34.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.064 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.9 176.11 39.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.362 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.74 -24.56 40.77 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.442 2.095 . . . . 0.0 112.219 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -70.03 -25.1 63.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.795 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -99.96 4.73 45.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.364 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 mt -116.09 139.47 50.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.648 0.261 . . . . 0.0 110.483 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.9 m-85 -137.84 165.69 31.91 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.884 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 2.7 Cg_exo -75.35 115.73 4.32 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.69 2.26 . . . . 0.0 111.733 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -53.03 -57.83 9.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.825 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -48.85 -42.98 38.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.98 0.419 . . . . 0.0 111.797 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.82 -39.72 72.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.441 -179.486 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.434 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 2.5 m -105.94 13.57 29.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 66' ' ' TYR . 6.0 ptmm? -58.06 -45.93 86.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.884 0.373 . . . . 0.0 111.452 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -67.66 -37.28 82.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 6.1 ptmt -83.39 -43.31 16.04 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.516 ' CZ ' ' CE1' ' A' ' 25' ' ' HIS . 20.5 m-30 -95.27 -13.22 25.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -89.42 74.65 1.94 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.843 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 7.7 mmtp -146.82 148.74 34.01 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.612 0.244 . . . . 0.0 110.41 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.03 155.37 2.77 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.51 2.14 . . . . 0.0 112.538 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.41 ' ND2' ' HG3' ' A' ' 24' ' ' PRO . 8.8 t-20 -137.15 166.95 22.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.591 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -15.52 35.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.268 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -13.75 61.71 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.038 0.446 . . . . 0.0 110.597 179.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm 64.18 142.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.337 -179.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.21 -16.84 56.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.585 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 38.6 t80 -59.08 -56.68 19.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.922 0.391 . . . . 0.0 110.74 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.4 -46.18 69.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.189 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -48.93 -30.69 6.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.913 0.387 . . . . 0.0 110.5 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.28 -31.4 59.35 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.818 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.78 -43.72 97.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.233 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.8 t90 -63.68 -45.29 90.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 1.5 mp0 -62.94 -51.36 67.19 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -26.3 8.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.748 0.308 . . . . 0.0 111.818 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.04 -44.68 5.92 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -82.64 -31.68 28.66 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -156.77 88.79 2.68 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.728 0.299 . . . . 0.0 111.092 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.6 Cg_endo -76.4 -10.37 18.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.764 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.49 11.6 38.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.496 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 120.78 0.324 . . . . 0.0 111.218 -179.873 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.892 0.377 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.5 m -51.92 134.63 31.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.346 -179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.37 -10.32 74.45 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.952 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.38 142.5 48.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.359 . . . . 0.0 111.171 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.1 mt -93.21 118.35 31.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.934 0.397 . . . . 0.0 110.532 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.6 m -142.84 171.71 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.683 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.546 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 33.2 m-85 -110.21 135.22 51.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.452 178.48 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.03 126.64 55.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 111.583 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.3 129.11 37.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.927 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 ttm -134.06 144.33 48.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.71 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -65.03 122.96 18.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.651 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.73 -8.93 56.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.769 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.66 146.13 21.55 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.604 0.24 . . . . 0.0 110.526 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.39 175.17 11.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.414 2.076 . . . . 0.0 112.512 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -48.21 111.88 0.5 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.527 179.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.468 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.7 t-105 -98.43 130.68 27.61 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.448 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.91 120.1 7.36 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.272 1.982 . . . . 0.0 110.909 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.39 174.36 10.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.359 0.6 . . . . 0.0 112.546 -178.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 18.2 ttp180 -143.14 155.65 44.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.487 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.464 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 32.6 mm -78.82 136.52 23.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -126.46 -20.8 4.3 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.38 . . . . 0.0 111.18 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 121.102 0.477 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -97.58 159.0 15.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.944 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -97.65 109.5 22.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.2 t -102.78 141.71 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.395 0.617 . . . . 0.0 112.421 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -105.25 121.25 43.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.693 179.044 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -93.86 110.89 22.53 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.585 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 49.9 m-85 -60.69 178.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.06 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.408 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 70.26 -63.53 0.78 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.857 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.3 p -91.38 -22.36 20.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.732 0.301 . . . . 0.0 110.528 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.7 m170 62.87 36.65 12.73 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.016 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.44 154.75 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.33 140.71 52.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.321 0.581 . . . . 0.0 111.6 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.99 167.59 29.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.038 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -111.92 126.91 55.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.935 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.3 mt -141.25 164.34 30.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.062 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.96 171.16 33.99 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.076 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.61 -19.06 48.56 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.407 2.071 . . . . 0.0 112.223 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -67.77 -28.44 67.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -100.22 16.5 24.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.657 179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mp -114.23 137.24 52.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.4 m-85 -136.74 155.87 76.4 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.715 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 10.1 Cg_exo -69.71 112.7 3.14 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.219 1.946 . . . . 0.0 111.178 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 89.5 t80 -47.65 -58.78 3.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.323 -178.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -50.61 -39.7 50.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.967 0.413 . . . . 0.0 111.772 -179.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.5 mt-10 -71.05 -39.87 72.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.605 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.438 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -102.66 8.09 39.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.24 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -55.61 -50.75 69.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.825 0.345 . . . . 0.0 111.384 179.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -70.95 -19.71 62.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.441 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HD3' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -85.01 -52.23 6.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.177 0.513 . . . . 0.0 111.939 -179.214 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CD1' ' HD3' ' A' ' 72' ' ' LYS . 6.7 m-85 -100.72 -10.24 21.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.448 -0.797 . . . . 0.0 112.712 -178.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -78.02 72.31 2.29 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.297 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -150.64 152.15 31.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.681 0.24 . . . . 0.0 110.478 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.62 138.97 14.02 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.661 2.241 . . . . 0.0 112.72 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 82' ' ' PHE . 9.4 t-20 -110.0 164.19 12.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.544 -179.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -20.73 23.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.685 179.418 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -69.35 -12.37 61.6 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt 65.33 146.52 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.386 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.13 -18.81 42.5 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.855 -178.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.468 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.6 t80 -58.24 -54.94 41.26 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.017 0.437 . . . . 0.0 110.834 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.27 -47.05 66.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.294 -179.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -48.3 -31.37 5.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.045 0.45 . . . . 0.0 110.494 179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.32 -31.69 58.92 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.031 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.9 mt -60.98 -43.54 98.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.986 0.422 . . . . 0.0 110.192 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -63.31 -45.46 91.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.053 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -62.73 -51.61 66.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.039 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.414 HD11 ' CD2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.32 -26.5 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.791 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.66 -44.86 5.97 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -80.47 -33.06 36.94 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -155.9 88.22 2.97 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 111.136 -179.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.1 Cg_endo -76.23 -12.12 19.2 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.695 2.263 . . . . 0.0 112.838 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 p -104.05 12.71 33.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.406 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 C--N 1.332 -0.189 0 CA-C-O 120.778 0.323 . . . . 0.0 111.348 -179.728 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.948 0.404 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.6 t -51.95 130.86 30.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.388 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.85 -13.45 65.12 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.967 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.51 140.87 51.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.762 0.315 . . . . 0.0 111.022 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -92.51 118.94 31.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 0.0 110.427 179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.9 m -141.08 173.5 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.803 -179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 16.1 m-85 -111.35 138.88 47.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.509 178.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 62' ' ' ASP . . . -117.29 126.42 52.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.171 0.51 . . . . 0.0 112.133 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . 10.7 tptm -91.18 129.56 37.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.01 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.42 140.15 48.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.743 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 123.32 17.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.79 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.65 -7.88 46.44 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.685 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.09 160.99 30.41 Favored Pre-proline 0 C--N 1.333 -0.142 0 CA-C-O 120.728 0.299 . . . . 0.0 110.626 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.67 171.16 13.58 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.635 2.224 . . . . 0.0 112.367 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 67.8 m80 -50.02 118.52 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.392 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.46 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.9 t-105 -99.49 133.05 22.2 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 11.7 Cg_endo -54.45 120.79 8.61 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.393 2.062 . . . . 0.0 110.819 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.01 176.35 9.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -142.61 155.57 44.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.47 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 mm -82.53 137.76 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -124.31 -14.99 6.84 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.084 0.468 . . . . 0.0 111.519 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.002 0.43 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.8 OUTLIER -95.48 163.19 13.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.663 179.439 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.03 110.26 22.57 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.3 t -104.74 143.61 15.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.304 -178.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 40.8 t80 -106.75 123.85 48.74 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.912 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -95.81 113.77 25.44 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.948 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.467 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 60.9 m-85 -61.47 179.54 0.22 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.248 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.62 -63.56 0.45 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.117 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.7 p -91.7 -21.56 20.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.746 0.307 . . . . 0.0 110.7 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 64.5 m170 62.0 37.46 14.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.181 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -90.8 155.88 18.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.492 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.04 140.05 53.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.391 0.615 . . . . 0.0 111.655 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.18 166.92 32.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.262 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -106.2 124.76 50.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.655 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.2 mt -139.78 162.69 34.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.25 167.19 26.13 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.495 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.17 -19.76 67.67 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.661 2.241 . . . . 0.0 112.615 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -69.12 -27.28 65.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.873 0.368 . . . . 0.0 110.856 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 24.8 m-20 -97.95 8.81 44.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.231 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 95.6 mt -109.35 139.87 43.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.693 0.283 . . . . 0.0 110.539 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.6 m-85 -134.06 156.67 78.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.09 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HB2' ' CB ' ' A' ' 68' ' ' GLU . 15.4 Cg_exo -68.19 109.66 2.03 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.605 2.203 . . . . 0.0 111.43 179.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 70' ' ' LYS . 83.4 t80 -54.9 -62.14 1.85 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.915 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -49.01 -42.13 36.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.081 0.467 . . . . 0.0 111.474 -179.149 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.411 ' CB ' ' HB2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -70.88 -39.77 72.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.485 -179.373 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.93 9.75 34.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.2 ptpp? -55.21 -45.21 75.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 111.401 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.3 mt-10 -70.09 -26.89 64.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.987 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -84.57 -46.44 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -105.07 -0.83 26.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.8 75.07 1.99 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.873 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -150.36 157.31 36.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.69 0.281 . . . . 0.0 110.861 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.82 149.89 10.25 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.704 2.269 . . . . 0.0 112.573 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.417 ' OD1' ' CD2' ' A' ' 82' ' ' PHE . 4.9 m120 -131.2 165.81 22.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.595 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.32 -17.53 30.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.259 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -66.25 -15.06 62.88 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.075 0.464 . . . . 0.0 110.61 179.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt 63.98 142.6 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.097 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.33 -17.91 48.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.801 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 18.4 t80 -58.66 -53.58 56.76 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.034 0.445 . . . . 0.0 110.505 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.61 -46.48 67.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.043 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.62 -32.66 8.53 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.019 0.438 . . . . 0.0 110.39 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.34 -31.83 60.74 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.814 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.84 -43.73 97.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.001 0.429 . . . . 0.0 110.268 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.452 ' CD1' ' ND2' ' A' ' 91' ' ' ASN . 61.1 t90 -65.46 -41.52 93.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.053 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -64.29 -53.67 45.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 tt -52.39 -25.38 7.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -100.37 -44.65 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.452 ' ND2' ' CD1' ' A' ' 87' ' ' TRP . 35.3 m-80 -81.33 -33.91 32.19 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.645 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -156.66 85.46 3.01 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.017 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 72.1 Cg_endo -74.97 -10.24 21.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.676 2.251 . . . . 0.0 112.685 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.1 p -104.18 11.78 34.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.538 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 120.851 0.357 . . . . 0.0 111.441 -179.645 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.968 0.413 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 t -52.2 124.68 13.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.77 -16.09 44.11 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.061 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.23 140.01 50.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.827 0.346 . . . . 0.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 15' ' ' LEU . 56.3 mt -92.8 118.68 31.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.301 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.67 171.77 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.743 -179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.4 m-85 -109.98 136.68 48.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.706 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' ASP . . . -113.43 126.44 55.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.993 0.425 . . . . 0.0 111.779 -179.186 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 14.2 tptm -92.96 130.64 38.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.854 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.41 ' HE2' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.94 148.6 50.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.77 179.946 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -67.36 106.67 2.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.774 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.82 -7.08 27.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.611 -0.805 . . . . 0.0 112.749 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -141.07 156.61 68.11 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.713 0.292 . . . . 0.0 110.656 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.98 171.92 9.01 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.744 2.296 . . . . 0.0 112.206 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.458 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 74.8 m80 -47.79 111.88 0.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.42 179.032 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 1.6 t-105 -99.57 129.06 29.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.783 -0.19 . . . . 0.0 111.24 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HG3' HD22 ' A' ' 86' ' ' LEU . 12.4 Cg_endo -55.46 121.13 9.38 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.152 1.902 . . . . 0.0 110.968 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.68 175.77 9.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.29 0.566 . . . . 0.0 112.257 -178.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -141.67 154.83 45.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.75 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 mm -82.27 114.25 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.87 -13.84 14.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.402 . . . . 0.0 111.309 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.004 0.431 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 62.4 m-85 -94.42 153.22 18.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.843 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -99.0 105.78 17.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.5 m -101.47 150.34 6.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.542 0.687 . . . . 0.0 112.211 -178.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 32.9 t80 -105.81 124.38 49.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.076 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.444 ' HE2' ' HB1' ' A' ' 56' ' ' ALA . 32.5 m-85 -91.72 107.62 19.33 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.565 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 36.0 m-85 -58.56 175.11 0.27 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.794 0.33 . . . . 0.0 110.934 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.53 -62.05 0.86 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.386 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.4 p -90.49 -21.51 21.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.652 0.263 . . . . 0.0 111.097 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 48.4 m170 64.02 34.9 10.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.889 0.376 . . . . 0.0 110.29 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -90.32 153.68 20.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.704 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.54 141.51 51.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.166 0.507 . . . . 0.0 111.633 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.444 ' HB1' ' HE2' ' A' ' 49' ' ' PHE . . . -155.41 177.53 11.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.406 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 9.0 m-85 -120.56 127.34 52.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.804 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mt -140.01 163.93 31.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.117 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.94 177.17 35.25 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.566 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.12 -25.26 51.07 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.665 2.243 . . . . 0.0 112.437 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -69.92 -25.43 63.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.352 . . . . 0.0 111.091 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 36.3 m-20 -98.39 4.79 48.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.388 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.8 mt -112.59 139.37 48.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.444 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.4 m-85 -136.01 159.93 69.18 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.067 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 12.2 Cg_exo -69.68 110.88 2.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.695 2.264 . . . . 0.0 111.64 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -51.82 -59.25 4.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.549 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -50.42 -41.41 52.38 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.701 -179.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 2.2 tm-20 -69.55 -39.81 77.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.458 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 m -108.15 13.77 25.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.5 ptpp? -56.09 -47.67 77.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 111.125 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.513 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.3 mt-10 -71.13 -21.32 62.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.316 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HD3' ' CE1' ' A' ' 73' ' ' PHE . 4.2 tttt -85.59 -49.35 8.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 9.5 m-85 -103.01 -4.79 24.13 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.32 71.1 3.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.077 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 9.1 mtmt -149.33 153.54 37.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.74 158.19 14.16 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.574 2.182 . . . . 0.0 112.733 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -137.15 167.27 21.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.469 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.46 -15.45 46.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.112 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -14.04 61.61 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.008 0.432 . . . . 0.0 110.792 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp 63.85 142.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.273 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.05 -17.79 48.94 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.742 -178.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 44.5 t80 -59.83 -54.19 49.09 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.998 0.428 . . . . 0.0 110.842 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.1 -46.33 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.236 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -48.39 -29.83 4.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.997 0.427 . . . . 0.0 110.601 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.97 -31.59 59.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.172 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.46 HD22 ' HG3' ' A' ' 27' ' ' PRO . 3.8 mm? -61.01 -44.16 97.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.959 0.409 . . . . 0.0 110.533 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 64.2 t90 -65.12 -45.71 83.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.339 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.48 -51.02 69.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.3 -27.18 10.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.711 0.291 . . . . 0.0 111.684 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -99.6 -44.73 6.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.33 -31.86 37.98 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -155.61 88.11 3.07 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 111.188 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -75.93 -13.39 19.54 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.676 2.25 . . . . 0.0 112.697 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.1 p -105.67 12.4 31.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.496 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.418 . . . . 0.0 111.481 -179.674 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.867 0.365 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.26 133.0 34.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.372 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.2 -10.97 72.75 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.915 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.03 142.8 49.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.768 0.318 . . . . 0.0 111.15 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.2 mt -90.81 116.79 28.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 110.281 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.48 168.9 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.663 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 44.5 m-85 -110.56 137.06 48.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.506 178.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.29 124.22 51.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.294 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -91.11 134.39 34.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.963 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mmm -128.19 149.27 50.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.646 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 115.22 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 0.0 111.063 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.72 -31.69 6.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.574 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -103.02 153.0 38.61 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 110.915 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.87 166.8 11.39 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.816 2.344 . . . . 0.0 112.43 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 46.7 m80 -48.61 113.98 0.88 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.477 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.7 t-105 -98.65 131.33 26.04 Favored Pre-proline 0 N--CA 1.464 0.266 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.9 120.34 7.74 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.357 2.038 . . . . 0.0 110.857 178.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.49 175.03 10.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 1.0 OUTLIER -143.07 155.93 44.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.336 179.619 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.463 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.0 mm -80.82 136.88 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -127.31 -18.1 4.57 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 CA-C-O 120.899 0.381 . . . . 0.0 111.334 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.967 0.413 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -92.18 158.79 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.231 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.55 98.22 9.13 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -99.79 147.29 7.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.659 0.742 . . . . 0.0 112.408 -177.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 28.4 t80 -105.63 124.97 50.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.283 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -91.85 108.15 19.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.548 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 38.0 m-85 -59.79 175.78 0.34 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.3 . . . . 0.0 110.979 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.68 -62.77 0.88 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.229 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.2 p -90.78 -22.07 21.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.794 0.331 . . . . 0.0 110.656 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 50.4 m170 63.51 36.04 11.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.388 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -90.41 153.52 20.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.589 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.25 139.55 53.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.113 0.483 . . . . 0.0 111.328 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.7 167.84 29.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.64 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.28 125.64 53.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.639 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -138.39 161.49 36.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.043 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.81 171.8 33.41 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.311 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.39 -20.85 47.93 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.351 2.034 . . . . 0.0 112.214 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -68.37 -28.9 67.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.958 0.409 . . . . 0.0 110.453 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.49 12.06 38.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.816 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mp -109.51 136.59 48.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.386 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.5 m-85 -135.05 146.0 56.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.902 0.382 . . . . 0.0 111.048 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.446 ' HG2' ' HB3' ' A' ' 68' ' ' GLU . 17.8 Cg_endo -60.06 112.25 1.24 Allowed 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.43 2.087 . . . . 0.0 111.334 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 78.6 t80 -49.71 -61.78 1.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.215 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.28 -40.8 49.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.125 0.488 . . . . 0.0 111.49 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.446 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 6.0 tt0 -71.01 -39.74 72.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.198 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 5.3 m -101.04 8.14 43.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HD3' ' CE2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.17 -53.68 46.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.267 0.556 . . . . 0.0 111.426 179.64 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.85 -17.79 62.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.831 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -85.26 -50.53 7.28 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 7.8 m-85 -107.29 -3.19 19.96 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.39 72.68 2.61 Favored Glycine 0 C--N 1.329 0.165 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.976 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -149.81 153.23 35.9 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.607 0.241 . . . . 0.0 110.678 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -51.13 153.57 9.06 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.55 2.167 . . . . 0.0 112.626 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -137.05 167.35 21.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.684 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 -15.38 41.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.324 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.9 mmt-85 -66.03 -15.19 62.82 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.032 0.444 . . . . 0.0 110.595 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm 63.62 142.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.136 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.04 -17.2 52.81 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.608 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 36.1 t80 -58.38 -56.08 26.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.986 0.422 . . . . 0.0 110.754 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.86 -46.28 67.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -48.58 -31.69 6.97 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.974 0.416 . . . . 0.0 110.426 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.33 -32.2 58.28 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.026 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 16.5 mt -60.68 -43.55 97.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.996 0.426 . . . . 0.0 110.123 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . 0.411 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 63.8 t90 -64.9 -43.22 93.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.935 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 21.6 mm-40 -63.46 -52.41 61.53 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -53.04 -25.44 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 87' ' ' TRP . 12.5 pt-20 -99.92 -44.77 5.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -82.55 -29.37 30.39 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -155.86 86.88 3.12 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.79 0.328 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.86 -14.29 17.3 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.667 2.245 . . . . 0.0 112.653 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.7 p -105.13 11.9 32.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.576 -179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.403 -179.67 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 121.048 0.451 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.73 131.86 35.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.516 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.81 -11.45 68.04 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.14 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.86 138.4 50.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 111.26 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -91.89 118.09 30.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.386 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 m -139.88 171.95 13.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.832 -179.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 30.3 m-85 -112.81 137.09 51.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.539 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.4 126.5 55.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 -179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 12.3 tptp -90.25 136.08 33.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.087 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -130.32 151.8 50.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.534 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -67.64 118.26 10.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.919 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -8.57 74.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.981 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.422 ' CD1' ' HD3' ' A' ' 79' ' ' ARG . 1.9 m-85 -132.19 154.45 81.65 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.849 0.324 . . . . 0.0 111.071 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.27 167.16 12.29 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.86 2.373 . . . . 0.0 112.495 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.446 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 80.2 m80 -47.09 115.23 1.02 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.629 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.467 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.1 t-105 -99.03 130.02 28.34 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.536 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.78 119.48 6.31 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.374 2.049 . . . . 0.0 111.112 178.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.12 174.34 10.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.425 0.631 . . . . 0.0 112.69 -177.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.46 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -142.92 155.8 44.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.305 179.686 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.46 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 28.5 mm -78.18 138.36 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.004 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.73 -20.33 5.5 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.055 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.069 0.461 . . . . 0.0 111.234 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 121.007 0.432 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 80.1 m-85 -95.82 155.02 16.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.678 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.4 mt-30 -96.39 106.71 18.99 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.211 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.4 t -100.77 143.06 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.294 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.89 122.02 45.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.156 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -94.97 110.28 22.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.415 179.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.441 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 57.2 m-85 -58.86 -179.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.025 -179.513 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.52 -63.64 0.61 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.205 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.9 p -91.11 -22.83 20.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.749 0.309 . . . . 0.0 110.734 179.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.4 m170 64.55 36.51 8.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.534 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -94.21 157.0 16.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.517 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -131.75 149.92 52.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.362 0.601 . . . . 0.0 112.009 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.52 170.94 20.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 52.4 m-85 -105.96 86.59 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.08 156.84 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.195 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.97 169.42 32.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.324 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.48 -20.86 47.35 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.504 2.136 . . . . 0.0 112.359 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -27.83 67.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.95 0.405 . . . . 0.0 110.413 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -100.7 12.46 37.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.791 179.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.73 137.37 46.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.676 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.7 m-85 -136.14 158.24 74.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.65 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.628 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.9 Cg_exo -71.79 111.51 3.16 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.391 2.061 . . . . 0.0 111.288 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.2 t80 -45.63 -58.97 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.438 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -50.95 -39.43 54.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.949 -179.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.1 mm-40 -70.62 -39.76 73.55 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.445 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 49.5 m -105.49 11.03 32.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.38 -49.47 74.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 111.554 179.977 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.51 -26.17 64.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.707 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -85.01 -46.93 10.73 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 2.5 m-30 -99.87 -12.95 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -80.68 71.1 2.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.289 -0.957 . . . . 0.0 113.043 -179.523 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.418 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.0 mttt -148.99 153.21 38.03 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.595 0.236 . . . . 0.0 110.384 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -51.27 153.31 9.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.463 2.109 . . . . 0.0 112.674 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -136.48 163.44 30.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.545 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -81.81 -16.54 50.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.153 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.422 ' HD3' ' CD1' ' A' ' 23' ' ' TYR . 17.9 mmm180 -64.52 -15.66 61.26 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.916 0.389 . . . . 0.0 110.823 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt 63.24 140.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.139 -179.38 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.88 -16.98 53.55 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.463 -178.196 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.467 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.5 t80 -58.57 -55.49 34.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.943 0.401 . . . . 0.0 110.649 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 m -53.54 -45.66 69.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.121 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.91 -31.69 7.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.038 0.446 . . . . 0.0 110.464 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.04 -31.75 61.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.921 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.12 -43.68 98.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.961 0.41 . . . . 0.0 110.314 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -63.61 -45.46 90.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.2 mp0 -62.38 -50.93 69.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.128 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.48 -25.99 8.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.723 0.297 . . . . 0.0 111.8 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -44.81 5.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.095 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -80.49 -32.23 37.05 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.32 87.85 3.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.798 0.332 . . . . 0.0 110.978 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 96.3 Cg_endo -79.6 -12.52 13.75 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.636 2.224 . . . . 0.0 112.958 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.1 p -103.8 12.8 34.11 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.837 0.351 . . . . 0.0 111.288 -179.856 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.805 0.336 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.12 89.8 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.774 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 78.85 1.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m 58.15 93.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.032 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -73.35 84.73 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -150.32 126.27 10.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.001 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -144.25 89.04 1.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -88.38 162.23 16.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.872 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -154.57 142.13 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.551 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.435 ' CD1' HG13 ' A' ' 16' ' ' VAL . 98.9 m-85 -114.59 160.04 19.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.907 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.17 159.38 41.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.011 0.434 . . . . 0.0 111.17 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 t -53.24 127.18 23.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.464 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.401 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 101.23 -14.84 58.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.096 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.07 138.8 54.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 0.0 111.115 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.7 mt -92.22 117.65 30.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.176 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.435 HG13 ' CD1' ' A' ' 10' ' ' TYR . 30.4 m -140.92 171.39 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.185 0.517 . . . . 0.0 111.956 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 32.5 m-85 -110.63 137.35 48.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.471 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.54 125.0 53.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.893 0.378 . . . . 0.0 111.586 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -90.37 134.37 34.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.906 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 mmm -129.8 151.85 49.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 122.62 18.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.81 -2.06 85.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.897 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -139.4 152.47 69.23 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.757 0.279 . . . . 0.0 110.674 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.87 163.8 13.85 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.6 2.2 . . . . 0.0 112.688 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 48.4 m80 -46.6 117.44 1.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.102 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.425 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.3 t-105 -101.13 128.04 30.42 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.584 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 9.5 Cg_endo -52.49 119.5 5.99 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.329 2.02 . . . . 0.0 111.073 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . -144.69 177.34 8.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.43 0.633 . . . . 0.0 112.67 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 4.3 ttp180 -143.2 156.66 44.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.84 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.459 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 24.1 mm -82.94 140.32 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.0 -19.38 6.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -163.47 151.4 13.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 111.001 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.6 mmt -91.94 167.05 16.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.608 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 17.4 Cg_exo -66.5 145.76 77.76 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.692 2.261 . . . . 0.0 112.11 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -80.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.762 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.94 -63.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.366 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.36 26.2 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.94 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.7 m -92.12 168.24 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.246 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.7 pttt 41.58 -164.65 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.499 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.44 56.09 3.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.874 0.369 . . . . 0.0 110.79 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.7 p -126.84 95.56 4.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.931 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.93 -63.96 0.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.815 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.448 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 6.0 m-80 -153.98 56.11 0.72 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 110.48 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 1.1 mmpt? -103.6 176.51 5.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.975 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 2.6 m-85 -149.46 159.77 44.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.188 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 57' ' ' PHE . 11.5 mt-30 -93.04 105.32 17.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.076 0.465 . . . . 0.0 109.832 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 m -102.95 146.87 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.615 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 3.9 t80 -103.82 123.44 47.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.456 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -93.72 105.26 17.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.814 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 57.9 m-85 -56.47 178.53 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 111.389 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.39 -62.35 1.1 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.15 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.8 p -91.38 -21.96 20.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 110.932 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.6 m170 65.26 34.12 8.65 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.521 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -95.51 157.35 15.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.649 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 t -129.76 148.68 51.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.354 0.597 . . . . 0.0 111.833 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.53 170.77 21.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.606 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.3 m-85 -108.13 124.2 49.88 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.758 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 28.6 mt -138.65 161.73 36.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.975 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.11 176.27 42.06 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.248 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 9.0 Cg_exo -69.45 -25.42 30.07 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.314 2.009 . . . . 0.0 111.865 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -68.96 -22.13 64.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.618 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.18 2.18 42.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.1 mt -110.99 139.35 46.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.291 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.2 m-85 -136.64 160.48 66.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 16.7 Cg_exo -67.59 112.62 2.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.646 2.231 . . . . 0.0 111.939 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.7 t80 -50.08 -61.41 2.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.242 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.83 -39.38 58.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.959 0.409 . . . . 0.0 111.638 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -71.37 -39.25 71.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.349 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.419 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 34.2 m -105.62 10.86 32.82 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 66' ' ' TYR . 14.6 tttt -54.76 -48.35 72.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.77 -29.77 68.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.934 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -83.77 -46.05 12.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.3 m-30 -98.13 -12.18 22.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.76 72.88 2.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.102 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.9 mttt -150.7 143.49 16.42 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.635 0.255 . . . . 0.0 110.592 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.26 158.59 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.468 2.112 . . . . 0.0 112.757 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.64 172.05 13.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.97 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -87.22 -16.85 34.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.393 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -13.96 61.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt 66.34 141.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.395 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -17.04 56.89 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.897 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.459 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 36.9 t80 -59.78 -53.76 54.17 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.944 0.402 . . . . 0.0 110.518 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.75 -47.08 71.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.72 -31.33 6.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.934 0.397 . . . . 0.0 110.367 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.14 -32.4 63.06 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.82 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.446 HD22 ' CE1' ' A' ' 82' ' ' PHE . 3.8 mm? -60.78 -43.66 97.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.985 0.421 . . . . 0.0 110.361 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -65.48 -44.17 87.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.237 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 24.3 mm-40 -63.56 -53.01 58.41 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.431 HG12 ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -52.77 -26.69 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.739 0.304 . . . . 0.0 111.775 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.71 -44.64 6.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -81.33 -32.63 32.93 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -156.72 90.95 2.54 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.715 0.293 . . . . 0.0 111.324 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -76.54 -11.02 18.83 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.48 2.12 . . . . 0.0 112.659 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.9 p -106.81 12.61 28.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.543 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.6 p -59.95 148.47 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.907 0.384 . . . . 0.0 111.542 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.52 159.92 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.975 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.88 -174.96 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.006 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 p -70.51 -38.22 74.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.816 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.65 151.28 8.81 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.459 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -118.62 154.35 32.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -96.66 106.98 19.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.17 128.99 34.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.783 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 m 60.9 108.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.768 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.72 -42.05 3.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.96 -37.59 7.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.23 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -155.99 159.3 39.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.371 . . . . 0.0 111.076 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.17 158.25 27.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 14.8 p -120.87 -42.38 2.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.941 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.49 -46.83 15.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.147 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 179.17 -36.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.013 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 64.27 98.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -136.68 -58.73 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -110.1 97.37 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.98 125.94 27.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.68 130.19 4.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -167.16 137.41 2.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.56 144.22 26.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.808 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.419 ' CE1' HG13 ' A' ' 16' ' ' VAL . 98.0 m-85 -113.88 159.18 20.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.652 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -134.19 157.8 45.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.065 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.9 m -52.01 129.38 27.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.396 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.99 58.51 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.939 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.05 138.16 51.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.836 0.351 . . . . 0.0 111.263 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.4 mt -91.81 119.64 31.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 110.156 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 10' ' ' TYR . 23.0 m -140.72 171.32 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.946 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 27' ' ' PRO . 10.0 m-85 -109.87 136.71 48.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.515 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -113.08 124.56 52.88 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.007 0.432 . . . . 0.0 111.775 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -92.09 131.69 37.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.75 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mtp -129.09 147.47 50.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.689 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 115.26 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.877 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.413 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 100.45 4.08 55.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.764 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -152.8 153.66 30.34 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.695 0.283 . . . . 0.0 110.653 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.83 167.6 18.3 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.562 2.174 . . . . 0.0 112.3 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.435 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 71.0 m80 -47.49 115.23 1.06 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.627 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.92 130.41 27.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.315 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 11.3 Cg_endo -54.89 120.89 8.89 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.206 1.937 . . . . 0.0 111.114 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.73 175.77 9.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.345 0.593 . . . . 0.0 112.252 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -142.84 155.7 44.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.455 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -78.85 135.28 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.98 -20.3 4.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -165.28 164.03 19.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.9 ptp -153.99 162.24 27.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.935 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.7 139.31 67.82 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.506 2.137 . . . . 0.0 112.26 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.21 -78.31 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.002 0.429 . . . . 0.0 111.025 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.76 -40.31 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.142 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.74 86.19 0.71 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.451 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.17 19.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.488 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mttp 46.05 -172.01 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.611 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.76 31.31 7.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.168 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.12 89.78 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.29 -75.18 0.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.298 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -156.64 52.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.156 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.95 144.34 45.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.422 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -94.82 154.45 17.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.767 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -99.3 107.04 19.23 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 m -103.47 150.5 6.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-O 121.433 0.635 . . . . 0.0 112.342 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 49.0 t80 -105.43 124.51 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.024 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -93.28 108.96 20.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.718 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 47.8 m-85 -61.53 177.93 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.815 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.97 -63.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.001 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.1 p -91.52 -22.46 20.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.729 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 10.6 m-70 64.56 36.96 8.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -91.64 155.44 18.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.603 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.11 140.26 53.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.188 0.518 . . . . 0.0 111.356 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.26 178.1 10.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.363 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -119.92 127.21 52.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.853 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.2 mp -138.84 161.75 36.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.994 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.48 176.4 35.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.653 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.68 -25.06 54.43 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.583 2.189 . . . . 0.0 112.409 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -69.53 -27.07 64.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 0.0 110.894 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -100.25 6.95 44.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.312 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 22.3 mt -114.31 138.1 50.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.651 0.262 . . . . 0.0 110.35 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.6 m-85 -137.11 159.58 69.33 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.066 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.9 Cg_exo -70.24 113.86 3.59 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.674 2.25 . . . . 0.0 111.65 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 89.1 t80 -53.6 -59.51 4.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.737 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -49.04 -42.63 39.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.649 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.08 -39.53 72.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.57 -179.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -105.33 10.39 33.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.4 ptpt -56.38 -44.33 80.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.633 0.254 . . . . 0.0 111.676 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.43 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mm-40 -68.56 -32.86 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 13.1 ptpt -84.01 -43.34 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.436 ' CD1' ' HG3' ' A' ' 72' ' ' LYS . 18.2 m-30 -98.3 -8.6 26.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.24 75.38 2.04 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.999 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mmmm -148.61 159.26 38.86 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.609 0.242 . . . . 0.0 110.412 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.62 151.87 59.76 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.553 2.169 . . . . 0.0 112.573 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.05 170.27 15.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.148 0.499 . . . . 0.0 111.547 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -15.67 28.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.405 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -66.35 -14.82 62.65 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.009 0.433 . . . . 0.0 110.751 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt 63.37 144.15 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.111 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.44 -18.8 35.59 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.617 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 15.0 t80 -58.56 -55.65 32.36 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-O 121.04 0.448 . . . . 0.0 110.623 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -52.83 -45.67 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -48.72 -31.35 6.75 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.922 0.391 . . . . 0.0 110.441 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.09 -31.42 61.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.881 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.9 mt -60.97 -43.8 98.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 110.231 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -64.14 -44.9 90.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.069 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.476 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -63.38 -50.92 68.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -51.81 -27.6 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 111.82 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.456 ' N ' HG23 ' A' ' 89' ' ' ILE . 0.8 OUTLIER -99.44 -44.66 6.1 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.76 -32.92 41.05 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.3 87.43 3.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.751 0.31 . . . . 0.0 111.241 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.53 -13.75 18.19 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.986 2.457 . . . . 0.0 112.633 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 p -104.01 13.07 33.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.553 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.89 147.01 12.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.939 0.399 . . . . 0.0 111.491 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -156.17 125.33 6.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -121.23 123.13 41.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.024 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.9 t -81.89 -172.8 4.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.87 167.45 35.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -147.83 -176.78 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.347 . . . . 0.0 110.85 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -134.0 132.39 40.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -103.63 150.86 23.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -90.12 -177.5 5.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -85.05 -38.47 19.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -123.33 167.01 14.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.63 176.52 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.3 m -124.39 165.34 17.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.924 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 t 60.53 101.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.67 149.1 41.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.028 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.882 0.373 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 p -100.76 -31.9 10.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.44 168.13 20.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.804 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.1 p -116.11 177.12 4.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -122.48 32.69 5.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.08 160.94 37.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 69.55 172.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 1.7 ptpp? -90.52 105.4 17.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.001 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -92.24 135.93 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.517 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.434 ' CE1' HG13 ' A' ' 16' ' ' VAL . 55.5 m-85 -106.26 152.22 23.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.802 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.47 147.05 50.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 110.878 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 t -52.21 126.72 19.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.294 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.525 ' HA2' ' HE ' ' A' ' 29' ' ' ARG . . . 109.72 -18.46 29.44 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.195 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.47 144.56 48.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 111.859 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.3 mt -92.54 123.73 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.105 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.434 HG13 ' CE1' ' A' ' 10' ' ' TYR . 24.1 m -141.9 173.01 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 112.193 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -111.84 135.88 51.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.746 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.75 122.24 47.09 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.003 0.43 . . . . 0.0 111.571 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.415 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 22.8 tptm -92.21 129.71 38.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 mtm -128.21 149.94 50.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.586 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 124.45 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.982 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 91.41 -0.75 75.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.049 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.1 m-85 -146.52 153.54 47.57 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.857 0.329 . . . . 0.0 110.813 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.41 165.31 16.47 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.771 2.314 . . . . 0.0 112.417 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.485 ' CE1' ' CZ ' ' A' ' 73' ' ' PHE . 70.1 m80 -47.94 115.42 1.17 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.489 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.429 ' CD1' ' HD2' ' A' ' 27' ' ' PRO . 2.5 t-105 -98.91 132.86 22.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.412 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 35.1 Cg_exo -54.54 120.05 7.42 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.04 1.827 . . . . 0.0 111.079 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.7 174.57 10.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.347 0.594 . . . . 0.0 112.373 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.525 ' HE ' ' HA2' ' A' ' 13' ' ' GLY . 43.1 ttt180 -141.53 154.8 45.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.607 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 mm -78.39 138.65 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -123.89 -23.21 4.7 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -164.28 153.2 13.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.979 0.419 . . . . 0.0 111.353 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 9.5 mmt -92.88 156.37 40.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.62 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 5.9 Cg_exo -78.22 131.26 10.66 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.845 2.364 . . . . 0.0 111.986 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.4 -86.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.68 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -173.8 -54.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.263 0.554 . . . . 0.0 110.417 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.3 65.67 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.046 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.4 m -148.96 156.97 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt 67.54 -72.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.695 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.31 40.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.275 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -137.3 109.09 7.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.091 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.22 -64.53 1.08 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.327 0.584 . . . . 0.0 109.888 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.44 56.65 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.747 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.47 149.96 52.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.543 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.461 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 61.1 m-85 -94.37 158.3 15.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.128 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.9 106.37 18.66 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.9 t -103.7 142.72 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.494 -178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -106.77 123.3 47.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.774 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -95.11 108.69 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.311 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 54.3 m-85 -57.57 179.32 0.06 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.27 -64.12 0.56 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.311 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.5 p -92.0 -22.63 19.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.8 m170 64.62 36.01 8.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.224 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -90.41 153.84 20.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.602 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.72 141.35 52.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.212 0.529 . . . . 0.0 111.526 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.97 166.74 32.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.305 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -107.08 124.85 50.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.9 mt -138.71 160.22 40.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.925 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.13 177.26 38.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.63 -24.8 47.7 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.507 2.138 . . . . 0.0 112.388 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -69.17 -25.26 64.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.92 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.6 6.48 45.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.322 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 38.6 mt -115.02 138.82 50.43 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.723 0.297 . . . . 0.0 110.57 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.1 m-85 -136.34 159.99 68.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.701 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.602 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 8.1 Cg_exo -71.28 114.17 3.84 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.46 2.107 . . . . 0.0 111.479 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 70' ' ' LYS . 74.3 t80 -51.07 -59.57 4.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.117 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 1.1 mt-10 -48.09 -43.7 30.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.923 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 7.0 mt-10 -71.37 -39.63 71.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.524 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.44 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 63.7 m -103.04 9.69 38.45 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.3 ptpp? -55.62 -44.62 77.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.69 0.281 . . . . 0.0 111.669 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.463 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 1.4 mt-10 -68.39 -34.25 75.7 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.44 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -84.25 -44.15 14.16 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.485 ' CZ ' ' CE1' ' A' ' 25' ' ' HIS . 19.2 m-30 -95.95 -14.1 23.33 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.98 74.89 2.34 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.195 -1.002 . . . . 0.0 113.071 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -149.11 159.31 37.45 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.589 0.233 . . . . 0.0 110.548 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.69 152.72 79.17 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.559 2.172 . . . . 0.0 112.621 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' ND2' ' HB2' ' A' ' 79' ' ' ARG . 50.6 p-10 -138.52 -172.37 3.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.291 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -100.35 -12.09 19.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.154 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 13.7 mmm180 -65.91 -15.95 63.42 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.993 0.425 . . . . 0.0 110.676 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt 62.7 141.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.996 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.49 59.3 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.562 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 26.5 t80 -57.5 -58.09 9.82 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.979 0.419 . . . . 0.0 110.941 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.37 -45.23 62.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.086 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.21 -32.28 10.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.012 0.434 . . . . 0.0 110.324 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.9 -32.59 58.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.826 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.62 -43.51 97.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.098 0.475 . . . . 0.0 110.141 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 59.0 t90 -63.32 -44.51 94.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.1 mp0 -62.93 -51.91 65.1 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -51.97 -25.63 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -101.04 -44.74 5.62 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -81.98 -32.5 30.63 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.24 84.09 3.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.804 0.335 . . . . 0.0 110.733 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 91.4 Cg_endo -77.08 -9.99 17.9 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.559 2.173 . . . . 0.0 112.856 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.1 p -104.12 12.2 34.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.588 0.232 . . . . 0.0 111.445 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.4 p -62.75 147.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 111.549 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -150.91 168.17 25.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.11 -48.27 10.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.085 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.8 p -142.78 126.69 17.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.76 -37.09 2.84 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.625 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.36 77.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -163.38 -46.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.827 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.7 p -121.77 111.66 17.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.58 120.03 14.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.824 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -108.02 -36.91 6.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.23 123.79 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -143.39 152.31 41.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.5 m -93.25 -46.78 7.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.975 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 13.1 t 60.54 109.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.05 113.86 13.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.995 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.809 0.337 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.96 127.51 35.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.56 105.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 p -170.4 141.49 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -107.35 152.06 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -93.2 174.48 7.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.809 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -93.52 93.46 8.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.819 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -94.34 148.93 21.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -95.25 139.92 30.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.55 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.446 ' CD1' HG12 ' A' ' 16' ' ' VAL . 94.1 m-85 -113.72 158.53 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -136.12 159.67 40.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 111.046 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.8 m -52.52 124.82 14.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.28 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 29' ' ' ARG . . . 105.58 -16.51 44.25 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.817 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.69 135.36 49.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.995 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 71.0 mt -92.07 117.26 29.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 110.286 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.446 HG12 ' CD1' ' A' ' 10' ' ' TYR . 33.5 m -139.1 171.38 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.995 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.568 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 28.6 m-85 -110.23 136.01 50.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.619 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -113.71 125.09 53.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.103 0.477 . . . . 0.0 111.781 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . 21.3 tptm -91.47 133.3 35.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.055 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -125.51 154.41 42.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.676 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.59 115.48 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.983 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.99 39.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.575 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -116.55 148.71 42.42 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-O 120.758 0.313 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.58 166.66 23.64 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.738 2.292 . . . . 0.0 112.731 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 69.6 m80 -51.64 115.13 1.48 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.373 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.469 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.6 t-105 -99.56 134.54 21.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 31.1 Cg_exo -54.44 120.89 8.77 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.164 1.909 . . . . 0.0 110.712 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.0 174.77 10.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.425 ' CZ ' ' HA2' ' A' ' 13' ' ' GLY . 5.1 ttp180 -141.59 156.85 45.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.745 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.414 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 27.0 mm -83.89 140.51 16.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.726 0.298 . . . . 0.0 110.574 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -124.55 -18.75 5.6 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -163.1 152.43 15.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.966 0.412 . . . . 0.0 111.214 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.5 mmt -89.5 158.4 45.81 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.693 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.426 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 85.2 Cg_endo -82.15 107.68 1.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.667 2.244 . . . . 0.0 112.477 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.29 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.723 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -174.33 -48.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.384 0.612 . . . . 0.0 110.17 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.06 80.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.104 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.3 m -146.78 14.36 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.877 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.05 -60.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.707 0.289 . . . . 0.0 111.07 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 171.98 43.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.616 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 p -135.97 112.24 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.261 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.58 -64.71 1.05 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.366 0.603 . . . . 0.0 109.525 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.06 56.52 0.59 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.786 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.96 148.82 52.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.482 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.426 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 72.1 m-85 -94.88 154.08 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.869 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -98.65 104.24 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.1 m -102.41 150.56 6.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.545 0.688 . . . . 0.0 112.432 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 36.4 t80 -105.4 124.81 50.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.967 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -91.47 108.1 19.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.494 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 45.0 m-85 -60.52 175.95 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.721 0.296 . . . . 0.0 110.955 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.58 -62.47 0.87 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.088 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 p -90.98 -22.52 20.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.841 0.353 . . . . 0.0 110.739 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 20.6 m170 63.83 35.51 11.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.499 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -91.3 155.38 18.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.64 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.79 140.6 52.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.326 0.584 . . . . 0.0 111.639 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.08 168.79 25.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.431 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -111.82 127.05 55.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.145 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.4 mp -138.36 160.23 40.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.58 177.33 37.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.77 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.89 -27.0 51.38 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.672 2.248 . . . . 0.0 112.363 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -69.25 -25.33 64.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -99.1 5.49 46.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.314 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 33.0 mt -113.17 138.71 49.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.814 0.34 . . . . 0.0 110.699 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 0.8 OUTLIER -134.74 154.01 79.18 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.83 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.464 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 15.0 Cg_exo -67.1 112.3 2.48 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.279 1.986 . . . . 0.0 111.157 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 77.2 t80 -51.49 -59.9 3.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.25 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -48.23 -43.0 31.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.012 0.434 . . . . 0.0 111.807 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 48.0 mt-10 -71.24 -39.69 71.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.466 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.0 8.49 38.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 66' ' ' TYR . 11.3 ptmt -55.35 -48.12 74.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.842 0.353 . . . . 0.0 111.38 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.01 -23.93 63.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.833 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -85.29 -47.51 9.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -105.58 -0.55 25.64 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.38 73.3 2.41 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.724 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.436 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 27.1 mmtt -148.53 159.11 39.44 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.588 0.232 . . . . 0.0 110.567 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.2 153.09 28.29 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.543 2.162 . . . . 0.0 112.374 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -131.96 165.57 23.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.113 0.483 . . . . 0.0 111.672 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -86.75 -17.27 34.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.009 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -14.47 62.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.049 0.452 . . . . 0.0 110.531 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm 63.65 144.56 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.131 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.59 -18.22 39.71 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.802 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 30.0 t80 -58.59 -54.4 47.44 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.037 0.446 . . . . 0.0 110.801 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -45.64 66.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.16 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -48.46 -31.7 6.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.43 . . . . 0.0 110.49 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.52 -31.89 60.31 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.054 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.9 mt -60.57 -43.82 96.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 110.35 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 69.4 t90 -64.35 -45.48 87.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.125 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -62.55 -51.23 68.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -51.83 -27.73 8.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.317 . . . . 0.0 111.709 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.32 -44.58 6.17 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -80.69 -31.71 36.17 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -156.59 88.59 2.75 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 111.351 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 80.2 Cg_endo -77.81 -11.91 16.6 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.625 2.217 . . . . 0.0 112.646 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.3 p -101.71 10.55 39.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.605 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.33 143.84 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.0 111.266 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.95 114.12 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.08 -66.79 0.88 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.098 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 88.8 p -63.79 -175.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.17 -45.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.555 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 58.58 83.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.5 92.46 4.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.0 m -123.94 99.74 6.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -156.12 -46.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -109.01 177.87 4.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.006 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -25.2 19.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.118 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm 62.71 -175.75 0.14 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.53 97.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.754 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.7 t 62.3 75.53 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.939 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.32 101.57 1.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.819 0.343 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -134.75 106.25 6.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.73 101.08 3.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.6 m 60.49 105.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -88.54 177.03 6.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 61.03 112.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.12 -178.1 4.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.773 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.15 119.07 23.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -95.59 143.73 26.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.725 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.44 ' CD2' HG11 ' A' ' 16' ' ' VAL . 87.8 m-85 -113.33 157.44 21.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -132.91 157.05 46.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.89 0.376 . . . . 0.0 111.102 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.5 m -51.9 132.12 31.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.594 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.19 -12.25 68.37 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.937 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.73 139.18 51.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 0.0 111.006 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.2 mt -91.18 116.51 28.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.996 0.427 . . . . 0.0 110.4 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 10' ' ' TYR . 30.6 m -139.69 170.34 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.552 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.521 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 18.0 m-85 -111.15 135.88 51.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.519 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.89 123.05 49.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.906 0.384 . . . . 0.0 111.397 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 23.8 tptp -92.08 130.94 37.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.134 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtm -127.03 147.86 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.47 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 113.48 4.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 111.013 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.96 -27.38 14.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.635 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.91 157.98 48.98 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.942 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.46 166.39 12.2 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.826 2.35 . . . . 0.0 112.372 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.505 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 59.0 m80 -47.23 113.99 0.78 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.516 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.466 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.49 130.7 27.49 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.642 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.55 119.03 5.75 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.376 2.051 . . . . 0.0 111.083 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.2 175.2 10.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.424 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 14.3 ttp180 -142.53 156.44 45.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.493 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.424 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 25.0 mm -79.91 138.76 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.21 -20.84 5.15 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -162.65 151.31 14.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.957 0.408 . . . . 0.0 111.227 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 31.2 mmt -91.51 161.63 33.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.66 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.443 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 90.8 Cg_endo -85.41 117.32 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.675 2.25 . . . . 0.0 112.11 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -85.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.101 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.13 -60.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.0 110.622 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.77 27.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.249 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.6 m -89.85 -2.68 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.772 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -163.74 -179.1 6.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.57 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 60.6 p -71.33 62.53 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.696 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' ASN . 13.4 t -129.75 -15.31 3.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.844 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 43.84 -87.12 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.731 0.301 . . . . 0.0 111.323 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -155.02 50.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.168 0.509 . . . . 0.0 110.235 179.083 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -141.48 166.44 24.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.048 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.443 ' CE2' ' HD3' ' A' ' 34' ' ' PRO . 45.5 m-85 -94.12 157.91 15.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.9 107.51 19.96 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.3 t -103.53 142.68 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 121.463 0.649 . . . . 0.0 112.56 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -105.61 121.89 44.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.507 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -94.16 106.62 18.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.049 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.443 ' HB3' ' HA2' ' A' ' 85' ' ' GLY . 49.4 m-85 -57.59 176.99 0.11 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.843 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.77 -63.55 0.67 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.418 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 81.0 p -90.19 -23.21 21.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.739 0.304 . . . . 0.0 110.738 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 52' ' ' THR . 4.0 m170 66.0 33.91 7.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.197 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.2 151.03 21.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.928 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.8 140.79 51.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.239 0.542 . . . . 0.0 111.307 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.88 168.11 28.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.289 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.415 ' CE2' ' O ' ' A' ' 40' ' ' SER . 13.4 m-85 -109.31 125.45 52.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.995 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 mt -139.33 160.62 39.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.37 -179.85 40.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.23 -26.82 41.74 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.511 2.14 . . . . 0.0 112.189 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -69.55 -22.59 63.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.077 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -99.0 3.66 47.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.463 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 18.4 mt -115.03 139.6 49.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.2 m-85 -136.59 166.3 28.65 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.845 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.414 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 4.8 Cg_exo -73.17 111.08 3.2 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.767 2.311 . . . . 0.0 111.69 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.2 t80 -49.95 -58.44 5.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.478 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -49.0 -41.09 33.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.611 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 4.9 mm-40 -71.02 -39.71 72.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.674 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.423 ' CB ' ' CD2' ' A' ' 73' ' ' PHE . 3.6 m -103.39 13.87 32.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 66' ' ' TYR . 2.2 mtmp? -55.52 -44.95 77.15 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.413 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.75 -40.83 88.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.75 -43.88 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.9 m-30 -94.71 -19.77 20.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -86.73 74.08 2.39 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.042 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 12.1 mttt -149.32 153.57 37.62 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.95 155.5 8.42 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.616 2.211 . . . . 0.0 112.638 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -136.39 165.58 25.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.578 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -85.73 -16.07 40.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.304 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.58 -13.8 61.53 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.987 0.423 . . . . 0.0 110.713 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt 63.79 142.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.159 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.71 -16.87 55.52 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.517 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 31.4 t80 -59.0 -56.88 16.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.943 0.402 . . . . 0.0 110.882 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.41 -45.42 65.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.113 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.62 -30.13 5.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.017 0.437 . . . . 0.0 110.503 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.443 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.96 -31.86 57.43 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.161 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.4 -43.35 96.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.064 0.459 . . . . 0.0 110.34 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 62.9 t90 -63.73 -45.71 88.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.229 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.67 -50.63 70.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.428 HG21 ' N ' ' A' ' 90' ' ' GLU . 1.1 tt -52.92 -27.03 12.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.744 0.306 . . . . 0.0 111.692 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' N ' HG21 ' A' ' 89' ' ' ILE . 17.5 mt-10 -99.31 -44.83 6.08 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -79.64 -31.55 41.54 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.455 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . 1.0 OUTLIER -156.99 87.08 2.76 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.751 0.31 . . . . 0.0 111.282 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.01 -12.94 26.21 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.933 2.422 . . . . 0.0 112.61 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 p -107.05 14.66 26.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.53 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 92' ' ' ASN . 14.6 p -62.56 150.66 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.075 0.464 . . . . 0.0 111.702 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -153.99 122.35 6.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.603 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 64.85 -76.67 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.086 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -140.47 175.4 9.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.808 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.39 -97.77 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.545 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 60.7 -172.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.808 0.337 . . . . 0.0 110.934 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -159.71 -45.63 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.3 t -143.66 143.75 31.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.844 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.55 165.75 11.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.41 28.86 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.033 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.0 113.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.981 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.74 81.95 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.7 31.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.3 t -151.44 145.96 25.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.71 87.87 6.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.089 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.926 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.795 0.331 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -113.01 31.93 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.83 135.73 39.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -76.03 122.77 24.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -160.29 138.72 10.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -146.7 31.42 0.97 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -121.75 134.62 54.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.691 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.652 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 1.7 tttp -146.68 -154.4 0.55 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.166 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.652 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 1.9 mm-40 82.09 134.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.857 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.455 ' CD2' HG11 ' A' ' 16' ' ' VAL . 4.6 m-85 -125.93 166.79 16.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.819 0.342 . . . . 0.0 111.475 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -140.56 165.91 26.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.897 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 98.8 m -52.01 125.36 15.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.409 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.34 -16.34 49.15 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.153 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.19 138.92 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.79 0.329 . . . . 0.0 111.323 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.3 mt -91.43 120.75 32.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.191 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.455 HG11 ' CD2' ' A' ' 10' ' ' TYR . 22.6 m -141.62 174.05 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.369 0.604 . . . . 0.0 112.133 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.508 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 9.4 m-85 -111.97 136.34 51.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.419 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.65 125.53 54.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.022 0.439 . . . . 0.0 111.449 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.82 132.58 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.979 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.7 mtm -129.81 155.01 46.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.701 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.73 119.62 13.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.034 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.23 -13.03 66.12 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.813 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.54 149.21 64.23 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.759 0.279 . . . . 0.0 110.836 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.24 167.91 15.39 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.723 2.282 . . . . 0.0 112.448 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -47.18 112.38 0.52 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.581 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.6 t-105 -97.79 130.5 28.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.436 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.38 119.38 6.28 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.364 2.043 . . . . 0.0 111.004 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.62 175.54 10.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -142.45 157.18 45.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.464 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -80.13 138.84 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -125.45 -20.36 4.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.53 152.71 14.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.025 0.441 . . . . 0.0 111.519 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 18.2 mmt -90.6 159.16 41.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.671 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 87.1 Cg_endo -81.95 111.02 2.15 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.613 2.209 . . . . 0.0 112.34 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.33 -89.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.647 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -172.72 -54.15 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.302 0.573 . . . . 0.0 110.291 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.0 78.52 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.053 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 m -143.55 10.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.798 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -166.33 -57.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.918 0.39 . . . . 0.0 110.815 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.02 40.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.353 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t -130.9 -178.73 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.141 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -172.41 -45.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.598 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.82 35.49 0.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.026 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.16 146.98 45.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.579 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 84.6 m-85 -92.49 155.06 18.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.108 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -96.38 106.55 18.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.54 142.94 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.431 -178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -105.14 120.88 42.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.568 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -94.08 111.36 23.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.787 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 47.8 m-85 -60.67 177.54 0.29 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.954 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.22 -62.93 0.78 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.22 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.5 p -92.08 -23.24 19.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 0.0 110.679 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.4 m170 63.88 37.64 9.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.339 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.99 153.95 19.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.829 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 144.15 49.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.365 0.603 . . . . 0.0 111.764 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.93 164.79 38.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.099 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 36.8 m-85 -107.87 87.8 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.155 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.6 mt -99.21 158.67 15.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.059 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.29 171.78 32.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.319 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.87 -22.53 48.84 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.536 2.157 . . . . 0.0 112.464 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -67.87 -27.22 66.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.694 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -100.0 14.55 30.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.964 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.6 mp -109.56 137.3 47.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.583 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.6 m-85 -136.18 157.85 74.83 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.958 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.5 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 9.5 Cg_exo -71.38 112.06 3.25 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.672 2.248 . . . . 0.0 111.525 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.4 t80 -51.37 -58.96 4.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.908 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.4 -40.28 49.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.081 0.467 . . . . 0.0 111.654 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.8 tt0 -71.66 -39.94 69.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.577 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -105.75 9.54 32.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.3 ptmm? -56.54 -47.51 79.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 0.0 111.435 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -23.27 62.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.75 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -85.06 -47.36 10.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -108.88 3.76 22.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 70' ' ' LYS . . . -83.77 16.84 29.38 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.684 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -94.07 157.91 36.99 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.39 0.595 . . . . 0.0 110.457 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.46 158.39 10.16 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.379 2.052 . . . . 0.0 112.246 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -132.23 169.07 16.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.625 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -89.18 -16.5 31.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.349 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -14.61 61.9 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 110.783 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt 63.35 141.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.084 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.8 -17.11 54.71 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.403 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 47.5 t80 -58.17 -54.88 41.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.03 0.443 . . . . 0.0 110.734 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.64 -46.37 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.306 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.34 -31.5 6.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.007 0.432 . . . . 0.0 110.619 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.42 -31.16 59.34 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.044 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.9 mt -60.88 -43.68 98.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.003 0.43 . . . . 0.0 110.415 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.1 t90 -63.74 -44.57 93.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.22 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -63.5 -50.5 69.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.439 HG23 ' N ' ' A' ' 90' ' ' GLU . 0.8 OUTLIER -51.72 -27.45 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.439 ' N ' HG23 ' A' ' 89' ' ' ILE . 55.4 mt-10 -100.29 -44.73 5.84 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -79.17 -33.71 43.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -156.37 90.2 2.68 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.317 . . . . 0.0 111.194 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.5 Cg_endo -77.27 -11.24 17.6 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.565 2.176 . . . . 0.0 112.748 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.2 p -103.09 12.54 35.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.507 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.7 p -62.68 144.81 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.944 0.402 . . . . 0.0 111.35 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -127.14 171.32 11.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.77 -46.9 3.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.3 t -89.62 147.48 23.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -123.18 -93.27 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.48 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -73.9 111.14 8.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -61.04 101.77 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.964 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.49 -178.22 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.035 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.8 t -171.61 172.52 4.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -129.31 169.95 14.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -90.27 -30.79 17.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 95.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.0 m -165.21 158.68 16.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.0 p -132.21 -43.78 0.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.009 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.61 -50.72 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.125 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.789 0.328 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -133.73 -51.83 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.06 -172.78 2.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.719 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.02 -177.19 3.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.056 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -142.82 -65.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.739 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 -122.06 23.09 10.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -126.03 105.44 8.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.69 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.442 ' HD2' ' CE2' ' A' ' 10' ' ' TYR . 2.5 pttp -140.68 176.43 8.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.156 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -154.29 142.65 20.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.568 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.472 ' CE1' HG12 ' A' ' 16' ' ' VAL . 88.8 m-85 -116.97 159.59 22.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.669 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -137.72 161.3 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 111.016 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 t -52.28 124.61 13.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.83 -16.11 43.85 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.023 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.26 140.0 50.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 111.081 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 15' ' ' LEU . 56.1 mt -92.74 118.7 31.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.339 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.472 HG12 ' CE1' ' A' ' 10' ' ' TYR . 31.0 m -139.67 171.82 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.185 0.517 . . . . 0.0 111.743 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.6 m-85 -109.99 136.6 49.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.764 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' ASP . . . -113.49 126.44 55.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.012 0.434 . . . . 0.0 111.799 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.457 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 14.2 tptm -92.9 130.64 38.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.902 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.41 ' HE2' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.88 148.53 50.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.802 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -67.36 106.76 2.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.745 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.75 -7.07 27.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.78 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -141.06 156.58 68.14 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.781 0.324 . . . . 0.0 110.637 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.89 171.92 9.12 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.735 2.29 . . . . 0.0 112.212 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.457 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 74.7 m80 -47.76 111.8 0.47 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.392 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 1.5 t-105 -99.54 129.04 29.84 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.322 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HG3' HD22 ' A' ' 86' ' ' LEU . 12.5 Cg_endo -55.44 121.15 9.42 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.13 1.886 . . . . 0.0 110.98 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.59 175.73 9.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.308 0.575 . . . . 0.0 112.266 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -141.7 154.84 45.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.765 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 mm -82.27 114.25 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.87 -13.85 14.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.31 152.48 14.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.039 0.447 . . . . 0.0 111.318 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.427 ' HE3' ' O ' ' A' ' 10' ' ' TYR . 6.3 ptp -154.77 156.34 31.32 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.21 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.73 160.73 24.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.701 2.267 . . . . 0.0 112.196 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -82.8 -37.95 23.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 110.754 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.81 -39.65 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.971 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.458 ' O ' ' CG2' ' A' ' 38' ' ' VAL . . . -162.53 -47.57 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.036 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 37' ' ' ALA . 5.3 m 50.94 21.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.856 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.5 60.5 2.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.733 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.5 p 177.18 -45.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.9 p -79.51 102.85 9.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.72 52.78 0.42 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.017 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t30 56.03 50.82 13.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.137 0.494 . . . . 0.0 111.01 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -132.07 138.77 48.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.248 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 62.9 m-85 -94.37 153.16 18.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.79 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -99.03 105.75 17.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -101.44 150.35 6.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.49 0.662 . . . . 0.0 112.214 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 33.0 t80 -105.82 124.51 49.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.04 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.446 ' HE2' ' HB1' ' A' ' 56' ' ' ALA . 32.7 m-85 -91.88 107.53 19.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.554 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 36.2 m-85 -58.46 174.99 0.27 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 0.0 111.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.57 -62.04 0.87 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.358 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.3 p -90.5 -21.57 21.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.606 0.241 . . . . 0.0 111.06 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 48.5 m170 64.02 34.94 10.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.912 0.386 . . . . 0.0 110.265 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -90.32 153.65 20.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.675 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.55 141.52 51.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.15 0.5 . . . . 0.0 111.69 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' HB1' ' HE2' ' A' ' 49' ' ' PHE . . . -155.32 177.54 11.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.391 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 8.6 m-85 -120.62 127.29 51.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.886 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mt -139.93 163.93 31.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.13 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.94 177.07 35.18 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.616 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.07 -25.19 51.44 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.624 2.216 . . . . 0.0 112.552 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -69.9 -25.54 63.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 111.064 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 35.7 m-20 -98.3 4.84 48.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.436 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.7 mt -112.55 139.25 48.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.696 0.284 . . . . 0.0 110.488 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.3 m-85 -135.94 160.06 68.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.07 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 12.3 Cg_exo -69.77 110.91 2.67 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.672 2.248 . . . . 0.0 111.604 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.4 t80 -51.91 -59.16 4.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.593 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -50.49 -41.36 53.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.684 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 2.2 tm-20 -69.58 -39.77 77.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.545 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.1 m -108.09 13.74 25.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.5 ptpp? -56.08 -47.74 77.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.922 0.391 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.4 mt-10 -71.06 -21.41 62.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.307 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.424 ' HD3' ' CE1' ' A' ' 73' ' ' PHE . 4.2 tttt -85.46 -49.47 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 9.4 m-85 -102.94 -4.8 24.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.3 70.95 3.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.048 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 9.1 mtmt -149.21 153.69 38.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.88 158.23 14.53 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.587 2.192 . . . . 0.0 112.632 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -137.12 167.29 21.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.565 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.45 -15.51 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.109 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -14.06 61.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.958 0.408 . . . . 0.0 110.767 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp 63.84 142.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.276 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.05 -17.72 49.43 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.775 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 44.6 t80 -59.96 -54.23 48.53 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.904 0.383 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.05 -46.34 68.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.224 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -48.47 -29.75 4.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.986 0.422 . . . . 0.0 110.614 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.02 -31.48 59.77 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.206 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' A' ' 27' ' ' PRO . 3.8 mm? -61.09 -44.11 97.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.968 0.413 . . . . 0.0 110.535 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 64.0 t90 -65.08 -45.72 84.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.347 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.59 -50.85 69.65 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.44 -27.13 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.712 0.291 . . . . 0.0 111.734 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -99.58 -44.76 6.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.23 -31.98 38.47 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -155.55 88.04 3.09 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.725 0.298 . . . . 0.0 111.252 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.2 Cg_endo -75.78 -13.46 19.83 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.679 2.253 . . . . 0.0 112.739 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.3 p -105.69 12.4 31.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.532 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.7 p -63.19 149.61 10.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.938 0.399 . . . . 0.0 111.461 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.09 143.25 25.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.933 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.5 104.14 16.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.993 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -83.5 138.33 33.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.966 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.26 141.81 10.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.45 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -125.78 153.01 44.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.806 0.336 . . . . 0.0 111.041 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.01 -46.68 0.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.2 t -133.89 99.83 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -101.89 -62.96 1.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.949 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.2 113.63 1.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.29 157.77 43.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.84 124.63 29.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.8 m -150.59 138.94 20.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 67.5 m -142.92 -56.63 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.92 167.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.604 0.24 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 p -68.21 86.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.996 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 60.14 91.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.6 p -134.78 29.84 3.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -129.8 104.42 7.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.791 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -79.97 -71.4 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.984 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -144.67 149.57 35.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.982 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 8.4 ttpt -142.68 -146.87 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.47 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 37.0 mt-10 86.28 129.9 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.894 0.478 . . . . 0.0 109.791 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.475 ' CD2' HG12 ' A' ' 16' ' ' VAL . 5.5 m-85 -112.95 159.13 19.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -135.64 160.1 39.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.047 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.4 t -52.21 129.15 27.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.49 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.75 -14.21 59.03 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.978 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.15 138.31 51.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 0.0 111.051 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.9 mt -92.19 118.79 31.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.967 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.475 HG12 ' CD2' ' A' ' 10' ' ' TYR . 25.0 m -140.61 175.8 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.252 0.549 . . . . 0.0 112.152 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.487 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 16.4 m-85 -114.02 137.32 51.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.74 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.71 124.6 52.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 0.0 111.537 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -91.98 132.96 36.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.079 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 mmm -127.74 150.66 49.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.598 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 116.15 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.836 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.07 -16.07 58.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.859 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -130.06 151.93 79.17 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.715 0.293 . . . . 0.0 110.703 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.13 167.81 17.55 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.639 2.226 . . . . 0.0 112.409 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 51.0 m80 -46.38 114.77 0.87 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.871 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.447 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.3 t-105 -98.33 129.44 30.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.609 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.406 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 9.8 Cg_endo -52.56 119.11 5.41 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.398 2.065 . . . . 0.0 111.214 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.403 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.9 175.75 9.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.431 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 3.1 ttt180 -142.28 155.81 45.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.397 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.431 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 25.4 mm -79.03 137.35 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.28 -20.85 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -163.32 151.37 13.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.041 0.448 . . . . 0.0 111.284 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 32.4 mmt -94.53 159.84 32.85 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.492 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.444 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 95.7 Cg_endo -81.0 127.18 6.01 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.466 2.111 . . . . 0.0 112.227 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.0 -80.36 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.071 0.463 . . . . 0.0 110.956 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 42' ' ' ALA . . . -169.82 -53.54 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.102 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.91 72.22 0.31 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.353 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.451 ' C ' ' HG2' ' A' ' 39' ' ' LYS . 6.8 m -150.36 161.89 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.1 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.451 ' HG2' ' C ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER 32.16 49.44 0.14 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.288 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m 60.99 68.31 0.75 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.295 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.4 HG23 ' CE2' ' A' ' 57' ' ' PHE . 69.1 p -150.28 170.15 19.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.139 0.495 . . . . 0.0 110.866 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 36' ' ' ALA . . . -169.28 -56.43 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.822 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -156.34 40.0 0.35 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.931 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.4 mttm -137.18 149.45 47.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.725 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 58.5 m-85 -94.2 154.51 17.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.99 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.03 108.06 20.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.403 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 60.5 t -103.2 142.46 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.576 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -104.14 120.3 40.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.807 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -93.66 108.36 20.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 47.5 m-85 -59.21 176.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.859 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 -63.34 0.84 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.287 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.2 p -90.79 -22.75 20.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.737 0.303 . . . . 0.0 110.742 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.2 m170 64.62 34.83 9.54 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.075 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -90.23 152.48 21.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.705 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.42 144.89 48.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.28 0.562 . . . . 0.0 111.549 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.37 165.01 37.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.161 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.494 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 74.1 m-85 -107.99 87.88 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.054 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.8 mp -97.84 156.47 16.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.17 179.52 39.37 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.57 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.27 -30.11 45.92 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.635 2.224 . . . . 0.0 112.45 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -69.48 -21.69 63.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.098 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -99.49 2.6 45.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.474 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 mt -110.16 139.34 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 0.0 110.653 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.8 m-85 -136.37 153.2 76.15 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.49 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 24.7 Cg_exo -63.49 112.4 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.469 2.113 . . . . 0.0 111.706 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' LYS . 60.0 t80 -53.39 -59.36 4.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.743 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.4 mt-10 -49.71 -41.76 44.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.106 0.479 . . . . 0.0 111.521 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -69.96 -39.76 75.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.42 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.9 m -105.9 12.2 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 66' ' ' TYR . 5.3 ptpp? -55.71 -48.42 75.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.953 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 16.6 pt-20 -71.65 -19.99 62.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.412 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.48 -49.99 8.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -103.36 -4.63 23.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.34 71.44 2.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.19 -1.005 . . . . 0.0 113.081 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.81 149.62 28.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.678 0.275 . . . . 0.0 110.303 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.54 155.61 2.2 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.588 2.192 . . . . 0.0 112.757 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.95 165.2 27.11 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.748 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -85.01 -16.44 40.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.123 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -65.68 -14.87 62.1 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.055 0.455 . . . . 0.0 110.619 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? 62.77 143.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.072 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.77 -18.0 41.82 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.337 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.447 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 43.7 t80 -58.46 -57.12 14.34 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -53.32 -45.69 69.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.989 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -48.86 -31.25 6.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.018 0.437 . . . . 0.0 110.525 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.39 -31.39 61.16 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.879 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.7 mt -60.56 -43.58 97.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.968 0.413 . . . . 0.0 110.359 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.1 t90 -63.21 -45.74 90.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.157 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.4 OUTLIER -62.91 -50.91 69.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.424 HG23 ' N ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -52.23 -26.28 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.322 . . . . 0.0 111.851 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.424 ' N ' HG23 ' A' ' 89' ' ' ILE . 4.1 mm-40 -100.55 -44.75 5.76 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -79.45 -32.77 42.74 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -156.92 90.41 2.53 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.698 0.285 . . . . 0.0 111.152 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 82.3 Cg_endo -78.01 -11.31 16.49 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.544 2.163 . . . . 0.0 112.745 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.5 p -106.33 13.96 28.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.531 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.47 150.49 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.875 0.369 . . . . 0.0 111.568 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.48 165.16 31.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.733 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -100.5 75.54 1.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.5 96.04 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.95 -155.37 0.63 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.528 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -143.06 -61.44 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.816 0.341 . . . . 0.0 110.974 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -104.91 109.33 21.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 p -86.77 133.13 33.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.3 m -91.81 -31.13 15.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.42 161.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -143.81 161.14 39.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 130.62 36.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.16 155.0 47.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 m -121.07 161.45 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -143.18 85.15 1.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.74 0.305 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.79 159.66 36.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -52.03 7.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.1 p -113.42 -176.2 2.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -116.76 162.47 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -171.56 143.41 1.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.987 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 61.43 153.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.031 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.44 147.75 31.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -95.78 142.57 27.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.735 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.419 ' CE1' HG12 ' A' ' 16' ' ' VAL . 87.7 m-85 -112.08 157.46 20.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.769 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -131.34 158.64 40.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.995 0.426 . . . . 0.0 111.241 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.77 131.85 35.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.515 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.89 -11.57 67.81 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.101 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.84 138.31 50.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.249 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.4 mt -91.83 118.12 30.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.386 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 10' ' ' TYR . 25.5 m -139.88 171.99 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.804 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 30.5 m-85 -112.88 137.05 51.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.492 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.43 126.6 55.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 111.248 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 12.3 tptp -90.27 136.01 33.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -130.21 151.88 50.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.547 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -67.62 118.22 10.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -8.62 74.48 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.968 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.422 ' CD1' ' HD3' ' A' ' 79' ' ' ARG . 1.9 m-85 -132.21 154.42 81.63 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-O 120.835 0.35 . . . . 0.0 111.03 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -84.23 167.15 12.36 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.832 2.355 . . . . 0.0 112.511 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.446 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 80.2 m80 -47.08 115.25 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.468 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.1 t-105 -99.02 129.98 28.42 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.503 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.77 119.46 6.29 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.374 2.049 . . . . 0.0 111.085 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.05 174.43 10.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -143.01 155.65 44.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.323 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.459 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 28.7 mm -78.13 138.4 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.73 -20.33 5.5 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.48 150.83 14.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.044 0.449 . . . . 0.0 111.239 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 29.3 mmt -93.32 161.22 31.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 96.8 Cg_endo -87.17 111.2 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.933 2.422 . . . . 0.0 112.379 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.48 -93.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.918 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -173.98 -52.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.225 0.536 . . . . 0.0 110.461 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.42 72.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.132 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.9 m -145.24 21.28 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.239 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 3.6 mmmp? -159.87 -79.61 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.508 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.7 t -179.8 41.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.503 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.428 HG23 ' CE2' ' A' ' 57' ' ' PHE . 38.2 p -138.04 122.07 17.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.199 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.69 -60.62 2.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.281 0.562 . . . . 0.0 109.714 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -155.67 50.25 0.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.79 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -114.17 139.76 49.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.725 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 79.8 m-85 -95.8 155.14 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.694 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.4 mt-30 -96.55 106.78 19.09 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.1 t -100.84 142.99 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.32 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.78 122.0 45.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.189 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -94.97 110.27 22.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.37 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.441 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 57.4 m-85 -58.83 -179.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.06 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.58 -63.66 0.63 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.146 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.9 p -91.07 -22.88 20.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 110.742 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.4 m170 64.57 36.52 8.48 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.598 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.32 157.04 16.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.44 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -131.79 149.97 52.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.313 0.578 . . . . 0.0 111.978 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.58 170.88 20.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.067 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 52.0 m-85 -105.94 86.58 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 0.0 110.875 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.23 156.84 16.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.126 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.98 169.46 32.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.295 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.54 -20.79 47.08 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.459 2.106 . . . . 0.0 112.375 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -27.83 67.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.969 0.414 . . . . 0.0 110.504 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -100.72 12.43 37.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.761 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.79 137.44 46.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.658 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.8 m-85 -136.17 158.16 74.22 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.558 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.6 Cg_exo -71.71 111.5 3.15 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.393 2.062 . . . . 0.0 111.235 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.5 t80 -45.63 -59.02 2.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.358 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -50.88 -39.55 54.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.9 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.1 mm-40 -70.6 -39.83 73.57 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.444 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 48.9 m -105.35 11.08 33.2 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.43 -49.46 74.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.797 0.332 . . . . 0.0 111.524 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.54 -26.12 64.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.649 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -84.99 -46.95 10.73 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 2.5 m-30 -99.77 -13.04 19.43 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -80.65 71.15 2.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.043 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.0 mttt -149.05 153.14 37.78 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.598 0.237 . . . . 0.0 110.39 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -51.17 153.31 9.57 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.501 2.134 . . . . 0.0 112.617 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -136.49 163.49 30.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.595 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -81.87 -16.47 50.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.196 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.422 ' HD3' ' CD1' ' A' ' 23' ' ' TYR . 17.9 mmm180 -64.54 -15.64 61.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.989 0.424 . . . . 0.0 110.809 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt 63.19 140.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.094 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.96 -17.0 53.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.399 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.468 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.6 t80 -58.54 -55.5 34.28 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.933 0.397 . . . . 0.0 110.658 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 m -53.58 -45.53 69.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.196 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.96 -31.69 7.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.997 0.427 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.02 -31.83 61.39 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.899 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.01 -43.74 98.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 0.0 110.318 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.8 t90 -63.51 -45.51 90.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.991 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.2 mp0 -62.31 -50.99 69.46 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.47 -26.02 8.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.731 0.3 . . . . 0.0 111.783 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.99 -44.79 5.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -80.42 -32.3 37.41 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.3 87.85 3.18 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 98.7 Cg_endo -79.47 -12.55 13.9 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.702 2.268 . . . . 0.0 113.029 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.0 p -103.78 12.67 34.3 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.3 p -65.53 149.37 11.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 111.33 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.92 165.82 24.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.98 178.43 8.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m 60.08 162.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.38 90.8 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.525 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -122.17 99.12 6.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -68.53 -37.42 79.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.52 93.5 4.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.4 p -143.27 128.49 18.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 61.39 113.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.86 101.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 154.47 33.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.69 179.09 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 p -173.02 35.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.979 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.64 102.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.091 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.789 0.328 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 179.11 -36.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 64.26 98.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.866 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -136.7 -58.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.788 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -110.14 97.34 6.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.04 125.97 28.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.66 130.25 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -167.2 137.39 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.51 144.26 26.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.798 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.418 ' CE1' HG13 ' A' ' 16' ' ' VAL . 98.0 m-85 -113.86 159.21 20.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.7 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -134.17 157.81 45.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 111.145 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.1 m -51.98 129.38 26.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.428 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.87 -14.91 58.61 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.91 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.04 138.16 51.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -91.79 119.66 31.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.246 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.418 HG13 ' CE1' ' A' ' 10' ' ' TYR . 23.3 m -140.77 171.27 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.133 0.492 . . . . 0.0 111.894 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.434 ' CE1' ' HA ' ' A' ' 27' ' ' PRO . 10.0 m-85 -109.79 136.62 48.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.565 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -113.09 124.6 52.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.098 0.475 . . . . 0.0 111.841 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.433 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -91.99 131.58 37.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.82 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mtp -129.04 147.52 50.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.701 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 115.29 5.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 100.46 3.96 55.12 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.823 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -152.75 153.62 30.39 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.628 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.76 167.7 18.34 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.585 2.19 . . . . 0.0 112.382 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.433 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 71.2 m80 -47.57 115.23 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.588 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.93 130.51 27.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.245 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 11.4 Cg_endo -54.95 120.83 8.8 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.171 1.914 . . . . 0.0 111.179 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.67 175.7 9.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.277 0.56 . . . . 0.0 112.241 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -142.78 155.73 44.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.439 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.9 mm -78.88 135.2 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.92 -20.23 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -165.3 164.01 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.074 0.464 . . . . 0.0 111.73 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.9 ptp -153.98 162.16 27.47 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.898 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.68 139.31 67.64 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.545 2.163 . . . . 0.0 112.168 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.2 -78.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.8 -40.3 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.136 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.71 86.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.454 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.19 19.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.442 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mttp 46.0 -172.04 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.962 0.41 . . . . 0.0 111.611 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 51.79 31.32 8.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.12 89.73 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.24 -75.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.298 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -156.58 52.87 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.185 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.01 144.21 45.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.435 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.77 154.48 17.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.758 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -99.27 107.0 19.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 m -103.46 150.4 6.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.411 0.624 . . . . 0.0 112.339 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 49.3 t80 -105.44 124.56 49.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.992 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -93.31 108.94 20.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.648 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.477 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 48.2 m-85 -61.37 177.9 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.933 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.96 -63.48 0.93 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.96 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -91.42 -22.37 20.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.0 110.779 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 10.6 m-70 64.41 37.02 8.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.461 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -91.65 155.47 18.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 140.29 53.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.194 0.521 . . . . 0.0 111.393 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.36 178.11 10.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.428 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -119.97 127.18 52.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.2 mp -138.8 161.74 36.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.43 176.37 35.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.703 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.72 -24.98 54.22 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.622 2.214 . . . . 0.0 112.41 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -69.57 -27.14 64.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.857 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -100.22 6.9 44.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.336 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 22.4 mt -114.23 138.2 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.733 0.302 . . . . 0.0 110.32 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.7 m-85 -137.13 159.58 69.27 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.057 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.473 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.9 Cg_exo -70.21 113.91 3.6 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.674 2.25 . . . . 0.0 111.63 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 89.1 t80 -53.7 -59.5 4.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.683 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -49.0 -42.74 38.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.124 0.488 . . . . 0.0 111.648 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.94 -39.58 72.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.565 -179.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -105.29 10.23 33.64 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.4 ptpt -56.38 -44.28 80.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.659 0.266 . . . . 0.0 111.713 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mm-40 -68.55 -32.92 73.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.435 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 13.1 ptpt -83.99 -43.32 15.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 72' ' ' LYS . 18.2 m-30 -98.35 -8.52 26.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.24 75.27 2.05 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.039 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mmmm -148.55 159.32 38.87 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.613 0.206 . . . . 0.0 110.511 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.59 151.89 59.46 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.585 2.19 . . . . 0.0 112.516 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.11 170.29 15.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.616 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -15.68 28.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.356 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -66.34 -14.81 62.62 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.984 0.421 . . . . 0.0 110.716 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt 63.4 144.17 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.075 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.36 -18.7 35.78 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.594 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.464 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 15.1 t80 -58.61 -55.55 33.67 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.044 0.45 . . . . 0.0 110.692 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -52.89 -45.67 67.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.062 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -48.56 -31.39 6.49 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.985 0.421 . . . . 0.0 110.543 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.06 -31.55 61.63 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.85 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.94 -43.8 98.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.226 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -64.05 -44.91 91.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.477 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -63.51 -50.87 67.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -51.9 -27.5 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 111.828 -179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.455 ' N ' HG23 ' A' ' 89' ' ' ILE . 0.8 OUTLIER -99.44 -44.68 6.1 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.093 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.82 -32.96 40.67 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.23 87.46 3.24 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.817 0.342 . . . . 0.0 111.257 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.58 -13.73 18.11 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.038 2.492 . . . . 0.0 112.644 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.1 p -104.04 13.08 33.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.537 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.89 147.05 12.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.929 0.395 . . . . 0.0 111.447 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -156.24 125.23 6.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.024 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -121.05 123.06 41.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.063 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.0 t -81.9 -172.86 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.92 167.43 35.41 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.43 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -147.74 -176.67 5.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.821 0.343 . . . . 0.0 110.838 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -134.01 132.49 40.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -103.71 150.88 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.6 m -90.21 -177.43 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -85.07 -38.46 19.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -123.29 166.96 14.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.73 176.58 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.3 m -124.41 165.3 17.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 t 60.49 101.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.71 149.13 41.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.065 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.817 0.341 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.6 m -135.79 -47.62 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.0 mtm-85 -150.72 118.21 6.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 t -134.74 105.58 6.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.35 159.45 19.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.34 -62.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -87.01 126.42 34.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.47 148.75 31.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -95.14 141.15 29.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.653 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.436 ' CD2' HG13 ' A' ' 16' ' ' VAL . 69.1 m-85 -115.62 159.12 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -136.08 159.96 40.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 111.03 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.27 127.38 19.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.263 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.88 -13.45 60.68 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.729 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.49 137.18 50.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.84 0.352 . . . . 0.0 111.072 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 mt -90.18 115.36 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 110.3 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 HG13 ' CD2' ' A' ' 10' ' ' TYR . 29.2 m -138.65 170.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.581 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 27' ' ' PRO . 9.3 m-85 -109.69 136.7 48.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.79 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -111.87 121.4 44.93 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.473 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 2.4 tptt -93.51 129.15 39.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.011 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.8 mtp -126.55 147.98 49.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.693 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -59.53 119.59 7.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.04 -34.96 4.59 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.441 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -105.14 150.36 38.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.696 0.284 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.409 ' HG3' ' OD1' ' A' ' 77' ' ' ASN . 97.7 Cg_endo -82.49 170.16 13.29 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.593 2.195 . . . . 0.0 112.226 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.417 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 61.2 m80 -51.06 112.11 0.67 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.525 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.44 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.7 t-105 -99.6 131.07 25.4 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.237 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 11.8 Cg_endo -54.98 121.35 9.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.295 1.996 . . . . 0.0 111.183 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.12 178.44 8.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 112.328 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -143.66 157.76 44.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.489 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.08 116.12 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -110.93 -14.0 14.03 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -163.62 156.68 18.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.042 0.449 . . . . 0.0 111.474 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 6.5 ptp -153.2 157.85 32.88 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.079 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 92.1 Cg_endo -78.93 159.9 27.35 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.722 2.281 . . . . 0.0 112.428 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -142.25 -49.95 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 0.0 111.046 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -171.15 -40.51 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.921 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.43 97.61 1.23 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.501 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.93 -38.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.45 -178.4 5.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 0.0 111.198 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t -69.89 66.71 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.314 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 42' ' ' ALA . 1.4 t -128.56 -179.82 5.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.771 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . -171.91 -42.56 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.888 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -155.97 33.45 0.34 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.251 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -136.85 138.5 40.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.472 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 86.9 m-85 -95.43 155.29 16.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -99.59 105.05 16.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.7 m -99.94 149.39 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.369 0.604 . . . . 0.0 112.041 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -105.08 123.93 48.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.259 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -92.75 109.39 20.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.448 ' HB3' ' HA2' ' A' ' 85' ' ' GLY . 42.5 m-85 -61.49 176.12 0.52 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.746 0.307 . . . . 0.0 110.911 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.01 -62.48 0.96 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.083 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.2 p -91.7 -22.2 20.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 110.586 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.1 m80 63.4 36.89 11.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.416 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -90.85 154.74 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.5 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.41 144.25 49.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.311 0.577 . . . . 0.0 111.806 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.76 166.13 34.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.279 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 30.6 m-85 -108.94 88.61 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.233 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 mp -97.92 158.32 15.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.984 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.09 172.05 33.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.352 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.1 -23.98 52.62 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.483 2.122 . . . . 0.0 112.38 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -27.93 66.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.973 0.416 . . . . 0.0 110.691 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -98.62 12.63 34.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.995 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.98 137.4 46.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.431 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.7 m-85 -134.79 157.64 76.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.765 0.317 . . . . 0.0 111.11 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.477 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.2 Cg_exo -71.02 110.93 2.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.731 2.287 . . . . 0.0 111.508 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 70' ' ' LYS . 93.2 t80 -55.29 -60.82 2.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.914 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -41.95 38.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.014 0.435 . . . . 0.0 111.48 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.31 -39.69 71.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.559 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 m -104.91 8.48 34.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.3 ptmt -56.55 -45.89 80.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.721 0.296 . . . . 0.0 111.337 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.44 -26.57 64.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.525 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.485 ' HG2' ' CE1' ' A' ' 73' ' ' PHE . 1.2 ttpm? -84.82 -45.7 12.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.485 ' CE1' ' HG2' ' A' ' 72' ' ' LYS . 18.8 m-30 -101.93 -6.15 23.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -86.44 75.39 2.25 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.284 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -151.91 153.09 31.11 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.523 0.201 . . . . 0.0 110.718 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.36 136.22 8.55 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.701 2.268 . . . . 0.0 112.504 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 0.7 OUTLIER -111.07 171.19 7.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.915 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.15 -21.61 18.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.748 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -67.34 -13.77 62.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.935 0.398 . . . . 0.0 110.585 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt 63.99 143.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.814 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.96 -17.23 54.36 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.931 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 13.0 t80 -59.13 -51.28 70.68 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.956 0.408 . . . . 0.0 110.322 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.45 -46.98 66.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.993 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -48.66 -32.76 8.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.979 0.418 . . . . 0.0 110.26 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.62 -31.76 60.26 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.788 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 71.3 mt -61.32 -43.79 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.168 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -64.78 -45.03 88.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.002 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.435 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -62.81 -50.9 69.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.42 HG21 ' N ' ' A' ' 90' ' ' GLU . 1.2 tt -52.32 -26.85 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.807 0.337 . . . . 0.0 111.768 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.42 ' N ' HG21 ' A' ' 89' ' ' ILE . 6.8 mm-40 -99.63 -44.75 6.02 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.74 -30.77 32.29 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -156.34 89.23 2.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 111.202 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.414 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 86.4 Cg_endo -78.46 -12.42 15.43 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.644 2.229 . . . . 0.0 112.72 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.1 p -102.34 10.98 38.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.586 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.65 143.82 14.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.819 0.343 . . . . 0.0 111.347 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.27 20.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.326 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 54.65 81.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.79 0.329 . . . . 0.0 111.174 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.9 t -104.27 143.34 33.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.34 40.08 24.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -130.87 98.11 4.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.18 110.81 13.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.44 158.57 18.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.942 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.5 m 60.25 41.42 16.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -100.47 130.59 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.47 155.5 36.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.64 145.51 51.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.64 -178.54 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.83 160.94 38.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -90.33 -63.8 1.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.772 0.32 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -134.67 106.24 6.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.7 101.15 3.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.915 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.3 m 60.5 105.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.949 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -88.41 177.1 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 61.01 112.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.977 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.09 -178.04 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.778 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.1 119.05 23.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -95.61 143.73 26.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.792 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.438 ' CD2' HG11 ' A' ' 16' ' ' VAL . 87.7 m-85 -113.32 157.41 21.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.901 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -132.92 157.0 46.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.389 . . . . 0.0 111.023 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.0 m -51.81 132.07 31.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.544 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.13 -12.14 68.56 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.909 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.77 139.21 50.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -91.14 116.56 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.964 0.411 . . . . 0.0 110.398 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.438 HG11 ' CD2' ' A' ' 10' ' ' TYR . 30.7 m -139.76 170.29 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.622 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.522 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 17.9 m-85 -111.09 135.86 50.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.521 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.93 123.04 49.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.345 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 23.8 tptp -92.07 130.95 37.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.163 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtm -127.04 147.82 50.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.461 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 113.47 4.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 111.008 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.99 -27.37 14.65 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.689 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.91 157.97 49.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.787 0.327 . . . . 0.0 110.942 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.47 166.44 12.16 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.802 2.335 . . . . 0.0 112.346 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.505 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 59.0 m80 -47.17 114.02 0.78 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.497 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.466 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.66 130.63 27.45 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.611 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.51 119.1 5.85 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.337 2.024 . . . . 0.0 111.056 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.2 175.09 10.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 112.438 -178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 14.2 ttp180 -142.52 156.49 45.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.449 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.423 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 24.6 mm -79.9 138.8 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.26 -20.8 5.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -162.65 151.34 14.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.957 0.408 . . . . 0.0 111.237 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 31.2 mmt -91.48 161.6 34.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.712 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.444 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 92.4 Cg_endo -85.33 117.23 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.731 2.288 . . . . 0.0 112.175 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.88 -85.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.089 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.18 -60.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.678 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.74 27.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.298 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.6 m -89.82 -2.73 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.752 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -163.76 -179.19 6.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.575 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 61.1 p -71.21 62.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.697 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' ASN . 13.4 t -129.69 -15.38 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.799 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 43.8 -87.13 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.655 0.264 . . . . 0.0 111.284 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -155.03 50.61 0.59 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.247 0.546 . . . . 0.0 110.309 179.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -141.45 166.41 24.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.014 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.444 ' CE2' ' HD3' ' A' ' 34' ' ' PRO . 45.5 m-85 -94.11 157.95 15.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.199 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.93 107.55 20.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.3 t -103.54 142.57 17.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.445 0.641 . . . . 0.0 112.567 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -105.55 121.87 44.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.528 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -94.03 106.51 18.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.087 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.443 ' HB3' ' HA2' ' A' ' 85' ' ' GLY . 49.7 m-85 -57.57 176.88 0.12 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.873 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.81 -63.57 0.68 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.384 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 80.9 p -90.16 -23.24 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.702 0.287 . . . . 0.0 110.712 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 52' ' ' THR . 3.9 m170 65.96 34.03 7.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.12 150.99 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.0 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.81 140.66 52.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.168 0.509 . . . . 0.0 111.329 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.78 168.22 27.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.333 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.415 ' CE2' ' O ' ' A' ' 40' ' ' SER . 13.5 m-85 -109.32 125.48 52.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.027 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 mt -139.36 160.67 39.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.46 -179.78 40.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.28 -26.81 41.45 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.521 2.147 . . . . 0.0 112.206 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -69.63 -22.56 63.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.008 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -98.99 3.6 47.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.49 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 18.3 mt -115.0 139.65 49.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 110.578 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.2 m-85 -136.6 166.28 28.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.415 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.2 Cg_exo -73.21 111.15 3.21 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.732 2.288 . . . . 0.0 111.707 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.1 t80 -49.99 -58.44 5.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.484 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -49.04 -41.08 33.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.564 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 5.0 mm-40 -70.97 -39.75 72.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.659 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 3.6 m -103.41 13.89 32.63 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 66' ' ' TYR . 2.2 mtmp? -55.53 -44.99 77.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.364 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.71 -40.82 88.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.83 -43.77 16.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.9 m-30 -94.85 -19.65 20.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -86.68 73.84 2.43 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.041 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 12.1 mttt -149.22 153.57 37.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.92 155.51 8.33 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.623 2.215 . . . . 0.0 112.638 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -136.43 165.52 25.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.579 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -85.72 -16.1 40.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.256 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -13.82 61.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.975 0.417 . . . . 0.0 110.682 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt 63.76 142.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.203 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.55 -16.7 55.68 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.468 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 31.6 t80 -59.01 -56.82 17.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.003 0.43 . . . . 0.0 110.865 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -45.35 66.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.057 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.68 -30.06 5.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.048 0.451 . . . . 0.0 110.535 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.443 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.93 -31.89 57.45 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.162 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.7 mt -60.43 -43.44 96.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.035 0.445 . . . . 0.0 110.254 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.403 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 62.9 t90 -63.59 -45.74 89.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.71 -50.58 70.58 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.428 HG21 ' N ' ' A' ' 90' ' ' GLU . 1.1 tt -52.9 -27.05 12.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 111.758 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' N ' HG21 ' A' ' 89' ' ' ILE . 17.6 mt-10 -99.29 -44.82 6.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -79.65 -31.54 41.52 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.455 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . 1.0 OUTLIER -157.06 86.9 2.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 111.302 -179.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.93 -12.93 26.39 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.93 2.42 . . . . 0.0 112.65 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.0 p -106.98 14.61 26.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.587 0.232 . . . . 0.0 111.605 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 92' ' ' ASN . 14.3 p -62.57 150.74 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.008 0.432 . . . . 0.0 111.69 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -154.03 122.4 6.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.576 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 64.88 -76.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -140.49 175.39 9.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.34 -97.78 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.549 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 60.68 -172.17 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -159.6 -45.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.3 t -143.61 143.69 31.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.53 165.71 11.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.38 28.88 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.15 113.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.957 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 81.95 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.94 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.68 31.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.3 t -151.53 145.83 25.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.68 87.94 6.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.058 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 m -127.41 169.77 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.62 -49.65 4.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.4 t -132.25 -46.68 0.91 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.13 123.27 21.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.28 124.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -140.41 -176.33 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -156.3 -157.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.033 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 3.4 mt-10 79.52 143.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.295 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.456 ' CD2' ' CG1' ' A' ' 16' ' ' VAL . 4.7 m-85 -123.36 166.27 15.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.313 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.45 165.78 25.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 110.954 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 m -52.87 130.72 34.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.277 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.76 68.54 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.086 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.65 140.76 48.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.915 0.388 . . . . 0.0 111.299 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.6 mt -91.79 119.16 31.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.079 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.456 ' CG1' ' CD2' ' A' ' 10' ' ' TYR . 26.8 m -138.84 171.91 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.224 0.535 . . . . 0.0 111.992 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 8.5 m-85 -111.08 134.81 52.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.656 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.36 124.3 52.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.006 0.431 . . . . 0.0 111.591 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -91.18 132.81 35.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.906 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -131.23 150.11 52.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.7 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' O ' ' CE2' ' A' ' 23' ' ' TYR . 1.2 mtpm? -62.46 121.8 14.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.104 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 81.82 15.93 74.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.897 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.427 ' CE2' ' O ' ' A' ' 21' ' ' LYS . 3.4 m-85 -151.4 147.96 21.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.63 0.252 . . . . 0.0 110.841 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.16 165.01 17.15 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.615 2.21 . . . . 0.0 112.221 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -47.51 115.42 1.12 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.571 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.76 130.13 28.44 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-O 120.527 0.203 . . . . 0.0 111.527 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.14 121.45 9.68 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.373 2.049 . . . . 0.0 111.155 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.61 176.09 9.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -141.43 154.63 45.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.492 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mm -81.8 140.12 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 0.0 110.541 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.17 -22.5 7.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.794 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -163.93 155.02 15.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.111 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 29.5 mmt -91.68 163.34 28.47 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.003 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.435 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 94.7 Cg_endo -91.69 38.26 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.05 2.5 . . . . 0.0 112.209 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -151.78 41.17 0.67 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.75 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.86 -35.63 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.182 0.515 . . . . 0.0 109.726 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.69 73.87 1.49 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.635 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.6 m -153.4 172.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.976 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 25.1 mmtp -159.11 -68.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.595 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.19 46.31 1.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 110.438 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.9 p -143.33 128.22 18.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.029 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.17 -52.66 15.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.242 0.544 . . . . 0.0 109.817 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -155.98 48.45 0.5 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.903 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -99.29 129.16 45.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.352 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 40.4 m-85 -93.77 154.71 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.122 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -96.65 98.82 10.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.84 148.92 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.358 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -105.96 125.1 50.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.252 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -91.39 113.16 25.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.699 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 44.0 m-85 -63.31 174.61 1.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.02 -61.75 0.75 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.3 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.8 p -90.36 -23.49 21.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.66 0.267 . . . . 0.0 110.723 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.8 m170 63.56 37.93 10.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.524 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -93.32 156.67 16.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.814 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 143.19 50.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.322 0.582 . . . . 0.0 111.926 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.65 168.2 27.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.5 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 75.6 m-85 -111.58 89.81 3.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.038 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.7 mp -97.72 157.45 16.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.251 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.76 171.77 34.92 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.409 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.18 -24.66 44.07 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.45 2.1 . . . . 0.0 112.316 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -27.73 67.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.423 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.63 14.7 31.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.858 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 mp -113.2 136.29 52.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.618 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.6 m-85 -135.93 155.47 77.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.636 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.8 Cg_exo -72.54 112.23 3.42 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.481 2.121 . . . . 0.0 111.2 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.7 t80 -48.34 -58.78 4.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.172 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -43.35 34.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.928 0.394 . . . . 0.0 112.033 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 5.8 mm-40 -70.28 -39.74 74.74 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.422 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 51.5 m -105.58 10.72 32.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.9 ptpt -55.97 -48.13 76.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.817 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.9 mm-40 -72.54 -19.91 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.586 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -84.92 -49.83 8.03 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 7.3 m-85 -104.41 -4.44 22.8 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.95 71.46 2.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.193 -1.004 . . . . 0.0 113.066 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -149.57 151.19 32.68 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.699 0.285 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.29 156.0 18.31 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.565 2.177 . . . . 0.0 112.7 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -138.77 -172.51 3.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.378 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -99.03 -13.81 19.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.058 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -67.87 -14.35 62.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt 62.88 142.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.175 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.55 -15.89 59.17 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.733 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 35.6 t80 -57.38 -58.7 7.1 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.061 0.458 . . . . 0.0 110.907 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -51.76 -46.17 64.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.281 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -48.79 -32.7 9.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.903 0.382 . . . . 0.0 110.501 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.45 -31.68 60.69 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.839 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.49 -43.63 96.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.012 0.434 . . . . 0.0 110.287 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.8 t90 -63.74 -43.0 97.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.926 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 39.6 mm-40 -62.84 -52.38 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -52.25 -25.71 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -44.75 5.73 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -81.05 -32.95 33.83 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -156.39 88.9 2.78 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.76 0.314 . . . . 0.0 111.152 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 72.2 Cg_endo -77.44 -12.05 17.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.662 2.242 . . . . 0.0 112.897 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.7 p -106.51 14.44 27.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.607 0.241 . . . . 0.0 111.587 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.23 151.22 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.874 0.369 . . . . 0.0 111.404 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -134.43 164.64 27.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.56 171.43 8.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.148 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m 61.6 150.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.025 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.2 129.89 1.44 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.568 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.27 148.24 37.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.708 0.289 . . . . 0.0 110.732 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -143.45 123.47 13.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.058 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.0 m 76.93 -1.71 2.79 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.779 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.5 m 52.78 177.17 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.838 0.352 . . . . 0.0 111.172 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 51.45 -177.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.13 -45.35 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.57 -48.97 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.2 p 59.14 175.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.77 89.7 3.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 67.04 -72.64 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.171 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 tpt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.848 0.356 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m 62.69 101.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.965 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.57 86.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.054 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 p -129.16 111.41 12.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.801 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -110.74 -27.06 9.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.172 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 61.79 91.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 0.0 110.651 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -79.49 157.79 27.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.076 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' HE2' ' CE1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -174.66 123.99 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.649 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -95.75 143.08 27.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.422 ' CE1' ' HE2' ' A' ' 8' ' ' LYS . 79.4 m-85 -109.56 155.73 21.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.798 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -131.56 155.07 48.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.409 . . . . 0.0 111.078 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.8 m -52.4 129.92 29.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.572 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.26 -13.43 63.14 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.048 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.3 138.14 51.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 111.057 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.5 mt -91.59 117.45 29.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.357 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.416 HG11 ' CE1' ' A' ' 10' ' ' TYR . 31.2 m -139.99 172.1 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.851 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 13.4 m-85 -113.14 135.72 53.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.722 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.82 123.3 49.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 0.0 111.432 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 8.1 tptp -92.37 133.86 35.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.0 mtm -128.32 151.86 48.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.78 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.86 102.15 3.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.51 -1.21 23.53 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.818 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -146.91 149.71 36.77 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.706 0.289 . . . . 0.0 110.716 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.63 162.97 34.76 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.636 2.224 . . . . 0.0 112.387 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.416 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 80.1 m80 -47.72 116.78 1.58 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.62 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.452 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.5 t-105 -98.63 132.09 24.64 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.48 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 14.7 Cg_endo -56.34 120.98 9.2 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.37 2.047 . . . . 0.0 110.969 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 48' ' ' PHE . . . -145.16 176.39 9.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 0.0 112.28 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.43 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 1.8 ttt180 -142.23 155.72 45.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.453 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.43 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 23.6 mm -80.4 138.73 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.376 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -126.05 -21.58 4.29 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.47 152.13 8.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.907 0.384 . . . . 0.0 111.28 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.1 165.33 21.98 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.641 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 35.2 Cg_exo -57.9 139.55 90.74 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.639 2.226 . . . . 0.0 112.219 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.31 -86.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.426 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -178.07 -52.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.5 0.667 . . . . 0.0 110.278 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.25 92.71 0.27 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.611 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.05 11.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.709 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.14 -65.66 0.31 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 m -52.79 -27.35 17.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.731 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -121.82 -33.08 3.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.115 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 41.06 -86.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.477 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 41' ' ' THR . 3.2 p30 -152.82 55.42 0.79 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.322 0.582 . . . . 0.0 109.989 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -139.36 167.07 22.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.803 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.447 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 87.3 m-85 -95.23 157.64 15.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.033 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -98.69 108.18 20.81 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 28' ' ' ALA . 45.4 t -104.31 141.4 19.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.397 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.446 ' O ' ' HB1' ' A' ' 28' ' ' ALA . 25.8 t80 -106.57 122.22 45.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.897 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -94.34 109.42 21.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.156 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.47 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 73.9 m-85 -58.78 -178.97 0.06 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.998 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.61 -63.82 0.44 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.255 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.5 p -91.95 -22.52 19.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.843 0.354 . . . . 0.0 110.633 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.8 m170 64.81 35.44 8.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.973 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -89.8 153.12 20.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.683 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.12 141.6 50.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.318 0.58 . . . . 0.0 111.614 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.49 170.76 21.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -115.13 126.96 55.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 0.0 111.069 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.1 mt -139.62 162.03 36.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.0 176.62 36.21 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.364 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.96 -25.42 59.52 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.493 2.129 . . . . 0.0 112.269 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.71 -26.34 64.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.94 8.33 45.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 53.0 mt -117.06 139.07 51.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.694 0.283 . . . . 0.0 110.408 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.4 m-85 -137.39 157.89 73.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.576 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.576 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 13.4 Cg_exo -67.72 113.82 3.11 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.188 1.925 . . . . 0.0 111.395 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' LYS . 81.4 t80 -48.97 -57.15 6.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.031 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.429 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 15.7 mm-40 -51.46 -39.83 58.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.02 0.438 . . . . 0.0 111.984 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.576 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 15.8 mm-40 -70.08 -39.81 75.37 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.44 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 6.4 m -106.78 12.09 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.552 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 2.4 ptpp? -56.59 -48.74 76.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 0.0 111.024 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.552 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -72.33 -20.95 61.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.459 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.38 -49.34 8.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 8.3 m-85 -100.68 -13.56 18.47 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.82 73.05 1.96 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.972 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -149.75 147.98 24.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.663 0.268 . . . . 0.0 110.562 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.5 153.35 14.03 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.496 2.131 . . . . 0.0 112.769 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -139.08 -173.27 3.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.316 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -99.97 -13.31 19.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.971 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 79' ' ' ARG . 21.1 mmt180 -67.25 -14.5 62.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.927 0.394 . . . . 0.0 110.557 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp 63.06 141.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.261 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.21 -16.38 58.92 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.875 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.452 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 47.7 t80 -57.64 -57.07 14.31 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.928 0.394 . . . . 0.0 110.824 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -52.2 -46.22 65.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.138 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -48.86 -33.05 9.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.075 0.464 . . . . 0.0 110.289 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.92 -32.75 58.49 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.807 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 46.2 mt -60.49 -43.66 96.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.108 0.48 . . . . 0.0 109.956 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -64.09 -45.35 89.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.895 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.47 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -62.59 -51.89 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.23 -26.34 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.15 -44.83 6.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.57 -33.19 31.8 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -156.57 81.52 3.5 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.758 0.313 . . . . 0.0 110.974 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.0 Cg_endo -73.99 -8.94 21.78 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.627 2.218 . . . . 0.0 112.953 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 72.6 p -101.48 12.25 37.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.586 0.232 . . . . 0.0 111.515 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.06 144.91 14.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.812 0.339 . . . . 0.0 111.325 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -161.69 122.13 2.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.017 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 57.23 167.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.067 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.3 m 60.01 108.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.738 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.6 58.53 4.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.622 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 6.7 t80 55.97 89.84 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.908 0.385 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -89.53 89.81 8.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.5 p -67.2 177.54 1.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.5 t 60.35 107.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.35 41.49 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.75 31.96 3.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm 59.56 97.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.0 t -142.48 119.57 11.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.3 t -87.19 -57.48 2.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.36 179.39 6.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.937 0.399 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.81 158.45 28.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.909 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -32.93 12.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.36 106.73 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.856 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.79 113.99 21.45 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.06 -42.2 2.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -165.72 146.19 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.77 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -105.75 115.2 29.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.955 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 142.45 27.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.725 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CD2' HG13 ' A' ' 16' ' ' VAL . 90.2 m-85 -114.33 157.89 22.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.986 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -130.17 157.44 42.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.786 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.4 t -53.67 131.85 39.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.083 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.71 -12.19 64.48 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.265 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -73.25 142.94 47.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 111.207 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.1 mt -91.79 119.6 31.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.391 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 10' ' ' TYR . 29.3 m -140.77 170.1 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.661 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.402 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 8.4 m-85 -109.84 136.51 49.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.695 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 62' ' ' ASP . . . -113.95 122.72 47.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.007 0.432 . . . . 0.0 111.453 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -91.35 128.71 37.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.882 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.6 mtp -126.96 148.12 50.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.658 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.64 125.4 23.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.907 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.435 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 85.01 11.48 76.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.977 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -154.39 152.47 26.26 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 110.782 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.56 166.31 13.78 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.725 2.283 . . . . 0.0 112.233 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 66.7 m80 -47.19 114.82 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.601 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.2 130.34 28.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.514 0.197 . . . . 0.0 111.523 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.35 119.53 6.53 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.234 1.956 . . . . 0.0 111.065 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.19 175.44 10.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.29 0.567 . . . . 0.0 112.334 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -142.74 156.92 45.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.332 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.3 mm -78.26 136.26 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -125.5 -21.4 4.52 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.37 152.9 15.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.362 . . . . 0.0 111.002 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.15 166.59 15.82 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.247 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.44 172.11 2.88 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.7 2.267 . . . . 0.0 111.953 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.97 -31.62 7.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.98 -41.15 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.323 0.582 . . . . 0.0 109.514 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.77 -69.51 0.32 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.369 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.8 t 61.04 101.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.697 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -75.58 -13.52 60.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.473 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -76.29 -42.85 44.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 110.755 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.0 t -89.13 116.83 27.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.57 52.96 0.53 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.619 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.6 t30 60.39 47.08 9.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.575 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -130.99 138.48 49.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.438 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -95.12 159.91 14.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.033 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -99.16 107.51 19.88 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.7 t -103.59 143.85 14.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.335 -178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -106.19 122.73 46.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.829 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -94.9 110.02 21.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.922 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.467 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 58.9 m-85 -59.73 178.91 0.14 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.884 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.7 -63.91 0.65 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.117 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.2 p -91.35 -22.63 20.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.508 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.7 m80 63.71 36.58 10.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.346 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.75 155.07 19.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.695 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.68 141.8 51.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.226 0.536 . . . . 0.0 111.574 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.31 168.25 27.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.84 125.17 51.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.817 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.4 mt -139.55 162.29 35.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.63 177.79 40.72 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.72 -25.58 39.86 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.624 2.216 . . . . 0.0 112.362 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -69.04 -21.72 64.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.128 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.7 m-20 -99.47 4.76 46.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.556 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 25.9 mt -113.4 139.72 48.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.707 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.9 m-85 -137.22 163.8 46.45 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.816 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.435 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 3.0 Cg_exo -74.01 111.7 3.37 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.669 2.246 . . . . 0.0 111.75 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -50.77 -57.32 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.646 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.89 -40.79 57.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.995 0.426 . . . . 0.0 111.71 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 3.9 mm-40 -69.89 -39.93 75.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.59 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.444 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 4.3 m -108.43 13.58 25.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.3 ptpt -56.64 -47.02 80.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.849 0.357 . . . . 0.0 111.284 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -70.62 -24.89 62.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.744 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -84.73 -47.74 10.13 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 73' ' ' PHE . 1.5 m-30 -101.02 -7.81 22.92 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.9 72.96 2.75 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.143 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.438 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.7 mtmt -148.98 155.68 40.49 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.554 0.216 . . . . 0.0 110.435 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.91 155.37 23.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.549 2.166 . . . . 0.0 112.687 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -136.78 172.93 12.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.485 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.93 -15.79 27.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.366 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.7 mmt-85 -66.05 -14.44 61.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.994 0.426 . . . . 0.0 110.769 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp 63.81 141.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.168 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.4 -17.12 53.94 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.653 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 23.0 t80 -58.96 -56.33 23.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.038 0.447 . . . . 0.0 110.724 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.81 -45.43 67.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.038 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.78 -30.95 6.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.956 0.407 . . . . 0.0 110.495 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.59 -31.9 60.15 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.992 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.9 mt -60.77 -43.77 97.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 110.3 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -64.06 -44.94 90.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -63.56 -51.53 65.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -51.44 -28.37 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.716 0.293 . . . . 0.0 111.685 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -98.86 -44.67 6.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -80.2 -32.56 38.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -157.05 91.24 2.44 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.678 0.275 . . . . 0.0 111.26 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.1 -10.78 16.48 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.503 2.135 . . . . 0.0 112.686 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.27 11.85 36.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.496 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.86 145.2 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 111.364 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.7 168.88 18.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.017 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.64 29.91 7.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.998 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.0 p -66.31 153.47 42.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.53 -169.3 16.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.461 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 61.44 88.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.15 -173.57 2.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 t 62.25 170.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 t 63.5 141.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 61.09 88.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.934 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.1 157.26 36.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.909 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.75 -35.25 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.1 m 61.36 31.17 19.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.922 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 90.2 m 59.08 164.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.92 -46.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mtt . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.852 0.358 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -163.81 165.43 22.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.46 153.38 31.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -70.72 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.984 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.33 27.91 12.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.063 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 57.32 88.97 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.842 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -109.55 122.88 48.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.248 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.48 ' CG ' ' CZ ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -59.59 129.66 43.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.186 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -95.55 139.86 31.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.565 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.48 ' CZ ' ' CG ' ' A' ' 8' ' ' LYS . 68.5 m-85 -113.82 158.81 20.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.044 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.52 158.96 42.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.934 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.2 m -51.87 130.62 29.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.36 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.01 -11.94 68.96 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.859 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -71.04 138.83 50.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.751 0.31 . . . . 0.0 110.985 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.413 ' HA ' HD22 ' A' ' 15' ' ' LEU . 72.9 mt -91.1 116.38 28.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 110.318 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.434 HG13 ' CE1' ' A' ' 10' ' ' TYR . 31.3 m -139.4 170.78 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.698 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 36.5 m-85 -110.57 138.59 46.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.746 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.1 120.4 40.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.939 0.399 . . . . 0.0 111.195 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 129.3 39.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.243 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 mtm -119.22 161.12 20.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.611 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 119.72 13.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.108 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.63 -4.2 85.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.017 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.56 150.6 73.34 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.833 0.316 . . . . 0.0 110.756 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.81 160.74 18.79 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.742 2.294 . . . . 0.0 112.513 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 69.9 m80 -48.98 115.45 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.612 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.474 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 4.4 t-105 -98.67 133.5 22.48 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.0 119.26 6.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.384 2.056 . . . . 0.0 110.956 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.48 174.8 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.361 0.6 . . . . 0.0 112.394 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -142.98 156.75 44.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.477 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mm -78.85 135.79 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.6 -21.58 4.1 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.44 165.76 16.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.012 0.434 . . . . 0.0 111.593 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.21 158.24 32.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.99 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.52 162.07 27.84 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.649 2.232 . . . . 0.0 112.468 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.15 -31.19 9.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.825 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.93 -40.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.546 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.78 -66.87 0.19 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.799 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 40' ' ' SER . 16.1 t 64.71 13.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.892 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? 59.71 -79.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.77 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 38' ' ' VAL . 2.0 m -80.45 57.48 2.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.967 0.413 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -164.58 -21.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.724 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 39.12 -87.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.78 0.432 . . . . 0.0 111.564 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 41' ' ' THR . 2.2 m-20 -154.78 52.85 0.64 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.312 0.577 . . . . 0.0 110.259 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.18 152.33 48.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.142 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -93.42 160.56 14.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.877 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.17 109.72 22.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.5 t -104.03 141.51 19.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.249 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -105.12 121.32 43.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.702 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -93.52 106.74 18.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.482 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 49.4 m-85 -58.12 177.21 0.13 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.2 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.7 -63.02 0.88 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.034 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.1 p -91.45 -22.47 20.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.701 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.2 m170 63.81 35.31 11.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.303 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -89.92 153.71 20.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.545 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.34 141.71 51.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.31 0.576 . . . . 0.0 111.614 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.0 170.59 21.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.257 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -111.49 126.26 54.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.077 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.1 mt -138.82 160.79 38.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.26 179.86 39.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.512 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -65.99 -27.86 50.1 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.599 2.199 . . . . 0.0 112.221 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -69.3 -23.31 63.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.175 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -98.69 7.3 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.541 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.7 mt -116.21 140.01 49.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 110.697 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.9 m-85 -136.55 161.56 61.25 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.695 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 6.9 Cg_exo -71.43 109.91 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.437 2.092 . . . . 0.0 111.431 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 89.0 t80 -46.76 -58.72 3.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.223 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -38.41 59.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.082 0.468 . . . . 0.0 111.427 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 4.1 mm-40 -70.85 -39.8 72.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.444 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.463 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 1.2 m -104.67 11.62 33.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HG3' ' CE2' ' A' ' 66' ' ' TYR . 9.3 tttt -56.09 -49.43 73.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.795 0.331 . . . . 0.0 111.863 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -67.5 -35.19 78.65 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 2.7 ptpt -83.62 -43.83 15.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 18.9 m-30 -96.05 -17.77 20.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -83.37 73.51 2.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.02 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 74' ' ' GLY . 2.7 mttp -147.41 151.69 40.59 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.576 0.227 . . . . 0.0 110.409 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.52 152.03 9.47 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.495 2.13 . . . . 0.0 112.465 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.41 169.28 17.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.082 0.468 . . . . 0.0 111.718 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -15.19 36.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.366 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -14.93 62.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.958 0.409 . . . . 0.0 110.608 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm 63.37 140.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.142 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.85 -15.89 58.13 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.493 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 38.8 t80 -58.52 -58.29 9.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.916 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.82 -45.73 64.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.073 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.99 -32.59 9.45 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.974 0.416 . . . . 0.0 110.379 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.75 -31.95 61.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.751 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.72 -43.5 97.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.07 0.462 . . . . 0.0 110.179 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 59.1 t90 -64.04 -45.33 89.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.066 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 1.8 mp0 -62.86 -51.61 66.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -52.27 -27.21 10.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.777 0.322 . . . . 0.0 111.654 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.39 -44.84 6.36 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.48 -31.75 32.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -155.62 87.19 3.16 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.738 0.304 . . . . 0.0 111.104 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 76.0 Cg_endo -77.57 -12.17 16.88 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.687 2.258 . . . . 0.0 112.85 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 75.6 p -105.47 12.93 30.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.9 p -62.48 148.36 10.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.882 0.373 . . . . 0.0 111.421 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -156.53 165.85 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.037 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.9 144.01 41.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.76 120.7 32.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.71 111.12 1.08 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.548 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -94.8 149.01 21.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.352 . . . . 0.0 110.815 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -168.75 -42.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.7 m 65.05 33.28 9.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.01 101.31 2.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -130.75 -54.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? 60.14 100.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -117.77 158.46 24.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.6 t 59.6 102.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.7 t -66.7 95.56 0.35 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.82 -41.34 7.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.064 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.769 0.318 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.4 p -157.01 -48.14 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -121.91 101.06 7.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.021 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -154.69 89.23 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -97.35 158.04 15.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.776 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -164.0 113.97 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -75.05 131.65 40.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.756 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -154.51 135.93 14.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.978 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -95.87 140.79 30.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.715 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CD1' HG12 ' A' ' 16' ' ' VAL . 47.5 m-85 -117.95 162.04 18.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.74 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.486 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 13.6 mmtt -135.83 163.22 30.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.079 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 p -52.11 129.6 27.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.049 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.08 -10.49 71.77 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.911 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -72.95 141.83 47.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt -92.22 117.23 29.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.427 HG12 ' CD1' ' A' ' 10' ' ' TYR . 30.8 m -139.43 172.35 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.632 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.451 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 10.6 m-85 -113.13 136.94 52.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.992 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.73 121.82 45.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.89 0.376 . . . . 0.0 111.327 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -90.85 131.37 36.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.945 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.3 mtm -132.05 145.7 51.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.788 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 118.63 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.629 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 102.11 -0.51 51.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.61 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 0.5 OUTLIER -155.89 143.08 13.73 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.69 168.36 24.69 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.34 2.027 . . . . 0.0 112.366 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 39.1 m80 -45.66 115.9 1.06 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.043 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.432 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.6 t-105 -98.27 131.94 25.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.396 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.45 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 44.8 Cg_exo -53.64 119.0 5.51 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.244 1.963 . . . . 0.0 111.044 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.47 174.32 11.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.34 0.59 . . . . 0.0 112.389 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -142.72 156.23 44.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.434 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 30' ' ' ILE . 37.0 mm -77.56 135.22 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.3 -20.01 4.55 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.02 156.36 19.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.998 0.427 . . . . 0.0 111.019 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.486 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 3.2 ptp -153.53 168.18 12.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.382 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 33' ' ' MET . 52.0 Cg_exo -53.81 112.08 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.568 2.179 . . . . 0.0 112.119 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.94 -78.64 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.104 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.21 -38.42 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.579 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.15 94.14 2.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.261 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 m -148.45 -42.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.284 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp 80.76 -48.41 0.29 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.59 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 p -47.83 -27.29 2.0 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.812 0.339 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 t -149.53 137.78 20.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.55 -62.47 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.59 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -85.06 -5.26 59.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.007 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.77 145.92 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.907 0.384 . . . . 0.0 111.304 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -94.17 158.68 15.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.946 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -98.85 109.83 22.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -104.18 143.02 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.279 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -107.0 123.1 47.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.945 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -94.93 111.69 23.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.78 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 59.5 m-85 -60.71 178.82 0.2 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.991 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.51 -63.45 0.62 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.268 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.6 p -91.43 -23.02 20.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.962 0.41 . . . . 0.0 110.618 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.9 m170 63.6 38.24 9.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.342 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -92.08 154.2 18.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.637 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.99 141.75 51.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.259 0.552 . . . . 0.0 111.576 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.41 167.12 31.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.314 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -108.03 125.23 51.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 mt -139.94 162.15 35.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.083 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.75 170.37 32.1 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.286 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.25 -19.04 50.74 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.428 2.085 . . . . 0.0 112.324 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -28.55 67.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.587 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -99.48 14.22 30.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.852 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.79 137.53 49.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.539 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.4 m-85 -137.51 155.13 75.54 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.912 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.568 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 14.5 Cg_exo -68.98 112.53 2.97 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.589 2.193 . . . . 0.0 111.6 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 70' ' ' LYS . 79.3 t80 -52.04 -58.92 5.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.056 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -49.36 -41.8 40.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.957 0.408 . . . . 0.0 112.022 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.07 -39.48 72.17 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -106.13 10.69 31.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -55.89 -45.83 78.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.755 0.312 . . . . 0.0 111.47 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -70.08 -24.88 63.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.925 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -84.69 -45.97 11.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.6 m-30 -101.82 -10.44 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.48 74.01 2.42 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.359 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -151.85 155.33 33.71 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.661 0.267 . . . . 0.0 110.666 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -47.14 139.52 15.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.744 2.296 . . . . 0.0 112.812 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.411 ' HB3' ' CB ' ' A' ' 82' ' ' PHE . 9.6 t-20 -112.41 162.89 15.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.358 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -20.42 25.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.726 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? -69.34 -13.51 62.42 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.979 0.418 . . . . 0.0 110.711 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 0.3 OUTLIER 65.25 147.49 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.021 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.59 -19.59 35.87 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.68 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.45 ' CE2' ' HD3' ' A' ' 27' ' ' PRO . 11.9 t80 -57.88 -52.47 65.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.014 0.435 . . . . 0.0 110.545 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.51 -47.44 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.261 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -48.33 -32.45 7.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.036 0.446 . . . . 0.0 110.423 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.8 -31.81 57.81 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.436 -0.887 . . . . 0.0 111.928 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 82.8 mt -60.53 -43.69 96.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 0.0 110.285 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -64.06 -43.11 96.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.955 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.447 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 35.3 mm-40 -63.69 -51.88 63.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 90' ' ' GLU . 1.0 OUTLIER -51.88 -26.3 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.42 ' N ' HG23 ' A' ' 89' ' ' ILE . 8.2 mm-40 -101.48 -44.6 5.56 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.6 -32.81 41.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.47 89.05 2.74 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.76 0.314 . . . . 0.0 111.103 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -77.76 -12.53 16.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.635 2.224 . . . . 0.0 112.705 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -102.26 11.57 37.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.733 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.2 p -63.11 146.35 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.853 0.359 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.87 164.98 18.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.125 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -106.24 84.46 2.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.159 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.2 t -122.39 116.79 24.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.82 42.72 0.78 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.57 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.415 ' O ' ' CD2' ' A' ' 100' ' ' TYR . 17.7 p90 -99.25 83.46 2.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.911 0.386 . . . . 0.0 110.831 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.22 -33.47 7.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.002 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 t -102.3 139.03 38.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 m -160.41 123.71 3.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 60.95 99.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -62.67 -31.03 71.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 171.94 8.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.9 t 60.6 82.99 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.48 -57.79 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.83 -44.37 1.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.056 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtp . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.864 0.364 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -124.74 -45.02 1.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -141.92 86.69 2.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.56 98.17 7.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -170.77 -43.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -119.74 101.04 7.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.967 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -98.97 -176.67 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 9' ' ' GLU . 10.0 pttt -162.87 -151.67 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.885 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 81.92 140.44 0.07 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.465 ' CD2' ' CG1' ' A' ' 16' ' ' VAL . 3.7 m-85 -124.74 165.59 17.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.806 0.336 . . . . 0.0 111.497 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -139.06 165.87 25.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 t -52.92 126.97 22.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.495 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.47 -13.61 62.7 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.309 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.01 142.46 49.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.971 0.386 . . . . 0.0 111.147 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.3 mt -91.39 118.03 30.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.382 . . . . 0.0 110.327 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.465 ' CG1' ' CD2' ' A' ' 10' ' ' TYR . 29.0 m -139.94 173.93 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.791 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.417 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.8 m-85 -113.38 137.67 51.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.716 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -113.59 122.49 47.37 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.892 0.377 . . . . 0.0 111.425 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HD3' ' CG ' ' A' ' 25' ' ' HIS . 21.1 tptp -91.18 131.46 36.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.927 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mmm -124.7 155.21 39.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.774 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.85 111.45 7.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.74 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 102.6 -1.21 49.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.845 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.1 m-85 -146.02 150.25 41.55 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.308 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.49 166.92 23.5 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.672 2.248 . . . . 0.0 112.517 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.42 ' CG ' ' HD3' ' A' ' 19' ' ' LYS . 79.7 m80 -47.48 115.67 1.2 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.056 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.8 t-105 -98.25 130.9 27.33 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.05 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 11.0 Cg_endo -54.0 119.01 5.59 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.302 2.001 . . . . 0.0 111.054 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.19 175.8 9.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.32 0.581 . . . . 0.0 112.305 -178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -143.13 156.96 44.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.379 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.407 HD13 HG23 ' A' ' 30' ' ' ILE . 13.4 mm -81.69 136.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -123.93 -16.76 6.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.409 ' C ' ' HG2' ' A' ' 33' ' ' MET . 4.1 mt-10 -163.53 160.32 23.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.118 0.485 . . . . 0.0 111.669 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.409 ' HG2' ' C ' ' A' ' 32' ' ' GLU . 0.4 OUTLIER -145.71 128.38 8.08 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.273 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.17 156.97 9.31 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.462 2.108 . . . . 0.0 112.313 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -67.11 -70.61 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.02 -42.01 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.332 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.29 75.25 0.19 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.413 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 m -150.87 157.45 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.182 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 pttt 43.21 -167.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.604 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.0 t -94.25 110.05 21.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.978 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.44 -18.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.858 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 40.87 37.84 0.57 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.761 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.467 ' C ' ' HG2' ' A' ' 44' ' ' LYS . 70.6 m-20 57.61 55.95 5.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.941 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HG2' ' C ' ' A' ' 43' ' ' ASN . 5.5 mtmt -138.41 145.52 41.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.395 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.7 OUTLIER -99.52 165.52 11.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.692 179.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -100.95 113.63 26.79 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.5 t -103.45 142.48 17.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.866 -179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -104.87 121.29 43.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.962 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -94.43 108.71 20.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.643 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 50.0 m-85 -59.33 178.1 0.15 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.926 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.97 -63.62 0.71 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.097 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.8 p -91.29 -23.13 20.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.881 0.372 . . . . 0.0 110.502 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 m170 63.89 37.46 9.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.452 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -90.99 154.28 19.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.6 141.61 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.259 0.552 . . . . 0.0 111.509 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.29 167.36 30.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.361 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -107.17 124.83 50.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 mp -140.23 162.01 36.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.028 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.01 163.06 25.39 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.166 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.24 -17.98 49.48 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.448 2.099 . . . . 0.0 112.442 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -28.49 66.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.864 0.364 . . . . 0.0 110.656 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.54 12.23 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.88 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 6.5 mp -107.42 138.58 43.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.39 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.6 m-85 -137.38 147.96 59.98 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.109 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.504 ' HG2' ' HB2' ' A' ' 68' ' ' GLU . 20.8 Cg_endo -61.82 109.15 0.73 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.666 2.244 . . . . 0.0 111.568 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' A' ' 70' ' ' LYS . 86.2 t80 -50.74 -58.26 6.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.878 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -50.85 -39.62 54.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.164 0.507 . . . . 0.0 111.376 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.504 ' HB2' ' HG2' ' A' ' 65' ' ' PRO . 33.8 mt-10 -70.68 -40.02 73.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.507 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.78 11.36 30.25 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.6 ptpp? -56.4 -45.72 80.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.827 0.346 . . . . 0.0 111.382 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.463 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 18.8 mt-10 -70.51 -26.54 63.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.859 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -83.86 -46.4 12.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 2.6 m-30 -100.18 -11.2 20.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.19 74.4 2.49 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.296 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -152.15 154.55 32.53 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.616 0.246 . . . . 0.0 110.63 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -44.98 136.21 10.16 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.707 2.271 . . . . 0.0 112.596 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.438 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -109.77 175.03 5.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.817 -178.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -100.7 -22.52 14.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.621 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -13.22 61.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.684 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt 63.99 144.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.968 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.85 -18.01 49.75 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.714 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.47 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 12.0 t80 -59.53 -50.44 73.9 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.895 0.379 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -52.58 -47.48 66.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.233 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -48.3 -30.89 5.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.01 0.434 . . . . 0.0 110.45 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.441 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.44 -31.19 59.28 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.052 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.4 mt -60.64 -43.94 96.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 110.277 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.0 t90 -64.43 -45.24 88.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -62.61 -51.04 68.86 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -51.8 -26.99 7.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.784 0.325 . . . . 0.0 111.826 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 89' ' ' ILE . 1.9 mt-10 -99.7 -44.8 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.22 -32.33 38.5 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -156.71 89.36 2.66 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.738 0.304 . . . . 0.0 111.079 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.411 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 93.2 Cg_endo -79.08 -11.44 14.88 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.677 2.251 . . . . 0.0 112.983 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.6 p -103.95 13.27 33.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.614 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.9 p -62.58 146.88 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.894 0.378 . . . . 0.0 111.4 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -111.52 163.49 14.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.107 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.43 -177.79 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.8 m -89.03 176.57 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.26 57.59 0.53 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.52 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -149.51 90.9 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -127.73 -56.55 1.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.65 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.001 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.7 p -111.86 117.09 31.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -78.71 141.56 37.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -149.73 157.06 42.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.01 31.74 4.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.81 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.6 104.14 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.964 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 86.9 m -145.02 -178.9 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.14 37.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.825 0.345 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.77 -76.04 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.51 170.19 8.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.982 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.7 p -105.47 -173.92 2.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -152.07 99.47 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.88 30.07 19.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -129.44 149.8 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.65 145.64 46.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.98 141.21 28.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.623 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.464 ' CE1' HG13 ' A' ' 16' ' ' VAL . 27.1 m-85 -116.82 159.45 22.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.768 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -136.18 160.46 38.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 0.0 110.991 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.3 m -51.36 123.98 10.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.181 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.79 -13.87 56.24 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.238 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.44 140.46 50.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 111.211 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.8 mt -92.62 116.71 29.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.408 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.464 HG13 ' CE1' ' A' ' 10' ' ' TYR . 30.8 m -139.36 172.4 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.744 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.492 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 12.3 m-85 -111.71 136.18 51.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.801 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.94 123.63 50.77 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.889 0.376 . . . . 0.0 111.648 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -92.21 128.75 38.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.858 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.58 146.75 51.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.846 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -65.1 116.31 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.719 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 101.35 -0.91 53.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.726 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m-85 -148.78 151.28 34.98 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.683 0.278 . . . . 0.0 110.672 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.26 168.38 16.81 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.621 2.214 . . . . 0.0 112.193 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 74.3 m80 -47.27 113.52 0.7 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.654 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.446 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.2 t-105 -99.22 128.99 30.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.353 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HA ' ' CE1' ' A' ' 17' ' ' PHE . 11.1 Cg_endo -53.99 119.81 6.91 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.268 1.979 . . . . 0.0 111.126 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . -143.76 176.45 9.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 3.2 ttt180 -144.69 157.59 44.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.456 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.49 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 27.8 mm -81.44 137.04 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.4 -18.91 4.77 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -165.74 156.29 13.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.349 . . . . 0.0 111.164 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.423 ' HE1' ' O ' ' A' ' 10' ' ' TYR . 5.8 ptp -156.64 163.15 25.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.348 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HA ' ' CG2' ' A' ' 38' ' ' VAL . 13.8 Cg_exo -68.95 124.69 11.68 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.836 2.357 . . . . 0.0 112.132 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.1 -28.96 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.13 -37.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.103 0.478 . . . . 0.0 109.916 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.61 99.2 3.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.69 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 34' ' ' PRO . 16.1 m -151.34 16.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.841 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? 50.71 77.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.878 0.371 . . . . 0.0 111.501 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.2 t 61.95 -80.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.47 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 m 69.06 104.76 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.877 0.37 . . . . 0.0 110.939 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.403 ' C ' ' HG3' ' A' ' 44' ' ' LYS . . . -74.06 59.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.373 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 p30 49.14 51.73 15.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.302 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HG3' ' C ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -130.66 139.29 50.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.108 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 40.9 m-85 -95.67 155.9 16.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.768 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.88 105.68 17.44 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.8 m -100.61 148.04 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.315 0.579 . . . . 0.0 112.03 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 4.9 t80 -105.39 124.5 49.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.482 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -94.05 108.06 19.92 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.112 179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.417 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 60.6 m-85 -58.24 178.79 0.09 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.204 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.56 -62.07 0.87 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.378 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 46.4 p -91.28 -21.23 21.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.571 0.224 . . . . 0.0 110.934 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 52' ' ' THR . 26.3 m170 64.92 33.39 9.96 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.91 0.386 . . . . 0.0 110.432 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -94.93 158.49 15.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.46 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -132.85 149.26 52.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.31 0.576 . . . . 0.0 111.74 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.55 171.5 19.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.44 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 17.4 m-85 -107.78 124.52 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.923 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.9 mp -138.04 160.19 40.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.989 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.43 175.59 39.34 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.187 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.36 -24.92 49.54 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.405 2.07 . . . . 0.0 112.161 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -69.34 -25.74 64.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.086 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -97.97 7.7 45.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.31 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 71.8 mt -115.15 139.4 49.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.748 0.308 . . . . 0.0 110.37 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.7 m-85 -137.58 159.61 68.43 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.499 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 13.2 Cg_exo -69.48 111.88 2.88 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.685 2.256 . . . . 0.0 111.717 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 70' ' ' LYS . 78.1 t80 -51.97 -58.38 6.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.79 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.96 -41.73 47.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.08 0.467 . . . . 0.0 111.639 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.61 -39.72 73.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.477 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.23 12.19 30.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.6 ptpt -55.73 -46.38 77.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 0.0 111.49 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.461 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -70.1 -25.69 63.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.931 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -47.33 10.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.8 m-30 -101.02 -8.01 22.75 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.1 73.05 2.71 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.219 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.3 mtmt -149.09 158.19 39.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.592 0.234 . . . . 0.0 110.398 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.41 155.44 25.41 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.601 2.201 . . . . 0.0 112.555 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -136.36 168.74 18.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.545 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -89.42 -16.37 31.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.221 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -66.72 -14.51 62.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.004 0.431 . . . . 0.0 110.67 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt 63.6 143.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.124 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.67 -18.39 39.03 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.58 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 20.0 t80 -58.91 -56.08 26.86 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.976 0.417 . . . . 0.0 110.697 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.64 -45.33 66.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.82 -30.99 6.39 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.992 0.425 . . . . 0.0 110.52 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.88 -31.36 60.2 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.994 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.5 mt -60.9 -43.65 98.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.973 0.416 . . . . 0.0 110.471 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -64.26 -44.21 92.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.177 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.47 -50.91 69.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -52.09 -26.19 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.43 ' N ' HG23 ' A' ' 89' ' ' ILE . 2.2 mt-10 -100.92 -44.89 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.62 -33.34 41.54 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.9 87.1 3.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.848 0.356 . . . . 0.0 111.1 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.417 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -76.18 -12.01 19.31 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.638 2.225 . . . . 0.0 112.646 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.3 p -104.32 11.97 34.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.546 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.8 p -62.18 148.35 10.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.351 . . . . 0.0 111.466 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.48 166.42 33.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.974 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.66 108.3 16.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.4 m -146.58 -51.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.942 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.01 -176.76 36.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.446 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -132.29 -47.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -134.76 105.8 6.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 m -119.13 156.97 28.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.989 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.4 p -157.57 164.77 36.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 60.86 99.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -137.15 138.3 40.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.807 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -36.37 3.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.3 m -84.23 149.77 25.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.035 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.59 -57.34 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.36 30.74 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.1 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -168.17 -74.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.73 106.73 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.81 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.69 173.99 7.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t30 60.74 19.72 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.184 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.15 156.46 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.838 0.351 . . . . 0.0 110.839 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -130.31 -58.24 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.682 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 9' ' ' GLU . 4.7 tttp 59.84 -153.18 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 8' ' ' LYS . 5.1 mt-10 83.8 136.83 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD2' HG13 ' A' ' 16' ' ' VAL . 9.0 m-85 -124.41 164.69 19.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.93 0.395 . . . . 0.0 111.529 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.97 164.49 28.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 m -52.83 127.56 23.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.09 -14.15 57.18 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.163 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.01 141.0 47.69 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.798 0.333 . . . . 0.0 111.277 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.1 mt -93.17 122.6 35.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.343 179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.47 HG13 ' CD2' ' A' ' 10' ' ' TYR . 33.9 m -142.43 173.62 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.183 0.516 . . . . 0.0 111.93 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 9.4 m-85 -112.22 134.54 53.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.671 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.13 123.65 50.15 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.036 0.446 . . . . 0.0 111.659 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -91.72 127.39 37.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.787 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 ttm -127.02 152.29 47.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.582 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -67.14 126.93 30.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.92 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 91.54 -3.72 79.03 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.954 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 1.6 m-85 -148.72 149.7 31.41 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-N 116.808 0.304 . . . . 0.0 110.729 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.79 172.2 15.42 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.5 2.133 . . . . 0.0 112.508 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -49.15 114.52 1.03 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.772 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.86 132.46 23.7 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.293 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 32.5 Cg_exo -54.48 120.52 8.18 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.069 1.846 . . . . 0.0 110.953 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.16 175.04 10.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.394 0.616 . . . . 0.0 112.412 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -142.74 155.27 44.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.551 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.8 mm -78.66 135.0 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.78 -20.1 4.34 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.2 159.76 17.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.034 0.445 . . . . 0.0 111.266 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.28 162.28 26.91 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.984 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.6 107.45 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.569 2.18 . . . . 0.0 112.153 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.79 -77.77 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.177 0.513 . . . . 0.0 111.21 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.9 -38.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.325 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.72 93.08 2.42 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.061 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.1 t -142.41 7.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.528 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp 66.04 -73.35 0.07 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.677 0.275 . . . . 0.0 111.367 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.63 102.34 1.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.785 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -166.54 143.28 4.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.288 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -171.36 41.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.595 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.92 40.95 2.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.559 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 144.79 39.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.015 -179.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.26 154.01 17.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.837 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.426 ' HG3' ' CE1' ' A' ' 57' ' ' PHE . 5.1 tt0 -100.39 106.09 17.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.3 m -101.95 150.91 5.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.499 0.666 . . . . 0.0 112.126 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 17.9 t80 -105.33 125.31 50.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.289 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.4 ' CE2' ' HB1' ' A' ' 56' ' ' ALA . 47.7 m-85 -91.37 106.97 18.89 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.422 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.429 ' HB3' ' HA2' ' A' ' 85' ' ' GLY . 41.0 m-85 -59.43 175.17 0.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.692 0.282 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.39 -61.66 0.84 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.31 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.7 p -90.33 -22.48 21.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.7 0.286 . . . . 0.0 110.986 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 44.3 m170 64.84 34.32 9.38 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.351 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -91.4 154.74 18.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.755 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.07 143.67 49.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.251 0.548 . . . . 0.0 111.617 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.4 ' HB1' ' CE2' ' A' ' 49' ' ' PHE . . . -155.35 172.18 18.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.511 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.426 ' CE1' ' HG3' ' A' ' 46' ' ' GLN . 15.3 m-85 -116.66 126.16 52.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.482 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mt -140.02 163.24 33.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.174 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.27 171.55 31.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.321 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.52 -19.48 54.68 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.474 2.116 . . . . 0.0 112.517 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -68.62 -29.48 68.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.936 0.398 . . . . 0.0 110.569 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.59 10.91 40.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.891 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 mp -108.36 137.3 46.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.519 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.6 m-85 -137.03 157.03 75.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 6.7 Cg_exo -72.32 111.6 3.24 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.429 2.086 . . . . 0.0 111.327 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.2 t80 -48.46 -57.47 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.875 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.26 -40.52 48.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 111.348 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 17.3 mt-10 -71.24 -39.95 71.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.535 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.467 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -104.35 9.38 35.85 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.372 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -57.52 -46.43 83.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.758 0.314 . . . . 0.0 111.792 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.75 -35.56 78.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 13.4 ptpt -82.81 -41.52 18.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CD1' ' HG3' ' A' ' 72' ' ' LYS . 15.8 m-30 -97.92 -13.11 21.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -84.53 75.35 2.37 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.266 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -152.13 153.96 31.82 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.585 0.231 . . . . 0.0 110.586 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -45.31 136.14 11.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.717 2.278 . . . . 0.0 112.727 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.456 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 31.5 t30 -108.79 174.45 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.676 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 -22.4 15.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.851 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -12.94 61.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.8 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp 64.66 145.15 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.952 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.1 -18.25 46.05 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.753 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CE2' ' HD3' ' A' ' 27' ' ' PRO . 11.3 t80 -58.88 -51.87 68.18 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 121.005 0.431 . . . . 0.0 110.559 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -46.66 66.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.409 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -48.11 -31.25 5.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.85 -31.22 60.44 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.063 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.3 mt -61.02 -43.8 98.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.971 0.415 . . . . 0.0 110.315 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -64.13 -45.15 89.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.097 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -63.09 -50.99 68.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -51.73 -27.4 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.758 0.313 . . . . 0.0 111.754 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -99.52 -44.73 6.06 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -80.98 -31.7 34.66 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.64 87.73 3.1 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.819 0.342 . . . . 0.0 111.132 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 75.4 Cg_endo -77.71 -12.93 16.44 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.58 2.187 . . . . 0.0 112.791 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.8 p -104.45 12.78 32.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.634 0.254 . . . . 0.0 111.577 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.65 146.98 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.845 0.355 . . . . 0.0 111.432 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -143.18 178.76 7.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.032 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.24 -172.42 3.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.097 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.1 p -152.82 165.79 34.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 154.78 118.31 0.64 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -128.48 37.7 4.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 110.877 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 61.24 98.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.3 m 63.17 -79.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.8 78.39 0.29 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.905 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -172.16 112.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.7 mttm 61.63 102.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.91 123.15 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.24 123.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.972 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.8 m -74.47 158.75 33.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.09 166.34 13.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.081 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.986 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.974 0.416 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 t -100.1 -33.15 10.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.58 93.1 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.3 155.03 44.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.818 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.6 t30 67.62 -69.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.077 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.3 120.62 24.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -139.12 -165.6 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.731 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 9' ' ' GLU . 8.2 ttmm -93.38 4.23 54.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.628 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 1.7 mm-40 82.57 -130.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.469 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 9' ' ' GLU . 0.6 OUTLIER 161.8 97.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -133.48 160.32 37.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.432 . . . . 0.0 111.265 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 t -52.3 135.82 31.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.372 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.85 -11.27 69.89 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.003 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.33 142.93 47.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 0.0 111.103 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.2 mt -90.77 118.53 30.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.205 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.28 167.44 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.834 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 8.2 m-85 -109.86 132.62 53.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.65 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -110.83 124.06 51.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 111.523 -179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.71 133.21 35.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.96 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.83 147.15 51.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.62 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 112.69 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.89 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 109.56 -5.79 31.41 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.911 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 1.4 m-85 -147.96 161.57 34.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.784 0.326 . . . . 0.0 110.886 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 95.1 Cg_endo -83.94 168.98 11.98 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.895 2.397 . . . . 0.0 112.503 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 73' ' ' PHE . 67.9 m80 -47.53 116.68 1.52 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.544 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.476 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.04 130.76 27.9 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.59 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.43 120.5 8.13 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.084 1.856 . . . . 0.0 111.044 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.74 175.06 10.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.352 0.596 . . . . 0.0 112.533 -178.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.421 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 2.0 ttt180 -142.89 156.07 44.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.527 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.421 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 21.1 mm -77.67 135.05 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.32 -21.66 4.18 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.28 157.2 15.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 111.272 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.09 157.83 32.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.28 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.59 97.78 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.866 2.377 . . . . 0.0 112.232 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -153.15 13.77 0.51 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.031 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -171.1 -37.38 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.872 -179.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.06 106.45 3.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.333 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.07 -42.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.423 -179.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.05 -71.49 0.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.803 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -160.42 0.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.329 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.7 m 65.97 120.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.812 0.339 . . . . 0.0 110.815 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.11 -61.04 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.135 0.493 . . . . 0.0 110.056 179.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -155.68 47.07 0.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.151 179.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -105.58 133.3 50.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.191 -178.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -93.32 156.55 16.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.005 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.74 97.09 8.7 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.027 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -100.05 148.58 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.485 -177.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 33.0 t80 -106.33 125.6 51.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.293 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -93.39 110.65 22.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.743 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.462 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 50.3 m-85 -60.96 175.91 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.065 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.55 -62.94 0.85 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.132 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -90.63 -22.95 20.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 110.581 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 38.0 m80 63.93 37.05 9.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.013 0.435 . . . . 0.0 110.194 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -91.21 153.97 19.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.72 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.8 139.16 53.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.162 0.506 . . . . 0.0 111.137 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.35 169.6 23.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.634 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -112.07 126.41 55.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.773 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mp -139.21 162.53 34.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.064 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.9 176.11 39.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.362 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.74 -24.56 40.77 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.442 2.095 . . . . 0.0 112.219 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -70.03 -25.1 63.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.795 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -99.96 4.73 45.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.364 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 mt -116.09 139.47 50.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.648 0.261 . . . . 0.0 110.483 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.9 m-85 -137.84 165.69 31.91 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.884 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 2.7 Cg_exo -75.35 115.73 4.32 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.69 2.26 . . . . 0.0 111.733 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -53.03 -57.83 9.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.825 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -48.85 -42.98 38.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.98 0.419 . . . . 0.0 111.797 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.82 -39.72 72.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.441 -179.486 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.434 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 2.5 m -105.94 13.57 29.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 66' ' ' TYR . 6.0 ptmm? -58.06 -45.93 86.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.884 0.373 . . . . 0.0 111.452 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -67.66 -37.28 82.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 6.1 ptmt -83.39 -43.31 16.04 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.516 ' CZ ' ' CE1' ' A' ' 25' ' ' HIS . 20.5 m-30 -95.27 -13.22 25.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -89.42 74.65 1.94 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.843 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 7.7 mmtp -146.82 148.74 34.01 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.612 0.244 . . . . 0.0 110.41 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.03 155.37 2.77 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.51 2.14 . . . . 0.0 112.538 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.41 ' ND2' ' HG3' ' A' ' 24' ' ' PRO . 8.8 t-20 -137.15 166.95 22.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.591 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -15.52 35.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.268 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.71 -13.75 61.71 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.038 0.446 . . . . 0.0 110.597 179.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm 64.18 142.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.337 -179.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.21 -16.84 56.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.585 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 38.6 t80 -59.08 -56.68 19.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.922 0.391 . . . . 0.0 110.74 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.4 -46.18 69.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.189 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -48.93 -30.69 6.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.913 0.387 . . . . 0.0 110.5 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -74.28 -31.4 59.35 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.818 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.2 mt -60.78 -43.72 97.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.233 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.8 t90 -63.68 -45.29 90.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 1.5 mp0 -62.94 -51.36 67.19 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -52.25 -26.3 8.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.748 0.308 . . . . 0.0 111.818 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.04 -44.68 5.92 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -82.64 -31.68 28.66 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -156.77 88.79 2.68 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.728 0.299 . . . . 0.0 111.092 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.6 Cg_endo -76.4 -10.37 18.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.764 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.49 11.6 38.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.496 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.51 142.11 17.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.78 0.324 . . . . 0.0 111.218 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.29 144.4 17.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.017 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -94.37 111.04 22.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.123 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 m 61.35 -179.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.86 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.7 -23.75 5.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.635 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -149.04 162.73 39.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.793 0.33 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 60.61 105.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.5 m -157.01 116.34 3.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.989 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.13 85.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.954 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -99.4 -46.44 5.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -157.23 35.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.91 87.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.23 171.93 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.4 t -122.17 -43.6 2.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -98.4 165.39 11.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.078 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptm . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.766 0.317 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 t -145.13 136.92 25.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -139.92 -70.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.36 -174.7 3.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.31 -73.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.75 143.43 38.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.772 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -138.23 82.01 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.014 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -113.57 118.99 35.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.767 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -96.57 141.57 29.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.779 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.428 ' CE1' HG12 ' A' ' 16' ' ' VAL . 91.5 m-85 -113.55 159.72 19.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.654 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.72 154.71 47.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 111.025 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 59.5 m -51.92 134.63 31.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.346 -179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.37 -10.32 74.45 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.952 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.38 142.5 48.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.359 . . . . 0.0 111.171 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.1 mt -93.21 118.35 31.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.934 0.397 . . . . 0.0 110.532 179.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.428 HG12 ' CE1' ' A' ' 10' ' ' TYR . 22.6 m -142.84 171.71 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.683 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.546 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 33.2 m-85 -110.21 135.22 51.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.452 178.48 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.03 126.64 55.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 111.583 -179.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.3 129.11 37.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.927 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 ttm -134.06 144.33 48.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.71 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -65.03 122.96 18.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.651 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.73 -8.93 56.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.769 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.66 146.13 21.55 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.604 0.24 . . . . 0.0 110.526 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.39 175.17 11.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.414 2.076 . . . . 0.0 112.512 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -48.21 111.88 0.5 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.527 179.01 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.468 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.7 t-105 -98.43 130.68 27.61 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.448 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.91 120.1 7.36 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.272 1.982 . . . . 0.0 110.909 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.39 174.36 10.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.359 0.6 . . . . 0.0 112.546 -178.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 18.2 ttp180 -143.14 155.65 44.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.487 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.464 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 32.6 mm -78.82 136.52 23.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -126.46 -20.8 4.3 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.02 157.84 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.38 . . . . 0.0 111.18 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -155.94 154.27 27.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -88.87 175.66 3.53 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.087 2.525 . . . . 0.0 112.17 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.34 -48.08 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.112 0.482 . . . . 0.0 111.061 179.594 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.07 -41.06 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.883 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.63 90.41 1.01 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.19 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.6 -39.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.672 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.91 140.43 6.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.95 179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -62.26 111.24 1.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.805 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 p -136.33 9.52 3.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.749 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 37.61 42.02 0.34 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.935 0.398 . . . . 0.0 111.688 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.518 ' C ' ' HG2' ' A' ' 44' ' ' LYS . 3.3 t-20 64.47 47.44 2.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.991 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.518 ' HG2' ' C ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -140.01 158.42 44.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.245 -179.362 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -97.58 159.0 15.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.944 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -97.65 109.5 22.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.2 t -102.78 141.71 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.395 0.617 . . . . 0.0 112.421 -178.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 96' ' ' LYS . 47.9 t80 -105.25 121.25 43.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.693 179.044 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -93.86 110.89 22.53 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.585 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 49.9 m-85 -60.69 178.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.06 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 70.26 -63.53 0.78 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.857 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.3 p -91.38 -22.36 20.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.732 0.301 . . . . 0.0 110.528 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.7 m170 62.87 36.65 12.73 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.016 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.44 154.75 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.33 140.71 52.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.321 0.581 . . . . 0.0 111.6 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.99 167.59 29.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.038 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -111.92 126.91 55.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.935 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 29.3 mt -141.25 164.34 30.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.062 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.96 171.16 33.99 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.076 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.61 -19.06 48.56 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.407 2.071 . . . . 0.0 112.223 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -67.77 -28.44 67.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -100.22 16.5 24.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.657 179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mp -114.23 137.24 52.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.4 m-85 -136.74 155.87 76.4 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.715 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 10.1 Cg_exo -69.71 112.7 3.14 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.219 1.946 . . . . 0.0 111.178 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.546 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 89.5 t80 -47.65 -58.78 3.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.323 -178.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -50.61 -39.7 50.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.967 0.413 . . . . 0.0 111.772 -179.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.5 mt-10 -71.05 -39.87 72.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.605 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.438 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -102.66 8.09 39.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.24 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -55.61 -50.75 69.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.825 0.345 . . . . 0.0 111.384 179.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -70.95 -19.71 62.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.441 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.458 ' HD3' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -85.01 -52.23 6.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.177 0.513 . . . . 0.0 111.939 -179.214 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CD1' ' HD3' ' A' ' 72' ' ' LYS . 6.7 m-85 -100.72 -10.24 21.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.448 -0.797 . . . . 0.0 112.712 -178.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -78.02 72.31 2.29 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.297 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -150.64 152.15 31.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.681 0.24 . . . . 0.0 110.478 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.62 138.97 14.02 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.661 2.241 . . . . 0.0 112.72 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 82' ' ' PHE . 9.4 t-20 -110.0 164.19 12.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.544 -179.338 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -20.73 23.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.685 179.418 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -69.35 -12.37 61.6 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt 65.33 146.52 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.386 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.13 -18.81 42.5 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.855 -178.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.468 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.6 t80 -58.24 -54.94 41.26 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.017 0.437 . . . . 0.0 110.834 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.27 -47.05 66.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.294 -179.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -48.3 -31.37 5.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.045 0.45 . . . . 0.0 110.494 179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.32 -31.69 58.92 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.031 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.9 mt -60.98 -43.54 98.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.986 0.422 . . . . 0.0 110.192 179.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -63.31 -45.46 91.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.053 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -62.73 -51.61 66.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.039 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.414 HD11 ' CD2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.32 -26.5 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.791 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.66 -44.86 5.97 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -80.47 -33.06 36.94 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -155.9 88.22 2.97 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 111.136 -179.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.1 Cg_endo -76.23 -12.12 19.2 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.695 2.263 . . . . 0.0 112.838 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 p -104.05 12.71 33.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.406 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.4 p -60.71 145.7 12.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.778 0.323 . . . . 0.0 111.348 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 13.0 mmtp 62.78 99.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.916 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 61.83 151.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.939 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.9 t -168.5 178.39 4.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.97 0.414 . . . . 0.0 111.082 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.75 36.26 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.56 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -117.07 129.81 56.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.328 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -157.82 115.47 3.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.7 p -123.47 177.06 5.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.823 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.7 t 60.51 159.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -56.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.95 -178.11 3.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.795 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.95 -54.9 5.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.83 176.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 33.7 m -122.25 -52.07 1.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.77 -56.21 17.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.961 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.842 0.353 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 m -147.89 87.08 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.88 94.74 4.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 61.67 95.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.038 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -102.86 119.64 39.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.36 144.02 44.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.995 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -73.98 -13.5 60.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.214 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.0 tptt 63.99 121.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.397 . . . . 0.0 111.075 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -96.49 144.57 26.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.757 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.441 ' CD2' HG13 ' A' ' 16' ' ' VAL . 59.6 m-85 -115.2 159.51 20.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.75 157.53 45.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 111.005 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.6 t -51.95 130.86 30.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.388 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.85 -13.45 65.12 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.967 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.51 140.87 51.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.762 0.315 . . . . 0.0 111.022 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.4 mt -92.51 118.94 31.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 0.0 110.427 179.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.441 HG13 ' CD2' ' A' ' 10' ' ' TYR . 29.9 m -141.08 173.5 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.803 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.521 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 16.1 m-85 -111.35 138.88 47.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.509 178.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 62' ' ' ASP . . . -117.29 126.42 52.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.171 0.51 . . . . 0.0 112.133 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . 10.7 tptm -91.18 129.56 37.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.01 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.42 140.15 48.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.743 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 123.32 17.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.79 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.65 -7.88 46.44 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.685 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.09 160.99 30.41 Favored Pre-proline 0 C--N 1.333 -0.142 0 CA-C-O 120.728 0.299 . . . . 0.0 110.626 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.67 171.16 13.58 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.635 2.224 . . . . 0.0 112.367 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 67.8 m80 -50.02 118.52 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.392 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.46 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.9 t-105 -99.49 133.05 22.2 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 11.7 Cg_endo -54.45 120.79 8.61 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.393 2.062 . . . . 0.0 110.819 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.01 176.35 9.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -142.61 155.57 44.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.47 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 mm -82.53 137.76 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -124.31 -14.99 6.84 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' C ' ' HG2' ' A' ' 33' ' ' MET . 0.9 OUTLIER -162.73 155.61 19.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.084 0.468 . . . . 0.0 111.519 -179.772 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.444 ' HG2' ' C ' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -147.92 137.28 12.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.087 179.682 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.443 ' HA ' ' CG1' ' A' ' 38' ' ' VAL . 59.7 Cg_endo -72.02 98.79 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.438 2.092 . . . . 0.0 112.148 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.88 5.21 0.49 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.36 -40.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.788 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.94 104.07 3.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.116 179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 34' ' ' PRO . 3.3 m -156.83 98.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.117 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -76.25 -78.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.934 -179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.82 84.57 0.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.866 0.365 . . . . 0.0 110.31 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.404 ' OG1' ' HB ' ' A' ' 38' ' ' VAL . 56.7 m -144.16 165.4 27.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.222 0.534 . . . . 0.0 111.421 -179.274 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -169.86 50.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.474 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m120 70.43 37.36 1.54 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.021 -178.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.71 142.61 38.91 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.499 -179.163 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.8 OUTLIER -95.48 163.19 13.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.663 179.439 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.03 110.26 22.57 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.3 t -104.74 143.61 15.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.304 -178.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 40.8 t80 -106.75 123.85 48.74 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.912 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -95.81 113.77 25.44 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.948 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.467 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 60.9 m-85 -61.47 179.54 0.22 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.248 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.62 -63.56 0.45 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.117 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.7 p -91.7 -21.56 20.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.746 0.307 . . . . 0.0 110.7 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 64.5 m170 62.0 37.46 14.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.181 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -90.8 155.88 18.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.492 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.04 140.05 53.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.391 0.615 . . . . 0.0 111.655 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.18 166.92 32.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.262 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -106.2 124.76 50.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.655 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.2 mt -139.78 162.69 34.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.25 167.19 26.13 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.495 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.17 -19.76 67.67 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.661 2.241 . . . . 0.0 112.615 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -69.12 -27.28 65.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.873 0.368 . . . . 0.0 110.856 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 24.8 m-20 -97.95 8.81 44.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.231 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 17' ' ' PHE . 95.6 mt -109.35 139.87 43.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.693 0.283 . . . . 0.0 110.539 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.6 m-85 -134.06 156.67 78.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.09 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HB2' ' CB ' ' A' ' 68' ' ' GLU . 15.4 Cg_exo -68.19 109.66 2.03 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.605 2.203 . . . . 0.0 111.43 179.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 70' ' ' LYS . 83.4 t80 -54.9 -62.14 1.85 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.915 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.445 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -49.01 -42.13 36.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.081 0.467 . . . . 0.0 111.474 -179.149 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.411 ' CB ' ' HB2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -70.88 -39.77 72.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.485 -179.373 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -104.93 9.75 34.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.2 ptpp? -55.21 -45.21 75.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 111.401 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.3 mt-10 -70.09 -26.89 64.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.987 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -84.57 -46.44 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -105.07 -0.83 26.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.8 75.07 1.99 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.873 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -150.36 157.31 36.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.69 0.281 . . . . 0.0 110.861 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.82 149.89 10.25 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.704 2.269 . . . . 0.0 112.573 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.417 ' OD1' ' CD2' ' A' ' 82' ' ' PHE . 4.9 m120 -131.2 165.81 22.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.595 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.32 -17.53 30.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.259 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -66.25 -15.06 62.88 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.075 0.464 . . . . 0.0 110.61 179.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt 63.98 142.6 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.097 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.33 -17.91 48.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.801 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 18.4 t80 -58.66 -53.58 56.76 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.034 0.445 . . . . 0.0 110.505 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.61 -46.48 67.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.043 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.62 -32.66 8.53 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.019 0.438 . . . . 0.0 110.39 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.34 -31.83 60.74 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.814 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.1 mt -60.84 -43.73 97.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.001 0.429 . . . . 0.0 110.268 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.452 ' CD1' ' ND2' ' A' ' 91' ' ' ASN . 61.1 t90 -65.46 -41.52 93.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.053 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -64.29 -53.67 45.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 tt -52.39 -25.38 7.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -100.37 -44.65 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.452 ' ND2' ' CD1' ' A' ' 87' ' ' TRP . 35.3 m-80 -81.33 -33.91 32.19 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.645 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -156.66 85.46 3.01 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.017 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 72.1 Cg_endo -74.97 -10.24 21.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.676 2.251 . . . . 0.0 112.685 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.1 p -104.18 11.78 34.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.538 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.4 p -61.71 147.2 11.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.851 0.357 . . . . 0.0 111.441 -179.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -142.86 145.28 32.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.857 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -100.11 143.73 29.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.14 93.59 2.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 125.51 51.63 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.576 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -107.29 117.73 34.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.4 102.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.22 130.11 44.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.6 m -126.12 -174.47 3.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 61.96 110.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.6 mttt 63.01 121.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.985 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -139.25 -56.84 0.6 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.92 -30.37 13.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 61.52 172.59 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.837 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.73 173.93 6.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.011 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.879 0.371 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -133.67 -51.99 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.796 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.93 -172.72 2.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.08 -177.19 3.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.056 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -142.82 -65.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.739 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 -122.02 23.04 10.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.02 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -126.02 105.48 8.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.643 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' HD2' ' CE2' ' A' ' 10' ' ' TYR . 2.5 pttp -140.73 176.39 8.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.102 -179.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -154.32 142.6 20.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.541 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.471 ' CE1' HG12 ' A' ' 16' ' ' VAL . 88.9 m-85 -116.81 159.55 22.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.74 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -137.77 161.15 37.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.968 0.413 . . . . 0.0 110.997 -179.56 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 t -52.2 124.68 13.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.77 -16.09 44.11 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.061 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.23 140.01 50.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.827 0.346 . . . . 0.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 15' ' ' LEU . 56.3 mt -92.8 118.68 31.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.301 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.471 HG12 ' CE1' ' A' ' 10' ' ' TYR . 31.1 m -139.67 171.77 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.743 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.4 m-85 -109.98 136.68 48.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.706 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 62' ' ' ASP . . . -113.43 126.44 55.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.993 0.425 . . . . 0.0 111.779 -179.186 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.458 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 14.2 tptm -92.96 130.64 38.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.854 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.41 ' HE2' ' CE2' ' A' ' 49' ' ' PHE . 0.0 OUTLIER -128.94 148.6 50.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.77 179.946 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -67.36 106.67 2.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.774 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.82 -7.08 27.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.611 -0.805 . . . . 0.0 112.749 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -141.07 156.61 68.11 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.713 0.292 . . . . 0.0 110.656 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.98 171.92 9.01 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.744 2.296 . . . . 0.0 112.206 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.458 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 74.8 m80 -47.79 111.88 0.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.42 179.032 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 1.6 t-105 -99.57 129.06 29.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.783 -0.19 . . . . 0.0 111.24 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HG3' HD22 ' A' ' 86' ' ' LEU . 12.4 Cg_endo -55.46 121.13 9.38 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.152 1.902 . . . . 0.0 110.968 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.68 175.77 9.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.29 0.566 . . . . 0.0 112.257 -178.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.3 ttp180 -141.67 154.83 45.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.75 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.1 mm -82.27 114.25 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.87 -13.84 14.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.26 152.48 14.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.402 . . . . 0.0 111.309 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.426 ' HE3' ' O ' ' A' ' 10' ' ' TYR . 6.3 ptp -154.75 156.35 31.35 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.168 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.82 160.76 24.46 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.678 2.252 . . . . 0.0 112.111 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -82.87 -37.85 23.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.167 0.508 . . . . 0.0 110.715 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.89 -39.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.052 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.459 ' O ' ' CG2' ' A' ' 38' ' ' VAL . . . -162.53 -47.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.12 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 37' ' ' ALA . 5.2 m 51.05 21.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.829 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.49 60.55 2.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.719 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.7 p 177.06 -45.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.4 p -79.55 102.88 9.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.922 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.7 52.76 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.021 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t30 56.08 50.8 12.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.047 0.451 . . . . 0.0 110.969 -179.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -132.06 138.82 48.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.208 -179.59 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 62.4 m-85 -94.42 153.22 18.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.843 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -99.0 105.78 17.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.5 m -101.47 150.34 6.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.542 0.687 . . . . 0.0 112.211 -178.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 32.9 t80 -105.81 124.38 49.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.076 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.444 ' HE2' ' HB1' ' A' ' 56' ' ' ALA . 32.5 m-85 -91.72 107.62 19.33 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.565 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.422 ' CZ ' ' HA ' ' A' ' 93' ' ' PRO . 36.0 m-85 -58.56 175.11 0.27 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.794 0.33 . . . . 0.0 110.934 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.53 -62.05 0.86 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.386 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.4 p -90.49 -21.51 21.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.652 0.263 . . . . 0.0 111.097 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 48.4 m170 64.02 34.9 10.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.889 0.376 . . . . 0.0 110.29 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -90.32 153.68 20.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.704 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.54 141.51 51.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.166 0.507 . . . . 0.0 111.633 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.444 ' HB1' ' HE2' ' A' ' 49' ' ' PHE . . . -155.41 177.53 11.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.406 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 9.0 m-85 -120.56 127.34 52.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.804 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.3 mt -140.01 163.93 31.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.117 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.94 177.17 35.25 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.566 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.12 -25.26 51.07 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.665 2.243 . . . . 0.0 112.437 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -69.92 -25.43 63.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.352 . . . . 0.0 111.091 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 36.3 m-20 -98.39 4.79 48.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.388 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 20.8 mt -112.59 139.37 48.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.444 179.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.4 m-85 -136.01 159.93 69.18 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.067 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 12.2 Cg_exo -69.68 110.88 2.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.695 2.264 . . . . 0.0 111.64 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -51.82 -59.25 4.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.549 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -50.42 -41.41 52.38 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.701 -179.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 2.2 tm-20 -69.55 -39.81 77.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.458 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 m -108.15 13.77 25.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.5 ptpp? -56.09 -47.67 77.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 111.125 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.513 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.3 mt-10 -71.13 -21.32 62.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.316 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HD3' ' CE1' ' A' ' 73' ' ' PHE . 4.2 tttt -85.59 -49.35 8.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 9.5 m-85 -103.01 -4.79 24.13 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.32 71.1 3.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.077 -179.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 9.1 mtmt -149.33 153.54 37.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.74 158.19 14.16 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.574 2.182 . . . . 0.0 112.733 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -137.15 167.27 21.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.469 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.46 -15.45 46.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.112 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -14.04 61.61 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.008 0.432 . . . . 0.0 110.792 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp 63.85 142.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.273 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.05 -17.79 48.94 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.742 -178.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 44.5 t80 -59.83 -54.19 49.09 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.998 0.428 . . . . 0.0 110.842 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.1 -46.33 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.236 -179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -48.39 -29.83 4.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.997 0.427 . . . . 0.0 110.601 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.416 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.97 -31.59 59.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.172 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.46 HD22 ' HG3' ' A' ' 27' ' ' PRO . 3.8 mm? -61.01 -44.16 97.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.959 0.409 . . . . 0.0 110.533 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 64.2 t90 -65.12 -45.71 83.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.339 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.48 -51.02 69.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.3 -27.18 10.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.711 0.291 . . . . 0.0 111.684 -179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -99.6 -44.73 6.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.33 -31.86 37.98 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -155.61 88.11 3.07 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 111.188 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -75.93 -13.39 19.54 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.676 2.25 . . . . 0.0 112.697 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 48.1 p -105.67 12.4 31.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.496 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 p -63.14 149.76 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.418 . . . . 0.0 111.481 -179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.14 143.23 25.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -91.56 104.0 16.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.054 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -83.3 138.4 33.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.999 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.34 141.91 10.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.431 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -125.79 153.04 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.0 110.99 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.01 -46.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.2 t -133.93 99.79 4.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -101.9 -62.93 1.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.22 113.5 1.87 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.29 157.68 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 124.58 29.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.5 m -150.5 138.94 20.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 67.5 m -142.89 -56.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.9 167.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.761 0.315 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -102.52 31.73 3.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -120.55 138.25 53.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 t -125.42 139.51 53.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.798 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -128.45 6.19 5.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.467 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -162.22 -67.0 0.05 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.72 0.295 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -58.47 174.81 0.28 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 9' ' ' GLU . 13.3 tppt? -153.86 162.07 41.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.438 ' N ' ' HG3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -157.17 146.67 20.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.811 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.434 ' CD2' HG13 ' A' ' 16' ' ' VAL . 47.9 m-85 -117.74 160.78 20.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.694 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -134.22 160.47 37.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 111.135 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.26 133.0 34.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.372 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.2 -10.97 72.75 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.915 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.03 142.8 49.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.768 0.318 . . . . 0.0 111.15 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 30.2 mt -90.81 116.79 28.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 110.281 179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.434 HG13 ' CD2' ' A' ' 10' ' ' TYR . 27.3 m -139.48 168.9 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.663 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 44.5 m-85 -110.56 137.06 48.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.506 178.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -112.29 124.22 51.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.294 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -91.11 134.39 34.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.963 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mmm -128.19 149.27 50.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.646 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 115.22 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 0.0 111.063 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.72 -31.69 6.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.574 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -103.02 153.0 38.61 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 110.915 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.87 166.8 11.39 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.816 2.344 . . . . 0.0 112.43 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 46.7 m80 -48.61 113.98 0.88 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.477 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.7 t-105 -98.65 131.33 26.04 Favored Pre-proline 0 N--CA 1.464 0.266 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.9 120.34 7.74 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.357 2.038 . . . . 0.0 110.857 178.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.49 175.03 10.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 1.0 OUTLIER -143.07 155.93 44.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.336 179.619 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.463 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.0 mm -80.82 136.88 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -127.31 -18.1 4.57 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -164.42 153.62 13.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.899 0.381 . . . . 0.0 111.334 -179.674 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 6.8 ptp -156.54 166.3 16.83 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.826 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.4 56.06 2.64 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.877 2.385 . . . . 0.0 112.274 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -164.36 37.57 0.08 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.685 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.12 -36.8 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.15 -64.18 1.1 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.214 178.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.2 t 55.25 100.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.355 179.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.69 -67.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.7 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -96.66 42.09 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.448 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.01 174.08 6.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.275 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -171.1 56.5 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.403 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.476 ' C ' ' HG2' ' A' ' 44' ' ' LYS . 7.6 m120 68.46 28.68 5.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.04 -178.361 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HG2' ' C ' ' A' ' 43' ' ' ASN . 2.2 mtmt -138.38 151.91 47.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.057 -179.231 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -92.18 158.79 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.231 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.55 98.22 9.13 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -99.79 147.29 7.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.659 0.742 . . . . 0.0 112.408 -177.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.443 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 28.4 t80 -105.63 124.97 50.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.283 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -91.85 108.15 19.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.548 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 38.0 m-85 -59.79 175.78 0.34 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.3 . . . . 0.0 110.979 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.68 -62.77 0.88 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.229 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.2 p -90.78 -22.07 21.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.794 0.331 . . . . 0.0 110.656 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 50.4 m170 63.51 36.04 11.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.388 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -90.41 153.52 20.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.589 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.25 139.55 53.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.113 0.483 . . . . 0.0 111.328 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.7 167.84 29.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.64 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.28 125.64 53.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.639 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.3 mt -138.39 161.49 36.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.043 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.81 171.8 33.41 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.311 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.39 -20.85 47.93 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.351 2.034 . . . . 0.0 112.214 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -68.37 -28.9 67.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.958 0.409 . . . . 0.0 110.453 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.49 12.06 38.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.816 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.3 mp -109.51 136.59 48.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.386 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.5 m-85 -135.05 146.0 56.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.902 0.382 . . . . 0.0 111.048 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.446 ' HG2' ' HB3' ' A' ' 68' ' ' GLU . 17.8 Cg_endo -60.06 112.25 1.24 Allowed 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.43 2.087 . . . . 0.0 111.334 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 78.6 t80 -49.71 -61.78 1.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.215 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.28 -40.8 49.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.125 0.488 . . . . 0.0 111.49 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.446 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 6.0 tt0 -71.01 -39.74 72.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.198 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 5.3 m -101.04 8.14 43.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HD3' ' CE2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.17 -53.68 46.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.267 0.556 . . . . 0.0 111.426 179.64 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.85 -17.79 62.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.831 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -85.26 -50.53 7.28 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 7.8 m-85 -107.29 -3.19 19.96 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.39 72.68 2.61 Favored Glycine 0 C--N 1.329 0.165 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.976 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -149.81 153.23 35.9 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.607 0.241 . . . . 0.0 110.678 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -51.13 153.57 9.06 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.55 2.167 . . . . 0.0 112.626 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -137.05 167.35 21.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.684 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 -15.38 41.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.324 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.9 mmt-85 -66.03 -15.19 62.82 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.032 0.444 . . . . 0.0 110.595 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm 63.62 142.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.136 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.04 -17.2 52.81 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.608 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 36.1 t80 -58.38 -56.08 26.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.986 0.422 . . . . 0.0 110.754 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.86 -46.28 67.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -48.58 -31.69 6.97 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.974 0.416 . . . . 0.0 110.426 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.33 -32.2 58.28 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.026 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 16.5 mt -60.68 -43.55 97.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.996 0.426 . . . . 0.0 110.123 179.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . 0.411 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 63.8 t90 -64.9 -43.22 93.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.935 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 21.6 mm-40 -63.46 -52.41 61.53 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -53.04 -25.44 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 87' ' ' TRP . 12.5 pt-20 -99.92 -44.77 5.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -82.55 -29.37 30.39 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -155.86 86.88 3.12 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.79 0.328 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.86 -14.29 17.3 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.667 2.245 . . . . 0.0 112.653 179.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.7 p -105.13 11.9 32.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.576 -179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.72 147.25 10.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.403 -179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -152.94 21.57 0.58 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 51.6 28.85 5.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.291 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.46 47.83 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -118.15 68.51 0.33 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -144.92 32.75 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.894 0.378 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -83.01 166.29 18.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.1 t -141.9 -58.52 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.9 t 63.13 -79.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -73.1 170.2 15.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.929 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -177.1 149.61 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.946 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt 60.89 84.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.994 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.8 m 56.82 92.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.2 m -170.37 -66.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.76 158.11 36.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.074 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.968 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.778 0.323 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.84 159.7 36.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.71 -51.93 7.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.3 p -113.54 -176.25 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -116.71 162.54 17.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -171.68 143.31 1.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 61.46 153.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.002 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.57 147.7 31.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.742 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -95.69 142.63 27.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.748 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.42 ' CE1' HG12 ' A' ' 16' ' ' VAL . 87.7 m-85 -112.1 157.51 20.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.714 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -131.48 158.67 40.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.048 0.451 . . . . 0.0 111.169 -179.538 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.73 131.86 35.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.516 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.81 -11.45 68.04 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.14 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.86 138.4 50.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 111.26 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -91.89 118.09 30.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.386 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.42 HG12 ' CE1' ' A' ' 10' ' ' TYR . 25.5 m -139.88 171.95 13.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.832 -179.553 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 30.3 m-85 -112.81 137.09 51.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.539 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.4 126.5 55.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 -179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 12.3 tptp -90.25 136.08 33.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.087 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -130.32 151.8 50.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.534 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -67.64 118.26 10.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.919 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -8.57 74.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.981 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.422 ' CD1' ' HD3' ' A' ' 79' ' ' ARG . 1.9 m-85 -132.19 154.45 81.65 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.849 0.324 . . . . 0.0 111.071 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.27 167.16 12.29 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.86 2.373 . . . . 0.0 112.495 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.446 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 80.2 m80 -47.09 115.23 1.02 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.629 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.467 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.1 t-105 -99.03 130.02 28.34 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.536 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.78 119.48 6.31 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.374 2.049 . . . . 0.0 111.112 178.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.12 174.34 10.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.425 0.631 . . . . 0.0 112.69 -177.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.46 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -142.92 155.8 44.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.305 179.686 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.46 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 28.5 mm -78.18 138.36 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.004 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.73 -20.33 5.5 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.055 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.51 150.78 14.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.069 0.461 . . . . 0.0 111.234 -179.694 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 29.2 mmt -93.35 161.15 31.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.795 179.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.472 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 98.4 Cg_endo -87.15 111.24 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.904 2.403 . . . . 0.0 112.356 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.46 -93.5 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.919 179.761 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -173.97 -52.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 110.512 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.52 72.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.139 179.896 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.476 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.9 m -145.29 21.28 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.317 -179.422 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 3.6 mmmp? -159.89 -79.67 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.499 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.7 t -179.8 41.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.46 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.428 HG23 ' CE2' ' A' ' 57' ' ' PHE . 38.6 p -138.08 122.0 17.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.125 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.61 -60.64 2.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.252 0.549 . . . . 0.0 109.788 178.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -155.66 50.33 0.55 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.889 179.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -114.16 139.75 49.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.709 -178.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 80.1 m-85 -95.82 155.02 16.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.678 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.4 mt-30 -96.39 106.71 18.99 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.211 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.4 t -100.77 143.06 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.294 -178.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.89 122.02 45.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.156 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -94.97 110.28 22.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.415 179.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.441 ' CD1' ' HB3' ' A' ' 88' ' ' GLU . 57.2 m-85 -58.86 -179.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.025 -179.513 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.52 -63.64 0.61 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.205 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.9 p -91.11 -22.83 20.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.749 0.309 . . . . 0.0 110.734 179.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.4 m170 64.55 36.51 8.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.534 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -94.21 157.0 16.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.517 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -131.75 149.92 52.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.362 0.601 . . . . 0.0 112.009 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.52 170.94 20.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 52.4 m-85 -105.96 86.59 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.08 156.84 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.195 -179.87 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.97 169.42 32.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.324 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.48 -20.86 47.35 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.504 2.136 . . . . 0.0 112.359 179.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -27.83 67.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.95 0.405 . . . . 0.0 110.413 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -100.7 12.46 37.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.791 179.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.73 137.37 46.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.676 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.7 m-85 -136.14 158.24 74.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.65 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.628 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.9 Cg_exo -71.79 111.51 3.16 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.391 2.061 . . . . 0.0 111.288 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.2 t80 -45.63 -58.97 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.438 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -50.95 -39.43 54.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.949 -179.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.1 mm-40 -70.62 -39.76 73.55 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.445 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 49.5 m -105.49 11.03 32.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.55 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.38 -49.47 74.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 111.554 179.977 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.51 -26.17 64.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.707 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -85.01 -46.93 10.73 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 2.5 m-30 -99.87 -12.95 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -80.68 71.1 2.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.289 -0.957 . . . . 0.0 113.043 -179.523 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.0 mttt -148.99 153.21 38.03 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.595 0.236 . . . . 0.0 110.384 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -51.27 153.31 9.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.463 2.109 . . . . 0.0 112.674 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -136.48 163.44 30.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.545 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -81.81 -16.54 50.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.153 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.422 ' HD3' ' CD1' ' A' ' 23' ' ' TYR . 17.9 mmm180 -64.52 -15.66 61.26 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.916 0.389 . . . . 0.0 110.823 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt 63.24 140.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.139 -179.38 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.88 -16.98 53.55 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.463 -178.196 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.467 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.5 t80 -58.57 -55.49 34.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.943 0.401 . . . . 0.0 110.649 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 m -53.54 -45.66 69.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.121 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.91 -31.69 7.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.038 0.446 . . . . 0.0 110.464 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.04 -31.75 61.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.921 179.427 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.7 mt -61.12 -43.68 98.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.961 0.41 . . . . 0.0 110.314 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -63.61 -45.46 90.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.441 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.2 mp0 -62.38 -50.93 69.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.128 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -52.48 -25.99 8.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.723 0.297 . . . . 0.0 111.8 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -44.81 5.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.095 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -80.49 -32.23 37.05 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.32 87.85 3.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.798 0.332 . . . . 0.0 110.978 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.403 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 96.3 Cg_endo -79.6 -12.52 13.75 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.636 2.224 . . . . 0.0 112.958 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 21.1 p -103.8 12.8 34.11 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.2 p -65.62 149.37 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.837 0.351 . . . . 0.0 111.288 -179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 165.81 24.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.963 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.0 178.47 8.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m 60.05 162.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.36 90.76 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.531 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -122.14 99.1 6.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -68.52 -37.48 80.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.41 93.53 4.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.6 p -143.26 128.49 18.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 61.42 113.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.62 101.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 154.54 33.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.918 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.79 179.12 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.9 p -173.04 35.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.64 103.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.052 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 121.011 0.434 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 t -53.24 127.18 23.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.464 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.4 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 101.23 -14.84 58.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.096 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.07 138.8 54.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 0.0 111.115 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.7 mt -92.22 117.65 30.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.176 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.92 171.39 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.185 0.517 . . . . 0.0 111.956 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 32.5 m-85 -110.63 137.35 48.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.471 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.734 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -111.54 125.0 53.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.893 0.378 . . . . 0.0 111.586 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -90.37 134.37 34.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.906 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 mmm -129.8 151.85 49.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 122.62 18.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.81 -2.06 85.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.897 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -139.4 152.47 69.23 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.757 0.279 . . . . 0.0 110.674 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.87 163.8 13.85 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.6 2.2 . . . . 0.0 112.688 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 48.4 m80 -46.6 117.44 1.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.102 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.425 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.3 t-105 -101.13 128.04 30.42 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.584 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HG3' HD22 ' A' ' 86' ' ' LEU . 9.5 Cg_endo -52.49 119.5 5.99 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.329 2.02 . . . . 0.0 111.073 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . -144.69 177.34 8.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.43 0.633 . . . . 0.0 112.67 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 4.3 ttp180 -143.2 156.66 44.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.84 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.47 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 24.1 mm -82.94 140.32 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.0 -19.38 6.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 111.001 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 1.1 mmpt? . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.907 0.384 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 2.6 m-85 -149.46 159.77 44.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.188 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 57' ' ' PHE . 11.5 mt-30 -93.04 105.32 17.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.076 0.465 . . . . 0.0 109.832 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.625 HG11 HD21 ' A' ' 63' ' ' LEU . 11.3 m -102.95 146.87 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.615 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 3.9 t80 -103.82 123.44 47.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.456 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.665 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 73.0 m-85 -93.72 105.26 17.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.814 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.76 ' HE2' HD12 ' A' ' 89' ' ' ILE . 57.9 m-85 -56.47 178.53 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 111.389 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.39 -62.35 1.1 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.15 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.8 p -91.38 -21.96 20.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 110.932 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.6 m170 65.26 34.12 8.65 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.521 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -95.51 157.35 15.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.649 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 t -129.76 148.68 51.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.354 0.597 . . . . 0.0 111.833 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.53 170.77 21.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.606 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.3 m-85 -108.13 124.2 49.88 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.758 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.734 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 28.6 mt -138.65 161.73 36.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.975 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.11 176.27 42.06 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.248 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.45 -25.42 30.07 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.314 2.009 . . . . 0.0 111.865 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -68.96 -22.13 64.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.618 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.18 2.18 42.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.625 HD21 HG11 ' A' ' 47' ' ' VAL . 35.1 mt -110.99 139.35 46.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.291 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.449 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.2 m-85 -136.64 160.48 66.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 16.7 Cg_exo -67.59 112.62 2.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.646 2.231 . . . . 0.0 111.939 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.7 t80 -50.08 -61.41 2.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.242 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.83 -39.38 58.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.959 0.409 . . . . 0.0 111.638 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -71.37 -39.25 71.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.349 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 34.2 m -105.62 10.86 32.82 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 66' ' ' TYR . 14.6 tttt -54.76 -48.35 72.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.77 -29.77 68.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.934 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -83.77 -46.05 12.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.469 ' HB3' ' HB2' ' A' ' 25' ' ' HIS . 4.3 m-30 -98.13 -12.18 22.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.511 ' HA2' HD11 ' A' ' 86' ' ' LEU . . . -84.76 72.88 2.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.102 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.459 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.9 mttt -150.7 143.49 16.42 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.635 0.255 . . . . 0.0 110.592 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.26 158.59 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.468 2.112 . . . . 0.0 112.757 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.64 172.05 13.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.97 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -87.22 -16.85 34.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.393 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -13.96 61.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt 66.34 141.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.395 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -17.04 56.89 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.897 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.499 ' CE1' HD21 ' A' ' 86' ' ' LEU . 36.9 t80 -59.78 -53.76 54.17 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.944 0.402 . . . . 0.0 110.518 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.75 -47.08 71.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.72 -31.33 6.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.934 0.397 . . . . 0.0 110.367 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -72.14 -32.4 63.06 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.82 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.511 HD11 ' HA2' ' A' ' 74' ' ' GLY . 3.8 mm? -60.78 -43.66 97.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.985 0.421 . . . . 0.0 110.361 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -65.48 -44.17 87.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.237 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 24.3 mm-40 -63.56 -53.01 58.41 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.76 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -52.77 -26.69 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.739 0.304 . . . . 0.0 111.775 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.71 -44.64 6.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -81.33 -32.63 32.93 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -156.72 90.95 2.54 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.715 0.293 . . . . 0.0 111.324 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -76.54 -11.02 18.83 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.48 2.12 . . . . 0.0 112.659 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.9 p -106.81 12.61 28.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.543 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.442 HG12 ' HE1' ' A' ' 50' ' ' PHE . 10.6 p . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.907 0.384 . . . . 0.0 111.542 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 121.022 0.439 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.9 m -52.01 129.38 27.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.396 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.99 58.51 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.939 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.05 138.16 51.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.836 0.351 . . . . 0.0 111.263 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.774 HD23 ' HG3' ' A' ' 29' ' ' ARG . 62.4 mt -91.81 119.64 31.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 110.156 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.0 m -140.72 171.32 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.946 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 10.0 m-85 -109.87 136.71 48.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.515 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.644 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.08 124.56 52.88 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.007 0.432 . . . . 0.0 111.775 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -92.09 131.69 37.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.75 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mtp -129.09 147.47 50.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.689 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 115.26 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.877 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.413 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 100.45 4.08 55.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.764 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -152.8 153.66 30.34 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.695 0.283 . . . . 0.0 110.653 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.83 167.6 18.3 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.562 2.174 . . . . 0.0 112.3 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.454 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 71.0 m80 -47.49 115.23 1.06 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.627 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.92 130.41 27.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.315 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.89 120.89 8.89 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.206 1.937 . . . . 0.0 111.114 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.73 175.77 9.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.345 0.593 . . . . 0.0 112.252 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.774 ' HG3' HD23 ' A' ' 15' ' ' LEU . 5.3 ttp180 -142.84 155.7 44.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.455 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -78.85 135.28 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.98 -20.3 4.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -179.671 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.949 0.404 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 82.0 m-85 -94.82 154.45 17.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.767 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -99.3 107.04 19.23 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.639 HG11 HD21 ' A' ' 63' ' ' LEU . 7.2 m -103.47 150.5 6.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-O 121.433 0.635 . . . . 0.0 112.342 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 49.0 t80 -105.43 124.51 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.024 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.644 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 70.1 m-85 -93.28 108.96 20.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.718 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.699 ' CE2' HD12 ' A' ' 89' ' ' ILE . 47.8 m-85 -61.53 177.93 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.815 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.97 -63.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.001 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.1 p -91.52 -22.46 20.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.729 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 3.6 m80 64.56 36.96 8.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -91.64 155.44 18.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.603 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.11 140.26 53.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.188 0.518 . . . . 0.0 111.356 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.553 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.26 178.1 10.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.363 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.0 m-85 -119.92 127.21 52.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.2 mp -138.84 161.75 36.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.994 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.48 176.4 35.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.653 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.68 -25.06 54.43 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.583 2.189 . . . . 0.0 112.409 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -69.53 -27.07 64.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 0.0 110.894 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 4.0 m-20 -100.25 6.95 44.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.312 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.639 HD21 HG11 ' A' ' 47' ' ' VAL . 22.3 mt -114.31 138.1 50.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.651 0.262 . . . . 0.0 110.35 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.6 m-85 -137.11 159.58 69.33 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.066 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.9 Cg_exo -70.24 113.86 3.59 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.674 2.25 . . . . 0.0 111.65 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 89.1 t80 -53.6 -59.51 4.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.737 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -49.04 -42.63 39.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.649 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.08 -39.53 72.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.57 -179.399 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -105.33 10.39 33.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.4 ptpt -56.38 -44.33 80.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.633 0.254 . . . . 0.0 111.676 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mm-40 -68.56 -32.86 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 73' ' ' PHE . 13.1 ptpt -84.01 -43.34 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.435 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 18.2 m-30 -98.3 -8.6 26.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.24 75.38 2.04 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.999 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mmmm -148.61 159.26 38.86 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.609 0.242 . . . . 0.0 110.412 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.62 151.87 59.76 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.553 2.169 . . . . 0.0 112.573 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.05 170.27 15.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.148 0.499 . . . . 0.0 111.547 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -15.67 28.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.405 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -66.35 -14.82 62.65 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.009 0.433 . . . . 0.0 110.751 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt 63.37 144.15 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.111 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.44 -18.8 35.59 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.617 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 15.0 t80 -58.56 -55.65 32.36 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-O 121.04 0.448 . . . . 0.0 110.623 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -52.83 -45.67 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -48.72 -31.35 6.75 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.922 0.391 . . . . 0.0 110.441 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.09 -31.42 61.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.881 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 89' ' ' ILE . 88.9 mt -60.97 -43.8 98.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 110.231 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -64.14 -44.9 90.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.069 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.597 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -63.38 -50.92 68.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.699 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -51.81 -27.6 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 111.82 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.44 -44.66 6.1 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.76 -32.92 41.05 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.3 87.43 3.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.751 0.31 . . . . 0.0 111.241 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 3.6 Cg_exo -76.53 -13.75 18.19 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.986 2.457 . . . . 0.0 112.633 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 p -104.01 13.07 33.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.553 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.597 HG11 ' HG2' ' A' ' 88' ' ' GLU . 14.9 p . . . . . 0 C--N 1.332 -0.194 0 CA-C-O 120.939 0.399 . . . . 0.0 111.491 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.887 0.375 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 t -52.21 126.72 19.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.294 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.571 ' HA2' ' HE ' ' A' ' 29' ' ' ARG . . . 109.72 -18.46 29.44 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.195 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.47 144.56 48.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 111.859 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.562 HD23 ' HG3' ' A' ' 29' ' ' ARG . 61.3 mt -92.54 123.73 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.105 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 m -141.9 173.01 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 112.193 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -111.84 135.88 51.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.746 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.632 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -112.75 122.24 47.09 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.003 0.43 . . . . 0.0 111.571 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 22.8 tptm -92.21 129.71 38.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 mtm -128.21 149.94 50.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.586 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 124.45 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.982 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 91.41 -0.75 75.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.049 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.1 m-85 -146.52 153.54 47.57 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.857 0.329 . . . . 0.0 110.813 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.41 165.31 16.47 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.771 2.314 . . . . 0.0 112.417 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.485 ' CE1' ' CZ ' ' A' ' 73' ' ' PHE . 70.1 m80 -47.94 115.42 1.17 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.489 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.434 ' CD1' ' HD2' ' A' ' 27' ' ' PRO . 2.5 t-105 -98.91 132.86 22.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.412 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 35.1 Cg_exo -54.54 120.05 7.42 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.04 1.827 . . . . 0.0 111.079 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -143.7 174.57 10.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.347 0.594 . . . . 0.0 112.373 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.571 ' HE ' ' HA2' ' A' ' 13' ' ' GLY . 43.1 ttt180 -141.53 154.8 45.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.607 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 mm -78.39 138.65 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -123.89 -23.21 4.7 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 120.979 0.419 . . . . 0.0 111.353 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 121.118 0.485 . . . . 0.0 111.543 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -94.37 158.3 15.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.128 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.9 106.37 18.66 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.677 HG21 HD21 ' A' ' 63' ' ' LEU . 73.9 t -103.7 142.72 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.494 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -106.77 123.3 47.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.774 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.632 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 90.1 m-85 -95.11 108.69 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.311 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.805 ' HE2' HD12 ' A' ' 89' ' ' ILE . 54.3 m-85 -57.57 179.32 0.06 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.27 -64.12 0.56 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.311 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.5 p -92.0 -22.63 19.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.8 m170 64.62 36.01 8.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.224 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -90.41 153.84 20.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.602 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.72 141.35 52.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.212 0.529 . . . . 0.0 111.526 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.97 166.74 32.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.305 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -107.08 124.85 50.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.598 HD13 ' HB1' ' A' ' 18' ' ' ALA . 4.9 mt -138.71 160.22 40.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.925 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.13 177.26 38.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.63 -24.8 47.7 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.507 2.138 . . . . 0.0 112.388 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -69.17 -25.26 64.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.92 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.458 ' CB ' HD22 ' A' ' 58' ' ' LEU . 2.3 m-20 -99.6 6.48 45.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.322 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.677 HD21 HG21 ' A' ' 47' ' ' VAL . 38.6 mt -115.02 138.82 50.43 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.723 0.297 . . . . 0.0 110.57 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.1 m-85 -136.34 159.99 68.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.701 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.644 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 8.1 Cg_exo -71.28 114.17 3.84 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.46 2.107 . . . . 0.0 111.479 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 70' ' ' LYS . 74.3 t80 -51.07 -59.57 4.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.117 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.436 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 1.1 mt-10 -48.09 -43.7 30.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.923 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 7.0 mt-10 -71.37 -39.63 71.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.524 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.461 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 63.7 m -103.04 9.69 38.45 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.3 ptpp? -55.62 -44.62 77.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.69 0.281 . . . . 0.0 111.669 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 1.4 mt-10 -68.39 -34.25 75.7 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -84.25 -44.15 14.16 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.485 ' CZ ' ' CE1' ' A' ' 25' ' ' HIS . 19.2 m-30 -95.95 -14.1 23.33 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.98 74.89 2.34 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.195 -1.002 . . . . 0.0 113.071 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -149.11 159.31 37.45 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.589 0.233 . . . . 0.0 110.548 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.69 152.72 79.17 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.559 2.172 . . . . 0.0 112.621 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 79' ' ' ARG . 50.6 p-10 -138.52 -172.37 3.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.291 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -100.35 -12.09 19.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.154 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 13.7 mmm180 -65.91 -15.95 63.42 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.993 0.425 . . . . 0.0 110.676 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt 62.7 141.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.996 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.49 59.3 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.562 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 26.5 t80 -57.5 -58.09 9.82 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.979 0.419 . . . . 0.0 110.941 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.884 ' HA ' HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -51.37 -45.23 62.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.086 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.21 -32.28 10.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.012 0.434 . . . . 0.0 110.324 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.9 -32.59 58.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.826 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 83' ' ' SER . 19.2 mt -60.62 -43.51 97.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.098 0.475 . . . . 0.0 110.141 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 59.0 t90 -63.32 -44.51 94.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.1 mp0 -62.93 -51.91 65.1 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.805 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -51.97 -25.63 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -101.04 -44.74 5.62 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -81.98 -32.5 30.63 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.24 84.09 3.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.804 0.335 . . . . 0.0 110.733 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 91.4 Cg_endo -77.08 -9.99 17.9 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.559 2.173 . . . . 0.0 112.856 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.1 p -104.12 12.2 34.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.588 0.232 . . . . 0.0 111.445 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.444 HG12 ' HE1' ' A' ' 50' ' ' PHE . 11.4 p . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 111.549 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.8 m -52.52 124.82 14.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.28 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 29' ' ' ARG . . . 105.58 -16.51 44.25 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.817 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.69 135.36 49.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.995 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.443 HD23 ' HG3' ' A' ' 29' ' ' ARG . 71.0 mt -92.07 117.26 29.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 110.286 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.448 HG21 HD22 ' A' ' 63' ' ' LEU . 33.5 m -139.1 171.38 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.995 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.568 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 28.6 m-85 -110.23 136.01 50.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.619 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.793 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -113.71 125.09 53.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.103 0.477 . . . . 0.0 111.781 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . 21.3 tptm -91.47 133.3 35.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.055 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -125.51 154.41 42.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.676 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.59 115.48 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.983 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.99 39.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.575 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -116.55 148.71 42.42 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-O 120.758 0.313 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.58 166.66 23.64 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.738 2.292 . . . . 0.0 112.731 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 69.6 m80 -51.64 115.13 1.48 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.373 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.6 t-105 -99.56 134.54 21.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 31.1 Cg_exo -54.44 120.89 8.77 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.164 1.909 . . . . 0.0 110.712 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.0 174.77 10.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HG3' HD23 ' A' ' 15' ' ' LEU . 5.1 ttp180 -141.59 156.85 45.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.745 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.426 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 27.0 mm -83.89 140.51 16.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.726 0.298 . . . . 0.0 110.574 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -124.55 -18.75 5.6 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.966 0.412 . . . . 0.0 111.214 -179.738 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.075 0.464 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 72.1 m-85 -94.88 154.08 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.869 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -98.65 104.24 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.522 HG11 HD21 ' A' ' 63' ' ' LEU . 19.1 m -102.41 150.56 6.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.545 0.688 . . . . 0.0 112.432 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.502 ' HE2' HG13 ' A' ' 95' ' ' VAL . 36.4 t80 -105.4 124.81 50.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.967 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.626 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 34.5 m-85 -91.47 108.1 19.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.494 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.79 ' HE2' HD12 ' A' ' 89' ' ' ILE . 45.0 m-85 -60.52 175.95 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.721 0.296 . . . . 0.0 110.955 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.58 -62.47 0.87 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.088 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 p -90.98 -22.52 20.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.841 0.353 . . . . 0.0 110.739 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 20.6 m170 63.83 35.51 11.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.499 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -91.3 155.38 18.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.64 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.79 140.6 52.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.326 0.584 . . . . 0.0 111.639 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.08 168.79 25.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.431 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 64.4 m-85 -111.82 127.05 55.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.145 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.793 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.4 mp -138.36 160.23 40.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.58 177.33 37.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.77 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.89 -27.0 51.38 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.672 2.248 . . . . 0.0 112.363 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -69.25 -25.33 64.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -99.1 5.49 46.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.314 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.522 HD21 HG11 ' A' ' 47' ' ' VAL . 33.0 mt -113.17 138.71 49.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.814 0.34 . . . . 0.0 110.699 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.507 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 0.8 OUTLIER -134.74 154.01 79.18 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.83 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.476 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 15.0 Cg_exo -67.1 112.3 2.48 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.279 1.986 . . . . 0.0 111.157 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 77.2 t80 -51.49 -59.9 3.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.25 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -48.23 -43.0 31.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.012 0.434 . . . . 0.0 111.807 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 48.0 mt-10 -71.24 -39.69 71.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.466 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.412 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -103.0 8.49 38.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 66' ' ' TYR . 11.3 ptmt -55.35 -48.12 74.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.842 0.353 . . . . 0.0 111.38 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.01 -23.93 63.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.833 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -85.29 -47.51 9.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 69' ' ' SER . 24.0 m-85 -105.58 -0.55 25.64 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.38 73.3 2.41 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.724 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.436 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 27.1 mmtt -148.53 159.11 39.44 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.588 0.232 . . . . 0.0 110.567 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.2 153.09 28.29 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.543 2.162 . . . . 0.0 112.374 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -131.96 165.57 23.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.113 0.483 . . . . 0.0 111.672 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -86.75 -17.27 34.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.009 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -14.47 62.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.049 0.452 . . . . 0.0 110.531 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm 63.65 144.56 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.131 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.59 -18.22 39.71 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.802 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 30.0 t80 -58.59 -54.4 47.44 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.037 0.446 . . . . 0.0 110.801 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -45.64 66.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.16 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -48.46 -31.7 6.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.43 . . . . 0.0 110.49 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.52 -31.89 60.31 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.054 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.629 ' O ' HG22 ' A' ' 89' ' ' ILE . 24.9 mt -60.57 -43.82 96.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 110.35 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 69.4 t90 -64.35 -45.48 87.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.125 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.76 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -62.55 -51.23 68.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.79 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -51.83 -27.73 8.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.317 . . . . 0.0 111.709 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.32 -44.58 6.17 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -80.69 -31.71 36.17 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -156.59 88.59 2.75 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 111.351 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 80.2 Cg_endo -77.81 -11.91 16.6 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.625 2.217 . . . . 0.0 112.646 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.3 p -101.71 10.55 39.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.605 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.76 HG11 ' HG2' ' A' ' 88' ' ' GLU . 12.2 p . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.0 111.266 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.89 0.376 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.5 m -51.9 132.12 31.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.594 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.19 -12.25 68.37 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.937 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.73 139.18 51.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 0.0 111.006 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.4 HD23 ' HG3' ' A' ' 29' ' ' ARG . 68.2 mt -91.18 116.51 28.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.996 0.427 . . . . 0.0 110.4 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.69 170.34 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.552 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.521 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 18.0 m-85 -111.15 135.88 51.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.519 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.688 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.89 123.05 49.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.906 0.384 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 23.8 tptp -92.08 130.94 37.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.134 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtm -127.03 147.86 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.47 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 113.48 4.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 111.013 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.96 -27.38 14.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.635 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.91 157.98 48.98 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.942 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.46 166.39 12.2 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.826 2.35 . . . . 0.0 112.372 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.505 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 59.0 m80 -47.23 113.99 0.78 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.516 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.458 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.49 130.7 27.49 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.642 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.55 119.03 5.75 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.376 2.051 . . . . 0.0 111.083 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.2 175.2 10.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 14.3 ttp180 -142.53 156.44 45.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.493 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.436 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 25.0 mm -79.91 138.76 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.21 -20.84 5.15 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.957 0.408 . . . . 0.0 111.227 -179.732 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.982 0.42 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -94.12 157.91 15.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.135 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.9 107.51 19.96 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.659 HG21 HD21 ' A' ' 63' ' ' LEU . 84.3 t -103.53 142.68 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 121.463 0.649 . . . . 0.0 112.56 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -105.61 121.89 44.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.507 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.688 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 81.7 m-85 -94.16 106.62 18.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.049 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.7 ' CE2' HD12 ' A' ' 89' ' ' ILE . 49.4 m-85 -57.59 176.99 0.11 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.843 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.411 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 69.77 -63.55 0.67 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.418 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 81.0 p -90.19 -23.21 21.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.739 0.304 . . . . 0.0 110.738 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 52' ' ' THR . 4.0 m170 66.0 33.91 7.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.197 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.2 151.03 21.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.928 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.8 140.79 51.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.239 0.542 . . . . 0.0 111.307 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.88 168.11 28.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.289 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -109.31 125.45 52.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.995 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.556 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 19.7 mt -139.33 160.62 39.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.37 -179.85 40.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.23 -26.82 41.74 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.511 2.14 . . . . 0.0 112.189 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -69.55 -22.59 63.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.077 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.0 m-20 -99.0 3.66 47.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.463 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 47' ' ' VAL . 18.4 mt -115.03 139.6 49.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -136.59 166.3 28.65 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.845 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HB2' ' CG ' ' A' ' 68' ' ' GLU . 4.8 Cg_exo -73.17 111.08 3.2 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.767 2.311 . . . . 0.0 111.69 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.2 t80 -49.95 -58.44 5.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.478 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -49.0 -41.09 33.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.611 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 65' ' ' PRO . 4.9 mm-40 -71.02 -39.71 72.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.674 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 3.6 m -103.39 13.87 32.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 2.2 mtmp? -55.52 -44.95 77.15 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.413 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.75 -40.83 88.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.75 -43.88 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.9 m-30 -94.71 -19.77 20.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.73 74.08 2.39 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.042 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 12.1 mttt -149.32 153.57 37.62 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.95 155.5 8.42 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.616 2.211 . . . . 0.0 112.638 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -136.39 165.58 25.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.578 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -85.73 -16.07 40.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.304 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.58 -13.8 61.53 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.987 0.423 . . . . 0.0 110.713 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt 63.79 142.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.159 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.71 -16.87 55.52 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.517 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 31.4 t80 -59.0 -56.88 16.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.943 0.402 . . . . 0.0 110.882 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.41 -45.42 65.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.113 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.62 -30.13 5.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.017 0.437 . . . . 0.0 110.503 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.96 -31.86 57.43 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.161 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.621 ' O ' HG22 ' A' ' 89' ' ' ILE . 12.7 mt -60.4 -43.35 96.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.064 0.459 . . . . 0.0 110.34 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 62.9 t90 -63.73 -45.71 88.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.229 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.67 -50.63 70.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' CE2' ' A' ' 50' ' ' PHE . 1.1 tt -52.92 -27.03 12.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.744 0.306 . . . . 0.0 111.692 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -99.31 -44.83 6.08 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -79.64 -31.55 41.54 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . 1.0 OUTLIER -156.99 87.08 2.76 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.751 0.31 . . . . 0.0 111.282 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.01 -12.94 26.21 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.933 2.422 . . . . 0.0 112.61 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 p -107.05 14.66 26.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.53 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.581 HG12 ' HE1' ' A' ' 50' ' ' PHE . 14.6 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.075 0.464 . . . . 0.0 111.702 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.905 0.383 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 98.8 m -52.01 125.36 15.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.409 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.34 -16.34 49.15 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.153 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.19 138.92 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.79 0.329 . . . . 0.0 111.323 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.464 HD23 ' HG3' ' A' ' 29' ' ' ARG . 81.3 mt -91.43 120.75 32.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.191 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.6 m -141.62 174.05 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.369 0.604 . . . . 0.0 112.133 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.508 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 9.4 m-85 -111.97 136.34 51.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.419 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.766 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -112.65 125.53 54.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.022 0.439 . . . . 0.0 111.449 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.82 132.58 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.979 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.7 mtm -129.81 155.01 46.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.701 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.73 119.62 13.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.034 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.23 -13.03 66.12 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.813 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.54 149.21 64.23 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.759 0.279 . . . . 0.0 110.836 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.24 167.91 15.39 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.723 2.282 . . . . 0.0 112.448 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -47.18 112.38 0.52 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.581 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.453 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.6 t-105 -97.79 130.5 28.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.436 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.38 119.38 6.28 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.364 2.043 . . . . 0.0 111.004 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.62 175.54 10.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HG3' HD23 ' A' ' 15' ' ' LEU . 2.6 ttp180 -142.45 157.18 45.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.464 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -80.13 138.84 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -125.45 -20.36 4.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 121.025 0.441 . . . . 0.0 111.519 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.109 0.48 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 84.6 m-85 -92.49 155.06 18.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.108 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -96.38 106.55 18.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.605 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 59.5 t -101.54 142.94 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.431 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -105.14 120.88 42.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.568 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.651 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 92.3 m-85 -94.08 111.36 23.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.787 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.728 ' HE2' HD12 ' A' ' 89' ' ' ILE . 47.8 m-85 -60.67 177.54 0.29 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.954 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.22 -62.93 0.78 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.22 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.5 p -92.08 -23.24 19.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 0.0 110.679 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.4 m170 63.88 37.64 9.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.339 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.99 153.95 19.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.829 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 144.15 49.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.365 0.603 . . . . 0.0 111.764 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.93 164.79 38.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.099 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 36.8 m-85 -107.87 87.8 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.155 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.766 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 6.6 mt -99.21 158.67 15.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.059 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.643 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -93.29 171.78 32.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.319 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.87 -22.53 48.84 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.536 2.157 . . . . 0.0 112.464 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -67.87 -27.22 66.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.694 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -100.0 14.55 30.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.964 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.6 mp -109.56 137.3 47.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.583 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.6 m-85 -136.18 157.85 74.83 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.958 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 9.5 Cg_exo -71.38 112.06 3.25 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.672 2.248 . . . . 0.0 111.525 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.4 t80 -51.37 -58.96 4.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.908 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.4 -40.28 49.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.081 0.467 . . . . 0.0 111.654 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.8 tt0 -71.66 -39.94 69.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.577 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.456 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -105.75 9.54 32.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.3 ptmm? -56.54 -47.51 79.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 0.0 111.435 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -23.27 62.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.75 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -85.06 -47.36 10.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 69' ' ' SER . 0.9 OUTLIER -108.88 3.76 22.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.337 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 70' ' ' LYS . . . -83.77 16.84 29.38 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.684 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -94.07 157.91 36.99 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.39 0.595 . . . . 0.0 110.457 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.46 158.39 10.16 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.379 2.052 . . . . 0.0 112.246 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.54 ' ND2' ' CE2' ' A' ' 82' ' ' PHE . 20.2 m-20 -132.23 169.07 16.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.625 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -89.18 -16.5 31.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.349 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -14.61 61.9 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 110.783 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt 63.35 141.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.084 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.8 -17.11 54.71 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.403 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.54 ' CE2' ' ND2' ' A' ' 77' ' ' ASN . 47.5 t80 -58.17 -54.88 41.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.03 0.443 . . . . 0.0 110.734 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.64 -46.37 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.306 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.34 -31.5 6.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.007 0.432 . . . . 0.0 110.619 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.42 -31.16 59.34 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.044 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.669 ' O ' HG22 ' A' ' 89' ' ' ILE . 76.9 mt -60.88 -43.68 98.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.003 0.43 . . . . 0.0 110.415 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.1 t90 -63.74 -44.57 93.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.22 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.667 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -63.5 -50.5 69.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.728 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -51.72 -27.45 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 89' ' ' ILE . 55.4 mt-10 -100.29 -44.73 5.84 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -79.17 -33.71 43.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -156.37 90.2 2.68 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.317 . . . . 0.0 111.194 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.5 Cg_endo -77.27 -11.24 17.6 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.565 2.176 . . . . 0.0 112.748 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.2 p -103.09 12.54 35.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.507 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.667 HG11 ' HG2' ' A' ' 88' ' ' GLU . 11.7 p . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.944 0.402 . . . . 0.0 111.35 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 5.9 mmtm . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.907 0.384 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 t -52.28 124.61 13.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.83 -16.11 43.85 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.023 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.26 140.0 50.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 111.081 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 29' ' ' ARG . 56.1 mt -92.74 118.7 31.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.339 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.424 HG21 HD22 ' A' ' 63' ' ' LEU . 31.0 m -139.67 171.82 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.185 0.517 . . . . 0.0 111.743 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.6 m-85 -109.99 136.6 49.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.764 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.727 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -113.49 126.44 55.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.012 0.434 . . . . 0.0 111.799 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -92.9 130.64 38.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.902 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.88 148.53 50.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.802 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -67.36 106.76 2.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.745 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.75 -7.07 27.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.78 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -141.06 156.58 68.14 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.781 0.324 . . . . 0.0 110.637 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.89 171.92 9.12 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.735 2.29 . . . . 0.0 112.212 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 73' ' ' PHE . 63.6 m-70 -47.76 111.8 0.47 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.392 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.433 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 1.5 t-105 -99.54 129.04 29.84 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.322 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.404 ' HG3' HD22 ' A' ' 86' ' ' LEU . 12.5 Cg_endo -55.44 121.15 9.42 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.13 1.886 . . . . 0.0 110.98 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.59 175.73 9.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.308 0.575 . . . . 0.0 112.266 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.571 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.3 ttp180 -141.7 154.84 45.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.765 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.407 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.1 mm -82.27 114.25 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.87 -13.85 14.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 121.039 0.447 . . . . 0.0 111.318 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.973 0.416 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 62.9 m-85 -94.37 153.16 18.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.79 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -99.03 105.75 17.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.622 HG11 HD21 ' A' ' 63' ' ' LEU . 29.6 m -101.44 150.35 6.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.49 0.662 . . . . 0.0 112.214 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 33.0 t80 -105.82 124.51 49.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.04 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.465 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 32.7 m-85 -91.88 107.53 19.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.554 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.798 ' HE2' HD12 ' A' ' 89' ' ' ILE . 36.2 m-85 -58.46 174.99 0.27 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 0.0 111.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.57 -62.04 0.87 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.358 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.3 p -90.5 -21.57 21.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.606 0.241 . . . . 0.0 111.06 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 48.5 m170 64.02 34.94 10.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.912 0.386 . . . . 0.0 110.265 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -90.32 153.65 20.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.675 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.55 141.52 51.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.15 0.5 . . . . 0.0 111.69 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.32 177.54 11.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.391 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 8.6 m-85 -120.62 127.29 51.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.886 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.727 HD13 ' HB1' ' A' ' 18' ' ' ALA . 5.3 mt -139.93 163.93 31.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.13 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.94 177.07 35.18 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.616 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.07 -25.19 51.44 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.624 2.216 . . . . 0.0 112.552 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -69.9 -25.54 63.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 111.064 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 35.7 m-20 -98.3 4.84 48.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.436 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.622 HD21 HG11 ' A' ' 47' ' ' VAL . 20.7 mt -112.55 139.25 48.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.696 0.284 . . . . 0.0 110.488 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.3 m-85 -135.94 160.06 68.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.07 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 12.3 Cg_exo -69.77 110.91 2.67 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.672 2.248 . . . . 0.0 111.604 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.4 t80 -51.91 -59.16 4.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.593 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -50.49 -41.36 53.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.684 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 2.2 tm-20 -69.58 -39.77 77.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.545 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.1 m -108.09 13.74 25.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 4.5 ptpp? -56.08 -47.74 77.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.922 0.391 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.4 mt-10 -71.06 -21.41 62.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.307 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HD3' ' CE1' ' A' ' 73' ' ' PHE . 4.2 tttt -85.46 -49.47 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.423 ' CE1' ' HD3' ' A' ' 72' ' ' LYS . 9.4 m-85 -102.94 -4.8 24.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.443 ' HA2' HD11 ' A' ' 86' ' ' LEU . . . -83.3 70.95 3.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.048 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 9.1 mtmt -149.21 153.69 38.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.88 158.23 14.53 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.587 2.192 . . . . 0.0 112.632 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.423 ' ND2' ' CD2' ' A' ' 82' ' ' PHE . 26.0 m-80 -137.12 167.29 21.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.565 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.45 -15.51 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.109 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -14.06 61.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.958 0.408 . . . . 0.0 110.767 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp 63.84 142.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.276 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.05 -17.72 49.43 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.775 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 44.6 t80 -59.96 -54.23 48.53 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.904 0.383 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.51 ' HA ' HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -53.05 -46.34 68.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.224 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -48.47 -29.75 4.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.986 0.422 . . . . 0.0 110.614 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.02 -31.48 59.77 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.206 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 89' ' ' ILE . 3.8 mm? -61.09 -44.11 97.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.968 0.413 . . . . 0.0 110.535 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 64.0 t90 -65.08 -45.72 84.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.347 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.474 ' OE1' HG11 ' A' ' 95' ' ' VAL . 52.4 mt-10 -62.59 -50.85 69.65 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.798 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -52.44 -27.13 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.712 0.291 . . . . 0.0 111.734 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -99.58 -44.76 6.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -80.23 -31.98 38.47 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -155.55 88.04 3.09 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.725 0.298 . . . . 0.0 111.252 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.2 Cg_endo -75.78 -13.46 19.83 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.679 2.253 . . . . 0.0 112.739 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.559 HG22 HH12 ' A' ' 29' ' ' ARG . 48.3 p -105.69 12.4 31.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.532 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.566 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.7 p . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.938 0.399 . . . . 0.0 111.461 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 mptt . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.4 t -52.21 129.15 27.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.49 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.75 -14.21 59.03 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.978 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.15 138.31 51.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 0.0 111.051 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 29' ' ' ARG . 86.9 mt -92.19 118.79 31.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.967 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.0 m -140.61 175.8 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.252 0.549 . . . . 0.0 112.152 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 16.4 m-85 -114.02 137.32 51.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.74 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.979 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -114.71 124.6 52.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 0.0 111.537 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 15.9 tptm -91.98 132.96 36.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.079 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.522 ' SD ' HD11 ' A' ' 58' ' ' LEU . 2.0 mmm -127.74 150.66 49.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.598 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 116.15 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.836 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.07 -16.07 58.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.859 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -130.06 151.93 79.17 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.715 0.293 . . . . 0.0 110.703 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.13 167.81 17.55 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.639 2.226 . . . . 0.0 112.409 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 51.0 m80 -46.38 114.77 0.87 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.871 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.3 t-105 -98.33 129.44 30.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.609 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.56 119.11 5.41 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.398 2.065 . . . . 0.0 111.214 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.592 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.9 175.75 9.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HG3' HD23 ' A' ' 15' ' ' LEU . 3.1 ttt180 -142.28 155.81 45.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.397 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.441 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 25.4 mm -79.03 137.35 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.28 -20.85 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.041 0.448 . . . . 0.0 111.284 -179.717 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 57' ' ' PHE . 10.4 mttm . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.162 0.506 . . . . 0.0 111.725 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 58.5 m-85 -94.2 154.51 17.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.99 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.03 108.06 20.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG21 HD21 ' A' ' 63' ' ' LEU . 60.5 t -103.2 142.46 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.576 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -104.14 120.3 40.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.807 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.733 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 72.5 m-85 -93.66 108.36 20.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.695 ' CE2' HD12 ' A' ' 89' ' ' ILE . 47.5 m-85 -59.21 176.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.859 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 -63.34 0.84 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.287 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 66.2 p -90.79 -22.75 20.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.737 0.303 . . . . 0.0 110.742 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 52' ' ' THR . 10.2 m170 64.62 34.83 9.54 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.075 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -90.23 152.48 21.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.705 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.42 144.89 48.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.28 0.562 . . . . 0.0 111.549 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.37 165.01 37.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.161 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 74.1 m-85 -107.99 87.88 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.054 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.979 HD22 ' HB1' ' A' ' 18' ' ' ALA . 4.8 mp -97.84 156.47 16.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.134 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.17 179.52 39.37 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.57 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.536 ' HA ' HD12 ' A' ' 63' ' ' LEU . 37.2 Cg_endo -66.27 -30.11 45.92 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.635 2.224 . . . . 0.0 112.45 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -69.48 -21.69 63.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.098 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.787 ' HB3' HD23 ' A' ' 58' ' ' LEU . 12.9 m-20 -99.49 2.6 45.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.474 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.603 HD21 HG21 ' A' ' 47' ' ' VAL . 10.0 mt -110.16 139.34 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 0.0 110.653 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.8 m-85 -136.37 153.2 76.15 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 24.7 Cg_exo -63.49 112.4 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.469 2.113 . . . . 0.0 111.706 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' LYS . 60.0 t80 -53.39 -59.36 4.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.743 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.4 mt-10 -49.71 -41.76 44.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.106 0.479 . . . . 0.0 111.521 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -69.96 -39.76 75.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.42 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.9 m -105.9 12.2 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 66' ' ' TYR . 5.3 ptpp? -55.71 -48.42 75.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.953 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 16.6 pt-20 -71.65 -19.99 62.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.412 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HE2' ' CZ ' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -84.48 -49.99 8.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.413 ' CZ ' ' HE2' ' A' ' 72' ' ' LYS . 6.5 m-85 -103.36 -4.63 23.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.34 71.44 2.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.19 -1.005 . . . . 0.0 113.081 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.81 149.62 28.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.678 0.275 . . . . 0.0 110.303 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.54 155.61 2.2 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.588 2.192 . . . . 0.0 112.757 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.95 165.2 27.11 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.748 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -85.01 -16.44 40.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.123 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -65.68 -14.87 62.1 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.055 0.455 . . . . 0.0 110.619 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 2.8 mmmp? 62.77 143.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.072 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.77 -18.0 41.82 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.337 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 43.7 t80 -58.46 -57.12 14.34 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -53.32 -45.69 69.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.989 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -48.86 -31.25 6.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.018 0.437 . . . . 0.0 110.525 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.39 -31.39 61.16 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.879 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 89' ' ' ILE . 44.7 mt -60.56 -43.58 97.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.968 0.413 . . . . 0.0 110.359 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.1 t90 -63.21 -45.74 90.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.157 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.592 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.4 OUTLIER -62.91 -50.91 69.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.695 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -52.23 -26.28 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.322 . . . . 0.0 111.851 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.606 ' HG2' HG23 ' A' ' 89' ' ' ILE . 4.1 mm-40 -100.55 -44.75 5.76 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -79.45 -32.77 42.74 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -156.92 90.41 2.53 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.698 0.285 . . . . 0.0 111.152 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 82.3 Cg_endo -78.01 -11.31 16.49 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.544 2.163 . . . . 0.0 112.745 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.5 p -106.33 13.96 28.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.531 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.592 HG11 ' HG2' ' A' ' 88' ' ' GLU . 11.9 p . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.875 0.369 . . . . 0.0 111.568 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.995 0.426 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.77 131.85 35.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.515 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.89 -11.57 67.81 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.101 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.84 138.31 50.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.249 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.415 HD23 ' HG3' ' A' ' 29' ' ' ARG . 75.4 mt -91.83 118.12 30.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.386 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 m -139.88 171.99 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.804 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 30.5 m-85 -112.88 137.05 51.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.492 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -114.43 126.6 55.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 111.248 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -90.27 136.01 33.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.136 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -130.21 151.88 50.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.547 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -67.62 118.22 10.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -8.62 74.48 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.968 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.412 ' CD1' ' HD3' ' A' ' 79' ' ' ARG . 1.9 m-85 -132.21 154.42 81.63 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-O 120.835 0.35 . . . . 0.0 111.03 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -84.23 167.15 12.36 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.832 2.355 . . . . 0.0 112.511 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.438 ' CG ' ' CD2' ' A' ' 73' ' ' PHE . 81.3 m-70 -47.08 115.25 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.1 t-105 -99.02 129.98 28.42 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.503 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.77 119.46 6.29 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.374 2.049 . . . . 0.0 111.085 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.05 174.43 10.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -143.01 155.65 44.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.323 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 28.7 mm -78.13 138.4 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.73 -20.33 5.5 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.044 0.449 . . . . 0.0 111.239 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 121.066 0.46 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 79.8 m-85 -95.8 155.14 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.694 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.436 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.4 mt-30 -96.55 106.78 19.09 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.598 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 63.1 t -100.84 142.99 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.32 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.78 122.0 45.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.189 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.647 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 75.1 m-85 -94.97 110.27 22.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.37 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.722 ' HE2' HD12 ' A' ' 89' ' ' ILE . 57.4 m-85 -58.83 -179.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.06 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.58 -63.66 0.63 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.146 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.9 p -91.07 -22.88 20.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 110.742 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.4 m170 64.57 36.52 8.48 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.598 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.32 157.04 16.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.44 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -131.79 149.97 52.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.313 0.578 . . . . 0.0 111.978 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.58 170.88 20.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.067 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 52.0 m-85 -105.94 86.58 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 0.0 110.875 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.813 HD13 ' HB1' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -98.23 156.84 16.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.126 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.559 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -91.98 169.46 32.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.295 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 42.2 Cg_endo -67.54 -20.79 47.08 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.459 2.106 . . . . 0.0 112.375 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -27.83 67.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.969 0.414 . . . . 0.0 110.504 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -100.72 12.43 37.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.761 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.8 mp -108.79 137.44 46.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.658 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.8 m-85 -136.17 158.16 74.22 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.558 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.639 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.6 Cg_exo -71.71 111.5 3.15 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.393 2.062 . . . . 0.0 111.235 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.5 t80 -45.63 -59.02 2.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.358 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -50.88 -39.55 54.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.9 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.1 mm-40 -70.6 -39.83 73.57 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.464 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 48.9 m -105.35 11.08 33.2 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.43 -49.46 74.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.797 0.332 . . . . 0.0 111.524 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.54 -26.12 64.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.649 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -84.99 -46.95 10.73 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.464 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 2.5 m-30 -99.77 -13.04 19.43 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -80.65 71.15 2.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.043 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.417 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.0 mttt -149.05 153.14 37.78 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.598 0.237 . . . . 0.0 110.39 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -51.17 153.31 9.57 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.501 2.134 . . . . 0.0 112.617 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -136.49 163.49 30.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.595 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -81.87 -16.47 50.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.196 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HD3' ' CD1' ' A' ' 23' ' ' TYR . 17.9 mmm180 -64.54 -15.64 61.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.989 0.424 . . . . 0.0 110.809 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt 63.19 140.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.094 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.96 -17.0 53.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.399 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.6 t80 -58.54 -55.5 34.28 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.933 0.397 . . . . 0.0 110.658 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 m -53.58 -45.53 69.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.196 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.96 -31.69 7.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.997 0.427 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.02 -31.83 61.39 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.899 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.667 ' O ' HG22 ' A' ' 89' ' ' ILE . 19.7 mt -61.01 -43.74 98.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 0.0 110.318 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.8 t90 -63.51 -45.51 90.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.991 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.2 mp0 -62.31 -50.99 69.46 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.722 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -52.47 -26.02 8.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.731 0.3 . . . . 0.0 111.783 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.99 -44.79 5.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -80.42 -32.3 37.41 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.3 87.85 3.18 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 98.7 Cg_endo -79.47 -12.55 13.9 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.702 2.268 . . . . 0.0 113.029 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.419 HG22 ' NH1' ' A' ' 29' ' ' ARG . 21.0 p -103.78 12.67 34.3 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.552 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.3 p . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 111.33 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.957 0.408 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.1 m -51.98 129.38 26.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.428 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.402 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 100.87 -14.91 58.61 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.91 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.04 138.16 51.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.775 HD23 ' HG3' ' A' ' 29' ' ' ARG . 62.0 mt -91.79 119.66 31.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.246 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 m -140.77 171.27 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.133 0.492 . . . . 0.0 111.894 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 10.0 m-85 -109.79 136.62 48.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.565 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.644 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.09 124.6 52.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.098 0.475 . . . . 0.0 111.841 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -91.99 131.58 37.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.82 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mtp -129.04 147.52 50.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.701 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 115.29 5.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 100.46 3.96 55.12 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.823 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -152.75 153.62 30.39 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.628 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.76 167.7 18.34 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.585 2.19 . . . . 0.0 112.382 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.453 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 71.2 m80 -47.57 115.23 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.588 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.93 130.51 27.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.245 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.95 120.83 8.8 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.171 1.914 . . . . 0.0 111.179 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.67 175.7 9.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.277 0.56 . . . . 0.0 112.241 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.775 ' HG3' HD23 ' A' ' 15' ' ' LEU . 5.3 ttp180 -142.78 155.73 44.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.439 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.9 mm -78.88 135.2 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.92 -20.23 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.074 0.464 . . . . 0.0 111.73 -179.704 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.009 0.433 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 82.5 m-85 -94.77 154.48 17.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.758 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -99.27 107.0 19.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.64 HG11 HD21 ' A' ' 63' ' ' LEU . 7.1 m -103.46 150.4 6.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.411 0.624 . . . . 0.0 112.339 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 49.3 t80 -105.44 124.56 49.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.992 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.644 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 70.0 m-85 -93.31 108.94 20.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.648 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.698 ' CE2' HD12 ' A' ' 89' ' ' ILE . 48.2 m-85 -61.37 177.9 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.933 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.96 -63.48 0.93 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.96 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -91.42 -22.37 20.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.0 110.779 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 3.6 m80 64.41 37.02 8.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.461 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -91.65 155.47 18.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 140.29 53.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.194 0.521 . . . . 0.0 111.393 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.552 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.36 178.11 10.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.428 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.2 m-85 -119.97 127.18 52.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.2 mp -138.8 161.74 36.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.43 176.37 35.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.703 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.72 -24.98 54.22 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.622 2.214 . . . . 0.0 112.41 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -69.57 -27.14 64.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.857 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 3.9 m-20 -100.22 6.9 44.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.336 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.64 HD21 HG11 ' A' ' 47' ' ' VAL . 22.4 mt -114.23 138.2 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.733 0.302 . . . . 0.0 110.32 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.7 m-85 -137.13 159.58 69.27 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.057 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.9 Cg_exo -70.21 113.91 3.6 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.674 2.25 . . . . 0.0 111.63 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 89.1 t80 -53.7 -59.5 4.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.683 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -49.0 -42.74 38.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.124 0.488 . . . . 0.0 111.648 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.94 -39.58 72.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.565 -179.454 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -105.29 10.23 33.64 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.4 ptpt -56.38 -44.28 80.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.659 0.266 . . . . 0.0 111.713 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mm-40 -68.55 -32.92 73.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 13.1 ptpt -83.99 -43.32 15.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.433 ' CD1' ' HG3' ' A' ' 72' ' ' LYS . 18.2 m-30 -98.35 -8.52 26.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.24 75.27 2.05 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.039 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mmmm -148.55 159.32 38.87 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.613 0.206 . . . . 0.0 110.511 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.59 151.89 59.46 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.585 2.19 . . . . 0.0 112.516 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.11 170.29 15.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.616 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -15.68 28.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.356 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -66.34 -14.81 62.62 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.984 0.421 . . . . 0.0 110.716 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt 63.4 144.17 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.075 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.36 -18.7 35.78 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.594 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 15.1 t80 -58.61 -55.55 33.67 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.044 0.45 . . . . 0.0 110.692 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -52.89 -45.67 67.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.062 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -48.56 -31.39 6.49 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.985 0.421 . . . . 0.0 110.543 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.06 -31.55 61.63 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.85 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 89' ' ' ILE . 89.0 mt -60.94 -43.8 98.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.226 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -64.05 -44.91 91.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.597 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -63.51 -50.87 67.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.698 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -51.9 -27.5 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 111.828 -179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.44 -44.68 6.1 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.82 -32.96 40.67 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.23 87.46 3.24 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.817 0.342 . . . . 0.0 111.257 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 3.5 Cg_exo -76.58 -13.73 18.11 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.038 2.492 . . . . 0.0 112.644 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.1 p -104.04 13.08 33.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.537 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.597 HG11 ' HG2' ' A' ' 88' ' ' GLU . 15.0 p . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.929 0.395 . . . . 0.0 111.447 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.879 0.371 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.27 127.38 19.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.263 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.88 -13.45 60.68 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.729 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 5.9 m-20 -70.49 137.18 50.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.84 0.352 . . . . 0.0 111.072 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 mt -90.18 115.36 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 110.3 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.2 m -138.65 170.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.581 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -109.69 136.7 48.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.79 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.659 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -111.87 121.4 44.93 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.473 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 2.4 tptt -93.51 129.15 39.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.011 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.8 mtp -126.55 147.98 49.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.693 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -59.53 119.59 7.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.04 -34.96 4.59 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.441 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -105.14 150.36 38.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.696 0.284 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HG3' ' OD1' ' A' ' 77' ' ' ASN . 97.7 Cg_endo -82.49 170.16 13.29 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.593 2.195 . . . . 0.0 112.226 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.441 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 61.2 m80 -51.06 112.11 0.67 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.525 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.439 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.7 t-105 -99.6 131.07 25.4 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.237 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 11.8 Cg_endo -54.98 121.35 9.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.295 1.996 . . . . 0.0 111.183 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.12 178.44 8.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 112.328 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 14' ' ' ASP . 15.8 ttp180 -143.66 157.76 44.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.489 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.08 116.12 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -110.93 -14.0 14.03 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--N 1.332 -0.193 0 CA-C-O 121.042 0.449 . . . . 0.0 111.474 -179.673 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 mttt . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.082 0.467 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 86.9 m-85 -95.43 155.29 16.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -99.59 105.05 16.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.7 m -99.94 149.39 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.369 0.604 . . . . 0.0 112.041 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.46 ' HE2' HG13 ' A' ' 95' ' ' VAL . 23.1 t80 -105.08 123.93 48.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.259 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.539 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 85.3 m-85 -92.75 109.39 20.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.614 ' CE2' HD12 ' A' ' 89' ' ' ILE . 42.5 m-85 -61.49 176.12 0.52 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.746 0.307 . . . . 0.0 110.911 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.01 -62.48 0.96 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.083 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.2 p -91.7 -22.2 20.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 110.586 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 63.4 36.89 11.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.416 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -90.85 154.74 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.5 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.41 144.25 49.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.311 0.577 . . . . 0.0 111.806 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.76 166.13 34.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.279 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 30.6 m-85 -108.94 88.61 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.233 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.659 HD22 ' HB1' ' A' ' 18' ' ' ALA . 1.3 mp -97.92 158.32 15.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.714 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -93.09 172.05 33.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.352 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.1 -23.98 52.62 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.483 2.122 . . . . 0.0 112.38 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -27.93 66.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.973 0.416 . . . . 0.0 110.691 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -98.62 12.63 34.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.995 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.714 HD13 ' O ' ' A' ' 59' ' ' GLY . 4.7 mp -108.98 137.4 46.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.431 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.7 m-85 -134.79 157.64 76.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.765 0.317 . . . . 0.0 111.11 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.532 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.2 Cg_exo -71.02 110.93 2.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.731 2.287 . . . . 0.0 111.508 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 70' ' ' LYS . 93.2 t80 -55.29 -60.82 2.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.914 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -41.95 38.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.014 0.435 . . . . 0.0 111.48 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.31 -39.69 71.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.559 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 m -104.91 8.48 34.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.3 ptmt -56.55 -45.89 80.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.721 0.296 . . . . 0.0 111.337 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.44 -26.57 64.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.525 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.506 ' HG2' ' CE1' ' A' ' 73' ' ' PHE . 1.2 ttpm? -84.82 -45.7 12.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.506 ' CE1' ' HG2' ' A' ' 72' ' ' LYS . 18.8 m-30 -101.93 -6.15 23.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -86.44 75.39 2.25 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.284 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -151.91 153.09 31.11 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.523 0.201 . . . . 0.0 110.718 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.36 136.22 8.55 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.701 2.268 . . . . 0.0 112.504 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.437 ' OD1' ' HG3' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -111.07 171.19 7.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.915 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.15 -21.61 18.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.748 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -67.34 -13.77 62.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.935 0.398 . . . . 0.0 110.585 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt 63.99 143.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.814 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.96 -17.23 54.36 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.931 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.621 ' HE1' HD11 ' A' ' 86' ' ' LEU . 13.0 t80 -59.13 -51.28 70.68 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.956 0.408 . . . . 0.0 110.322 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.45 -46.98 66.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.993 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -48.66 -32.76 8.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.979 0.418 . . . . 0.0 110.26 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.62 -31.76 60.26 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.788 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.643 ' O ' HG22 ' A' ' 89' ' ' ILE . 71.3 mt -61.32 -43.79 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.168 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -64.78 -45.03 88.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.002 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.537 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.7 OUTLIER -62.81 -50.9 69.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 86' ' ' LEU . 1.2 tt -52.32 -26.85 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.807 0.337 . . . . 0.0 111.768 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.527 ' HG2' HG23 ' A' ' 89' ' ' ILE . 6.8 mm-40 -99.63 -44.75 6.02 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.74 -30.77 32.29 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -156.34 89.23 2.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 111.202 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 86.4 Cg_endo -78.46 -12.42 15.43 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.644 2.229 . . . . 0.0 112.72 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.1 p -102.34 10.98 38.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.586 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.559 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.0 p . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.819 0.343 . . . . 0.0 111.347 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.918 0.389 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.0 m -51.81 132.07 31.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.544 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.13 -12.14 68.56 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.909 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.77 139.21 50.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -91.14 116.56 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.964 0.411 . . . . 0.0 110.398 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.76 170.29 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.622 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.522 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 17.9 m-85 -111.09 135.86 50.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.521 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.687 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.93 123.04 49.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.345 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 23.8 tptp -92.07 130.95 37.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.163 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtm -127.04 147.82 50.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.461 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 113.47 4.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 111.008 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.99 -27.37 14.65 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.689 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.91 157.97 49.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.787 0.327 . . . . 0.0 110.942 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.47 166.44 12.16 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.802 2.335 . . . . 0.0 112.346 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.505 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 59.0 m80 -47.17 114.02 0.78 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.497 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.459 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.66 130.63 27.45 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.611 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.51 119.1 5.85 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.337 2.024 . . . . 0.0 111.056 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.6 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.2 175.09 10.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 112.438 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 14.2 ttp180 -142.52 156.49 45.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.449 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.437 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 24.6 mm -79.9 138.8 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.26 -20.8 5.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.957 0.408 . . . . 0.0 111.237 -179.819 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.948 0.404 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -94.11 157.95 15.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.93 107.55 20.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.659 HG21 HD21 ' A' ' 63' ' ' LEU . 84.3 t -103.54 142.57 17.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.445 0.641 . . . . 0.0 112.567 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -105.55 121.87 44.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.528 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.687 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 82.0 m-85 -94.03 106.51 18.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.087 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.702 ' CE2' HD12 ' A' ' 89' ' ' ILE . 49.7 m-85 -57.57 176.88 0.12 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.873 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 69.81 -63.57 0.68 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.384 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 80.9 p -90.16 -23.24 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.702 0.287 . . . . 0.0 110.712 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' THR . 3.9 m170 65.96 34.03 7.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.12 150.99 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.0 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.81 140.66 52.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.168 0.509 . . . . 0.0 111.329 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.78 168.22 27.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.333 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -109.32 125.48 52.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.027 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.557 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 19.8 mt -139.36 160.67 39.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.46 -179.78 40.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.28 -26.81 41.45 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.521 2.147 . . . . 0.0 112.206 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -69.63 -22.56 63.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.008 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.1 m-20 -98.99 3.6 47.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.49 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 47' ' ' VAL . 18.3 mt -115.0 139.65 49.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 110.578 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -136.6 166.28 28.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.422 ' HB2' ' CG ' ' A' ' 68' ' ' GLU . 5.2 Cg_exo -73.21 111.15 3.21 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.732 2.288 . . . . 0.0 111.707 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.1 t80 -49.99 -58.44 5.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.484 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -49.04 -41.08 33.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.564 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.422 ' CG ' ' HB2' ' A' ' 65' ' ' PRO . 5.0 mm-40 -70.97 -39.75 72.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.659 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 3.6 m -103.41 13.89 32.63 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 2.2 mtmp? -55.53 -44.99 77.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.364 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.71 -40.82 88.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.83 -43.77 16.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.9 m-30 -94.85 -19.65 20.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.68 73.84 2.43 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.041 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 12.1 mttt -149.22 153.57 37.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.92 155.51 8.33 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.623 2.215 . . . . 0.0 112.638 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -136.43 165.52 25.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.579 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -85.72 -16.1 40.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.256 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -13.82 61.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.975 0.417 . . . . 0.0 110.682 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt 63.76 142.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.203 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.55 -16.7 55.68 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.468 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 31.6 t80 -59.01 -56.82 17.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.003 0.43 . . . . 0.0 110.865 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -45.35 66.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.057 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.68 -30.06 5.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.048 0.451 . . . . 0.0 110.535 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.93 -31.89 57.45 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.162 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 89' ' ' ILE . 12.7 mt -60.43 -43.44 96.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.035 0.445 . . . . 0.0 110.254 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 62.9 t90 -63.59 -45.74 89.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.71 -50.58 70.58 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.702 HD12 ' CE2' ' A' ' 50' ' ' PHE . 1.1 tt -52.9 -27.05 12.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 111.758 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -99.29 -44.82 6.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -79.65 -31.54 41.52 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.796 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.474 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . 1.0 OUTLIER -157.06 86.9 2.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 111.302 -179.337 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.93 -12.93 26.39 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.93 2.42 . . . . 0.0 112.65 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.0 p -106.98 14.61 26.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.587 0.232 . . . . 0.0 111.605 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.58 HG12 ' HE1' ' A' ' 50' ' ' PHE . 14.3 p . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 121.008 0.432 . . . . 0.0 111.69 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.931 0.396 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 m -52.87 130.72 34.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.277 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.76 68.54 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.086 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.65 140.76 48.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.915 0.388 . . . . 0.0 111.299 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HG3' ' A' ' 29' ' ' ARG . 67.6 mt -91.79 119.16 31.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.079 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.84 171.91 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.224 0.535 . . . . 0.0 111.992 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 8.5 m-85 -111.08 134.81 52.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.656 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.805 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -112.36 124.3 52.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.006 0.431 . . . . 0.0 111.591 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -91.18 132.81 35.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.906 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -131.23 150.11 52.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.7 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' O ' ' CE2' ' A' ' 23' ' ' TYR . 1.2 mtpm? -62.46 121.8 14.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.104 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 81.82 15.93 74.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.897 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.427 ' CE2' ' O ' ' A' ' 21' ' ' LYS . 3.4 m-85 -151.4 147.96 21.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.63 0.252 . . . . 0.0 110.841 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.16 165.01 17.15 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.615 2.21 . . . . 0.0 112.221 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -47.51 115.42 1.12 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.571 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.448 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.76 130.13 28.44 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-O 120.527 0.203 . . . . 0.0 111.527 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.14 121.45 9.68 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.373 2.049 . . . . 0.0 111.155 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.707 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -145.61 176.09 9.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.789 ' HG3' HD23 ' A' ' 15' ' ' LEU . 11.4 ttp180 -141.43 154.63 45.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.492 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mm -81.8 140.12 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 0.0 110.541 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.17 -22.5 7.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.794 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.421 ' CG ' ' HB3' ' A' ' 46' ' ' GLN . 2.0 pt-20 . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.111 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.085 0.469 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 40.4 m-85 -93.77 154.71 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.122 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.421 ' HB3' ' CG ' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -96.65 98.82 10.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.707 ' CG2' ' HB1' ' A' ' 28' ' ' ALA . 2.2 p -99.84 148.92 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.358 -177.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 23.3 t80 -105.96 125.1 50.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.252 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -91.39 113.16 25.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.699 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.769 ' HE2' HD12 ' A' ' 89' ' ' ILE . 44.0 m-85 -63.31 174.61 1.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.02 -61.75 0.75 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.3 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.8 p -90.36 -23.49 21.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.66 0.267 . . . . 0.0 110.723 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.402 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 1.5 m80 63.56 37.93 10.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.524 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -93.32 156.67 16.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.814 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 143.19 50.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.322 0.582 . . . . 0.0 111.926 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.65 168.2 27.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.5 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 75.6 m-85 -111.58 89.81 3.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.038 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.805 HD22 ' HB1' ' A' ' 18' ' ' ALA . 1.7 mp -97.72 157.45 16.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.251 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -91.76 171.77 34.92 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.409 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.18 -24.66 44.07 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.45 2.1 . . . . 0.0 112.316 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -27.73 67.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.423 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.63 14.7 31.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.858 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 59' ' ' GLY . 2.4 mp -113.2 136.29 52.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.618 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.6 m-85 -135.93 155.47 77.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.636 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.8 Cg_exo -72.54 112.23 3.42 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.481 2.121 . . . . 0.0 111.2 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.7 t80 -48.34 -58.78 4.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.172 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -43.35 34.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.928 0.394 . . . . 0.0 112.033 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 5.8 mm-40 -70.28 -39.74 74.74 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 51.5 m -105.58 10.72 32.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.9 ptpt -55.97 -48.13 76.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.817 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.9 mm-40 -72.54 -19.91 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.586 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -84.92 -49.83 8.03 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 7.3 m-85 -104.41 -4.44 22.8 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.95 71.46 2.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.193 -1.004 . . . . 0.0 113.066 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -149.57 151.19 32.68 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.699 0.285 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.29 156.0 18.31 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.565 2.177 . . . . 0.0 112.7 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -138.77 -172.51 3.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.378 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -99.03 -13.81 19.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.058 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -67.87 -14.35 62.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt 62.88 142.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.175 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.55 -15.89 59.17 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.733 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.448 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 35.6 t80 -57.38 -58.7 7.1 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.061 0.458 . . . . 0.0 110.907 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.457 ' HA ' HD12 ' A' ' 86' ' ' LEU . 1.1 m -51.76 -46.17 64.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.281 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -48.79 -32.7 9.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.903 0.382 . . . . 0.0 110.501 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.45 -31.68 60.69 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.839 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.641 ' O ' HG22 ' A' ' 89' ' ' ILE . 84.2 mt -60.49 -43.63 96.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.012 0.434 . . . . 0.0 110.287 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.8 t90 -63.74 -43.0 97.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.926 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.565 ' OE1' HG11 ' A' ' 95' ' ' VAL . 39.6 mm-40 -62.84 -52.38 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.769 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.25 -25.71 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -44.75 5.73 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -81.05 -32.95 33.83 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -156.39 88.9 2.78 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.76 0.314 . . . . 0.0 111.152 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 72.2 Cg_endo -77.44 -12.05 17.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.662 2.242 . . . . 0.0 112.897 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.7 p -106.51 14.44 27.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.607 0.241 . . . . 0.0 111.587 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.565 HG11 ' OE1' ' A' ' 88' ' ' GLU . 11.9 p . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.874 0.369 . . . . 0.0 111.404 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.96 0.409 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.8 m -52.4 129.92 29.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.572 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.26 -13.43 63.14 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.048 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.3 138.14 51.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 111.057 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' ' 29' ' ' ARG . 86.5 mt -91.59 117.45 29.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.357 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.2 m -139.99 172.1 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.851 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 13.4 m-85 -113.14 135.72 53.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.722 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.759 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.82 123.3 49.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 0.0 111.432 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 8.1 tptp -92.37 133.86 35.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.0 mtm -128.32 151.86 48.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.78 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.86 102.15 3.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.51 -1.21 23.53 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.818 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -146.91 149.71 36.77 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.706 0.289 . . . . 0.0 110.716 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.63 162.97 34.76 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.636 2.224 . . . . 0.0 112.387 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.405 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 80.1 m80 -47.72 116.78 1.58 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.62 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.452 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.5 t-105 -98.63 132.09 24.64 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.48 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.34 120.98 9.2 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.37 2.047 . . . . 0.0 110.969 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -145.16 176.39 9.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 0.0 112.28 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.637 ' NH1' HG22 ' A' ' 94' ' ' THR . 1.8 ttt180 -142.23 155.72 45.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.453 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.437 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 23.6 mm -80.4 138.73 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.376 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -126.05 -21.58 4.29 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 120.907 0.384 . . . . 0.0 111.28 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.7 mttt . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -95.23 157.64 15.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.033 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -98.69 108.18 20.81 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 63' ' ' LEU . 45.4 t -104.31 141.4 19.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.397 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.536 ' HE2' HG13 ' A' ' 95' ' ' VAL . 25.8 t80 -106.57 122.22 45.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.897 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.759 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 75.7 m-85 -94.34 109.42 21.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.156 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.792 ' HE2' HD12 ' A' ' 89' ' ' ILE . 73.9 m-85 -58.78 -178.97 0.06 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.998 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.61 -63.82 0.44 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.255 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.5 p -91.95 -22.52 19.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.843 0.354 . . . . 0.0 110.633 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.8 m170 64.81 35.44 8.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.973 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -89.8 153.12 20.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.683 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.12 141.6 50.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.318 0.58 . . . . 0.0 111.614 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.568 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.49 170.76 21.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -115.13 126.96 55.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 0.0 111.069 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 26.1 mt -139.62 162.03 36.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.0 176.62 36.21 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.364 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.96 -25.42 59.52 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.493 2.129 . . . . 0.0 112.269 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.71 -26.34 64.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.94 8.33 45.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 47' ' ' VAL . 53.0 mt -117.06 139.07 51.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.694 0.283 . . . . 0.0 110.408 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.4 m-85 -137.39 157.89 73.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.576 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 13.4 Cg_exo -67.72 113.82 3.11 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.188 1.925 . . . . 0.0 111.395 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' LYS . 81.4 t80 -48.97 -57.15 6.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.031 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 15.7 mm-40 -51.46 -39.83 58.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.02 0.438 . . . . 0.0 111.984 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 15.8 mm-40 -70.08 -39.81 75.37 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.454 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 6.4 m -106.78 12.09 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 2.4 ptpp? -56.59 -48.74 76.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 0.0 111.024 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -72.33 -20.95 61.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.459 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.38 -49.34 8.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 8.3 m-85 -100.68 -13.56 18.47 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.82 73.05 1.96 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.972 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -149.75 147.98 24.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.663 0.268 . . . . 0.0 110.562 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.5 153.35 14.03 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.496 2.131 . . . . 0.0 112.769 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 82' ' ' PHE . 51.1 p-10 -139.08 -173.27 3.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.316 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -99.97 -13.31 19.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.971 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 79' ' ' ARG . 21.1 mmt180 -67.25 -14.5 62.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.927 0.394 . . . . 0.0 110.557 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp 63.06 141.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.261 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.21 -16.38 58.92 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.875 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.452 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 47.7 t80 -57.64 -57.07 14.31 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.928 0.394 . . . . 0.0 110.824 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -52.2 -46.22 65.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.138 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -48.86 -33.05 9.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.075 0.464 . . . . 0.0 110.289 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.92 -32.75 58.49 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.807 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.598 ' O ' HG22 ' A' ' 89' ' ' ILE . 46.2 mt -60.49 -43.66 96.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.108 0.48 . . . . 0.0 109.956 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -64.09 -45.35 89.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.895 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.487 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -62.59 -51.89 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.792 HD12 ' HE2' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -52.23 -26.34 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.15 -44.83 6.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.57 -33.19 31.8 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -156.57 81.52 3.5 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.758 0.313 . . . . 0.0 110.974 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.0 Cg_endo -73.99 -8.94 21.78 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.627 2.218 . . . . 0.0 112.953 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.637 HG22 ' NH1' ' A' ' 29' ' ' ARG . 72.6 p -101.48 12.25 37.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.586 0.232 . . . . 0.0 111.515 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.536 HG13 ' HE2' ' A' ' 48' ' ' PHE . 9.8 p . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.812 0.339 . . . . 0.0 111.325 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.902 0.382 . . . . 0.0 110.786 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.4 t -53.67 131.85 39.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.083 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.71 -12.19 64.48 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.265 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -73.25 142.94 47.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 111.207 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.709 HD23 ' HG3' ' A' ' 29' ' ' ARG . 49.1 mt -91.79 119.6 31.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.391 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.482 HG21 HD22 ' A' ' 63' ' ' LEU . 29.3 m -140.77 170.1 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.661 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 8.4 m-85 -109.84 136.51 49.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.695 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.608 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.95 122.72 47.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.007 0.432 . . . . 0.0 111.453 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -91.35 128.71 37.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.882 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.6 mtp -126.96 148.12 50.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.658 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.64 125.4 23.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.907 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.435 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 85.01 11.48 76.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.977 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -154.39 152.47 26.26 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 110.782 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.56 166.31 13.78 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.725 2.283 . . . . 0.0 112.233 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 66.7 m80 -47.19 114.82 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.601 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.2 130.34 28.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.514 0.197 . . . . 0.0 111.523 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.35 119.53 6.53 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.234 1.956 . . . . 0.0 111.065 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.602 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.19 175.44 10.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.29 0.567 . . . . 0.0 112.334 -178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.709 ' HG3' HD23 ' A' ' 15' ' ' LEU . 15.8 ttp180 -142.74 156.92 45.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.332 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.3 mm -78.26 136.26 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -125.5 -21.4 4.52 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.362 . . . . 0.0 111.002 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 mttt . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 121.108 0.48 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -95.12 159.91 14.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.033 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -99.16 107.51 19.88 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.726 HG21 HD21 ' A' ' 63' ' ' LEU . 84.7 t -103.59 143.85 14.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.335 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.515 ' HE2' HG13 ' A' ' 95' ' ' VAL . 42.5 t80 -106.19 122.73 46.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.829 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.608 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 89.8 m-85 -94.9 110.02 21.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.922 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.766 ' HE2' HD12 ' A' ' 89' ' ' ILE . 58.9 m-85 -59.73 178.91 0.14 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.884 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.7 -63.91 0.65 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.117 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.2 p -91.35 -22.63 20.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.508 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 63.71 36.58 10.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.346 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.75 155.07 19.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.695 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.68 141.8 51.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.226 0.536 . . . . 0.0 111.574 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.491 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.31 168.25 27.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.84 125.17 51.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.817 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.4 mt -139.55 162.29 35.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.63 177.79 40.72 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.72 -25.58 39.86 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.624 2.216 . . . . 0.0 112.362 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -69.04 -21.72 64.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.128 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.7 m-20 -99.47 4.76 46.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.556 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 47' ' ' VAL . 25.9 mt -113.4 139.72 48.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.707 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.48 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 m-85 -137.22 163.8 46.45 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.816 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.434 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 3.0 Cg_exo -74.01 111.7 3.37 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.669 2.246 . . . . 0.0 111.75 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -50.77 -57.32 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.646 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.89 -40.79 57.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.995 0.426 . . . . 0.0 111.71 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 3.9 mm-40 -69.89 -39.93 75.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.59 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.461 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 4.3 m -108.43 13.58 25.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.3 ptpt -56.64 -47.02 80.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.849 0.357 . . . . 0.0 111.284 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -70.62 -24.89 62.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.744 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -84.73 -47.74 10.13 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.5 m-30 -101.02 -7.81 22.92 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.9 72.96 2.75 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.143 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.438 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.7 mtmt -148.98 155.68 40.49 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.554 0.216 . . . . 0.0 110.435 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.91 155.37 23.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.549 2.166 . . . . 0.0 112.687 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -136.78 172.93 12.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.485 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.93 -15.79 27.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.366 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.7 mmt-85 -66.05 -14.44 61.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.994 0.426 . . . . 0.0 110.769 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp 63.81 141.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.168 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.4 -17.12 53.94 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.653 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 23.0 t80 -58.96 -56.33 23.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.038 0.447 . . . . 0.0 110.724 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.81 -45.43 67.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.038 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.78 -30.95 6.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.956 0.407 . . . . 0.0 110.495 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.59 -31.9 60.15 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.992 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.595 ' O ' HG22 ' A' ' 89' ' ' ILE . 57.9 mt -60.77 -43.77 97.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 110.3 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -64.06 -44.94 90.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.599 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.8 OUTLIER -63.56 -51.53 65.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.766 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -51.44 -28.37 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.716 0.293 . . . . 0.0 111.685 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -98.86 -44.67 6.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -80.2 -32.56 38.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -157.05 91.24 2.44 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.678 0.275 . . . . 0.0 111.26 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 83.8 Cg_endo -78.1 -10.78 16.48 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.503 2.135 . . . . 0.0 112.686 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.43 HG22 HH12 ' A' ' 29' ' ' ARG . 0.8 OUTLIER -103.27 11.85 36.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.496 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.599 HG11 ' HG2' ' A' ' 88' ' ' GLU . 12.4 p . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 111.364 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.908 0.385 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.2 m -51.87 130.62 29.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.36 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.01 -11.94 68.96 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.859 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -71.04 138.83 50.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.751 0.31 . . . . 0.0 110.985 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.9 mt -91.1 116.38 28.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 110.318 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.501 HG21 HD22 ' A' ' 63' ' ' LEU . 31.3 m -139.4 170.78 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.698 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 36.5 m-85 -110.57 138.59 46.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.746 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.696 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -114.1 120.4 40.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.939 0.399 . . . . 0.0 111.195 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 129.3 39.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.243 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 mtm -119.22 161.12 20.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.611 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 119.72 13.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.108 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.63 -4.2 85.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.017 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.56 150.6 73.34 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.833 0.316 . . . . 0.0 110.756 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.81 160.74 18.79 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.742 2.294 . . . . 0.0 112.513 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 69.9 m80 -48.98 115.45 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.612 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.469 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 4.4 t-105 -98.67 133.5 22.48 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.0 119.26 6.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.384 2.056 . . . . 0.0 110.956 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.48 174.8 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.361 0.6 . . . . 0.0 112.394 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.725 HH12 HG22 ' A' ' 94' ' ' THR . 12.9 ttp180 -142.98 156.75 44.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.477 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.409 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 31.7 mm -78.85 135.79 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.6 -21.58 4.1 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 121.012 0.434 . . . . 0.0 111.593 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -93.42 160.56 14.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.877 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.17 109.72 22.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.577 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 57.5 t -104.03 141.51 19.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.249 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -105.12 121.32 43.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.702 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.664 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 84.1 m-85 -93.52 106.74 18.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.482 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.759 ' HE2' HD12 ' A' ' 89' ' ' ILE . 49.4 m-85 -58.12 177.21 0.13 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.2 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.7 -63.02 0.88 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.034 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.1 p -91.45 -22.47 20.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.701 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.2 m170 63.81 35.31 11.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.303 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -89.92 153.71 20.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.545 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.34 141.71 51.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.31 0.576 . . . . 0.0 111.614 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.533 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.0 170.59 21.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -111.49 126.26 54.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.077 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.696 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 86.1 mt -138.82 160.79 38.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.26 179.86 39.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.512 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HA ' HD12 ' A' ' 63' ' ' LEU . 15.4 Cg_exo -65.99 -27.86 50.1 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.599 2.199 . . . . 0.0 112.221 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -69.3 -23.31 63.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.175 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -98.69 7.3 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.541 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.501 HD22 HG21 ' A' ' 16' ' ' VAL . 10.7 mt -116.21 140.01 49.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 110.697 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 m-85 -136.55 161.56 61.25 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.695 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 6.9 Cg_exo -71.43 109.91 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.437 2.092 . . . . 0.0 111.431 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 89.0 t80 -46.76 -58.72 3.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.223 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -38.41 59.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.082 0.468 . . . . 0.0 111.427 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 4.1 mm-40 -70.85 -39.8 72.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.444 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.478 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 1.2 m -104.67 11.62 33.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 66' ' ' TYR . 9.3 tttt -56.09 -49.43 73.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.795 0.331 . . . . 0.0 111.863 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -67.5 -35.19 78.65 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 2.7 ptpt -83.62 -43.83 15.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 18.9 m-30 -96.05 -17.77 20.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -83.37 73.51 2.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.02 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 74' ' ' GLY . 2.7 mttp -147.41 151.69 40.59 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.576 0.227 . . . . 0.0 110.409 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.52 152.03 9.47 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.495 2.13 . . . . 0.0 112.465 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.41 169.28 17.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.082 0.468 . . . . 0.0 111.718 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -15.19 36.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.366 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -14.93 62.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.958 0.409 . . . . 0.0 110.608 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm 63.37 140.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.142 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.85 -15.89 58.13 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.493 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 38.8 t80 -58.52 -58.29 9.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.916 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.82 -45.73 64.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.073 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.99 -32.59 9.45 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.974 0.416 . . . . 0.0 110.379 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -72.75 -31.95 61.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.751 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.593 ' O ' HG22 ' A' ' 89' ' ' ILE . 98.3 mt -60.72 -43.5 97.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.07 0.462 . . . . 0.0 110.179 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 59.1 t90 -64.04 -45.33 89.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.066 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 1.8 mp0 -62.86 -51.61 66.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.759 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.27 -27.21 10.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.777 0.322 . . . . 0.0 111.654 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.39 -44.84 6.36 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -81.48 -31.75 32.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -155.62 87.19 3.16 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.738 0.304 . . . . 0.0 111.104 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 76.0 Cg_endo -77.57 -12.17 16.88 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.687 2.258 . . . . 0.0 112.85 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.725 HG22 HH12 ' A' ' 29' ' ' ARG . 75.6 p -105.47 12.93 30.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.559 HG12 ' HE1' ' A' ' 50' ' ' PHE . 11.9 p . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 120.882 0.373 . . . . 0.0 111.421 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 121.039 0.447 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 p -52.11 129.6 27.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.049 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.08 -10.49 71.77 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.911 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -72.95 141.83 47.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.769 HD23 ' HG3' ' A' ' 29' ' ' ARG . 21.2 mt -92.22 117.23 29.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.8 m -139.43 172.35 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.632 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.461 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 10.6 m-85 -113.13 136.94 52.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.992 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.644 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -112.73 121.82 45.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.89 0.376 . . . . 0.0 111.327 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -90.85 131.37 36.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.945 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.3 mtm -132.05 145.7 51.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.788 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 118.63 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.629 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 102.11 -0.51 51.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.61 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 0.5 OUTLIER -155.89 143.08 13.73 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 58.5 Cg_endo -72.69 168.36 24.69 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.34 2.027 . . . . 0.0 112.366 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 39.1 m80 -45.66 115.9 1.06 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.043 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.423 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.6 t-105 -98.27 131.94 25.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.396 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 44.8 Cg_exo -53.64 119.0 5.51 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.244 1.963 . . . . 0.0 111.044 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.594 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.47 174.32 11.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.34 0.59 . . . . 0.0 112.389 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.769 ' HG3' HD23 ' A' ' 15' ' ' LEU . 15.2 ttp180 -142.72 156.23 44.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.434 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.0 mm -77.56 135.22 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.3 -20.01 4.55 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.998 0.427 . . . . 0.0 111.019 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.907 0.384 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -94.17 158.68 15.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.946 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -98.85 109.83 22.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.594 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 59.6 t -104.18 143.02 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.279 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -107.0 123.1 47.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.945 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.644 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 81.2 m-85 -94.93 111.69 23.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.78 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.689 ' HE2' HD12 ' A' ' 89' ' ' ILE . 59.5 m-85 -60.71 178.82 0.2 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.991 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.51 -63.45 0.62 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.268 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.6 p -91.43 -23.02 20.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.962 0.41 . . . . 0.0 110.618 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 63.6 38.24 9.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.342 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -92.08 154.2 18.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.637 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.99 141.75 51.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.259 0.552 . . . . 0.0 111.576 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.41 167.12 31.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.314 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -108.03 125.23 51.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.534 HD13 ' HB1' ' A' ' 18' ' ' ALA . 14.9 mt -139.94 162.15 35.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.083 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -92.75 170.37 32.1 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.286 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.25 -19.04 50.74 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.428 2.085 . . . . 0.0 112.324 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -28.55 67.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.587 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -99.48 14.22 30.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.852 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.2 mp -111.79 137.53 49.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.539 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.4 m-85 -137.51 155.13 75.54 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.912 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.611 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 14.5 Cg_exo -68.98 112.53 2.97 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.589 2.193 . . . . 0.0 111.6 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 70' ' ' LYS . 79.3 t80 -52.04 -58.92 5.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.056 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -49.36 -41.8 40.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.957 0.408 . . . . 0.0 112.022 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.07 -39.48 72.17 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -106.13 10.69 31.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -55.89 -45.83 78.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.755 0.312 . . . . 0.0 111.47 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -70.08 -24.88 63.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.925 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -84.69 -45.97 11.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.6 m-30 -101.82 -10.44 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.48 74.01 2.42 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.359 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -151.85 155.33 33.71 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.661 0.267 . . . . 0.0 110.666 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -47.14 139.52 15.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.744 2.296 . . . . 0.0 112.812 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.435 ' HB3' ' CB ' ' A' ' 82' ' ' PHE . 9.6 t-20 -112.41 162.89 15.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.358 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -20.42 25.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.726 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? -69.34 -13.51 62.42 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.979 0.418 . . . . 0.0 110.711 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 65.25 147.49 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.021 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.59 -19.59 35.87 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.68 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.629 ' HE1' HD11 ' A' ' 86' ' ' LEU . 11.9 t80 -57.88 -52.47 65.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.014 0.435 . . . . 0.0 110.545 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.51 -47.44 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.261 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -48.33 -32.45 7.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.036 0.446 . . . . 0.0 110.423 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.8 -31.81 57.81 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.436 -0.887 . . . . 0.0 111.928 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.629 HD11 ' HE1' ' A' ' 82' ' ' PHE . 82.8 mt -60.53 -43.69 96.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 0.0 110.285 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -64.06 -43.11 96.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.955 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.469 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 35.3 mm-40 -63.69 -51.88 63.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.689 HD12 ' HE2' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -51.88 -26.3 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HG2' HG23 ' A' ' 89' ' ' ILE . 8.2 mm-40 -101.48 -44.6 5.56 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.6 -32.81 41.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.47 89.05 2.74 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.76 0.314 . . . . 0.0 111.103 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 78.0 Cg_endo -77.76 -12.53 16.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.635 2.224 . . . . 0.0 112.705 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -102.26 11.57 37.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.733 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.555 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.2 p . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 120.853 0.359 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 3.7 mmtt . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.888 0.375 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 t -52.92 126.97 22.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.495 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.47 -13.61 62.7 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.309 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -72.01 142.46 49.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.971 0.386 . . . . 0.0 111.147 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.627 HD23 ' HG3' ' A' ' 29' ' ' ARG . 59.3 mt -91.39 118.03 30.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.382 . . . . 0.0 110.327 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.94 173.93 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.791 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.417 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.8 m-85 -113.38 137.67 51.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.716 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.626 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.59 122.49 47.37 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.892 0.377 . . . . 0.0 111.425 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HD3' ' CG ' ' A' ' 25' ' ' HIS . 21.1 tptp -91.18 131.46 36.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.927 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mmm -124.7 155.21 39.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.774 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.85 111.45 7.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.74 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 102.6 -1.21 49.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.845 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.1 m-85 -146.02 150.25 41.55 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.308 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.49 166.92 23.5 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.672 2.248 . . . . 0.0 112.517 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.428 ' CG ' ' HD3' ' A' ' 19' ' ' LYS . 79.7 m80 -47.48 115.67 1.2 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.056 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.8 t-105 -98.25 130.9 27.33 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.05 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 11.0 Cg_endo -54.0 119.01 5.59 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.302 2.001 . . . . 0.0 111.054 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.607 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.19 175.8 9.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.32 0.581 . . . . 0.0 112.305 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.759 HH12 HG22 ' A' ' 94' ' ' THR . 21.2 ttp180 -143.13 156.96 44.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.379 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.411 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 13.4 mm -81.69 136.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -123.93 -16.76 6.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.118 0.485 . . . . 0.0 111.669 -179.658 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 0.7 OUTLIER -99.52 165.52 11.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.692 179.569 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -100.95 113.63 26.79 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.607 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 93.5 t -103.45 142.48 17.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.866 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.495 ' HE2' HG13 ' A' ' 95' ' ' VAL . 41.1 t80 -104.87 121.29 43.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.962 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.626 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 93.9 m-85 -94.43 108.71 20.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.643 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.7 ' CE2' HD12 ' A' ' 89' ' ' ILE . 50.0 m-85 -59.33 178.1 0.15 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.926 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 69.97 -63.62 0.71 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.097 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.8 p -91.29 -23.13 20.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.881 0.372 . . . . 0.0 110.502 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 m170 63.89 37.46 9.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.452 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -90.99 154.28 19.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.6 141.61 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.259 0.552 . . . . 0.0 111.509 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.29 167.36 30.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.361 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -107.17 124.83 50.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 mp -140.23 162.01 36.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.028 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.01 163.06 25.39 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.166 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.24 -17.98 49.48 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.448 2.099 . . . . 0.0 112.442 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -28.49 66.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.864 0.364 . . . . 0.0 110.656 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.54 12.23 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.88 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 6.5 mp -107.42 138.58 43.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.39 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.6 m-85 -137.38 147.96 59.98 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.109 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 68' ' ' GLU . 20.8 Cg_endo -61.82 109.15 0.73 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.666 2.244 . . . . 0.0 111.568 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' A' ' 70' ' ' LYS . 86.2 t80 -50.74 -58.26 6.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.878 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.4 mp0 -50.85 -39.62 54.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.164 0.507 . . . . 0.0 111.376 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 65' ' ' PRO . 33.8 mt-10 -70.68 -40.02 73.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.507 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.78 11.36 30.25 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.6 ptpp? -56.4 -45.72 80.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.827 0.346 . . . . 0.0 111.382 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 18.8 mt-10 -70.51 -26.54 63.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.859 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -83.86 -46.4 12.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 2.6 m-30 -100.18 -11.2 20.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.19 74.4 2.49 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.296 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -152.15 154.55 32.53 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.616 0.246 . . . . 0.0 110.63 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -44.98 136.21 10.16 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.707 2.271 . . . . 0.0 112.596 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.45 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -109.77 175.03 5.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.817 -178.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -100.7 -22.52 14.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.621 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -13.22 61.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.684 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt 63.99 144.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.968 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.85 -18.01 49.75 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.714 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 12.0 t80 -59.53 -50.44 73.9 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.895 0.379 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -52.58 -47.48 66.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.233 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -48.3 -30.89 5.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.01 0.434 . . . . 0.0 110.45 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.44 -31.19 59.28 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.052 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.647 ' O ' HG22 ' A' ' 89' ' ' ILE . 32.4 mt -60.64 -43.94 96.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 110.277 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.0 t90 -64.43 -45.24 88.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -62.61 -51.04 68.86 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -51.8 -26.99 7.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.784 0.325 . . . . 0.0 111.826 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -99.7 -44.8 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.22 -32.33 38.5 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -156.71 89.36 2.66 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.738 0.304 . . . . 0.0 111.079 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 93.2 Cg_endo -79.08 -11.44 14.88 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.677 2.251 . . . . 0.0 112.983 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.759 HG22 HH12 ' A' ' 29' ' ' ARG . 37.6 p -103.95 13.27 33.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.614 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.584 HG12 ' HE1' ' A' ' 50' ' ' PHE . 11.9 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.894 0.378 . . . . 0.0 111.4 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.782 0.325 . . . . 0.0 110.991 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.3 m -51.36 123.98 10.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.181 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.79 -13.87 56.24 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.238 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.44 140.46 50.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 111.211 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.8 mt -92.62 116.71 29.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.408 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.8 m -139.36 172.4 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.744 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.492 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 12.3 m-85 -111.71 136.18 51.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.801 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.658 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -112.94 123.63 50.77 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.889 0.376 . . . . 0.0 111.648 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -92.21 128.75 38.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.858 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.58 146.75 51.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.846 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -65.1 116.31 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.719 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 101.35 -0.91 53.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.726 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m-85 -148.78 151.28 34.98 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.683 0.278 . . . . 0.0 110.672 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.26 168.38 16.81 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.621 2.214 . . . . 0.0 112.193 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 74.3 m80 -47.27 113.52 0.7 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.654 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.2 t-105 -99.22 128.99 30.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.353 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.99 119.81 6.91 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.268 1.979 . . . . 0.0 111.126 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . -143.76 176.45 9.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.649 HH12 HG22 ' A' ' 94' ' ' THR . 3.2 ttt180 -144.69 157.59 44.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.456 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.505 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 27.8 mm -81.44 137.04 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.4 -18.91 4.77 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.349 . . . . 0.0 111.164 -179.707 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.917 0.389 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 40.9 m-85 -95.67 155.9 16.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.768 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.88 105.68 17.44 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.578 HG11 HD21 ' A' ' 63' ' ' LEU . 12.8 m -100.61 148.04 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.315 0.579 . . . . 0.0 112.03 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 4.9 t80 -105.39 124.5 49.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.482 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.423 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 76.1 m-85 -94.05 108.06 19.92 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.112 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.752 ' HE2' HD12 ' A' ' 89' ' ' ILE . 60.6 m-85 -58.24 178.79 0.09 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.204 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.56 -62.07 0.87 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.378 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 46.4 p -91.28 -21.23 21.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.571 0.224 . . . . 0.0 110.934 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 52' ' ' THR . 26.3 m170 64.92 33.39 9.96 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.91 0.386 . . . . 0.0 110.432 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -94.93 158.49 15.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.46 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -132.85 149.26 52.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.31 0.576 . . . . 0.0 111.74 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.55 171.5 19.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.44 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.437 ' C ' HD12 ' A' ' 58' ' ' LEU . 17.4 m-85 -107.78 124.52 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.923 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.658 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.9 mp -138.04 160.19 40.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.43 175.59 39.34 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.187 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.36 -24.92 49.54 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.405 2.07 . . . . 0.0 112.161 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -69.34 -25.74 64.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.086 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 30.0 m-20 -97.97 7.7 45.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.31 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.578 HD21 HG11 ' A' ' 47' ' ' VAL . 71.8 mt -115.15 139.4 49.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.748 0.308 . . . . 0.0 110.37 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.7 m-85 -137.58 159.61 68.43 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 13.2 Cg_exo -69.48 111.88 2.88 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.685 2.256 . . . . 0.0 111.717 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 70' ' ' LYS . 78.1 t80 -51.97 -58.38 6.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.79 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.96 -41.73 47.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.08 0.467 . . . . 0.0 111.639 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.61 -39.72 73.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.477 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.23 12.19 30.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.6 ptpt -55.73 -46.38 77.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 0.0 111.49 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -70.1 -25.69 63.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.931 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -47.33 10.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.8 m-30 -101.02 -8.01 22.75 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.1 73.05 2.71 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.219 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.3 mtmt -149.09 158.19 39.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.592 0.234 . . . . 0.0 110.398 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.41 155.44 25.41 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.601 2.201 . . . . 0.0 112.555 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -136.36 168.74 18.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.545 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -89.42 -16.37 31.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.221 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -66.72 -14.51 62.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.004 0.431 . . . . 0.0 110.67 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt 63.6 143.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.124 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.67 -18.39 39.03 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.58 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 20.0 t80 -58.91 -56.08 26.86 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.976 0.417 . . . . 0.0 110.697 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.64 -45.33 66.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.82 -30.99 6.39 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.992 0.425 . . . . 0.0 110.52 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.88 -31.36 60.2 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.994 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.687 ' O ' HG22 ' A' ' 89' ' ' ILE . 61.5 mt -60.9 -43.65 98.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.973 0.416 . . . . 0.0 110.471 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -64.26 -44.21 92.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.177 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.47 -50.91 69.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.752 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.09 -26.19 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -100.92 -44.89 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.62 -33.34 41.54 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.9 87.1 3.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.848 0.356 . . . . 0.0 111.1 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -76.18 -12.01 19.31 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.638 2.225 . . . . 0.0 112.646 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.649 HG22 HH12 ' A' ' 29' ' ' ARG . 24.3 p -104.32 11.97 34.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.546 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.622 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.8 p . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.351 . . . . 0.0 111.466 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.875 0.369 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 m -52.83 127.56 23.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.09 -14.15 57.18 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.163 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.01 141.0 47.69 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.798 0.333 . . . . 0.0 111.277 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.802 HD23 ' HG3' ' A' ' 29' ' ' ARG . 84.1 mt -93.17 122.6 35.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.343 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.43 173.62 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.183 0.516 . . . . 0.0 111.93 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 9.4 m-85 -112.22 134.54 53.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.671 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.899 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -114.13 123.65 50.15 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.036 0.446 . . . . 0.0 111.659 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -91.72 127.39 37.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.787 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 ttm -127.02 152.29 47.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.582 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -67.14 126.93 30.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.92 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 91.54 -3.72 79.03 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.954 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 1.6 m-85 -148.72 149.7 31.41 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-N 116.808 0.304 . . . . 0.0 110.729 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.79 172.2 15.42 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.5 2.133 . . . . 0.0 112.508 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -49.15 114.52 1.03 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.772 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.446 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.86 132.46 23.7 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.293 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.488 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 32.5 Cg_exo -54.48 120.52 8.18 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.069 1.846 . . . . 0.0 110.953 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.16 175.04 10.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.394 0.616 . . . . 0.0 112.412 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.802 ' HG3' HD23 ' A' ' 15' ' ' LEU . 9.5 ttp180 -142.74 155.27 44.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.551 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.402 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 30.8 mm -78.66 135.0 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.78 -20.1 4.34 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 121.034 0.445 . . . . 0.0 111.266 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.851 0.358 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 88.3 m-85 -94.26 154.01 17.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.837 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.433 ' HG3' ' CE1' ' A' ' 57' ' ' PHE . 5.1 tt0 -100.39 106.09 17.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.3 m -101.95 150.91 5.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.499 0.666 . . . . 0.0 112.126 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 17.9 t80 -105.33 125.31 50.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.289 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -91.37 106.97 18.89 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.422 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.795 ' HE2' HD12 ' A' ' 89' ' ' ILE . 41.0 m-85 -59.43 175.17 0.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.692 0.282 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.39 -61.66 0.84 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.31 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 71.7 p -90.33 -22.48 21.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.7 0.286 . . . . 0.0 110.986 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 44.3 m170 64.84 34.32 9.38 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.351 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -91.4 154.74 18.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.755 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.07 143.67 49.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.251 0.548 . . . . 0.0 111.617 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.35 172.18 18.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.511 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 46' ' ' GLN . 15.3 m-85 -116.66 126.16 52.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.482 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.899 HD13 ' HB1' ' A' ' 18' ' ' ALA . 3.0 mt -140.02 163.24 33.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.174 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.659 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -94.27 171.55 31.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.321 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.415 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 38.3 Cg_endo -66.52 -19.48 54.68 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.474 2.116 . . . . 0.0 112.517 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -68.62 -29.48 68.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.936 0.398 . . . . 0.0 110.569 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.59 10.91 40.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.891 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.4 mp -108.36 137.3 46.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.519 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.6 m-85 -137.03 157.03 75.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.461 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 6.7 Cg_exo -72.32 111.6 3.24 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.429 2.086 . . . . 0.0 111.327 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.2 t80 -48.46 -57.47 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.875 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.26 -40.52 48.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 111.348 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 17.3 mt-10 -71.24 -39.95 71.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.535 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.482 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -104.35 9.38 35.85 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.372 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -57.52 -46.43 83.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.758 0.314 . . . . 0.0 111.792 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.75 -35.56 78.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 13.4 ptpt -82.81 -41.52 18.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CZ ' ' HD2' ' A' ' 72' ' ' LYS . 15.8 m-30 -97.92 -13.11 21.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -84.53 75.35 2.37 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.266 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -152.13 153.96 31.82 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.585 0.231 . . . . 0.0 110.586 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -45.31 136.14 11.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.717 2.278 . . . . 0.0 112.727 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.473 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 31.5 t30 -108.79 174.45 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.676 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 -22.4 15.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.851 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -12.94 61.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.8 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp 64.66 145.15 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.952 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.1 -18.25 46.05 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.753 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.488 ' CE2' ' HD3' ' A' ' 27' ' ' PRO . 11.3 t80 -58.88 -51.87 68.18 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 121.005 0.431 . . . . 0.0 110.559 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -46.66 66.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.409 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -48.11 -31.25 5.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.85 -31.22 60.44 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.063 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.633 ' O ' HG22 ' A' ' 89' ' ' ILE . 56.3 mt -61.02 -43.8 98.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.971 0.415 . . . . 0.0 110.315 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -64.13 -45.15 89.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.097 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.417 ' OE1' HG11 ' A' ' 95' ' ' VAL . 60.9 mt-10 -63.09 -50.99 68.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.795 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -51.73 -27.4 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.758 0.313 . . . . 0.0 111.754 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' HG3' HG23 ' A' ' 89' ' ' ILE . 59.5 mt-10 -99.52 -44.73 6.06 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -80.98 -31.7 34.66 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.64 87.73 3.1 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.819 0.342 . . . . 0.0 111.132 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 75.4 Cg_endo -77.71 -12.93 16.44 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.58 2.187 . . . . 0.0 112.791 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.8 p -104.45 12.78 32.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.634 0.254 . . . . 0.0 111.577 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.579 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.4 p . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.845 0.355 . . . . 0.0 111.432 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 121.006 0.432 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 t -52.3 135.82 31.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.372 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.85 -11.27 69.89 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.003 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.33 142.93 47.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 0.0 111.103 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.428 HD23 ' HG3' ' A' ' 29' ' ' ARG . 77.2 mt -90.77 118.53 30.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.205 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.28 167.44 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.834 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 8.2 m-85 -109.86 132.62 53.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.65 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.581 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.83 124.06 51.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 111.523 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.71 133.21 35.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.96 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.83 147.15 51.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.62 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 112.69 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.89 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 109.56 -5.79 31.41 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.911 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 1.4 m-85 -147.96 161.57 34.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.784 0.326 . . . . 0.0 110.886 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 95.1 Cg_endo -83.94 168.98 11.98 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.895 2.397 . . . . 0.0 112.503 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 73' ' ' PHE . 67.9 m80 -47.53 116.68 1.52 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.544 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.471 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.04 130.76 27.9 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.59 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.43 120.5 8.13 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.084 1.856 . . . . 0.0 111.044 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.644 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -144.74 175.06 10.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.352 0.596 . . . . 0.0 112.533 -178.28 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 2.0 ttt180 -142.89 156.07 44.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.527 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 21.1 mm -77.67 135.05 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.32 -21.66 4.18 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.09 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 111.272 -179.619 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 mttp . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.096 0.474 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 34.0 m-85 -93.32 156.55 16.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.005 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.74 97.09 8.7 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.027 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.644 ' CG2' ' HB1' ' A' ' 28' ' ' ALA . 2.7 p -100.05 148.58 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.485 -177.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.526 ' HE2' HG13 ' A' ' 95' ' ' VAL . 33.0 t80 -106.33 125.6 51.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.293 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.597 ' HE2' ' HB3' ' A' ' 56' ' ' ALA . 79.2 m-85 -93.39 110.65 22.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.743 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.754 ' CE2' HD12 ' A' ' 89' ' ' ILE . 50.3 m-85 -60.96 175.91 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.065 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.55 -62.94 0.85 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.132 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -90.63 -22.95 20.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 110.581 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 38.0 m80 63.93 37.05 9.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.013 0.435 . . . . 0.0 110.194 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -91.21 153.97 19.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.72 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.8 139.16 53.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.162 0.506 . . . . 0.0 111.137 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.597 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.35 169.6 23.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.634 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 9.9 m-85 -112.07 126.41 55.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.773 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mp -139.21 162.53 34.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.064 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.9 176.11 39.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.362 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.74 -24.56 40.77 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.442 2.095 . . . . 0.0 112.219 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -70.03 -25.1 63.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.795 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -99.96 4.73 45.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.364 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 mt -116.09 139.47 50.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.648 0.261 . . . . 0.0 110.483 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.481 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 m-85 -137.84 165.69 31.91 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.884 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 2.7 Cg_exo -75.35 115.73 4.32 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.69 2.26 . . . . 0.0 111.733 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -53.03 -57.83 9.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.825 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -48.85 -42.98 38.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.98 0.419 . . . . 0.0 111.797 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.82 -39.72 72.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.441 -179.486 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.456 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 2.5 m -105.94 13.57 29.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 66' ' ' TYR . 6.0 ptmm? -58.06 -45.93 86.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.884 0.373 . . . . 0.0 111.452 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -67.66 -37.28 82.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.16 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 6.1 ptmt -83.39 -43.31 16.04 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.516 ' CZ ' ' CE1' ' A' ' 25' ' ' HIS . 20.5 m-30 -95.27 -13.22 25.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -89.42 74.65 1.94 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.843 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 7.7 mmtp -146.82 148.74 34.01 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.612 0.244 . . . . 0.0 110.41 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.03 155.37 2.77 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.51 2.14 . . . . 0.0 112.538 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.425 ' ND2' ' HG3' ' A' ' 24' ' ' PRO . 8.8 t-20 -137.15 166.95 22.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.591 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -15.52 35.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.268 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.404 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -66.71 -13.75 61.71 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.038 0.446 . . . . 0.0 110.597 179.304 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm 64.18 142.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.337 -179.551 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.21 -16.84 56.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.585 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 38.6 t80 -59.08 -56.68 19.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.922 0.391 . . . . 0.0 110.74 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.4 -46.18 69.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.189 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -48.93 -30.69 6.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.913 0.387 . . . . 0.0 110.5 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.28 -31.4 59.35 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.818 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.642 ' O ' HG22 ' A' ' 89' ' ' ILE . 84.2 mt -60.78 -43.72 97.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.233 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.8 t90 -63.68 -45.29 90.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.542 ' HG2' HG11 ' A' ' 95' ' ' VAL . 1.5 mp0 -62.94 -51.36 67.19 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.148 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.754 HD12 ' CE2' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -52.25 -26.3 8.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.748 0.308 . . . . 0.0 111.818 -179.824 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.04 -44.68 5.92 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -82.64 -31.68 28.66 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -156.77 88.79 2.68 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.728 0.299 . . . . 0.0 111.092 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.6 Cg_endo -76.4 -10.37 18.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.764 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.49 11.6 38.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.496 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.562 HG12 ' HE1' ' A' ' 50' ' ' PHE . 10.6 p . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 120.78 0.324 . . . . 0.0 111.218 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.892 0.377 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.418 ' HA ' HG22 ' A' ' 30' ' ' ILE . 59.5 m -51.92 134.63 31.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.346 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.37 -10.32 74.45 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.952 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.38 142.5 48.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.359 . . . . 0.0 111.171 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.488 HD23 ' HG3' ' A' ' 29' ' ' ARG . 64.1 mt -93.21 118.35 31.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.934 0.397 . . . . 0.0 110.532 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.6 m -142.84 171.71 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.683 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.546 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 33.2 m-85 -110.21 135.22 51.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.452 178.48 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.682 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -112.03 126.64 55.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 111.583 -179.46 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.3 129.11 37.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.927 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 ttm -134.06 144.33 48.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.71 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -65.03 122.96 18.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.651 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.73 -8.93 56.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.769 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.66 146.13 21.55 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.604 0.24 . . . . 0.0 110.526 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 71.9 Cg_endo -75.39 175.17 11.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.414 2.076 . . . . 0.0 112.512 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -48.21 111.88 0.5 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.527 179.01 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.7 t-105 -98.43 130.68 27.61 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.448 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.91 120.1 7.36 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.272 1.982 . . . . 0.0 110.909 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.39 174.36 10.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.359 0.6 . . . . 0.0 112.546 -178.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HG3' HD23 ' A' ' 15' ' ' LEU . 18.2 ttp180 -143.14 155.65 44.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.487 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.474 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 32.6 mm -78.82 136.52 23.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -126.46 -20.8 4.3 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.38 . . . . 0.0 111.18 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 121.102 0.477 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -97.58 159.0 15.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.944 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -97.65 109.5 22.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.577 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 50.2 t -102.78 141.71 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.395 0.617 . . . . 0.0 112.421 -178.342 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -105.25 121.25 43.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.693 179.044 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.682 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 76.8 m-85 -93.86 110.89 22.53 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.585 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 89' ' ' ILE . 49.9 m-85 -60.69 178.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.06 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.428 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 70.26 -63.53 0.78 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.857 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.3 p -91.38 -22.36 20.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.732 0.301 . . . . 0.0 110.528 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.7 m170 62.87 36.65 12.73 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.016 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.44 154.75 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.33 140.71 52.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.321 0.581 . . . . 0.0 111.6 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.528 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.99 167.59 29.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.038 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -111.92 126.91 55.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.935 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 29.3 mt -141.25 164.34 30.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.062 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.96 171.16 33.99 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.076 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.61 -19.06 48.56 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.407 2.071 . . . . 0.0 112.223 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -67.77 -28.44 67.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -100.22 16.5 24.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.657 179.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mp -114.23 137.24 52.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.4 m-85 -136.74 155.87 76.4 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.715 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.526 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 10.1 Cg_exo -69.71 112.7 3.14 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.219 1.946 . . . . 0.0 111.178 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.552 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.5 t80 -47.65 -58.78 3.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.323 -178.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -50.61 -39.7 50.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.967 0.413 . . . . 0.0 111.772 -179.158 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.5 mt-10 -71.05 -39.87 72.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.605 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -102.66 8.09 39.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.24 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.552 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -55.61 -50.75 69.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.825 0.345 . . . . 0.0 111.384 179.885 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -70.95 -19.71 62.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.441 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HD3' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -85.01 -52.23 6.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.177 0.513 . . . . 0.0 111.939 -179.214 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CD1' ' HD3' ' A' ' 72' ' ' LYS . 6.7 m-85 -100.72 -10.24 21.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.448 -0.797 . . . . 0.0 112.712 -178.394 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.02 72.31 2.29 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.297 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -150.64 152.15 31.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.681 0.24 . . . . 0.0 110.478 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.62 138.97 14.02 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.661 2.241 . . . . 0.0 112.72 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.457 ' HB3' ' CB ' ' A' ' 82' ' ' PHE . 9.4 t-20 -110.0 164.19 12.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.544 -179.338 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -20.73 23.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.685 179.418 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -69.35 -12.37 61.6 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt 65.33 146.52 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.386 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.13 -18.81 42.5 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.855 -178.699 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.6 t80 -58.24 -54.94 41.26 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.017 0.437 . . . . 0.0 110.834 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.27 -47.05 66.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.294 -179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -48.3 -31.37 5.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.045 0.45 . . . . 0.0 110.494 179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.32 -31.69 58.92 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.031 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.615 ' O ' HG22 ' A' ' 89' ' ' ILE . 41.9 mt -60.98 -43.54 98.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.986 0.422 . . . . 0.0 110.192 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -63.31 -45.46 91.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.053 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.445 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -62.73 -51.61 66.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.039 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.8 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.32 -26.5 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.791 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.66 -44.86 5.97 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -80.47 -33.06 36.94 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -155.9 88.22 2.97 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 111.136 -179.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.1 Cg_endo -76.23 -12.12 19.2 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.695 2.263 . . . . 0.0 112.838 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 p -104.05 12.71 33.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.406 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.635 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.4 p . . . . . 0 C--N 1.332 -0.189 0 CA-C-O 120.778 0.323 . . . . 0.0 111.348 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.948 0.404 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.6 t -51.95 130.86 30.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.388 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.85 -13.45 65.12 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.967 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.51 140.87 51.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.762 0.315 . . . . 0.0 111.022 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.832 HD23 ' HG3' ' A' ' 29' ' ' ARG . 60.4 mt -92.51 118.94 31.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 0.0 110.427 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.558 HG21 HD22 ' A' ' 63' ' ' LEU . 29.9 m -141.08 173.5 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.803 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.541 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 16.1 m-85 -111.35 138.88 47.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.509 178.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -117.29 126.42 52.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.171 0.51 . . . . 0.0 112.133 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . 10.7 tptm -91.18 129.56 37.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.01 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.42 140.15 48.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.743 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 123.32 17.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.79 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.65 -7.88 46.44 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.685 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.09 160.99 30.41 Favored Pre-proline 0 C--N 1.333 -0.142 0 CA-C-O 120.728 0.299 . . . . 0.0 110.626 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.67 171.16 13.58 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.635 2.224 . . . . 0.0 112.367 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 67.8 m80 -50.02 118.52 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.392 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.457 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.9 t-105 -99.49 133.05 22.2 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 11.7 Cg_endo -54.45 120.79 8.61 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.393 2.062 . . . . 0.0 110.819 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -145.01 176.35 9.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.832 ' HG3' HD23 ' A' ' 15' ' ' LEU . 11.7 ttp180 -142.61 155.57 44.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.47 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 mm -82.53 137.76 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -124.31 -14.99 6.84 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.084 0.468 . . . . 0.0 111.519 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.002 0.43 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.8 OUTLIER -95.48 163.19 13.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.663 179.439 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.03 110.26 22.57 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.612 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 99.3 t -104.74 143.61 15.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.304 -178.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 40.8 t80 -106.75 123.85 48.74 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.912 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.614 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 86.1 m-85 -95.81 113.77 25.44 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.948 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.723 ' HE2' HD12 ' A' ' 89' ' ' ILE . 60.9 m-85 -61.47 179.54 0.22 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.248 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.62 -63.56 0.45 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.117 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.7 p -91.7 -21.56 20.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.746 0.307 . . . . 0.0 110.7 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 64.5 m170 62.0 37.46 14.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.181 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -90.8 155.88 18.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.492 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.04 140.05 53.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.391 0.615 . . . . 0.0 111.655 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.18 166.92 32.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.262 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -106.2 124.76 50.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.655 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 86.2 mt -139.78 162.69 34.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.25 167.19 26.13 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.495 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.17 -19.76 67.67 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.661 2.241 . . . . 0.0 112.615 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -69.12 -27.28 65.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.873 0.368 . . . . 0.0 110.856 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 24.8 m-20 -97.95 8.81 44.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.231 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.558 HD22 HG21 ' A' ' 16' ' ' VAL . 95.6 mt -109.35 139.87 43.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.693 0.283 . . . . 0.0 110.539 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.6 m-85 -134.06 156.67 78.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.09 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 15.4 Cg_exo -68.19 109.66 2.03 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.605 2.203 . . . . 0.0 111.43 179.378 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 70' ' ' LYS . 83.4 t80 -54.9 -62.14 1.85 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.915 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -49.01 -42.13 36.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.081 0.467 . . . . 0.0 111.474 -179.149 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -70.88 -39.77 72.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.485 -179.373 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.418 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -104.93 9.75 34.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.522 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.2 ptpp? -55.21 -45.21 75.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 111.401 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.3 mt-10 -70.09 -26.89 64.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.987 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -84.57 -46.44 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 69' ' ' SER . 23.7 m-85 -105.07 -0.83 26.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.312 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.8 75.07 1.99 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.873 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -150.36 157.31 36.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.69 0.281 . . . . 0.0 110.861 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.82 149.89 10.25 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.704 2.269 . . . . 0.0 112.573 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.567 ' ND2' ' CD2' ' A' ' 82' ' ' PHE . 16.4 m-80 -131.2 165.81 22.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.595 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.32 -17.53 30.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.259 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -66.25 -15.06 62.88 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.075 0.464 . . . . 0.0 110.61 179.5 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt 63.98 142.6 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.097 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.33 -17.91 48.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.801 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.567 ' CD2' ' ND2' ' A' ' 77' ' ' ASN . 18.4 t80 -58.66 -53.58 56.76 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.034 0.445 . . . . 0.0 110.505 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.61 -46.48 67.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.043 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.62 -32.66 8.53 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.019 0.438 . . . . 0.0 110.39 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.34 -31.83 60.74 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.814 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 89' ' ' ILE . 84.1 mt -60.84 -43.73 97.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.001 0.429 . . . . 0.0 110.268 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.409 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 61.1 t90 -65.46 -41.52 93.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.053 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.419 ' OE1' HG11 ' A' ' 95' ' ' VAL . 58.7 mm-40 -64.29 -53.67 45.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.723 HD12 ' HE2' ' A' ' 50' ' ' PHE . 1.2 tt -52.39 -25.38 7.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 87' ' ' TRP . 15.8 pt-20 -100.37 -44.65 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.226 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.33 -33.91 32.19 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -156.66 85.46 3.01 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.017 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 72.1 Cg_endo -74.97 -10.24 21.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.676 2.251 . . . . 0.0 112.685 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.1 p -104.18 11.78 34.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.538 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.419 HG11 ' OE1' ' A' ' 88' ' ' GLU . 11.4 p . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 120.851 0.357 . . . . 0.0 111.441 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 5.8 mmtm . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.968 0.413 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 t -52.2 124.68 13.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.77 -16.09 44.11 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.061 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.23 140.01 50.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.827 0.346 . . . . 0.0 111.126 -179.877 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.57 HD23 ' HG3' ' A' ' 29' ' ' ARG . 56.3 mt -92.8 118.68 31.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.301 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.423 HG21 HD22 ' A' ' 63' ' ' LEU . 31.1 m -139.67 171.77 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.743 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.4 m-85 -109.98 136.68 48.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.706 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.728 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -113.43 126.44 55.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.993 0.425 . . . . 0.0 111.779 -179.186 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -92.96 130.64 38.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.854 179.368 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.94 148.6 50.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.77 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -67.36 106.67 2.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.774 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.82 -7.08 27.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.611 -0.805 . . . . 0.0 112.749 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -141.07 156.61 68.11 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.713 0.292 . . . . 0.0 110.656 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.98 171.92 9.01 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.744 2.296 . . . . 0.0 112.206 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 73' ' ' PHE . 63.6 m-70 -47.79 111.88 0.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.42 179.032 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.432 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 1.6 t-105 -99.57 129.06 29.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.783 -0.19 . . . . 0.0 111.24 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HG3' HD22 ' A' ' 86' ' ' LEU . 12.4 Cg_endo -55.46 121.13 9.38 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.152 1.902 . . . . 0.0 110.968 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.68 175.77 9.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.29 0.566 . . . . 0.0 112.257 -178.535 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.57 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.3 ttp180 -141.67 154.83 45.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.75 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.408 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.1 mm -82.27 114.25 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.87 -13.84 14.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.402 . . . . 0.0 111.309 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.004 0.431 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 62.4 m-85 -94.42 153.22 18.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.843 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -99.0 105.78 17.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.022 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.623 HG11 HD21 ' A' ' 63' ' ' LEU . 29.5 m -101.47 150.34 6.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.542 0.687 . . . . 0.0 112.211 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 32.9 t80 -105.81 124.38 49.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.076 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.466 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 32.5 m-85 -91.72 107.62 19.33 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.565 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.799 ' HE2' HD12 ' A' ' 89' ' ' ILE . 36.0 m-85 -58.56 175.11 0.27 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.794 0.33 . . . . 0.0 110.934 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.53 -62.05 0.86 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.386 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.4 p -90.49 -21.51 21.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.652 0.263 . . . . 0.0 111.097 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 48.4 m170 64.02 34.9 10.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.889 0.376 . . . . 0.0 110.29 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -90.32 153.68 20.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.704 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.54 141.51 51.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.166 0.507 . . . . 0.0 111.633 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.41 177.53 11.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.406 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 9.0 m-85 -120.56 127.34 52.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.804 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.728 HD13 ' HB1' ' A' ' 18' ' ' ALA . 5.3 mt -140.01 163.93 31.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.117 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.94 177.17 35.25 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.566 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.12 -25.26 51.07 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.665 2.243 . . . . 0.0 112.437 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -69.92 -25.43 63.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.352 . . . . 0.0 111.091 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 36.3 m-20 -98.39 4.79 48.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.388 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.623 HD21 HG11 ' A' ' 47' ' ' VAL . 20.8 mt -112.59 139.37 48.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.444 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.4 m-85 -136.01 159.93 69.18 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.067 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 12.2 Cg_exo -69.68 110.88 2.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.695 2.264 . . . . 0.0 111.64 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -51.82 -59.25 4.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.549 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -50.42 -41.41 52.38 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.701 -179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 2.2 tm-20 -69.55 -39.81 77.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.458 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 m -108.15 13.77 25.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 4.5 ptpp? -56.09 -47.67 77.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 111.125 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.3 mt-10 -71.13 -21.32 62.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.316 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HD3' ' CE1' ' A' ' 73' ' ' PHE . 4.2 tttt -85.59 -49.35 8.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.422 ' CE1' ' HD3' ' A' ' 72' ' ' LYS . 9.5 m-85 -103.01 -4.79 24.13 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.398 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.443 ' HA2' HD11 ' A' ' 86' ' ' LEU . . . -83.32 71.1 3.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.077 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 9.1 mtmt -149.33 153.54 37.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.74 158.19 14.16 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.574 2.182 . . . . 0.0 112.733 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.423 ' ND2' ' CD2' ' A' ' 82' ' ' PHE . 25.8 m-80 -137.15 167.27 21.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.469 -179.297 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.46 -15.45 46.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.112 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -14.04 61.61 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.008 0.432 . . . . 0.0 110.792 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp 63.85 142.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.273 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.05 -17.79 48.94 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.742 -178.535 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 44.5 t80 -59.83 -54.19 49.09 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.998 0.428 . . . . 0.0 110.842 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.511 ' HA ' HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -53.1 -46.33 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.236 -179.823 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -48.39 -29.83 4.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.997 0.427 . . . . 0.0 110.601 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.97 -31.59 59.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.172 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 89' ' ' ILE . 3.8 mm? -61.01 -44.16 97.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.959 0.409 . . . . 0.0 110.533 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 64.2 t90 -65.12 -45.71 83.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.339 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.474 ' OE1' HG11 ' A' ' 95' ' ' VAL . 52.5 mt-10 -62.48 -51.02 69.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.799 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -52.3 -27.18 10.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.711 0.291 . . . . 0.0 111.684 -179.64 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -99.6 -44.73 6.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -80.33 -31.86 37.98 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -155.61 88.11 3.07 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 111.188 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -75.93 -13.39 19.54 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.676 2.25 . . . . 0.0 112.697 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.558 HG22 HH12 ' A' ' 29' ' ' ARG . 48.1 p -105.67 12.4 31.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.496 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.567 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.8 p . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.418 . . . . 0.0 111.481 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.867 0.365 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.26 133.0 34.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.372 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.2 -10.97 72.75 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.915 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.03 142.8 49.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.768 0.318 . . . . 0.0 111.15 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.419 HD23 ' HG3' ' A' ' 29' ' ' ARG . 30.2 mt -90.81 116.79 28.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 110.281 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.48 168.9 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.663 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 44.5 m-85 -110.56 137.06 48.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.506 178.698 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.705 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -112.29 124.22 51.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.294 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -91.11 134.39 34.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.963 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mmm -128.19 149.27 50.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.646 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 115.22 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 0.0 111.063 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.72 -31.69 6.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.574 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -103.02 153.0 38.61 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 110.915 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.87 166.8 11.39 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.816 2.344 . . . . 0.0 112.43 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 46.7 m80 -48.61 113.98 0.88 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.472 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.7 t-105 -98.65 131.33 26.04 Favored Pre-proline 0 N--CA 1.464 0.266 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.9 120.34 7.74 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.357 2.038 . . . . 0.0 110.857 178.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.624 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -145.49 175.03 10.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.692 HH12 HG22 ' A' ' 94' ' ' THR . 1.0 OUTLIER -143.07 155.93 44.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.336 179.619 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.0 mm -80.82 136.88 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -127.31 -18.1 4.57 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 CA-C-O 120.899 0.381 . . . . 0.0 111.334 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.967 0.413 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -92.18 158.79 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.231 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.55 98.22 9.13 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.624 ' CG2' ' HB1' ' A' ' 28' ' ' ALA . 2.1 p -99.79 147.29 7.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.659 0.742 . . . . 0.0 112.408 -177.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 28.4 t80 -105.63 124.97 50.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.283 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.609 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 63.7 m-85 -91.85 108.15 19.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.548 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.752 ' CE2' HD12 ' A' ' 89' ' ' ILE . 38.0 m-85 -59.79 175.78 0.34 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.3 . . . . 0.0 110.979 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.408 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 70.68 -62.77 0.88 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.229 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.2 p -90.78 -22.07 21.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.794 0.331 . . . . 0.0 110.656 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.457 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 50.4 m170 63.51 36.04 11.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.388 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -90.41 153.52 20.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.589 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.25 139.55 53.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.113 0.483 . . . . 0.0 111.328 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.7 167.84 29.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.64 -179.731 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.28 125.64 53.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.639 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.705 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 62.3 mt -138.39 161.49 36.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.043 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.81 171.8 33.41 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.311 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.416 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 40.1 Cg_endo -67.39 -20.85 47.93 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.351 2.034 . . . . 0.0 112.214 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -68.37 -28.9 67.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.958 0.409 . . . . 0.0 110.453 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.49 12.06 38.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.816 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 2.3 mp -109.51 136.59 48.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.386 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.5 m-85 -135.05 146.0 56.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.902 0.382 . . . . 0.0 111.048 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.477 ' HG2' ' HB3' ' A' ' 68' ' ' GLU . 17.8 Cg_endo -60.06 112.25 1.24 Allowed 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.43 2.087 . . . . 0.0 111.334 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 78.6 t80 -49.71 -61.78 1.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.215 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.28 -40.8 49.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.125 0.488 . . . . 0.0 111.49 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.477 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 6.0 tt0 -71.01 -39.74 72.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.198 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.452 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 5.3 m -101.04 8.14 43.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HD3' ' CE2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.17 -53.68 46.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.267 0.556 . . . . 0.0 111.426 179.64 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.85 -17.79 62.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.831 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -85.26 -50.53 7.28 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 7.8 m-85 -107.29 -3.19 19.96 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.39 72.68 2.61 Favored Glycine 0 C--N 1.329 0.165 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.976 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -149.81 153.23 35.9 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.607 0.241 . . . . 0.0 110.678 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -51.13 153.57 9.06 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.55 2.167 . . . . 0.0 112.626 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -137.05 167.35 21.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.684 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 -15.38 41.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.324 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.9 mmt-85 -66.03 -15.19 62.82 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.032 0.444 . . . . 0.0 110.595 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm 63.62 142.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.136 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.04 -17.2 52.81 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.608 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.472 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 36.1 t80 -58.38 -56.08 26.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.986 0.422 . . . . 0.0 110.754 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.86 -46.28 67.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -48.58 -31.69 6.97 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.974 0.416 . . . . 0.0 110.426 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.33 -32.2 58.28 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.026 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.557 ' O ' HG22 ' A' ' 89' ' ' ILE . 16.5 mt -60.68 -43.55 97.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.996 0.426 . . . . 0.0 110.123 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' TRP . . . . . 0.441 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 63.8 t90 -64.9 -43.22 93.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.935 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 21.6 mm-40 -63.46 -52.41 61.53 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.752 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -53.04 -25.44 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.738 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 87' ' ' TRP . 12.5 pt-20 -99.92 -44.77 5.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.073 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 1.2 m-80 -82.55 -29.37 30.39 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -155.86 86.88 3.12 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.79 0.328 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.9 Cg_endo -76.86 -14.29 17.3 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.667 2.245 . . . . 0.0 112.653 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.692 HG22 HH12 ' A' ' 29' ' ' ARG . 16.7 p -105.13 11.9 32.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.576 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.7 p . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.403 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 121.048 0.451 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.73 131.86 35.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.516 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.81 -11.45 68.04 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.14 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.86 138.4 50.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 111.26 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.415 HD23 ' HG3' ' A' ' 29' ' ' ARG . 75.5 mt -91.89 118.09 30.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.386 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 m -139.88 171.95 13.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.832 -179.553 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 30.3 m-85 -112.81 137.09 51.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.539 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -114.4 126.5 55.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -90.25 136.08 33.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -130.32 151.8 50.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.534 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -67.64 118.26 10.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.919 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -8.57 74.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.981 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.411 ' CD1' ' HD3' ' A' ' 79' ' ' ARG . 1.9 m-85 -132.19 154.45 81.65 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.849 0.324 . . . . 0.0 111.071 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.27 167.16 12.29 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.86 2.373 . . . . 0.0 112.495 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.438 ' CG ' ' CD2' ' A' ' 73' ' ' PHE . 81.5 m-70 -47.09 115.23 1.02 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.629 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.458 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.1 t-105 -99.03 130.02 28.34 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.536 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.78 119.48 6.31 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.374 2.049 . . . . 0.0 111.112 178.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.12 174.34 10.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.425 0.631 . . . . 0.0 112.69 -177.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -142.92 155.8 44.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.305 179.686 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 28.5 mm -78.18 138.36 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.004 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.73 -20.33 5.5 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.055 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.069 0.461 . . . . 0.0 111.234 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 121.007 0.432 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 80.1 m-85 -95.82 155.02 16.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.678 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.436 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.4 mt-30 -96.39 106.71 18.99 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.211 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.598 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 63.4 t -100.77 143.06 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.294 -178.297 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.89 122.02 45.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.156 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.646 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 75.0 m-85 -94.97 110.28 22.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.415 179.629 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.725 ' HE2' HD12 ' A' ' 89' ' ' ILE . 57.2 m-85 -58.86 -179.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.025 -179.513 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.52 -63.64 0.61 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.205 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.9 p -91.11 -22.83 20.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.749 0.309 . . . . 0.0 110.734 179.197 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.4 m170 64.55 36.51 8.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.534 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -94.21 157.0 16.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.517 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -131.75 149.92 52.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.362 0.601 . . . . 0.0 112.009 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.52 170.94 20.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 52.4 m-85 -105.96 86.59 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.813 HD13 ' HB1' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -98.08 156.84 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.195 -179.87 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.559 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -91.97 169.42 32.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.324 179.649 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 42.0 Cg_endo -67.48 -20.86 47.35 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.504 2.136 . . . . 0.0 112.359 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -27.83 67.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.95 0.405 . . . . 0.0 110.413 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -100.7 12.46 37.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.791 179.622 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.8 mp -108.73 137.37 46.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.676 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.7 m-85 -136.14 158.24 74.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.65 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.639 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.9 Cg_exo -71.79 111.51 3.16 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.391 2.061 . . . . 0.0 111.288 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.566 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.2 t80 -45.63 -58.97 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.438 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -50.95 -39.43 54.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.949 -179.092 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.1 mm-40 -70.62 -39.76 73.55 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.465 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 49.5 m -105.49 11.03 32.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.447 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.566 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.38 -49.47 74.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 111.554 179.977 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.51 -26.17 64.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.707 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -85.01 -46.93 10.73 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.465 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 2.5 m-30 -99.87 -12.95 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -80.68 71.1 2.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.289 -0.957 . . . . 0.0 113.043 -179.523 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.418 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.0 mttt -148.99 153.21 38.03 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.595 0.236 . . . . 0.0 110.384 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -51.27 153.31 9.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.463 2.109 . . . . 0.0 112.674 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -136.48 163.44 30.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.545 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -81.81 -16.54 50.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.153 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.411 ' HD3' ' CD1' ' A' ' 23' ' ' TYR . 17.9 mmm180 -64.52 -15.66 61.26 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.916 0.389 . . . . 0.0 110.823 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt 63.24 140.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.139 -179.38 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.88 -16.98 53.55 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.463 -178.196 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.458 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.5 t80 -58.57 -55.49 34.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.943 0.401 . . . . 0.0 110.649 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 m -53.54 -45.66 69.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.121 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.91 -31.69 7.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.038 0.446 . . . . 0.0 110.464 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.04 -31.75 61.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.921 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.667 ' O ' HG22 ' A' ' 89' ' ' ILE . 19.7 mt -61.12 -43.68 98.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.961 0.41 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -63.61 -45.46 90.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.2 mp0 -62.38 -50.93 69.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.128 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.725 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -52.48 -25.99 8.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.723 0.297 . . . . 0.0 111.8 -179.708 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -44.81 5.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.095 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -80.49 -32.23 37.05 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.32 87.85 3.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.798 0.332 . . . . 0.0 110.978 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 96.3 Cg_endo -79.6 -12.52 13.75 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.636 2.224 . . . . 0.0 112.958 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.419 HG22 ' NH1' ' A' ' 29' ' ' ARG . 21.1 p -103.8 12.8 34.11 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.563 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.551 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.2 p . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.837 0.351 . . . . 0.0 111.288 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.805 0.336 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.12 89.8 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.774 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 78.85 1.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m 58.15 93.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.032 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -73.35 84.73 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -150.32 126.27 10.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.001 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.25 89.04 1.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -88.38 162.23 16.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.872 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -154.57 142.13 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.551 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' CE1' HG11 ' A' ' 16' ' ' VAL . 98.9 m-85 -114.59 160.04 19.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.907 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.17 159.38 41.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.011 0.434 . . . . 0.0 111.17 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 t -53.24 127.18 23.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.464 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.4 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 101.23 -14.84 58.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.096 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.07 138.8 54.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 0.0 111.115 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.7 mt -92.22 117.65 30.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.176 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.52 HG11 ' CE1' ' A' ' 10' ' ' TYR . 30.4 m -140.92 171.39 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.185 0.517 . . . . 0.0 111.956 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 32.5 m-85 -110.63 137.35 48.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.471 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.734 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -111.54 125.0 53.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.893 0.378 . . . . 0.0 111.586 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -90.37 134.37 34.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.906 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 mmm -129.8 151.85 49.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 122.62 18.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.81 -2.06 85.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.897 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -139.4 152.47 69.23 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.757 0.279 . . . . 0.0 110.674 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.87 163.8 13.85 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.6 2.2 . . . . 0.0 112.688 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 48.4 m80 -46.6 117.44 1.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.102 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.425 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.3 t-105 -101.13 128.04 30.42 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.584 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HG3' HD22 ' A' ' 86' ' ' LEU . 9.5 Cg_endo -52.49 119.5 5.99 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.329 2.02 . . . . 0.0 111.073 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . -144.69 177.34 8.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.43 0.633 . . . . 0.0 112.67 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 4.3 ttp180 -143.2 156.66 44.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.84 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.47 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 24.1 mm -82.94 140.32 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.0 -19.38 6.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -163.47 151.4 13.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 111.001 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.42 ' HE2' ' HA ' ' A' ' 33' ' ' MET . 2.6 mmt -91.94 167.05 16.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.608 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.5 145.76 77.76 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.692 2.261 . . . . 0.0 112.11 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -80.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.762 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.94 -63.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.366 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.36 26.2 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.94 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.511 HG23 ' HG2' ' A' ' 39' ' ' LYS . 28.7 m -92.12 168.24 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.246 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HG2' HG23 ' A' ' 38' ' ' VAL . 1.7 pttt 41.58 -164.65 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.499 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.44 56.09 3.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.874 0.369 . . . . 0.0 110.79 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.7 p -126.84 95.56 4.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.931 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.93 -63.96 0.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.815 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 6.0 m-80 -153.98 56.11 0.72 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 110.48 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 1.1 mmpt? -103.6 176.51 5.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.975 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 2.6 m-85 -149.46 159.77 44.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.188 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 57' ' ' PHE . 11.5 mt-30 -93.04 105.32 17.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.076 0.465 . . . . 0.0 109.832 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.625 HG11 HD21 ' A' ' 63' ' ' LEU . 11.3 m -102.95 146.87 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.615 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 3.9 t80 -103.82 123.44 47.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.456 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.665 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 73.0 m-85 -93.72 105.26 17.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.814 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.76 ' HE2' HD12 ' A' ' 89' ' ' ILE . 57.9 m-85 -56.47 178.53 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 111.389 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.39 -62.35 1.1 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.15 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.8 p -91.38 -21.96 20.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 110.932 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.6 m170 65.26 34.12 8.65 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.521 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -95.51 157.35 15.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.649 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 t -129.76 148.68 51.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.354 0.597 . . . . 0.0 111.833 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.53 170.77 21.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.606 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.3 m-85 -108.13 124.2 49.88 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.758 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.734 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 28.6 mt -138.65 161.73 36.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.975 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.11 176.27 42.06 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.248 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 9.0 Cg_exo -69.45 -25.42 30.07 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.314 2.009 . . . . 0.0 111.865 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -68.96 -22.13 64.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.618 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.18 2.18 42.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.625 HD21 HG11 ' A' ' 47' ' ' VAL . 35.1 mt -110.99 139.35 46.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.291 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.2 m-85 -136.64 160.48 66.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 16.7 Cg_exo -67.59 112.62 2.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.646 2.231 . . . . 0.0 111.939 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.7 t80 -50.08 -61.41 2.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.242 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.83 -39.38 58.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.959 0.409 . . . . 0.0 111.638 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -71.37 -39.25 71.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.349 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 34.2 m -105.62 10.86 32.82 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 66' ' ' TYR . 14.6 tttt -54.76 -48.35 72.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.77 -29.77 68.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.934 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -83.77 -46.05 12.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.469 ' HB3' ' HB2' ' A' ' 25' ' ' HIS . 4.3 m-30 -98.13 -12.18 22.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.511 ' HA2' HD11 ' A' ' 86' ' ' LEU . . . -84.76 72.88 2.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.102 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.9 mttt -150.7 143.49 16.42 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.635 0.255 . . . . 0.0 110.592 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.26 158.59 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.468 2.112 . . . . 0.0 112.757 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.64 172.05 13.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.97 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -87.22 -16.85 34.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.393 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -13.96 61.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt 66.34 141.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.395 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -17.04 56.89 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.897 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.499 ' CE1' HD21 ' A' ' 86' ' ' LEU . 36.9 t80 -59.78 -53.76 54.17 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.944 0.402 . . . . 0.0 110.518 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.75 -47.08 71.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.72 -31.33 6.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.934 0.397 . . . . 0.0 110.367 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -72.14 -32.4 63.06 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.82 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.511 HD11 ' HA2' ' A' ' 74' ' ' GLY . 3.8 mm? -60.78 -43.66 97.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.985 0.421 . . . . 0.0 110.361 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -65.48 -44.17 87.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.237 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 24.3 mm-40 -63.56 -53.01 58.41 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.76 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -52.77 -26.69 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.739 0.304 . . . . 0.0 111.775 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.71 -44.64 6.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -81.33 -32.63 32.93 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -156.72 90.95 2.54 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.715 0.293 . . . . 0.0 111.324 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -76.54 -11.02 18.83 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.48 2.12 . . . . 0.0 112.659 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.9 p -106.81 12.61 28.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.543 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.442 HG12 ' HE1' ' A' ' 50' ' ' PHE . 10.6 p -59.95 148.47 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.907 0.384 . . . . 0.0 111.542 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.52 159.92 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.975 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.88 -174.96 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.006 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 p -70.51 -38.22 74.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.816 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.65 151.28 8.81 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.459 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -118.62 154.35 32.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -96.66 106.98 19.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.17 128.99 34.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.783 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 m 60.9 108.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.768 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.72 -42.05 3.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.96 -37.59 7.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.23 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -155.99 159.3 39.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.371 . . . . 0.0 111.076 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.17 158.25 27.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 14.8 p -120.87 -42.38 2.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.941 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.49 -46.83 15.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.147 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 179.17 -36.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.013 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 64.27 98.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -136.68 -58.73 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -110.1 97.37 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.98 125.94 27.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.68 130.19 4.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -167.16 137.41 2.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.56 144.22 26.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.808 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -113.88 159.18 20.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.652 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -134.19 157.8 45.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.065 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.9 m -52.01 129.38 27.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.396 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.99 58.51 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.939 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.05 138.16 51.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.836 0.351 . . . . 0.0 111.263 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.774 HD23 ' HG3' ' A' ' 29' ' ' ARG . 62.4 mt -91.81 119.64 31.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 110.156 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.0 m -140.72 171.32 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.946 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 10.0 m-85 -109.87 136.71 48.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.515 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.644 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.08 124.56 52.88 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.007 0.432 . . . . 0.0 111.775 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -92.09 131.69 37.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.75 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mtp -129.09 147.47 50.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.689 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 115.26 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.877 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.413 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 100.45 4.08 55.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.764 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -152.8 153.66 30.34 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.695 0.283 . . . . 0.0 110.653 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.83 167.6 18.3 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.562 2.174 . . . . 0.0 112.3 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.454 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 71.0 m80 -47.49 115.23 1.06 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.627 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.92 130.41 27.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.315 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.89 120.89 8.89 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.206 1.937 . . . . 0.0 111.114 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.73 175.77 9.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.345 0.593 . . . . 0.0 112.252 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.774 ' HG3' HD23 ' A' ' 15' ' ' LEU . 5.3 ttp180 -142.84 155.7 44.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.455 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -78.85 135.28 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.98 -20.3 4.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -165.28 164.03 19.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.9 ptp -153.99 162.24 27.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.935 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.7 139.31 67.82 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.506 2.137 . . . . 0.0 112.26 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.21 -78.31 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.002 0.429 . . . . 0.0 111.025 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.76 -40.31 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.142 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.74 86.19 0.71 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.451 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.17 19.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.488 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mttp 46.05 -172.01 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.611 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 41' ' ' THR . 0.7 OUTLIER 51.76 31.31 7.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.168 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -165.12 89.78 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.29 -75.18 0.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.298 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -156.64 52.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.156 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.95 144.34 45.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.422 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 82.0 m-85 -94.82 154.45 17.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.767 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -99.3 107.04 19.23 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.639 HG11 HD21 ' A' ' 63' ' ' LEU . 7.2 m -103.47 150.5 6.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-O 121.433 0.635 . . . . 0.0 112.342 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 49.0 t80 -105.43 124.51 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.024 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.644 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 70.1 m-85 -93.28 108.96 20.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.718 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.699 ' CE2' HD12 ' A' ' 89' ' ' ILE . 47.8 m-85 -61.53 177.93 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.815 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.97 -63.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.001 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.1 p -91.52 -22.46 20.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.729 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 3.6 m80 64.56 36.96 8.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -91.64 155.44 18.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.603 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.11 140.26 53.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.188 0.518 . . . . 0.0 111.356 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.553 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.26 178.1 10.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.363 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.0 m-85 -119.92 127.21 52.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.2 mp -138.84 161.75 36.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.994 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.48 176.4 35.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.653 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.68 -25.06 54.43 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.583 2.189 . . . . 0.0 112.409 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -69.53 -27.07 64.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 0.0 110.894 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 4.0 m-20 -100.25 6.95 44.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.312 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.639 HD21 HG11 ' A' ' 47' ' ' VAL . 22.3 mt -114.31 138.1 50.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.651 0.262 . . . . 0.0 110.35 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.6 m-85 -137.11 159.58 69.33 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.066 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.9 Cg_exo -70.24 113.86 3.59 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.674 2.25 . . . . 0.0 111.65 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 89.1 t80 -53.6 -59.51 4.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.737 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -49.04 -42.63 39.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.649 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.08 -39.53 72.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.57 -179.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -105.33 10.39 33.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.4 ptpt -56.38 -44.33 80.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.633 0.254 . . . . 0.0 111.676 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mm-40 -68.56 -32.86 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 73' ' ' PHE . 13.1 ptpt -84.01 -43.34 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.435 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 18.2 m-30 -98.3 -8.6 26.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.24 75.38 2.04 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.999 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mmmm -148.61 159.26 38.86 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.609 0.242 . . . . 0.0 110.412 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.62 151.87 59.76 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.553 2.169 . . . . 0.0 112.573 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.05 170.27 15.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.148 0.499 . . . . 0.0 111.547 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -15.67 28.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.405 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -66.35 -14.82 62.65 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.009 0.433 . . . . 0.0 110.751 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt 63.37 144.15 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.111 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.44 -18.8 35.59 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.617 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 15.0 t80 -58.56 -55.65 32.36 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-O 121.04 0.448 . . . . 0.0 110.623 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -52.83 -45.67 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -48.72 -31.35 6.75 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.922 0.391 . . . . 0.0 110.441 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.09 -31.42 61.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.881 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 89' ' ' ILE . 88.9 mt -60.97 -43.8 98.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 110.231 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -64.14 -44.9 90.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.069 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.597 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -63.38 -50.92 68.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.699 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -51.81 -27.6 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 111.82 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.44 -44.66 6.1 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.76 -32.92 41.05 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.3 87.43 3.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.751 0.31 . . . . 0.0 111.241 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 3.6 Cg_exo -76.53 -13.75 18.19 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.986 2.457 . . . . 0.0 112.633 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 p -104.01 13.07 33.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.553 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.597 HG11 ' HG2' ' A' ' 88' ' ' GLU . 14.9 p -62.89 147.01 12.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.939 0.399 . . . . 0.0 111.491 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -156.17 125.33 6.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -121.23 123.13 41.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.024 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.9 t -81.89 -172.8 4.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.87 167.45 35.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -147.83 -176.78 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.347 . . . . 0.0 110.85 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -134.0 132.39 40.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -103.63 150.86 23.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -90.12 -177.5 5.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -85.05 -38.47 19.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -123.33 167.01 14.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.63 176.52 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.3 m -124.39 165.34 17.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.924 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 t 60.53 101.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.67 149.1 41.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.028 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.882 0.373 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 p -100.76 -31.9 10.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.44 168.13 20.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.804 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.1 p -116.11 177.12 4.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -122.48 32.69 5.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.08 160.94 37.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 69.55 172.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 1.7 ptpp? -90.52 105.4 17.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.001 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -92.24 135.93 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.517 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.635 ' CE1' HG11 ' A' ' 16' ' ' VAL . 55.5 m-85 -106.26 152.22 23.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.802 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.47 147.05 50.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 110.878 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 t -52.21 126.72 19.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.294 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.571 ' HA2' ' HE ' ' A' ' 29' ' ' ARG . . . 109.72 -18.46 29.44 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.195 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.47 144.56 48.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 111.859 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.562 HD23 ' HG3' ' A' ' 29' ' ' ARG . 61.3 mt -92.54 123.73 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.105 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.635 HG11 ' CE1' ' A' ' 10' ' ' TYR . 24.1 m -141.9 173.01 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 112.193 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -111.84 135.88 51.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.746 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.632 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -112.75 122.24 47.09 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.003 0.43 . . . . 0.0 111.571 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 22.8 tptm -92.21 129.71 38.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 mtm -128.21 149.94 50.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.586 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 124.45 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.982 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 91.41 -0.75 75.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.049 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.1 m-85 -146.52 153.54 47.57 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.857 0.329 . . . . 0.0 110.813 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.41 165.31 16.47 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.771 2.314 . . . . 0.0 112.417 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.485 ' CE1' ' CZ ' ' A' ' 73' ' ' PHE . 70.1 m80 -47.94 115.42 1.17 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.489 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.434 ' CD1' ' HD2' ' A' ' 27' ' ' PRO . 2.5 t-105 -98.91 132.86 22.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.412 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 35.1 Cg_exo -54.54 120.05 7.42 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.04 1.827 . . . . 0.0 111.079 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -143.7 174.57 10.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.347 0.594 . . . . 0.0 112.373 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.571 ' HE ' ' HA2' ' A' ' 13' ' ' GLY . 43.1 ttt180 -141.53 154.8 45.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.607 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 mm -78.39 138.65 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -123.89 -23.21 4.7 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -164.28 153.2 13.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.979 0.419 . . . . 0.0 111.353 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 9.5 mmt -92.88 156.37 40.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.62 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 5.9 Cg_exo -78.22 131.26 10.66 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.845 2.364 . . . . 0.0 111.986 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.4 -86.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.68 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -173.8 -54.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.263 0.554 . . . . 0.0 110.417 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.3 65.67 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.046 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.4 m -148.96 156.97 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt 67.54 -72.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.695 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.31 40.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.275 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -137.3 109.09 7.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.091 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.22 -64.53 1.08 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.327 0.584 . . . . 0.0 109.888 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.44 56.65 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.747 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.47 149.96 52.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.543 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 61.1 m-85 -94.37 158.3 15.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.128 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.9 106.37 18.66 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.677 HG21 HD21 ' A' ' 63' ' ' LEU . 73.9 t -103.7 142.72 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.494 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -106.77 123.3 47.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.774 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.632 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 90.1 m-85 -95.11 108.69 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.311 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.805 ' HE2' HD12 ' A' ' 89' ' ' ILE . 54.3 m-85 -57.57 179.32 0.06 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.27 -64.12 0.56 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.311 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.5 p -92.0 -22.63 19.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.8 m170 64.62 36.01 8.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.224 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -90.41 153.84 20.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.602 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.72 141.35 52.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.212 0.529 . . . . 0.0 111.526 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.97 166.74 32.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.305 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -107.08 124.85 50.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.598 HD13 ' HB1' ' A' ' 18' ' ' ALA . 4.9 mt -138.71 160.22 40.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.925 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.13 177.26 38.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.63 -24.8 47.7 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.507 2.138 . . . . 0.0 112.388 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -69.17 -25.26 64.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.92 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.458 ' CB ' HD22 ' A' ' 58' ' ' LEU . 2.3 m-20 -99.6 6.48 45.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.322 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.677 HD21 HG21 ' A' ' 47' ' ' VAL . 38.6 mt -115.02 138.82 50.43 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.723 0.297 . . . . 0.0 110.57 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.1 m-85 -136.34 159.99 68.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.701 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.644 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 8.1 Cg_exo -71.28 114.17 3.84 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.46 2.107 . . . . 0.0 111.479 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 70' ' ' LYS . 74.3 t80 -51.07 -59.57 4.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.117 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.436 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 1.1 mt-10 -48.09 -43.7 30.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.923 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 7.0 mt-10 -71.37 -39.63 71.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.524 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.461 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 63.7 m -103.04 9.69 38.45 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.3 ptpp? -55.62 -44.62 77.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.69 0.281 . . . . 0.0 111.669 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 1.4 mt-10 -68.39 -34.25 75.7 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -84.25 -44.15 14.16 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.485 ' CZ ' ' CE1' ' A' ' 25' ' ' HIS . 19.2 m-30 -95.95 -14.1 23.33 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.98 74.89 2.34 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.195 -1.002 . . . . 0.0 113.071 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -149.11 159.31 37.45 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.589 0.233 . . . . 0.0 110.548 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.69 152.72 79.17 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.559 2.172 . . . . 0.0 112.621 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 79' ' ' ARG . 50.6 p-10 -138.52 -172.37 3.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.291 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -100.35 -12.09 19.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.154 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 13.7 mmm180 -65.91 -15.95 63.42 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.993 0.425 . . . . 0.0 110.676 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt 62.7 141.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.996 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.49 59.3 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.562 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 26.5 t80 -57.5 -58.09 9.82 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.979 0.419 . . . . 0.0 110.941 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.884 ' HA ' HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -51.37 -45.23 62.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.086 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.21 -32.28 10.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.012 0.434 . . . . 0.0 110.324 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.9 -32.59 58.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.826 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 83' ' ' SER . 19.2 mt -60.62 -43.51 97.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.098 0.475 . . . . 0.0 110.141 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 59.0 t90 -63.32 -44.51 94.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.1 mp0 -62.93 -51.91 65.1 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.805 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -51.97 -25.63 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -101.04 -44.74 5.62 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -81.98 -32.5 30.63 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.24 84.09 3.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.804 0.335 . . . . 0.0 110.733 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 91.4 Cg_endo -77.08 -9.99 17.9 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.559 2.173 . . . . 0.0 112.856 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.1 p -104.12 12.2 34.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.588 0.232 . . . . 0.0 111.445 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.444 HG12 ' HE1' ' A' ' 50' ' ' PHE . 11.4 p -62.75 147.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 111.549 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -150.91 168.17 25.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.11 -48.27 10.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.085 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.8 p -142.78 126.69 17.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.76 -37.09 2.84 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.625 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.36 77.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -163.38 -46.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.827 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.7 p -121.77 111.66 17.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.58 120.03 14.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.824 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -108.02 -36.91 6.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.23 123.79 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -143.39 152.31 41.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.5 m -93.25 -46.78 7.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.975 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 13.1 t 60.54 109.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.05 113.86 13.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.995 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.809 0.337 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.96 127.51 35.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.56 105.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 p -170.4 141.49 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -107.35 152.06 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -93.2 174.48 7.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.809 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -93.52 93.46 8.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.819 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -94.34 148.93 21.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -95.25 139.92 30.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.55 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.482 ' CE1' HG11 ' A' ' 16' ' ' VAL . 94.1 m-85 -113.72 158.53 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -136.12 159.67 40.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 111.046 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.8 m -52.52 124.82 14.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.28 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 29' ' ' ARG . . . 105.58 -16.51 44.25 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.817 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.69 135.36 49.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.995 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.443 HD23 ' HG3' ' A' ' 29' ' ' ARG . 71.0 mt -92.07 117.26 29.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 110.286 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.482 HG11 ' CE1' ' A' ' 10' ' ' TYR . 33.5 m -139.1 171.38 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.995 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.568 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 28.6 m-85 -110.23 136.01 50.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.619 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.793 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -113.71 125.09 53.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.103 0.477 . . . . 0.0 111.781 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . 21.3 tptm -91.47 133.3 35.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.055 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -125.51 154.41 42.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.676 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.59 115.48 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.983 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.99 39.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.575 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -116.55 148.71 42.42 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-O 120.758 0.313 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.58 166.66 23.64 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.738 2.292 . . . . 0.0 112.731 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 69.6 m80 -51.64 115.13 1.48 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.373 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.6 t-105 -99.56 134.54 21.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 31.1 Cg_exo -54.44 120.89 8.77 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.164 1.909 . . . . 0.0 110.712 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.0 174.77 10.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HG3' HD23 ' A' ' 15' ' ' LEU . 5.1 ttp180 -141.59 156.85 45.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.745 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.426 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 27.0 mm -83.89 140.51 16.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.726 0.298 . . . . 0.0 110.574 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -124.55 -18.75 5.6 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -163.1 152.43 15.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.966 0.412 . . . . 0.0 111.214 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.5 mmt -89.5 158.4 45.81 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.693 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 85.2 Cg_endo -82.15 107.68 1.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.667 2.244 . . . . 0.0 112.477 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.589 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -55.29 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.723 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -174.33 -48.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.384 0.612 . . . . 0.0 110.17 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.06 80.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.104 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.589 HG22 ' HG3' ' A' ' 35' ' ' GLU . 4.3 m -146.78 14.36 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.877 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.05 -60.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.707 0.289 . . . . 0.0 111.07 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 171.98 43.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.616 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 p -135.97 112.24 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.261 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.58 -64.71 1.05 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.366 0.603 . . . . 0.0 109.525 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -156.06 56.52 0.59 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.786 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.96 148.82 52.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.482 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.431 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 72.1 m-85 -94.88 154.08 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.869 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -98.65 104.24 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.522 HG11 HD21 ' A' ' 63' ' ' LEU . 19.1 m -102.41 150.56 6.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.545 0.688 . . . . 0.0 112.432 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.502 ' HE2' HG13 ' A' ' 95' ' ' VAL . 36.4 t80 -105.4 124.81 50.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.967 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.626 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 34.5 m-85 -91.47 108.1 19.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.494 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.79 ' HE2' HD12 ' A' ' 89' ' ' ILE . 45.0 m-85 -60.52 175.95 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.721 0.296 . . . . 0.0 110.955 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.58 -62.47 0.87 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.088 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 p -90.98 -22.52 20.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.841 0.353 . . . . 0.0 110.739 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 20.6 m170 63.83 35.51 11.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.499 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -91.3 155.38 18.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.64 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.79 140.6 52.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.326 0.584 . . . . 0.0 111.639 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.08 168.79 25.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.431 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 64.4 m-85 -111.82 127.05 55.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.145 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.793 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.4 mp -138.36 160.23 40.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.58 177.33 37.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.77 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.89 -27.0 51.38 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.672 2.248 . . . . 0.0 112.363 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -69.25 -25.33 64.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -99.1 5.49 46.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.314 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.522 HD21 HG11 ' A' ' 47' ' ' VAL . 33.0 mt -113.17 138.71 49.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.814 0.34 . . . . 0.0 110.699 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.507 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 0.8 OUTLIER -134.74 154.01 79.18 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.83 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.476 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 15.0 Cg_exo -67.1 112.3 2.48 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.279 1.986 . . . . 0.0 111.157 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 77.2 t80 -51.49 -59.9 3.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.25 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -48.23 -43.0 31.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.012 0.434 . . . . 0.0 111.807 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 48.0 mt-10 -71.24 -39.69 71.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.466 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.412 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -103.0 8.49 38.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 66' ' ' TYR . 11.3 ptmt -55.35 -48.12 74.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.842 0.353 . . . . 0.0 111.38 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.01 -23.93 63.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.833 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -85.29 -47.51 9.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 69' ' ' SER . 24.0 m-85 -105.58 -0.55 25.64 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.38 73.3 2.41 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.724 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.436 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 27.1 mmtt -148.53 159.11 39.44 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.588 0.232 . . . . 0.0 110.567 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.2 153.09 28.29 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.543 2.162 . . . . 0.0 112.374 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -131.96 165.57 23.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.113 0.483 . . . . 0.0 111.672 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -86.75 -17.27 34.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.009 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -14.47 62.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.049 0.452 . . . . 0.0 110.531 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm 63.65 144.56 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.131 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.59 -18.22 39.71 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.802 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 30.0 t80 -58.59 -54.4 47.44 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.037 0.446 . . . . 0.0 110.801 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -45.64 66.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.16 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -48.46 -31.7 6.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.43 . . . . 0.0 110.49 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.52 -31.89 60.31 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.054 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.629 ' O ' HG22 ' A' ' 89' ' ' ILE . 24.9 mt -60.57 -43.82 96.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 110.35 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 69.4 t90 -64.35 -45.48 87.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.125 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.76 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -62.55 -51.23 68.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.79 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -51.83 -27.73 8.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.317 . . . . 0.0 111.709 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.32 -44.58 6.17 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -80.69 -31.71 36.17 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -156.59 88.59 2.75 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 111.351 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 80.2 Cg_endo -77.81 -11.91 16.6 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.625 2.217 . . . . 0.0 112.646 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.3 p -101.71 10.55 39.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.605 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.76 HG11 ' HG2' ' A' ' 88' ' ' GLU . 12.2 p -61.33 143.84 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.0 111.266 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.95 114.12 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.08 -66.79 0.88 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.098 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 88.8 p -63.79 -175.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.17 -45.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.555 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 58.58 83.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.5 92.46 4.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.0 m -123.94 99.74 6.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -156.12 -46.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -109.01 177.87 4.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.006 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -25.2 19.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.118 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm 62.71 -175.75 0.14 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.53 97.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.754 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.7 t 62.3 75.53 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.939 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.32 101.57 1.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.819 0.343 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -134.75 106.25 6.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.73 101.08 3.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.6 m 60.49 105.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -88.54 177.03 6.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 61.03 112.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.12 -178.1 4.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.773 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.15 119.07 23.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -95.59 143.73 26.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.725 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.587 ' CD2' HG11 ' A' ' 16' ' ' VAL . 87.8 m-85 -113.33 157.44 21.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -132.91 157.05 46.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.89 0.376 . . . . 0.0 111.102 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.5 m -51.9 132.12 31.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.594 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.19 -12.25 68.37 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.937 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.73 139.18 51.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 0.0 111.006 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.4 HD23 ' HG3' ' A' ' 29' ' ' ARG . 68.2 mt -91.18 116.51 28.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.996 0.427 . . . . 0.0 110.4 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 10' ' ' TYR . 30.6 m -139.69 170.34 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.552 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.521 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 18.0 m-85 -111.15 135.88 51.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.519 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.688 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.89 123.05 49.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.906 0.384 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 23.8 tptp -92.08 130.94 37.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.134 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtm -127.03 147.86 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.47 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 113.48 4.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 111.013 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.96 -27.38 14.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.635 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.91 157.98 48.98 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.942 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.46 166.39 12.2 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.826 2.35 . . . . 0.0 112.372 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.505 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 59.0 m80 -47.23 113.99 0.78 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.516 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.458 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.49 130.7 27.49 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.642 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.55 119.03 5.75 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.376 2.051 . . . . 0.0 111.083 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.2 175.2 10.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 14.3 ttp180 -142.53 156.44 45.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.493 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.436 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 25.0 mm -79.91 138.76 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.21 -20.84 5.15 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -162.65 151.31 14.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.957 0.408 . . . . 0.0 111.227 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.403 ' HE2' ' HA ' ' A' ' 33' ' ' MET . 31.2 mmt -91.51 161.63 33.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.66 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 90.8 Cg_endo -85.41 117.32 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.675 2.25 . . . . 0.0 112.11 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -85.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.101 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.13 -60.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.0 110.622 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.77 27.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.249 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.6 m -89.85 -2.68 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.772 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -163.74 -179.1 6.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.57 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 60.6 p -71.33 62.53 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.696 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' ASN . 13.4 t -129.75 -15.31 3.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.844 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 43.84 -87.12 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.731 0.301 . . . . 0.0 111.323 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -155.02 50.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.168 0.509 . . . . 0.0 110.235 179.083 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -141.48 166.44 24.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.048 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' CE2' ' HD3' ' A' ' 34' ' ' PRO . 45.5 m-85 -94.12 157.91 15.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.9 107.51 19.96 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.659 HG21 HD21 ' A' ' 63' ' ' LEU . 84.3 t -103.53 142.68 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 121.463 0.649 . . . . 0.0 112.56 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -105.61 121.89 44.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.507 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.688 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 81.7 m-85 -94.16 106.62 18.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.049 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.7 ' CE2' HD12 ' A' ' 89' ' ' ILE . 49.4 m-85 -57.59 176.99 0.11 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.843 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.411 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 69.77 -63.55 0.67 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.418 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 81.0 p -90.19 -23.21 21.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.739 0.304 . . . . 0.0 110.738 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 52' ' ' THR . 4.0 m170 66.0 33.91 7.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.197 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.2 151.03 21.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.928 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.8 140.79 51.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.239 0.542 . . . . 0.0 111.307 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.88 168.11 28.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.289 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.415 ' CE2' ' O ' ' A' ' 40' ' ' SER . 13.4 m-85 -109.31 125.45 52.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.995 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.556 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 19.7 mt -139.33 160.62 39.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.37 -179.85 40.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.23 -26.82 41.74 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.511 2.14 . . . . 0.0 112.189 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -69.55 -22.59 63.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.077 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.0 m-20 -99.0 3.66 47.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.463 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 47' ' ' VAL . 18.4 mt -115.03 139.6 49.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -136.59 166.3 28.65 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.845 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HB2' ' CG ' ' A' ' 68' ' ' GLU . 4.8 Cg_exo -73.17 111.08 3.2 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.767 2.311 . . . . 0.0 111.69 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.2 t80 -49.95 -58.44 5.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.478 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -49.0 -41.09 33.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.611 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 65' ' ' PRO . 4.9 mm-40 -71.02 -39.71 72.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.674 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 3.6 m -103.39 13.87 32.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 2.2 mtmp? -55.52 -44.95 77.15 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.413 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.75 -40.83 88.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.75 -43.88 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.9 m-30 -94.71 -19.77 20.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.73 74.08 2.39 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.042 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 12.1 mttt -149.32 153.57 37.62 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.95 155.5 8.42 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.616 2.211 . . . . 0.0 112.638 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -136.39 165.58 25.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.578 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -85.73 -16.07 40.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.304 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.58 -13.8 61.53 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.987 0.423 . . . . 0.0 110.713 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt 63.79 142.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.159 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.71 -16.87 55.52 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.517 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 31.4 t80 -59.0 -56.88 16.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.943 0.402 . . . . 0.0 110.882 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.41 -45.42 65.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.113 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.62 -30.13 5.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.017 0.437 . . . . 0.0 110.503 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.96 -31.86 57.43 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.161 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.621 ' O ' HG22 ' A' ' 89' ' ' ILE . 12.7 mt -60.4 -43.35 96.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.064 0.459 . . . . 0.0 110.34 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 62.9 t90 -63.73 -45.71 88.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.229 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.67 -50.63 70.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' CE2' ' A' ' 50' ' ' PHE . 1.1 tt -52.92 -27.03 12.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.744 0.306 . . . . 0.0 111.692 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -99.31 -44.83 6.08 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -79.64 -31.55 41.54 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . 1.0 OUTLIER -156.99 87.08 2.76 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.751 0.31 . . . . 0.0 111.282 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.01 -12.94 26.21 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.933 2.422 . . . . 0.0 112.61 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 p -107.05 14.66 26.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.53 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.581 HG12 ' HE1' ' A' ' 50' ' ' PHE . 14.6 p -62.56 150.66 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.075 0.464 . . . . 0.0 111.702 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -153.99 122.35 6.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.603 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 64.85 -76.67 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.086 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -140.47 175.4 9.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.808 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.39 -97.77 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.545 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 60.7 -172.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.808 0.337 . . . . 0.0 110.934 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -159.71 -45.63 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.3 t -143.66 143.75 31.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.844 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.55 165.75 11.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.41 28.86 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.033 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.0 113.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.981 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.74 81.95 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.7 31.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.3 t -151.44 145.96 25.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.71 87.87 6.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.089 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.926 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.795 0.331 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -113.01 31.93 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.83 135.73 39.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -76.03 122.77 24.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -160.29 138.72 10.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -146.7 31.42 0.97 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -121.75 134.62 54.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.691 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 1.7 tttp -146.68 -154.4 0.55 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.166 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.665 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 1.9 mm-40 82.09 134.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.857 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.454 ' CD2' HG11 ' A' ' 16' ' ' VAL . 4.6 m-85 -125.93 166.79 16.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.819 0.342 . . . . 0.0 111.475 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -140.56 165.91 26.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.897 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 98.8 m -52.01 125.36 15.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.409 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.34 -16.34 49.15 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.153 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.19 138.92 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.79 0.329 . . . . 0.0 111.323 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.464 HD23 ' HG3' ' A' ' 29' ' ' ARG . 81.3 mt -91.43 120.75 32.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.191 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.454 HG11 ' CD2' ' A' ' 10' ' ' TYR . 22.6 m -141.62 174.05 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.369 0.604 . . . . 0.0 112.133 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.508 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 9.4 m-85 -111.97 136.34 51.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.419 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.766 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -112.65 125.53 54.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.022 0.439 . . . . 0.0 111.449 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.82 132.58 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.979 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.7 mtm -129.81 155.01 46.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.701 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.73 119.62 13.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.034 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.23 -13.03 66.12 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.813 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.54 149.21 64.23 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.759 0.279 . . . . 0.0 110.836 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.24 167.91 15.39 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.723 2.282 . . . . 0.0 112.448 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -47.18 112.38 0.52 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.581 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.453 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.6 t-105 -97.79 130.5 28.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.436 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.38 119.38 6.28 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.364 2.043 . . . . 0.0 111.004 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.62 175.54 10.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HG3' HD23 ' A' ' 15' ' ' LEU . 2.6 ttp180 -142.45 157.18 45.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.464 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -80.13 138.84 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -125.45 -20.36 4.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.53 152.71 14.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.025 0.441 . . . . 0.0 111.519 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.406 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 18.2 mmt -90.6 159.16 41.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.671 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 87.1 Cg_endo -81.95 111.02 2.15 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.613 2.209 . . . . 0.0 112.34 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.679 ' OE2' HG21 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -74.33 -89.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.647 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -172.72 -54.15 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.302 0.573 . . . . 0.0 110.291 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.0 78.52 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.053 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.679 HG21 ' OE2' ' A' ' 35' ' ' GLU . 4.8 m -143.55 10.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.798 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -166.33 -57.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.918 0.39 . . . . 0.0 110.815 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.02 40.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.353 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t -130.9 -178.73 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.141 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -172.41 -45.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.598 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.82 35.49 0.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.026 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.16 146.98 45.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.579 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 84.6 m-85 -92.49 155.06 18.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.108 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -96.38 106.55 18.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.605 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 59.5 t -101.54 142.94 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.431 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -105.14 120.88 42.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.568 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.651 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 92.3 m-85 -94.08 111.36 23.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.787 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.728 ' HE2' HD12 ' A' ' 89' ' ' ILE . 47.8 m-85 -60.67 177.54 0.29 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.954 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.22 -62.93 0.78 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.22 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.5 p -92.08 -23.24 19.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 0.0 110.679 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 34.4 m170 63.88 37.64 9.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.339 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.99 153.95 19.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.829 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 144.15 49.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.365 0.603 . . . . 0.0 111.764 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.93 164.79 38.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.099 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 36.8 m-85 -107.87 87.8 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.155 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.766 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 6.6 mt -99.21 158.67 15.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.059 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.643 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -93.29 171.78 32.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.319 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.87 -22.53 48.84 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.536 2.157 . . . . 0.0 112.464 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -67.87 -27.22 66.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.694 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -100.0 14.55 30.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.964 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.6 mp -109.56 137.3 47.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.583 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.6 m-85 -136.18 157.85 74.83 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.958 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 9.5 Cg_exo -71.38 112.06 3.25 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.672 2.248 . . . . 0.0 111.525 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.4 t80 -51.37 -58.96 4.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.908 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.4 -40.28 49.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.081 0.467 . . . . 0.0 111.654 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.8 tt0 -71.66 -39.94 69.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.577 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.456 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -105.75 9.54 32.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.3 ptmm? -56.54 -47.51 79.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 0.0 111.435 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -23.27 62.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.75 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -85.06 -47.36 10.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 69' ' ' SER . 0.9 OUTLIER -108.88 3.76 22.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.337 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 70' ' ' LYS . . . -83.77 16.84 29.38 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.684 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -94.07 157.91 36.99 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.39 0.595 . . . . 0.0 110.457 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.46 158.39 10.16 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.379 2.052 . . . . 0.0 112.246 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.54 ' ND2' ' CE2' ' A' ' 82' ' ' PHE . 20.2 m-20 -132.23 169.07 16.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.625 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -89.18 -16.5 31.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.349 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -14.61 61.9 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 110.783 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt 63.35 141.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.084 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.8 -17.11 54.71 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.403 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.54 ' CE2' ' ND2' ' A' ' 77' ' ' ASN . 47.5 t80 -58.17 -54.88 41.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.03 0.443 . . . . 0.0 110.734 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.64 -46.37 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.306 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.34 -31.5 6.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.007 0.432 . . . . 0.0 110.619 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.42 -31.16 59.34 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.044 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.669 ' O ' HG22 ' A' ' 89' ' ' ILE . 76.9 mt -60.88 -43.68 98.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.003 0.43 . . . . 0.0 110.415 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.1 t90 -63.74 -44.57 93.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.22 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.667 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -63.5 -50.5 69.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.728 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -51.72 -27.45 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 89' ' ' ILE . 55.4 mt-10 -100.29 -44.73 5.84 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -79.17 -33.71 43.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -156.37 90.2 2.68 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.317 . . . . 0.0 111.194 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.5 Cg_endo -77.27 -11.24 17.6 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.565 2.176 . . . . 0.0 112.748 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.2 p -103.09 12.54 35.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.507 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.667 HG11 ' HG2' ' A' ' 88' ' ' GLU . 11.7 p -62.68 144.81 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.944 0.402 . . . . 0.0 111.35 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -127.14 171.32 11.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 53' ' ' HIS . . . -106.77 -46.9 3.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.3 t -89.62 147.48 23.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -123.18 -93.27 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.48 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -73.9 111.14 8.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -61.04 101.77 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.964 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.49 -178.22 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.035 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.8 t -171.61 172.52 4.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -129.31 169.95 14.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -90.27 -30.79 17.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 95.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.0 m -165.21 158.68 16.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.0 p -132.21 -43.78 0.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.009 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.61 -50.72 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.125 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.789 0.328 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -133.73 -51.83 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.06 -172.78 2.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.719 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.02 -177.19 3.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.056 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -142.82 -65.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.739 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 -122.06 23.09 10.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -126.03 105.44 8.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.69 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.46 ' HD2' ' CE2' ' A' ' 10' ' ' TYR . 2.5 pttp -140.68 176.43 8.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.156 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -154.29 142.65 20.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.568 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.46 ' CE2' ' HD2' ' A' ' 8' ' ' LYS . 88.8 m-85 -116.97 159.59 22.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.669 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 5.9 mmtm -137.72 161.3 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 111.016 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 t -52.28 124.61 13.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.83 -16.11 43.85 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.023 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.26 140.0 50.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 111.081 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 29' ' ' ARG . 56.1 mt -92.74 118.7 31.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.339 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.424 HG21 HD22 ' A' ' 63' ' ' LEU . 31.0 m -139.67 171.82 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.185 0.517 . . . . 0.0 111.743 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.6 m-85 -109.99 136.6 49.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.764 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.727 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -113.49 126.44 55.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.012 0.434 . . . . 0.0 111.799 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -92.9 130.64 38.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.902 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.88 148.53 50.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.802 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -67.36 106.76 2.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.745 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.75 -7.07 27.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.78 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -141.06 156.58 68.14 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.781 0.324 . . . . 0.0 110.637 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.89 171.92 9.12 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.735 2.29 . . . . 0.0 112.212 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 73' ' ' PHE . 63.6 m-70 -47.76 111.8 0.47 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.392 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.433 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 1.5 t-105 -99.54 129.04 29.84 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.322 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.404 ' HG3' HD22 ' A' ' 86' ' ' LEU . 12.5 Cg_endo -55.44 121.15 9.42 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.13 1.886 . . . . 0.0 110.98 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.59 175.73 9.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.308 0.575 . . . . 0.0 112.266 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.571 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.3 ttp180 -141.7 154.84 45.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.765 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.407 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.1 mm -82.27 114.25 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.87 -13.85 14.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.31 152.48 14.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.039 0.447 . . . . 0.0 111.318 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.44 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 6.3 ptp -154.77 156.34 31.32 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.21 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.73 160.73 24.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.701 2.267 . . . . 0.0 112.196 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -82.8 -37.95 23.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 110.754 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.81 -39.65 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.971 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.691 ' O ' HG22 ' A' ' 38' ' ' VAL . . . -162.53 -47.57 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.036 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 37' ' ' ALA . 5.3 m 50.94 21.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.856 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.5 60.5 2.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.733 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.599 ' OG ' HG23 ' A' ' 38' ' ' VAL . 13.5 p 177.18 -45.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.9 p -79.51 102.85 9.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . . . -73.72 52.78 0.42 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.017 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t30 56.03 50.82 13.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.137 0.494 . . . . 0.0 111.01 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.434 ' HD3' ' HB3' ' A' ' 42' ' ' ALA . 1.6 mtmt -132.07 138.77 48.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.248 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 62.9 m-85 -94.37 153.16 18.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.79 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -99.03 105.75 17.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.622 HG11 HD21 ' A' ' 63' ' ' LEU . 29.6 m -101.44 150.35 6.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.49 0.662 . . . . 0.0 112.214 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 33.0 t80 -105.82 124.51 49.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.04 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.465 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 32.7 m-85 -91.88 107.53 19.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.554 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.798 ' HE2' HD12 ' A' ' 89' ' ' ILE . 36.2 m-85 -58.46 174.99 0.27 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 0.0 111.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.57 -62.04 0.87 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.358 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.3 p -90.5 -21.57 21.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.606 0.241 . . . . 0.0 111.06 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 48.5 m170 64.02 34.94 10.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.912 0.386 . . . . 0.0 110.265 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -90.32 153.65 20.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.675 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.55 141.52 51.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.15 0.5 . . . . 0.0 111.69 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.32 177.54 11.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.391 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 8.6 m-85 -120.62 127.29 51.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.886 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.727 HD13 ' HB1' ' A' ' 18' ' ' ALA . 5.3 mt -139.93 163.93 31.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.13 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.94 177.07 35.18 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.616 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.07 -25.19 51.44 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.624 2.216 . . . . 0.0 112.552 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -69.9 -25.54 63.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 111.064 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 35.7 m-20 -98.3 4.84 48.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.436 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.622 HD21 HG11 ' A' ' 47' ' ' VAL . 20.7 mt -112.55 139.25 48.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.696 0.284 . . . . 0.0 110.488 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.3 m-85 -135.94 160.06 68.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.07 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 12.3 Cg_exo -69.77 110.91 2.67 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.672 2.248 . . . . 0.0 111.604 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.4 t80 -51.91 -59.16 4.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.593 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -50.49 -41.36 53.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.684 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 2.2 tm-20 -69.58 -39.77 77.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.545 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.1 m -108.09 13.74 25.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 4.5 ptpp? -56.08 -47.74 77.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.922 0.391 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.4 mt-10 -71.06 -21.41 62.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.307 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HD3' ' CE1' ' A' ' 73' ' ' PHE . 4.2 tttt -85.46 -49.47 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.423 ' CE1' ' HD3' ' A' ' 72' ' ' LYS . 9.4 m-85 -102.94 -4.8 24.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.443 ' HA2' HD11 ' A' ' 86' ' ' LEU . . . -83.3 70.95 3.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.048 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 9.1 mtmt -149.21 153.69 38.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.88 158.23 14.53 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.587 2.192 . . . . 0.0 112.632 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.423 ' ND2' ' CD2' ' A' ' 82' ' ' PHE . 26.0 m-80 -137.12 167.29 21.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.565 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.45 -15.51 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.109 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -14.06 61.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.958 0.408 . . . . 0.0 110.767 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp 63.84 142.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.276 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.05 -17.72 49.43 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.775 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 44.6 t80 -59.96 -54.23 48.53 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.904 0.383 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.51 ' HA ' HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -53.05 -46.34 68.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.224 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -48.47 -29.75 4.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.986 0.422 . . . . 0.0 110.614 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.02 -31.48 59.77 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.206 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 89' ' ' ILE . 3.8 mm? -61.09 -44.11 97.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.968 0.413 . . . . 0.0 110.535 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 64.0 t90 -65.08 -45.72 84.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.347 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.474 ' OE1' HG11 ' A' ' 95' ' ' VAL . 52.4 mt-10 -62.59 -50.85 69.65 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.798 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -52.44 -27.13 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.712 0.291 . . . . 0.0 111.734 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -99.58 -44.76 6.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -80.23 -31.98 38.47 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -155.55 88.04 3.09 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.725 0.298 . . . . 0.0 111.252 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.2 Cg_endo -75.78 -13.46 19.83 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.679 2.253 . . . . 0.0 112.739 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.559 HG22 HH12 ' A' ' 29' ' ' ARG . 48.3 p -105.69 12.4 31.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.532 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.566 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.7 p -63.19 149.61 10.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.938 0.399 . . . . 0.0 111.461 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.09 143.25 25.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.933 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB2' ' ND1' ' A' ' 53' ' ' HIS . . . -91.5 104.14 16.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.993 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -83.5 138.33 33.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.966 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.26 141.81 10.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.45 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -125.78 153.01 44.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.806 0.336 . . . . 0.0 111.041 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.01 -46.68 0.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.2 t -133.89 99.83 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -101.89 -62.96 1.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.949 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.2 113.63 1.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.29 157.77 43.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.84 124.63 29.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.8 m -150.59 138.94 20.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 67.5 m -142.92 -56.63 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.92 167.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.604 0.24 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 p -68.21 86.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.996 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 60.14 91.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.6 p -134.78 29.84 3.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -129.8 104.42 7.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.791 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -79.97 -71.4 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.984 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -144.67 149.57 35.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.982 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 8.4 ttpt -142.68 -146.87 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.47 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 37.0 mt-10 86.28 129.9 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.894 0.478 . . . . 0.0 109.791 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.491 ' CD2' HG11 ' A' ' 16' ' ' VAL . 5.5 m-85 -112.95 159.13 19.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -135.64 160.1 39.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.047 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.4 t -52.21 129.15 27.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.49 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.75 -14.21 59.03 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.978 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.15 138.31 51.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 0.0 111.051 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 29' ' ' ARG . 86.9 mt -92.19 118.79 31.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.967 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.491 HG11 ' CD2' ' A' ' 10' ' ' TYR . 25.0 m -140.61 175.8 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.252 0.549 . . . . 0.0 112.152 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 16.4 m-85 -114.02 137.32 51.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.74 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.979 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -114.71 124.6 52.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 0.0 111.537 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 15.9 tptm -91.98 132.96 36.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.079 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.522 ' SD ' HD11 ' A' ' 58' ' ' LEU . 2.0 mmm -127.74 150.66 49.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.598 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 116.15 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.836 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.07 -16.07 58.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.859 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -130.06 151.93 79.17 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.715 0.293 . . . . 0.0 110.703 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.13 167.81 17.55 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.639 2.226 . . . . 0.0 112.409 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 51.0 m80 -46.38 114.77 0.87 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.871 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.3 t-105 -98.33 129.44 30.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.609 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.56 119.11 5.41 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.398 2.065 . . . . 0.0 111.214 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.592 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.9 175.75 9.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HG3' HD23 ' A' ' 15' ' ' LEU . 3.1 ttt180 -142.28 155.81 45.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.397 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.526 HG21 ' CE ' ' A' ' 33' ' ' MET . 25.4 mm -79.03 137.35 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.28 -20.85 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -163.32 151.37 13.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.041 0.448 . . . . 0.0 111.284 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.526 ' CE ' HG21 ' A' ' 30' ' ' ILE . 32.4 mmt -94.53 159.84 32.85 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.492 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 95.7 Cg_endo -81.0 127.18 6.01 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.466 2.111 . . . . 0.0 112.227 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.407 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -82.0 -80.36 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.071 0.463 . . . . 0.0 110.956 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 42' ' ' ALA . . . -169.82 -53.54 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.102 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.91 72.22 0.31 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.353 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.455 ' C ' ' HG2' ' A' ' 39' ' ' LYS . 6.8 m -150.36 161.89 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.1 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.455 ' HG2' ' C ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER 32.16 49.44 0.14 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.288 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m 60.99 68.31 0.75 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.295 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.1 p -150.28 170.15 19.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.139 0.495 . . . . 0.0 110.866 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 36' ' ' ALA . . . -169.28 -56.43 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.822 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -156.34 40.0 0.35 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.931 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 57' ' ' PHE . 10.4 mttm -137.18 149.45 47.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.725 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 58.5 m-85 -94.2 154.51 17.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.99 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.03 108.06 20.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG21 HD21 ' A' ' 63' ' ' LEU . 60.5 t -103.2 142.46 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.576 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -104.14 120.3 40.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.807 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.733 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 72.5 m-85 -93.66 108.36 20.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.695 ' CE2' HD12 ' A' ' 89' ' ' ILE . 47.5 m-85 -59.21 176.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.859 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 -63.34 0.84 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.287 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 66.2 p -90.79 -22.75 20.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.737 0.303 . . . . 0.0 110.742 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 52' ' ' THR . 10.2 m170 64.62 34.83 9.54 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.075 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -90.23 152.48 21.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.705 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.42 144.89 48.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.28 0.562 . . . . 0.0 111.549 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.37 165.01 37.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.161 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 74.1 m-85 -107.99 87.88 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.054 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.979 HD22 ' HB1' ' A' ' 18' ' ' ALA . 4.8 mp -97.84 156.47 16.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.134 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.17 179.52 39.37 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.57 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.536 ' HA ' HD12 ' A' ' 63' ' ' LEU . 37.2 Cg_endo -66.27 -30.11 45.92 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.635 2.224 . . . . 0.0 112.45 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -69.48 -21.69 63.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.098 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.787 ' HB3' HD23 ' A' ' 58' ' ' LEU . 12.9 m-20 -99.49 2.6 45.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.474 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.603 HD21 HG21 ' A' ' 47' ' ' VAL . 10.0 mt -110.16 139.34 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 0.0 110.653 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.8 m-85 -136.37 153.2 76.15 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 24.7 Cg_exo -63.49 112.4 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.469 2.113 . . . . 0.0 111.706 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' LYS . 60.0 t80 -53.39 -59.36 4.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.743 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.4 mt-10 -49.71 -41.76 44.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.106 0.479 . . . . 0.0 111.521 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -69.96 -39.76 75.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.42 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.9 m -105.9 12.2 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 66' ' ' TYR . 5.3 ptpp? -55.71 -48.42 75.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.953 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 16.6 pt-20 -71.65 -19.99 62.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.412 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HE2' ' CZ ' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -84.48 -49.99 8.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.413 ' CZ ' ' HE2' ' A' ' 72' ' ' LYS . 6.5 m-85 -103.36 -4.63 23.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.34 71.44 2.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.19 -1.005 . . . . 0.0 113.081 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.81 149.62 28.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.678 0.275 . . . . 0.0 110.303 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.54 155.61 2.2 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.588 2.192 . . . . 0.0 112.757 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.95 165.2 27.11 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.748 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -85.01 -16.44 40.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.123 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -65.68 -14.87 62.1 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.055 0.455 . . . . 0.0 110.619 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 2.8 mmmp? 62.77 143.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.072 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.77 -18.0 41.82 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.337 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 43.7 t80 -58.46 -57.12 14.34 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -53.32 -45.69 69.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.989 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -48.86 -31.25 6.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.018 0.437 . . . . 0.0 110.525 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.39 -31.39 61.16 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.879 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 89' ' ' ILE . 44.7 mt -60.56 -43.58 97.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.968 0.413 . . . . 0.0 110.359 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.1 t90 -63.21 -45.74 90.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.157 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.592 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.4 OUTLIER -62.91 -50.91 69.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.695 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -52.23 -26.28 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.322 . . . . 0.0 111.851 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.606 ' HG2' HG23 ' A' ' 89' ' ' ILE . 4.1 mm-40 -100.55 -44.75 5.76 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -79.45 -32.77 42.74 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -156.92 90.41 2.53 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.698 0.285 . . . . 0.0 111.152 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 82.3 Cg_endo -78.01 -11.31 16.49 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.544 2.163 . . . . 0.0 112.745 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.5 p -106.33 13.96 28.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.531 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.592 HG11 ' HG2' ' A' ' 88' ' ' GLU . 11.9 p -63.47 150.49 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.875 0.369 . . . . 0.0 111.568 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.48 165.16 31.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.733 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -100.5 75.54 1.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.5 96.04 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.95 -155.37 0.63 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.528 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -143.06 -61.44 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.816 0.341 . . . . 0.0 110.974 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -104.91 109.33 21.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 p -86.77 133.13 33.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.3 m -91.81 -31.13 15.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.42 161.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -143.81 161.14 39.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 130.62 36.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.16 155.0 47.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 m -121.07 161.45 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -143.18 85.15 1.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.74 0.305 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.79 159.66 36.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -52.03 7.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.1 p -113.42 -176.2 2.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -116.76 162.47 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -171.56 143.41 1.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.987 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 61.43 153.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.031 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.44 147.75 31.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -95.78 142.57 27.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.735 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.558 ' CE1' HG11 ' A' ' 16' ' ' VAL . 87.7 m-85 -112.08 157.46 20.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.769 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -131.34 158.64 40.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.995 0.426 . . . . 0.0 111.241 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.77 131.85 35.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.515 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.89 -11.57 67.81 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.101 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.84 138.31 50.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.249 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.415 HD23 ' HG3' ' A' ' 29' ' ' ARG . 75.4 mt -91.83 118.12 30.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.386 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.558 HG11 ' CE1' ' A' ' 10' ' ' TYR . 25.5 m -139.88 171.99 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.804 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 30.5 m-85 -112.88 137.05 51.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.492 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -114.43 126.6 55.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 111.248 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -90.27 136.01 33.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.136 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -130.21 151.88 50.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.547 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -67.62 118.22 10.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -8.62 74.48 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.968 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.412 ' CD1' ' HD3' ' A' ' 79' ' ' ARG . 1.9 m-85 -132.21 154.42 81.63 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-O 120.835 0.35 . . . . 0.0 111.03 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -84.23 167.15 12.36 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.832 2.355 . . . . 0.0 112.511 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.438 ' CG ' ' CD2' ' A' ' 73' ' ' PHE . 81.3 m-70 -47.08 115.25 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.1 t-105 -99.02 129.98 28.42 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.503 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.77 119.46 6.29 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.374 2.049 . . . . 0.0 111.085 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.05 174.43 10.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -143.01 155.65 44.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.323 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 28.7 mm -78.13 138.4 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.73 -20.33 5.5 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.48 150.83 14.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.044 0.449 . . . . 0.0 111.239 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 29.3 mmt -93.32 161.22 31.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.489 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 96.8 Cg_endo -87.17 111.2 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.933 2.422 . . . . 0.0 112.379 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -51.48 -93.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.918 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -173.98 -52.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.225 0.536 . . . . 0.0 110.461 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.42 72.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.132 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.9 m -145.24 21.28 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.239 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 3.6 mmmp? -159.87 -79.61 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.508 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.7 t -179.8 41.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.503 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.482 HG21 ' CE2' ' A' ' 57' ' ' PHE . 38.2 p -138.04 122.07 17.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.199 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.69 -60.62 2.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.281 0.562 . . . . 0.0 109.714 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -155.67 50.25 0.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.79 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -114.17 139.76 49.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.725 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 79.8 m-85 -95.8 155.14 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.694 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.436 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.4 mt-30 -96.55 106.78 19.09 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.598 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 63.1 t -100.84 142.99 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.32 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.78 122.0 45.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.189 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.647 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 75.1 m-85 -94.97 110.27 22.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.37 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.722 ' HE2' HD12 ' A' ' 89' ' ' ILE . 57.4 m-85 -58.83 -179.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.06 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.58 -63.66 0.63 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.146 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.9 p -91.07 -22.88 20.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 110.742 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.4 m170 64.57 36.52 8.48 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.598 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.32 157.04 16.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.44 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -131.79 149.97 52.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.313 0.578 . . . . 0.0 111.978 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.58 170.88 20.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.067 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 52.0 m-85 -105.94 86.58 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 0.0 110.875 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.813 HD13 ' HB1' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -98.23 156.84 16.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.126 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.559 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -91.98 169.46 32.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.295 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 42.2 Cg_endo -67.54 -20.79 47.08 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.459 2.106 . . . . 0.0 112.375 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -27.83 67.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.969 0.414 . . . . 0.0 110.504 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -100.72 12.43 37.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.761 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.8 mp -108.79 137.44 46.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.658 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.8 m-85 -136.17 158.16 74.22 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.558 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.639 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.6 Cg_exo -71.71 111.5 3.15 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.393 2.062 . . . . 0.0 111.235 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.5 t80 -45.63 -59.02 2.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.358 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -50.88 -39.55 54.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.9 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.1 mm-40 -70.6 -39.83 73.57 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.464 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 48.9 m -105.35 11.08 33.2 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.43 -49.46 74.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.797 0.332 . . . . 0.0 111.524 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.54 -26.12 64.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.649 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -84.99 -46.95 10.73 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.464 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 2.5 m-30 -99.77 -13.04 19.43 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -80.65 71.15 2.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.043 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.0 mttt -149.05 153.14 37.78 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.598 0.237 . . . . 0.0 110.39 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -51.17 153.31 9.57 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.501 2.134 . . . . 0.0 112.617 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -136.49 163.49 30.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.595 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -81.87 -16.47 50.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.196 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HD3' ' CD1' ' A' ' 23' ' ' TYR . 17.9 mmm180 -64.54 -15.64 61.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.989 0.424 . . . . 0.0 110.809 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt 63.19 140.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.094 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.96 -17.0 53.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.399 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.6 t80 -58.54 -55.5 34.28 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.933 0.397 . . . . 0.0 110.658 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 m -53.58 -45.53 69.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.196 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.96 -31.69 7.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.997 0.427 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.02 -31.83 61.39 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.899 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.667 ' O ' HG22 ' A' ' 89' ' ' ILE . 19.7 mt -61.01 -43.74 98.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 0.0 110.318 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.8 t90 -63.51 -45.51 90.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.991 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.2 mp0 -62.31 -50.99 69.46 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.722 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -52.47 -26.02 8.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.731 0.3 . . . . 0.0 111.783 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.99 -44.79 5.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -80.42 -32.3 37.41 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.3 87.85 3.18 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 98.7 Cg_endo -79.47 -12.55 13.9 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.702 2.268 . . . . 0.0 113.029 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.419 HG22 ' NH1' ' A' ' 29' ' ' ARG . 21.0 p -103.78 12.67 34.3 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.552 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.3 p -65.53 149.37 11.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 111.33 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.92 165.82 24.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.98 178.43 8.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m 60.08 162.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.38 90.8 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.525 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -122.17 99.12 6.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -68.53 -37.42 79.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.52 93.5 4.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.4 p -143.27 128.49 18.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 61.39 113.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.86 101.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 154.47 33.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.69 179.09 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 p -173.02 35.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.979 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.64 102.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.091 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.789 0.328 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 179.11 -36.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 64.26 98.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.866 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -136.7 -58.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.788 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -110.14 97.34 6.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.04 125.97 28.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.66 130.25 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -167.2 137.39 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.51 144.26 26.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.798 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -113.86 159.21 20.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.7 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -134.17 157.81 45.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 111.145 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.1 m -51.98 129.38 26.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.428 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.402 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 100.87 -14.91 58.61 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.91 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.04 138.16 51.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.775 HD23 ' HG3' ' A' ' 29' ' ' ARG . 62.0 mt -91.79 119.66 31.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.246 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 m -140.77 171.27 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.133 0.492 . . . . 0.0 111.894 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 10.0 m-85 -109.79 136.62 48.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.565 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.644 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.09 124.6 52.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.098 0.475 . . . . 0.0 111.841 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -91.99 131.58 37.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.82 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mtp -129.04 147.52 50.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.701 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 115.29 5.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 100.46 3.96 55.12 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.823 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -152.75 153.62 30.39 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.628 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.76 167.7 18.34 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.585 2.19 . . . . 0.0 112.382 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.453 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 71.2 m80 -47.57 115.23 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.588 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.93 130.51 27.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.245 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.95 120.83 8.8 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.171 1.914 . . . . 0.0 111.179 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.67 175.7 9.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.277 0.56 . . . . 0.0 112.241 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.775 ' HG3' HD23 ' A' ' 15' ' ' LEU . 5.3 ttp180 -142.78 155.73 44.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.439 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.9 mm -78.88 135.2 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.92 -20.23 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -165.3 164.01 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.074 0.464 . . . . 0.0 111.73 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.9 ptp -153.98 162.16 27.47 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.898 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.68 139.31 67.64 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.545 2.163 . . . . 0.0 112.168 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.2 -78.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.8 -40.3 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.136 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.71 86.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.454 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.19 19.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.442 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mttp 46.0 -172.04 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.962 0.41 . . . . 0.0 111.611 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 41' ' ' THR . 0.7 OUTLIER 51.79 31.32 8.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -165.12 89.73 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.24 -75.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.298 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -156.58 52.87 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.185 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.01 144.21 45.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.435 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 82.5 m-85 -94.77 154.48 17.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.758 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -99.27 107.0 19.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.64 HG11 HD21 ' A' ' 63' ' ' LEU . 7.1 m -103.46 150.4 6.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.411 0.624 . . . . 0.0 112.339 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 49.3 t80 -105.44 124.56 49.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.992 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.644 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 70.0 m-85 -93.31 108.94 20.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.648 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.698 ' CE2' HD12 ' A' ' 89' ' ' ILE . 48.2 m-85 -61.37 177.9 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.933 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.96 -63.48 0.93 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.96 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -91.42 -22.37 20.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.0 110.779 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 3.6 m80 64.41 37.02 8.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.461 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -91.65 155.47 18.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 140.29 53.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.194 0.521 . . . . 0.0 111.393 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.552 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.36 178.11 10.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.428 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.2 m-85 -119.97 127.18 52.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.2 mp -138.8 161.74 36.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.43 176.37 35.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.703 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.72 -24.98 54.22 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.622 2.214 . . . . 0.0 112.41 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -69.57 -27.14 64.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.857 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 3.9 m-20 -100.22 6.9 44.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.336 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.64 HD21 HG11 ' A' ' 47' ' ' VAL . 22.4 mt -114.23 138.2 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.733 0.302 . . . . 0.0 110.32 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.7 m-85 -137.13 159.58 69.27 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.057 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.9 Cg_exo -70.21 113.91 3.6 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.674 2.25 . . . . 0.0 111.63 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 89.1 t80 -53.7 -59.5 4.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.683 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -49.0 -42.74 38.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.124 0.488 . . . . 0.0 111.648 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.94 -39.58 72.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.565 -179.454 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -105.29 10.23 33.64 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.4 ptpt -56.38 -44.28 80.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.659 0.266 . . . . 0.0 111.713 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mm-40 -68.55 -32.92 73.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 13.1 ptpt -83.99 -43.32 15.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.433 ' CD1' ' HG3' ' A' ' 72' ' ' LYS . 18.2 m-30 -98.35 -8.52 26.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.24 75.27 2.05 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.039 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mmmm -148.55 159.32 38.87 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.613 0.206 . . . . 0.0 110.511 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.59 151.89 59.46 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.585 2.19 . . . . 0.0 112.516 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.11 170.29 15.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.616 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -15.68 28.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.356 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -66.34 -14.81 62.62 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.984 0.421 . . . . 0.0 110.716 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt 63.4 144.17 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.075 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.36 -18.7 35.78 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.594 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 15.1 t80 -58.61 -55.55 33.67 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.044 0.45 . . . . 0.0 110.692 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -52.89 -45.67 67.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.062 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -48.56 -31.39 6.49 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.985 0.421 . . . . 0.0 110.543 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.06 -31.55 61.63 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.85 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 89' ' ' ILE . 89.0 mt -60.94 -43.8 98.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.226 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -64.05 -44.91 91.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.597 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -63.51 -50.87 67.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.698 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -51.9 -27.5 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 111.828 -179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.44 -44.68 6.1 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.82 -32.96 40.67 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.23 87.46 3.24 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.817 0.342 . . . . 0.0 111.257 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 3.5 Cg_exo -76.58 -13.73 18.11 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.038 2.492 . . . . 0.0 112.644 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.1 p -104.04 13.08 33.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.537 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.597 HG11 ' HG2' ' A' ' 88' ' ' GLU . 15.0 p -62.89 147.05 12.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.929 0.395 . . . . 0.0 111.447 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -156.24 125.23 6.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.024 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -121.05 123.06 41.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.063 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.0 t -81.9 -172.86 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.92 167.43 35.41 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.43 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -147.74 -176.67 5.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.821 0.343 . . . . 0.0 110.838 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -134.01 132.49 40.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -103.71 150.88 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.6 m -90.21 -177.43 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -85.07 -38.46 19.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -123.29 166.96 14.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.73 176.58 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.3 m -124.41 165.3 17.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 t 60.49 101.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.71 149.13 41.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.065 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.817 0.341 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.6 m -135.79 -47.62 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.0 mtm-85 -150.72 118.21 6.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 t -134.74 105.58 6.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.35 159.45 19.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.34 -62.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -87.01 126.42 34.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.47 148.75 31.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -95.14 141.15 29.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.653 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.651 ' CD2' HG11 ' A' ' 16' ' ' VAL . 69.1 m-85 -115.62 159.12 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -136.08 159.96 40.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 111.03 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.27 127.38 19.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.263 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.88 -13.45 60.68 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.729 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 5.9 m-20 -70.49 137.18 50.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.84 0.352 . . . . 0.0 111.072 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 mt -90.18 115.36 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 110.3 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.651 HG11 ' CD2' ' A' ' 10' ' ' TYR . 29.2 m -138.65 170.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.581 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -109.69 136.7 48.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.79 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.659 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -111.87 121.4 44.93 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.473 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 2.4 tptt -93.51 129.15 39.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.011 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.8 mtp -126.55 147.98 49.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.693 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -59.53 119.59 7.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.04 -34.96 4.59 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.441 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -105.14 150.36 38.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.696 0.284 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HG3' ' OD1' ' A' ' 77' ' ' ASN . 97.7 Cg_endo -82.49 170.16 13.29 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.593 2.195 . . . . 0.0 112.226 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.441 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 61.2 m80 -51.06 112.11 0.67 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.525 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.439 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.7 t-105 -99.6 131.07 25.4 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.237 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 11.8 Cg_endo -54.98 121.35 9.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.295 1.996 . . . . 0.0 111.183 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.12 178.44 8.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 112.328 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 14' ' ' ASP . 15.8 ttp180 -143.66 157.76 44.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.489 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.08 116.12 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -110.93 -14.0 14.03 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -163.62 156.68 18.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.042 0.449 . . . . 0.0 111.474 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 6.5 ptp -153.2 157.85 32.88 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.079 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 92.1 Cg_endo -78.93 159.9 27.35 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.722 2.281 . . . . 0.0 112.428 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -142.25 -49.95 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 0.0 111.046 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -171.15 -40.51 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.921 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.43 97.61 1.23 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.501 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.516 HG23 ' HG2' ' A' ' 39' ' ' LYS . 3.3 m -145.93 -38.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.516 ' HG2' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -164.45 -178.4 5.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 0.0 111.198 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t -69.89 66.71 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.314 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 34' ' ' PRO . 1.4 t -128.56 -179.82 5.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.771 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . -171.91 -42.56 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.888 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -155.97 33.45 0.34 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.251 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -136.85 138.5 40.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.472 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 86.9 m-85 -95.43 155.29 16.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -99.59 105.05 16.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.7 m -99.94 149.39 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.369 0.604 . . . . 0.0 112.041 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' HE2' HG13 ' A' ' 95' ' ' VAL . 23.1 t80 -105.08 123.93 48.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.259 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.539 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 85.3 m-85 -92.75 109.39 20.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.614 ' CE2' HD12 ' A' ' 89' ' ' ILE . 42.5 m-85 -61.49 176.12 0.52 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.746 0.307 . . . . 0.0 110.911 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.01 -62.48 0.96 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.083 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.2 p -91.7 -22.2 20.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 110.586 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 63.4 36.89 11.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.416 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -90.85 154.74 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.5 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.41 144.25 49.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.311 0.577 . . . . 0.0 111.806 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.76 166.13 34.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.279 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 30.6 m-85 -108.94 88.61 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.233 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.659 HD22 ' HB1' ' A' ' 18' ' ' ALA . 1.3 mp -97.92 158.32 15.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.714 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -93.09 172.05 33.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.352 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.1 -23.98 52.62 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.483 2.122 . . . . 0.0 112.38 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -27.93 66.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.973 0.416 . . . . 0.0 110.691 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -98.62 12.63 34.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.995 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.714 HD13 ' O ' ' A' ' 59' ' ' GLY . 4.7 mp -108.98 137.4 46.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.431 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.7 m-85 -134.79 157.64 76.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.765 0.317 . . . . 0.0 111.11 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.532 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.2 Cg_exo -71.02 110.93 2.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.731 2.287 . . . . 0.0 111.508 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 70' ' ' LYS . 93.2 t80 -55.29 -60.82 2.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.914 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -41.95 38.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.014 0.435 . . . . 0.0 111.48 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.31 -39.69 71.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.559 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 m -104.91 8.48 34.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.3 ptmt -56.55 -45.89 80.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.721 0.296 . . . . 0.0 111.337 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.44 -26.57 64.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.525 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.506 ' HG2' ' CE1' ' A' ' 73' ' ' PHE . 1.2 ttpm? -84.82 -45.7 12.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.506 ' CE1' ' HG2' ' A' ' 72' ' ' LYS . 18.8 m-30 -101.93 -6.15 23.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -86.44 75.39 2.25 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.284 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -151.91 153.09 31.11 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.523 0.201 . . . . 0.0 110.718 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.36 136.22 8.55 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.701 2.268 . . . . 0.0 112.504 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.437 ' OD1' ' HG3' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -111.07 171.19 7.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.915 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.15 -21.61 18.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.748 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -67.34 -13.77 62.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.935 0.398 . . . . 0.0 110.585 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt 63.99 143.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.814 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.96 -17.23 54.36 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.931 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.621 ' HE1' HD11 ' A' ' 86' ' ' LEU . 13.0 t80 -59.13 -51.28 70.68 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.956 0.408 . . . . 0.0 110.322 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.45 -46.98 66.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.993 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -48.66 -32.76 8.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.979 0.418 . . . . 0.0 110.26 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.62 -31.76 60.26 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.788 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.643 ' O ' HG22 ' A' ' 89' ' ' ILE . 71.3 mt -61.32 -43.79 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.168 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -64.78 -45.03 88.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.002 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.537 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.7 OUTLIER -62.81 -50.9 69.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 86' ' ' LEU . 1.2 tt -52.32 -26.85 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.807 0.337 . . . . 0.0 111.768 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.527 ' HG2' HG23 ' A' ' 89' ' ' ILE . 6.8 mm-40 -99.63 -44.75 6.02 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.74 -30.77 32.29 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -156.34 89.23 2.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 111.202 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 86.4 Cg_endo -78.46 -12.42 15.43 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.644 2.229 . . . . 0.0 112.72 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.1 p -102.34 10.98 38.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.586 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.0 p -61.65 143.82 14.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.819 0.343 . . . . 0.0 111.347 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.27 20.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.326 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 54.65 81.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.79 0.329 . . . . 0.0 111.174 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.9 t -104.27 143.34 33.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.34 40.08 24.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -130.87 98.11 4.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.18 110.81 13.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.44 158.57 18.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.942 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.5 m 60.25 41.42 16.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -100.47 130.59 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.47 155.5 36.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.64 145.51 51.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.64 -178.54 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.83 160.94 38.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -90.33 -63.8 1.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.772 0.32 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -134.67 106.24 6.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.7 101.15 3.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.915 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.3 m 60.5 105.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.949 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -88.41 177.1 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 61.01 112.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.977 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.09 -178.04 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.778 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.1 119.05 23.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -95.61 143.73 26.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.792 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.586 ' CD2' HG11 ' A' ' 16' ' ' VAL . 87.7 m-85 -113.32 157.41 21.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.901 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -132.92 157.0 46.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.389 . . . . 0.0 111.023 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.0 m -51.81 132.07 31.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.544 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.13 -12.14 68.56 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.909 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.77 139.21 50.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -91.14 116.56 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.964 0.411 . . . . 0.0 110.398 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' A' ' 10' ' ' TYR . 30.7 m -139.76 170.29 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.622 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.522 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 17.9 m-85 -111.09 135.86 50.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.521 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.687 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.93 123.04 49.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.345 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 23.8 tptp -92.07 130.95 37.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.163 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtm -127.04 147.82 50.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.461 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 113.47 4.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 111.008 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.99 -27.37 14.65 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.689 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.91 157.97 49.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.787 0.327 . . . . 0.0 110.942 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.47 166.44 12.16 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.802 2.335 . . . . 0.0 112.346 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.505 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 59.0 m80 -47.17 114.02 0.78 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.497 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.459 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.66 130.63 27.45 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.611 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.51 119.1 5.85 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.337 2.024 . . . . 0.0 111.056 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.6 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.2 175.09 10.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 112.438 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 14.2 ttp180 -142.52 156.49 45.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.449 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.437 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 24.6 mm -79.9 138.8 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.26 -20.8 5.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -162.65 151.34 14.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.957 0.408 . . . . 0.0 111.237 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.4 ' HE2' ' HA ' ' A' ' 33' ' ' MET . 31.2 mmt -91.48 161.6 34.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.712 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 92.4 Cg_endo -85.33 117.23 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.731 2.288 . . . . 0.0 112.175 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.88 -85.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.089 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.18 -60.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.678 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.74 27.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.298 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.6 m -89.82 -2.73 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.752 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -163.76 -179.19 6.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.575 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 61.1 p -71.21 62.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.697 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' ASN . 13.4 t -129.69 -15.38 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.799 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 43.8 -87.13 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.655 0.264 . . . . 0.0 111.284 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -155.03 50.61 0.59 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.247 0.546 . . . . 0.0 110.309 179.134 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -141.45 166.41 24.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.014 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' CE2' ' HD3' ' A' ' 34' ' ' PRO . 45.5 m-85 -94.11 157.95 15.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.199 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.93 107.55 20.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.659 HG21 HD21 ' A' ' 63' ' ' LEU . 84.3 t -103.54 142.57 17.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.445 0.641 . . . . 0.0 112.567 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -105.55 121.87 44.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.528 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.687 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 82.0 m-85 -94.03 106.51 18.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.087 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.702 ' CE2' HD12 ' A' ' 89' ' ' ILE . 49.7 m-85 -57.57 176.88 0.12 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.873 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 69.81 -63.57 0.68 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.384 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 80.9 p -90.16 -23.24 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.702 0.287 . . . . 0.0 110.712 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' THR . 3.9 m170 65.96 34.03 7.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.12 150.99 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.0 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.81 140.66 52.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.168 0.509 . . . . 0.0 111.329 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.78 168.22 27.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.333 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.415 ' CE2' ' O ' ' A' ' 40' ' ' SER . 13.5 m-85 -109.32 125.48 52.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.027 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.557 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 19.8 mt -139.36 160.67 39.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.46 -179.78 40.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.28 -26.81 41.45 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.521 2.147 . . . . 0.0 112.206 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -69.63 -22.56 63.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.008 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.1 m-20 -98.99 3.6 47.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.49 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 47' ' ' VAL . 18.3 mt -115.0 139.65 49.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 110.578 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -136.6 166.28 28.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.422 ' HB2' ' CG ' ' A' ' 68' ' ' GLU . 5.2 Cg_exo -73.21 111.15 3.21 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.732 2.288 . . . . 0.0 111.707 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.1 t80 -49.99 -58.44 5.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.484 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -49.04 -41.08 33.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.564 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.422 ' CG ' ' HB2' ' A' ' 65' ' ' PRO . 5.0 mm-40 -70.97 -39.75 72.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.659 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 3.6 m -103.41 13.89 32.63 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 2.2 mtmp? -55.53 -44.99 77.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.364 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.71 -40.82 88.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.83 -43.77 16.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.9 m-30 -94.85 -19.65 20.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.68 73.84 2.43 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.041 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 12.1 mttt -149.22 153.57 37.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.92 155.51 8.33 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.623 2.215 . . . . 0.0 112.638 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -136.43 165.52 25.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.579 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -85.72 -16.1 40.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.256 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -13.82 61.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.975 0.417 . . . . 0.0 110.682 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt 63.76 142.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.203 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.55 -16.7 55.68 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.468 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 31.6 t80 -59.01 -56.82 17.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.003 0.43 . . . . 0.0 110.865 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -45.35 66.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.057 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.68 -30.06 5.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.048 0.451 . . . . 0.0 110.535 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.93 -31.89 57.45 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.162 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 89' ' ' ILE . 12.7 mt -60.43 -43.44 96.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.035 0.445 . . . . 0.0 110.254 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 62.9 t90 -63.59 -45.74 89.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.71 -50.58 70.58 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.702 HD12 ' CE2' ' A' ' 50' ' ' PHE . 1.1 tt -52.9 -27.05 12.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 111.758 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -99.29 -44.82 6.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -79.65 -31.54 41.52 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.796 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.474 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . 1.0 OUTLIER -157.06 86.9 2.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 111.302 -179.337 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.93 -12.93 26.39 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.93 2.42 . . . . 0.0 112.65 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.0 p -106.98 14.61 26.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.587 0.232 . . . . 0.0 111.605 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.58 HG12 ' HE1' ' A' ' 50' ' ' PHE . 14.3 p -62.57 150.74 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.008 0.432 . . . . 0.0 111.69 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -154.03 122.4 6.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.576 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 64.88 -76.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -140.49 175.39 9.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.34 -97.78 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.549 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 60.68 -172.17 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -159.6 -45.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.3 t -143.61 143.69 31.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.53 165.71 11.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.38 28.88 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.15 113.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.957 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 81.95 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.94 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.68 31.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.3 t -151.53 145.83 25.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.68 87.94 6.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.058 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 m -127.41 169.77 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.62 -49.65 4.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.4 t -132.25 -46.68 0.91 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.13 123.27 21.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.28 124.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -140.41 -176.33 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -156.3 -157.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.033 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 3.4 mt-10 79.52 143.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.295 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.655 ' CD2' HG11 ' A' ' 16' ' ' VAL . 4.7 m-85 -123.36 166.27 15.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.313 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.45 165.78 25.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 110.954 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 m -52.87 130.72 34.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.277 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.76 68.54 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.086 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.65 140.76 48.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.915 0.388 . . . . 0.0 111.299 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HG3' ' A' ' 29' ' ' ARG . 67.6 mt -91.79 119.16 31.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.079 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.655 HG11 ' CD2' ' A' ' 10' ' ' TYR . 26.8 m -138.84 171.91 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.224 0.535 . . . . 0.0 111.992 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 8.5 m-85 -111.08 134.81 52.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.656 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.805 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -112.36 124.3 52.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.006 0.431 . . . . 0.0 111.591 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -91.18 132.81 35.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.906 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -131.23 150.11 52.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.7 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' O ' ' CE2' ' A' ' 23' ' ' TYR . 1.2 mtpm? -62.46 121.8 14.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.104 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 81.82 15.93 74.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.897 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.427 ' CE2' ' O ' ' A' ' 21' ' ' LYS . 3.4 m-85 -151.4 147.96 21.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.63 0.252 . . . . 0.0 110.841 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.16 165.01 17.15 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.615 2.21 . . . . 0.0 112.221 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -47.51 115.42 1.12 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.571 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.448 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.76 130.13 28.44 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-O 120.527 0.203 . . . . 0.0 111.527 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.14 121.45 9.68 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.373 2.049 . . . . 0.0 111.155 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.707 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -145.61 176.09 9.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.789 ' HG3' HD23 ' A' ' 15' ' ' LEU . 11.4 ttp180 -141.43 154.63 45.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.492 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mm -81.8 140.12 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 0.0 110.541 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.17 -22.5 7.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.794 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.421 ' CG ' ' HB3' ' A' ' 46' ' ' GLN . 2.0 pt-20 -163.93 155.02 15.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.111 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 29.5 mmt -91.68 163.34 28.47 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.003 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 94.7 Cg_endo -91.69 38.26 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.05 2.5 . . . . 0.0 112.209 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -151.78 41.17 0.67 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.75 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.86 -35.63 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.182 0.515 . . . . 0.0 109.726 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.69 73.87 1.49 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.635 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.6 m -153.4 172.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.976 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 25.1 mmtp -159.11 -68.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.595 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.19 46.31 1.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 110.438 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 44' ' ' LYS . 33.9 p -143.33 128.22 18.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.029 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.17 -52.66 15.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.242 0.544 . . . . 0.0 109.817 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -155.98 48.45 0.5 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.903 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HG3' HG22 ' A' ' 41' ' ' THR . 5.7 mmtt -99.29 129.16 45.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.352 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 40.4 m-85 -93.77 154.71 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.122 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.421 ' HB3' ' CG ' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -96.65 98.82 10.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.707 ' CG2' ' HB1' ' A' ' 28' ' ' ALA . 2.2 p -99.84 148.92 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.358 -177.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 23.3 t80 -105.96 125.1 50.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.252 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -91.39 113.16 25.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.699 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.769 ' HE2' HD12 ' A' ' 89' ' ' ILE . 44.0 m-85 -63.31 174.61 1.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.02 -61.75 0.75 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.3 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.8 p -90.36 -23.49 21.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.66 0.267 . . . . 0.0 110.723 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 10.8 m170 63.56 37.93 10.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.524 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -93.32 156.67 16.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.814 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 143.19 50.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.322 0.582 . . . . 0.0 111.926 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.65 168.2 27.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.5 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 75.6 m-85 -111.58 89.81 3.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.038 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.805 HD22 ' HB1' ' A' ' 18' ' ' ALA . 1.7 mp -97.72 157.45 16.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.251 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -91.76 171.77 34.92 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.409 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.18 -24.66 44.07 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.45 2.1 . . . . 0.0 112.316 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -27.73 67.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.423 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.63 14.7 31.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.858 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 59' ' ' GLY . 2.4 mp -113.2 136.29 52.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.618 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.6 m-85 -135.93 155.47 77.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.636 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.8 Cg_exo -72.54 112.23 3.42 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.481 2.121 . . . . 0.0 111.2 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.7 t80 -48.34 -58.78 4.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.172 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -43.35 34.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.928 0.394 . . . . 0.0 112.033 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 5.8 mm-40 -70.28 -39.74 74.74 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 51.5 m -105.58 10.72 32.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.9 ptpt -55.97 -48.13 76.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.817 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.9 mm-40 -72.54 -19.91 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.586 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -84.92 -49.83 8.03 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 7.3 m-85 -104.41 -4.44 22.8 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.95 71.46 2.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.193 -1.004 . . . . 0.0 113.066 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -149.57 151.19 32.68 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.699 0.285 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.29 156.0 18.31 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.565 2.177 . . . . 0.0 112.7 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -138.77 -172.51 3.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.378 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -99.03 -13.81 19.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.058 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -67.87 -14.35 62.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt 62.88 142.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.175 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.55 -15.89 59.17 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.733 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.448 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 35.6 t80 -57.38 -58.7 7.1 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.061 0.458 . . . . 0.0 110.907 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.457 ' HA ' HD12 ' A' ' 86' ' ' LEU . 1.1 m -51.76 -46.17 64.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.281 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -48.79 -32.7 9.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.903 0.382 . . . . 0.0 110.501 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.45 -31.68 60.69 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.839 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.641 ' O ' HG22 ' A' ' 89' ' ' ILE . 84.2 mt -60.49 -43.63 96.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.012 0.434 . . . . 0.0 110.287 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.8 t90 -63.74 -43.0 97.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.926 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.565 ' OE1' HG11 ' A' ' 95' ' ' VAL . 39.6 mm-40 -62.84 -52.38 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.769 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.25 -25.71 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -44.75 5.73 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -81.05 -32.95 33.83 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -156.39 88.9 2.78 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.76 0.314 . . . . 0.0 111.152 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 72.2 Cg_endo -77.44 -12.05 17.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.662 2.242 . . . . 0.0 112.897 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.7 p -106.51 14.44 27.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.607 0.241 . . . . 0.0 111.587 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.565 HG11 ' OE1' ' A' ' 88' ' ' GLU . 11.9 p -65.23 151.22 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.874 0.369 . . . . 0.0 111.404 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -134.43 164.64 27.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' A' ' 53' ' ' HIS . . . -118.56 171.43 8.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.148 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m 61.6 150.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.025 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.2 129.89 1.44 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.568 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.27 148.24 37.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.708 0.289 . . . . 0.0 110.732 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -143.45 123.47 13.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.058 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.0 m 76.93 -1.71 2.79 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.779 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.5 m 52.78 177.17 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.838 0.352 . . . . 0.0 111.172 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 51.45 -177.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.13 -45.35 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.57 -48.97 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.2 p 59.14 175.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.77 89.7 3.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 67.04 -72.64 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.171 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 tpt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.848 0.356 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m 62.69 101.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.965 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.57 86.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.054 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 p -129.16 111.41 12.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.801 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -110.74 -27.06 9.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.172 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 61.79 91.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 0.0 110.651 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -79.49 157.79 27.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.076 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.42 ' HE2' ' CE1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -174.66 123.99 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.649 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -95.75 143.08 27.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.699 ' CE1' HG11 ' A' ' 16' ' ' VAL . 79.4 m-85 -109.56 155.73 21.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.798 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -131.56 155.07 48.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.409 . . . . 0.0 111.078 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.8 m -52.4 129.92 29.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.572 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.26 -13.43 63.14 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.048 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.3 138.14 51.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 111.057 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' ' 29' ' ' ARG . 86.5 mt -91.59 117.45 29.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.357 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.699 HG11 ' CE1' ' A' ' 10' ' ' TYR . 31.2 m -139.99 172.1 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.851 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 13.4 m-85 -113.14 135.72 53.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.722 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.759 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.82 123.3 49.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 0.0 111.432 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 8.1 tptp -92.37 133.86 35.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.0 mtm -128.32 151.86 48.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.78 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.86 102.15 3.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.51 -1.21 23.53 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.818 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -146.91 149.71 36.77 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.706 0.289 . . . . 0.0 110.716 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.63 162.97 34.76 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.636 2.224 . . . . 0.0 112.387 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.405 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 80.1 m80 -47.72 116.78 1.58 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.62 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.452 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.5 t-105 -98.63 132.09 24.64 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.48 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.34 120.98 9.2 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.37 2.047 . . . . 0.0 110.969 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -145.16 176.39 9.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 0.0 112.28 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.637 ' NH1' HG22 ' A' ' 94' ' ' THR . 1.8 ttt180 -142.23 155.72 45.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.453 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.437 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 23.6 mm -80.4 138.73 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.376 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -126.05 -21.58 4.29 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.47 152.13 8.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.907 0.384 . . . . 0.0 111.28 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.1 165.33 21.98 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.641 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.457 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 35.2 Cg_exo -57.9 139.55 90.74 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.639 2.226 . . . . 0.0 112.219 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.31 -86.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.426 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -178.07 -52.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.5 0.667 . . . . 0.0 110.278 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.25 92.71 0.27 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.611 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.05 11.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.709 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.14 -65.66 0.31 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 m -52.79 -27.35 17.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.731 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -121.82 -33.08 3.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.115 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 41.06 -86.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.477 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 41' ' ' THR . 3.2 p30 -152.82 55.42 0.79 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.322 0.582 . . . . 0.0 109.989 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -139.36 167.07 22.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.803 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.457 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 87.3 m-85 -95.23 157.64 15.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.033 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -98.69 108.18 20.81 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 63' ' ' LEU . 45.4 t -104.31 141.4 19.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.397 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.536 ' HE2' HG13 ' A' ' 95' ' ' VAL . 25.8 t80 -106.57 122.22 45.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.897 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.759 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 75.7 m-85 -94.34 109.42 21.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.156 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.792 ' HE2' HD12 ' A' ' 89' ' ' ILE . 73.9 m-85 -58.78 -178.97 0.06 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.998 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.61 -63.82 0.44 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.255 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.5 p -91.95 -22.52 19.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.843 0.354 . . . . 0.0 110.633 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.8 m170 64.81 35.44 8.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.973 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -89.8 153.12 20.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.683 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.12 141.6 50.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.318 0.58 . . . . 0.0 111.614 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.568 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.49 170.76 21.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -115.13 126.96 55.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 0.0 111.069 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 26.1 mt -139.62 162.03 36.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.0 176.62 36.21 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.364 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.96 -25.42 59.52 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.493 2.129 . . . . 0.0 112.269 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.71 -26.34 64.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.94 8.33 45.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 47' ' ' VAL . 53.0 mt -117.06 139.07 51.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.694 0.283 . . . . 0.0 110.408 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.4 m-85 -137.39 157.89 73.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.576 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 13.4 Cg_exo -67.72 113.82 3.11 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.188 1.925 . . . . 0.0 111.395 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' LYS . 81.4 t80 -48.97 -57.15 6.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.031 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 15.7 mm-40 -51.46 -39.83 58.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.02 0.438 . . . . 0.0 111.984 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 15.8 mm-40 -70.08 -39.81 75.37 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.454 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 6.4 m -106.78 12.09 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 2.4 ptpp? -56.59 -48.74 76.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 0.0 111.024 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -72.33 -20.95 61.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.459 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.38 -49.34 8.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 8.3 m-85 -100.68 -13.56 18.47 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.82 73.05 1.96 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.972 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -149.75 147.98 24.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.663 0.268 . . . . 0.0 110.562 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.5 153.35 14.03 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.496 2.131 . . . . 0.0 112.769 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 82' ' ' PHE . 51.1 p-10 -139.08 -173.27 3.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.316 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -99.97 -13.31 19.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.971 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 79' ' ' ARG . 21.1 mmt180 -67.25 -14.5 62.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.927 0.394 . . . . 0.0 110.557 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp 63.06 141.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.261 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.21 -16.38 58.92 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.875 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.452 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 47.7 t80 -57.64 -57.07 14.31 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.928 0.394 . . . . 0.0 110.824 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -52.2 -46.22 65.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.138 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -48.86 -33.05 9.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.075 0.464 . . . . 0.0 110.289 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.92 -32.75 58.49 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.807 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.598 ' O ' HG22 ' A' ' 89' ' ' ILE . 46.2 mt -60.49 -43.66 96.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.108 0.48 . . . . 0.0 109.956 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -64.09 -45.35 89.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.895 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.487 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -62.59 -51.89 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.792 HD12 ' HE2' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -52.23 -26.34 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.15 -44.83 6.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.57 -33.19 31.8 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -156.57 81.52 3.5 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.758 0.313 . . . . 0.0 110.974 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.0 Cg_endo -73.99 -8.94 21.78 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.627 2.218 . . . . 0.0 112.953 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.637 HG22 ' NH1' ' A' ' 29' ' ' ARG . 72.6 p -101.48 12.25 37.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.586 0.232 . . . . 0.0 111.515 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.536 HG13 ' HE2' ' A' ' 48' ' ' PHE . 9.8 p -64.06 144.91 14.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.812 0.339 . . . . 0.0 111.325 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -161.69 122.13 2.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.017 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 57.23 167.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.067 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.3 m 60.01 108.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.738 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.6 58.53 4.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.622 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 6.7 t80 55.97 89.84 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.908 0.385 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -89.53 89.81 8.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.5 p -67.2 177.54 1.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.5 t 60.35 107.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.35 41.49 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.75 31.96 3.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm 59.56 97.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.0 t -142.48 119.57 11.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.3 t -87.19 -57.48 2.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.36 179.39 6.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.937 0.399 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.81 158.45 28.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.909 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -32.93 12.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.36 106.73 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.856 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.79 113.99 21.45 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.06 -42.2 2.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -165.72 146.19 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.77 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -105.75 115.2 29.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.955 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 142.45 27.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.725 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.53 ' CD2' HG11 ' A' ' 16' ' ' VAL . 90.2 m-85 -114.33 157.89 22.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.986 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -130.17 157.44 42.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.786 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.4 t -53.67 131.85 39.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.083 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.71 -12.19 64.48 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.265 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -73.25 142.94 47.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 111.207 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.709 HD23 ' HG3' ' A' ' 29' ' ' ARG . 49.1 mt -91.79 119.6 31.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.391 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 10' ' ' TYR . 29.3 m -140.77 170.1 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.661 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 8.4 m-85 -109.84 136.51 49.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.695 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.608 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.95 122.72 47.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.007 0.432 . . . . 0.0 111.453 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -91.35 128.71 37.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.882 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.6 mtp -126.96 148.12 50.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.658 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.64 125.4 23.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.907 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.435 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 85.01 11.48 76.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.977 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -154.39 152.47 26.26 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 110.782 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.56 166.31 13.78 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.725 2.283 . . . . 0.0 112.233 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 66.7 m80 -47.19 114.82 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.601 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.2 130.34 28.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.514 0.197 . . . . 0.0 111.523 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.35 119.53 6.53 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.234 1.956 . . . . 0.0 111.065 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.602 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.19 175.44 10.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.29 0.567 . . . . 0.0 112.334 -178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.709 ' HG3' HD23 ' A' ' 15' ' ' LEU . 15.8 ttp180 -142.74 156.92 45.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.332 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.3 mm -78.26 136.26 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -125.5 -21.4 4.52 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.37 152.9 15.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.362 . . . . 0.0 111.002 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.406 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -155.15 166.59 15.82 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.247 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 33' ' ' MET . 36.5 Cg_exo -60.44 172.11 2.88 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.7 2.267 . . . . 0.0 111.953 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.97 -31.62 7.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.98 -41.15 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.323 0.582 . . . . 0.0 109.514 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.77 -69.51 0.32 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.369 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.657 ' HB ' HG22 ' A' ' 41' ' ' THR . 11.8 t 61.04 101.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.697 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -75.58 -13.52 60.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.473 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -76.29 -42.85 44.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 110.755 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.657 HG22 ' HB ' ' A' ' 38' ' ' VAL . 15.0 t -89.13 116.83 27.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.906 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 44' ' ' LYS . . . -74.57 52.96 0.53 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.619 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.6 t30 60.39 47.08 9.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.575 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 2.7 mttt -130.99 138.48 49.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.438 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -95.12 159.91 14.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.033 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -99.16 107.51 19.88 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.726 HG21 HD21 ' A' ' 63' ' ' LEU . 84.7 t -103.59 143.85 14.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.335 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.515 ' HE2' HG13 ' A' ' 95' ' ' VAL . 42.5 t80 -106.19 122.73 46.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.829 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.608 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 89.8 m-85 -94.9 110.02 21.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.922 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.766 ' HE2' HD12 ' A' ' 89' ' ' ILE . 58.9 m-85 -59.73 178.91 0.14 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.884 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.7 -63.91 0.65 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.117 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.2 p -91.35 -22.63 20.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.508 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 63.71 36.58 10.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.346 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.75 155.07 19.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.695 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.68 141.8 51.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.226 0.536 . . . . 0.0 111.574 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.31 168.25 27.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.84 125.17 51.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.817 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.4 mt -139.55 162.29 35.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.63 177.79 40.72 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.72 -25.58 39.86 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.624 2.216 . . . . 0.0 112.362 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -69.04 -21.72 64.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.128 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.7 m-20 -99.47 4.76 46.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.556 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 47' ' ' VAL . 25.9 mt -113.4 139.72 48.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.707 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.48 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 m-85 -137.22 163.8 46.45 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.816 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.434 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 3.0 Cg_exo -74.01 111.7 3.37 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.669 2.246 . . . . 0.0 111.75 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -50.77 -57.32 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.646 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.89 -40.79 57.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.995 0.426 . . . . 0.0 111.71 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 3.9 mm-40 -69.89 -39.93 75.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.59 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.461 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 4.3 m -108.43 13.58 25.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.3 ptpt -56.64 -47.02 80.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.849 0.357 . . . . 0.0 111.284 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -70.62 -24.89 62.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.744 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -84.73 -47.74 10.13 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.5 m-30 -101.02 -7.81 22.92 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.9 72.96 2.75 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.143 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.438 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.7 mtmt -148.98 155.68 40.49 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.554 0.216 . . . . 0.0 110.435 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.91 155.37 23.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.549 2.166 . . . . 0.0 112.687 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -136.78 172.93 12.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.485 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.93 -15.79 27.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.366 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.7 mmt-85 -66.05 -14.44 61.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.994 0.426 . . . . 0.0 110.769 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp 63.81 141.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.168 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.4 -17.12 53.94 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.653 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 23.0 t80 -58.96 -56.33 23.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.038 0.447 . . . . 0.0 110.724 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.81 -45.43 67.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.038 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.78 -30.95 6.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.956 0.407 . . . . 0.0 110.495 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.59 -31.9 60.15 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.992 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.595 ' O ' HG22 ' A' ' 89' ' ' ILE . 57.9 mt -60.77 -43.77 97.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 110.3 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -64.06 -44.94 90.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.599 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.8 OUTLIER -63.56 -51.53 65.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.766 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -51.44 -28.37 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.716 0.293 . . . . 0.0 111.685 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -98.86 -44.67 6.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -80.2 -32.56 38.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -157.05 91.24 2.44 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.678 0.275 . . . . 0.0 111.26 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 83.8 Cg_endo -78.1 -10.78 16.48 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.503 2.135 . . . . 0.0 112.686 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.43 HG22 HH12 ' A' ' 29' ' ' ARG . 0.8 OUTLIER -103.27 11.85 36.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.496 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.599 HG11 ' HG2' ' A' ' 88' ' ' GLU . 12.4 p -61.86 145.2 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 111.364 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.7 168.88 18.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.017 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.64 29.91 7.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.998 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.0 p -66.31 153.47 42.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.53 -169.3 16.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.461 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 61.44 88.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.15 -173.57 2.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 t 62.25 170.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 t 63.5 141.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 61.09 88.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.934 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.1 157.26 36.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.909 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.75 -35.25 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.1 m 61.36 31.17 19.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.922 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 90.2 m 59.08 164.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.92 -46.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mtt . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.852 0.358 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -163.81 165.43 22.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.46 153.38 31.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -70.72 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.984 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.33 27.91 12.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.063 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 57.32 88.97 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.842 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -109.55 122.88 48.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.248 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.48 ' CG ' ' CZ ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -59.59 129.66 43.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.186 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -95.55 139.86 31.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.565 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' CD1' HG11 ' A' ' 16' ' ' VAL . 68.5 m-85 -113.82 158.81 20.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.044 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.52 158.96 42.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.934 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.2 m -51.87 130.62 29.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.36 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.01 -11.94 68.96 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.859 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -71.04 138.83 50.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.751 0.31 . . . . 0.0 110.985 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.9 mt -91.1 116.38 28.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 110.318 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.512 HG11 ' CD1' ' A' ' 10' ' ' TYR . 31.3 m -139.4 170.78 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.698 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 36.5 m-85 -110.57 138.59 46.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.746 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.696 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -114.1 120.4 40.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.939 0.399 . . . . 0.0 111.195 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 129.3 39.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.243 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 mtm -119.22 161.12 20.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.611 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 119.72 13.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.108 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.63 -4.2 85.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.017 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.56 150.6 73.34 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.833 0.316 . . . . 0.0 110.756 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.81 160.74 18.79 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.742 2.294 . . . . 0.0 112.513 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 69.9 m80 -48.98 115.45 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.612 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.469 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 4.4 t-105 -98.67 133.5 22.48 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.0 119.26 6.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.384 2.056 . . . . 0.0 110.956 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.48 174.8 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.361 0.6 . . . . 0.0 112.394 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.725 HH12 HG22 ' A' ' 94' ' ' THR . 12.9 ttp180 -142.98 156.75 44.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.477 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.409 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 31.7 mm -78.85 135.79 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.6 -21.58 4.1 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.44 165.76 16.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.012 0.434 . . . . 0.0 111.593 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.21 158.24 32.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.99 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.52 162.07 27.84 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.649 2.232 . . . . 0.0 112.468 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.15 -31.19 9.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.825 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.93 -40.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.546 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.78 -66.87 0.19 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.799 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 38' ' ' VAL . 16.1 t 64.71 13.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.892 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? 59.71 -79.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.77 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 38' ' ' VAL . 2.0 m -80.45 57.48 2.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.967 0.413 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -164.58 -21.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.724 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 39.12 -87.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.78 0.432 . . . . 0.0 111.564 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 41' ' ' THR . 2.2 m-20 -154.78 52.85 0.64 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.312 0.577 . . . . 0.0 110.259 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.18 152.33 48.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.142 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -93.42 160.56 14.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.877 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.17 109.72 22.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.577 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 57.5 t -104.03 141.51 19.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.249 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -105.12 121.32 43.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.702 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.664 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 84.1 m-85 -93.52 106.74 18.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.482 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.759 ' HE2' HD12 ' A' ' 89' ' ' ILE . 49.4 m-85 -58.12 177.21 0.13 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.2 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.7 -63.02 0.88 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.034 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.1 p -91.45 -22.47 20.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.701 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.2 m170 63.81 35.31 11.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.303 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -89.92 153.71 20.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.545 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.34 141.71 51.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.31 0.576 . . . . 0.0 111.614 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.533 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.0 170.59 21.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -111.49 126.26 54.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.077 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.696 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 86.1 mt -138.82 160.79 38.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.26 179.86 39.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.512 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HA ' HD12 ' A' ' 63' ' ' LEU . 15.4 Cg_exo -65.99 -27.86 50.1 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.599 2.199 . . . . 0.0 112.221 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -69.3 -23.31 63.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.175 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -98.69 7.3 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.541 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.501 HD22 HG21 ' A' ' 16' ' ' VAL . 10.7 mt -116.21 140.01 49.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 110.697 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 m-85 -136.55 161.56 61.25 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.695 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 6.9 Cg_exo -71.43 109.91 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.437 2.092 . . . . 0.0 111.431 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 89.0 t80 -46.76 -58.72 3.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.223 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -38.41 59.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.082 0.468 . . . . 0.0 111.427 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 4.1 mm-40 -70.85 -39.8 72.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.444 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.478 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 1.2 m -104.67 11.62 33.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 66' ' ' TYR . 9.3 tttt -56.09 -49.43 73.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.795 0.331 . . . . 0.0 111.863 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -67.5 -35.19 78.65 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 2.7 ptpt -83.62 -43.83 15.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 18.9 m-30 -96.05 -17.77 20.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -83.37 73.51 2.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.02 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 74' ' ' GLY . 2.7 mttp -147.41 151.69 40.59 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.576 0.227 . . . . 0.0 110.409 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.52 152.03 9.47 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.495 2.13 . . . . 0.0 112.465 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.41 169.28 17.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.082 0.468 . . . . 0.0 111.718 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -15.19 36.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.366 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -14.93 62.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.958 0.409 . . . . 0.0 110.608 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm 63.37 140.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.142 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.85 -15.89 58.13 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.493 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 38.8 t80 -58.52 -58.29 9.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.916 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.82 -45.73 64.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.073 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.99 -32.59 9.45 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.974 0.416 . . . . 0.0 110.379 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -72.75 -31.95 61.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.751 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.593 ' O ' HG22 ' A' ' 89' ' ' ILE . 98.3 mt -60.72 -43.5 97.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.07 0.462 . . . . 0.0 110.179 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 59.1 t90 -64.04 -45.33 89.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.066 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 1.8 mp0 -62.86 -51.61 66.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.759 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.27 -27.21 10.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.777 0.322 . . . . 0.0 111.654 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.39 -44.84 6.36 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -81.48 -31.75 32.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -155.62 87.19 3.16 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.738 0.304 . . . . 0.0 111.104 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 76.0 Cg_endo -77.57 -12.17 16.88 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.687 2.258 . . . . 0.0 112.85 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.725 HG22 HH12 ' A' ' 29' ' ' ARG . 75.6 p -105.47 12.93 30.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG12 ' HE1' ' A' ' 50' ' ' PHE . 11.9 p -62.48 148.36 10.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.882 0.373 . . . . 0.0 111.421 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -156.53 165.85 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.037 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.9 144.01 41.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.76 120.7 32.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.71 111.12 1.08 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.548 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -94.8 149.01 21.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.352 . . . . 0.0 110.815 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -168.75 -42.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.7 m 65.05 33.28 9.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.01 101.31 2.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -130.75 -54.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? 60.14 100.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -117.77 158.46 24.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.6 t 59.6 102.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.7 t -66.7 95.56 0.35 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.82 -41.34 7.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.064 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.769 0.318 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.4 p -157.01 -48.14 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -121.91 101.06 7.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.021 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -154.69 89.23 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -97.35 158.04 15.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.776 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -164.0 113.97 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -75.05 131.65 40.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.756 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -154.51 135.93 14.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.978 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -95.87 140.79 30.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.715 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.633 ' CD1' HG11 ' A' ' 16' ' ' VAL . 47.5 m-85 -117.95 162.04 18.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.74 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.639 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 13.6 mmtt -135.83 163.22 30.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.079 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 p -52.11 129.6 27.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.049 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.08 -10.49 71.77 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.911 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -72.95 141.83 47.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.769 HD23 ' HG3' ' A' ' 29' ' ' ARG . 21.2 mt -92.22 117.23 29.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 10' ' ' TYR . 30.8 m -139.43 172.35 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.632 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.461 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 10.6 m-85 -113.13 136.94 52.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.992 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.644 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -112.73 121.82 45.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.89 0.376 . . . . 0.0 111.327 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -90.85 131.37 36.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.945 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.3 mtm -132.05 145.7 51.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.788 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 118.63 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.629 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 102.11 -0.51 51.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.61 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 0.5 OUTLIER -155.89 143.08 13.73 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 58.5 Cg_endo -72.69 168.36 24.69 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.34 2.027 . . . . 0.0 112.366 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 39.1 m80 -45.66 115.9 1.06 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.043 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.423 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.6 t-105 -98.27 131.94 25.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.396 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 44.8 Cg_exo -53.64 119.0 5.51 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.244 1.963 . . . . 0.0 111.044 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.594 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.47 174.32 11.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.34 0.59 . . . . 0.0 112.389 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.769 ' HG3' HD23 ' A' ' 15' ' ' LEU . 15.2 ttp180 -142.72 156.23 44.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.434 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.0 mm -77.56 135.22 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.3 -20.01 4.55 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.02 156.36 19.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.998 0.427 . . . . 0.0 111.019 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.639 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 3.2 ptp -153.53 168.18 12.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.382 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 33' ' ' MET . 52.0 Cg_exo -53.81 112.08 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.568 2.179 . . . . 0.0 112.119 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.94 -78.64 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.104 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.21 -38.42 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.579 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.15 94.14 2.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.261 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 m -148.45 -42.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.284 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp 80.76 -48.41 0.29 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.59 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 p -47.83 -27.29 2.0 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.812 0.339 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 t -149.53 137.78 20.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.55 -62.47 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.59 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -85.06 -5.26 59.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.007 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.77 145.92 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.907 0.384 . . . . 0.0 111.304 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -94.17 158.68 15.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.946 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -98.85 109.83 22.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.594 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 59.6 t -104.18 143.02 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.279 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -107.0 123.1 47.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.945 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.644 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 81.2 m-85 -94.93 111.69 23.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.78 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.689 ' HE2' HD12 ' A' ' 89' ' ' ILE . 59.5 m-85 -60.71 178.82 0.2 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.991 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.51 -63.45 0.62 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.268 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.6 p -91.43 -23.02 20.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.962 0.41 . . . . 0.0 110.618 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.85 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 5.4 m-70 63.6 38.24 9.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.342 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -92.08 154.2 18.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.637 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.99 141.75 51.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.259 0.552 . . . . 0.0 111.576 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.41 167.12 31.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.314 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -108.03 125.23 51.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.534 HD13 ' HB1' ' A' ' 18' ' ' ALA . 14.9 mt -139.94 162.15 35.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.083 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -92.75 170.37 32.1 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.286 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.25 -19.04 50.74 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.428 2.085 . . . . 0.0 112.324 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -28.55 67.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.587 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -99.48 14.22 30.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.852 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.2 mp -111.79 137.53 49.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.539 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.4 m-85 -137.51 155.13 75.54 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.912 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.611 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 14.5 Cg_exo -68.98 112.53 2.97 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.589 2.193 . . . . 0.0 111.6 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 70' ' ' LYS . 79.3 t80 -52.04 -58.92 5.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.056 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -49.36 -41.8 40.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.957 0.408 . . . . 0.0 112.022 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.07 -39.48 72.17 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -106.13 10.69 31.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -55.89 -45.83 78.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.755 0.312 . . . . 0.0 111.47 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -70.08 -24.88 63.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.925 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -84.69 -45.97 11.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.6 m-30 -101.82 -10.44 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.48 74.01 2.42 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.359 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -151.85 155.33 33.71 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.661 0.267 . . . . 0.0 110.666 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -47.14 139.52 15.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.744 2.296 . . . . 0.0 112.812 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.435 ' HB3' ' CB ' ' A' ' 82' ' ' PHE . 9.6 t-20 -112.41 162.89 15.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.358 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -20.42 25.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.726 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? -69.34 -13.51 62.42 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.979 0.418 . . . . 0.0 110.711 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 65.25 147.49 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.021 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.59 -19.59 35.87 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.68 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.629 ' HE1' HD11 ' A' ' 86' ' ' LEU . 11.9 t80 -57.88 -52.47 65.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.014 0.435 . . . . 0.0 110.545 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.51 -47.44 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.261 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -48.33 -32.45 7.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.036 0.446 . . . . 0.0 110.423 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.8 -31.81 57.81 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.436 -0.887 . . . . 0.0 111.928 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.629 HD11 ' HE1' ' A' ' 82' ' ' PHE . 82.8 mt -60.53 -43.69 96.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 0.0 110.285 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -64.06 -43.11 96.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.955 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.469 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 35.3 mm-40 -63.69 -51.88 63.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.689 HD12 ' HE2' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -51.88 -26.3 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HG2' HG23 ' A' ' 89' ' ' ILE . 8.2 mm-40 -101.48 -44.6 5.56 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.6 -32.81 41.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.47 89.05 2.74 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.76 0.314 . . . . 0.0 111.103 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 78.0 Cg_endo -77.76 -12.53 16.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.635 2.224 . . . . 0.0 112.705 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -102.26 11.57 37.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.733 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.555 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.2 p -63.11 146.35 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.853 0.359 . . . . 0.0 111.29 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.87 164.98 18.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.125 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.85 ' HB2' ' HB3' ' A' ' 53' ' ' HIS . . . -106.24 84.46 2.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.159 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.2 t -122.39 116.79 24.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.82 42.72 0.78 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.57 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 100' ' ' TYR . 17.7 p90 -99.25 83.46 2.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.911 0.386 . . . . 0.0 110.831 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.22 -33.47 7.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.002 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 t -102.3 139.03 38.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 m -160.41 123.71 3.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 60.95 99.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -62.67 -31.03 71.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 171.94 8.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.9 t 60.6 82.99 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.48 -57.79 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.83 -44.37 1.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.056 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtp . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.864 0.364 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -124.74 -45.02 1.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -141.92 86.69 2.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.56 98.17 7.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -170.77 -43.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -119.74 101.04 7.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.967 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -98.97 -176.67 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 9' ' ' GLU . 10.0 pttt -162.87 -151.67 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.885 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 81.92 140.44 0.07 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.733 ' CD2' HG11 ' A' ' 16' ' ' VAL . 3.7 m-85 -124.74 165.59 17.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.806 0.336 . . . . 0.0 111.497 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 3.7 mmtt -139.06 165.87 25.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 t -52.92 126.97 22.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.495 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.47 -13.61 62.7 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.309 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -72.01 142.46 49.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.971 0.386 . . . . 0.0 111.147 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.627 HD23 ' HG3' ' A' ' 29' ' ' ARG . 59.3 mt -91.39 118.03 30.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.382 . . . . 0.0 110.327 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.733 HG11 ' CD2' ' A' ' 10' ' ' TYR . 29.0 m -139.94 173.93 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.791 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.417 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.8 m-85 -113.38 137.67 51.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.716 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.626 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.59 122.49 47.37 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.892 0.377 . . . . 0.0 111.425 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HD3' ' CG ' ' A' ' 25' ' ' HIS . 21.1 tptp -91.18 131.46 36.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.927 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mmm -124.7 155.21 39.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.774 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.85 111.45 7.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.74 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 102.6 -1.21 49.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.845 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.1 m-85 -146.02 150.25 41.55 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.308 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.49 166.92 23.5 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.672 2.248 . . . . 0.0 112.517 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.428 ' CG ' ' HD3' ' A' ' 19' ' ' LYS . 79.7 m80 -47.48 115.67 1.2 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.056 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.8 t-105 -98.25 130.9 27.33 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.05 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 11.0 Cg_endo -54.0 119.01 5.59 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.302 2.001 . . . . 0.0 111.054 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.607 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.19 175.8 9.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.32 0.581 . . . . 0.0 112.305 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.759 HH12 HG22 ' A' ' 94' ' ' THR . 21.2 ttp180 -143.13 156.96 44.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.379 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.411 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 13.4 mm -81.69 136.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -123.93 -16.76 6.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' C ' ' HG2' ' A' ' 33' ' ' MET . 4.1 mt-10 -163.53 160.32 23.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.118 0.485 . . . . 0.0 111.669 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.422 ' HG2' ' C ' ' A' ' 32' ' ' GLU . 0.4 OUTLIER -145.71 128.38 8.08 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.273 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.17 156.97 9.31 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.462 2.108 . . . . 0.0 112.313 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -67.11 -70.61 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.02 -42.01 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.332 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.29 75.25 0.19 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.413 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 m -150.87 157.45 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.182 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 pttt 43.21 -167.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.604 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.0 t -94.25 110.05 21.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.978 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.44 -18.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.858 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 40.87 37.84 0.57 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.761 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.469 ' C ' ' HG2' ' A' ' 44' ' ' LYS . 70.6 m-20 57.61 55.95 5.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.941 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.469 ' HG2' ' C ' ' A' ' 43' ' ' ASN . 5.5 mtmt -138.41 145.52 41.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.395 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 0.7 OUTLIER -99.52 165.52 11.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.692 179.569 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -100.95 113.63 26.79 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.607 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 93.5 t -103.45 142.48 17.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.866 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.495 ' HE2' HG13 ' A' ' 95' ' ' VAL . 41.1 t80 -104.87 121.29 43.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.962 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.626 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 93.9 m-85 -94.43 108.71 20.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.643 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.7 ' CE2' HD12 ' A' ' 89' ' ' ILE . 50.0 m-85 -59.33 178.1 0.15 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.926 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 69.97 -63.62 0.71 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.097 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.8 p -91.29 -23.13 20.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.881 0.372 . . . . 0.0 110.502 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 m170 63.89 37.46 9.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.452 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -90.99 154.28 19.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.6 141.61 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.259 0.552 . . . . 0.0 111.509 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.29 167.36 30.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.361 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -107.17 124.83 50.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 mp -140.23 162.01 36.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.028 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.01 163.06 25.39 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.166 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.24 -17.98 49.48 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.448 2.099 . . . . 0.0 112.442 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -28.49 66.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.864 0.364 . . . . 0.0 110.656 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.54 12.23 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.88 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 6.5 mp -107.42 138.58 43.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.39 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.6 m-85 -137.38 147.96 59.98 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.109 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 68' ' ' GLU . 20.8 Cg_endo -61.82 109.15 0.73 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.666 2.244 . . . . 0.0 111.568 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' A' ' 70' ' ' LYS . 86.2 t80 -50.74 -58.26 6.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.878 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.4 mp0 -50.85 -39.62 54.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.164 0.507 . . . . 0.0 111.376 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 65' ' ' PRO . 33.8 mt-10 -70.68 -40.02 73.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.507 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.78 11.36 30.25 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.6 ptpp? -56.4 -45.72 80.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.827 0.346 . . . . 0.0 111.382 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 18.8 mt-10 -70.51 -26.54 63.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.859 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -83.86 -46.4 12.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 2.6 m-30 -100.18 -11.2 20.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.19 74.4 2.49 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.296 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -152.15 154.55 32.53 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.616 0.246 . . . . 0.0 110.63 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -44.98 136.21 10.16 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.707 2.271 . . . . 0.0 112.596 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.45 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -109.77 175.03 5.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.817 -178.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -100.7 -22.52 14.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.621 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -13.22 61.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.684 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt 63.99 144.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.968 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.85 -18.01 49.75 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.714 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 12.0 t80 -59.53 -50.44 73.9 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.895 0.379 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -52.58 -47.48 66.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.233 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -48.3 -30.89 5.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.01 0.434 . . . . 0.0 110.45 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.44 -31.19 59.28 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.052 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.647 ' O ' HG22 ' A' ' 89' ' ' ILE . 32.4 mt -60.64 -43.94 96.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 110.277 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.0 t90 -64.43 -45.24 88.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -62.61 -51.04 68.86 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -51.8 -26.99 7.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.784 0.325 . . . . 0.0 111.826 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -99.7 -44.8 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.22 -32.33 38.5 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -156.71 89.36 2.66 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.738 0.304 . . . . 0.0 111.079 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 93.2 Cg_endo -79.08 -11.44 14.88 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.677 2.251 . . . . 0.0 112.983 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.759 HG22 HH12 ' A' ' 29' ' ' ARG . 37.6 p -103.95 13.27 33.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.614 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.584 HG12 ' HE1' ' A' ' 50' ' ' PHE . 11.9 p -62.58 146.88 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.894 0.378 . . . . 0.0 111.4 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -111.52 163.49 14.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.107 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.43 -177.79 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.8 m -89.03 176.57 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.26 57.59 0.53 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.52 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -149.51 90.9 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -127.73 -56.55 1.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.65 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.001 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.7 p -111.86 117.09 31.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -78.71 141.56 37.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -149.73 157.06 42.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.01 31.74 4.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.81 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.6 104.14 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.964 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 86.9 m -145.02 -178.9 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.14 37.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.825 0.345 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.77 -76.04 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.51 170.19 8.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.982 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.7 p -105.47 -173.92 2.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -152.07 99.47 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.88 30.07 19.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -129.44 149.8 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.65 145.64 46.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.98 141.21 28.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.623 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.606 ' CD1' HG11 ' A' ' 16' ' ' VAL . 27.1 m-85 -116.82 159.45 22.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.768 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -136.18 160.46 38.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 0.0 110.991 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.3 m -51.36 123.98 10.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.181 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.79 -13.87 56.24 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.238 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.44 140.46 50.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 111.211 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.8 mt -92.62 116.71 29.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.408 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.606 HG11 ' CD1' ' A' ' 10' ' ' TYR . 30.8 m -139.36 172.4 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.744 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.492 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 12.3 m-85 -111.71 136.18 51.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.801 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.658 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -112.94 123.63 50.77 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.889 0.376 . . . . 0.0 111.648 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -92.21 128.75 38.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.858 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.58 146.75 51.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.846 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -65.1 116.31 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.719 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 101.35 -0.91 53.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.726 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m-85 -148.78 151.28 34.98 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.683 0.278 . . . . 0.0 110.672 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.26 168.38 16.81 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.621 2.214 . . . . 0.0 112.193 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 74.3 m80 -47.27 113.52 0.7 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.654 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.2 t-105 -99.22 128.99 30.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.353 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.99 119.81 6.91 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.268 1.979 . . . . 0.0 111.126 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . -143.76 176.45 9.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.649 HH12 HG22 ' A' ' 94' ' ' THR . 3.2 ttt180 -144.69 157.59 44.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.456 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.505 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 27.8 mm -81.44 137.04 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.4 -18.91 4.77 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -165.74 156.29 13.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.349 . . . . 0.0 111.164 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.522 ' HE1' ' O ' ' A' ' 10' ' ' TYR . 5.8 ptp -156.64 163.15 25.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.348 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.679 ' HG3' HG21 ' A' ' 41' ' ' THR . 13.8 Cg_exo -68.95 124.69 11.68 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.836 2.357 . . . . 0.0 112.132 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.1 -28.96 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.13 -37.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.103 0.478 . . . . 0.0 109.916 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.61 99.2 3.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.69 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.64 HG11 ' HA ' ' A' ' 34' ' ' PRO . 16.1 m -151.34 16.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.841 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? 50.71 77.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.878 0.371 . . . . 0.0 111.501 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.2 t 61.95 -80.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.47 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.679 HG21 ' HG3' ' A' ' 34' ' ' PRO . 2.4 m 69.06 104.76 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.877 0.37 . . . . 0.0 110.939 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.535 ' HB3' ' HD2' ' A' ' 44' ' ' LYS . . . -74.06 59.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.373 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.488 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 2.9 p-10 49.14 51.73 15.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.302 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.535 ' HD2' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -130.66 139.29 50.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.108 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 40.9 m-85 -95.67 155.9 16.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.768 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.88 105.68 17.44 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.578 HG11 HD21 ' A' ' 63' ' ' LEU . 12.8 m -100.61 148.04 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.315 0.579 . . . . 0.0 112.03 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 4.9 t80 -105.39 124.5 49.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.482 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.423 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 76.1 m-85 -94.05 108.06 19.92 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.112 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.752 ' HE2' HD12 ' A' ' 89' ' ' ILE . 60.6 m-85 -58.24 178.79 0.09 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.204 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.56 -62.07 0.87 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.378 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 46.4 p -91.28 -21.23 21.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.571 0.224 . . . . 0.0 110.934 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 52' ' ' THR . 26.3 m170 64.92 33.39 9.96 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.91 0.386 . . . . 0.0 110.432 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -94.93 158.49 15.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.46 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -132.85 149.26 52.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.31 0.576 . . . . 0.0 111.74 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.55 171.5 19.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.44 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.437 ' C ' HD12 ' A' ' 58' ' ' LEU . 17.4 m-85 -107.78 124.52 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.923 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.658 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.9 mp -138.04 160.19 40.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.43 175.59 39.34 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.187 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.36 -24.92 49.54 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.405 2.07 . . . . 0.0 112.161 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -69.34 -25.74 64.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.086 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 30.0 m-20 -97.97 7.7 45.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.31 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.578 HD21 HG11 ' A' ' 47' ' ' VAL . 71.8 mt -115.15 139.4 49.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.748 0.308 . . . . 0.0 110.37 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.7 m-85 -137.58 159.61 68.43 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 13.2 Cg_exo -69.48 111.88 2.88 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.685 2.256 . . . . 0.0 111.717 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 70' ' ' LYS . 78.1 t80 -51.97 -58.38 6.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.79 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.96 -41.73 47.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.08 0.467 . . . . 0.0 111.639 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.61 -39.72 73.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.477 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.23 12.19 30.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.6 ptpt -55.73 -46.38 77.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 0.0 111.49 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -70.1 -25.69 63.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.931 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -47.33 10.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.8 m-30 -101.02 -8.01 22.75 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.1 73.05 2.71 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.219 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.3 mtmt -149.09 158.19 39.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.592 0.234 . . . . 0.0 110.398 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.41 155.44 25.41 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.601 2.201 . . . . 0.0 112.555 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -136.36 168.74 18.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.545 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -89.42 -16.37 31.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.221 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -66.72 -14.51 62.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.004 0.431 . . . . 0.0 110.67 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt 63.6 143.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.124 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.67 -18.39 39.03 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.58 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 20.0 t80 -58.91 -56.08 26.86 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.976 0.417 . . . . 0.0 110.697 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.64 -45.33 66.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.82 -30.99 6.39 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.992 0.425 . . . . 0.0 110.52 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.88 -31.36 60.2 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.994 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.687 ' O ' HG22 ' A' ' 89' ' ' ILE . 61.5 mt -60.9 -43.65 98.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.973 0.416 . . . . 0.0 110.471 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -64.26 -44.21 92.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.177 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.47 -50.91 69.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.752 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.09 -26.19 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -100.92 -44.89 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.62 -33.34 41.54 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.9 87.1 3.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.848 0.356 . . . . 0.0 111.1 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -76.18 -12.01 19.31 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.638 2.225 . . . . 0.0 112.646 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.649 HG22 HH12 ' A' ' 29' ' ' ARG . 24.3 p -104.32 11.97 34.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.546 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.622 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.8 p -62.18 148.35 10.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.351 . . . . 0.0 111.466 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.48 166.42 33.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.974 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.66 108.3 16.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.4 m -146.58 -51.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.942 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.01 -176.76 36.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.446 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -132.29 -47.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -134.76 105.8 6.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 m -119.13 156.97 28.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.989 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.4 p -157.57 164.77 36.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 60.86 99.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -137.15 138.3 40.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.807 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -36.37 3.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.3 m -84.23 149.77 25.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.035 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.59 -57.34 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.36 30.74 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.1 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -168.17 -74.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.73 106.73 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.81 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.69 173.99 7.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t30 60.74 19.72 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.184 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.15 156.46 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.838 0.351 . . . . 0.0 110.839 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -130.31 -58.24 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.682 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 9' ' ' GLU . 4.7 tttp 59.84 -153.18 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 8' ' ' LYS . 5.1 mt-10 83.8 136.83 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.551 ' CD2' HG11 ' A' ' 16' ' ' VAL . 9.0 m-85 -124.41 164.69 19.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.93 0.395 . . . . 0.0 111.529 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.97 164.49 28.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 m -52.83 127.56 23.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.09 -14.15 57.18 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.163 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.01 141.0 47.69 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.798 0.333 . . . . 0.0 111.277 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.802 HD23 ' HG3' ' A' ' 29' ' ' ARG . 84.1 mt -93.17 122.6 35.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.343 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.551 HG11 ' CD2' ' A' ' 10' ' ' TYR . 33.9 m -142.43 173.62 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.183 0.516 . . . . 0.0 111.93 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 9.4 m-85 -112.22 134.54 53.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.671 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.899 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -114.13 123.65 50.15 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.036 0.446 . . . . 0.0 111.659 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -91.72 127.39 37.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.787 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 ttm -127.02 152.29 47.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.582 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -67.14 126.93 30.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.92 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 91.54 -3.72 79.03 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.954 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 1.6 m-85 -148.72 149.7 31.41 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-N 116.808 0.304 . . . . 0.0 110.729 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.79 172.2 15.42 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.5 2.133 . . . . 0.0 112.508 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -49.15 114.52 1.03 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.772 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.446 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.86 132.46 23.7 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.293 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.488 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 32.5 Cg_exo -54.48 120.52 8.18 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.069 1.846 . . . . 0.0 110.953 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.16 175.04 10.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.394 0.616 . . . . 0.0 112.412 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.802 ' HG3' HD23 ' A' ' 15' ' ' LEU . 9.5 ttp180 -142.74 155.27 44.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.551 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.402 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 30.8 mm -78.66 135.0 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.78 -20.1 4.34 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.2 159.76 17.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.034 0.445 . . . . 0.0 111.266 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.28 162.28 26.91 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.984 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.6 107.45 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.569 2.18 . . . . 0.0 112.153 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.79 -77.77 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.177 0.513 . . . . 0.0 111.21 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.9 -38.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.325 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.72 93.08 2.42 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.061 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 38' ' ' VAL . 11.1 t -142.41 7.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.528 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp 66.04 -73.35 0.07 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.677 0.275 . . . . 0.0 111.367 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.681 ' O ' HG23 ' A' ' 41' ' ' THR . 0.7 OUTLIER -68.63 102.34 1.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.785 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 40' ' ' SER . 0.9 OUTLIER -166.54 143.28 4.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.288 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB3' ' HD2' ' A' ' 44' ' ' LYS . . . -171.36 41.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.595 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.92 40.95 2.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.559 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -138.98 144.79 39.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.015 -179.334 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 88.3 m-85 -94.26 154.01 17.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.837 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.433 ' HG3' ' CE1' ' A' ' 57' ' ' PHE . 5.1 tt0 -100.39 106.09 17.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.3 m -101.95 150.91 5.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.499 0.666 . . . . 0.0 112.126 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 17.9 t80 -105.33 125.31 50.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.289 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -91.37 106.97 18.89 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.422 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.795 ' HE2' HD12 ' A' ' 89' ' ' ILE . 41.0 m-85 -59.43 175.17 0.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.692 0.282 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.39 -61.66 0.84 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.31 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 71.7 p -90.33 -22.48 21.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.7 0.286 . . . . 0.0 110.986 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 44.3 m170 64.84 34.32 9.38 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.351 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -91.4 154.74 18.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.755 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.07 143.67 49.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.251 0.548 . . . . 0.0 111.617 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.35 172.18 18.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.511 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 46' ' ' GLN . 15.3 m-85 -116.66 126.16 52.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.482 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.899 HD13 ' HB1' ' A' ' 18' ' ' ALA . 3.0 mt -140.02 163.24 33.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.174 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.659 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -94.27 171.55 31.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.321 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.415 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 38.3 Cg_endo -66.52 -19.48 54.68 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.474 2.116 . . . . 0.0 112.517 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -68.62 -29.48 68.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.936 0.398 . . . . 0.0 110.569 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.59 10.91 40.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.891 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.4 mp -108.36 137.3 46.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.519 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.6 m-85 -137.03 157.03 75.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.461 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 6.7 Cg_exo -72.32 111.6 3.24 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.429 2.086 . . . . 0.0 111.327 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.2 t80 -48.46 -57.47 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.875 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.26 -40.52 48.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 111.348 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 17.3 mt-10 -71.24 -39.95 71.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.535 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.482 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -104.35 9.38 35.85 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.372 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -57.52 -46.43 83.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.758 0.314 . . . . 0.0 111.792 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.75 -35.56 78.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 13.4 ptpt -82.81 -41.52 18.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CZ ' ' HD2' ' A' ' 72' ' ' LYS . 15.8 m-30 -97.92 -13.11 21.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -84.53 75.35 2.37 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.266 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -152.13 153.96 31.82 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.585 0.231 . . . . 0.0 110.586 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -45.31 136.14 11.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.717 2.278 . . . . 0.0 112.727 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.473 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 31.5 t30 -108.79 174.45 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.676 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 -22.4 15.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.851 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -12.94 61.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.8 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp 64.66 145.15 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.952 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.1 -18.25 46.05 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.753 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.488 ' CE2' ' HD3' ' A' ' 27' ' ' PRO . 11.3 t80 -58.88 -51.87 68.18 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 121.005 0.431 . . . . 0.0 110.559 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -46.66 66.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.409 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -48.11 -31.25 5.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.85 -31.22 60.44 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.063 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.633 ' O ' HG22 ' A' ' 89' ' ' ILE . 56.3 mt -61.02 -43.8 98.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.971 0.415 . . . . 0.0 110.315 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -64.13 -45.15 89.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.097 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.417 ' OE1' HG11 ' A' ' 95' ' ' VAL . 60.9 mt-10 -63.09 -50.99 68.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.795 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -51.73 -27.4 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.758 0.313 . . . . 0.0 111.754 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' HG3' HG23 ' A' ' 89' ' ' ILE . 59.5 mt-10 -99.52 -44.73 6.06 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -80.98 -31.7 34.66 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.64 87.73 3.1 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.819 0.342 . . . . 0.0 111.132 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 75.4 Cg_endo -77.71 -12.93 16.44 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.58 2.187 . . . . 0.0 112.791 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.8 p -104.45 12.78 32.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.634 0.254 . . . . 0.0 111.577 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.579 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.4 p -61.65 146.98 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.845 0.355 . . . . 0.0 111.432 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -143.18 178.76 7.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.032 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.24 -172.42 3.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.097 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.1 p -152.82 165.79 34.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 154.78 118.31 0.64 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -128.48 37.7 4.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 110.877 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 61.24 98.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.3 m 63.17 -79.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.8 78.39 0.29 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.905 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -172.16 112.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.7 mttm 61.63 102.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.91 123.15 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.24 123.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.972 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.8 m -74.47 158.75 33.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.09 166.34 13.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.081 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.986 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.974 0.416 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 t -100.1 -33.15 10.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.58 93.1 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.3 155.03 44.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.818 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.6 t30 67.62 -69.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.077 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.3 120.62 24.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -139.12 -165.6 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.731 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 9' ' ' GLU . 8.2 ttmm -93.38 4.23 54.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.628 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 1.7 mm-40 82.57 -130.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.469 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 9' ' ' GLU . 0.6 OUTLIER 161.8 97.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -133.48 160.32 37.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.432 . . . . 0.0 111.265 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 t -52.3 135.82 31.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.372 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.85 -11.27 69.89 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.003 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.33 142.93 47.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 0.0 111.103 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.428 HD23 ' HG3' ' A' ' 29' ' ' ARG . 77.2 mt -90.77 118.53 30.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.205 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.28 167.44 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.834 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 8.2 m-85 -109.86 132.62 53.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.65 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.581 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.83 124.06 51.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 111.523 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.71 133.21 35.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.96 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.83 147.15 51.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.62 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 112.69 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.89 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 109.56 -5.79 31.41 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.911 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 1.4 m-85 -147.96 161.57 34.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.784 0.326 . . . . 0.0 110.886 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 95.1 Cg_endo -83.94 168.98 11.98 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.895 2.397 . . . . 0.0 112.503 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 73' ' ' PHE . 67.9 m80 -47.53 116.68 1.52 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.544 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.471 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.04 130.76 27.9 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.59 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.43 120.5 8.13 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.084 1.856 . . . . 0.0 111.044 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.644 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -144.74 175.06 10.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.352 0.596 . . . . 0.0 112.533 -178.28 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 2.0 ttt180 -142.89 156.07 44.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.527 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 21.1 mm -77.67 135.05 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.32 -21.66 4.18 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.09 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.28 157.2 15.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 111.272 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.09 157.83 32.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.28 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.529 ' CB ' HG21 ' A' ' 38' ' ' VAL . 96.1 Cg_endo -80.59 97.78 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.866 2.377 . . . . 0.0 112.232 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -153.15 13.77 0.51 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.031 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -171.1 -37.38 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.872 -179.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.06 106.45 3.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.333 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -154.07 -42.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.423 -179.967 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.05 -71.49 0.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.803 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -160.42 0.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.329 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.678 HG23 ' HD2' ' A' ' 44' ' ' LYS . 9.7 m 65.97 120.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.812 0.339 . . . . 0.0 110.815 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.11 -61.04 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.135 0.493 . . . . 0.0 110.056 179.285 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -155.68 47.07 0.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.151 179.072 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.678 ' HD2' HG23 ' A' ' 41' ' ' THR . 1.3 mttp -105.58 133.3 50.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.191 -178.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 34.0 m-85 -93.32 156.55 16.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.005 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.74 97.09 8.7 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.027 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.644 ' CG2' ' HB1' ' A' ' 28' ' ' ALA . 2.7 p -100.05 148.58 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.485 -177.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.526 ' HE2' HG13 ' A' ' 95' ' ' VAL . 33.0 t80 -106.33 125.6 51.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.293 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.597 ' HE2' ' HB3' ' A' ' 56' ' ' ALA . 79.2 m-85 -93.39 110.65 22.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.743 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.754 ' CE2' HD12 ' A' ' 89' ' ' ILE . 50.3 m-85 -60.96 175.91 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.065 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.55 -62.94 0.85 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.132 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -90.63 -22.95 20.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 110.581 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 38.0 m80 63.93 37.05 9.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.013 0.435 . . . . 0.0 110.194 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -91.21 153.97 19.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.72 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.8 139.16 53.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.162 0.506 . . . . 0.0 111.137 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.597 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.35 169.6 23.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.634 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 9.9 m-85 -112.07 126.41 55.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.773 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mp -139.21 162.53 34.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.064 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.9 176.11 39.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.362 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.74 -24.56 40.77 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.442 2.095 . . . . 0.0 112.219 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -70.03 -25.1 63.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.795 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -99.96 4.73 45.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.364 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 mt -116.09 139.47 50.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.648 0.261 . . . . 0.0 110.483 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.481 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 m-85 -137.84 165.69 31.91 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.884 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 2.7 Cg_exo -75.35 115.73 4.32 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.69 2.26 . . . . 0.0 111.733 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -53.03 -57.83 9.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.825 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -48.85 -42.98 38.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.98 0.419 . . . . 0.0 111.797 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.82 -39.72 72.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.441 -179.486 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.456 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 2.5 m -105.94 13.57 29.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 66' ' ' TYR . 6.0 ptmm? -58.06 -45.93 86.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.884 0.373 . . . . 0.0 111.452 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -67.66 -37.28 82.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 6.1 ptmt -83.39 -43.31 16.04 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.516 ' CZ ' ' CE1' ' A' ' 25' ' ' HIS . 20.5 m-30 -95.27 -13.22 25.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -89.42 74.65 1.94 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.843 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 7.7 mmtp -146.82 148.74 34.01 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.612 0.244 . . . . 0.0 110.41 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.03 155.37 2.77 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.51 2.14 . . . . 0.0 112.538 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.425 ' ND2' ' HG3' ' A' ' 24' ' ' PRO . 8.8 t-20 -137.15 166.95 22.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.591 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -15.52 35.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.268 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.404 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -66.71 -13.75 61.71 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.038 0.446 . . . . 0.0 110.597 179.304 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm 64.18 142.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.337 -179.551 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.21 -16.84 56.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.585 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 38.6 t80 -59.08 -56.68 19.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.922 0.391 . . . . 0.0 110.74 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.4 -46.18 69.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.189 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -48.93 -30.69 6.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.913 0.387 . . . . 0.0 110.5 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.28 -31.4 59.35 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.818 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.642 ' O ' HG22 ' A' ' 89' ' ' ILE . 84.2 mt -60.78 -43.72 97.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.233 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.8 t90 -63.68 -45.29 90.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.542 ' HG2' HG11 ' A' ' 95' ' ' VAL . 1.5 mp0 -62.94 -51.36 67.19 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.148 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.754 HD12 ' CE2' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -52.25 -26.3 8.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.748 0.308 . . . . 0.0 111.818 -179.824 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.04 -44.68 5.92 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -82.64 -31.68 28.66 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -156.77 88.79 2.68 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.728 0.299 . . . . 0.0 111.092 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.6 Cg_endo -76.4 -10.37 18.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.764 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.49 11.6 38.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.496 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.562 HG12 ' HE1' ' A' ' 50' ' ' PHE . 10.6 p -62.51 142.11 17.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.78 0.324 . . . . 0.0 111.218 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.29 144.4 17.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.017 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -94.37 111.04 22.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.123 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 m 61.35 -179.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.86 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.7 -23.75 5.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.635 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -149.04 162.73 39.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.793 0.33 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 60.61 105.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.5 m -157.01 116.34 3.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.989 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.13 85.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.954 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -99.4 -46.44 5.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -157.23 35.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.91 87.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.23 171.93 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.4 t -122.17 -43.6 2.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -98.4 165.39 11.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.078 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptm . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.766 0.317 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 t -145.13 136.92 25.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -139.92 -70.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.36 -174.7 3.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.31 -73.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.75 143.43 38.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.772 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -138.23 82.01 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.014 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -113.57 118.99 35.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.767 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -96.57 141.57 29.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.779 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.513 ' CE1' HG11 ' A' ' 16' ' ' VAL . 91.5 m-85 -113.55 159.72 19.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.654 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.72 154.71 47.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 111.025 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.418 ' HA ' HG22 ' A' ' 30' ' ' ILE . 59.5 m -51.92 134.63 31.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.346 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.37 -10.32 74.45 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.952 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.38 142.5 48.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.359 . . . . 0.0 111.171 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.488 HD23 ' HG3' ' A' ' 29' ' ' ARG . 64.1 mt -93.21 118.35 31.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.934 0.397 . . . . 0.0 110.532 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.513 HG11 ' CE1' ' A' ' 10' ' ' TYR . 22.6 m -142.84 171.71 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.683 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.546 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 33.2 m-85 -110.21 135.22 51.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.452 178.48 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.682 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -112.03 126.64 55.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 111.583 -179.46 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.3 129.11 37.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.927 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 ttm -134.06 144.33 48.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.71 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -65.03 122.96 18.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.651 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.73 -8.93 56.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.769 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.66 146.13 21.55 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.604 0.24 . . . . 0.0 110.526 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 71.9 Cg_endo -75.39 175.17 11.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.414 2.076 . . . . 0.0 112.512 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -48.21 111.88 0.5 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.527 179.01 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.7 t-105 -98.43 130.68 27.61 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.448 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.91 120.1 7.36 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.272 1.982 . . . . 0.0 110.909 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.39 174.36 10.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.359 0.6 . . . . 0.0 112.546 -178.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HG3' HD23 ' A' ' 15' ' ' LEU . 18.2 ttp180 -143.14 155.65 44.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.487 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.474 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 32.6 mm -78.82 136.52 23.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -126.46 -20.8 4.3 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.02 157.84 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.38 . . . . 0.0 111.18 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.49 ' HE1' ' O ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -155.94 154.27 27.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 179.834 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -88.87 175.66 3.53 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.087 2.525 . . . . 0.0 112.17 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.34 -48.08 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.112 0.482 . . . . 0.0 111.061 179.594 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.07 -41.06 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.883 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.63 90.41 1.01 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.19 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG23 ' HG2' ' A' ' 39' ' ' LYS . 3.0 m -148.6 -39.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.672 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HG2' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -163.91 140.43 6.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.95 179.781 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -62.26 111.24 1.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.805 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.478 HG22 ' CE2' ' A' ' 57' ' ' PHE . 2.3 p -136.33 9.52 3.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.749 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 37.61 42.02 0.34 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.935 0.398 . . . . 0.0 111.688 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' C ' ' HG2' ' A' ' 44' ' ' LYS . 3.3 t-20 64.47 47.44 2.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.991 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HG2' ' C ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -140.01 158.42 44.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.245 -179.362 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -97.58 159.0 15.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.944 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -97.65 109.5 22.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.577 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 50.2 t -102.78 141.71 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.395 0.617 . . . . 0.0 112.421 -178.342 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 96' ' ' LYS . 47.9 t80 -105.25 121.25 43.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.693 179.044 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.682 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 76.8 m-85 -93.86 110.89 22.53 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.585 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 89' ' ' ILE . 49.9 m-85 -60.69 178.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.06 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.428 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 70.26 -63.53 0.78 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.857 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.3 p -91.38 -22.36 20.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.732 0.301 . . . . 0.0 110.528 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.7 m170 62.87 36.65 12.73 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.016 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.44 154.75 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.33 140.71 52.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.321 0.581 . . . . 0.0 111.6 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.528 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.99 167.59 29.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.038 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.478 ' CE2' HG22 ' A' ' 41' ' ' THR . 14.0 m-85 -111.92 126.91 55.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 29.3 mt -141.25 164.34 30.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.062 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.96 171.16 33.99 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.076 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.61 -19.06 48.56 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.407 2.071 . . . . 0.0 112.223 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -67.77 -28.44 67.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -100.22 16.5 24.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.657 179.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mp -114.23 137.24 52.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.4 m-85 -136.74 155.87 76.4 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.715 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.526 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 10.1 Cg_exo -69.71 112.7 3.14 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.219 1.946 . . . . 0.0 111.178 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.552 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.5 t80 -47.65 -58.78 3.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.323 -178.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -50.61 -39.7 50.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.967 0.413 . . . . 0.0 111.772 -179.158 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.5 mt-10 -71.05 -39.87 72.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.605 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -102.66 8.09 39.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.24 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.552 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -55.61 -50.75 69.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.825 0.345 . . . . 0.0 111.384 179.885 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -70.95 -19.71 62.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.441 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HD3' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -85.01 -52.23 6.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.177 0.513 . . . . 0.0 111.939 -179.214 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CD1' ' HD3' ' A' ' 72' ' ' LYS . 6.7 m-85 -100.72 -10.24 21.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.448 -0.797 . . . . 0.0 112.712 -178.394 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.02 72.31 2.29 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.297 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -150.64 152.15 31.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.681 0.24 . . . . 0.0 110.478 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.62 138.97 14.02 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.661 2.241 . . . . 0.0 112.72 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.457 ' HB3' ' CB ' ' A' ' 82' ' ' PHE . 9.4 t-20 -110.0 164.19 12.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.544 -179.338 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -20.73 23.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.685 179.418 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -69.35 -12.37 61.6 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt 65.33 146.52 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.386 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.13 -18.81 42.5 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.855 -178.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.6 t80 -58.24 -54.94 41.26 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.017 0.437 . . . . 0.0 110.834 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.27 -47.05 66.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.294 -179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -48.3 -31.37 5.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.045 0.45 . . . . 0.0 110.494 179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.32 -31.69 58.92 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.031 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.615 ' O ' HG22 ' A' ' 89' ' ' ILE . 41.9 mt -60.98 -43.54 98.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.986 0.422 . . . . 0.0 110.192 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -63.31 -45.46 91.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.053 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.445 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -62.73 -51.61 66.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.039 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.8 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.32 -26.5 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.791 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.66 -44.86 5.97 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -80.47 -33.06 36.94 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -155.9 88.22 2.97 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 111.136 -179.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.1 Cg_endo -76.23 -12.12 19.2 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.695 2.263 . . . . 0.0 112.838 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 p -104.05 12.71 33.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.406 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.635 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.4 p -60.71 145.7 12.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.778 0.323 . . . . 0.0 111.348 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 13.0 mmtp 62.78 99.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.916 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 61.83 151.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.939 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.9 t -168.5 178.39 4.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.97 0.414 . . . . 0.0 111.082 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.75 36.26 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.56 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -117.07 129.81 56.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.328 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -157.82 115.47 3.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.7 p -123.47 177.06 5.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.823 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.7 t 60.51 159.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -56.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.95 -178.11 3.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.795 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.95 -54.9 5.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.83 176.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 33.7 m -122.25 -52.07 1.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.77 -56.21 17.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.961 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.842 0.353 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 m -147.89 87.08 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.88 94.74 4.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 61.67 95.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.038 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -102.86 119.64 39.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.36 144.02 44.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.995 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -73.98 -13.5 60.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.214 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.0 tptt 63.99 121.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.397 . . . . 0.0 111.075 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -96.49 144.57 26.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.757 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.563 ' CD2' HG11 ' A' ' 16' ' ' VAL . 59.6 m-85 -115.2 159.51 20.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.75 157.53 45.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 111.005 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.6 t -51.95 130.86 30.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.388 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.85 -13.45 65.12 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.967 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.51 140.87 51.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.762 0.315 . . . . 0.0 111.022 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.832 HD23 ' HG3' ' A' ' 29' ' ' ARG . 60.4 mt -92.51 118.94 31.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 0.0 110.427 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.563 HG11 ' CD2' ' A' ' 10' ' ' TYR . 29.9 m -141.08 173.5 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.803 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.541 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 16.1 m-85 -111.35 138.88 47.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.509 178.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -117.29 126.42 52.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.171 0.51 . . . . 0.0 112.133 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . 10.7 tptm -91.18 129.56 37.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.01 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.42 140.15 48.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.743 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 123.32 17.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.79 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.65 -7.88 46.44 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.685 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.09 160.99 30.41 Favored Pre-proline 0 C--N 1.333 -0.142 0 CA-C-O 120.728 0.299 . . . . 0.0 110.626 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.67 171.16 13.58 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.635 2.224 . . . . 0.0 112.367 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 67.8 m80 -50.02 118.52 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.392 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.457 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.9 t-105 -99.49 133.05 22.2 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 11.7 Cg_endo -54.45 120.79 8.61 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.393 2.062 . . . . 0.0 110.819 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -145.01 176.35 9.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.832 ' HG3' HD23 ' A' ' 15' ' ' LEU . 11.7 ttp180 -142.61 155.57 44.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.47 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 mm -82.53 137.76 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -124.31 -14.99 6.84 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.461 ' C ' ' HG2' ' A' ' 33' ' ' MET . 0.9 OUTLIER -162.73 155.61 19.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.084 0.468 . . . . 0.0 111.519 -179.772 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.461 ' HG2' ' C ' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -147.92 137.28 12.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.087 179.682 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.652 ' CB ' HG21 ' A' ' 38' ' ' VAL . 59.7 Cg_endo -72.02 98.79 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.438 2.092 . . . . 0.0 112.148 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.88 5.21 0.49 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.36 -40.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.788 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 38' ' ' VAL . . . -147.94 104.07 3.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.116 179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.652 HG21 ' CB ' ' A' ' 34' ' ' PRO . 3.3 m -156.83 98.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.117 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -76.25 -78.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.934 -179.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.82 84.57 0.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.866 0.365 . . . . 0.0 110.31 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 42' ' ' ALA . 56.7 m -144.16 165.4 27.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.222 0.534 . . . . 0.0 111.421 -179.274 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 41' ' ' THR . . . -169.86 50.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.474 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m120 70.43 37.36 1.54 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.021 -178.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -138.71 142.61 38.91 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.499 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.8 OUTLIER -95.48 163.19 13.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.663 179.439 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.03 110.26 22.57 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.612 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 99.3 t -104.74 143.61 15.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.304 -178.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 40.8 t80 -106.75 123.85 48.74 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.912 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.614 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 86.1 m-85 -95.81 113.77 25.44 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.948 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.723 ' HE2' HD12 ' A' ' 89' ' ' ILE . 60.9 m-85 -61.47 179.54 0.22 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.248 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.62 -63.56 0.45 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.117 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.7 p -91.7 -21.56 20.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.746 0.307 . . . . 0.0 110.7 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 64.5 m170 62.0 37.46 14.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.181 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -90.8 155.88 18.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.492 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.04 140.05 53.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.391 0.615 . . . . 0.0 111.655 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.18 166.92 32.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.262 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -106.2 124.76 50.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.655 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 86.2 mt -139.78 162.69 34.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.25 167.19 26.13 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.495 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.17 -19.76 67.67 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.661 2.241 . . . . 0.0 112.615 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -69.12 -27.28 65.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.873 0.368 . . . . 0.0 110.856 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 24.8 m-20 -97.95 8.81 44.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.231 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.558 HD22 HG21 ' A' ' 16' ' ' VAL . 95.6 mt -109.35 139.87 43.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.693 0.283 . . . . 0.0 110.539 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.6 m-85 -134.06 156.67 78.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.09 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 15.4 Cg_exo -68.19 109.66 2.03 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.605 2.203 . . . . 0.0 111.43 179.378 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 70' ' ' LYS . 83.4 t80 -54.9 -62.14 1.85 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.915 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -49.01 -42.13 36.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.081 0.467 . . . . 0.0 111.474 -179.149 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -70.88 -39.77 72.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.485 -179.373 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.418 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -104.93 9.75 34.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.522 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.2 ptpp? -55.21 -45.21 75.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 111.401 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.3 mt-10 -70.09 -26.89 64.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.987 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -84.57 -46.44 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 69' ' ' SER . 23.7 m-85 -105.07 -0.83 26.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.312 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.8 75.07 1.99 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.873 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -150.36 157.31 36.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.69 0.281 . . . . 0.0 110.861 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.82 149.89 10.25 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.704 2.269 . . . . 0.0 112.573 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.567 ' ND2' ' CD2' ' A' ' 82' ' ' PHE . 16.4 m-80 -131.2 165.81 22.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.595 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.32 -17.53 30.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.259 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -66.25 -15.06 62.88 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.075 0.464 . . . . 0.0 110.61 179.5 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt 63.98 142.6 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.097 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.33 -17.91 48.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.801 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.567 ' CD2' ' ND2' ' A' ' 77' ' ' ASN . 18.4 t80 -58.66 -53.58 56.76 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.034 0.445 . . . . 0.0 110.505 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.61 -46.48 67.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.043 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.62 -32.66 8.53 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.019 0.438 . . . . 0.0 110.39 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.34 -31.83 60.74 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.814 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 89' ' ' ILE . 84.1 mt -60.84 -43.73 97.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.001 0.429 . . . . 0.0 110.268 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.409 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 61.1 t90 -65.46 -41.52 93.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.053 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.419 ' OE1' HG11 ' A' ' 95' ' ' VAL . 58.7 mm-40 -64.29 -53.67 45.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.723 HD12 ' HE2' ' A' ' 50' ' ' PHE . 1.2 tt -52.39 -25.38 7.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 87' ' ' TRP . 15.8 pt-20 -100.37 -44.65 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.226 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -81.33 -33.91 32.19 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -156.66 85.46 3.01 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.017 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 72.1 Cg_endo -74.97 -10.24 21.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.676 2.251 . . . . 0.0 112.685 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.1 p -104.18 11.78 34.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.538 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.419 HG11 ' OE1' ' A' ' 88' ' ' GLU . 11.4 p -61.71 147.2 11.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.851 0.357 . . . . 0.0 111.441 -179.645 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -142.86 145.28 32.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.857 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -100.11 143.73 29.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.14 93.59 2.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 125.51 51.63 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.576 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -107.29 117.73 34.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.4 102.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.22 130.11 44.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.6 m -126.12 -174.47 3.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 61.96 110.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.6 mttt 63.01 121.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.985 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -139.25 -56.84 0.6 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.92 -30.37 13.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 61.52 172.59 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.837 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.73 173.93 6.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.011 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.879 0.371 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -133.67 -51.99 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.796 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.93 -172.72 2.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.08 -177.19 3.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.056 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -142.82 -65.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.739 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 -122.02 23.04 10.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.02 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -126.02 105.48 8.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.643 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 10' ' ' TYR . 2.5 pttp -140.73 176.39 8.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.102 -179.715 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -154.32 142.6 20.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.541 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.458 ' CE2' ' HD2' ' A' ' 8' ' ' LYS . 88.9 m-85 -116.81 159.55 22.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.74 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 5.8 mmtm -137.77 161.15 37.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.968 0.413 . . . . 0.0 110.997 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 t -52.2 124.68 13.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.77 -16.09 44.11 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.061 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.23 140.01 50.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.827 0.346 . . . . 0.0 111.126 -179.877 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.57 HD23 ' HG3' ' A' ' 29' ' ' ARG . 56.3 mt -92.8 118.68 31.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.301 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.423 HG21 HD22 ' A' ' 63' ' ' LEU . 31.1 m -139.67 171.77 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.743 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.4 m-85 -109.98 136.68 48.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.706 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.728 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -113.43 126.44 55.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.993 0.425 . . . . 0.0 111.779 -179.186 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -92.96 130.64 38.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.854 179.368 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.94 148.6 50.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.77 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -67.36 106.67 2.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.774 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.82 -7.08 27.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.611 -0.805 . . . . 0.0 112.749 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -141.07 156.61 68.11 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.713 0.292 . . . . 0.0 110.656 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.98 171.92 9.01 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.744 2.296 . . . . 0.0 112.206 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 73' ' ' PHE . 63.6 m-70 -47.79 111.88 0.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.42 179.032 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.432 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 1.6 t-105 -99.57 129.06 29.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.783 -0.19 . . . . 0.0 111.24 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HG3' HD22 ' A' ' 86' ' ' LEU . 12.4 Cg_endo -55.46 121.13 9.38 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.152 1.902 . . . . 0.0 110.968 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.68 175.77 9.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.29 0.566 . . . . 0.0 112.257 -178.535 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.57 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.3 ttp180 -141.67 154.83 45.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.75 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.408 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.1 mm -82.27 114.25 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.87 -13.84 14.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.26 152.48 14.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.402 . . . . 0.0 111.309 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.44 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 6.3 ptp -154.75 156.35 31.35 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.168 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.82 160.76 24.46 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.678 2.252 . . . . 0.0 112.111 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -82.87 -37.85 23.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.167 0.508 . . . . 0.0 110.715 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.89 -39.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.052 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.693 ' O ' HG22 ' A' ' 38' ' ' VAL . . . -162.53 -47.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.12 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 37' ' ' ALA . 5.2 m 51.05 21.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.829 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.49 60.55 2.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.719 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.598 ' OG ' HG23 ' A' ' 38' ' ' VAL . 13.7 p 177.06 -45.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.4 p -79.55 102.88 9.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.922 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . . . -73.7 52.76 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.021 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t30 56.08 50.8 12.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.047 0.451 . . . . 0.0 110.969 -179.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 42' ' ' ALA . 1.6 mtmt -132.06 138.82 48.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.208 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 62.4 m-85 -94.42 153.22 18.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.843 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -99.0 105.78 17.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.022 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.623 HG11 HD21 ' A' ' 63' ' ' LEU . 29.5 m -101.47 150.34 6.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.542 0.687 . . . . 0.0 112.211 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 32.9 t80 -105.81 124.38 49.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.076 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.466 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 32.5 m-85 -91.72 107.62 19.33 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.565 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.799 ' HE2' HD12 ' A' ' 89' ' ' ILE . 36.0 m-85 -58.56 175.11 0.27 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.794 0.33 . . . . 0.0 110.934 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.53 -62.05 0.86 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.386 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.4 p -90.49 -21.51 21.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.652 0.263 . . . . 0.0 111.097 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 48.4 m170 64.02 34.9 10.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.889 0.376 . . . . 0.0 110.29 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -90.32 153.68 20.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.704 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.54 141.51 51.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.166 0.507 . . . . 0.0 111.633 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.41 177.53 11.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.406 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 9.0 m-85 -120.56 127.34 52.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.804 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.728 HD13 ' HB1' ' A' ' 18' ' ' ALA . 5.3 mt -140.01 163.93 31.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.117 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.94 177.17 35.25 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.566 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.12 -25.26 51.07 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.665 2.243 . . . . 0.0 112.437 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -69.92 -25.43 63.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.352 . . . . 0.0 111.091 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 36.3 m-20 -98.39 4.79 48.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.388 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.623 HD21 HG11 ' A' ' 47' ' ' VAL . 20.8 mt -112.59 139.37 48.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.444 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.4 m-85 -136.01 159.93 69.18 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.067 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 12.2 Cg_exo -69.68 110.88 2.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.695 2.264 . . . . 0.0 111.64 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -51.82 -59.25 4.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.549 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -50.42 -41.41 52.38 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.701 -179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 2.2 tm-20 -69.55 -39.81 77.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.458 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 m -108.15 13.77 25.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 4.5 ptpp? -56.09 -47.67 77.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 111.125 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.3 mt-10 -71.13 -21.32 62.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.316 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HD3' ' CE1' ' A' ' 73' ' ' PHE . 4.2 tttt -85.59 -49.35 8.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.422 ' CE1' ' HD3' ' A' ' 72' ' ' LYS . 9.5 m-85 -103.01 -4.79 24.13 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.398 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.443 ' HA2' HD11 ' A' ' 86' ' ' LEU . . . -83.32 71.1 3.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.077 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 9.1 mtmt -149.33 153.54 37.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.74 158.19 14.16 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.574 2.182 . . . . 0.0 112.733 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.423 ' ND2' ' CD2' ' A' ' 82' ' ' PHE . 25.8 m-80 -137.15 167.27 21.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.469 -179.297 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.46 -15.45 46.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.112 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -14.04 61.61 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.008 0.432 . . . . 0.0 110.792 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp 63.85 142.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.273 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.05 -17.79 48.94 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.742 -178.535 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 44.5 t80 -59.83 -54.19 49.09 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.998 0.428 . . . . 0.0 110.842 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.511 ' HA ' HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -53.1 -46.33 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.236 -179.823 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -48.39 -29.83 4.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.997 0.427 . . . . 0.0 110.601 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.97 -31.59 59.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.172 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 89' ' ' ILE . 3.8 mm? -61.01 -44.16 97.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.959 0.409 . . . . 0.0 110.533 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 64.2 t90 -65.12 -45.71 83.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.339 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.474 ' OE1' HG11 ' A' ' 95' ' ' VAL . 52.5 mt-10 -62.48 -51.02 69.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.799 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -52.3 -27.18 10.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.711 0.291 . . . . 0.0 111.684 -179.64 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -99.6 -44.73 6.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -80.33 -31.86 37.98 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -155.61 88.11 3.07 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 111.188 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -75.93 -13.39 19.54 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.676 2.25 . . . . 0.0 112.697 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.558 HG22 HH12 ' A' ' 29' ' ' ARG . 48.1 p -105.67 12.4 31.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.496 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.567 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.8 p -63.14 149.76 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.418 . . . . 0.0 111.481 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.14 143.23 25.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB2' ' ND1' ' A' ' 53' ' ' HIS . . . -91.56 104.0 16.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.054 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -83.3 138.4 33.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.999 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.34 141.91 10.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.431 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -125.79 153.04 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.0 110.99 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.01 -46.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.2 t -133.93 99.79 4.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -101.9 -62.93 1.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.22 113.5 1.87 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.29 157.68 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 124.58 29.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.5 m -150.5 138.94 20.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 67.5 m -142.89 -56.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.9 167.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.761 0.315 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -102.52 31.73 3.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -120.55 138.25 53.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 t -125.42 139.51 53.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.798 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.45 6.19 5.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.467 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -162.22 -67.0 0.05 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.72 0.295 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -58.47 174.81 0.28 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 9' ' ' GLU . 13.3 tppt? -153.86 162.07 41.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -157.17 146.67 20.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.811 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.634 ' CD2' HG11 ' A' ' 16' ' ' VAL . 47.9 m-85 -117.74 160.78 20.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.694 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -134.22 160.47 37.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 111.135 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.26 133.0 34.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.372 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.2 -10.97 72.75 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.915 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.03 142.8 49.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.768 0.318 . . . . 0.0 111.15 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.419 HD23 ' HG3' ' A' ' 29' ' ' ARG . 30.2 mt -90.81 116.79 28.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 110.281 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.634 HG11 ' CD2' ' A' ' 10' ' ' TYR . 27.3 m -139.48 168.9 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.663 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 44.5 m-85 -110.56 137.06 48.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.506 178.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.705 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -112.29 124.22 51.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.294 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -91.11 134.39 34.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.963 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mmm -128.19 149.27 50.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.646 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 115.22 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 0.0 111.063 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.72 -31.69 6.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.574 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -103.02 153.0 38.61 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 110.915 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.87 166.8 11.39 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.816 2.344 . . . . 0.0 112.43 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 46.7 m80 -48.61 113.98 0.88 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.472 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.7 t-105 -98.65 131.33 26.04 Favored Pre-proline 0 N--CA 1.464 0.266 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.9 120.34 7.74 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.357 2.038 . . . . 0.0 110.857 178.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.624 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -145.49 175.03 10.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.692 HH12 HG22 ' A' ' 94' ' ' THR . 1.0 OUTLIER -143.07 155.93 44.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.336 179.619 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.0 mm -80.82 136.88 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -127.31 -18.1 4.57 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -164.42 153.62 13.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.899 0.381 . . . . 0.0 111.334 -179.674 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.544 ' HE1' ' O ' ' A' ' 10' ' ' TYR . 6.8 ptp -156.54 166.3 16.83 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.826 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.851 ' HA ' HG22 ' A' ' 38' ' ' VAL . 8.2 Cg_exo -72.4 56.06 2.64 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.877 2.385 . . . . 0.0 112.274 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -164.36 37.57 0.08 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.685 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.12 -36.8 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.15 -64.18 1.1 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.214 178.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.851 HG22 ' HA ' ' A' ' 34' ' ' PRO . 9.2 t 55.25 100.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.355 179.165 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.69 -67.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.7 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -96.66 42.09 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.448 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.01 174.08 6.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.275 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -171.1 56.5 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.403 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.481 ' C ' ' HG2' ' A' ' 44' ' ' LYS . 7.6 m120 68.46 28.68 5.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.04 -178.361 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HG2' ' C ' ' A' ' 43' ' ' ASN . 2.2 mtmt -138.38 151.91 47.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.057 -179.231 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -92.18 158.79 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.231 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.55 98.22 9.13 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.624 ' CG2' ' HB1' ' A' ' 28' ' ' ALA . 2.1 p -99.79 147.29 7.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.659 0.742 . . . . 0.0 112.408 -177.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 28.4 t80 -105.63 124.97 50.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.283 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.609 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 63.7 m-85 -91.85 108.15 19.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.548 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.752 ' CE2' HD12 ' A' ' 89' ' ' ILE . 38.0 m-85 -59.79 175.78 0.34 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.3 . . . . 0.0 110.979 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 70.68 -62.77 0.88 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.229 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.2 p -90.78 -22.07 21.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.794 0.331 . . . . 0.0 110.656 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.457 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 50.4 m170 63.51 36.04 11.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.388 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -90.41 153.52 20.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.589 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.25 139.55 53.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.113 0.483 . . . . 0.0 111.328 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.7 167.84 29.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.64 -179.731 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.28 125.64 53.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.639 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.705 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 62.3 mt -138.39 161.49 36.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.043 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.81 171.8 33.41 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.311 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.416 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 40.1 Cg_endo -67.39 -20.85 47.93 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.351 2.034 . . . . 0.0 112.214 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -68.37 -28.9 67.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.958 0.409 . . . . 0.0 110.453 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.49 12.06 38.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.816 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 2.3 mp -109.51 136.59 48.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.386 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.5 m-85 -135.05 146.0 56.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.902 0.382 . . . . 0.0 111.048 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.477 ' HG2' ' HB3' ' A' ' 68' ' ' GLU . 17.8 Cg_endo -60.06 112.25 1.24 Allowed 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.43 2.087 . . . . 0.0 111.334 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 78.6 t80 -49.71 -61.78 1.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.215 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.28 -40.8 49.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.125 0.488 . . . . 0.0 111.49 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.477 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 6.0 tt0 -71.01 -39.74 72.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.198 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.452 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 5.3 m -101.04 8.14 43.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HD3' ' CE2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.17 -53.68 46.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.267 0.556 . . . . 0.0 111.426 179.64 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.85 -17.79 62.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.831 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -85.26 -50.53 7.28 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 7.8 m-85 -107.29 -3.19 19.96 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.39 72.68 2.61 Favored Glycine 0 C--N 1.329 0.165 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.976 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -149.81 153.23 35.9 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.607 0.241 . . . . 0.0 110.678 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -51.13 153.57 9.06 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.55 2.167 . . . . 0.0 112.626 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -137.05 167.35 21.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.684 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 -15.38 41.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.324 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.9 mmt-85 -66.03 -15.19 62.82 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.032 0.444 . . . . 0.0 110.595 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm 63.62 142.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.136 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.04 -17.2 52.81 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.608 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.472 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 36.1 t80 -58.38 -56.08 26.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.986 0.422 . . . . 0.0 110.754 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.86 -46.28 67.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -48.58 -31.69 6.97 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.974 0.416 . . . . 0.0 110.426 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.33 -32.2 58.28 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.026 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.557 ' O ' HG22 ' A' ' 89' ' ' ILE . 16.5 mt -60.68 -43.55 97.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.996 0.426 . . . . 0.0 110.123 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' TRP . . . . . 0.441 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 63.8 t90 -64.9 -43.22 93.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.935 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 21.6 mm-40 -63.46 -52.41 61.53 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.752 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -53.04 -25.44 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.738 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 87' ' ' TRP . 12.5 pt-20 -99.92 -44.77 5.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.073 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 1.2 m-80 -82.55 -29.37 30.39 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -155.86 86.88 3.12 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.79 0.328 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.9 Cg_endo -76.86 -14.29 17.3 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.667 2.245 . . . . 0.0 112.653 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.692 HG22 HH12 ' A' ' 29' ' ' ARG . 16.7 p -105.13 11.9 32.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.576 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.7 p -60.72 147.25 10.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.403 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -152.94 21.57 0.58 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 51.6 28.85 5.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.291 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.46 47.83 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -118.15 68.51 0.33 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -144.92 32.75 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.894 0.378 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -83.01 166.29 18.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.1 t -141.9 -58.52 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.9 t 63.13 -79.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -73.1 170.2 15.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.929 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -177.1 149.61 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.946 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt 60.89 84.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.994 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.8 m 56.82 92.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.2 m -170.37 -66.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.76 158.11 36.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.074 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.968 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.778 0.323 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.84 159.7 36.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.71 -51.93 7.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.3 p -113.54 -176.25 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -116.71 162.54 17.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -171.68 143.31 1.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 61.46 153.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.002 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.57 147.7 31.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.742 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -95.69 142.63 27.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.748 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.558 ' CE1' HG11 ' A' ' 16' ' ' VAL . 87.7 m-85 -112.1 157.51 20.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.714 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -131.48 158.67 40.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.048 0.451 . . . . 0.0 111.169 -179.538 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.73 131.86 35.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.516 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.81 -11.45 68.04 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.14 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.86 138.4 50.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 111.26 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.415 HD23 ' HG3' ' A' ' 29' ' ' ARG . 75.5 mt -91.89 118.09 30.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.386 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.558 HG11 ' CE1' ' A' ' 10' ' ' TYR . 25.5 m -139.88 171.95 13.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.832 -179.553 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 30.3 m-85 -112.81 137.09 51.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.539 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -114.4 126.5 55.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -90.25 136.08 33.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -130.32 151.8 50.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.534 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -67.64 118.26 10.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.919 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -8.57 74.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.981 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.411 ' CD1' ' HD3' ' A' ' 79' ' ' ARG . 1.9 m-85 -132.19 154.45 81.65 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.849 0.324 . . . . 0.0 111.071 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.27 167.16 12.29 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.86 2.373 . . . . 0.0 112.495 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.438 ' CG ' ' CD2' ' A' ' 73' ' ' PHE . 81.5 m-70 -47.09 115.23 1.02 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.629 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.458 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.1 t-105 -99.03 130.02 28.34 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.536 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.78 119.48 6.31 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.374 2.049 . . . . 0.0 111.112 178.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.12 174.34 10.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.425 0.631 . . . . 0.0 112.69 -177.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -142.92 155.8 44.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.305 179.686 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 28.5 mm -78.18 138.36 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.004 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.73 -20.33 5.5 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.055 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.51 150.78 14.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.069 0.461 . . . . 0.0 111.234 -179.694 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.401 ' HE2' ' HA ' ' A' ' 33' ' ' MET . 29.2 mmt -93.35 161.15 31.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.795 179.512 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.489 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 98.4 Cg_endo -87.15 111.24 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.904 2.403 . . . . 0.0 112.356 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -51.46 -93.5 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.919 179.761 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -173.97 -52.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 110.512 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.52 72.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.139 179.896 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.9 m -145.29 21.28 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.317 -179.422 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 3.6 mmmp? -159.89 -79.67 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.499 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.7 t -179.8 41.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.46 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.48 HG21 ' CE2' ' A' ' 57' ' ' PHE . 38.6 p -138.08 122.0 17.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.125 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.61 -60.64 2.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.252 0.549 . . . . 0.0 109.788 178.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -155.66 50.33 0.55 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.889 179.004 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -114.16 139.75 49.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.709 -178.571 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 80.1 m-85 -95.82 155.02 16.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.678 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.436 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.4 mt-30 -96.39 106.71 18.99 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.211 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.598 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 63.4 t -100.77 143.06 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.294 -178.297 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.89 122.02 45.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.156 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.646 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 75.0 m-85 -94.97 110.28 22.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.415 179.629 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.725 ' HE2' HD12 ' A' ' 89' ' ' ILE . 57.2 m-85 -58.86 -179.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.025 -179.513 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.52 -63.64 0.61 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.205 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.9 p -91.11 -22.83 20.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.749 0.309 . . . . 0.0 110.734 179.197 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.4 m170 64.55 36.51 8.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.534 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -94.21 157.0 16.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.517 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -131.75 149.92 52.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.362 0.601 . . . . 0.0 112.009 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.52 170.94 20.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 52.4 m-85 -105.96 86.59 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.813 HD13 ' HB1' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -98.08 156.84 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.195 -179.87 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.559 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -91.97 169.42 32.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.324 179.649 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 42.0 Cg_endo -67.48 -20.86 47.35 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.504 2.136 . . . . 0.0 112.359 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -27.83 67.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.95 0.405 . . . . 0.0 110.413 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -100.7 12.46 37.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.791 179.622 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.8 mp -108.73 137.37 46.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.676 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.7 m-85 -136.14 158.24 74.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.65 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.639 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.9 Cg_exo -71.79 111.51 3.16 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.391 2.061 . . . . 0.0 111.288 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.566 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.2 t80 -45.63 -58.97 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.438 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -50.95 -39.43 54.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.949 -179.092 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.1 mm-40 -70.62 -39.76 73.55 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.465 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 49.5 m -105.49 11.03 32.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.447 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.566 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.38 -49.47 74.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 111.554 179.977 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.51 -26.17 64.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.707 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -85.01 -46.93 10.73 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.465 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 2.5 m-30 -99.87 -12.95 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -80.68 71.1 2.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.289 -0.957 . . . . 0.0 113.043 -179.523 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.0 mttt -148.99 153.21 38.03 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.595 0.236 . . . . 0.0 110.384 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -51.27 153.31 9.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.463 2.109 . . . . 0.0 112.674 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -136.48 163.44 30.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.545 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -81.81 -16.54 50.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.153 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.411 ' HD3' ' CD1' ' A' ' 23' ' ' TYR . 17.9 mmm180 -64.52 -15.66 61.26 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.916 0.389 . . . . 0.0 110.823 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt 63.24 140.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.139 -179.38 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.88 -16.98 53.55 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.463 -178.196 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.458 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.5 t80 -58.57 -55.49 34.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.943 0.401 . . . . 0.0 110.649 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 m -53.54 -45.66 69.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.121 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.91 -31.69 7.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.038 0.446 . . . . 0.0 110.464 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.04 -31.75 61.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.921 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.667 ' O ' HG22 ' A' ' 89' ' ' ILE . 19.7 mt -61.12 -43.68 98.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.961 0.41 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -63.61 -45.46 90.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.2 mp0 -62.38 -50.93 69.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.128 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.725 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -52.48 -25.99 8.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.723 0.297 . . . . 0.0 111.8 -179.708 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -44.81 5.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.095 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -80.49 -32.23 37.05 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.32 87.85 3.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.798 0.332 . . . . 0.0 110.978 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 96.3 Cg_endo -79.6 -12.52 13.75 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.636 2.224 . . . . 0.0 112.958 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.419 HG22 ' NH1' ' A' ' 29' ' ' ARG . 21.1 p -103.8 12.8 34.11 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.563 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.551 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.2 p -65.62 149.37 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.837 0.351 . . . . 0.0 111.288 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 165.81 24.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.963 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.0 178.47 8.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m 60.05 162.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.36 90.76 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.531 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -122.14 99.1 6.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -68.52 -37.48 80.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.41 93.53 4.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.6 p -143.26 128.49 18.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 61.42 113.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.62 101.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 154.54 33.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.918 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.79 179.12 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.9 p -173.04 35.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.64 103.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.052 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 121.011 0.434 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 t -53.24 127.18 23.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.464 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.4 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 101.23 -14.84 58.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.096 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.07 138.8 54.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 0.0 111.115 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.7 mt -92.22 117.65 30.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.176 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.92 171.39 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.185 0.517 . . . . 0.0 111.956 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 32.5 m-85 -110.63 137.35 48.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.471 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.734 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -111.54 125.0 53.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.893 0.378 . . . . 0.0 111.586 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -90.37 134.37 34.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.906 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 mmm -129.8 151.85 49.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 122.62 18.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.81 -2.06 85.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.897 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -139.4 152.47 69.23 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.757 0.279 . . . . 0.0 110.674 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.87 163.8 13.85 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.6 2.2 . . . . 0.0 112.688 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 48.4 m80 -46.6 117.44 1.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.102 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.425 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.3 t-105 -101.13 128.04 30.42 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.584 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HG3' HD22 ' A' ' 86' ' ' LEU . 9.5 Cg_endo -52.49 119.5 5.99 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.329 2.02 . . . . 0.0 111.073 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . -144.69 177.34 8.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.43 0.633 . . . . 0.0 112.67 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 4.3 ttp180 -143.2 156.66 44.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.84 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.47 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 24.1 mm -82.94 140.32 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.0 -19.38 6.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 111.001 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 1.1 mmpt? . . . . . 0 N--CA 1.456 -0.15 0 CA-C-O 120.907 0.384 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 2.6 m-85 -149.46 159.77 44.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.188 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 57' ' ' PHE . 11.5 mt-30 -93.04 105.32 17.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.076 0.465 . . . . 0.0 109.832 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.625 HG11 HD21 ' A' ' 63' ' ' LEU . 11.3 m -102.95 146.87 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.615 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 3.9 t80 -103.82 123.44 47.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.456 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.665 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 73.0 m-85 -93.72 105.26 17.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.814 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.76 ' HE2' HD12 ' A' ' 89' ' ' ILE . 57.9 m-85 -56.47 178.53 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 111.389 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.39 -62.35 1.1 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.15 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.8 p -91.38 -21.96 20.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 110.932 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.6 m170 65.26 34.12 8.65 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.521 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -95.51 157.35 15.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.649 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 t -129.76 148.68 51.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.354 0.597 . . . . 0.0 111.833 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.53 170.77 21.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.606 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.3 m-85 -108.13 124.2 49.88 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.758 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.734 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 28.6 mt -138.65 161.73 36.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.975 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.11 176.27 42.06 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.248 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -69.45 -25.42 30.07 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.314 2.009 . . . . 0.0 111.865 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -68.96 -22.13 64.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.618 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.18 2.18 42.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.625 HD21 HG11 ' A' ' 47' ' ' VAL . 35.1 mt -110.99 139.35 46.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.291 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.449 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.2 m-85 -136.64 160.48 66.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 16.7 Cg_exo -67.59 112.62 2.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.646 2.231 . . . . 0.0 111.939 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.7 t80 -50.08 -61.41 2.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.242 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.83 -39.38 58.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.959 0.409 . . . . 0.0 111.638 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -71.37 -39.25 71.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.349 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 34.2 m -105.62 10.86 32.82 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 66' ' ' TYR . 14.6 tttt -54.76 -48.35 72.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.77 -29.77 68.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.934 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -83.77 -46.05 12.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.469 ' HB3' ' HB2' ' A' ' 25' ' ' HIS . 4.3 m-30 -98.13 -12.18 22.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.511 ' HA2' HD11 ' A' ' 86' ' ' LEU . . . -84.76 72.88 2.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.102 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.459 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.9 mttt -150.7 143.49 16.42 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.635 0.255 . . . . 0.0 110.592 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.26 158.59 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.468 2.112 . . . . 0.0 112.757 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.64 172.05 13.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.97 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -87.22 -16.85 34.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.393 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -13.96 61.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt 66.34 141.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.395 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -17.04 56.89 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.897 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.499 ' CE1' HD21 ' A' ' 86' ' ' LEU . 36.9 t80 -59.78 -53.76 54.17 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.944 0.402 . . . . 0.0 110.518 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.75 -47.08 71.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.72 -31.33 6.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.934 0.397 . . . . 0.0 110.367 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -72.14 -32.4 63.06 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.82 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.511 HD11 ' HA2' ' A' ' 74' ' ' GLY . 3.8 mm? -60.78 -43.66 97.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.985 0.421 . . . . 0.0 110.361 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -65.48 -44.17 87.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.237 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 24.3 mm-40 -63.56 -53.01 58.41 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.76 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -52.77 -26.69 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.739 0.304 . . . . 0.0 111.775 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.71 -44.64 6.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -81.33 -32.63 32.93 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -156.72 90.95 2.54 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.715 0.293 . . . . 0.0 111.324 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -76.54 -11.02 18.83 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.48 2.12 . . . . 0.0 112.659 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.9 p -106.81 12.61 28.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.543 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.442 HG12 ' HE1' ' A' ' 50' ' ' PHE . 10.6 p . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.907 0.384 . . . . 0.0 111.542 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 121.022 0.439 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.9 m -52.01 129.38 27.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.396 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.99 58.51 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.939 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.05 138.16 51.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.836 0.351 . . . . 0.0 111.263 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.774 HD23 ' HG3' ' A' ' 29' ' ' ARG . 62.4 mt -91.81 119.64 31.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 110.156 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.0 m -140.72 171.32 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.946 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 10.0 m-85 -109.87 136.71 48.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.515 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.644 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.08 124.56 52.88 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.007 0.432 . . . . 0.0 111.775 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -92.09 131.69 37.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.75 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mtp -129.09 147.47 50.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.689 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 115.26 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.877 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.413 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 100.45 4.08 55.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.764 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -152.8 153.66 30.34 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.695 0.283 . . . . 0.0 110.653 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.83 167.6 18.3 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.562 2.174 . . . . 0.0 112.3 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.454 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 71.0 m80 -47.49 115.23 1.06 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.627 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.92 130.41 27.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.315 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.89 120.89 8.89 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.206 1.937 . . . . 0.0 111.114 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.73 175.77 9.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.345 0.593 . . . . 0.0 112.252 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.774 ' HG3' HD23 ' A' ' 15' ' ' LEU . 5.3 ttp180 -142.84 155.7 44.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.455 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -78.85 135.28 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.98 -20.3 4.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -179.671 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.088 0 CA-C-O 120.949 0.404 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 82.0 m-85 -94.82 154.45 17.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.767 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -99.3 107.04 19.23 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.639 HG11 HD21 ' A' ' 63' ' ' LEU . 7.2 m -103.47 150.5 6.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-O 121.433 0.635 . . . . 0.0 112.342 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 49.0 t80 -105.43 124.51 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.024 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.644 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 70.1 m-85 -93.28 108.96 20.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.718 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.699 ' CE2' HD12 ' A' ' 89' ' ' ILE . 47.8 m-85 -61.53 177.93 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.815 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.97 -63.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.001 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.1 p -91.52 -22.46 20.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.729 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 10.6 m-70 64.56 36.96 8.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -91.64 155.44 18.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.603 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.11 140.26 53.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.188 0.518 . . . . 0.0 111.356 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.553 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.26 178.1 10.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.363 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.0 m-85 -119.92 127.21 52.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.2 mp -138.84 161.75 36.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.994 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.48 176.4 35.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.653 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.68 -25.06 54.43 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.583 2.189 . . . . 0.0 112.409 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -69.53 -27.07 64.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 0.0 110.894 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 4.0 m-20 -100.25 6.95 44.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.312 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.639 HD21 HG11 ' A' ' 47' ' ' VAL . 22.3 mt -114.31 138.1 50.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.651 0.262 . . . . 0.0 110.35 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.6 m-85 -137.11 159.58 69.33 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.066 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.9 Cg_exo -70.24 113.86 3.59 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.674 2.25 . . . . 0.0 111.65 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 89.1 t80 -53.6 -59.51 4.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.737 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -49.04 -42.63 39.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.649 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.08 -39.53 72.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.57 -179.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -105.33 10.39 33.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.4 ptpt -56.38 -44.33 80.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.633 0.254 . . . . 0.0 111.676 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mm-40 -68.56 -32.86 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 73' ' ' PHE . 13.1 ptpt -84.01 -43.34 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.435 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 18.2 m-30 -98.3 -8.6 26.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.24 75.38 2.04 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.999 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mmmm -148.61 159.26 38.86 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.609 0.242 . . . . 0.0 110.412 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.62 151.87 59.76 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.553 2.169 . . . . 0.0 112.573 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.05 170.27 15.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.148 0.499 . . . . 0.0 111.547 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -15.67 28.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.405 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -66.35 -14.82 62.65 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.009 0.433 . . . . 0.0 110.751 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt 63.37 144.15 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.111 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.44 -18.8 35.59 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.617 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 15.0 t80 -58.56 -55.65 32.36 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-O 121.04 0.448 . . . . 0.0 110.623 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -52.83 -45.67 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -48.72 -31.35 6.75 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.922 0.391 . . . . 0.0 110.441 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.09 -31.42 61.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.881 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 89' ' ' ILE . 88.9 mt -60.97 -43.8 98.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 110.231 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -64.14 -44.9 90.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.069 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.597 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -63.38 -50.92 68.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.699 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -51.81 -27.6 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 111.82 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.44 -44.66 6.1 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.76 -32.92 41.05 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.3 87.43 3.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.751 0.31 . . . . 0.0 111.241 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 3.6 Cg_exo -76.53 -13.75 18.19 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.986 2.457 . . . . 0.0 112.633 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 p -104.01 13.07 33.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.553 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.597 HG11 ' HG2' ' A' ' 88' ' ' GLU . 14.9 p . . . . . 0 C--N 1.332 -0.194 0 CA-C-O 120.939 0.399 . . . . 0.0 111.491 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.887 0.375 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 t -52.21 126.72 19.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.294 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.571 ' HA2' ' HE ' ' A' ' 29' ' ' ARG . . . 109.72 -18.46 29.44 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.195 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.47 144.56 48.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 111.859 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.562 HD23 ' HG3' ' A' ' 29' ' ' ARG . 61.3 mt -92.54 123.73 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.105 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 m -141.9 173.01 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 112.193 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -111.84 135.88 51.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.746 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.632 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -112.75 122.24 47.09 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.003 0.43 . . . . 0.0 111.571 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 22.8 tptm -92.21 129.71 38.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 mtm -128.21 149.94 50.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.586 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 124.45 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.982 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 91.41 -0.75 75.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.049 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.1 m-85 -146.52 153.54 47.57 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.857 0.329 . . . . 0.0 110.813 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.41 165.31 16.47 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.771 2.314 . . . . 0.0 112.417 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.485 ' CE1' ' CZ ' ' A' ' 73' ' ' PHE . 70.1 m80 -47.94 115.42 1.17 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.489 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.434 ' CD1' ' HD2' ' A' ' 27' ' ' PRO . 2.5 t-105 -98.91 132.86 22.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.412 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 35.1 Cg_exo -54.54 120.05 7.42 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.04 1.827 . . . . 0.0 111.079 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -143.7 174.57 10.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.347 0.594 . . . . 0.0 112.373 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.571 ' HE ' ' HA2' ' A' ' 13' ' ' GLY . 43.1 ttt180 -141.53 154.8 45.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.607 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 mm -78.39 138.65 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -123.89 -23.21 4.7 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 120.979 0.419 . . . . 0.0 111.353 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 121.118 0.485 . . . . 0.0 111.543 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -94.37 158.3 15.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.128 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.9 106.37 18.66 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.677 HG21 HD21 ' A' ' 63' ' ' LEU . 73.9 t -103.7 142.72 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.494 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -106.77 123.3 47.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.774 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.632 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 90.1 m-85 -95.11 108.69 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.311 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.805 ' HE2' HD12 ' A' ' 89' ' ' ILE . 54.3 m-85 -57.57 179.32 0.06 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.27 -64.12 0.56 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.311 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.5 p -92.0 -22.63 19.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.8 m170 64.62 36.01 8.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.224 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -90.41 153.84 20.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.602 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.72 141.35 52.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.212 0.529 . . . . 0.0 111.526 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.97 166.74 32.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.305 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -107.08 124.85 50.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.598 HD13 ' HB1' ' A' ' 18' ' ' ALA . 4.9 mt -138.71 160.22 40.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.925 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.13 177.26 38.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.63 -24.8 47.7 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.507 2.138 . . . . 0.0 112.388 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -69.17 -25.26 64.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.92 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.458 ' CB ' HD22 ' A' ' 58' ' ' LEU . 2.3 m-20 -99.6 6.48 45.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.322 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.677 HD21 HG21 ' A' ' 47' ' ' VAL . 38.6 mt -115.02 138.82 50.43 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.723 0.297 . . . . 0.0 110.57 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.1 m-85 -136.34 159.99 68.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.701 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.644 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 8.1 Cg_exo -71.28 114.17 3.84 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.46 2.107 . . . . 0.0 111.479 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 70' ' ' LYS . 74.3 t80 -51.07 -59.57 4.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.117 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.436 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 1.1 mt-10 -48.09 -43.7 30.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.923 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 7.0 mt-10 -71.37 -39.63 71.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.524 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.461 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 63.7 m -103.04 9.69 38.45 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.3 ptpp? -55.62 -44.62 77.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.69 0.281 . . . . 0.0 111.669 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 1.4 mt-10 -68.39 -34.25 75.7 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -84.25 -44.15 14.16 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.485 ' CZ ' ' CE1' ' A' ' 25' ' ' HIS . 19.2 m-30 -95.95 -14.1 23.33 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.98 74.89 2.34 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.195 -1.002 . . . . 0.0 113.071 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -149.11 159.31 37.45 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.589 0.233 . . . . 0.0 110.548 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.69 152.72 79.17 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.559 2.172 . . . . 0.0 112.621 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 79' ' ' ARG . 50.6 p-10 -138.52 -172.37 3.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.291 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -100.35 -12.09 19.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.154 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 13.7 mmm180 -65.91 -15.95 63.42 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.993 0.425 . . . . 0.0 110.676 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt 62.7 141.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.996 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.49 59.3 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.562 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 26.5 t80 -57.5 -58.09 9.82 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.979 0.419 . . . . 0.0 110.941 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.884 ' HA ' HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -51.37 -45.23 62.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.086 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.21 -32.28 10.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.012 0.434 . . . . 0.0 110.324 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.9 -32.59 58.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.826 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 83' ' ' SER . 19.2 mt -60.62 -43.51 97.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.098 0.475 . . . . 0.0 110.141 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 59.0 t90 -63.32 -44.51 94.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.1 mp0 -62.93 -51.91 65.1 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.805 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -51.97 -25.63 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -101.04 -44.74 5.62 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -81.98 -32.5 30.63 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.24 84.09 3.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.804 0.335 . . . . 0.0 110.733 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 91.4 Cg_endo -77.08 -9.99 17.9 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.559 2.173 . . . . 0.0 112.856 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.1 p -104.12 12.2 34.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.588 0.232 . . . . 0.0 111.445 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.444 HG12 ' HE1' ' A' ' 50' ' ' PHE . 11.4 p . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 111.549 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt . . . . . 0 N--CA 1.456 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.8 m -52.52 124.82 14.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.28 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 29' ' ' ARG . . . 105.58 -16.51 44.25 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.817 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.69 135.36 49.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.995 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.443 HD23 ' HG3' ' A' ' 29' ' ' ARG . 71.0 mt -92.07 117.26 29.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 110.286 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.448 HG21 HD22 ' A' ' 63' ' ' LEU . 33.5 m -139.1 171.38 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.995 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.568 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 28.6 m-85 -110.23 136.01 50.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.619 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.793 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -113.71 125.09 53.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.103 0.477 . . . . 0.0 111.781 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . 21.3 tptm -91.47 133.3 35.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.055 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -125.51 154.41 42.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.676 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.59 115.48 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.983 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.99 39.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.575 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -116.55 148.71 42.42 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-O 120.758 0.313 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.58 166.66 23.64 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.738 2.292 . . . . 0.0 112.731 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 69.6 m80 -51.64 115.13 1.48 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.373 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.6 t-105 -99.56 134.54 21.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 31.1 Cg_exo -54.44 120.89 8.77 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.164 1.909 . . . . 0.0 110.712 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.0 174.77 10.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HG3' HD23 ' A' ' 15' ' ' LEU . 5.1 ttp180 -141.59 156.85 45.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.745 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.426 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 27.0 mm -83.89 140.51 16.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.726 0.298 . . . . 0.0 110.574 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -124.55 -18.75 5.6 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 120.966 0.412 . . . . 0.0 111.214 -179.738 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.075 0.464 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 72.1 m-85 -94.88 154.08 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.869 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -98.65 104.24 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.522 HG11 HD21 ' A' ' 63' ' ' LEU . 19.1 m -102.41 150.56 6.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.545 0.688 . . . . 0.0 112.432 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.502 ' HE2' HG13 ' A' ' 95' ' ' VAL . 36.4 t80 -105.4 124.81 50.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.967 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.626 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 34.5 m-85 -91.47 108.1 19.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.494 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.79 ' HE2' HD12 ' A' ' 89' ' ' ILE . 45.0 m-85 -60.52 175.95 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.721 0.296 . . . . 0.0 110.955 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.58 -62.47 0.87 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.088 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 p -90.98 -22.52 20.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.841 0.353 . . . . 0.0 110.739 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 20.6 m170 63.83 35.51 11.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.499 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -91.3 155.38 18.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.64 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.79 140.6 52.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.326 0.584 . . . . 0.0 111.639 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.08 168.79 25.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.431 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 64.4 m-85 -111.82 127.05 55.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.145 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.793 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.4 mp -138.36 160.23 40.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.58 177.33 37.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.77 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.89 -27.0 51.38 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.672 2.248 . . . . 0.0 112.363 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -69.25 -25.33 64.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -99.1 5.49 46.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.314 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.522 HD21 HG11 ' A' ' 47' ' ' VAL . 33.0 mt -113.17 138.71 49.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.814 0.34 . . . . 0.0 110.699 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.507 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 0.8 OUTLIER -134.74 154.01 79.18 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.83 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.476 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 15.0 Cg_exo -67.1 112.3 2.48 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.279 1.986 . . . . 0.0 111.157 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 77.2 t80 -51.49 -59.9 3.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.25 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -48.23 -43.0 31.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.012 0.434 . . . . 0.0 111.807 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 48.0 mt-10 -71.24 -39.69 71.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.466 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.412 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -103.0 8.49 38.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 66' ' ' TYR . 11.3 ptmt -55.35 -48.12 74.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.842 0.353 . . . . 0.0 111.38 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.01 -23.93 63.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.833 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -85.29 -47.51 9.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 69' ' ' SER . 24.0 m-85 -105.58 -0.55 25.64 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.38 73.3 2.41 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.724 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.436 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 27.1 mmtt -148.53 159.11 39.44 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.588 0.232 . . . . 0.0 110.567 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.2 153.09 28.29 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.543 2.162 . . . . 0.0 112.374 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -131.96 165.57 23.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.113 0.483 . . . . 0.0 111.672 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -86.75 -17.27 34.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.009 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -14.47 62.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.049 0.452 . . . . 0.0 110.531 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm 63.65 144.56 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.131 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.59 -18.22 39.71 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.802 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 30.0 t80 -58.59 -54.4 47.44 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.037 0.446 . . . . 0.0 110.801 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -45.64 66.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.16 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -48.46 -31.7 6.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.43 . . . . 0.0 110.49 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.52 -31.89 60.31 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.054 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.629 ' O ' HG22 ' A' ' 89' ' ' ILE . 24.9 mt -60.57 -43.82 96.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 110.35 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 69.4 t90 -64.35 -45.48 87.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.125 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.76 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -62.55 -51.23 68.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.79 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -51.83 -27.73 8.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.317 . . . . 0.0 111.709 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.32 -44.58 6.17 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -80.69 -31.71 36.17 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -156.59 88.59 2.75 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 111.351 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 80.2 Cg_endo -77.81 -11.91 16.6 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.625 2.217 . . . . 0.0 112.646 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.3 p -101.71 10.55 39.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.605 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.76 HG11 ' HG2' ' A' ' 88' ' ' GLU . 12.2 p . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.0 111.266 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.89 0.376 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.5 m -51.9 132.12 31.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.594 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.19 -12.25 68.37 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.937 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.73 139.18 51.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 0.0 111.006 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.4 HD23 ' HG3' ' A' ' 29' ' ' ARG . 68.2 mt -91.18 116.51 28.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.996 0.427 . . . . 0.0 110.4 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.6 m -139.69 170.34 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.552 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.521 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 18.0 m-85 -111.15 135.88 51.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.519 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.688 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.89 123.05 49.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.906 0.384 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 23.8 tptp -92.08 130.94 37.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.134 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtm -127.03 147.86 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.47 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 113.48 4.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 111.013 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.96 -27.38 14.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.635 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.91 157.98 48.98 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.942 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.46 166.39 12.2 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.826 2.35 . . . . 0.0 112.372 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.505 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 59.0 m80 -47.23 113.99 0.78 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.516 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.458 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.49 130.7 27.49 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.642 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.55 119.03 5.75 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.376 2.051 . . . . 0.0 111.083 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.2 175.2 10.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 14.3 ttp180 -142.53 156.44 45.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.493 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.436 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 25.0 mm -79.91 138.76 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.21 -20.84 5.15 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.957 0.408 . . . . 0.0 111.227 -179.732 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.982 0.42 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -94.12 157.91 15.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.135 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.9 107.51 19.96 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.659 HG21 HD21 ' A' ' 63' ' ' LEU . 84.3 t -103.53 142.68 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 121.463 0.649 . . . . 0.0 112.56 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -105.61 121.89 44.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.507 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.688 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 81.7 m-85 -94.16 106.62 18.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.049 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.7 ' CE2' HD12 ' A' ' 89' ' ' ILE . 49.4 m-85 -57.59 176.99 0.11 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.843 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.411 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 69.77 -63.55 0.67 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.418 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 81.0 p -90.19 -23.21 21.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.739 0.304 . . . . 0.0 110.738 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 52' ' ' THR . 4.0 m170 66.0 33.91 7.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.197 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.2 151.03 21.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.928 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.8 140.79 51.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.239 0.542 . . . . 0.0 111.307 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.88 168.11 28.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.289 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -109.31 125.45 52.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.995 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.556 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 19.7 mt -139.33 160.62 39.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.37 -179.85 40.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.23 -26.82 41.74 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.511 2.14 . . . . 0.0 112.189 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -69.55 -22.59 63.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.077 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.0 m-20 -99.0 3.66 47.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.463 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 47' ' ' VAL . 18.4 mt -115.03 139.6 49.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -136.59 166.3 28.65 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.845 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HB2' ' CG ' ' A' ' 68' ' ' GLU . 4.8 Cg_exo -73.17 111.08 3.2 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.767 2.311 . . . . 0.0 111.69 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.2 t80 -49.95 -58.44 5.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.478 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -49.0 -41.09 33.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.611 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 65' ' ' PRO . 4.9 mm-40 -71.02 -39.71 72.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.674 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 3.6 m -103.39 13.87 32.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 2.2 mtmp? -55.52 -44.95 77.15 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.413 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.75 -40.83 88.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.75 -43.88 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.9 m-30 -94.71 -19.77 20.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.73 74.08 2.39 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.042 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 12.1 mttt -149.32 153.57 37.62 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.95 155.5 8.42 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.616 2.211 . . . . 0.0 112.638 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -136.39 165.58 25.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.578 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -85.73 -16.07 40.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.304 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.58 -13.8 61.53 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.987 0.423 . . . . 0.0 110.713 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt 63.79 142.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.159 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.71 -16.87 55.52 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.517 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 31.4 t80 -59.0 -56.88 16.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.943 0.402 . . . . 0.0 110.882 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.41 -45.42 65.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.113 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.62 -30.13 5.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.017 0.437 . . . . 0.0 110.503 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.96 -31.86 57.43 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.161 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.621 ' O ' HG22 ' A' ' 89' ' ' ILE . 12.7 mt -60.4 -43.35 96.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.064 0.459 . . . . 0.0 110.34 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 62.9 t90 -63.73 -45.71 88.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.229 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.67 -50.63 70.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' CE2' ' A' ' 50' ' ' PHE . 1.1 tt -52.92 -27.03 12.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.744 0.306 . . . . 0.0 111.692 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -99.31 -44.83 6.08 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -79.64 -31.55 41.54 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.475 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . 1.0 OUTLIER -156.99 87.08 2.76 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.751 0.31 . . . . 0.0 111.282 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.01 -12.94 26.21 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.933 2.422 . . . . 0.0 112.61 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 p -107.05 14.66 26.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.53 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.581 HG12 ' HE1' ' A' ' 50' ' ' PHE . 14.6 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.075 0.464 . . . . 0.0 111.702 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.905 0.383 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 98.8 m -52.01 125.36 15.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.409 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.34 -16.34 49.15 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.153 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.19 138.92 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.79 0.329 . . . . 0.0 111.323 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.464 HD23 ' HG3' ' A' ' 29' ' ' ARG . 81.3 mt -91.43 120.75 32.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.191 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.6 m -141.62 174.05 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.369 0.604 . . . . 0.0 112.133 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.508 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 9.4 m-85 -111.97 136.34 51.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.419 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.766 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -112.65 125.53 54.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.022 0.439 . . . . 0.0 111.449 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.82 132.58 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.979 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.7 mtm -129.81 155.01 46.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.701 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.73 119.62 13.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.034 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.23 -13.03 66.12 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.813 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.54 149.21 64.23 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.759 0.279 . . . . 0.0 110.836 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 91.5 Cg_endo -82.24 167.91 15.39 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.723 2.282 . . . . 0.0 112.448 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -47.18 112.38 0.52 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.581 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.453 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.6 t-105 -97.79 130.5 28.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.436 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.38 119.38 6.28 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.364 2.043 . . . . 0.0 111.004 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.62 175.54 10.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HG3' HD23 ' A' ' 15' ' ' LEU . 2.6 ttp180 -142.45 157.18 45.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.464 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -80.13 138.84 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -125.45 -20.36 4.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 121.025 0.441 . . . . 0.0 111.519 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.109 0.48 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 84.6 m-85 -92.49 155.06 18.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.108 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -96.38 106.55 18.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.605 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 59.5 t -101.54 142.94 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.431 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -105.14 120.88 42.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.568 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.651 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 92.3 m-85 -94.08 111.36 23.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.787 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.728 ' HE2' HD12 ' A' ' 89' ' ' ILE . 47.8 m-85 -60.67 177.54 0.29 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.954 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.22 -62.93 0.78 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.22 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.5 p -92.08 -23.24 19.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 0.0 110.679 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.4 m170 63.88 37.64 9.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.339 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.99 153.95 19.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.829 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 144.15 49.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.365 0.603 . . . . 0.0 111.764 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.93 164.79 38.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.099 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 36.8 m-85 -107.87 87.8 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.155 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.766 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 6.6 mt -99.21 158.67 15.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.059 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.643 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -93.29 171.78 32.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.319 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.87 -22.53 48.84 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.536 2.157 . . . . 0.0 112.464 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -67.87 -27.22 66.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.694 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -100.0 14.55 30.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.964 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.6 mp -109.56 137.3 47.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.583 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.6 m-85 -136.18 157.85 74.83 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.958 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 9.5 Cg_exo -71.38 112.06 3.25 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.672 2.248 . . . . 0.0 111.525 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.4 t80 -51.37 -58.96 4.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.908 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.4 -40.28 49.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.081 0.467 . . . . 0.0 111.654 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.8 tt0 -71.66 -39.94 69.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.577 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.456 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -105.75 9.54 32.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.3 ptmm? -56.54 -47.51 79.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 0.0 111.435 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -23.27 62.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.75 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -85.06 -47.36 10.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 69' ' ' SER . 0.9 OUTLIER -108.88 3.76 22.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 70' ' ' LYS . . . -83.77 16.84 29.38 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.684 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -94.07 157.91 36.99 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.39 0.595 . . . . 0.0 110.457 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.46 158.39 10.16 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.379 2.052 . . . . 0.0 112.246 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.404 ' ND2' ' HG3' ' A' ' 24' ' ' PRO . 3.7 m120 -132.23 169.07 16.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.625 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -89.18 -16.5 31.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.349 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -14.61 61.9 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 110.783 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt 63.35 141.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.084 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.8 -17.11 54.71 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.403 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.453 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 47.5 t80 -58.17 -54.88 41.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.03 0.443 . . . . 0.0 110.734 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.64 -46.37 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.306 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.34 -31.5 6.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.007 0.432 . . . . 0.0 110.619 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.42 -31.16 59.34 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.044 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.669 ' O ' HG22 ' A' ' 89' ' ' ILE . 76.9 mt -60.88 -43.68 98.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.003 0.43 . . . . 0.0 110.415 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.1 t90 -63.74 -44.57 93.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.22 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.667 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -63.5 -50.5 69.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.728 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -51.72 -27.45 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 89' ' ' ILE . 55.4 mt-10 -100.29 -44.73 5.84 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -79.17 -33.71 43.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -156.37 90.2 2.68 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.317 . . . . 0.0 111.194 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.5 Cg_endo -77.27 -11.24 17.6 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.565 2.176 . . . . 0.0 112.748 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.2 p -103.09 12.54 35.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.507 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.667 HG11 ' HG2' ' A' ' 88' ' ' GLU . 11.7 p . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.944 0.402 . . . . 0.0 111.35 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 5.9 mmtm . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.907 0.384 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 t -52.28 124.61 13.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.83 -16.11 43.85 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.023 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.26 140.0 50.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 111.081 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 29' ' ' ARG . 56.1 mt -92.74 118.7 31.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.339 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.424 HG21 HD22 ' A' ' 63' ' ' LEU . 31.0 m -139.67 171.82 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.185 0.517 . . . . 0.0 111.743 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.6 m-85 -109.99 136.6 49.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.764 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.727 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -113.49 126.44 55.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.012 0.434 . . . . 0.0 111.799 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 14.2 tptm -92.9 130.64 38.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.902 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.88 148.53 50.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.802 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -67.36 106.76 2.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.745 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.75 -7.07 27.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.78 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -141.06 156.58 68.14 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.781 0.324 . . . . 0.0 110.637 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.89 171.92 9.12 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.735 2.29 . . . . 0.0 112.212 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.479 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 74.7 m80 -47.76 111.8 0.47 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.392 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.433 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 1.5 t-105 -99.54 129.04 29.84 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.322 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.404 ' HG3' HD22 ' A' ' 86' ' ' LEU . 12.5 Cg_endo -55.44 121.15 9.42 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.13 1.886 . . . . 0.0 110.98 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.59 175.73 9.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.308 0.575 . . . . 0.0 112.266 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.571 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.3 ttp180 -141.7 154.84 45.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.765 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.407 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.1 mm -82.27 114.25 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.87 -13.85 14.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 121.039 0.447 . . . . 0.0 111.318 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.973 0.416 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 62.9 m-85 -94.37 153.16 18.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.79 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -99.03 105.75 17.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.622 HG11 HD21 ' A' ' 63' ' ' LEU . 29.6 m -101.44 150.35 6.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.49 0.662 . . . . 0.0 112.214 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 33.0 t80 -105.82 124.51 49.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.04 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.465 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 32.7 m-85 -91.88 107.53 19.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.554 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.798 ' HE2' HD12 ' A' ' 89' ' ' ILE . 36.2 m-85 -58.46 174.99 0.27 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 0.0 111.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.57 -62.04 0.87 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.358 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.3 p -90.5 -21.57 21.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.606 0.241 . . . . 0.0 111.06 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 48.5 m170 64.02 34.94 10.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.912 0.386 . . . . 0.0 110.265 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -90.32 153.65 20.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.675 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.55 141.52 51.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.15 0.5 . . . . 0.0 111.69 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.32 177.54 11.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.391 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 8.6 m-85 -120.62 127.29 51.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.886 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.727 HD13 ' HB1' ' A' ' 18' ' ' ALA . 5.3 mt -139.93 163.93 31.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.13 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.94 177.07 35.18 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.616 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.07 -25.19 51.44 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.624 2.216 . . . . 0.0 112.552 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -69.9 -25.54 63.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 111.064 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 35.7 m-20 -98.3 4.84 48.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.436 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.622 HD21 HG11 ' A' ' 47' ' ' VAL . 20.7 mt -112.55 139.25 48.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.696 0.284 . . . . 0.0 110.488 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.3 m-85 -135.94 160.06 68.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.07 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 12.3 Cg_exo -69.77 110.91 2.67 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.672 2.248 . . . . 0.0 111.604 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.4 t80 -51.91 -59.16 4.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.593 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -50.49 -41.36 53.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.684 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 2.2 tm-20 -69.58 -39.77 77.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.545 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.1 m -108.09 13.74 25.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 4.5 ptpp? -56.08 -47.74 77.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.922 0.391 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.4 mt-10 -71.06 -21.41 62.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.307 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HD3' ' CE1' ' A' ' 73' ' ' PHE . 4.2 tttt -85.46 -49.47 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 9.4 m-85 -102.94 -4.8 24.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.443 ' HA2' HD11 ' A' ' 86' ' ' LEU . . . -83.3 70.95 3.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.048 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 9.1 mtmt -149.21 153.69 38.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.88 158.23 14.53 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.587 2.192 . . . . 0.0 112.632 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -137.12 167.29 21.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.565 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.45 -15.51 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.109 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -14.06 61.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.958 0.408 . . . . 0.0 110.767 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp 63.84 142.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.276 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.05 -17.72 49.43 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.775 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 44.6 t80 -59.96 -54.23 48.53 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.904 0.383 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.51 ' HA ' HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -53.05 -46.34 68.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.224 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -48.47 -29.75 4.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.986 0.422 . . . . 0.0 110.614 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.02 -31.48 59.77 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.206 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 89' ' ' ILE . 3.8 mm? -61.09 -44.11 97.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.968 0.413 . . . . 0.0 110.535 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 64.0 t90 -65.08 -45.72 84.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.347 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.474 ' OE1' HG11 ' A' ' 95' ' ' VAL . 52.4 mt-10 -62.59 -50.85 69.65 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.798 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -52.44 -27.13 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.712 0.291 . . . . 0.0 111.734 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -99.58 -44.76 6.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -80.23 -31.98 38.47 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -155.55 88.04 3.09 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.725 0.298 . . . . 0.0 111.252 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.2 Cg_endo -75.78 -13.46 19.83 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.679 2.253 . . . . 0.0 112.739 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.559 HG22 HH12 ' A' ' 29' ' ' ARG . 48.3 p -105.69 12.4 31.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.532 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.566 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.7 p . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 120.938 0.399 . . . . 0.0 111.461 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 mptt . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.4 t -52.21 129.15 27.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.49 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.75 -14.21 59.03 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.978 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.15 138.31 51.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 0.0 111.051 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 29' ' ' ARG . 86.9 mt -92.19 118.79 31.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.967 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.0 m -140.61 175.8 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.252 0.549 . . . . 0.0 112.152 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 16.4 m-85 -114.02 137.32 51.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.74 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.979 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -114.71 124.6 52.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 0.0 111.537 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 15.9 tptm -91.98 132.96 36.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.079 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.522 ' SD ' HD11 ' A' ' 58' ' ' LEU . 2.0 mmm -127.74 150.66 49.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.598 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 116.15 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.836 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.07 -16.07 58.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.859 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -130.06 151.93 79.17 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.715 0.293 . . . . 0.0 110.703 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.13 167.81 17.55 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.639 2.226 . . . . 0.0 112.409 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 51.0 m80 -46.38 114.77 0.87 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.871 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.3 t-105 -98.33 129.44 30.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.609 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.56 119.11 5.41 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.398 2.065 . . . . 0.0 111.214 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.592 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.9 175.75 9.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HG3' HD23 ' A' ' 15' ' ' LEU . 3.1 ttt180 -142.28 155.81 45.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.397 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.441 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 25.4 mm -79.03 137.35 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.28 -20.85 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 121.041 0.448 . . . . 0.0 111.284 -179.717 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 57' ' ' PHE . 10.4 mttm . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.162 0.506 . . . . 0.0 111.725 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 58.5 m-85 -94.2 154.51 17.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.99 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.03 108.06 20.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG21 HD21 ' A' ' 63' ' ' LEU . 60.5 t -103.2 142.46 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.576 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -104.14 120.3 40.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.807 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.733 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 72.5 m-85 -93.66 108.36 20.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.695 ' CE2' HD12 ' A' ' 89' ' ' ILE . 47.5 m-85 -59.21 176.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.859 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 -63.34 0.84 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.287 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 66.2 p -90.79 -22.75 20.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.737 0.303 . . . . 0.0 110.742 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 52' ' ' THR . 10.2 m170 64.62 34.83 9.54 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.075 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -90.23 152.48 21.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.705 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.42 144.89 48.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.28 0.562 . . . . 0.0 111.549 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.37 165.01 37.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.161 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 74.1 m-85 -107.99 87.88 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.054 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.979 HD22 ' HB1' ' A' ' 18' ' ' ALA . 4.8 mp -97.84 156.47 16.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.134 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.17 179.52 39.37 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.57 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.536 ' HA ' HD12 ' A' ' 63' ' ' LEU . 37.2 Cg_endo -66.27 -30.11 45.92 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.635 2.224 . . . . 0.0 112.45 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -69.48 -21.69 63.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.098 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.787 ' HB3' HD23 ' A' ' 58' ' ' LEU . 12.9 m-20 -99.49 2.6 45.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.474 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.603 HD21 HG21 ' A' ' 47' ' ' VAL . 10.0 mt -110.16 139.34 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 0.0 110.653 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.8 m-85 -136.37 153.2 76.15 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 24.7 Cg_exo -63.49 112.4 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.469 2.113 . . . . 0.0 111.706 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' LYS . 60.0 t80 -53.39 -59.36 4.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.743 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.4 mt-10 -49.71 -41.76 44.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.106 0.479 . . . . 0.0 111.521 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -69.96 -39.76 75.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.42 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.9 m -105.9 12.2 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 66' ' ' TYR . 5.3 ptpp? -55.71 -48.42 75.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.953 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 16.6 pt-20 -71.65 -19.99 62.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.412 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HE2' ' CZ ' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -84.48 -49.99 8.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.413 ' CZ ' ' HE2' ' A' ' 72' ' ' LYS . 6.5 m-85 -103.36 -4.63 23.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.34 71.44 2.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.19 -1.005 . . . . 0.0 113.081 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.81 149.62 28.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.678 0.275 . . . . 0.0 110.303 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.54 155.61 2.2 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.588 2.192 . . . . 0.0 112.757 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.95 165.2 27.11 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.748 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -85.01 -16.44 40.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.123 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -65.68 -14.87 62.1 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.055 0.455 . . . . 0.0 110.619 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 2.8 mmmp? 62.77 143.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.072 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.77 -18.0 41.82 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.337 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 43.7 t80 -58.46 -57.12 14.34 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -53.32 -45.69 69.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.989 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -48.86 -31.25 6.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.018 0.437 . . . . 0.0 110.525 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.39 -31.39 61.16 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.879 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 89' ' ' ILE . 44.7 mt -60.56 -43.58 97.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.968 0.413 . . . . 0.0 110.359 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.1 t90 -63.21 -45.74 90.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.157 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.592 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.4 OUTLIER -62.91 -50.91 69.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.695 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -52.23 -26.28 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.322 . . . . 0.0 111.851 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.606 ' HG2' HG23 ' A' ' 89' ' ' ILE . 4.1 mm-40 -100.55 -44.75 5.76 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -79.45 -32.77 42.74 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -156.92 90.41 2.53 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.698 0.285 . . . . 0.0 111.152 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 82.3 Cg_endo -78.01 -11.31 16.49 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.544 2.163 . . . . 0.0 112.745 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.5 p -106.33 13.96 28.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.531 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.592 HG11 ' HG2' ' A' ' 88' ' ' GLU . 11.9 p . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.875 0.369 . . . . 0.0 111.568 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.995 0.426 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.77 131.85 35.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.515 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.89 -11.57 67.81 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.101 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.84 138.31 50.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.249 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.415 HD23 ' HG3' ' A' ' 29' ' ' ARG . 75.4 mt -91.83 118.12 30.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.386 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 m -139.88 171.99 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.804 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 30.5 m-85 -112.88 137.05 51.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.492 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -114.43 126.6 55.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 111.248 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 12.3 tptp -90.27 136.01 33.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -130.21 151.88 50.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.547 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -67.62 118.22 10.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -8.62 74.48 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.968 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.412 ' CD1' ' HD3' ' A' ' 79' ' ' ARG . 1.9 m-85 -132.21 154.42 81.63 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-O 120.835 0.35 . . . . 0.0 111.03 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -84.23 167.15 12.36 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.832 2.355 . . . . 0.0 112.511 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.455 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 80.2 m80 -47.08 115.25 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.1 t-105 -99.02 129.98 28.42 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.503 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.77 119.46 6.29 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.374 2.049 . . . . 0.0 111.085 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.05 174.43 10.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -143.01 155.65 44.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.323 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 28.7 mm -78.13 138.4 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.73 -20.33 5.5 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.044 0.449 . . . . 0.0 111.239 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 121.066 0.46 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 79.8 m-85 -95.8 155.14 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.694 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.436 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.4 mt-30 -96.55 106.78 19.09 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.598 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 63.1 t -100.84 142.99 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.32 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.78 122.0 45.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.189 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.647 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 75.1 m-85 -94.97 110.27 22.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.37 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.722 ' HE2' HD12 ' A' ' 89' ' ' ILE . 57.4 m-85 -58.83 -179.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.06 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.58 -63.66 0.63 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.146 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.9 p -91.07 -22.88 20.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 110.742 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.4 m170 64.57 36.52 8.48 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.598 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.32 157.04 16.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.44 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -131.79 149.97 52.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.313 0.578 . . . . 0.0 111.978 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.58 170.88 20.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.067 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 52.0 m-85 -105.94 86.58 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 0.0 110.875 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.813 HD13 ' HB1' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -98.23 156.84 16.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.126 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.559 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -91.98 169.46 32.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.295 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 42.2 Cg_endo -67.54 -20.79 47.08 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.459 2.106 . . . . 0.0 112.375 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -27.83 67.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.969 0.414 . . . . 0.0 110.504 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -100.72 12.43 37.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.761 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.8 mp -108.79 137.44 46.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.658 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.8 m-85 -136.17 158.16 74.22 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.558 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.639 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.6 Cg_exo -71.71 111.5 3.15 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.393 2.062 . . . . 0.0 111.235 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.5 t80 -45.63 -59.02 2.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.358 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -50.88 -39.55 54.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.9 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.1 mm-40 -70.6 -39.83 73.57 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.464 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 48.9 m -105.35 11.08 33.2 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.43 -49.46 74.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.797 0.332 . . . . 0.0 111.524 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.54 -26.12 64.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.649 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -84.99 -46.95 10.73 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.464 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 2.5 m-30 -99.77 -13.04 19.43 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -80.65 71.15 2.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.043 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.417 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.0 mttt -149.05 153.14 37.78 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.598 0.237 . . . . 0.0 110.39 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -51.17 153.31 9.57 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.501 2.134 . . . . 0.0 112.617 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -136.49 163.49 30.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.595 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -81.87 -16.47 50.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.196 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HD3' ' CD1' ' A' ' 23' ' ' TYR . 17.9 mmm180 -64.54 -15.64 61.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.989 0.424 . . . . 0.0 110.809 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt 63.19 140.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.094 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.96 -17.0 53.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.399 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.6 t80 -58.54 -55.5 34.28 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.933 0.397 . . . . 0.0 110.658 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 m -53.58 -45.53 69.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.196 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.96 -31.69 7.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.997 0.427 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.02 -31.83 61.39 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.899 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.667 ' O ' HG22 ' A' ' 89' ' ' ILE . 19.7 mt -61.01 -43.74 98.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 0.0 110.318 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.8 t90 -63.51 -45.51 90.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.991 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.2 mp0 -62.31 -50.99 69.46 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.722 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -52.47 -26.02 8.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.731 0.3 . . . . 0.0 111.783 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.99 -44.79 5.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -80.42 -32.3 37.41 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.3 87.85 3.18 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 98.7 Cg_endo -79.47 -12.55 13.9 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.702 2.268 . . . . 0.0 113.029 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.419 HG22 ' NH1' ' A' ' 29' ' ' ARG . 21.0 p -103.78 12.67 34.3 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.552 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.3 p . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 111.33 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.957 0.408 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.1 m -51.98 129.38 26.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.428 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.402 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 100.87 -14.91 58.61 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.91 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.04 138.16 51.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.775 HD23 ' HG3' ' A' ' 29' ' ' ARG . 62.0 mt -91.79 119.66 31.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.246 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 m -140.77 171.27 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.133 0.492 . . . . 0.0 111.894 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 10.0 m-85 -109.79 136.62 48.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.565 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.644 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.09 124.6 52.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.098 0.475 . . . . 0.0 111.841 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -91.99 131.58 37.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.82 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mtp -129.04 147.52 50.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.701 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 115.29 5.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 100.46 3.96 55.12 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.823 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -152.75 153.62 30.39 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.628 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.76 167.7 18.34 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.585 2.19 . . . . 0.0 112.382 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.453 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 71.2 m80 -47.57 115.23 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.588 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.93 130.51 27.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.245 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.95 120.83 8.8 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.171 1.914 . . . . 0.0 111.179 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.67 175.7 9.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.277 0.56 . . . . 0.0 112.241 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.775 ' HG3' HD23 ' A' ' 15' ' ' LEU . 5.3 ttp180 -142.78 155.73 44.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.439 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.9 mm -78.88 135.2 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.92 -20.23 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.074 0.464 . . . . 0.0 111.73 -179.704 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.009 0.433 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 82.5 m-85 -94.77 154.48 17.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.758 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -99.27 107.0 19.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.64 HG11 HD21 ' A' ' 63' ' ' LEU . 7.1 m -103.46 150.4 6.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.411 0.624 . . . . 0.0 112.339 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 49.3 t80 -105.44 124.56 49.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.992 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.644 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 70.0 m-85 -93.31 108.94 20.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.648 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.698 ' CE2' HD12 ' A' ' 89' ' ' ILE . 48.2 m-85 -61.37 177.9 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.933 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.96 -63.48 0.93 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.96 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -91.42 -22.37 20.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.0 110.779 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 10.6 m-70 64.41 37.02 8.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.461 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -91.65 155.47 18.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 140.29 53.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.194 0.521 . . . . 0.0 111.393 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.552 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.36 178.11 10.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.428 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.2 m-85 -119.97 127.18 52.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.2 mp -138.8 161.74 36.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.43 176.37 35.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.703 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.72 -24.98 54.22 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.622 2.214 . . . . 0.0 112.41 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -69.57 -27.14 64.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.857 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 3.9 m-20 -100.22 6.9 44.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.336 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.64 HD21 HG11 ' A' ' 47' ' ' VAL . 22.4 mt -114.23 138.2 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.733 0.302 . . . . 0.0 110.32 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.7 m-85 -137.13 159.58 69.27 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.057 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.9 Cg_exo -70.21 113.91 3.6 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.674 2.25 . . . . 0.0 111.63 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 89.1 t80 -53.7 -59.5 4.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.683 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -49.0 -42.74 38.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.124 0.488 . . . . 0.0 111.648 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.94 -39.58 72.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.565 -179.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -105.29 10.23 33.64 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.4 ptpt -56.38 -44.28 80.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.659 0.266 . . . . 0.0 111.713 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mm-40 -68.55 -32.92 73.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 13.1 ptpt -83.99 -43.32 15.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.433 ' CD1' ' HG3' ' A' ' 72' ' ' LYS . 18.2 m-30 -98.35 -8.52 26.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.24 75.27 2.05 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.039 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mmmm -148.55 159.32 38.87 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.613 0.206 . . . . 0.0 110.511 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.59 151.89 59.46 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.585 2.19 . . . . 0.0 112.516 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.11 170.29 15.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.616 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -15.68 28.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.356 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -66.34 -14.81 62.62 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.984 0.421 . . . . 0.0 110.716 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt 63.4 144.17 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.075 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.36 -18.7 35.78 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.594 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 15.1 t80 -58.61 -55.55 33.67 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.044 0.45 . . . . 0.0 110.692 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -52.89 -45.67 67.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.062 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -48.56 -31.39 6.49 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.985 0.421 . . . . 0.0 110.543 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.06 -31.55 61.63 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.85 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 89' ' ' ILE . 89.0 mt -60.94 -43.8 98.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.226 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -64.05 -44.91 91.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.597 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -63.51 -50.87 67.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.698 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -51.9 -27.5 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 111.828 -179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.44 -44.68 6.1 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.82 -32.96 40.67 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.23 87.46 3.24 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.817 0.342 . . . . 0.0 111.257 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 3.5 Cg_exo -76.58 -13.73 18.11 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.038 2.492 . . . . 0.0 112.644 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.1 p -104.04 13.08 33.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.537 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.597 HG11 ' HG2' ' A' ' 88' ' ' GLU . 15.0 p . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.929 0.395 . . . . 0.0 111.447 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm . . . . . 0 N--CA 1.455 -0.198 0 CA-C-O 120.879 0.371 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.27 127.38 19.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.263 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.88 -13.45 60.68 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.729 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 5.9 m-20 -70.49 137.18 50.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.84 0.352 . . . . 0.0 111.072 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 mt -90.18 115.36 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 110.3 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.2 m -138.65 170.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.581 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -109.69 136.7 48.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.79 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.659 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -111.87 121.4 44.93 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.473 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 2.4 tptt -93.51 129.15 39.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.011 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.8 mtp -126.55 147.98 49.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.693 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -59.53 119.59 7.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.04 -34.96 4.59 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.441 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -105.14 150.36 38.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.696 0.284 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HG3' ' OD1' ' A' ' 77' ' ' ASN . 97.7 Cg_endo -82.49 170.16 13.29 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.593 2.195 . . . . 0.0 112.226 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.441 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 61.2 m80 -51.06 112.11 0.67 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.525 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.439 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.7 t-105 -99.6 131.07 25.4 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.237 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 11.8 Cg_endo -54.98 121.35 9.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.295 1.996 . . . . 0.0 111.183 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.12 178.44 8.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 112.328 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 14' ' ' ASP . 15.8 ttp180 -143.66 157.76 44.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.489 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.08 116.12 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -110.93 -14.0 14.03 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 C--N 1.332 -0.193 0 CA-C-O 121.042 0.449 . . . . 0.0 111.474 -179.673 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 mttt . . . . . 0 N--CA 1.455 -0.185 0 CA-C-O 121.082 0.467 . . . . 0.0 111.472 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 86.9 m-85 -95.43 155.29 16.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -99.59 105.05 16.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.7 m -99.94 149.39 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.369 0.604 . . . . 0.0 112.041 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.46 ' HE2' HG13 ' A' ' 95' ' ' VAL . 23.1 t80 -105.08 123.93 48.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.259 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.539 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 85.3 m-85 -92.75 109.39 20.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.614 ' CE2' HD12 ' A' ' 89' ' ' ILE . 42.5 m-85 -61.49 176.12 0.52 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.746 0.307 . . . . 0.0 110.911 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.01 -62.48 0.96 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.083 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.2 p -91.7 -22.2 20.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 110.586 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.1 m80 63.4 36.89 11.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.416 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -90.85 154.74 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.5 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.41 144.25 49.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.311 0.577 . . . . 0.0 111.806 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.76 166.13 34.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.279 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 30.6 m-85 -108.94 88.61 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.233 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.659 HD22 ' HB1' ' A' ' 18' ' ' ALA . 1.3 mp -97.92 158.32 15.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.714 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -93.09 172.05 33.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.352 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.1 -23.98 52.62 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.483 2.122 . . . . 0.0 112.38 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -27.93 66.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.973 0.416 . . . . 0.0 110.691 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -98.62 12.63 34.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.995 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.714 HD13 ' O ' ' A' ' 59' ' ' GLY . 4.7 mp -108.98 137.4 46.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.431 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.7 m-85 -134.79 157.64 76.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.765 0.317 . . . . 0.0 111.11 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.532 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.2 Cg_exo -71.02 110.93 2.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.731 2.287 . . . . 0.0 111.508 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 70' ' ' LYS . 93.2 t80 -55.29 -60.82 2.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.914 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -41.95 38.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.014 0.435 . . . . 0.0 111.48 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.31 -39.69 71.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.559 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 m -104.91 8.48 34.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.3 ptmt -56.55 -45.89 80.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.721 0.296 . . . . 0.0 111.337 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.44 -26.57 64.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.525 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.506 ' HG2' ' CE1' ' A' ' 73' ' ' PHE . 1.2 ttpm? -84.82 -45.7 12.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.506 ' CE1' ' HG2' ' A' ' 72' ' ' LYS . 18.8 m-30 -101.93 -6.15 23.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -86.44 75.39 2.25 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.284 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -151.91 153.09 31.11 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.523 0.201 . . . . 0.0 110.718 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.36 136.22 8.55 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.701 2.268 . . . . 0.0 112.504 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.437 ' OD1' ' HG3' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -111.07 171.19 7.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.915 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.15 -21.61 18.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.748 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -67.34 -13.77 62.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.935 0.398 . . . . 0.0 110.585 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt 63.99 143.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.814 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.96 -17.23 54.36 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.931 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.621 ' HE1' HD11 ' A' ' 86' ' ' LEU . 13.0 t80 -59.13 -51.28 70.68 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.956 0.408 . . . . 0.0 110.322 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.45 -46.98 66.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.993 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -48.66 -32.76 8.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.979 0.418 . . . . 0.0 110.26 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.62 -31.76 60.26 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.788 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.643 ' O ' HG22 ' A' ' 89' ' ' ILE . 71.3 mt -61.32 -43.79 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.168 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -64.78 -45.03 88.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.002 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.537 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.7 OUTLIER -62.81 -50.9 69.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 86' ' ' LEU . 1.2 tt -52.32 -26.85 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.807 0.337 . . . . 0.0 111.768 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.527 ' HG2' HG23 ' A' ' 89' ' ' ILE . 6.8 mm-40 -99.63 -44.75 6.02 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.74 -30.77 32.29 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -156.34 89.23 2.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 111.202 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 86.4 Cg_endo -78.46 -12.42 15.43 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.644 2.229 . . . . 0.0 112.72 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.1 p -102.34 10.98 38.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.586 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.559 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.0 p . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.819 0.343 . . . . 0.0 111.347 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.918 0.389 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.0 m -51.81 132.07 31.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.544 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.13 -12.14 68.56 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.909 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.77 139.21 50.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -91.14 116.56 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.964 0.411 . . . . 0.0 110.398 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.7 m -139.76 170.29 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.622 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.522 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 17.9 m-85 -111.09 135.86 50.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.521 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.687 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.93 123.04 49.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.345 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 23.8 tptp -92.07 130.95 37.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.163 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtm -127.04 147.82 50.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.461 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 113.47 4.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 111.008 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.99 -27.37 14.65 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.689 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.91 157.97 49.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.787 0.327 . . . . 0.0 110.942 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.47 166.44 12.16 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.802 2.335 . . . . 0.0 112.346 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.505 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 59.0 m80 -47.17 114.02 0.78 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.497 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.459 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.66 130.63 27.45 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.611 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.51 119.1 5.85 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.337 2.024 . . . . 0.0 111.056 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.6 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.2 175.09 10.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 112.438 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 14.2 ttp180 -142.52 156.49 45.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.449 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.437 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 24.6 mm -79.9 138.8 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.26 -20.8 5.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.957 0.408 . . . . 0.0 111.237 -179.819 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt . . . . . 0 N--CA 1.456 -0.143 0 CA-C-O 120.948 0.404 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -94.11 157.95 15.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.199 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.93 107.55 20.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.659 HG21 HD21 ' A' ' 63' ' ' LEU . 84.3 t -103.54 142.57 17.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.445 0.641 . . . . 0.0 112.567 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -105.55 121.87 44.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.528 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.687 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 82.0 m-85 -94.03 106.51 18.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.087 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.702 ' CE2' HD12 ' A' ' 89' ' ' ILE . 49.7 m-85 -57.57 176.88 0.12 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.873 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 69.81 -63.57 0.68 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.384 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 80.9 p -90.16 -23.24 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.702 0.287 . . . . 0.0 110.712 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' THR . 3.9 m170 65.96 34.03 7.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.12 150.99 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.0 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.81 140.66 52.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.168 0.509 . . . . 0.0 111.329 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.78 168.22 27.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.333 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -109.32 125.48 52.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.027 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.557 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 19.8 mt -139.36 160.67 39.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.46 -179.78 40.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.28 -26.81 41.45 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.521 2.147 . . . . 0.0 112.206 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -69.63 -22.56 63.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.008 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.1 m-20 -98.99 3.6 47.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.49 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 47' ' ' VAL . 18.3 mt -115.0 139.65 49.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 110.578 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -136.6 166.28 28.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.422 ' HB2' ' CG ' ' A' ' 68' ' ' GLU . 5.2 Cg_exo -73.21 111.15 3.21 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.732 2.288 . . . . 0.0 111.707 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.1 t80 -49.99 -58.44 5.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.484 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -49.04 -41.08 33.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.564 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.422 ' CG ' ' HB2' ' A' ' 65' ' ' PRO . 5.0 mm-40 -70.97 -39.75 72.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.659 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 3.6 m -103.41 13.89 32.63 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 2.2 mtmp? -55.53 -44.99 77.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.364 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.71 -40.82 88.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.83 -43.77 16.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.9 m-30 -94.85 -19.65 20.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.68 73.84 2.43 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.041 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 12.1 mttt -149.22 153.57 37.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.92 155.51 8.33 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.623 2.215 . . . . 0.0 112.638 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -136.43 165.52 25.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.579 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -85.72 -16.1 40.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.256 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -13.82 61.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.975 0.417 . . . . 0.0 110.682 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt 63.76 142.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.203 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.55 -16.7 55.68 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.468 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 31.6 t80 -59.01 -56.82 17.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.003 0.43 . . . . 0.0 110.865 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -45.35 66.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.057 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.68 -30.06 5.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.048 0.451 . . . . 0.0 110.535 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.93 -31.89 57.45 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.162 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 89' ' ' ILE . 12.7 mt -60.43 -43.44 96.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.035 0.445 . . . . 0.0 110.254 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 62.9 t90 -63.59 -45.74 89.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.71 -50.58 70.58 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.702 HD12 ' CE2' ' A' ' 50' ' ' PHE . 1.1 tt -52.9 -27.05 12.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 111.758 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -99.29 -44.82 6.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -79.65 -31.54 41.52 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.474 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . 1.0 OUTLIER -157.06 86.9 2.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 111.302 -179.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.93 -12.93 26.39 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.93 2.42 . . . . 0.0 112.65 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.0 p -106.98 14.61 26.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.587 0.232 . . . . 0.0 111.605 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.58 HG12 ' HE1' ' A' ' 50' ' ' PHE . 14.3 p . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 121.008 0.432 . . . . 0.0 111.69 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.931 0.396 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 m -52.87 130.72 34.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.277 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.76 68.54 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.086 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.65 140.76 48.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.915 0.388 . . . . 0.0 111.299 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HG3' ' A' ' 29' ' ' ARG . 67.6 mt -91.79 119.16 31.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.079 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.8 m -138.84 171.91 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.224 0.535 . . . . 0.0 111.992 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 8.5 m-85 -111.08 134.81 52.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.656 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.805 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -112.36 124.3 52.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.006 0.431 . . . . 0.0 111.591 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -91.18 132.81 35.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.906 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -131.23 150.11 52.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.7 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' O ' ' CE2' ' A' ' 23' ' ' TYR . 1.2 mtpm? -62.46 121.8 14.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.104 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 81.82 15.93 74.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.897 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.427 ' CE2' ' O ' ' A' ' 21' ' ' LYS . 3.4 m-85 -151.4 147.96 21.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.63 0.252 . . . . 0.0 110.841 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.16 165.01 17.15 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.615 2.21 . . . . 0.0 112.221 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -47.51 115.42 1.12 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.571 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.448 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.76 130.13 28.44 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-O 120.527 0.203 . . . . 0.0 111.527 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.14 121.45 9.68 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.373 2.049 . . . . 0.0 111.155 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.707 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -145.61 176.09 9.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.789 ' HG3' HD23 ' A' ' 15' ' ' LEU . 11.4 ttp180 -141.43 154.63 45.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.492 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mm -81.8 140.12 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 0.0 110.541 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.17 -22.5 7.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.794 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.421 ' CG ' ' HB3' ' A' ' 46' ' ' GLN . 2.0 pt-20 . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.111 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt . . . . . 0 N--CA 1.454 -0.272 0 CA-C-O 121.085 0.469 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 40.4 m-85 -93.77 154.71 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.122 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.421 ' HB3' ' CG ' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -96.65 98.82 10.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.707 ' CG2' ' HB1' ' A' ' 28' ' ' ALA . 2.2 p -99.84 148.92 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.358 -177.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 23.3 t80 -105.96 125.1 50.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.252 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -91.39 113.16 25.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.699 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.769 ' HE2' HD12 ' A' ' 89' ' ' ILE . 44.0 m-85 -63.31 174.61 1.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.02 -61.75 0.75 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.3 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.8 p -90.36 -23.49 21.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.66 0.267 . . . . 0.0 110.723 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.402 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 10.8 m170 63.56 37.93 10.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.524 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -93.32 156.67 16.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.814 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 143.19 50.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.322 0.582 . . . . 0.0 111.926 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.65 168.2 27.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.5 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 75.6 m-85 -111.58 89.81 3.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.038 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.805 HD22 ' HB1' ' A' ' 18' ' ' ALA . 1.7 mp -97.72 157.45 16.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.251 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -91.76 171.77 34.92 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.409 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.18 -24.66 44.07 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.45 2.1 . . . . 0.0 112.316 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -27.73 67.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.423 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.63 14.7 31.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.858 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 59' ' ' GLY . 2.4 mp -113.2 136.29 52.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.618 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.6 m-85 -135.93 155.47 77.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.636 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.8 Cg_exo -72.54 112.23 3.42 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.481 2.121 . . . . 0.0 111.2 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.7 t80 -48.34 -58.78 4.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.172 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -43.35 34.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.928 0.394 . . . . 0.0 112.033 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 5.8 mm-40 -70.28 -39.74 74.74 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 51.5 m -105.58 10.72 32.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.9 ptpt -55.97 -48.13 76.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.817 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.9 mm-40 -72.54 -19.91 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.586 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -84.92 -49.83 8.03 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 7.3 m-85 -104.41 -4.44 22.8 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.95 71.46 2.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.193 -1.004 . . . . 0.0 113.066 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -149.57 151.19 32.68 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.699 0.285 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.29 156.0 18.31 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.565 2.177 . . . . 0.0 112.7 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -138.77 -172.51 3.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.378 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -99.03 -13.81 19.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.058 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -67.87 -14.35 62.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt 62.88 142.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.175 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.55 -15.89 59.17 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.733 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.448 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 35.6 t80 -57.38 -58.7 7.1 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.061 0.458 . . . . 0.0 110.907 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.457 ' HA ' HD12 ' A' ' 86' ' ' LEU . 1.1 m -51.76 -46.17 64.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.281 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -48.79 -32.7 9.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.903 0.382 . . . . 0.0 110.501 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.45 -31.68 60.69 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.839 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.641 ' O ' HG22 ' A' ' 89' ' ' ILE . 84.2 mt -60.49 -43.63 96.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.012 0.434 . . . . 0.0 110.287 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.8 t90 -63.74 -43.0 97.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.926 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.565 ' OE1' HG11 ' A' ' 95' ' ' VAL . 39.6 mm-40 -62.84 -52.38 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.769 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.25 -25.71 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -44.75 5.73 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -81.05 -32.95 33.83 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -156.39 88.9 2.78 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.76 0.314 . . . . 0.0 111.152 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 72.2 Cg_endo -77.44 -12.05 17.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.662 2.242 . . . . 0.0 112.897 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.7 p -106.51 14.44 27.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.607 0.241 . . . . 0.0 111.587 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.565 HG11 ' OE1' ' A' ' 88' ' ' GLU . 11.9 p . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.874 0.369 . . . . 0.0 111.404 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.96 0.409 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.8 m -52.4 129.92 29.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.572 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.26 -13.43 63.14 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.048 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.3 138.14 51.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 111.057 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' ' 29' ' ' ARG . 86.5 mt -91.59 117.45 29.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.357 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.2 m -139.99 172.1 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.851 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 13.4 m-85 -113.14 135.72 53.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.722 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.759 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.82 123.3 49.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 0.0 111.432 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 8.1 tptp -92.37 133.86 35.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.0 mtm -128.32 151.86 48.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.78 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.86 102.15 3.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.51 -1.21 23.53 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.818 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -146.91 149.71 36.77 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.706 0.289 . . . . 0.0 110.716 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.63 162.97 34.76 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.636 2.224 . . . . 0.0 112.387 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.405 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 80.1 m80 -47.72 116.78 1.58 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.62 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.452 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.5 t-105 -98.63 132.09 24.64 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.48 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.34 120.98 9.2 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.37 2.047 . . . . 0.0 110.969 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -145.16 176.39 9.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 0.0 112.28 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.637 ' NH1' HG22 ' A' ' 94' ' ' THR . 1.8 ttt180 -142.23 155.72 45.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.453 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.437 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 23.6 mm -80.4 138.73 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.376 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -126.05 -21.58 4.29 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-O 120.907 0.384 . . . . 0.0 111.28 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.7 mttt . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.905 0.383 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -95.23 157.64 15.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.033 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -98.69 108.18 20.81 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 63' ' ' LEU . 45.4 t -104.31 141.4 19.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.397 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.536 ' HE2' HG13 ' A' ' 95' ' ' VAL . 25.8 t80 -106.57 122.22 45.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.897 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.759 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 75.7 m-85 -94.34 109.42 21.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.156 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.792 ' HE2' HD12 ' A' ' 89' ' ' ILE . 73.9 m-85 -58.78 -178.97 0.06 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.998 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.61 -63.82 0.44 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.255 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.5 p -91.95 -22.52 19.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.843 0.354 . . . . 0.0 110.633 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.8 m170 64.81 35.44 8.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.973 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -89.8 153.12 20.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.683 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.12 141.6 50.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.318 0.58 . . . . 0.0 111.614 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.568 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.49 170.76 21.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -115.13 126.96 55.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 0.0 111.069 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 26.1 mt -139.62 162.03 36.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.0 176.62 36.21 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.364 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.96 -25.42 59.52 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.493 2.129 . . . . 0.0 112.269 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.71 -26.34 64.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.94 8.33 45.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 47' ' ' VAL . 53.0 mt -117.06 139.07 51.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.694 0.283 . . . . 0.0 110.408 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.4 m-85 -137.39 157.89 73.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.576 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 13.4 Cg_exo -67.72 113.82 3.11 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.188 1.925 . . . . 0.0 111.395 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' LYS . 81.4 t80 -48.97 -57.15 6.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.031 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 15.7 mm-40 -51.46 -39.83 58.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.02 0.438 . . . . 0.0 111.984 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 15.8 mm-40 -70.08 -39.81 75.37 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.454 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 6.4 m -106.78 12.09 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 2.4 ptpp? -56.59 -48.74 76.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 0.0 111.024 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -72.33 -20.95 61.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.459 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.38 -49.34 8.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 8.3 m-85 -100.68 -13.56 18.47 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.82 73.05 1.96 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.972 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -149.75 147.98 24.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.663 0.268 . . . . 0.0 110.562 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.5 153.35 14.03 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.496 2.131 . . . . 0.0 112.769 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 82' ' ' PHE . 51.1 p-10 -139.08 -173.27 3.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.316 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -99.97 -13.31 19.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.971 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 79' ' ' ARG . 21.1 mmt180 -67.25 -14.5 62.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.927 0.394 . . . . 0.0 110.557 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp 63.06 141.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.261 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.21 -16.38 58.92 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.875 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.452 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 47.7 t80 -57.64 -57.07 14.31 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.928 0.394 . . . . 0.0 110.824 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -52.2 -46.22 65.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.138 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -48.86 -33.05 9.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.075 0.464 . . . . 0.0 110.289 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.92 -32.75 58.49 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.807 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.598 ' O ' HG22 ' A' ' 89' ' ' ILE . 46.2 mt -60.49 -43.66 96.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.108 0.48 . . . . 0.0 109.956 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -64.09 -45.35 89.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.895 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.487 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -62.59 -51.89 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.792 HD12 ' HE2' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -52.23 -26.34 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.15 -44.83 6.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.57 -33.19 31.8 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -156.57 81.52 3.5 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.758 0.313 . . . . 0.0 110.974 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.0 Cg_endo -73.99 -8.94 21.78 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.627 2.218 . . . . 0.0 112.953 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.637 HG22 ' NH1' ' A' ' 29' ' ' ARG . 72.6 p -101.48 12.25 37.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.586 0.232 . . . . 0.0 111.515 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.536 HG13 ' HE2' ' A' ' 48' ' ' PHE . 9.8 p . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.812 0.339 . . . . 0.0 111.325 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 120.902 0.382 . . . . 0.0 110.786 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.4 t -53.67 131.85 39.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.083 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.71 -12.19 64.48 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.265 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -73.25 142.94 47.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 111.207 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.709 HD23 ' HG3' ' A' ' 29' ' ' ARG . 49.1 mt -91.79 119.6 31.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.391 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.482 HG21 HD22 ' A' ' 63' ' ' LEU . 29.3 m -140.77 170.1 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.661 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 8.4 m-85 -109.84 136.51 49.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.695 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.608 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.95 122.72 47.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.007 0.432 . . . . 0.0 111.453 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -91.35 128.71 37.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.882 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.6 mtp -126.96 148.12 50.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.658 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.64 125.4 23.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.907 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.435 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 85.01 11.48 76.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.977 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -154.39 152.47 26.26 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 110.782 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.56 166.31 13.78 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.725 2.283 . . . . 0.0 112.233 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 66.7 m80 -47.19 114.82 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.601 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.2 130.34 28.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.514 0.197 . . . . 0.0 111.523 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.35 119.53 6.53 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.234 1.956 . . . . 0.0 111.065 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.602 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.19 175.44 10.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.29 0.567 . . . . 0.0 112.334 -178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.709 ' HG3' HD23 ' A' ' 15' ' ' LEU . 15.8 ttp180 -142.74 156.92 45.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.332 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.3 mm -78.26 136.26 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -125.5 -21.4 4.52 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.362 . . . . 0.0 111.002 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.7 mttt . . . . . 0 N--CA 1.456 -0.125 0 CA-C-O 121.108 0.48 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -95.12 159.91 14.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.033 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -99.16 107.51 19.88 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.726 HG21 HD21 ' A' ' 63' ' ' LEU . 84.7 t -103.59 143.85 14.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.335 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.515 ' HE2' HG13 ' A' ' 95' ' ' VAL . 42.5 t80 -106.19 122.73 46.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.829 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.608 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 89.8 m-85 -94.9 110.02 21.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.922 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.766 ' HE2' HD12 ' A' ' 89' ' ' ILE . 58.9 m-85 -59.73 178.91 0.14 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.884 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.7 -63.91 0.65 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.117 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.2 p -91.35 -22.63 20.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.508 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.7 m80 63.71 36.58 10.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.346 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.75 155.07 19.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.695 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.68 141.8 51.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.226 0.536 . . . . 0.0 111.574 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.491 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.31 168.25 27.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.84 125.17 51.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.817 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.4 mt -139.55 162.29 35.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.63 177.79 40.72 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.72 -25.58 39.86 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.624 2.216 . . . . 0.0 112.362 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -69.04 -21.72 64.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.128 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.7 m-20 -99.47 4.76 46.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.556 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 47' ' ' VAL . 25.9 mt -113.4 139.72 48.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.707 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.48 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 m-85 -137.22 163.8 46.45 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.816 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.434 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 3.0 Cg_exo -74.01 111.7 3.37 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.669 2.246 . . . . 0.0 111.75 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -50.77 -57.32 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.646 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.89 -40.79 57.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.995 0.426 . . . . 0.0 111.71 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 3.9 mm-40 -69.89 -39.93 75.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.59 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.461 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 4.3 m -108.43 13.58 25.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.3 ptpt -56.64 -47.02 80.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.849 0.357 . . . . 0.0 111.284 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -70.62 -24.89 62.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.744 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -84.73 -47.74 10.13 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.5 m-30 -101.02 -7.81 22.92 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.9 72.96 2.75 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.143 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.438 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.7 mtmt -148.98 155.68 40.49 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.554 0.216 . . . . 0.0 110.435 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.91 155.37 23.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.549 2.166 . . . . 0.0 112.687 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -136.78 172.93 12.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.485 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.93 -15.79 27.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.366 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.7 mmt-85 -66.05 -14.44 61.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.994 0.426 . . . . 0.0 110.769 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp 63.81 141.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.168 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.4 -17.12 53.94 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.653 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 23.0 t80 -58.96 -56.33 23.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.038 0.447 . . . . 0.0 110.724 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.81 -45.43 67.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.038 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.78 -30.95 6.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.956 0.407 . . . . 0.0 110.495 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.59 -31.9 60.15 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.992 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.595 ' O ' HG22 ' A' ' 89' ' ' ILE . 57.9 mt -60.77 -43.77 97.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 110.3 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -64.06 -44.94 90.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.599 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.8 OUTLIER -63.56 -51.53 65.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.766 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -51.44 -28.37 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.716 0.293 . . . . 0.0 111.685 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -98.86 -44.67 6.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -80.2 -32.56 38.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -157.05 91.24 2.44 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.678 0.275 . . . . 0.0 111.26 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 83.8 Cg_endo -78.1 -10.78 16.48 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.503 2.135 . . . . 0.0 112.686 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.43 HG22 HH12 ' A' ' 29' ' ' ARG . 0.8 OUTLIER -103.27 11.85 36.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.496 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.599 HG11 ' HG2' ' A' ' 88' ' ' GLU . 12.4 p . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 111.364 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.908 0.385 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.2 m -51.87 130.62 29.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.36 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.01 -11.94 68.96 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.859 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -71.04 138.83 50.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.751 0.31 . . . . 0.0 110.985 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.9 mt -91.1 116.38 28.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 110.318 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.501 HG21 HD22 ' A' ' 63' ' ' LEU . 31.3 m -139.4 170.78 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.698 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 36.5 m-85 -110.57 138.59 46.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.746 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.696 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -114.1 120.4 40.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.939 0.399 . . . . 0.0 111.195 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 129.3 39.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.243 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 mtm -119.22 161.12 20.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.611 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 119.72 13.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.108 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.63 -4.2 85.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.017 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.56 150.6 73.34 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.833 0.316 . . . . 0.0 110.756 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.81 160.74 18.79 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.742 2.294 . . . . 0.0 112.513 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 69.9 m80 -48.98 115.45 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.612 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.469 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 4.4 t-105 -98.67 133.5 22.48 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.0 119.26 6.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.384 2.056 . . . . 0.0 110.956 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.48 174.8 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.361 0.6 . . . . 0.0 112.394 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.725 HH12 HG22 ' A' ' 94' ' ' THR . 12.9 ttp180 -142.98 156.75 44.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.477 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.409 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 31.7 mm -78.85 135.79 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.6 -21.58 4.1 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 121.012 0.434 . . . . 0.0 111.593 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.96 0.41 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -93.42 160.56 14.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.877 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.17 109.72 22.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.577 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 57.5 t -104.03 141.51 19.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.249 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -105.12 121.32 43.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.702 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.664 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 84.1 m-85 -93.52 106.74 18.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.482 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.759 ' HE2' HD12 ' A' ' 89' ' ' ILE . 49.4 m-85 -58.12 177.21 0.13 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.2 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.7 -63.02 0.88 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.034 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.1 p -91.45 -22.47 20.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.701 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.2 m170 63.81 35.31 11.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.303 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -89.92 153.71 20.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.545 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.34 141.71 51.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.31 0.576 . . . . 0.0 111.614 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.533 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.0 170.59 21.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -111.49 126.26 54.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.077 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.696 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 86.1 mt -138.82 160.79 38.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.26 179.86 39.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.512 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HA ' HD12 ' A' ' 63' ' ' LEU . 15.4 Cg_exo -65.99 -27.86 50.1 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.599 2.199 . . . . 0.0 112.221 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -69.3 -23.31 63.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.175 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -98.69 7.3 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.541 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.501 HD22 HG21 ' A' ' 16' ' ' VAL . 10.7 mt -116.21 140.01 49.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 110.697 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 m-85 -136.55 161.56 61.25 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.695 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 6.9 Cg_exo -71.43 109.91 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.437 2.092 . . . . 0.0 111.431 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 89.0 t80 -46.76 -58.72 3.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.223 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -38.41 59.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.082 0.468 . . . . 0.0 111.427 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 4.1 mm-40 -70.85 -39.8 72.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.444 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.478 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 1.2 m -104.67 11.62 33.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 66' ' ' TYR . 9.3 tttt -56.09 -49.43 73.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.795 0.331 . . . . 0.0 111.863 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -67.5 -35.19 78.65 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 2.7 ptpt -83.62 -43.83 15.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 18.9 m-30 -96.05 -17.77 20.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -83.37 73.51 2.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.02 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 74' ' ' GLY . 2.7 mttp -147.41 151.69 40.59 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.576 0.227 . . . . 0.0 110.409 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.52 152.03 9.47 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.495 2.13 . . . . 0.0 112.465 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.41 169.28 17.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.082 0.468 . . . . 0.0 111.718 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -15.19 36.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.366 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -14.93 62.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.958 0.409 . . . . 0.0 110.608 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm 63.37 140.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.142 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.85 -15.89 58.13 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.493 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 38.8 t80 -58.52 -58.29 9.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.916 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.82 -45.73 64.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.073 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.99 -32.59 9.45 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.974 0.416 . . . . 0.0 110.379 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -72.75 -31.95 61.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.751 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.593 ' O ' HG22 ' A' ' 89' ' ' ILE . 98.3 mt -60.72 -43.5 97.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.07 0.462 . . . . 0.0 110.179 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 59.1 t90 -64.04 -45.33 89.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.066 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 1.8 mp0 -62.86 -51.61 66.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.759 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.27 -27.21 10.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.777 0.322 . . . . 0.0 111.654 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.39 -44.84 6.36 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -81.48 -31.75 32.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -155.62 87.19 3.16 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.738 0.304 . . . . 0.0 111.104 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 76.0 Cg_endo -77.57 -12.17 16.88 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.687 2.258 . . . . 0.0 112.85 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.725 HG22 HH12 ' A' ' 29' ' ' ARG . 75.6 p -105.47 12.93 30.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.559 HG12 ' HE1' ' A' ' 50' ' ' PHE . 11.9 p . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 120.882 0.373 . . . . 0.0 111.421 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 121.039 0.447 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 p -52.11 129.6 27.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.049 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.08 -10.49 71.77 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.911 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -72.95 141.83 47.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.769 HD23 ' HG3' ' A' ' 29' ' ' ARG . 21.2 mt -92.22 117.23 29.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.8 m -139.43 172.35 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.632 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.461 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 10.6 m-85 -113.13 136.94 52.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.992 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.644 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -112.73 121.82 45.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.89 0.376 . . . . 0.0 111.327 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -90.85 131.37 36.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.945 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.3 mtm -132.05 145.7 51.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.788 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 118.63 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.629 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 102.11 -0.51 51.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.61 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 0.5 OUTLIER -155.89 143.08 13.73 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 58.5 Cg_endo -72.69 168.36 24.69 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.34 2.027 . . . . 0.0 112.366 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 39.1 m80 -45.66 115.9 1.06 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.043 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.423 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.6 t-105 -98.27 131.94 25.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.396 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 44.8 Cg_exo -53.64 119.0 5.51 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.244 1.963 . . . . 0.0 111.044 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.594 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.47 174.32 11.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.34 0.59 . . . . 0.0 112.389 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.769 ' HG3' HD23 ' A' ' 15' ' ' LEU . 15.2 ttp180 -142.72 156.23 44.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.434 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.0 mm -77.56 135.22 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.3 -20.01 4.55 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.998 0.427 . . . . 0.0 111.019 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.907 0.384 . . . . 0.0 111.304 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -94.17 158.68 15.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.946 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -98.85 109.83 22.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.594 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 59.6 t -104.18 143.02 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.279 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -107.0 123.1 47.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.945 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.644 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 81.2 m-85 -94.93 111.69 23.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.78 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.689 ' HE2' HD12 ' A' ' 89' ' ' ILE . 59.5 m-85 -60.71 178.82 0.2 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.991 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.51 -63.45 0.62 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.268 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.6 p -91.43 -23.02 20.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.962 0.41 . . . . 0.0 110.618 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.9 m170 63.6 38.24 9.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.342 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -92.08 154.2 18.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.637 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.99 141.75 51.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.259 0.552 . . . . 0.0 111.576 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.41 167.12 31.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.314 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -108.03 125.23 51.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.534 HD13 ' HB1' ' A' ' 18' ' ' ALA . 14.9 mt -139.94 162.15 35.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.083 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.488 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -92.75 170.37 32.1 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.286 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.25 -19.04 50.74 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.428 2.085 . . . . 0.0 112.324 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -28.55 67.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.587 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -99.48 14.22 30.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.852 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.2 mp -111.79 137.53 49.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.539 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.4 m-85 -137.51 155.13 75.54 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.912 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.611 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 14.5 Cg_exo -68.98 112.53 2.97 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.589 2.193 . . . . 0.0 111.6 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 70' ' ' LYS . 79.3 t80 -52.04 -58.92 5.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.056 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -49.36 -41.8 40.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.957 0.408 . . . . 0.0 112.022 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.07 -39.48 72.17 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -106.13 10.69 31.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -55.89 -45.83 78.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.755 0.312 . . . . 0.0 111.47 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -70.08 -24.88 63.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.925 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -84.69 -45.97 11.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.6 m-30 -101.82 -10.44 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.48 74.01 2.42 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.359 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -151.85 155.33 33.71 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.661 0.267 . . . . 0.0 110.666 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -47.14 139.52 15.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.744 2.296 . . . . 0.0 112.812 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.435 ' HB3' ' CB ' ' A' ' 82' ' ' PHE . 9.6 t-20 -112.41 162.89 15.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.358 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -20.42 25.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.726 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? -69.34 -13.51 62.42 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.979 0.418 . . . . 0.0 110.711 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 65.25 147.49 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.021 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.59 -19.59 35.87 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.68 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.629 ' HE1' HD11 ' A' ' 86' ' ' LEU . 11.9 t80 -57.88 -52.47 65.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.014 0.435 . . . . 0.0 110.545 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.51 -47.44 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.261 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -48.33 -32.45 7.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.036 0.446 . . . . 0.0 110.423 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.8 -31.81 57.81 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.436 -0.887 . . . . 0.0 111.928 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.629 HD11 ' HE1' ' A' ' 82' ' ' PHE . 82.8 mt -60.53 -43.69 96.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 0.0 110.285 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -64.06 -43.11 96.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.955 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.469 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 35.3 mm-40 -63.69 -51.88 63.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.689 HD12 ' HE2' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -51.88 -26.3 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HG2' HG23 ' A' ' 89' ' ' ILE . 8.2 mm-40 -101.48 -44.6 5.56 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.6 -32.81 41.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.47 89.05 2.74 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.76 0.314 . . . . 0.0 111.103 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 78.0 Cg_endo -77.76 -12.53 16.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.635 2.224 . . . . 0.0 112.705 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -102.26 11.57 37.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.733 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.555 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.2 p . . . . . 0 C--N 1.331 -0.217 0 CA-C-O 120.853 0.359 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 3.7 mmtt . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.888 0.375 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 t -52.92 126.97 22.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.495 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.47 -13.61 62.7 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.309 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -72.01 142.46 49.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.971 0.386 . . . . 0.0 111.147 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.627 HD23 ' HG3' ' A' ' 29' ' ' ARG . 59.3 mt -91.39 118.03 30.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.382 . . . . 0.0 110.327 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.94 173.93 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.791 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.417 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.8 m-85 -113.38 137.67 51.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.716 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.626 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.59 122.49 47.37 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.892 0.377 . . . . 0.0 111.425 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HD3' ' CG ' ' A' ' 25' ' ' HIS . 21.1 tptp -91.18 131.46 36.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.927 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mmm -124.7 155.21 39.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.774 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.85 111.45 7.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.74 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 102.6 -1.21 49.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.845 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.1 m-85 -146.02 150.25 41.55 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.308 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.49 166.92 23.5 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.672 2.248 . . . . 0.0 112.517 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.428 ' CG ' ' HD3' ' A' ' 19' ' ' LYS . 79.7 m80 -47.48 115.67 1.2 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.056 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.8 t-105 -98.25 130.9 27.33 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.05 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 11.0 Cg_endo -54.0 119.01 5.59 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.302 2.001 . . . . 0.0 111.054 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.607 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.19 175.8 9.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.32 0.581 . . . . 0.0 112.305 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.759 HH12 HG22 ' A' ' 94' ' ' THR . 21.2 ttp180 -143.13 156.96 44.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.379 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.411 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 13.4 mm -81.69 136.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -123.93 -16.76 6.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.118 0.485 . . . . 0.0 111.669 -179.658 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 0.7 OUTLIER -99.52 165.52 11.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.692 179.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -100.95 113.63 26.79 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.607 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 93.5 t -103.45 142.48 17.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.866 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.495 ' HE2' HG13 ' A' ' 95' ' ' VAL . 41.1 t80 -104.87 121.29 43.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.962 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.626 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 93.9 m-85 -94.43 108.71 20.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.643 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.7 ' CE2' HD12 ' A' ' 89' ' ' ILE . 50.0 m-85 -59.33 178.1 0.15 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.926 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 69.97 -63.62 0.71 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.097 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.8 p -91.29 -23.13 20.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.881 0.372 . . . . 0.0 110.502 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 m170 63.89 37.46 9.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.452 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -90.99 154.28 19.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.6 141.61 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.259 0.552 . . . . 0.0 111.509 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.29 167.36 30.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.361 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -107.17 124.83 50.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 mp -140.23 162.01 36.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.028 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.01 163.06 25.39 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.166 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.24 -17.98 49.48 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.448 2.099 . . . . 0.0 112.442 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -28.49 66.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.864 0.364 . . . . 0.0 110.656 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.54 12.23 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.88 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 6.5 mp -107.42 138.58 43.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.39 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.6 m-85 -137.38 147.96 59.98 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.109 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 68' ' ' GLU . 20.8 Cg_endo -61.82 109.15 0.73 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.666 2.244 . . . . 0.0 111.568 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' A' ' 70' ' ' LYS . 86.2 t80 -50.74 -58.26 6.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.878 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.4 mp0 -50.85 -39.62 54.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.164 0.507 . . . . 0.0 111.376 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 65' ' ' PRO . 33.8 mt-10 -70.68 -40.02 73.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.507 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.78 11.36 30.25 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.6 ptpp? -56.4 -45.72 80.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.827 0.346 . . . . 0.0 111.382 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 18.8 mt-10 -70.51 -26.54 63.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.859 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -83.86 -46.4 12.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 2.6 m-30 -100.18 -11.2 20.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.19 74.4 2.49 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.296 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -152.15 154.55 32.53 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.616 0.246 . . . . 0.0 110.63 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -44.98 136.21 10.16 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.707 2.271 . . . . 0.0 112.596 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.45 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -109.77 175.03 5.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.817 -178.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -100.7 -22.52 14.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.621 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -13.22 61.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.684 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt 63.99 144.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.968 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.85 -18.01 49.75 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.714 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 12.0 t80 -59.53 -50.44 73.9 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.895 0.379 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -52.58 -47.48 66.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.233 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -48.3 -30.89 5.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.01 0.434 . . . . 0.0 110.45 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.44 -31.19 59.28 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.052 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.647 ' O ' HG22 ' A' ' 89' ' ' ILE . 32.4 mt -60.64 -43.94 96.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 110.277 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.0 t90 -64.43 -45.24 88.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -62.61 -51.04 68.86 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -51.8 -26.99 7.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.784 0.325 . . . . 0.0 111.826 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -99.7 -44.8 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.22 -32.33 38.5 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -156.71 89.36 2.66 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.738 0.304 . . . . 0.0 111.079 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 93.2 Cg_endo -79.08 -11.44 14.88 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.677 2.251 . . . . 0.0 112.983 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.759 HG22 HH12 ' A' ' 29' ' ' ARG . 37.6 p -103.95 13.27 33.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.614 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.584 HG12 ' HE1' ' A' ' 50' ' ' PHE . 11.9 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.894 0.378 . . . . 0.0 111.4 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 120.782 0.325 . . . . 0.0 110.991 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.3 m -51.36 123.98 10.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.181 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.79 -13.87 56.24 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.238 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.44 140.46 50.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 111.211 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.8 mt -92.62 116.71 29.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.408 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 30.8 m -139.36 172.4 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.744 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.492 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 12.3 m-85 -111.71 136.18 51.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.801 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.658 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -112.94 123.63 50.77 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.889 0.376 . . . . 0.0 111.648 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -92.21 128.75 38.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.858 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.58 146.75 51.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.846 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -65.1 116.31 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.719 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 101.35 -0.91 53.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.726 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m-85 -148.78 151.28 34.98 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.683 0.278 . . . . 0.0 110.672 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.26 168.38 16.81 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.621 2.214 . . . . 0.0 112.193 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 74.3 m80 -47.27 113.52 0.7 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.654 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.2 t-105 -99.22 128.99 30.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.353 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.99 119.81 6.91 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.268 1.979 . . . . 0.0 111.126 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . -143.76 176.45 9.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.649 HH12 HG22 ' A' ' 94' ' ' THR . 3.2 ttt180 -144.69 157.59 44.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.456 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.505 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 27.8 mm -81.44 137.04 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.4 -18.91 4.77 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.349 . . . . 0.0 111.164 -179.707 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.917 0.389 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 40.9 m-85 -95.67 155.9 16.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.768 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.88 105.68 17.44 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.578 HG11 HD21 ' A' ' 63' ' ' LEU . 12.8 m -100.61 148.04 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.315 0.579 . . . . 0.0 112.03 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 4.9 t80 -105.39 124.5 49.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.482 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.423 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 76.1 m-85 -94.05 108.06 19.92 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.112 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.752 ' HE2' HD12 ' A' ' 89' ' ' ILE . 60.6 m-85 -58.24 178.79 0.09 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.204 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.56 -62.07 0.87 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.378 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 46.4 p -91.28 -21.23 21.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.571 0.224 . . . . 0.0 110.934 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 52' ' ' THR . 26.3 m170 64.92 33.39 9.96 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.91 0.386 . . . . 0.0 110.432 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -94.93 158.49 15.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.46 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -132.85 149.26 52.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.31 0.576 . . . . 0.0 111.74 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.55 171.5 19.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.44 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.437 ' C ' HD12 ' A' ' 58' ' ' LEU . 17.4 m-85 -107.78 124.52 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.923 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.658 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.9 mp -138.04 160.19 40.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.43 175.59 39.34 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.187 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.36 -24.92 49.54 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.405 2.07 . . . . 0.0 112.161 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -69.34 -25.74 64.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.086 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 30.0 m-20 -97.97 7.7 45.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.31 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.578 HD21 HG11 ' A' ' 47' ' ' VAL . 71.8 mt -115.15 139.4 49.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.748 0.308 . . . . 0.0 110.37 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.7 m-85 -137.58 159.61 68.43 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 13.2 Cg_exo -69.48 111.88 2.88 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.685 2.256 . . . . 0.0 111.717 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 70' ' ' LYS . 78.1 t80 -51.97 -58.38 6.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.79 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.96 -41.73 47.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.08 0.467 . . . . 0.0 111.639 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.61 -39.72 73.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.477 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.23 12.19 30.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.6 ptpt -55.73 -46.38 77.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 0.0 111.49 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -70.1 -25.69 63.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.931 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -47.33 10.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.8 m-30 -101.02 -8.01 22.75 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.1 73.05 2.71 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.219 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.3 mtmt -149.09 158.19 39.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.592 0.234 . . . . 0.0 110.398 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.41 155.44 25.41 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.601 2.201 . . . . 0.0 112.555 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -136.36 168.74 18.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.545 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -89.42 -16.37 31.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.221 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -66.72 -14.51 62.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.004 0.431 . . . . 0.0 110.67 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt 63.6 143.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.124 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.67 -18.39 39.03 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.58 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 20.0 t80 -58.91 -56.08 26.86 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.976 0.417 . . . . 0.0 110.697 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.64 -45.33 66.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.82 -30.99 6.39 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.992 0.425 . . . . 0.0 110.52 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.88 -31.36 60.2 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.994 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.687 ' O ' HG22 ' A' ' 89' ' ' ILE . 61.5 mt -60.9 -43.65 98.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.973 0.416 . . . . 0.0 110.471 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -64.26 -44.21 92.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.177 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.47 -50.91 69.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.752 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.09 -26.19 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -100.92 -44.89 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.62 -33.34 41.54 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.9 87.1 3.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.848 0.356 . . . . 0.0 111.1 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -76.18 -12.01 19.31 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.638 2.225 . . . . 0.0 112.646 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.649 HG22 HH12 ' A' ' 29' ' ' ARG . 24.3 p -104.32 11.97 34.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.546 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.622 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.8 p . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.351 . . . . 0.0 111.466 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.875 0.369 . . . . 0.0 110.836 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 m -52.83 127.56 23.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.09 -14.15 57.18 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.163 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.01 141.0 47.69 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.798 0.333 . . . . 0.0 111.277 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.802 HD23 ' HG3' ' A' ' 29' ' ' ARG . 84.1 mt -93.17 122.6 35.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.343 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.43 173.62 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.183 0.516 . . . . 0.0 111.93 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 9.4 m-85 -112.22 134.54 53.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.671 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.899 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -114.13 123.65 50.15 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.036 0.446 . . . . 0.0 111.659 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -91.72 127.39 37.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.787 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 ttm -127.02 152.29 47.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.582 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -67.14 126.93 30.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.92 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 91.54 -3.72 79.03 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.954 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 1.6 m-85 -148.72 149.7 31.41 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-N 116.808 0.304 . . . . 0.0 110.729 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.79 172.2 15.42 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.5 2.133 . . . . 0.0 112.508 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -49.15 114.52 1.03 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.772 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.446 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.86 132.46 23.7 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.293 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.488 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 32.5 Cg_exo -54.48 120.52 8.18 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.069 1.846 . . . . 0.0 110.953 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.16 175.04 10.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.394 0.616 . . . . 0.0 112.412 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.802 ' HG3' HD23 ' A' ' 15' ' ' LEU . 9.5 ttp180 -142.74 155.27 44.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.551 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.402 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 30.8 mm -78.66 135.0 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.78 -20.1 4.34 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-O 121.034 0.445 . . . . 0.0 111.266 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.851 0.358 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 88.3 m-85 -94.26 154.01 17.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.837 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.433 ' HG3' ' CE1' ' A' ' 57' ' ' PHE . 5.1 tt0 -100.39 106.09 17.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.3 m -101.95 150.91 5.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.499 0.666 . . . . 0.0 112.126 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 17.9 t80 -105.33 125.31 50.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.289 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -91.37 106.97 18.89 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.422 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.795 ' HE2' HD12 ' A' ' 89' ' ' ILE . 41.0 m-85 -59.43 175.17 0.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.692 0.282 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.39 -61.66 0.84 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.31 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 71.7 p -90.33 -22.48 21.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.7 0.286 . . . . 0.0 110.986 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 44.3 m170 64.84 34.32 9.38 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.351 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -91.4 154.74 18.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.755 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.07 143.67 49.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.251 0.548 . . . . 0.0 111.617 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.35 172.18 18.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.511 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 46' ' ' GLN . 15.3 m-85 -116.66 126.16 52.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.482 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.899 HD13 ' HB1' ' A' ' 18' ' ' ALA . 3.0 mt -140.02 163.24 33.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.174 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.659 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -94.27 171.55 31.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.321 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.415 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 38.3 Cg_endo -66.52 -19.48 54.68 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.474 2.116 . . . . 0.0 112.517 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -68.62 -29.48 68.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.936 0.398 . . . . 0.0 110.569 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.59 10.91 40.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.891 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.4 mp -108.36 137.3 46.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.519 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.6 m-85 -137.03 157.03 75.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.461 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 6.7 Cg_exo -72.32 111.6 3.24 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.429 2.086 . . . . 0.0 111.327 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.2 t80 -48.46 -57.47 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.875 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.26 -40.52 48.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 111.348 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 17.3 mt-10 -71.24 -39.95 71.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.535 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.482 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -104.35 9.38 35.85 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -57.52 -46.43 83.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.758 0.314 . . . . 0.0 111.792 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.75 -35.56 78.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 13.4 ptpt -82.81 -41.52 18.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CZ ' ' HD2' ' A' ' 72' ' ' LYS . 15.8 m-30 -97.92 -13.11 21.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -84.53 75.35 2.37 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.266 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -152.13 153.96 31.82 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.585 0.231 . . . . 0.0 110.586 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -45.31 136.14 11.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.717 2.278 . . . . 0.0 112.727 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.473 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 31.5 t30 -108.79 174.45 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.676 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 -22.4 15.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.851 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -12.94 61.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.8 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp 64.66 145.15 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.952 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.1 -18.25 46.05 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.753 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.488 ' CE2' ' HD3' ' A' ' 27' ' ' PRO . 11.3 t80 -58.88 -51.87 68.18 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 121.005 0.431 . . . . 0.0 110.559 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -46.66 66.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.409 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -48.11 -31.25 5.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.85 -31.22 60.44 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.063 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.633 ' O ' HG22 ' A' ' 89' ' ' ILE . 56.3 mt -61.02 -43.8 98.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.971 0.415 . . . . 0.0 110.315 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -64.13 -45.15 89.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.097 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.417 ' OE1' HG11 ' A' ' 95' ' ' VAL . 60.9 mt-10 -63.09 -50.99 68.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.795 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -51.73 -27.4 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.758 0.313 . . . . 0.0 111.754 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' HG3' HG23 ' A' ' 89' ' ' ILE . 59.5 mt-10 -99.52 -44.73 6.06 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -80.98 -31.7 34.66 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.64 87.73 3.1 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.819 0.342 . . . . 0.0 111.132 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 75.4 Cg_endo -77.71 -12.93 16.44 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.58 2.187 . . . . 0.0 112.791 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.8 p -104.45 12.78 32.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.634 0.254 . . . . 0.0 111.577 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.579 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.4 p . . . . . 0 C--N 1.331 -0.223 0 CA-C-O 120.845 0.355 . . . . 0.0 111.432 -179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 121.006 0.432 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 t -52.3 135.82 31.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.372 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.85 -11.27 69.89 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.003 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.33 142.93 47.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 0.0 111.103 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.428 HD23 ' HG3' ' A' ' 29' ' ' ARG . 77.2 mt -90.77 118.53 30.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.205 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.28 167.44 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.834 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 8.2 m-85 -109.86 132.62 53.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.65 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.581 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.83 124.06 51.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 111.523 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.71 133.21 35.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.96 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.83 147.15 51.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.62 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 112.69 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.89 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 109.56 -5.79 31.41 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.911 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 1.4 m-85 -147.96 161.57 34.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.784 0.326 . . . . 0.0 110.886 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 95.1 Cg_endo -83.94 168.98 11.98 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.895 2.397 . . . . 0.0 112.503 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 73' ' ' PHE . 67.9 m80 -47.53 116.68 1.52 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.544 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.471 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.04 130.76 27.9 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.59 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.43 120.5 8.13 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.084 1.856 . . . . 0.0 111.044 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.644 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -144.74 175.06 10.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.352 0.596 . . . . 0.0 112.533 -178.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 2.0 ttt180 -142.89 156.07 44.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.527 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 21.1 mm -77.67 135.05 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.32 -21.66 4.18 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 111.272 -179.619 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 mttp . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.096 0.474 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 34.0 m-85 -93.32 156.55 16.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.005 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.74 97.09 8.7 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.027 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.644 ' CG2' ' HB1' ' A' ' 28' ' ' ALA . 2.7 p -100.05 148.58 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.485 -177.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.526 ' HE2' HG13 ' A' ' 95' ' ' VAL . 33.0 t80 -106.33 125.6 51.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.293 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.597 ' HE2' ' HB3' ' A' ' 56' ' ' ALA . 79.2 m-85 -93.39 110.65 22.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.743 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.754 ' CE2' HD12 ' A' ' 89' ' ' ILE . 50.3 m-85 -60.96 175.91 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.065 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.55 -62.94 0.85 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.132 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -90.63 -22.95 20.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 110.581 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 38.0 m80 63.93 37.05 9.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.013 0.435 . . . . 0.0 110.194 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -91.21 153.97 19.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.72 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.8 139.16 53.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.162 0.506 . . . . 0.0 111.137 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.597 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.35 169.6 23.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.634 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 9.9 m-85 -112.07 126.41 55.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.773 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mp -139.21 162.53 34.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.064 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.9 176.11 39.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.362 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.74 -24.56 40.77 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.442 2.095 . . . . 0.0 112.219 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -70.03 -25.1 63.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.795 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -99.96 4.73 45.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.364 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 mt -116.09 139.47 50.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.648 0.261 . . . . 0.0 110.483 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.481 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 m-85 -137.84 165.69 31.91 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.884 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 2.7 Cg_exo -75.35 115.73 4.32 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.69 2.26 . . . . 0.0 111.733 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -53.03 -57.83 9.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.825 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -48.85 -42.98 38.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.98 0.419 . . . . 0.0 111.797 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.82 -39.72 72.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.441 -179.486 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.456 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 2.5 m -105.94 13.57 29.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 66' ' ' TYR . 6.0 ptmm? -58.06 -45.93 86.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.884 0.373 . . . . 0.0 111.452 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -67.66 -37.28 82.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 6.1 ptmt -83.39 -43.31 16.04 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.516 ' CZ ' ' CE1' ' A' ' 25' ' ' HIS . 20.5 m-30 -95.27 -13.22 25.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -89.42 74.65 1.94 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.843 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 7.7 mmtp -146.82 148.74 34.01 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.612 0.244 . . . . 0.0 110.41 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.03 155.37 2.77 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.51 2.14 . . . . 0.0 112.538 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.425 ' ND2' ' HG3' ' A' ' 24' ' ' PRO . 8.8 t-20 -137.15 166.95 22.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.591 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -15.52 35.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.268 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.404 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -66.71 -13.75 61.71 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.038 0.446 . . . . 0.0 110.597 179.304 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm 64.18 142.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.337 -179.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.21 -16.84 56.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.585 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 38.6 t80 -59.08 -56.68 19.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.922 0.391 . . . . 0.0 110.74 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.4 -46.18 69.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.189 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -48.93 -30.69 6.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.913 0.387 . . . . 0.0 110.5 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.28 -31.4 59.35 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.818 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.642 ' O ' HG22 ' A' ' 89' ' ' ILE . 84.2 mt -60.78 -43.72 97.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.233 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.8 t90 -63.68 -45.29 90.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.542 ' HG2' HG11 ' A' ' 95' ' ' VAL . 1.5 mp0 -62.94 -51.36 67.19 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.754 HD12 ' CE2' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -52.25 -26.3 8.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.748 0.308 . . . . 0.0 111.818 -179.824 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.04 -44.68 5.92 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -82.64 -31.68 28.66 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -156.77 88.79 2.68 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.728 0.299 . . . . 0.0 111.092 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.6 Cg_endo -76.4 -10.37 18.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.764 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.49 11.6 38.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.496 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.562 HG12 ' HE1' ' A' ' 50' ' ' PHE . 10.6 p . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 120.78 0.324 . . . . 0.0 111.218 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.892 0.377 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.418 ' HA ' HG22 ' A' ' 30' ' ' ILE . 59.5 m -51.92 134.63 31.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.346 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.37 -10.32 74.45 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.952 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.38 142.5 48.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.359 . . . . 0.0 111.171 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.488 HD23 ' HG3' ' A' ' 29' ' ' ARG . 64.1 mt -93.21 118.35 31.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.934 0.397 . . . . 0.0 110.532 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.6 m -142.84 171.71 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.683 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.546 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 33.2 m-85 -110.21 135.22 51.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.452 178.48 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.682 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -112.03 126.64 55.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 111.583 -179.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.3 129.11 37.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.927 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 ttm -134.06 144.33 48.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.71 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -65.03 122.96 18.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.651 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.73 -8.93 56.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.769 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.66 146.13 21.55 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.604 0.24 . . . . 0.0 110.526 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 71.9 Cg_endo -75.39 175.17 11.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.414 2.076 . . . . 0.0 112.512 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -48.21 111.88 0.5 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.527 179.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.7 t-105 -98.43 130.68 27.61 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.448 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.91 120.1 7.36 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.272 1.982 . . . . 0.0 110.909 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.39 174.36 10.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.359 0.6 . . . . 0.0 112.546 -178.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HG3' HD23 ' A' ' 15' ' ' LEU . 18.2 ttp180 -143.14 155.65 44.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.487 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.474 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 32.6 mm -78.82 136.52 23.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -126.46 -20.8 4.3 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.38 . . . . 0.0 111.18 -179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 121.102 0.477 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -97.58 159.0 15.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.944 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -97.65 109.5 22.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.577 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 50.2 t -102.78 141.71 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.395 0.617 . . . . 0.0 112.421 -178.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -105.25 121.25 43.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.693 179.044 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.682 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 76.8 m-85 -93.86 110.89 22.53 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.585 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 89' ' ' ILE . 49.9 m-85 -60.69 178.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.06 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.428 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 70.26 -63.53 0.78 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.857 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.3 p -91.38 -22.36 20.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.732 0.301 . . . . 0.0 110.528 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.7 m170 62.87 36.65 12.73 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.016 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.44 154.75 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.33 140.71 52.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.321 0.581 . . . . 0.0 111.6 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.528 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.99 167.59 29.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.038 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -111.92 126.91 55.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.935 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 29.3 mt -141.25 164.34 30.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.062 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.96 171.16 33.99 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.076 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.61 -19.06 48.56 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.407 2.071 . . . . 0.0 112.223 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -67.77 -28.44 67.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -100.22 16.5 24.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.657 179.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mp -114.23 137.24 52.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.4 m-85 -136.74 155.87 76.4 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.715 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.526 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 10.1 Cg_exo -69.71 112.7 3.14 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.219 1.946 . . . . 0.0 111.178 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.552 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.5 t80 -47.65 -58.78 3.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.323 -178.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -50.61 -39.7 50.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.967 0.413 . . . . 0.0 111.772 -179.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.5 mt-10 -71.05 -39.87 72.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.605 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -102.66 8.09 39.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.24 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.552 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -55.61 -50.75 69.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.825 0.345 . . . . 0.0 111.384 179.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -70.95 -19.71 62.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.441 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HD3' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -85.01 -52.23 6.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.177 0.513 . . . . 0.0 111.939 -179.214 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CD1' ' HD3' ' A' ' 72' ' ' LYS . 6.7 m-85 -100.72 -10.24 21.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.448 -0.797 . . . . 0.0 112.712 -178.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.02 72.31 2.29 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.297 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -150.64 152.15 31.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.681 0.24 . . . . 0.0 110.478 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.62 138.97 14.02 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.661 2.241 . . . . 0.0 112.72 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.457 ' HB3' ' CB ' ' A' ' 82' ' ' PHE . 9.4 t-20 -110.0 164.19 12.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.544 -179.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -20.73 23.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.685 179.418 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -69.35 -12.37 61.6 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt 65.33 146.52 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.386 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.13 -18.81 42.5 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.855 -178.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.6 t80 -58.24 -54.94 41.26 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.017 0.437 . . . . 0.0 110.834 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.27 -47.05 66.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.294 -179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -48.3 -31.37 5.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.045 0.45 . . . . 0.0 110.494 179.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.32 -31.69 58.92 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.031 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.615 ' O ' HG22 ' A' ' 89' ' ' ILE . 41.9 mt -60.98 -43.54 98.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.986 0.422 . . . . 0.0 110.192 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -63.31 -45.46 91.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.053 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.445 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -62.73 -51.61 66.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.039 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.8 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.32 -26.5 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.791 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.66 -44.86 5.97 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -80.47 -33.06 36.94 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -155.9 88.22 2.97 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 111.136 -179.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.1 Cg_endo -76.23 -12.12 19.2 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.695 2.263 . . . . 0.0 112.838 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 p -104.05 12.71 33.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.406 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.635 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.4 p . . . . . 0 C--N 1.332 -0.189 0 CA-C-O 120.778 0.323 . . . . 0.0 111.348 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.948 0.404 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.6 t -51.95 130.86 30.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.388 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.85 -13.45 65.12 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.967 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.51 140.87 51.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.762 0.315 . . . . 0.0 111.022 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.832 HD23 ' HG3' ' A' ' 29' ' ' ARG . 60.4 mt -92.51 118.94 31.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 0.0 110.427 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.558 HG21 HD22 ' A' ' 63' ' ' LEU . 29.9 m -141.08 173.5 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.803 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.541 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 16.1 m-85 -111.35 138.88 47.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.509 178.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -117.29 126.42 52.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.171 0.51 . . . . 0.0 112.133 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . 10.7 tptm -91.18 129.56 37.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.01 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.42 140.15 48.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.743 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 123.32 17.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.79 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.65 -7.88 46.44 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.685 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.09 160.99 30.41 Favored Pre-proline 0 C--N 1.333 -0.142 0 CA-C-O 120.728 0.299 . . . . 0.0 110.626 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 94.7 Cg_endo -81.67 171.16 13.58 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.635 2.224 . . . . 0.0 112.367 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 67.8 m80 -50.02 118.52 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.392 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.457 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.9 t-105 -99.49 133.05 22.2 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 11.7 Cg_endo -54.45 120.79 8.61 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.393 2.062 . . . . 0.0 110.819 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -145.01 176.35 9.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.832 ' HG3' HD23 ' A' ' 15' ' ' LEU . 11.7 ttp180 -142.61 155.57 44.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.47 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 mm -82.53 137.76 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -124.31 -14.99 6.84 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 121.084 0.468 . . . . 0.0 111.519 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 121.002 0.43 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.8 OUTLIER -95.48 163.19 13.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.663 179.439 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.03 110.26 22.57 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.612 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 99.3 t -104.74 143.61 15.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.304 -178.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 40.8 t80 -106.75 123.85 48.74 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.912 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.614 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 86.1 m-85 -95.81 113.77 25.44 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.948 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.723 ' HE2' HD12 ' A' ' 89' ' ' ILE . 60.9 m-85 -61.47 179.54 0.22 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.248 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.62 -63.56 0.45 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.117 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.7 p -91.7 -21.56 20.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.746 0.307 . . . . 0.0 110.7 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 64.5 m170 62.0 37.46 14.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.181 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -90.8 155.88 18.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.492 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.04 140.05 53.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.391 0.615 . . . . 0.0 111.655 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.18 166.92 32.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.262 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -106.2 124.76 50.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.655 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 86.2 mt -139.78 162.69 34.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.25 167.19 26.13 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.495 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.17 -19.76 67.67 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.661 2.241 . . . . 0.0 112.615 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -69.12 -27.28 65.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.873 0.368 . . . . 0.0 110.856 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 24.8 m-20 -97.95 8.81 44.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.231 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.558 HD22 HG21 ' A' ' 16' ' ' VAL . 95.6 mt -109.35 139.87 43.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.693 0.283 . . . . 0.0 110.539 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.6 m-85 -134.06 156.67 78.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.09 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 15.4 Cg_exo -68.19 109.66 2.03 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.605 2.203 . . . . 0.0 111.43 179.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 70' ' ' LYS . 83.4 t80 -54.9 -62.14 1.85 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.915 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.468 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -49.01 -42.13 36.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.081 0.467 . . . . 0.0 111.474 -179.149 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -70.88 -39.77 72.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.485 -179.373 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.418 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -104.93 9.75 34.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.522 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.2 ptpp? -55.21 -45.21 75.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 111.401 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.3 mt-10 -70.09 -26.89 64.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.987 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -84.57 -46.44 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 69' ' ' SER . 23.7 m-85 -105.07 -0.83 26.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.8 75.07 1.99 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.873 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -150.36 157.31 36.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.69 0.281 . . . . 0.0 110.861 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.82 149.89 10.25 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.704 2.269 . . . . 0.0 112.573 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.417 ' OD1' ' CD2' ' A' ' 82' ' ' PHE . 4.9 m120 -131.2 165.81 22.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.595 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.32 -17.53 30.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.259 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -66.25 -15.06 62.88 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.075 0.464 . . . . 0.0 110.61 179.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt 63.98 142.6 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.097 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.33 -17.91 48.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.801 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.457 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 18.4 t80 -58.66 -53.58 56.76 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.034 0.445 . . . . 0.0 110.505 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.61 -46.48 67.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.043 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.62 -32.66 8.53 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.019 0.438 . . . . 0.0 110.39 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.34 -31.83 60.74 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.814 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 89' ' ' ILE . 84.1 mt -60.84 -43.73 97.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.001 0.429 . . . . 0.0 110.268 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.452 ' CD1' ' ND2' ' A' ' 91' ' ' ASN . 61.1 t90 -65.46 -41.52 93.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.053 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.419 ' OE1' HG11 ' A' ' 95' ' ' VAL . 58.7 mm-40 -64.29 -53.67 45.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.723 HD12 ' HE2' ' A' ' 50' ' ' PHE . 1.2 tt -52.39 -25.38 7.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 87' ' ' TRP . 15.8 pt-20 -100.37 -44.65 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.452 ' ND2' ' CD1' ' A' ' 87' ' ' TRP . 35.3 m-80 -81.33 -33.91 32.19 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -156.66 85.46 3.01 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.017 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 72.1 Cg_endo -74.97 -10.24 21.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.676 2.251 . . . . 0.0 112.685 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.1 p -104.18 11.78 34.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.538 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.419 HG11 ' OE1' ' A' ' 88' ' ' GLU . 11.4 p . . . . . 0 C--N 1.332 -0.188 0 CA-C-O 120.851 0.357 . . . . 0.0 111.441 -179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 5.8 mmtm . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.968 0.413 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 t -52.2 124.68 13.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.77 -16.09 44.11 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.061 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.23 140.01 50.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.827 0.346 . . . . 0.0 111.126 -179.877 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.57 HD23 ' HG3' ' A' ' 29' ' ' ARG . 56.3 mt -92.8 118.68 31.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.301 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.423 HG21 HD22 ' A' ' 63' ' ' LEU . 31.1 m -139.67 171.77 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.743 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.4 m-85 -109.98 136.68 48.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.706 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.728 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -113.43 126.44 55.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.993 0.425 . . . . 0.0 111.779 -179.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 14.2 tptm -92.96 130.64 38.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.854 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.94 148.6 50.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.77 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -67.36 106.67 2.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.774 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.82 -7.08 27.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.611 -0.805 . . . . 0.0 112.749 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -141.07 156.61 68.11 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.713 0.292 . . . . 0.0 110.656 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.98 171.92 9.01 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.744 2.296 . . . . 0.0 112.206 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.48 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 74.8 m80 -47.79 111.88 0.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.42 179.032 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.432 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 1.6 t-105 -99.57 129.06 29.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.783 -0.19 . . . . 0.0 111.24 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HG3' HD22 ' A' ' 86' ' ' LEU . 12.4 Cg_endo -55.46 121.13 9.38 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.152 1.902 . . . . 0.0 110.968 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.68 175.77 9.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.29 0.566 . . . . 0.0 112.257 -178.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.57 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.3 ttp180 -141.67 154.83 45.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.75 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.408 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.1 mm -82.27 114.25 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.87 -13.84 14.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.402 . . . . 0.0 111.309 -179.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.004 0.431 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 62.4 m-85 -94.42 153.22 18.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.843 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -99.0 105.78 17.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.623 HG11 HD21 ' A' ' 63' ' ' LEU . 29.5 m -101.47 150.34 6.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.542 0.687 . . . . 0.0 112.211 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 32.9 t80 -105.81 124.38 49.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.076 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.466 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 32.5 m-85 -91.72 107.62 19.33 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.565 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.799 ' HE2' HD12 ' A' ' 89' ' ' ILE . 36.0 m-85 -58.56 175.11 0.27 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.794 0.33 . . . . 0.0 110.934 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.53 -62.05 0.86 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.386 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.4 p -90.49 -21.51 21.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.652 0.263 . . . . 0.0 111.097 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 48.4 m170 64.02 34.9 10.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.889 0.376 . . . . 0.0 110.29 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -90.32 153.68 20.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.704 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.54 141.51 51.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.166 0.507 . . . . 0.0 111.633 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.41 177.53 11.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.406 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 9.0 m-85 -120.56 127.34 52.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.804 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.728 HD13 ' HB1' ' A' ' 18' ' ' ALA . 5.3 mt -140.01 163.93 31.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.117 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.94 177.17 35.25 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.566 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.12 -25.26 51.07 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.665 2.243 . . . . 0.0 112.437 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -69.92 -25.43 63.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.352 . . . . 0.0 111.091 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 36.3 m-20 -98.39 4.79 48.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.388 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.623 HD21 HG11 ' A' ' 47' ' ' VAL . 20.8 mt -112.59 139.37 48.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.444 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.4 m-85 -136.01 159.93 69.18 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.067 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 12.2 Cg_exo -69.68 110.88 2.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.695 2.264 . . . . 0.0 111.64 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -51.82 -59.25 4.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.549 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -50.42 -41.41 52.38 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.701 -179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 2.2 tm-20 -69.55 -39.81 77.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.458 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 m -108.15 13.77 25.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 4.5 ptpp? -56.09 -47.67 77.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 111.125 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.3 mt-10 -71.13 -21.32 62.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.316 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HD3' ' CE1' ' A' ' 73' ' ' PHE . 4.2 tttt -85.59 -49.35 8.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 9.5 m-85 -103.01 -4.79 24.13 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.443 ' HA2' HD11 ' A' ' 86' ' ' LEU . . . -83.32 71.1 3.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.077 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 9.1 mtmt -149.33 153.54 37.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.74 158.19 14.16 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.574 2.182 . . . . 0.0 112.733 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -137.15 167.27 21.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.469 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.46 -15.45 46.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.112 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -14.04 61.61 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.008 0.432 . . . . 0.0 110.792 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp 63.85 142.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.273 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.05 -17.79 48.94 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.742 -178.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 44.5 t80 -59.83 -54.19 49.09 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.998 0.428 . . . . 0.0 110.842 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.511 ' HA ' HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -53.1 -46.33 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.236 -179.823 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -48.39 -29.83 4.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.997 0.427 . . . . 0.0 110.601 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.97 -31.59 59.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.172 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 89' ' ' ILE . 3.8 mm? -61.01 -44.16 97.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.959 0.409 . . . . 0.0 110.533 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 64.2 t90 -65.12 -45.71 83.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.339 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.474 ' OE1' HG11 ' A' ' 95' ' ' VAL . 52.5 mt-10 -62.48 -51.02 69.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.799 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -52.3 -27.18 10.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.711 0.291 . . . . 0.0 111.684 -179.64 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -99.6 -44.73 6.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -80.33 -31.86 37.98 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -155.61 88.11 3.07 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 111.188 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -75.93 -13.39 19.54 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.676 2.25 . . . . 0.0 112.697 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.558 HG22 HH12 ' A' ' 29' ' ' ARG . 48.1 p -105.67 12.4 31.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.496 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.567 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.8 p . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.418 . . . . 0.0 111.481 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.867 0.365 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.26 133.0 34.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.372 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.2 -10.97 72.75 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.915 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.03 142.8 49.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.768 0.318 . . . . 0.0 111.15 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.419 HD23 ' HG3' ' A' ' 29' ' ' ARG . 30.2 mt -90.81 116.79 28.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 110.281 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.48 168.9 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.663 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 44.5 m-85 -110.56 137.06 48.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.506 178.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.705 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -112.29 124.22 51.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.294 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -91.11 134.39 34.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.963 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mmm -128.19 149.27 50.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.646 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 115.22 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 0.0 111.063 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.72 -31.69 6.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.574 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -103.02 153.0 38.61 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 110.915 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.87 166.8 11.39 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.816 2.344 . . . . 0.0 112.43 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 46.7 m80 -48.61 113.98 0.88 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.472 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.7 t-105 -98.65 131.33 26.04 Favored Pre-proline 0 N--CA 1.464 0.266 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.9 120.34 7.74 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.357 2.038 . . . . 0.0 110.857 178.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.624 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -145.49 175.03 10.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.692 HH12 HG22 ' A' ' 94' ' ' THR . 1.0 OUTLIER -143.07 155.93 44.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.336 179.619 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.0 mm -80.82 136.88 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -127.31 -18.1 4.57 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.214 0 CA-C-O 120.899 0.381 . . . . 0.0 111.334 -179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.967 0.413 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -92.18 158.79 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.231 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.55 98.22 9.13 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.624 ' CG2' ' HB1' ' A' ' 28' ' ' ALA . 2.1 p -99.79 147.29 7.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.659 0.742 . . . . 0.0 112.408 -177.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 28.4 t80 -105.63 124.97 50.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.283 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.609 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 63.7 m-85 -91.85 108.15 19.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.548 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.752 ' CE2' HD12 ' A' ' 89' ' ' ILE . 38.0 m-85 -59.79 175.78 0.34 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.3 . . . . 0.0 110.979 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.408 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 70.68 -62.77 0.88 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.229 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.2 p -90.78 -22.07 21.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.794 0.331 . . . . 0.0 110.656 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.457 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 50.4 m170 63.51 36.04 11.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.388 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -90.41 153.52 20.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.589 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.25 139.55 53.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.113 0.483 . . . . 0.0 111.328 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.7 167.84 29.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.64 -179.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.28 125.64 53.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.639 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.705 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 62.3 mt -138.39 161.49 36.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.043 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.81 171.8 33.41 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.311 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.416 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 40.1 Cg_endo -67.39 -20.85 47.93 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.351 2.034 . . . . 0.0 112.214 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -68.37 -28.9 67.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.958 0.409 . . . . 0.0 110.453 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.49 12.06 38.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.816 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 2.3 mp -109.51 136.59 48.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.386 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.5 m-85 -135.05 146.0 56.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.902 0.382 . . . . 0.0 111.048 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.477 ' HG2' ' HB3' ' A' ' 68' ' ' GLU . 17.8 Cg_endo -60.06 112.25 1.24 Allowed 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.43 2.087 . . . . 0.0 111.334 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 78.6 t80 -49.71 -61.78 1.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.215 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.28 -40.8 49.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.125 0.488 . . . . 0.0 111.49 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.477 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 6.0 tt0 -71.01 -39.74 72.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.198 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.452 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 5.3 m -101.04 8.14 43.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HD3' ' CE2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.17 -53.68 46.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.267 0.556 . . . . 0.0 111.426 179.64 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.85 -17.79 62.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.831 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -85.26 -50.53 7.28 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 7.8 m-85 -107.29 -3.19 19.96 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.39 72.68 2.61 Favored Glycine 0 C--N 1.329 0.165 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.976 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -149.81 153.23 35.9 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.607 0.241 . . . . 0.0 110.678 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -51.13 153.57 9.06 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.55 2.167 . . . . 0.0 112.626 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -137.05 167.35 21.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.684 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 -15.38 41.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.324 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.9 mmt-85 -66.03 -15.19 62.82 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.032 0.444 . . . . 0.0 110.595 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm 63.62 142.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.136 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.04 -17.2 52.81 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.608 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.472 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 36.1 t80 -58.38 -56.08 26.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.986 0.422 . . . . 0.0 110.754 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.86 -46.28 67.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -48.58 -31.69 6.97 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.974 0.416 . . . . 0.0 110.426 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.33 -32.2 58.28 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.026 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.557 ' O ' HG22 ' A' ' 89' ' ' ILE . 16.5 mt -60.68 -43.55 97.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.996 0.426 . . . . 0.0 110.123 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . 0.441 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 63.8 t90 -64.9 -43.22 93.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.935 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 21.6 mm-40 -63.46 -52.41 61.53 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.752 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -53.04 -25.44 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.738 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 87' ' ' TRP . 12.5 pt-20 -99.92 -44.77 5.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.073 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 1.2 m-80 -82.55 -29.37 30.39 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -155.86 86.88 3.12 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.79 0.328 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.9 Cg_endo -76.86 -14.29 17.3 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.667 2.245 . . . . 0.0 112.653 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.692 HG22 HH12 ' A' ' 29' ' ' ARG . 16.7 p -105.13 11.9 32.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.576 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.7 p . . . . . 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.403 -179.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt . . . . . 0 N--CA 1.456 -0.147 0 CA-C-O 121.048 0.451 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.73 131.86 35.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.516 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.81 -11.45 68.04 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.14 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.86 138.4 50.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 111.26 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.415 HD23 ' HG3' ' A' ' 29' ' ' ARG . 75.5 mt -91.89 118.09 30.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.386 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.5 m -139.88 171.95 13.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.832 -179.553 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 30.3 m-85 -112.81 137.09 51.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.539 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -114.4 126.5 55.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.456 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 12.3 tptp -90.25 136.08 33.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.087 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -130.32 151.8 50.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.534 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -67.64 118.26 10.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.919 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -8.57 74.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.981 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.411 ' CD1' ' HD3' ' A' ' 79' ' ' ARG . 1.9 m-85 -132.19 154.45 81.65 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.849 0.324 . . . . 0.0 111.071 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.27 167.16 12.29 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.86 2.373 . . . . 0.0 112.495 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.456 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 80.2 m80 -47.09 115.23 1.02 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.629 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.458 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.1 t-105 -99.03 130.02 28.34 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.536 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.78 119.48 6.31 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.374 2.049 . . . . 0.0 111.112 178.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.12 174.34 10.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.425 0.631 . . . . 0.0 112.69 -177.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -142.92 155.8 44.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.305 179.686 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 28.5 mm -78.18 138.36 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.004 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.73 -20.33 5.5 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.055 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.069 0.461 . . . . 0.0 111.234 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 121.007 0.432 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 80.1 m-85 -95.82 155.02 16.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.678 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.436 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.4 mt-30 -96.39 106.71 18.99 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.598 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 63.4 t -100.77 143.06 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.294 -178.297 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.89 122.02 45.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.156 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.646 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 75.0 m-85 -94.97 110.28 22.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.415 179.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.725 ' HE2' HD12 ' A' ' 89' ' ' ILE . 57.2 m-85 -58.86 -179.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.025 -179.513 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.52 -63.64 0.61 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.205 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.9 p -91.11 -22.83 20.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.749 0.309 . . . . 0.0 110.734 179.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.4 m170 64.55 36.51 8.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.534 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -94.21 157.0 16.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.517 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -131.75 149.92 52.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.362 0.601 . . . . 0.0 112.009 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.52 170.94 20.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 52.4 m-85 -105.96 86.59 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.813 HD13 ' HB1' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -98.08 156.84 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.195 -179.87 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.559 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -91.97 169.42 32.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.324 179.649 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 42.0 Cg_endo -67.48 -20.86 47.35 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.504 2.136 . . . . 0.0 112.359 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -27.83 67.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.95 0.405 . . . . 0.0 110.413 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -100.7 12.46 37.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.791 179.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.8 mp -108.73 137.37 46.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.676 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.7 m-85 -136.14 158.24 74.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.65 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.639 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.9 Cg_exo -71.79 111.51 3.16 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.391 2.061 . . . . 0.0 111.288 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.566 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.2 t80 -45.63 -58.97 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.438 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -50.95 -39.43 54.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.949 -179.092 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.1 mm-40 -70.62 -39.76 73.55 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.465 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 49.5 m -105.49 11.03 32.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.566 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.38 -49.47 74.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 111.554 179.977 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.51 -26.17 64.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.707 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -85.01 -46.93 10.73 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.465 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 2.5 m-30 -99.87 -12.95 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -80.68 71.1 2.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.289 -0.957 . . . . 0.0 113.043 -179.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.418 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.0 mttt -148.99 153.21 38.03 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.595 0.236 . . . . 0.0 110.384 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -51.27 153.31 9.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.463 2.109 . . . . 0.0 112.674 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -136.48 163.44 30.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.545 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -81.81 -16.54 50.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.153 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.411 ' HD3' ' CD1' ' A' ' 23' ' ' TYR . 17.9 mmm180 -64.52 -15.66 61.26 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.916 0.389 . . . . 0.0 110.823 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt 63.24 140.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.139 -179.38 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.88 -16.98 53.55 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.463 -178.196 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.458 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.5 t80 -58.57 -55.49 34.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.943 0.401 . . . . 0.0 110.649 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 m -53.54 -45.66 69.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.121 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.91 -31.69 7.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.038 0.446 . . . . 0.0 110.464 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.04 -31.75 61.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.921 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.667 ' O ' HG22 ' A' ' 89' ' ' ILE . 19.7 mt -61.12 -43.68 98.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.961 0.41 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -63.61 -45.46 90.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.2 mp0 -62.38 -50.93 69.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.128 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.725 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -52.48 -25.99 8.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.723 0.297 . . . . 0.0 111.8 -179.708 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -44.81 5.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.095 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -80.49 -32.23 37.05 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.32 87.85 3.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.798 0.332 . . . . 0.0 110.978 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 96.3 Cg_endo -79.6 -12.52 13.75 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.636 2.224 . . . . 0.0 112.958 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.419 HG22 ' NH1' ' A' ' 29' ' ' ARG . 21.1 p -103.8 12.8 34.11 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.551 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.2 p . . . . . 0 C--N 1.331 -0.231 0 CA-C-O 120.837 0.351 . . . . 0.0 111.288 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.805 0.336 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.12 89.8 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.774 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 78.85 1.3 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m 58.15 93.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.032 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -73.35 84.73 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.843 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -150.32 126.27 10.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.001 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -144.25 89.04 1.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -88.38 162.23 16.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.872 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -154.57 142.13 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.551 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' CE1' HG11 ' A' ' 16' ' ' VAL . 98.9 m-85 -114.59 160.04 19.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.907 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.17 159.38 41.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.011 0.434 . . . . 0.0 111.17 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 t -53.24 127.18 23.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.464 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.4 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 101.23 -14.84 58.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.096 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.07 138.8 54.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 0.0 111.115 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.7 mt -92.22 117.65 30.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.176 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.52 HG11 ' CE1' ' A' ' 10' ' ' TYR . 30.4 m -140.92 171.39 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.185 0.517 . . . . 0.0 111.956 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 32.5 m-85 -110.63 137.35 48.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.471 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.734 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -111.54 125.0 53.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.893 0.378 . . . . 0.0 111.586 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -90.37 134.37 34.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.906 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 mmm -129.8 151.85 49.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.598 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 122.62 18.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.81 -2.06 85.63 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.897 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -139.4 152.47 69.23 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.757 0.279 . . . . 0.0 110.674 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.87 163.8 13.85 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.6 2.2 . . . . 0.0 112.688 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 48.4 m80 -46.6 117.44 1.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.102 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.425 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.3 t-105 -101.13 128.04 30.42 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.584 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.502 ' HG3' HD22 ' A' ' 86' ' ' LEU . 9.5 Cg_endo -52.49 119.5 5.99 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.329 2.02 . . . . 0.0 111.073 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . -144.69 177.34 8.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.43 0.633 . . . . 0.0 112.67 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 4.3 ttp180 -143.2 156.66 44.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.84 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.47 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 24.1 mm -82.94 140.32 16.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.0 -19.38 6.1 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -163.47 151.4 13.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 111.001 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.42 ' HE2' ' HA ' ' A' ' 33' ' ' MET . 2.6 mmt -91.94 167.05 16.05 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.608 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.5 145.76 77.76 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.692 2.261 . . . . 0.0 112.11 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -80.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.975 0.417 . . . . 0.0 110.762 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.94 -63.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.366 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.36 26.2 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.94 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.511 HG23 ' HG2' ' A' ' 39' ' ' LYS . 28.7 m -92.12 168.24 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.246 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' HG2' HG23 ' A' ' 38' ' ' VAL . 1.7 pttt 41.58 -164.65 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.499 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.44 56.09 3.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.874 0.369 . . . . 0.0 110.79 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.7 p -126.84 95.56 4.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.931 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.93 -63.96 0.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.815 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.462 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 6.0 m-80 -153.98 56.11 0.72 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.311 0.577 . . . . 0.0 110.48 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 1.1 mmpt? -103.6 176.51 5.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.975 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 2.6 m-85 -149.46 159.77 44.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.188 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 57' ' ' PHE . 11.5 mt-30 -93.04 105.32 17.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.076 0.465 . . . . 0.0 109.832 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.625 HG11 HD21 ' A' ' 63' ' ' LEU . 11.3 m -102.95 146.87 10.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.615 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 3.9 t80 -103.82 123.44 47.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.456 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.665 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 73.0 m-85 -93.72 105.26 17.31 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.814 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.76 ' HE2' HD12 ' A' ' 89' ' ' ILE . 57.9 m-85 -56.47 178.53 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 111.389 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.39 -62.35 1.1 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.15 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.8 p -91.38 -21.96 20.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 110.932 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.6 m170 65.26 34.12 8.65 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.521 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -95.51 157.35 15.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.649 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.8 t -129.76 148.68 51.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.354 0.597 . . . . 0.0 111.833 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.53 170.77 21.2 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.606 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.3 m-85 -108.13 124.2 49.88 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.758 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.734 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 28.6 mt -138.65 161.73 36.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.975 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -90.11 176.27 42.06 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.248 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 43' ' ' ASN . 9.0 Cg_exo -69.45 -25.42 30.07 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.314 2.009 . . . . 0.0 111.865 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -68.96 -22.13 64.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.618 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.18 2.18 42.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.942 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.625 HD21 HG11 ' A' ' 47' ' ' VAL . 35.1 mt -110.99 139.35 46.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.291 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.449 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.2 m-85 -136.64 160.48 66.37 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 111.079 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 16.7 Cg_exo -67.59 112.62 2.68 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.646 2.231 . . . . 0.0 111.939 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.535 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.7 t80 -50.08 -61.41 2.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.242 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.83 -39.38 58.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.959 0.409 . . . . 0.0 111.638 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.5 OUTLIER -71.37 -39.25 71.35 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.349 -179.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 34.2 m -105.62 10.86 32.82 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 66' ' ' TYR . 14.6 tttt -54.76 -48.35 72.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.804 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.77 -29.77 68.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.934 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -83.77 -46.05 12.66 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.469 ' HB3' ' HB2' ' A' ' 25' ' ' HIS . 4.3 m-30 -98.13 -12.18 22.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -177.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.511 ' HA2' HD11 ' A' ' 86' ' ' LEU . . . -84.76 72.88 2.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.157 -1.02 . . . . 0.0 113.102 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.459 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 4.9 mttt -150.7 143.49 16.42 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.635 0.255 . . . . 0.0 110.592 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -48.26 158.59 0.93 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.468 2.112 . . . . 0.0 112.757 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.64 172.05 13.45 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.97 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -87.22 -16.85 34.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.393 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -13.96 61.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.952 0.406 . . . . 0.0 110.461 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt 66.34 141.28 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.395 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.87 -17.04 56.89 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.897 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.499 ' CE1' HD21 ' A' ' 86' ' ' LEU . 36.9 t80 -59.78 -53.76 54.17 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.944 0.402 . . . . 0.0 110.518 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.75 -47.08 71.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -48.72 -31.33 6.72 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.934 0.397 . . . . 0.0 110.367 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -72.14 -32.4 63.06 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.82 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.511 HD11 ' HA2' ' A' ' 74' ' ' GLY . 3.8 mm? -60.78 -43.66 97.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.985 0.421 . . . . 0.0 110.361 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -65.48 -44.17 87.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.237 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.448 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 24.3 mm-40 -63.56 -53.01 58.41 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.76 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -52.77 -26.69 11.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.739 0.304 . . . . 0.0 111.775 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.71 -44.64 6.33 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -81.33 -32.63 32.93 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -156.72 90.95 2.54 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-O 120.715 0.293 . . . . 0.0 111.324 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.476 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -76.54 -11.02 18.83 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.48 2.12 . . . . 0.0 112.659 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 14.9 p -106.81 12.61 28.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.543 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.442 HG12 ' HE1' ' A' ' 50' ' ' PHE . 10.6 p -59.95 148.47 7.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.907 0.384 . . . . 0.0 111.542 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.52 159.92 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.975 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.88 -174.96 4.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.006 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 p -70.51 -38.22 74.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.816 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.65 151.28 8.81 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.459 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -118.62 154.35 32.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -96.66 106.98 19.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.17 128.99 34.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.783 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 42.1 m 60.9 108.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.768 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -112.72 -42.05 3.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.96 -37.59 7.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.23 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -155.99 159.3 39.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.88 0.371 . . . . 0.0 111.076 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.17 158.25 27.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 14.8 p -120.87 -42.38 2.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.941 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.49 -46.83 15.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.147 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.774 0.321 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 179.17 -36.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.013 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 64.27 98.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.9 m -136.68 -58.73 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -110.1 97.37 6.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.98 125.94 27.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.941 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.68 130.19 4.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -167.16 137.41 2.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.933 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.56 144.22 26.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.808 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -113.88 159.18 20.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.652 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -134.19 157.8 45.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.022 0.439 . . . . 0.0 111.065 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 29.9 m -52.01 129.38 27.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.396 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.92 -14.99 58.51 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.939 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.05 138.16 51.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.836 0.351 . . . . 0.0 111.263 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.774 HD23 ' HG3' ' A' ' 29' ' ' ARG . 62.4 mt -91.81 119.64 31.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.927 0.394 . . . . 0.0 110.156 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.0 m -140.72 171.32 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.946 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 10.0 m-85 -109.87 136.71 48.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.515 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.644 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.08 124.56 52.88 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.007 0.432 . . . . 0.0 111.775 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -92.09 131.69 37.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.75 179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mtp -129.09 147.47 50.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.689 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.75 115.26 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.877 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.413 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 100.45 4.08 55.07 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.764 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.413 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -152.8 153.66 30.34 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.695 0.283 . . . . 0.0 110.653 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.83 167.6 18.3 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.562 2.174 . . . . 0.0 112.3 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.454 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 71.0 m80 -47.49 115.23 1.06 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.627 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.92 130.41 27.63 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.315 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -54.89 120.89 8.89 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.206 1.937 . . . . 0.0 111.114 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.73 175.77 9.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.345 0.593 . . . . 0.0 112.252 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.774 ' HG3' HD23 ' A' ' 15' ' ' LEU . 5.3 ttp180 -142.84 155.7 44.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.455 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -78.85 135.28 26.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.98 -20.3 4.6 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -165.28 164.03 19.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.116 0.484 . . . . 0.0 111.677 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.9 ptp -153.99 162.24 27.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.935 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.7 139.31 67.82 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.506 2.137 . . . . 0.0 112.26 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.21 -78.31 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.002 0.429 . . . . 0.0 111.025 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.76 -40.31 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.142 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.74 86.19 0.71 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.451 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.17 19.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.488 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mttp 46.05 -172.01 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.611 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 41' ' ' THR . 0.7 OUTLIER 51.76 31.31 7.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.168 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -165.12 89.78 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.29 -75.18 0.18 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.298 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -156.64 52.81 0.52 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.156 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.95 144.34 45.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.422 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 82.0 m-85 -94.82 154.45 17.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.767 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -99.3 107.04 19.23 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.639 HG11 HD21 ' A' ' 63' ' ' LEU . 7.2 m -103.47 150.5 6.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-O 121.433 0.635 . . . . 0.0 112.342 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 49.0 t80 -105.43 124.51 49.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.024 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.644 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 70.1 m-85 -93.28 108.96 20.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.718 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.699 ' CE2' HD12 ' A' ' 89' ' ' ILE . 47.8 m-85 -61.53 177.93 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.815 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.97 -63.35 0.94 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.001 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.1 p -91.52 -22.46 20.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 0.0 110.729 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 10.6 m-70 64.56 36.96 8.21 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.438 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -91.64 155.44 18.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.603 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.11 140.26 53.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.188 0.518 . . . . 0.0 111.356 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.553 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.26 178.1 10.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.363 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.0 m-85 -119.92 127.21 52.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.2 mp -138.84 161.75 36.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.994 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.48 176.4 35.3 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.653 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.68 -25.06 54.43 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.583 2.189 . . . . 0.0 112.409 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -69.53 -27.07 64.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.892 0.377 . . . . 0.0 110.894 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 4.0 m-20 -100.25 6.95 44.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.312 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.639 HD21 HG11 ' A' ' 47' ' ' VAL . 22.3 mt -114.31 138.1 50.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.651 0.262 . . . . 0.0 110.35 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.6 m-85 -137.11 159.58 69.33 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.066 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.9 Cg_exo -70.24 113.86 3.59 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.674 2.25 . . . . 0.0 111.65 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 89.1 t80 -53.6 -59.51 4.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.737 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -49.04 -42.63 39.05 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 111.649 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.08 -39.53 72.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.57 -179.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -105.33 10.39 33.51 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.4 ptpt -56.38 -44.33 80.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.633 0.254 . . . . 0.0 111.676 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mm-40 -68.56 -32.86 73.09 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 73' ' ' PHE . 13.1 ptpt -84.01 -43.34 15.26 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.435 ' N ' ' HG3' ' A' ' 72' ' ' LYS . 18.2 m-30 -98.3 -8.6 26.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.24 75.38 2.04 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.999 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mmmm -148.61 159.26 38.86 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.609 0.242 . . . . 0.0 110.412 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.62 151.87 59.76 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.553 2.169 . . . . 0.0 112.573 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.05 170.27 15.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.148 0.499 . . . . 0.0 111.547 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -15.67 28.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.405 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -66.35 -14.82 62.65 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.009 0.433 . . . . 0.0 110.751 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt 63.37 144.15 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.111 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.44 -18.8 35.59 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.617 -178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 15.0 t80 -58.56 -55.65 32.36 Favored 'General case' 0 N--CA 1.457 -0.086 0 CA-C-O 121.04 0.448 . . . . 0.0 110.623 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -52.83 -45.67 67.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.022 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -48.72 -31.35 6.75 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.922 0.391 . . . . 0.0 110.441 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.09 -31.42 61.72 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.881 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 89' ' ' ILE . 88.9 mt -60.97 -43.8 98.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.033 0.444 . . . . 0.0 110.231 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -64.14 -44.9 90.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.069 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.597 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -63.38 -50.92 68.0 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.699 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -51.81 -27.6 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 111.82 -179.588 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.44 -44.66 6.1 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.76 -32.92 41.05 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.3 87.43 3.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 120.751 0.31 . . . . 0.0 111.241 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 3.6 Cg_exo -76.53 -13.75 18.19 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.986 2.457 . . . . 0.0 112.633 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 p -104.01 13.07 33.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.553 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.597 HG11 ' HG2' ' A' ' 88' ' ' GLU . 14.9 p -62.89 147.01 12.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.939 0.399 . . . . 0.0 111.491 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -156.17 125.33 6.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -121.23 123.13 41.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.024 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.9 t -81.89 -172.8 4.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.87 167.45 35.4 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -147.83 -176.78 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.347 . . . . 0.0 110.85 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -134.0 132.39 40.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.928 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.1 p -103.63 150.86 23.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -90.12 -177.5 5.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -85.05 -38.47 19.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -123.33 167.01 14.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.63 176.52 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.3 m -124.39 165.34 17.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.924 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 t 60.53 101.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.67 149.1 41.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.028 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.889 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.882 0.373 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 p -100.76 -31.9 10.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.44 168.13 20.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.804 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.1 p -116.11 177.12 4.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -122.48 32.69 5.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.08 160.94 37.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.876 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 69.55 172.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.818 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 8' ' ' LYS . 1.7 ptpp? -90.52 105.4 17.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.001 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -92.24 135.93 33.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.517 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.635 ' CE1' HG11 ' A' ' 16' ' ' VAL . 55.5 m-85 -106.26 152.22 23.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.802 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.47 147.05 50.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.887 0.375 . . . . 0.0 110.878 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 12.0 t -52.21 126.72 19.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.294 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.571 ' HA2' ' HE ' ' A' ' 29' ' ' ARG . . . 109.72 -18.46 29.44 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.195 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -72.47 144.56 48.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 111.859 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.562 HD23 ' HG3' ' A' ' 29' ' ' ARG . 61.3 mt -92.54 123.73 36.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.105 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.635 HG11 ' CE1' ' A' ' 10' ' ' TYR . 24.1 m -141.9 173.01 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 112.193 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -111.84 135.88 51.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.746 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.632 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -112.75 122.24 47.09 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.003 0.43 . . . . 0.0 111.571 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 22.8 tptm -92.21 129.71 38.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.874 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.3 mtm -128.21 149.94 50.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.586 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.56 124.45 22.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.982 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 91.41 -0.75 75.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.798 -0.715 . . . . 0.0 113.049 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.1 m-85 -146.52 153.54 47.57 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.857 0.329 . . . . 0.0 110.813 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.41 165.31 16.47 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.771 2.314 . . . . 0.0 112.417 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.485 ' CE1' ' CZ ' ' A' ' 73' ' ' PHE . 70.1 m80 -47.94 115.42 1.17 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.489 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.434 ' CD1' ' HD2' ' A' ' 27' ' ' PRO . 2.5 t-105 -98.91 132.86 22.91 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.412 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 35.1 Cg_exo -54.54 120.05 7.42 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.04 1.827 . . . . 0.0 111.079 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -143.7 174.57 10.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.347 0.594 . . . . 0.0 112.373 -178.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.571 ' HE ' ' HA2' ' A' ' 13' ' ' GLY . 43.1 ttt180 -141.53 154.8 45.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.607 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 mm -78.39 138.65 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -123.89 -23.21 4.7 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -164.28 153.2 13.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.979 0.419 . . . . 0.0 111.353 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 9.5 mmt -92.88 156.37 40.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.62 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 5.9 Cg_exo -78.22 131.26 10.66 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.845 2.364 . . . . 0.0 111.986 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.4 -86.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.68 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -173.8 -54.58 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.263 0.554 . . . . 0.0 110.417 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.3 65.67 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.046 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.4 m -148.96 156.97 7.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.923 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt 67.54 -72.04 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.695 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.31 40.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.275 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -137.3 109.09 7.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.091 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.22 -64.53 1.08 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.327 0.584 . . . . 0.0 109.888 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -156.44 56.65 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.747 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.47 149.96 52.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.543 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 61.1 m-85 -94.37 158.3 15.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.128 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.9 106.37 18.66 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.677 HG21 HD21 ' A' ' 63' ' ' LEU . 73.9 t -103.7 142.72 16.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.494 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -106.77 123.3 47.95 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.774 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.632 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 90.1 m-85 -95.11 108.69 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.311 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.805 ' HE2' HD12 ' A' ' 89' ' ' ILE . 54.3 m-85 -57.57 179.32 0.06 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.869 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.27 -64.12 0.56 Allowed Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.311 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.5 p -92.0 -22.63 19.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.81 0.338 . . . . 0.0 110.619 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 22.8 m170 64.62 36.01 8.7 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.224 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -90.41 153.84 20.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.602 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.72 141.35 52.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.212 0.529 . . . . 0.0 111.526 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.97 166.74 32.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.305 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -107.08 124.85 50.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.865 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.598 HD13 ' HB1' ' A' ' 18' ' ' ALA . 4.9 mt -138.71 160.22 40.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.925 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.13 177.26 38.02 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.63 -24.8 47.7 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.507 2.138 . . . . 0.0 112.388 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -69.17 -25.26 64.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.814 0.34 . . . . 0.0 110.92 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.458 ' CB ' HD22 ' A' ' 58' ' ' LEU . 2.3 m-20 -99.6 6.48 45.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.322 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.677 HD21 HG21 ' A' ' 47' ' ' VAL . 38.6 mt -115.02 138.82 50.43 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.723 0.297 . . . . 0.0 110.57 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.1 m-85 -136.34 159.99 68.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.701 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.644 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 8.1 Cg_exo -71.28 114.17 3.84 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.46 2.107 . . . . 0.0 111.479 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.491 ' O ' ' N ' ' A' ' 70' ' ' LYS . 74.3 t80 -51.07 -59.57 4.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.117 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.436 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 1.1 mt-10 -48.09 -43.7 30.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.923 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.644 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 7.0 mt-10 -71.37 -39.63 71.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.524 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.461 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 63.7 m -103.04 9.69 38.45 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.3 ptpp? -55.62 -44.62 77.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.69 0.281 . . . . 0.0 111.669 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 1.4 mt-10 -68.39 -34.25 75.7 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -84.25 -44.15 14.16 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.485 ' CZ ' ' CE1' ' A' ' 25' ' ' HIS . 19.2 m-30 -95.95 -14.1 23.33 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.98 74.89 2.34 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.195 -1.002 . . . . 0.0 113.071 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 0.8 OUTLIER -149.11 159.31 37.45 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.589 0.233 . . . . 0.0 110.548 179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.69 152.72 79.17 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.559 2.172 . . . . 0.0 112.621 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 79' ' ' ARG . 50.6 p-10 -138.52 -172.37 3.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.291 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.6 tmtt? -100.35 -12.09 19.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.154 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.427 ' HB2' ' ND2' ' A' ' 77' ' ' ASN . 13.7 mmm180 -65.91 -15.95 63.42 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.993 0.425 . . . . 0.0 110.676 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.1 mmtt 62.7 141.22 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.996 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.49 59.3 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.562 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 26.5 t80 -57.5 -58.09 9.82 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.979 0.419 . . . . 0.0 110.941 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.884 ' HA ' HD12 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -51.37 -45.23 62.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.086 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.21 -32.28 10.17 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.012 0.434 . . . . 0.0 110.324 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.9 -32.59 58.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.826 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 83' ' ' SER . 19.2 mt -60.62 -43.51 97.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.098 0.475 . . . . 0.0 110.141 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 59.0 t90 -63.32 -44.51 94.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.1 mp0 -62.93 -51.91 65.1 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.805 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -51.97 -25.63 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -101.04 -44.74 5.62 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -81.98 -32.5 30.63 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.24 84.09 3.3 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.804 0.335 . . . . 0.0 110.733 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 91.4 Cg_endo -77.08 -9.99 17.9 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.559 2.173 . . . . 0.0 112.856 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.1 p -104.12 12.2 34.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.588 0.232 . . . . 0.0 111.445 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.444 HG12 ' HE1' ' A' ' 50' ' ' PHE . 11.4 p -62.75 147.98 11.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.014 0.435 . . . . 0.0 111.549 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -150.91 168.17 25.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.872 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.11 -48.27 10.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.085 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 93.8 p -142.78 126.69 17.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.76 -37.09 2.84 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.625 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.36 77.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -163.38 -46.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.827 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.7 p -121.77 111.66 17.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.58 120.03 14.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.824 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -108.02 -36.91 6.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.23 123.79 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -143.39 152.31 41.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.952 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.5 m -93.25 -46.78 7.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.975 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 13.1 t 60.54 109.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.05 113.86 13.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.108 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.995 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.809 0.337 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.96 127.51 35.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.56 105.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.844 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 p -170.4 141.49 1.99 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.872 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 28.1 m-20 -107.35 152.06 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -93.2 174.48 7.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.809 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -93.52 93.46 8.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.819 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -94.34 148.93 21.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -95.25 139.92 30.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.55 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.482 ' CE1' HG11 ' A' ' 16' ' ' VAL . 94.1 m-85 -113.72 158.53 20.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.918 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -136.12 159.67 40.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.929 0.395 . . . . 0.0 111.046 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.8 m -52.52 124.82 14.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.28 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' HA2' ' CZ ' ' A' ' 29' ' ' ARG . . . 105.58 -16.51 44.25 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.817 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.69 135.36 49.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.878 0.37 . . . . 0.0 110.995 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.443 HD23 ' HG3' ' A' ' 29' ' ' ARG . 71.0 mt -92.07 117.26 29.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.968 0.413 . . . . 0.0 110.286 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.482 HG11 ' CE1' ' A' ' 10' ' ' TYR . 33.5 m -139.1 171.38 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.995 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.568 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 28.6 m-85 -110.23 136.01 50.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.619 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.793 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -113.71 125.09 53.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.103 0.477 . . . . 0.0 111.781 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . 21.3 tptm -91.47 133.3 35.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.055 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -125.51 154.41 42.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.676 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.59 115.48 6.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.983 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.99 39.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.575 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -116.55 148.71 42.42 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-O 120.758 0.313 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -78.58 166.66 23.64 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.738 2.292 . . . . 0.0 112.731 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 69.6 m80 -51.64 115.13 1.48 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.373 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.6 t-105 -99.56 134.54 21.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD2' ' CD1' ' A' ' 26' ' ' TRP . 31.1 Cg_exo -54.44 120.89 8.77 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.164 1.909 . . . . 0.0 110.712 178.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.0 174.77 10.75 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.443 ' HG3' HD23 ' A' ' 15' ' ' LEU . 5.1 ttp180 -141.59 156.85 45.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.745 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.426 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 27.0 mm -83.89 140.51 16.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.726 0.298 . . . . 0.0 110.574 179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -124.55 -18.75 5.6 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -163.1 152.43 15.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.966 0.412 . . . . 0.0 111.214 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.5 mmt -89.5 158.4 45.81 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.693 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 85.2 Cg_endo -82.15 107.68 1.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.667 2.244 . . . . 0.0 112.477 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.589 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -55.29 -94.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.723 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -174.33 -48.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.384 0.612 . . . . 0.0 110.17 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.06 80.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.104 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.589 HG22 ' HG3' ' A' ' 35' ' ' GLU . 4.3 m -146.78 14.36 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.877 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.05 -60.6 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.707 0.289 . . . . 0.0 111.07 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 171.98 43.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.993 0.425 . . . . 0.0 110.616 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.2 p -135.97 112.24 9.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.261 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.58 -64.71 1.05 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.366 0.603 . . . . 0.0 109.525 178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.06 56.52 0.59 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.786 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.96 148.82 52.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.482 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.431 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 72.1 m-85 -94.88 154.08 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.869 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -98.65 104.24 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.522 HG11 HD21 ' A' ' 63' ' ' LEU . 19.1 m -102.41 150.56 6.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.545 0.688 . . . . 0.0 112.432 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.502 ' HE2' HG13 ' A' ' 95' ' ' VAL . 36.4 t80 -105.4 124.81 50.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.967 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.626 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 34.5 m-85 -91.47 108.1 19.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.494 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.79 ' HE2' HD12 ' A' ' 89' ' ' ILE . 45.0 m-85 -60.52 175.95 0.41 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.721 0.296 . . . . 0.0 110.955 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.58 -62.47 0.87 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.088 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.6 p -90.98 -22.52 20.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.841 0.353 . . . . 0.0 110.739 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 20.6 m170 63.83 35.51 11.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.499 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -91.3 155.38 18.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.64 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.79 140.6 52.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.326 0.584 . . . . 0.0 111.639 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.08 168.79 25.86 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.431 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 64.4 m-85 -111.82 127.05 55.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.145 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.793 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.4 mp -138.36 160.23 40.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.58 177.33 37.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.77 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.89 -27.0 51.38 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.672 2.248 . . . . 0.0 112.363 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -69.25 -25.33 64.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -99.1 5.49 46.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.314 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.522 HD21 HG11 ' A' ' 47' ' ' VAL . 33.0 mt -113.17 138.71 49.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.814 0.34 . . . . 0.0 110.699 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.507 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 0.8 OUTLIER -134.74 154.01 79.18 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.83 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.476 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 15.0 Cg_exo -67.1 112.3 2.48 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.279 1.986 . . . . 0.0 111.157 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.568 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 77.2 t80 -51.49 -59.9 3.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.25 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -48.23 -43.0 31.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.012 0.434 . . . . 0.0 111.807 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 48.0 mt-10 -71.24 -39.69 71.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.466 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.412 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -103.0 8.49 38.94 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 66' ' ' TYR . 11.3 ptmt -55.35 -48.12 74.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.842 0.353 . . . . 0.0 111.38 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -70.01 -23.93 63.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.833 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 24.4 mtpt -85.29 -47.51 9.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 69' ' ' SER . 24.0 m-85 -105.58 -0.55 25.64 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.38 73.3 2.41 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.724 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.436 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 27.1 mmtt -148.53 159.11 39.44 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.588 0.232 . . . . 0.0 110.567 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.2 153.09 28.29 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.543 2.162 . . . . 0.0 112.374 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -131.96 165.57 23.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.113 0.483 . . . . 0.0 111.672 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tptt -86.75 -17.27 34.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.009 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.18 -14.47 62.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.049 0.452 . . . . 0.0 110.531 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm 63.65 144.56 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.131 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.59 -18.22 39.71 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.802 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 30.0 t80 -58.59 -54.4 47.44 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.037 0.446 . . . . 0.0 110.801 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -45.64 66.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.16 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -48.46 -31.7 6.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.002 0.43 . . . . 0.0 110.49 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.52 -31.89 60.31 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.054 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.629 ' O ' HG22 ' A' ' 89' ' ' ILE . 24.9 mt -60.57 -43.82 96.86 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.062 0.458 . . . . 0.0 110.35 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 69.4 t90 -64.35 -45.48 87.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.125 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.76 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -62.55 -51.23 68.2 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.79 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -51.83 -27.73 8.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.317 . . . . 0.0 111.709 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.32 -44.58 6.17 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -80.69 -31.71 36.17 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -156.59 88.59 2.75 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.724 0.297 . . . . 0.0 111.351 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 80.2 Cg_endo -77.81 -11.91 16.6 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.625 2.217 . . . . 0.0 112.646 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.3 p -101.71 10.55 39.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.605 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.76 HG11 ' HG2' ' A' ' 88' ' ' GLU . 12.2 p -61.33 143.84 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.944 0.402 . . . . 0.0 111.266 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.95 114.12 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -88.08 -66.79 0.88 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.098 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 88.8 p -63.79 -175.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.835 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -177.17 -45.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.555 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 58.58 83.63 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.848 0.356 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.5 92.46 4.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.0 m -123.94 99.74 6.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 p -156.12 -46.69 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -109.01 177.87 4.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.006 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.85 -25.2 19.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.118 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm 62.71 -175.75 0.14 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.53 97.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.754 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 49.7 t 62.3 75.53 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.939 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.32 101.57 1.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.819 0.343 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -134.75 106.25 6.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.73 101.08 3.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.6 m 60.49 105.63 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -88.54 177.03 6.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.7 ttm-85 61.03 112.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.936 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.12 -178.1 4.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.773 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.15 119.07 23.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.92 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -95.59 143.73 26.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.725 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.587 ' CD2' HG11 ' A' ' 16' ' ' VAL . 87.8 m-85 -113.33 157.44 21.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -132.91 157.05 46.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.89 0.376 . . . . 0.0 111.102 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 72.5 m -51.9 132.12 31.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.594 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.19 -12.25 68.37 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.937 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.73 139.18 51.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.82 0.343 . . . . 0.0 111.006 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.4 HD23 ' HG3' ' A' ' 29' ' ' ARG . 68.2 mt -91.18 116.51 28.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.996 0.427 . . . . 0.0 110.4 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.587 HG11 ' CD2' ' A' ' 10' ' ' TYR . 30.6 m -139.69 170.34 15.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.552 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.521 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 18.0 m-85 -111.15 135.88 51.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.519 178.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.688 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.89 123.05 49.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.906 0.384 . . . . 0.0 111.397 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 23.8 tptp -92.08 130.94 37.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.134 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtm -127.03 147.86 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.47 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.37 113.48 4.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 111.013 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.96 -27.38 14.69 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.635 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.91 157.98 48.98 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.742 0.306 . . . . 0.0 110.942 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.46 166.39 12.2 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.826 2.35 . . . . 0.0 112.372 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.505 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 59.0 m80 -47.23 113.99 0.78 Allowed 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.516 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.458 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.49 130.7 27.49 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.642 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.55 119.03 5.75 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.376 2.051 . . . . 0.0 111.083 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.2 175.2 10.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 14.3 ttp180 -142.53 156.44 45.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.493 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.436 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 25.0 mm -79.91 138.76 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.21 -20.84 5.15 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -162.65 151.31 14.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.957 0.408 . . . . 0.0 111.227 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.403 ' HE2' ' HA ' ' A' ' 33' ' ' MET . 31.2 mmt -91.51 161.63 33.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.66 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 90.8 Cg_endo -85.41 117.32 1.79 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.675 2.25 . . . . 0.0 112.11 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -85.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.101 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.13 -60.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.029 0.442 . . . . 0.0 110.622 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.77 27.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.249 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.6 m -89.85 -2.68 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.772 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -163.74 -179.1 6.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.57 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 60.6 p -71.33 62.53 0.35 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.696 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' ASN . 13.4 t -129.75 -15.31 3.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.844 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 43.84 -87.12 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.731 0.301 . . . . 0.0 111.323 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -155.02 50.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.168 0.509 . . . . 0.0 110.235 179.083 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -141.48 166.44 24.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.048 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' CE2' ' HD3' ' A' ' 34' ' ' PRO . 45.5 m-85 -94.12 157.91 15.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.135 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.9 107.51 19.96 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.659 HG21 HD21 ' A' ' 63' ' ' LEU . 84.3 t -103.53 142.68 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 121.463 0.649 . . . . 0.0 112.56 -178.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -105.61 121.89 44.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.507 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.688 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 81.7 m-85 -94.16 106.62 18.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.049 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.7 ' CE2' HD12 ' A' ' 89' ' ' ILE . 49.4 m-85 -57.59 176.99 0.11 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.843 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.411 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 69.77 -63.55 0.67 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.418 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 81.0 p -90.19 -23.21 21.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.739 0.304 . . . . 0.0 110.738 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 52' ' ' THR . 4.0 m170 66.0 33.91 7.39 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.197 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -90.2 151.03 21.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.928 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.8 140.79 51.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.239 0.542 . . . . 0.0 111.307 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.88 168.11 28.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.289 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.415 ' CE2' ' O ' ' A' ' 40' ' ' SER . 13.4 m-85 -109.31 125.45 52.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.995 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.556 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 19.7 mt -139.33 160.62 39.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.937 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.37 -179.85 40.85 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.23 -26.82 41.74 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.511 2.14 . . . . 0.0 112.189 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -69.55 -22.59 63.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.077 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.0 m-20 -99.0 3.66 47.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.463 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 47' ' ' VAL . 18.4 mt -115.03 139.6 49.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.752 0.311 . . . . 0.0 110.504 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.47 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -136.59 166.3 28.65 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.845 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.421 ' HB2' ' CG ' ' A' ' 68' ' ' GLU . 4.8 Cg_exo -73.17 111.08 3.2 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.767 2.311 . . . . 0.0 111.69 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.521 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.2 t80 -49.95 -58.44 5.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.478 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -49.0 -41.09 33.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.611 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.421 ' CG ' ' HB2' ' A' ' 65' ' ' PRO . 4.9 mm-40 -71.02 -39.71 72.21 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.674 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 3.6 m -103.39 13.87 32.7 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 2.2 mtmp? -55.52 -44.95 77.15 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.413 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.75 -40.83 88.44 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.75 -43.88 16.25 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.9 m-30 -94.71 -19.77 20.11 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.73 74.08 2.39 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.042 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 12.1 mttt -149.32 153.57 37.62 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.95 155.5 8.42 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.616 2.211 . . . . 0.0 112.638 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -136.39 165.58 25.46 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.578 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -85.73 -16.07 40.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.304 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.58 -13.8 61.53 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.987 0.423 . . . . 0.0 110.713 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.6 mmtt 63.79 142.01 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.159 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.71 -16.87 55.52 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.517 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 31.4 t80 -59.0 -56.88 16.58 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.943 0.402 . . . . 0.0 110.882 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.41 -45.42 65.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.113 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.62 -30.13 5.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.017 0.437 . . . . 0.0 110.503 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.96 -31.86 57.43 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.161 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.621 ' O ' HG22 ' A' ' 89' ' ' ILE . 12.7 mt -60.4 -43.35 96.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.064 0.459 . . . . 0.0 110.34 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 62.9 t90 -63.73 -45.71 88.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.229 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.67 -50.63 70.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' CE2' ' A' ' 50' ' ' PHE . 1.1 tt -52.92 -27.03 12.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.744 0.306 . . . . 0.0 111.692 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -99.31 -44.83 6.08 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -79.64 -31.55 41.54 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -178.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . 1.0 OUTLIER -156.99 87.08 2.76 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.751 0.31 . . . . 0.0 111.282 -179.417 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.01 -12.94 26.21 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.933 2.422 . . . . 0.0 112.61 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.3 p -107.05 14.66 26.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.53 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.581 HG12 ' HE1' ' A' ' 50' ' ' PHE . 14.6 p -62.56 150.66 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.075 0.464 . . . . 0.0 111.702 -179.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -153.99 122.35 6.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.603 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 64.85 -76.67 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.086 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -140.47 175.4 9.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.808 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.39 -97.77 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.545 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 60.7 -172.09 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.808 0.337 . . . . 0.0 110.934 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -159.71 -45.63 0.05 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.3 t -143.66 143.75 31.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.844 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.55 165.75 11.55 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.41 28.86 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.033 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.0 113.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.981 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.74 81.95 1.53 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.7 31.6 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.3 t -151.44 145.96 25.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.71 87.87 6.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.089 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.926 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.795 0.331 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -113.01 31.93 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.913 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.83 135.73 39.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -76.03 122.77 24.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -160.29 138.72 10.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -146.7 31.42 0.97 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -121.75 134.62 54.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.691 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.665 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 1.7 tttp -146.68 -154.4 0.55 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.166 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.665 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 1.9 mm-40 82.09 134.13 0.06 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.857 -178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.454 ' CD2' HG11 ' A' ' 16' ' ' VAL . 4.6 m-85 -125.93 166.79 16.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.819 0.342 . . . . 0.0 111.475 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.5 mmmm -140.56 165.91 26.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.897 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 98.8 m -52.01 125.36 15.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.409 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.34 -16.34 49.15 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.731 -0.747 . . . . 0.0 113.153 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.19 138.92 52.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.79 0.329 . . . . 0.0 111.323 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.464 HD23 ' HG3' ' A' ' 29' ' ' ARG . 81.3 mt -91.43 120.75 32.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.191 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.454 HG11 ' CD2' ' A' ' 10' ' ' TYR . 22.6 m -141.62 174.05 7.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.369 0.604 . . . . 0.0 112.133 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.508 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 9.4 m-85 -111.97 136.34 51.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.419 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.766 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -112.65 125.53 54.39 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.022 0.439 . . . . 0.0 111.449 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.82 132.58 35.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.979 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.7 mtm -129.81 155.01 46.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.701 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.73 119.62 13.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.034 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.23 -13.03 66.12 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.813 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -125.54 149.21 64.23 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.759 0.279 . . . . 0.0 110.836 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 91.5 Cg_endo -82.24 167.91 15.39 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.723 2.282 . . . . 0.0 112.448 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -47.18 112.38 0.52 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.581 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.453 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.6 t-105 -97.79 130.5 28.82 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.436 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -54.38 119.38 6.28 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.364 2.043 . . . . 0.0 111.004 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.605 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.62 175.54 10.08 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.464 ' HG3' HD23 ' A' ' 15' ' ' LEU . 2.6 ttp180 -142.45 157.18 45.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.464 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.6 mm -80.13 138.84 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -125.45 -20.36 4.79 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -163.53 152.71 14.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.025 0.441 . . . . 0.0 111.519 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.406 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 18.2 mmt -90.6 159.16 41.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.671 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 87.1 Cg_endo -81.95 111.02 2.15 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.613 2.209 . . . . 0.0 112.34 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.679 ' OE2' HG21 ' A' ' 38' ' ' VAL . 0.6 OUTLIER -74.33 -89.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.647 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -172.72 -54.15 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.302 0.573 . . . . 0.0 110.291 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -170.0 78.52 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.053 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.679 HG21 ' OE2' ' A' ' 35' ' ' GLU . 4.8 m -143.55 10.5 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.798 -179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -166.33 -57.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.918 0.39 . . . . 0.0 110.815 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 173.02 40.31 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.353 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t -130.9 -178.73 4.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.141 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -172.41 -45.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.598 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.82 35.49 0.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.026 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.16 146.98 45.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.579 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 84.6 m-85 -92.49 155.06 18.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.108 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -96.38 106.55 18.8 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.605 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 59.5 t -101.54 142.94 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.431 -178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -105.14 120.88 42.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.992 -1.003 . . . . 0.0 109.568 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.651 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 92.3 m-85 -94.08 111.36 23.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.787 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.728 ' HE2' HD12 ' A' ' 89' ' ' ILE . 47.8 m-85 -60.67 177.54 0.29 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.954 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.22 -62.93 0.78 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.22 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 80.5 p -92.08 -23.24 19.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.858 0.361 . . . . 0.0 110.679 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 34.4 m170 63.88 37.64 9.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.339 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -90.99 153.95 19.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.829 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.93 144.15 49.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.365 0.603 . . . . 0.0 111.764 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.93 164.79 38.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.099 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 36.8 m-85 -107.87 87.8 2.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.155 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.766 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 6.6 mt -99.21 158.67 15.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.059 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.643 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -93.29 171.78 32.69 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.319 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.87 -22.53 48.84 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.536 2.157 . . . . 0.0 112.464 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -67.87 -27.22 66.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.694 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -100.0 14.55 30.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.964 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.6 mp -109.56 137.3 47.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.583 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.6 m-85 -136.18 157.85 74.83 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.958 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.553 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 9.5 Cg_exo -71.38 112.06 3.25 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.672 2.248 . . . . 0.0 111.525 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.4 t80 -51.37 -58.96 4.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.908 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.4 -40.28 49.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.081 0.467 . . . . 0.0 111.654 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.553 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.8 tt0 -71.66 -39.94 69.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.577 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.456 ' HB2' ' CD2' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -105.75 9.54 32.99 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.3 ptmm? -56.54 -47.51 79.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.817 0.341 . . . . 0.0 111.435 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -23.27 62.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.75 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 mtpp -85.06 -47.36 10.27 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 69' ' ' SER . 0.9 OUTLIER -108.88 3.76 22.72 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 70' ' ' LYS . . . -83.77 16.84 29.38 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.228 -0.987 . . . . 0.0 113.684 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -94.07 157.91 36.99 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.39 0.595 . . . . 0.0 110.457 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.46 158.39 10.16 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.379 2.052 . . . . 0.0 112.246 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.404 ' ND2' ' HG3' ' A' ' 24' ' ' PRO . 3.7 m120 -132.23 169.07 16.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.625 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.2 mmtt -89.18 -16.5 31.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.349 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -14.61 61.9 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 110.783 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt 63.35 141.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.084 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.8 -17.11 54.71 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.403 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.453 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 47.5 t80 -58.17 -54.88 41.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.03 0.443 . . . . 0.0 110.734 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.64 -46.37 70.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.306 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.34 -31.5 6.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.007 0.432 . . . . 0.0 110.619 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.42 -31.16 59.34 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.044 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.669 ' O ' HG22 ' A' ' 89' ' ' ILE . 76.9 mt -60.88 -43.68 98.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.003 0.43 . . . . 0.0 110.415 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.1 t90 -63.74 -44.57 93.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.22 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.667 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.6 OUTLIER -63.5 -50.5 69.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.728 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.8 OUTLIER -51.72 -27.45 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' HG3' HG23 ' A' ' 89' ' ' ILE . 55.4 mt-10 -100.29 -44.73 5.84 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -79.17 -33.71 43.75 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -156.37 90.2 2.68 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.767 0.317 . . . . 0.0 111.194 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.5 Cg_endo -77.27 -11.24 17.6 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.565 2.176 . . . . 0.0 112.748 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.2 p -103.09 12.54 35.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.507 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.667 HG11 ' HG2' ' A' ' 88' ' ' GLU . 11.7 p -62.68 144.81 14.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.944 0.402 . . . . 0.0 111.35 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -127.14 171.32 11.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.954 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.554 ' HB2' ' HB3' ' A' ' 53' ' ' HIS . . . -106.77 -46.9 3.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.3 t -89.62 147.48 23.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -123.18 -93.27 1.1 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.48 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -73.9 111.14 8.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -61.04 101.77 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.964 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.49 -178.22 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.035 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.8 t -171.61 172.52 4.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -129.31 169.95 14.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -90.27 -30.79 17.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.904 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 95.58 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.0 m -165.21 158.68 16.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 16.0 p -132.21 -43.78 0.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.009 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.61 -50.72 3.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.125 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.889 -179.966 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.789 0.328 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -133.73 -51.83 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.06 -172.78 2.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.719 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.02 -177.19 3.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.056 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -142.82 -65.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.739 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 -122.06 23.09 10.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.932 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -126.03 105.44 8.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.69 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.46 ' HD2' ' CE2' ' A' ' 10' ' ' TYR . 2.5 pttp -140.68 176.43 8.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.156 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -154.29 142.65 20.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.568 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.46 ' CE2' ' HD2' ' A' ' 8' ' ' LYS . 88.8 m-85 -116.97 159.59 22.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.669 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 5.9 mmtm -137.72 161.3 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.907 0.384 . . . . 0.0 111.016 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 t -52.28 124.61 13.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.173 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.83 -16.11 43.85 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.023 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.26 140.0 50.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 111.081 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.571 HD23 ' HG3' ' A' ' 29' ' ' ARG . 56.1 mt -92.74 118.7 31.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.339 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.424 HG21 HD22 ' A' ' 63' ' ' LEU . 31.0 m -139.67 171.82 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.185 0.517 . . . . 0.0 111.743 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.6 m-85 -109.99 136.6 49.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.764 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.727 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -113.49 126.44 55.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.012 0.434 . . . . 0.0 111.799 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 14.2 tptm -92.9 130.64 38.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.902 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.88 148.53 50.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.802 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -67.36 106.76 2.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.745 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.75 -7.07 27.79 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.78 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -141.06 156.58 68.14 Favored Pre-proline 0 C--N 1.332 -0.161 0 CA-C-O 120.781 0.324 . . . . 0.0 110.637 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.89 171.92 9.12 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.735 2.29 . . . . 0.0 112.212 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.479 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 74.7 m80 -47.76 111.8 0.47 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.392 179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.433 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 1.5 t-105 -99.54 129.04 29.84 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.791 -0.186 . . . . 0.0 111.322 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.404 ' HG3' HD22 ' A' ' 86' ' ' LEU . 12.5 Cg_endo -55.44 121.15 9.42 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.13 1.886 . . . . 0.0 110.98 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.59 175.73 9.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.308 0.575 . . . . 0.0 112.266 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.571 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.3 ttp180 -141.7 154.84 45.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.765 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.407 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.1 mm -82.27 114.25 22.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.87 -13.85 14.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.31 152.48 14.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.039 0.447 . . . . 0.0 111.318 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.44 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 6.3 ptp -154.77 156.34 31.32 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.21 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -79.73 160.73 24.75 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.701 2.267 . . . . 0.0 112.196 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -82.8 -37.95 23.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.148 0.499 . . . . 0.0 110.754 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.81 -39.65 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.971 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.691 ' O ' HG22 ' A' ' 38' ' ' VAL . . . -162.53 -47.57 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.036 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 37' ' ' ALA . 5.3 m 50.94 21.82 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.856 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.5 60.5 2.1 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.733 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.599 ' OG ' HG23 ' A' ' 38' ' ' VAL . 13.5 p 177.18 -45.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 76.9 p -79.51 102.85 9.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.929 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . . . -73.72 52.78 0.42 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.017 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t30 56.03 50.82 13.01 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.137 0.494 . . . . 0.0 111.01 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.434 ' HD3' ' HB3' ' A' ' 42' ' ' ALA . 1.6 mtmt -132.07 138.77 48.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.248 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 62.9 m-85 -94.37 153.16 18.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.79 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -99.03 105.75 17.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.622 HG11 HD21 ' A' ' 63' ' ' LEU . 29.6 m -101.44 150.35 6.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.49 0.662 . . . . 0.0 112.214 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 33.0 t80 -105.82 124.51 49.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.04 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.465 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 32.7 m-85 -91.88 107.53 19.28 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.554 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.798 ' HE2' HD12 ' A' ' 89' ' ' ILE . 36.2 m-85 -58.46 174.99 0.27 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 0.0 111.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.57 -62.04 0.87 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.358 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.3 p -90.5 -21.57 21.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.606 0.241 . . . . 0.0 111.06 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 48.5 m170 64.02 34.94 10.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.912 0.386 . . . . 0.0 110.265 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -90.32 153.65 20.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.675 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.55 141.52 51.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.15 0.5 . . . . 0.0 111.69 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.32 177.54 11.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.391 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 8.6 m-85 -120.62 127.29 51.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.886 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.727 HD13 ' HB1' ' A' ' 18' ' ' ALA . 5.3 mt -139.93 163.93 31.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.13 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.94 177.07 35.18 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.616 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.07 -25.19 51.44 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.624 2.216 . . . . 0.0 112.552 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -69.9 -25.54 63.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 0.0 111.064 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 35.7 m-20 -98.3 4.84 48.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.436 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.622 HD21 HG11 ' A' ' 47' ' ' VAL . 20.7 mt -112.55 139.25 48.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.696 0.284 . . . . 0.0 110.488 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.3 m-85 -135.94 160.06 68.78 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.07 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 12.3 Cg_exo -69.77 110.91 2.67 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.672 2.248 . . . . 0.0 111.604 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.4 t80 -51.91 -59.16 4.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.593 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.411 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -50.49 -41.36 53.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.039 0.447 . . . . 0.0 111.684 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 2.2 tm-20 -69.58 -39.77 77.12 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.545 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.1 m -108.09 13.74 25.72 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.168 0.432 . . . . 0.0 112.168 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 4.5 ptpp? -56.08 -47.74 77.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.922 0.391 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.4 mt-10 -71.06 -21.41 62.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.307 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' HD3' ' CE1' ' A' ' 73' ' ' PHE . 4.2 tttt -85.46 -49.47 8.06 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 9.4 m-85 -102.94 -4.8 24.22 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.443 ' HA2' HD11 ' A' ' 86' ' ' LEU . . . -83.3 70.95 3.09 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.048 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 9.1 mtmt -149.21 153.69 38.07 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.88 158.23 14.53 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.587 2.192 . . . . 0.0 112.632 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -137.12 167.29 21.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.565 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.45 -15.51 45.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.109 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -14.06 61.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.958 0.408 . . . . 0.0 110.767 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp 63.84 142.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.276 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.05 -17.72 49.43 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.775 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 44.6 t80 -59.96 -54.23 48.53 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.904 0.383 . . . . 0.0 110.765 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.51 ' HA ' HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -53.05 -46.34 68.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.224 -179.854 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -48.47 -29.75 4.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.986 0.422 . . . . 0.0 110.614 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.02 -31.48 59.77 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.206 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 89' ' ' ILE . 3.8 mm? -61.09 -44.11 97.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.968 0.413 . . . . 0.0 110.535 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 64.0 t90 -65.08 -45.72 84.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.347 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.474 ' OE1' HG11 ' A' ' 95' ' ' VAL . 52.4 mt-10 -62.59 -50.85 69.65 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.798 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -52.44 -27.13 10.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.712 0.291 . . . . 0.0 111.734 -179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -99.58 -44.76 6.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -80.23 -31.98 38.47 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -155.55 88.04 3.09 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.725 0.298 . . . . 0.0 111.252 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.2 Cg_endo -75.78 -13.46 19.83 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.679 2.253 . . . . 0.0 112.739 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.559 HG22 HH12 ' A' ' 29' ' ' ARG . 48.3 p -105.69 12.4 31.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.532 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.566 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.7 p -63.19 149.61 10.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.938 0.399 . . . . 0.0 111.461 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.09 143.25 25.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.933 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.457 ' HB2' ' ND1' ' A' ' 53' ' ' HIS . . . -91.5 104.14 16.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.993 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -83.5 138.33 33.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.966 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.26 141.81 10.21 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.45 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -125.78 153.01 44.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.806 0.336 . . . . 0.0 111.041 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.01 -46.68 0.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.2 t -133.89 99.83 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -101.89 -62.96 1.19 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.949 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.2 113.63 1.88 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.29 157.77 43.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.84 124.63 29.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.8 m -150.59 138.94 20.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.876 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 67.5 m -142.92 -56.63 0.42 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.92 167.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.116 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 120.604 0.24 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 p -68.21 86.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.996 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 60.14 91.21 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.898 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.6 p -134.78 29.84 3.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.977 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -129.8 104.42 7.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.791 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 -79.97 -71.4 0.46 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.984 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -144.67 149.57 35.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.982 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 8.4 ttpt -142.68 -146.87 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.47 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 37.0 mt-10 86.28 129.9 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.894 0.478 . . . . 0.0 109.791 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.491 ' CD2' HG11 ' A' ' 16' ' ' VAL . 5.5 m-85 -112.95 159.13 19.41 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.209 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -135.64 160.1 39.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.047 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.4 t -52.21 129.15 27.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.49 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.75 -14.21 59.03 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.978 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.15 138.31 51.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 0.0 111.051 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.485 HD23 ' HG3' ' A' ' 29' ' ' ARG . 86.9 mt -92.19 118.79 31.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.306 -0.406 . . . . 0.0 109.967 179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.491 HG11 ' CD2' ' A' ' 10' ' ' TYR . 25.0 m -140.61 175.8 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.252 0.549 . . . . 0.0 112.152 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 16.4 m-85 -114.02 137.32 51.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.74 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.979 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -114.71 124.6 52.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.936 0.398 . . . . 0.0 111.537 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 15.9 tptm -91.98 132.96 36.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.079 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.522 ' SD ' HD11 ' A' ' 58' ' ' LEU . 2.0 mmm -127.74 150.66 49.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.598 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 116.15 7.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.836 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.07 -16.07 58.64 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.859 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -130.06 151.93 79.17 Favored Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.715 0.293 . . . . 0.0 110.703 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.13 167.81 17.55 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.639 2.226 . . . . 0.0 112.409 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 51.0 m80 -46.38 114.77 0.87 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.871 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.3 t-105 -98.33 129.44 30.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.609 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.56 119.11 5.41 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.398 2.065 . . . . 0.0 111.214 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.592 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.9 175.75 9.98 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HG3' HD23 ' A' ' 15' ' ' LEU . 3.1 ttt180 -142.28 155.81 45.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.397 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.526 HG21 ' CE ' ' A' ' 33' ' ' MET . 25.4 mm -79.03 137.35 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -123.28 -20.85 5.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -163.32 151.37 13.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.041 0.448 . . . . 0.0 111.284 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.526 ' CE ' HG21 ' A' ' 30' ' ' ILE . 32.4 mmt -94.53 159.84 32.85 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.492 179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 95.7 Cg_endo -81.0 127.18 6.01 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.466 2.111 . . . . 0.0 112.227 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.407 ' HB3' HG22 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -82.0 -80.36 0.16 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.071 0.463 . . . . 0.0 110.956 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 42' ' ' ALA . . . -169.82 -53.54 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.102 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.91 72.22 0.31 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.353 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.455 ' C ' ' HG2' ' A' ' 39' ' ' LYS . 6.8 m -150.36 161.89 3.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.1 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.455 ' HG2' ' C ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER 32.16 49.44 0.14 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.288 179.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 m 60.99 68.31 0.75 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.295 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 69.1 p -150.28 170.15 19.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.139 0.495 . . . . 0.0 110.866 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 36' ' ' ALA . . . -169.28 -56.43 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.822 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -156.34 40.0 0.35 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.931 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 57' ' ' PHE . 10.4 mttm -137.18 149.45 47.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.725 -178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.515 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 58.5 m-85 -94.2 154.51 17.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.99 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -95.03 108.06 20.13 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG21 HD21 ' A' ' 63' ' ' LEU . 60.5 t -103.2 142.46 17.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.576 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -104.14 120.3 40.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.151 -0.932 . . . . 0.0 109.807 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.733 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 72.5 m-85 -93.66 108.36 20.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.862 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.695 ' CE2' HD12 ' A' ' 89' ' ' ILE . 47.5 m-85 -59.21 176.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.859 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 -63.34 0.84 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.287 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 66.2 p -90.79 -22.75 20.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.737 0.303 . . . . 0.0 110.742 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 52' ' ' THR . 10.2 m170 64.62 34.83 9.54 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.075 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -90.23 152.48 21.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.705 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.42 144.89 48.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.28 0.562 . . . . 0.0 111.549 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.37 165.01 37.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.161 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 74.1 m-85 -107.99 87.88 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.054 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.979 HD22 ' HB1' ' A' ' 18' ' ' ALA . 4.8 mp -97.84 156.47 16.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.134 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.17 179.52 39.37 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.57 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.536 ' HA ' HD12 ' A' ' 63' ' ' LEU . 37.2 Cg_endo -66.27 -30.11 45.92 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.635 2.224 . . . . 0.0 112.45 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -69.48 -21.69 63.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.098 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.787 ' HB3' HD23 ' A' ' 58' ' ' LEU . 12.9 m-20 -99.49 2.6 45.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.474 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.603 HD21 HG21 ' A' ' 47' ' ' VAL . 10.0 mt -110.16 139.34 45.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 0.0 110.653 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.8 m-85 -136.37 153.2 76.15 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 24.7 Cg_exo -63.49 112.4 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.469 2.113 . . . . 0.0 111.706 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 70' ' ' LYS . 60.0 t80 -53.39 -59.36 4.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.743 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 5.4 mt-10 -49.71 -41.76 44.24 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.106 0.479 . . . . 0.0 111.521 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.0 OUTLIER -69.96 -39.76 75.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.42 -179.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.9 m -105.9 12.2 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 66' ' ' TYR . 5.3 ptpp? -55.71 -48.42 75.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 110.953 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 16.6 pt-20 -71.65 -19.99 62.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.412 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.413 ' HE2' ' CZ ' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -84.48 -49.99 8.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 -179.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.413 ' CZ ' ' HE2' ' A' ' 72' ' ' LYS . 6.5 m-85 -103.36 -4.63 23.91 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.34 71.44 2.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.19 -1.005 . . . . 0.0 113.081 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.81 149.62 28.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.678 0.275 . . . . 0.0 110.303 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -48.54 155.61 2.2 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.588 2.192 . . . . 0.0 112.757 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.95 165.2 27.11 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.748 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -85.01 -16.44 40.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.123 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -65.68 -14.87 62.1 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 121.055 0.455 . . . . 0.0 110.619 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 2.8 mmmp? 62.77 143.64 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.072 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.77 -18.0 41.82 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.337 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 43.7 t80 -58.46 -57.12 14.34 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 121.039 0.447 . . . . 0.0 110.67 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -53.32 -45.69 69.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.989 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -48.86 -31.25 6.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.018 0.437 . . . . 0.0 110.525 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.39 -31.39 61.16 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.403 -0.903 . . . . 0.0 111.879 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.634 ' O ' HG22 ' A' ' 89' ' ' ILE . 44.7 mt -60.56 -43.58 97.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.968 0.413 . . . . 0.0 110.359 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.1 t90 -63.21 -45.74 90.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.157 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.592 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.4 OUTLIER -62.91 -50.91 69.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.695 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -52.23 -26.28 8.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.322 . . . . 0.0 111.851 -179.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.606 ' HG2' HG23 ' A' ' 89' ' ' ILE . 4.1 mm-40 -100.55 -44.75 5.76 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -79.45 -32.77 42.74 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -156.92 90.41 2.53 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.698 0.285 . . . . 0.0 111.152 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 82.3 Cg_endo -78.01 -11.31 16.49 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.544 2.163 . . . . 0.0 112.745 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.5 p -106.33 13.96 28.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.531 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.592 HG11 ' HG2' ' A' ' 88' ' ' GLU . 11.9 p -63.47 150.49 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.875 0.369 . . . . 0.0 111.568 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.48 165.16 31.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.733 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -100.5 75.54 1.77 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.5 96.04 1.37 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -67.95 -155.37 0.63 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.528 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -143.06 -61.44 0.42 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.816 0.341 . . . . 0.0 110.974 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -104.91 109.33 21.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.837 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.8 p -86.77 133.13 33.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.954 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.3 m -91.81 -31.13 15.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.42 161.66 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -143.81 161.14 39.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.884 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.83 130.62 36.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.16 155.0 47.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 35.1 m -121.07 161.45 21.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -143.18 85.15 1.85 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.74 0.305 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.79 159.66 36.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.66 -52.03 7.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.838 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.1 p -113.42 -176.2 2.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.895 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -116.76 162.47 17.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -171.56 143.41 1.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.987 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 61.43 153.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.031 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.44 147.75 31.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -95.78 142.57 27.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.735 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.558 ' CE1' HG11 ' A' ' 16' ' ' VAL . 87.7 m-85 -112.08 157.46 20.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.769 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -131.34 158.64 40.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.995 0.426 . . . . 0.0 111.241 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.77 131.85 35.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.515 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.89 -11.57 67.81 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.831 -0.699 . . . . 0.0 113.101 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.84 138.31 50.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.249 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.415 HD23 ' HG3' ' A' ' 29' ' ' ARG . 75.4 mt -91.83 118.12 30.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.938 0.399 . . . . 0.0 110.386 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.558 HG11 ' CE1' ' A' ' 10' ' ' TYR . 25.5 m -139.88 171.99 13.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.804 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 30.5 m-85 -112.88 137.05 51.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.492 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -114.43 126.6 55.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 111.248 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.455 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 12.3 tptp -90.27 136.01 33.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -130.21 151.88 50.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.547 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -67.62 118.22 10.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.934 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -8.62 74.48 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.968 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.412 ' CD1' ' HD3' ' A' ' 79' ' ' ARG . 1.9 m-85 -132.21 154.42 81.63 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-O 120.835 0.35 . . . . 0.0 111.03 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -84.23 167.15 12.36 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.832 2.355 . . . . 0.0 112.511 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.455 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 80.2 m80 -47.08 115.25 1.03 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.729 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.1 t-105 -99.02 129.98 28.42 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.503 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.77 119.46 6.29 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.374 2.049 . . . . 0.0 111.085 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.05 174.43 10.87 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -143.01 155.65 44.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.323 179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 28.7 mm -78.13 138.4 20.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.73 -20.33 5.5 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.48 150.83 14.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.044 0.449 . . . . 0.0 111.239 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 29.3 mmt -93.32 161.22 31.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.489 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 96.8 Cg_endo -87.17 111.2 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 122.933 2.422 . . . . 0.0 112.379 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -51.48 -93.47 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.918 179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -173.98 -52.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.225 0.536 . . . . 0.0 110.461 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.42 72.15 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.132 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.9 m -145.24 21.28 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.239 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 3.6 mmmp? -159.87 -79.61 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.508 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.7 t -179.8 41.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.503 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.482 HG21 ' CE2' ' A' ' 57' ' ' PHE . 38.2 p -138.04 122.07 17.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.199 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.69 -60.62 2.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.281 0.562 . . . . 0.0 109.714 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -155.67 50.25 0.54 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.79 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -114.17 139.76 49.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.725 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 79.8 m-85 -95.8 155.14 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.694 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.436 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.4 mt-30 -96.55 106.78 19.09 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.598 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 63.1 t -100.84 142.99 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.32 -178.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.78 122.0 45.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.189 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.647 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 75.1 m-85 -94.97 110.27 22.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.37 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.722 ' HE2' HD12 ' A' ' 89' ' ' ILE . 57.4 m-85 -58.83 -179.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.06 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.58 -63.66 0.63 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.146 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.9 p -91.07 -22.88 20.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 110.742 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.4 m170 64.57 36.52 8.48 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.598 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -94.32 157.04 16.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.44 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -131.79 149.97 52.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.313 0.578 . . . . 0.0 111.978 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.58 170.88 20.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.067 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 52.0 m-85 -105.94 86.58 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 0.0 110.875 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.813 HD13 ' HB1' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -98.23 156.84 16.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.126 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.559 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -91.98 169.46 32.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.295 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 42.2 Cg_endo -67.54 -20.79 47.08 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.459 2.106 . . . . 0.0 112.375 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -27.83 67.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.969 0.414 . . . . 0.0 110.504 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -100.72 12.43 37.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.761 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.8 mp -108.79 137.44 46.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.658 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.8 m-85 -136.17 158.16 74.22 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.558 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.639 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.6 Cg_exo -71.71 111.5 3.15 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.393 2.062 . . . . 0.0 111.235 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.564 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.5 t80 -45.63 -59.02 2.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.358 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -50.88 -39.55 54.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.9 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.1 mm-40 -70.6 -39.83 73.57 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.464 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 48.9 m -105.35 11.08 33.2 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.564 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.43 -49.46 74.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.797 0.332 . . . . 0.0 111.524 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.54 -26.12 64.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.649 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -84.99 -46.95 10.73 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.464 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 2.5 m-30 -99.77 -13.04 19.43 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.412 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -80.65 71.15 2.89 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.043 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.417 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.0 mttt -149.05 153.14 37.78 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.598 0.237 . . . . 0.0 110.39 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_exo -51.17 153.31 9.57 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.501 2.134 . . . . 0.0 112.617 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -136.49 163.49 30.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.595 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -81.87 -16.47 50.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.196 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' HD3' ' CD1' ' A' ' 23' ' ' TYR . 17.9 mmm180 -64.54 -15.64 61.28 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.989 0.424 . . . . 0.0 110.809 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt 63.19 140.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.094 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.96 -17.0 53.84 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.399 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.6 t80 -58.54 -55.5 34.28 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.933 0.397 . . . . 0.0 110.658 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 m -53.58 -45.53 69.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.196 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.96 -31.69 7.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.997 0.427 . . . . 0.0 110.462 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.02 -31.83 61.39 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.899 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.667 ' O ' HG22 ' A' ' 89' ' ' ILE . 19.7 mt -61.01 -43.74 98.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.018 0.437 . . . . 0.0 110.318 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.8 t90 -63.51 -45.51 90.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.991 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.2 mp0 -62.31 -50.99 69.46 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.722 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -52.47 -26.02 8.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.731 0.3 . . . . 0.0 111.783 -179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.99 -44.79 5.9 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -80.42 -32.3 37.41 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.3 87.85 3.18 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.814 0.34 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 98.7 Cg_endo -79.47 -12.55 13.9 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.702 2.268 . . . . 0.0 113.029 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.419 HG22 ' NH1' ' A' ' 29' ' ' ARG . 21.0 p -103.78 12.67 34.3 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.552 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.3 p -65.53 149.37 11.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.821 0.343 . . . . 0.0 111.33 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.92 165.82 24.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.98 178.43 8.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.086 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m 60.08 162.61 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.38 90.8 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.525 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -122.17 99.12 6.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -68.53 -37.42 79.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.52 93.5 4.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.4 p -143.27 128.49 18.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 61.39 113.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.86 101.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.9 154.47 33.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.69 179.09 4.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 6.0 p -173.02 35.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.979 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.64 102.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.091 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.789 0.328 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m 179.11 -36.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 64.26 98.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.866 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m -136.7 -58.65 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.788 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -110.14 97.34 6.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.04 125.97 28.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -161.66 130.25 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -167.2 137.39 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.51 144.26 26.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.798 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -113.86 159.21 20.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.7 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -134.17 157.81 45.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 111.145 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 30.1 m -51.98 129.38 26.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.428 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.402 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 100.87 -14.91 58.61 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.91 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.04 138.16 51.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.801 0.334 . . . . 0.0 111.152 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.775 HD23 ' HG3' ' A' ' 29' ' ' ARG . 62.0 mt -91.79 119.66 31.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.246 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 m -140.77 171.27 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.133 0.492 . . . . 0.0 111.894 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 10.0 m-85 -109.79 136.62 48.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.565 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.644 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.09 124.6 52.96 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.098 0.475 . . . . 0.0 111.841 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -91.99 131.58 37.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.82 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mtp -129.04 147.52 50.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.701 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.84 115.29 5.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.82 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 100.46 3.96 55.12 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.823 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -152.75 153.62 30.39 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.628 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -80.76 167.7 18.34 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.585 2.19 . . . . 0.0 112.382 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.453 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 71.2 m80 -47.57 115.23 1.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.588 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.93 130.51 27.37 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.245 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.95 120.83 8.8 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.171 1.914 . . . . 0.0 111.179 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.67 175.7 9.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.277 0.56 . . . . 0.0 112.241 -178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.775 ' HG3' HD23 ' A' ' 15' ' ' LEU . 5.3 ttp180 -142.78 155.73 44.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.439 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.9 mm -78.88 135.2 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -125.92 -20.23 4.64 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -165.3 164.01 19.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.074 0.464 . . . . 0.0 111.73 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.9 ptp -153.98 162.16 27.47 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.898 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.68 139.31 67.64 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.545 2.163 . . . . 0.0 112.168 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.2 -78.3 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.8 -40.3 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.136 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.71 86.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.454 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.19 19.09 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.442 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mttp 46.0 -172.04 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.962 0.41 . . . . 0.0 111.611 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 41' ' ' THR . 0.7 OUTLIER 51.79 31.32 8.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.134 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 40' ' ' SER . 0.6 OUTLIER -165.12 89.73 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.24 -75.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.298 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -156.58 52.87 0.53 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.185 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.01 144.21 45.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.435 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 82.5 m-85 -94.77 154.48 17.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.758 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -99.27 107.0 19.2 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.64 HG11 HD21 ' A' ' 63' ' ' LEU . 7.1 m -103.46 150.4 6.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.411 0.624 . . . . 0.0 112.339 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 49.3 t80 -105.44 124.56 49.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.992 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.644 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 70.0 m-85 -93.31 108.94 20.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.648 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.698 ' CE2' HD12 ' A' ' 89' ' ' ILE . 48.2 m-85 -61.37 177.9 0.33 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.933 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.96 -63.48 0.93 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.96 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 p -91.42 -22.37 20.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.0 110.779 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 10.6 m-70 64.41 37.02 8.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.461 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -91.65 155.47 18.3 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 140.29 53.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.194 0.521 . . . . 0.0 111.393 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.552 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.36 178.11 10.6 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.428 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 5.2 m-85 -119.97 127.18 52.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.832 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.556 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.2 mp -138.8 161.74 36.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.994 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.43 176.37 35.34 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.703 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.72 -24.98 54.22 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.622 2.214 . . . . 0.0 112.41 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -69.57 -27.14 64.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.819 0.342 . . . . 0.0 110.857 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 3.9 m-20 -100.22 6.9 44.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.336 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.64 HD21 HG11 ' A' ' 47' ' ' VAL . 22.4 mt -114.23 138.2 50.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.733 0.302 . . . . 0.0 110.32 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.7 m-85 -137.13 159.58 69.27 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.057 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.9 Cg_exo -70.21 113.91 3.6 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.674 2.25 . . . . 0.0 111.63 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.536 ' O ' ' N ' ' A' ' 70' ' ' LYS . 89.1 t80 -53.7 -59.5 4.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.683 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -49.0 -42.74 38.99 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.124 0.488 . . . . 0.0 111.648 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.94 -39.58 72.53 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.565 -179.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.1 m -105.29 10.23 33.64 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.536 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.4 ptpt -56.38 -44.28 80.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.659 0.266 . . . . 0.0 111.713 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 3.9 mm-40 -68.55 -32.92 73.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 13.1 ptpt -83.99 -43.32 15.29 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.433 ' CD1' ' HG3' ' A' ' 72' ' ' LYS . 18.2 m-30 -98.35 -8.52 26.88 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.24 75.27 2.05 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.039 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.43 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.7 mmmm -148.55 159.32 38.87 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.613 0.206 . . . . 0.0 110.511 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.59 151.89 59.46 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.585 2.19 . . . . 0.0 112.516 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -134.11 170.29 15.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.616 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.62 -15.68 28.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.356 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -66.34 -14.81 62.62 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.984 0.421 . . . . 0.0 110.716 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt 63.4 144.17 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.075 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.36 -18.7 35.78 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.594 -178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 15.1 t80 -58.61 -55.55 33.67 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 121.044 0.45 . . . . 0.0 110.692 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.3 m -52.89 -45.67 67.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.062 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -48.56 -31.39 6.49 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.985 0.421 . . . . 0.0 110.543 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.06 -31.55 61.63 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.85 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.644 ' O ' HG22 ' A' ' 89' ' ' ILE . 89.0 mt -60.94 -43.8 98.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.226 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.5 t90 -64.05 -44.91 91.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.13 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.597 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -63.51 -50.87 67.89 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.698 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -51.9 -27.5 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.819 0.342 . . . . 0.0 111.828 -179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.44 -44.68 6.1 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.82 -32.96 40.67 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.23 87.46 3.24 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.817 0.342 . . . . 0.0 111.257 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 3.5 Cg_exo -76.58 -13.73 18.11 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.038 2.492 . . . . 0.0 112.644 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 23.1 p -104.04 13.08 33.27 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.537 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.597 HG11 ' HG2' ' A' ' 88' ' ' GLU . 15.0 p -62.89 147.05 12.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.929 0.395 . . . . 0.0 111.447 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -156.24 125.23 6.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.024 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -121.05 123.06 41.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.063 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.0 t -81.9 -172.86 4.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.92 167.43 35.41 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.43 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -147.74 -176.67 5.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.821 0.343 . . . . 0.0 110.838 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -134.01 132.49 40.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -103.71 150.88 23.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.6 m -90.21 -177.43 5.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -85.07 -38.46 19.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 17.0 mmtt -123.29 166.96 14.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.907 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.73 176.58 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.854 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.3 m -124.41 165.3 17.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.882 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.6 t 60.49 101.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.71 149.13 41.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.065 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.817 0.341 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.6 m -135.79 -47.62 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 13.0 mtm-85 -150.72 118.21 6.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 t -134.74 105.58 6.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -86.35 159.45 19.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.34 -62.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.847 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -87.01 126.42 34.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.47 148.75 31.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.897 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -95.14 141.15 29.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.653 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.651 ' CD2' HG11 ' A' ' 16' ' ' VAL . 69.1 m-85 -115.62 159.12 21.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.843 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 mmtm -136.08 159.96 40.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.879 0.371 . . . . 0.0 111.03 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -51.27 127.38 19.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.263 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.88 -13.45 60.68 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.729 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 29' ' ' ARG . 5.9 m-20 -70.49 137.18 50.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.84 0.352 . . . . 0.0 111.072 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 mt -90.18 115.36 27.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.99 0.424 . . . . 0.0 110.3 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.651 HG11 ' CD2' ' A' ' 10' ' ' TYR . 29.2 m -138.65 170.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.581 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -109.69 136.7 48.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.79 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.659 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -111.87 121.4 44.93 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.03 0.443 . . . . 0.0 111.473 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HD2' ' CE1' ' A' ' 25' ' ' HIS . 2.4 tptt -93.51 129.15 39.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.011 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.8 mtp -126.55 147.98 49.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.693 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -59.53 119.59 7.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 0.0 110.902 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.04 -34.96 4.59 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.441 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -105.14 150.36 38.71 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.696 0.284 . . . . 0.0 110.866 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HG3' ' OD1' ' A' ' 77' ' ' ASN . 97.7 Cg_endo -82.49 170.16 13.29 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 122.593 2.195 . . . . 0.0 112.226 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.441 ' CE1' ' HD2' ' A' ' 19' ' ' LYS . 61.2 m80 -51.06 112.11 0.67 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.525 179.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.439 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.7 t-105 -99.6 131.07 25.4 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.237 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.449 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 11.8 Cg_endo -54.98 121.35 9.73 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.295 1.996 . . . . 0.0 111.183 179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -145.12 178.44 8.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.377 0.608 . . . . 0.0 112.328 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 14' ' ' ASP . 15.8 ttp180 -143.66 157.76 44.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.489 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.08 116.12 26.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -110.93 -14.0 14.03 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -163.62 156.68 18.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.042 0.449 . . . . 0.0 111.474 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 6.5 ptp -153.2 157.85 32.88 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.079 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.438 ' HB3' ' CG2' ' A' ' 41' ' ' THR . 92.1 Cg_endo -78.93 159.9 27.35 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.722 2.281 . . . . 0.0 112.428 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -142.25 -49.95 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.101 0.477 . . . . 0.0 111.046 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -171.15 -40.51 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.921 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.43 97.61 1.23 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.501 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.516 HG23 ' HG2' ' A' ' 39' ' ' LYS . 3.3 m -145.93 -38.25 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.516 ' HG2' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -164.45 -178.4 5.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 0.0 111.198 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t -69.89 66.71 0.25 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.314 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.438 ' CG2' ' HB3' ' A' ' 34' ' ' PRO . 1.4 t -128.56 -179.82 5.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.771 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' N ' ' OG1' ' A' ' 41' ' ' THR . . . -171.91 -42.56 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.888 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -155.97 33.45 0.34 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.251 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -136.85 138.5 40.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.472 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 86.9 m-85 -95.43 155.29 16.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.85 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -99.59 105.05 16.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.7 m -99.94 149.39 5.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.369 0.604 . . . . 0.0 112.041 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' HE2' HG13 ' A' ' 95' ' ' VAL . 23.1 t80 -105.08 123.93 48.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.259 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.539 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 85.3 m-85 -92.75 109.39 20.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.463 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.614 ' CE2' HD12 ' A' ' 89' ' ' ILE . 42.5 m-85 -61.49 176.12 0.52 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.746 0.307 . . . . 0.0 110.911 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.01 -62.48 0.96 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.083 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.2 p -91.7 -22.2 20.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.776 0.322 . . . . 0.0 110.586 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.1 m80 63.4 36.89 11.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.416 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -90.85 154.74 19.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.5 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.41 144.25 49.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.311 0.577 . . . . 0.0 111.806 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.451 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.76 166.13 34.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.279 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 30.6 m-85 -108.94 88.61 2.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.233 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.659 HD22 ' HB1' ' A' ' 18' ' ' ALA . 1.3 mp -97.92 158.32 15.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.984 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.714 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -93.09 172.05 33.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.352 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.1 -23.98 52.62 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.483 2.122 . . . . 0.0 112.38 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.39 -27.93 66.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.973 0.416 . . . . 0.0 110.691 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -98.62 12.63 34.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.995 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.714 HD13 ' O ' ' A' ' 59' ' ' GLY . 4.7 mp -108.98 137.4 46.95 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.431 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.7 m-85 -134.79 157.64 76.73 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.765 0.317 . . . . 0.0 111.11 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.532 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 11.2 Cg_exo -71.02 110.93 2.93 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.731 2.287 . . . . 0.0 111.508 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.575 ' O ' ' N ' ' A' ' 70' ' ' LYS . 93.2 t80 -55.29 -60.82 2.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.914 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.21 -41.95 38.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.014 0.435 . . . . 0.0 111.48 -179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.31 -39.69 71.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.559 -179.563 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.6 m -104.91 8.48 34.64 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.3 ptmt -56.55 -45.89 80.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.721 0.296 . . . . 0.0 111.337 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.44 -26.57 64.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.525 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.506 ' HG2' ' CE1' ' A' ' 73' ' ' PHE . 1.2 ttpm? -84.82 -45.7 12.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.506 ' CE1' ' HG2' ' A' ' 72' ' ' LYS . 18.8 m-30 -101.93 -6.15 23.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -86.44 75.39 2.25 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.284 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -151.91 153.09 31.11 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.523 0.201 . . . . 0.0 110.718 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.36 136.22 8.55 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.701 2.268 . . . . 0.0 112.504 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.437 ' OD1' ' HG3' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -111.07 171.19 7.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.915 -178.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.15 -21.61 18.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.748 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -67.34 -13.77 62.3 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.935 0.398 . . . . 0.0 110.585 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt 63.99 143.57 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.814 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.96 -17.23 54.36 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.404 -0.903 . . . . 0.0 111.931 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.621 ' HE1' HD11 ' A' ' 86' ' ' LEU . 13.0 t80 -59.13 -51.28 70.68 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.956 0.408 . . . . 0.0 110.322 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.45 -46.98 66.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.993 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -48.66 -32.76 8.8 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.979 0.418 . . . . 0.0 110.26 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.62 -31.76 60.26 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.788 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.643 ' O ' HG22 ' A' ' 89' ' ' ILE . 71.3 mt -61.32 -43.79 98.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.0 0.429 . . . . 0.0 110.168 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 66.1 t90 -64.78 -45.03 88.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.002 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.537 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.7 OUTLIER -62.81 -50.9 69.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -179.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.643 HG22 ' O ' ' A' ' 86' ' ' LEU . 1.2 tt -52.32 -26.85 9.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.807 0.337 . . . . 0.0 111.768 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.527 ' HG2' HG23 ' A' ' 89' ' ' ILE . 6.8 mm-40 -99.63 -44.75 6.02 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -81.74 -30.77 32.29 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -156.34 89.23 2.77 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 111.202 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 86.4 Cg_endo -78.46 -12.42 15.43 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.644 2.229 . . . . 0.0 112.72 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 3.1 p -102.34 10.98 38.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.586 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.0 p -61.65 143.82 14.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.819 0.343 . . . . 0.0 111.347 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.27 20.59 1.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.326 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 54.65 81.92 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.79 0.329 . . . . 0.0 111.174 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.9 t -104.27 143.34 33.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.918 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 77.34 40.08 24.7 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -130.87 98.11 4.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.801 0.334 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -78.18 110.81 13.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.872 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.44 158.57 18.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.942 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.5 m 60.25 41.42 16.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -100.47 130.59 46.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.47 155.5 36.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.64 145.51 51.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.64 -178.54 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.869 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.83 160.94 38.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.866 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -90.33 -63.8 1.22 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.772 0.32 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -134.67 106.24 6.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.7 101.15 3.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.915 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.3 m 60.5 105.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.949 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -88.41 177.1 6.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.943 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 61.01 112.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.977 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.09 -178.04 4.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.778 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.1 119.05 23.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -95.61 143.73 26.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.792 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.586 ' CD2' HG11 ' A' ' 16' ' ' VAL . 87.7 m-85 -113.32 157.41 21.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.901 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -132.92 157.0 46.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.918 0.389 . . . . 0.0 111.023 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 73.0 m -51.81 132.07 31.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.544 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.13 -12.14 68.56 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.909 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -70.77 139.21 50.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -91.14 116.56 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.964 0.411 . . . . 0.0 110.398 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' A' ' 10' ' ' TYR . 30.7 m -139.76 170.29 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.622 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.522 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 17.9 m-85 -111.09 135.86 50.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.521 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.687 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.93 123.04 49.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.911 0.386 . . . . 0.0 111.345 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 23.8 tptp -92.07 130.95 37.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.163 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtm -127.04 147.82 50.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.461 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.41 113.47 4.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.864 0.364 . . . . 0.0 111.008 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.99 -27.37 14.65 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.689 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.91 157.97 49.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.787 0.327 . . . . 0.0 110.942 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.47 166.44 12.16 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.802 2.335 . . . . 0.0 112.346 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.505 ' CD2' ' CE2' ' A' ' 73' ' ' PHE . 59.0 m80 -47.17 114.02 0.78 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.497 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.459 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.66 130.63 27.45 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.611 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.51 119.1 5.85 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.337 2.024 . . . . 0.0 111.056 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.6 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.2 175.09 10.33 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.308 0.575 . . . . 0.0 112.438 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 14.2 ttp180 -142.52 156.49 45.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.449 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.437 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 24.6 mm -79.9 138.8 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -124.26 -20.8 5.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -162.65 151.34 14.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.957 0.408 . . . . 0.0 111.237 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.4 ' HE2' ' HA ' ' A' ' 33' ' ' MET . 31.2 mmt -91.48 161.6 34.01 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.712 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 92.4 Cg_endo -85.33 117.23 1.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.731 2.288 . . . . 0.0 112.175 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.88 -85.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.089 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.18 -60.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.02 0.438 . . . . 0.0 110.678 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.74 27.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.298 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 34.6 m -89.82 -2.73 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.752 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -163.76 -179.19 6.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.575 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.415 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 61.1 p -71.21 62.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.791 0.329 . . . . 0.0 110.697 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' ASN . 13.4 t -129.69 -15.38 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.799 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 43.8 -87.13 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.655 0.264 . . . . 0.0 111.284 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -155.03 50.61 0.59 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.247 0.546 . . . . 0.0 110.309 179.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -141.45 166.41 24.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.014 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.458 ' CE2' ' HD3' ' A' ' 34' ' ' PRO . 45.5 m-85 -94.11 157.95 15.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.199 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.93 107.55 20.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.659 HG21 HD21 ' A' ' 63' ' ' LEU . 84.3 t -103.54 142.57 17.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 121.445 0.641 . . . . 0.0 112.567 -178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -105.55 121.87 44.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.528 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.687 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 82.0 m-85 -94.03 106.51 18.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.087 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.702 ' CE2' HD12 ' A' ' 89' ' ' ILE . 49.7 m-85 -57.57 176.88 0.12 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.873 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 69.81 -63.57 0.68 Allowed Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.384 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.425 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 80.9 p -90.16 -23.24 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.702 0.287 . . . . 0.0 110.712 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' THR . 3.9 m170 65.96 34.03 7.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -90.12 150.99 21.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.0 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.81 140.66 52.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.168 0.509 . . . . 0.0 111.329 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.78 168.22 27.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.333 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.415 ' CE2' ' O ' ' A' ' 40' ' ' SER . 13.5 m-85 -109.32 125.48 52.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.027 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.557 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 19.8 mt -139.36 160.67 39.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.889 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.46 -179.78 40.73 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.495 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.28 -26.81 41.45 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.521 2.147 . . . . 0.0 112.206 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -69.63 -22.56 63.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.008 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.1 m-20 -98.99 3.6 47.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.49 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.659 HD21 HG21 ' A' ' 47' ' ' VAL . 18.3 mt -115.0 139.65 49.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 110.578 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.2 m-85 -136.6 166.28 28.79 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.422 ' HB2' ' CG ' ' A' ' 68' ' ' GLU . 5.2 Cg_exo -73.21 111.15 3.21 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.732 2.288 . . . . 0.0 111.707 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 90.1 t80 -49.99 -58.44 5.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.484 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -49.04 -41.08 33.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.564 -179.383 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.422 ' CG ' ' HB2' ' A' ' 65' ' ' PRO . 5.0 mm-40 -70.97 -39.75 72.35 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.659 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.442 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 3.6 m -103.41 13.89 32.63 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.478 ' HG3' ' HA ' ' A' ' 67' ' ' GLU . 2.2 mtmp? -55.53 -44.99 77.23 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.364 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.71 -40.82 88.6 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.83 -43.77 16.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 4.9 m-30 -94.85 -19.65 20.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -177.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.68 73.84 2.43 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.299 -0.953 . . . . 0.0 113.041 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.461 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 12.1 mttt -149.22 153.57 37.89 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.92 155.51 8.33 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.623 2.215 . . . . 0.0 112.638 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -136.43 165.52 25.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.579 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -85.72 -16.1 40.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.256 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -13.82 61.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.975 0.417 . . . . 0.0 110.682 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt 63.76 142.05 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.203 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.55 -16.7 55.68 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.468 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.461 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 31.6 t80 -59.01 -56.82 17.33 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.003 0.43 . . . . 0.0 110.865 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.59 -45.35 66.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.057 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.68 -30.06 5.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.048 0.451 . . . . 0.0 110.535 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.93 -31.89 57.45 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.162 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.62 ' O ' HG22 ' A' ' 89' ' ' ILE . 12.7 mt -60.43 -43.44 96.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.035 0.445 . . . . 0.0 110.254 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.407 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 62.9 t90 -63.59 -45.74 89.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.235 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.71 -50.58 70.58 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.702 HD12 ' CE2' ' A' ' 50' ' ' PHE . 1.1 tt -52.9 -27.05 12.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.795 0.331 . . . . 0.0 111.758 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -99.29 -44.82 6.09 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.9 OUTLIER -79.65 -31.54 41.52 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -178.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.474 ' HB3' ' HB ' ' A' ' 95' ' ' VAL . 1.0 OUTLIER -157.06 86.9 2.76 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 0.0 111.302 -179.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.93 -12.93 26.39 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.93 2.42 . . . . 0.0 112.65 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.0 p -106.98 14.61 26.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.587 0.232 . . . . 0.0 111.605 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.58 HG12 ' HE1' ' A' ' 50' ' ' PHE . 14.3 p -62.57 150.74 8.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.008 0.432 . . . . 0.0 111.69 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -154.03 122.4 6.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.576 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 64.88 -76.74 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -140.49 175.39 9.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.34 -97.78 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.549 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 60.68 -172.17 0.14 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -159.6 -45.66 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.3 t -143.61 143.69 31.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.53 165.71 11.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.82 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -159.38 28.88 0.2 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.15 113.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.957 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 81.95 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.94 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.68 31.63 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.918 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 42.3 t -151.53 145.83 25.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.941 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.68 87.94 6.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.058 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.844 0.354 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 m -127.41 169.77 13.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -100.62 -49.65 4.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.4 t -132.25 -46.68 0.91 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.856 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.13 123.27 21.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.925 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.28 124.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.944 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -140.41 -176.33 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.742 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -156.3 -157.74 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.033 -179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 8' ' ' LYS . 3.4 mt-10 79.52 143.41 0.08 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.295 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.655 ' CD2' HG11 ' A' ' 16' ' ' VAL . 4.7 m-85 -123.36 166.27 15.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.313 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -137.45 165.78 25.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 0.0 110.954 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 20.7 m -52.87 130.72 34.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.277 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.76 68.54 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.086 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -72.65 140.76 48.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.915 0.388 . . . . 0.0 111.299 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.789 HD23 ' HG3' ' A' ' 29' ' ' ARG . 67.6 mt -91.79 119.16 31.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.079 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.655 HG11 ' CD2' ' A' ' 10' ' ' TYR . 26.8 m -138.84 171.91 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.224 0.535 . . . . 0.0 111.992 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.447 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 8.5 m-85 -111.08 134.81 52.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.656 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.805 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -112.36 124.3 52.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.006 0.431 . . . . 0.0 111.591 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -91.18 132.81 35.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.906 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -131.23 150.11 52.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.7 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' O ' ' CE2' ' A' ' 23' ' ' TYR . 1.2 mtpm? -62.46 121.8 14.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.104 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 81.82 15.93 74.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.897 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.427 ' CE2' ' O ' ' A' ' 21' ' ' LYS . 3.4 m-85 -151.4 147.96 21.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.63 0.252 . . . . 0.0 110.841 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.16 165.01 17.15 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.615 2.21 . . . . 0.0 112.221 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -47.51 115.42 1.12 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.571 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.448 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.76 130.13 28.44 Favored Pre-proline 0 N--CA 1.464 0.243 0 CA-C-O 120.527 0.203 . . . . 0.0 111.527 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.14 121.45 9.68 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.373 2.049 . . . . 0.0 111.155 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.707 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -145.61 176.09 9.87 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.789 ' HG3' HD23 ' A' ' 15' ' ' LEU . 11.4 ttp180 -141.43 154.63 45.7 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.492 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.7 mm -81.8 140.12 16.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 0.0 110.541 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -119.17 -22.5 7.15 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.794 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.421 ' CG ' ' HB3' ' A' ' 46' ' ' GLN . 2.0 pt-20 -163.93 155.02 15.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.111 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 29.5 mmt -91.68 163.34 28.47 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.003 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 94.7 Cg_endo -91.69 38.26 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 123.05 2.5 . . . . 0.0 112.209 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -151.78 41.17 0.67 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.75 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.86 -35.63 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.182 0.515 . . . . 0.0 109.726 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.69 73.87 1.49 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.635 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.6 m -153.4 172.55 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.976 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 25.1 mmtp -159.11 -68.55 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.595 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.19 46.31 1.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 110.438 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 44' ' ' LYS . 33.9 p -143.33 128.22 18.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.029 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.17 -52.66 15.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.242 0.544 . . . . 0.0 109.817 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -155.98 48.45 0.5 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.903 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HG3' HG22 ' A' ' 41' ' ' THR . 5.7 mmtt -99.29 129.16 45.49 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.352 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.497 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 40.4 m-85 -93.77 154.71 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.122 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.421 ' HB3' ' CG ' ' A' ' 32' ' ' GLU . 0.5 OUTLIER -96.65 98.82 10.5 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.707 ' CG2' ' HB1' ' A' ' 28' ' ' ALA . 2.2 p -99.84 148.92 6.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.358 -177.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.402 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 23.3 t80 -105.96 125.1 50.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.658 -1.155 . . . . 0.0 110.252 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -91.39 113.16 25.35 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.699 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.769 ' HE2' HD12 ' A' ' 89' ' ' ILE . 44.0 m-85 -63.31 174.61 1.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.746 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.02 -61.75 0.75 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.3 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.8 p -90.36 -23.49 21.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.66 0.267 . . . . 0.0 110.723 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 10.8 m170 63.56 37.93 10.04 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.524 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 61.3 mt-10 -93.32 156.67 16.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.814 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.89 143.19 50.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.322 0.582 . . . . 0.0 111.926 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.65 168.2 27.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.5 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 75.6 m-85 -111.58 89.81 3.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.038 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.805 HD22 ' HB1' ' A' ' 18' ' ' ALA . 1.7 mp -97.72 157.45 16.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.251 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -91.76 171.77 34.92 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.409 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.18 -24.66 44.07 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.45 2.1 . . . . 0.0 112.316 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -27.73 67.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.423 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -101.63 14.7 31.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.858 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 59' ' ' GLY . 2.4 mp -113.2 136.29 52.89 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.618 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.6 m-85 -135.93 155.47 77.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.636 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.542 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.8 Cg_exo -72.54 112.23 3.42 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.481 2.121 . . . . 0.0 111.2 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.54 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.7 t80 -48.34 -58.78 4.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.172 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.45 -43.35 34.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.928 0.394 . . . . 0.0 112.033 -178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 5.8 mm-40 -70.28 -39.74 74.74 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.439 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 51.5 m -105.58 10.72 32.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.9 ptpt -55.97 -48.13 76.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.913 0.387 . . . . 0.0 110.817 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.506 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 4.9 mm-40 -72.54 -19.91 61.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.586 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -84.92 -49.83 8.03 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 7.3 m-85 -104.41 -4.44 22.8 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.95 71.46 2.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.193 -1.004 . . . . 0.0 113.066 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -149.57 151.19 32.68 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.699 0.285 . . . . 0.0 110.477 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.29 156.0 18.31 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.565 2.177 . . . . 0.0 112.7 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 -138.77 -172.51 3.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.378 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -99.03 -13.81 19.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.058 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.2 mmt-85 -67.87 -14.35 62.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.034 0.445 . . . . 0.0 110.734 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt 62.88 142.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.175 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.55 -15.89 59.17 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.733 -178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.448 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 35.6 t80 -57.38 -58.7 7.1 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.061 0.458 . . . . 0.0 110.907 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.457 ' HA ' HD12 ' A' ' 86' ' ' LEU . 1.1 m -51.76 -46.17 64.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.281 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -48.79 -32.7 9.07 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.903 0.382 . . . . 0.0 110.501 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.41 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.45 -31.68 60.69 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.839 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.641 ' O ' HG22 ' A' ' 89' ' ' ILE . 84.2 mt -60.49 -43.63 96.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.012 0.434 . . . . 0.0 110.287 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.8 t90 -63.74 -43.0 97.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.926 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.565 ' OE1' HG11 ' A' ' 95' ' ' VAL . 39.6 mm-40 -62.84 -52.38 63.35 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.769 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.25 -25.71 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -44.75 5.73 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -81.05 -32.95 33.83 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -156.39 88.9 2.78 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.76 0.314 . . . . 0.0 111.152 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 72.2 Cg_endo -77.44 -12.05 17.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.662 2.242 . . . . 0.0 112.897 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.7 p -106.51 14.44 27.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.607 0.241 . . . . 0.0 111.587 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.565 HG11 ' OE1' ' A' ' 88' ' ' GLU . 11.9 p -65.23 151.22 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.874 0.369 . . . . 0.0 111.404 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -134.43 164.64 27.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.827 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.472 ' HB2' ' HB3' ' A' ' 53' ' ' HIS . . . -118.56 171.43 8.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.148 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m 61.6 150.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.025 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.2 129.89 1.44 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.568 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.27 148.24 37.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.708 0.289 . . . . 0.0 110.732 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -143.45 123.47 13.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.058 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.0 m 76.93 -1.71 2.79 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.779 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 18.5 m 52.78 177.17 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.838 0.352 . . . . 0.0 111.172 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 51.45 -177.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.113 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.13 -45.35 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.57 -48.97 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.2 p 59.14 175.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.5 m -124.77 89.7 3.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 67.04 -72.64 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.171 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 tpt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.848 0.356 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m 62.69 101.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.965 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.57 86.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.054 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 p -129.16 111.41 12.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.801 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -110.74 -27.06 9.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.172 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 61.79 91.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.829 0.347 . . . . 0.0 110.651 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -79.49 157.79 27.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.076 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.42 ' HE2' ' CE1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -174.66 123.99 0.28 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.649 179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -95.75 143.08 27.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.699 ' CE1' HG11 ' A' ' 16' ' ' VAL . 79.4 m-85 -109.56 155.73 21.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.798 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -131.56 155.07 48.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.409 . . . . 0.0 111.078 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.8 m -52.4 129.92 29.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.572 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.26 -13.43 63.14 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.048 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.3 138.14 51.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 111.057 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' ' 29' ' ' ARG . 86.5 mt -91.59 117.45 29.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.357 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.699 HG11 ' CE1' ' A' ' 10' ' ' TYR . 31.2 m -139.99 172.1 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.851 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 13.4 m-85 -113.14 135.72 53.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.722 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.759 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.82 123.3 49.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 0.0 111.432 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 8.1 tptp -92.37 133.86 35.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.051 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 18.0 mtm -128.32 151.86 48.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.78 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.86 102.15 3.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 114.51 -1.21 23.53 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.818 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -146.91 149.71 36.77 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.706 0.289 . . . . 0.0 110.716 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.63 162.97 34.76 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.636 2.224 . . . . 0.0 112.387 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.405 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 80.1 m80 -47.72 116.78 1.58 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.62 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.452 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.5 t-105 -98.63 132.09 24.64 Favored Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.48 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -56.34 120.98 9.2 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.37 2.047 . . . . 0.0 110.969 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -145.16 176.39 9.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.27 0.557 . . . . 0.0 112.28 -178.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.637 ' NH1' HG22 ' A' ' 94' ' ' THR . 1.8 ttt180 -142.23 155.72 45.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.453 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.437 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 23.6 mm -80.4 138.73 19.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.376 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -126.05 -21.58 4.29 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -166.47 152.13 8.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.907 0.384 . . . . 0.0 111.28 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.1 165.33 21.98 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.641 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.457 ' HD3' ' CD2' ' A' ' 45' ' ' TYR . 35.2 Cg_exo -57.9 139.55 90.74 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.639 2.226 . . . . 0.0 112.219 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.31 -86.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.426 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -178.07 -52.23 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.5 0.667 . . . . 0.0 110.278 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.25 92.71 0.27 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.611 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.8 m -149.05 11.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.709 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.14 -65.66 0.31 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.772 0.32 . . . . 0.0 111.069 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 m -52.79 -27.35 17.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.731 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.6 OUTLIER -121.82 -33.08 3.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.115 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 41.06 -86.37 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.477 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 41' ' ' THR . 3.2 p30 -152.82 55.42 0.79 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.322 0.582 . . . . 0.0 109.989 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -139.36 167.07 22.9 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.803 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.457 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 87.3 m-85 -95.23 157.64 15.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.033 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -98.69 108.18 20.81 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.543 HG21 HD21 ' A' ' 63' ' ' LEU . 45.4 t -104.31 141.4 19.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.397 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.536 ' HE2' HG13 ' A' ' 95' ' ' VAL . 25.8 t80 -106.57 122.22 45.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.897 178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.759 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 75.7 m-85 -94.34 109.42 21.26 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.156 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.792 ' HE2' HD12 ' A' ' 89' ' ' ILE . 73.9 m-85 -58.78 -178.97 0.06 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.998 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.61 -63.82 0.44 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.255 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 79.5 p -91.95 -22.52 19.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.843 0.354 . . . . 0.0 110.633 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 27.8 m170 64.81 35.44 8.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.973 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -89.8 153.12 20.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.683 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.12 141.6 50.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.318 0.58 . . . . 0.0 111.614 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.568 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.49 170.76 21.21 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -115.13 126.96 55.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.903 0.382 . . . . 0.0 111.069 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 26.1 mt -139.62 162.03 36.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.812 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.0 176.62 36.21 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.364 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.96 -25.42 59.52 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.493 2.129 . . . . 0.0 112.269 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.71 -26.34 64.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.835 0.35 . . . . 0.0 110.901 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.94 8.33 45.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 47' ' ' VAL . 53.0 mt -117.06 139.07 51.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.694 0.283 . . . . 0.0 110.408 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.4 m-85 -137.39 157.89 73.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.576 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.574 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 13.4 Cg_exo -67.72 113.82 3.11 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.188 1.925 . . . . 0.0 111.395 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.488 ' O ' ' N ' ' A' ' 70' ' ' LYS . 81.4 t80 -48.97 -57.15 6.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.031 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.428 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 15.7 mm-40 -51.46 -39.83 58.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.02 0.438 . . . . 0.0 111.984 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 15.8 mm-40 -70.08 -39.81 75.37 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.454 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 6.4 m -106.78 12.09 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 2.4 ptpp? -56.59 -48.74 76.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.827 0.346 . . . . 0.0 111.024 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -72.33 -20.95 61.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.459 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -85.38 -49.34 8.2 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 8.3 m-85 -100.68 -13.56 18.47 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.82 73.05 1.96 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.972 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -149.75 147.98 24.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.663 0.268 . . . . 0.0 110.562 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.5 153.35 14.03 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.496 2.131 . . . . 0.0 112.769 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.406 ' ND2' ' HB2' ' A' ' 82' ' ' PHE . 51.1 p-10 -139.08 -173.27 3.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.316 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -99.97 -13.31 19.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.971 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 79' ' ' ARG . 21.1 mmt180 -67.25 -14.5 62.97 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-O 120.927 0.394 . . . . 0.0 110.557 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp 63.06 141.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.261 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.21 -16.38 58.92 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.347 -0.93 . . . . 0.0 111.875 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.452 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 47.7 t80 -57.64 -57.07 14.31 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.928 0.394 . . . . 0.0 110.824 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -52.2 -46.22 65.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.138 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -48.86 -33.05 9.87 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.075 0.464 . . . . 0.0 110.289 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.92 -32.75 58.49 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.807 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.598 ' O ' HG22 ' A' ' 89' ' ' ILE . 46.2 mt -60.49 -43.66 96.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.108 0.48 . . . . 0.0 109.956 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 66.3 t90 -64.09 -45.35 89.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.895 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.487 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -62.59 -51.89 65.55 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.792 HD12 ' HE2' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -52.23 -26.34 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.15 -44.83 6.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.57 -33.19 31.8 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -156.57 81.52 3.5 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.758 0.313 . . . . 0.0 110.974 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.0 Cg_endo -73.99 -8.94 21.78 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.627 2.218 . . . . 0.0 112.953 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.637 HG22 ' NH1' ' A' ' 29' ' ' ARG . 72.6 p -101.48 12.25 37.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.586 0.232 . . . . 0.0 111.515 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.536 HG13 ' HE2' ' A' ' 48' ' ' PHE . 9.8 p -64.06 144.91 14.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.812 0.339 . . . . 0.0 111.325 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -161.69 122.13 2.64 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.017 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 57.23 167.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.067 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.3 m 60.01 108.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.738 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.6 58.53 4.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.622 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 6.7 t80 55.97 89.84 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.908 0.385 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -89.53 89.81 8.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.5 p -67.2 177.54 1.78 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.5 t 60.35 107.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.35 41.49 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.75 31.96 3.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.88 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm 59.56 97.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.933 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.0 t -142.48 119.57 11.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.3 t -87.19 -57.48 2.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -165.36 179.39 6.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.112 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.807 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.937 0.399 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.81 158.45 28.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.909 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -32.93 12.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.858 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.36 106.73 0.95 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.856 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.79 113.99 21.45 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.06 -42.2 2.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -165.72 146.19 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.77 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -105.75 115.2 29.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.955 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -95.58 142.45 27.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.725 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.53 ' CD2' HG11 ' A' ' 16' ' ' VAL . 90.2 m-85 -114.33 157.89 22.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.986 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -130.17 157.44 42.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 110.786 -179.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.4 t -53.67 131.85 39.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.083 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.71 -12.19 64.48 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.725 -0.75 . . . . 0.0 113.265 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -73.25 142.94 47.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.914 0.388 . . . . 0.0 111.207 -179.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.709 HD23 ' HG3' ' A' ' 29' ' ' ARG . 49.1 mt -91.79 119.6 31.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.391 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.53 HG11 ' CD2' ' A' ' 10' ' ' TYR . 29.3 m -140.77 170.1 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.661 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 8.4 m-85 -109.84 136.51 49.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.695 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.608 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.95 122.72 47.82 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.007 0.432 . . . . 0.0 111.453 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -91.35 128.71 37.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.882 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.6 mtp -126.96 148.12 50.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.658 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.64 125.4 23.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.907 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.435 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 85.01 11.48 76.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.977 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.435 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.0 m-85 -154.39 152.47 26.26 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.74 0.305 . . . . 0.0 110.782 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -83.56 166.31 13.78 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.725 2.283 . . . . 0.0 112.233 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 66.7 m80 -47.19 114.82 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.601 179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.2 130.34 28.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 120.514 0.197 . . . . 0.0 111.523 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.35 119.53 6.53 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.234 1.956 . . . . 0.0 111.065 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.602 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.19 175.44 10.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.29 0.567 . . . . 0.0 112.334 -178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.709 ' HG3' HD23 ' A' ' 15' ' ' LEU . 15.8 ttp180 -142.74 156.92 45.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.332 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.3 mm -78.26 136.26 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -125.5 -21.4 4.52 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.37 152.9 15.0 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.362 . . . . 0.0 111.002 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.406 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -155.15 166.59 15.82 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.247 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 33' ' ' MET . 36.5 Cg_exo -60.44 172.11 2.88 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.7 2.267 . . . . 0.0 111.953 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.97 -31.62 7.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.98 -41.15 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.323 0.582 . . . . 0.0 109.514 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.77 -69.51 0.32 Allowed 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.369 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.657 ' HB ' HG22 ' A' ' 41' ' ' THR . 11.8 t 61.04 101.74 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.697 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -75.58 -13.52 60.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.473 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -76.29 -42.85 44.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.885 0.374 . . . . 0.0 110.755 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.657 HG22 ' HB ' ' A' ' 38' ' ' VAL . 15.0 t -89.13 116.83 27.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.906 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 44' ' ' LYS . . . -74.57 52.96 0.53 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.619 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.6 t30 60.39 47.08 9.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.575 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 42' ' ' ALA . 2.7 mttt -130.99 138.48 49.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.438 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -95.12 159.91 14.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.033 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -99.16 107.51 19.88 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.726 HG21 HD21 ' A' ' 63' ' ' LEU . 84.7 t -103.59 143.85 14.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.335 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.515 ' HE2' HG13 ' A' ' 95' ' ' VAL . 42.5 t80 -106.19 122.73 46.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.829 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.608 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 89.8 m-85 -94.9 110.02 21.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.922 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.766 ' HE2' HD12 ' A' ' 89' ' ' ILE . 58.9 m-85 -59.73 178.91 0.14 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.884 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.7 -63.91 0.65 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.117 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.2 p -91.35 -22.63 20.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.802 0.334 . . . . 0.0 110.508 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.7 m80 63.71 36.58 10.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.346 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.75 155.07 19.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.695 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.68 141.8 51.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.226 0.536 . . . . 0.0 111.574 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.31 168.25 27.69 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.449 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -108.84 125.17 51.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.817 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 44.4 mt -139.55 162.29 35.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.127 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.63 177.79 40.72 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.452 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.72 -25.58 39.86 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.624 2.216 . . . . 0.0 112.362 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -69.04 -21.72 64.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.128 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 8.7 m-20 -99.47 4.76 46.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.556 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.726 HD21 HG21 ' A' ' 47' ' ' VAL . 25.9 mt -113.4 139.72 48.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.707 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.48 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 m-85 -137.22 163.8 46.45 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.816 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.434 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 3.0 Cg_exo -74.01 111.7 3.37 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.669 2.246 . . . . 0.0 111.75 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -50.77 -57.32 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.646 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -50.89 -40.79 57.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.995 0.426 . . . . 0.0 111.71 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 3.9 mm-40 -69.89 -39.93 75.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.59 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.461 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 4.3 m -108.43 13.58 25.38 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' N ' ' O ' ' A' ' 66' ' ' TYR . 2.3 ptpt -56.64 -47.02 80.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.849 0.357 . . . . 0.0 111.284 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -70.62 -24.89 62.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.744 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 mttp -84.73 -47.74 10.13 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.5 m-30 -101.02 -7.81 22.92 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.9 72.96 2.75 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.211 -0.995 . . . . 0.0 113.143 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.438 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.7 mtmt -148.98 155.68 40.49 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 120.554 0.216 . . . . 0.0 110.435 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.91 155.37 23.23 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.549 2.166 . . . . 0.0 112.687 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -136.78 172.93 12.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.485 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.93 -15.79 27.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.366 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.7 mmt-85 -66.05 -14.44 61.7 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.994 0.426 . . . . 0.0 110.769 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp 63.81 141.48 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.168 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.4 -17.12 53.94 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.653 -178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 23.0 t80 -58.96 -56.33 23.67 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.038 0.447 . . . . 0.0 110.724 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.81 -45.43 67.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.038 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -48.78 -30.95 6.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.956 0.407 . . . . 0.0 110.495 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.433 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.59 -31.9 60.15 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.992 179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.595 ' O ' HG22 ' A' ' 89' ' ' ILE . 57.9 mt -60.77 -43.77 97.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 110.3 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.1 t90 -64.06 -44.94 90.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.599 ' HG2' HG11 ' A' ' 95' ' ' VAL . 0.8 OUTLIER -63.56 -51.53 65.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.766 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -51.44 -28.37 8.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.716 0.293 . . . . 0.0 111.685 -179.67 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -98.86 -44.67 6.27 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -80.2 -32.56 38.59 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -157.05 91.24 2.44 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.678 0.275 . . . . 0.0 111.26 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 83.8 Cg_endo -78.1 -10.78 16.48 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.503 2.135 . . . . 0.0 112.686 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.43 HG22 HH12 ' A' ' 29' ' ' ARG . 0.8 OUTLIER -103.27 11.85 36.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.496 -179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.599 HG11 ' HG2' ' A' ' 88' ' ' GLU . 12.4 p -61.86 145.2 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.858 0.361 . . . . 0.0 111.364 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.7 168.88 18.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.017 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.64 29.91 7.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.998 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.0 p -66.31 153.47 42.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.53 -169.3 16.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.461 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 61.44 88.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 0.0 110.842 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -112.15 -173.57 2.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.2 t 62.25 170.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 t 63.5 141.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 61.09 88.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.934 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.1 157.26 36.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.909 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.75 -35.25 3.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 12.1 m 61.36 31.17 19.27 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.922 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 90.2 m 59.08 164.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -161.92 -46.46 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mtt . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.852 0.358 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -163.81 165.43 22.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.827 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -78.46 153.38 31.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.854 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -70.72 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.984 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.33 27.91 12.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.063 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 57.32 88.97 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.842 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -109.55 122.88 48.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.248 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.48 ' CG ' ' CZ ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -59.59 129.66 43.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.186 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -95.55 139.86 31.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.565 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' CD1' HG11 ' A' ' 16' ' ' VAL . 68.5 m-85 -113.82 158.81 20.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.044 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.52 158.96 42.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.934 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.2 m -51.87 130.62 29.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.36 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.01 -11.94 68.96 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.859 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -71.04 138.83 50.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.751 0.31 . . . . 0.0 110.985 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.9 mt -91.1 116.38 28.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.014 0.435 . . . . 0.0 110.318 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.512 HG11 ' CD1' ' A' ' 10' ' ' TYR . 31.3 m -139.4 170.78 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.698 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 36.5 m-85 -110.57 138.59 46.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.746 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.696 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -114.1 120.4 40.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.939 0.399 . . . . 0.0 111.195 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 129.3 39.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.243 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.9 mtm -119.22 161.12 20.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.611 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 119.72 13.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.108 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.63 -4.2 85.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.017 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -127.56 150.6 73.34 Favored Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 116.833 0.316 . . . . 0.0 110.756 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -81.81 160.74 18.79 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.742 2.294 . . . . 0.0 112.513 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 69.9 m80 -48.98 115.45 1.29 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.612 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.469 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 4.4 t-105 -98.67 133.5 22.48 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.0 119.26 6.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.384 2.056 . . . . 0.0 110.956 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.48 174.8 10.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.361 0.6 . . . . 0.0 112.394 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.725 HH12 HG22 ' A' ' 94' ' ' THR . 12.9 ttp180 -142.98 156.75 44.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.477 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.409 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 31.7 mm -78.85 135.79 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.6 -21.58 4.1 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.44 165.76 16.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.012 0.434 . . . . 0.0 111.593 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.21 158.24 32.4 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.99 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -78.52 162.07 27.84 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.649 2.232 . . . . 0.0 112.468 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.15 -31.19 9.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.825 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.93 -40.04 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.546 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.78 -66.87 0.19 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.799 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 38' ' ' VAL . 16.1 t 64.71 13.28 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.892 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? 59.71 -79.45 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.77 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 38' ' ' VAL . 2.0 m -80.45 57.48 2.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.967 0.413 . . . . 0.0 111.16 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 43' ' ' ASN . 0.4 OUTLIER -164.58 -21.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.724 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 39.12 -87.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 122.78 0.432 . . . . 0.0 111.564 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 41' ' ' THR . 2.2 m-20 -154.78 52.85 0.64 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.312 0.577 . . . . 0.0 110.259 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.18 152.33 48.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.142 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -93.42 160.56 14.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.877 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.17 109.72 22.37 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.577 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 57.5 t -104.03 141.51 19.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.249 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -105.12 121.32 43.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.702 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.664 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 84.1 m-85 -93.52 106.74 18.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.482 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.759 ' HE2' HD12 ' A' ' 89' ' ' ILE . 49.4 m-85 -58.12 177.21 0.13 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.2 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.7 -63.02 0.88 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.034 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.1 p -91.45 -22.47 20.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.701 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.2 m170 63.81 35.31 11.24 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.303 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -89.92 153.71 20.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.545 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.34 141.71 51.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.31 0.576 . . . . 0.0 111.614 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.533 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.0 170.59 21.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.257 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -111.49 126.26 54.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.077 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.696 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 86.1 mt -138.82 160.79 38.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.835 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -93.26 179.86 39.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.512 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HA ' HD12 ' A' ' 63' ' ' LEU . 15.4 Cg_exo -65.99 -27.86 50.1 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.599 2.199 . . . . 0.0 112.221 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -69.3 -23.31 63.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.175 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -98.69 7.3 46.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.541 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.501 HD22 HG21 ' A' ' 16' ' ' VAL . 10.7 mt -116.21 140.01 49.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 110.697 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 m-85 -136.55 161.56 61.25 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.695 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 6.9 Cg_exo -71.43 109.91 2.73 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.437 2.092 . . . . 0.0 111.431 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 89.0 t80 -46.76 -58.72 3.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.223 -179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.53 -38.41 59.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.082 0.468 . . . . 0.0 111.427 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 4.1 mm-40 -70.85 -39.8 72.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.444 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.478 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 1.2 m -104.67 11.62 33.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HG3' ' CE2' ' A' ' 66' ' ' TYR . 9.3 tttt -56.09 -49.43 73.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.795 0.331 . . . . 0.0 111.863 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -67.5 -35.19 78.65 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 2.7 ptpt -83.62 -43.83 15.21 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 18.9 m-30 -96.05 -17.77 20.69 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -83.37 73.51 2.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.02 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 74' ' ' GLY . 2.7 mttp -147.41 151.69 40.59 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.576 0.227 . . . . 0.0 110.409 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.52 152.03 9.47 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.495 2.13 . . . . 0.0 112.465 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -136.41 169.28 17.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.082 0.468 . . . . 0.0 111.718 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -15.19 36.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.366 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.78 -14.93 62.32 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.958 0.409 . . . . 0.0 110.608 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.2 mmtm 63.37 140.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.142 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.85 -15.89 58.13 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.493 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 38.8 t80 -58.52 -58.29 9.18 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 110.916 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.82 -45.73 64.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.073 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.99 -32.59 9.45 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.974 0.416 . . . . 0.0 110.379 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.429 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -72.75 -31.95 61.93 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.751 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.593 ' O ' HG22 ' A' ' 89' ' ' ILE . 98.3 mt -60.72 -43.5 97.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.07 0.462 . . . . 0.0 110.179 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.402 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 59.1 t90 -64.04 -45.33 89.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.066 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 1.8 mp0 -62.86 -51.61 66.33 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.759 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.27 -27.21 10.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.777 0.322 . . . . 0.0 111.654 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.39 -44.84 6.36 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.7 OUTLIER -81.48 -31.75 32.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.108 0.411 . . . . 0.0 112.108 -178.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -155.62 87.19 3.16 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.738 0.304 . . . . 0.0 111.104 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 76.0 Cg_endo -77.57 -12.17 16.88 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.687 2.258 . . . . 0.0 112.85 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.725 HG22 HH12 ' A' ' 29' ' ' ARG . 75.6 p -105.47 12.93 30.88 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG12 ' HE1' ' A' ' 50' ' ' PHE . 11.9 p -62.48 148.36 10.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.882 0.373 . . . . 0.0 111.421 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -156.53 165.85 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.037 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.9 144.01 41.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.074 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.76 120.7 32.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -130.71 111.12 1.08 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.548 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -94.8 149.01 21.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.352 . . . . 0.0 110.815 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -168.75 -42.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.7 m 65.05 33.28 9.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.01 101.31 2.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -130.75 -54.88 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? 60.14 100.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.82 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -117.77 158.46 24.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.6 t 59.6 102.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.953 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 8.7 t -66.7 95.56 0.35 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -99.82 -41.34 7.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.064 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.769 0.318 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.4 p -157.01 -48.14 0.07 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -121.91 101.06 7.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.021 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -154.69 89.23 1.24 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -97.35 158.04 15.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.776 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -164.0 113.97 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -75.05 131.65 40.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.756 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.9 tttt -154.51 135.93 14.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.978 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -95.87 140.79 30.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.715 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.633 ' CD1' HG11 ' A' ' 16' ' ' VAL . 47.5 m-85 -117.95 162.04 18.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.74 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.639 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 13.6 mmtt -135.83 163.22 30.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.039 0.447 . . . . 0.0 111.079 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 23.8 p -52.11 129.6 27.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.049 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.08 -10.49 71.77 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.911 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -72.95 141.83 47.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.769 HD23 ' HG3' ' A' ' 29' ' ' ARG . 21.2 mt -92.22 117.23 29.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 10' ' ' TYR . 30.8 m -139.43 172.35 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.632 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.461 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 10.6 m-85 -113.13 136.94 52.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.992 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.644 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -112.73 121.82 45.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.89 0.376 . . . . 0.0 111.327 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -90.85 131.37 36.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.945 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.3 mtm -132.05 145.7 51.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.788 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.18 118.63 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.629 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 102.11 -0.51 51.08 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.61 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 0.5 OUTLIER -155.89 143.08 13.73 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 179.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 58.5 Cg_endo -72.69 168.36 24.69 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.34 2.027 . . . . 0.0 112.366 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 39.1 m80 -45.66 115.9 1.06 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.043 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.423 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.6 t-105 -98.27 131.94 25.33 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.396 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.472 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 44.8 Cg_exo -53.64 119.0 5.51 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.244 1.963 . . . . 0.0 111.044 178.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.594 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.47 174.32 11.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.34 0.59 . . . . 0.0 112.389 -178.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.769 ' HG3' HD23 ' A' ' 15' ' ' LEU . 15.2 ttp180 -142.72 156.23 44.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.434 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.0 mm -77.56 135.22 26.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.3 -20.01 4.55 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.02 156.36 19.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.998 0.427 . . . . 0.0 111.019 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.639 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 3.2 ptp -153.53 168.18 12.12 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.382 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 33' ' ' MET . 52.0 Cg_exo -53.81 112.08 0.87 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.568 2.179 . . . . 0.0 112.119 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.94 -78.64 0.14 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.104 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.21 -38.42 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.579 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.15 94.14 2.19 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.261 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 m -148.45 -42.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.284 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp 80.76 -48.41 0.29 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.59 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 p -47.83 -27.29 2.0 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.812 0.339 . . . . 0.0 111.163 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.7 t -149.53 137.78 20.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -166.55 -62.47 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.59 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.8 m-80 -85.06 -5.26 59.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.007 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.77 145.92 37.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.907 0.384 . . . . 0.0 111.304 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -94.17 158.68 15.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.946 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -98.85 109.83 22.52 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.594 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 59.6 t -104.18 143.02 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.279 -178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -107.0 123.1 47.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.945 179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.644 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 81.2 m-85 -94.93 111.69 23.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.78 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.689 ' HE2' HD12 ' A' ' 89' ' ' ILE . 59.5 m-85 -60.71 178.82 0.2 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.991 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.51 -63.45 0.62 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.268 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.6 p -91.43 -23.02 20.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.962 0.41 . . . . 0.0 110.618 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.85 ' HB3' ' HB2' ' A' ' 97' ' ' ALA . 58.9 m170 63.6 38.24 9.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.342 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -92.08 154.2 18.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.637 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -122.99 141.75 51.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.259 0.552 . . . . 0.0 111.576 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.41 167.12 31.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.314 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -108.03 125.23 51.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.534 HD13 ' HB1' ' A' ' 18' ' ' ALA . 14.9 mt -139.94 162.15 35.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.083 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.488 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -92.75 170.37 32.1 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.286 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.25 -19.04 50.74 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.428 2.085 . . . . 0.0 112.324 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -28.55 67.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.98 0.419 . . . . 0.0 110.587 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -99.48 14.22 30.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.852 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.2 mp -111.79 137.53 49.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.539 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.4 m-85 -137.51 155.13 75.54 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.912 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.611 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 14.5 Cg_exo -68.98 112.53 2.97 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.589 2.193 . . . . 0.0 111.6 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.522 ' O ' ' N ' ' A' ' 70' ' ' LYS . 79.3 t80 -52.04 -58.92 5.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.056 -179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -49.36 -41.8 40.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.957 0.408 . . . . 0.0 112.022 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -71.07 -39.48 72.17 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -106.13 10.69 31.93 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 66' ' ' TYR . 0.4 OUTLIER -55.89 -45.83 78.49 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.755 0.312 . . . . 0.0 111.47 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -70.08 -24.88 63.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.925 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -84.69 -45.97 11.92 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.6 m-30 -101.82 -10.44 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -178.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.48 74.01 2.42 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.359 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -151.85 155.33 33.71 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 120.661 0.267 . . . . 0.0 110.666 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -47.14 139.52 15.38 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.744 2.296 . . . . 0.0 112.812 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.435 ' HB3' ' CB ' ' A' ' 82' ' ' PHE . 9.6 t-20 -112.41 162.89 15.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.358 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.4 -20.42 25.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.726 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.8 mmp_? -69.34 -13.51 62.42 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.979 0.418 . . . . 0.0 110.711 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 65.25 147.49 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.021 -178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.59 -19.59 35.87 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.68 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.629 ' HE1' HD11 ' A' ' 86' ' ' LEU . 11.9 t80 -57.88 -52.47 65.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.014 0.435 . . . . 0.0 110.545 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.51 -47.44 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.261 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -48.33 -32.45 7.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.036 0.446 . . . . 0.0 110.423 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.469 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.8 -31.81 57.81 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.436 -0.887 . . . . 0.0 111.928 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.629 HD11 ' HE1' ' A' ' 82' ' ' PHE . 82.8 mt -60.53 -43.69 96.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 0.0 110.285 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.1 t90 -64.06 -43.11 96.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.955 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.469 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 35.3 mm-40 -63.69 -51.88 63.09 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.689 HD12 ' HE2' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -51.88 -26.3 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 -179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.458 ' HG2' HG23 ' A' ' 89' ' ' ILE . 8.2 mm-40 -101.48 -44.6 5.56 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -79.6 -32.81 41.91 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.47 89.05 2.74 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.76 0.314 . . . . 0.0 111.103 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.427 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 78.0 Cg_endo -77.76 -12.53 16.48 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.635 2.224 . . . . 0.0 112.705 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.2 p -102.26 11.57 37.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.733 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.555 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.2 p -63.11 146.35 12.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.853 0.359 . . . . 0.0 111.29 -179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.87 164.98 18.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.125 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.85 ' HB2' ' HB3' ' A' ' 53' ' ' HIS . . . -106.24 84.46 2.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.159 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.2 t -122.39 116.79 24.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 114.82 42.72 0.78 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.57 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.415 ' CD2' ' O ' ' A' ' 100' ' ' TYR . 17.7 p90 -99.25 83.46 2.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.911 0.386 . . . . 0.0 110.831 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.22 -33.47 7.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.002 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.9 t -102.3 139.03 38.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 m -160.41 123.71 3.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 60.95 99.66 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -62.67 -31.03 71.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.27 171.94 8.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.9 t 60.6 82.99 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.48 -57.79 0.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.83 -44.37 1.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.056 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.93 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtp . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.864 0.364 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -124.74 -45.02 1.92 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -141.92 86.69 2.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.56 98.17 7.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -170.77 -43.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.94 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -119.74 101.04 7.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.967 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -98.97 -176.67 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.425 ' O ' ' CB ' ' A' ' 9' ' ' GLU . 10.0 pttt -162.87 -151.67 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.885 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.425 ' CB ' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 81.92 140.44 0.07 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.733 ' CD2' HG11 ' A' ' 16' ' ' VAL . 3.7 m-85 -124.74 165.59 17.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.806 0.336 . . . . 0.0 111.497 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 3.7 mmtt -139.06 165.87 25.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 8.6 t -52.92 126.97 22.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.495 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.47 -13.61 62.7 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.309 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -72.01 142.46 49.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.971 0.386 . . . . 0.0 111.147 -179.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.627 HD23 ' HG3' ' A' ' 29' ' ' ARG . 59.3 mt -91.39 118.03 30.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.903 0.382 . . . . 0.0 110.327 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.733 HG11 ' CD2' ' A' ' 10' ' ' TYR . 29.0 m -139.94 173.93 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.791 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.417 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.8 m-85 -113.38 137.67 51.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.716 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.626 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -113.59 122.49 47.37 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.892 0.377 . . . . 0.0 111.425 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HD3' ' CG ' ' A' ' 25' ' ' HIS . 21.1 tptp -91.18 131.46 36.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.927 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 mmm -124.7 155.21 39.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.774 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.85 111.45 7.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.74 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 102.6 -1.21 49.24 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.845 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.406 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.1 m-85 -146.02 150.25 41.55 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.746 0.308 . . . . 0.0 110.649 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.49 166.92 23.5 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.672 2.248 . . . . 0.0 112.517 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.428 ' CG ' ' HD3' ' A' ' 19' ' ' LYS . 79.7 m80 -47.48 115.67 1.2 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.056 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.8 t-105 -98.25 130.9 27.33 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.05 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 11.0 Cg_endo -54.0 119.01 5.59 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.302 2.001 . . . . 0.0 111.054 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.607 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.19 175.8 9.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.32 0.581 . . . . 0.0 112.305 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.759 HH12 HG22 ' A' ' 94' ' ' THR . 21.2 ttp180 -143.13 156.96 44.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.379 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.411 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 13.4 mm -81.69 136.17 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -123.93 -16.76 6.49 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' C ' ' HG2' ' A' ' 33' ' ' MET . 4.1 mt-10 -163.53 160.32 23.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.118 0.485 . . . . 0.0 111.669 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.422 ' HG2' ' C ' ' A' ' 32' ' ' GLU . 0.4 OUTLIER -145.71 128.38 8.08 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.273 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.17 156.97 9.31 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.462 2.108 . . . . 0.0 112.313 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -67.11 -70.61 0.24 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.855 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -169.02 -42.01 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.332 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.29 75.25 0.19 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.413 179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.0 m -150.87 157.45 5.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.182 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 pttt 43.21 -167.82 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.604 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.0 t -94.25 110.05 21.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.978 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.44 -18.14 0.88 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.858 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 40.87 37.84 0.57 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.761 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.469 ' C ' ' HG2' ' A' ' 44' ' ' LYS . 70.6 m-20 57.61 55.95 5.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.941 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.469 ' HG2' ' C ' ' A' ' 43' ' ' ASN . 5.5 mtmt -138.41 145.52 41.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.395 -179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 0.7 OUTLIER -99.52 165.52 11.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.692 179.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -100.95 113.63 26.79 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.607 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 93.5 t -103.45 142.48 17.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.866 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.495 ' HE2' HG13 ' A' ' 95' ' ' VAL . 41.1 t80 -104.87 121.29 43.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.962 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.626 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 93.9 m-85 -94.43 108.71 20.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.643 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.7 ' CE2' HD12 ' A' ' 89' ' ' ILE . 50.0 m-85 -59.33 178.1 0.15 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.926 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 69.97 -63.62 0.71 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.097 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.8 p -91.29 -23.13 20.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.881 0.372 . . . . 0.0 110.502 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.5 m170 63.89 37.46 9.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.452 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -90.99 154.28 19.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.6 141.61 51.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.259 0.552 . . . . 0.0 111.509 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.29 167.36 30.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.361 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -107.17 124.83 50.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.603 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 mp -140.23 162.01 36.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.028 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.01 163.06 25.39 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.166 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.24 -17.98 49.48 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.448 2.099 . . . . 0.0 112.442 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.66 -28.49 66.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.864 0.364 . . . . 0.0 110.656 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -98.54 12.23 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.88 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 6.5 mp -107.42 138.58 43.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.39 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.6 m-85 -137.38 147.96 59.98 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.109 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HG2' ' HB2' ' A' ' 68' ' ' GLU . 20.8 Cg_endo -61.82 109.15 0.73 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.666 2.244 . . . . 0.0 111.568 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.519 ' O ' ' N ' ' A' ' 70' ' ' LYS . 86.2 t80 -50.74 -58.26 6.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.878 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.4 mp0 -50.85 -39.62 54.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.164 0.507 . . . . 0.0 111.376 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.529 ' HB2' ' HG2' ' A' ' 65' ' ' PRO . 33.8 mt-10 -70.68 -40.02 73.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.507 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.78 11.36 30.25 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.6 ptpp? -56.4 -45.72 80.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.827 0.346 . . . . 0.0 111.382 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.484 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 18.8 mt-10 -70.51 -26.54 63.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.859 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -83.86 -46.4 12.19 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 2.6 m-30 -100.18 -11.2 20.63 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.19 74.4 2.49 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.32 -0.943 . . . . 0.0 113.296 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -152.15 154.55 32.53 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.616 0.246 . . . . 0.0 110.63 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -44.98 136.21 10.16 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.707 2.271 . . . . 0.0 112.596 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.45 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 0.4 OUTLIER -109.77 175.03 5.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.817 -178.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.6 tptp -100.7 -22.52 14.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.621 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -13.22 61.93 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.684 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt 63.99 144.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.968 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.85 -18.01 49.75 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.714 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 12.0 t80 -59.53 -50.44 73.9 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.895 0.379 . . . . 0.0 110.568 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.1 m -52.58 -47.48 66.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.233 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -48.3 -30.89 5.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.01 0.434 . . . . 0.0 110.45 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.44 -31.19 59.28 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.052 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.647 ' O ' HG22 ' A' ' 89' ' ' ILE . 32.4 mt -60.64 -43.94 96.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 110.277 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 60.0 t90 -64.43 -45.24 88.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -62.61 -51.04 68.86 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.7 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -51.8 -26.99 7.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.784 0.325 . . . . 0.0 111.826 -179.612 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -99.7 -44.8 5.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.22 -32.33 38.5 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -156.71 89.36 2.66 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 120.738 0.304 . . . . 0.0 111.079 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 93.2 Cg_endo -79.08 -11.44 14.88 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.677 2.251 . . . . 0.0 112.983 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.759 HG22 HH12 ' A' ' 29' ' ' ARG . 37.6 p -103.95 13.27 33.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.614 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.584 HG12 ' HE1' ' A' ' 50' ' ' PHE . 11.9 p -62.58 146.88 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.894 0.378 . . . . 0.0 111.4 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 mttp -111.52 163.49 14.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.107 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.43 -177.79 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.8 m -89.03 176.57 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 109.26 57.59 0.53 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.52 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -149.51 90.9 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -127.73 -56.55 1.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.65 -78.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.001 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.7 p -111.86 117.09 31.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.929 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -78.71 141.56 37.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -149.73 157.06 42.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.01 31.74 4.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.81 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.6 104.14 16.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.964 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 86.9 m -145.02 -178.9 6.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.14 37.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mpp? . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.825 0.345 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.77 -76.04 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.51 170.19 8.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.982 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 79.7 p -105.47 -173.92 2.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.912 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -152.07 99.47 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.83 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.88 30.07 19.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -129.44 149.8 51.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.779 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.65 145.64 46.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.077 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.98 141.21 28.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.623 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.606 ' CD1' HG11 ' A' ' 16' ' ' VAL . 27.1 m-85 -116.82 159.45 22.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.768 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -136.18 160.46 38.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 0.0 110.991 -179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 61.3 m -51.36 123.98 10.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.181 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.79 -13.87 56.24 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.238 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.44 140.46 50.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 111.211 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.8 mt -92.62 116.71 29.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.408 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.606 HG11 ' CD1' ' A' ' 10' ' ' TYR . 30.8 m -139.36 172.4 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.744 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.492 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 12.3 m-85 -111.71 136.18 51.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.801 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.658 ' HB1' HD22 ' A' ' 58' ' ' LEU . . . -112.94 123.63 50.77 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.889 0.376 . . . . 0.0 111.648 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.7 tptt -92.21 128.75 38.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.858 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.58 146.75 51.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.846 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 pttt -65.1 116.31 6.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.719 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 101.35 -0.91 53.76 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.726 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m-85 -148.78 151.28 34.98 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 120.683 0.278 . . . . 0.0 110.672 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.26 168.38 16.81 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.621 2.214 . . . . 0.0 112.193 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 74.3 m80 -47.27 113.52 0.7 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.654 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.2 t-105 -99.22 128.99 30.33 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.353 -179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.99 119.81 6.91 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.268 1.979 . . . . 0.0 111.126 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' PHE . . . -143.76 176.45 9.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.649 HH12 HG22 ' A' ' 94' ' ' THR . 3.2 ttt180 -144.69 157.59 44.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.456 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.505 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 27.8 mm -81.44 137.04 21.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.4 -18.91 4.77 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -165.74 156.29 13.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.349 . . . . 0.0 111.164 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.522 ' HE1' ' O ' ' A' ' 10' ' ' TYR . 5.8 ptp -156.64 163.15 25.94 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.348 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.679 ' HG3' HG21 ' A' ' 41' ' ' THR . 13.8 Cg_exo -68.95 124.69 11.68 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.836 2.357 . . . . 0.0 112.132 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.1 -28.96 0.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.13 -37.08 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.103 0.478 . . . . 0.0 109.916 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.61 99.2 3.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.69 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.64 HG11 ' HA ' ' A' ' 34' ' ' PRO . 16.1 m -151.34 16.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.841 -179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? 50.71 77.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.878 0.371 . . . . 0.0 111.501 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.2 t 61.95 -80.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.47 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.679 HG21 ' HG3' ' A' ' 34' ' ' PRO . 2.4 m 69.06 104.76 0.06 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.877 0.37 . . . . 0.0 110.939 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.535 ' HB3' ' HD2' ' A' ' 44' ' ' LYS . . . -74.06 59.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.373 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 p30 49.14 51.73 15.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.302 -178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.535 ' HD2' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -130.66 139.29 50.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.108 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 40.9 m-85 -95.67 155.9 16.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.768 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.88 105.68 17.44 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.578 HG11 HD21 ' A' ' 63' ' ' LEU . 12.8 m -100.61 148.04 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.315 0.579 . . . . 0.0 112.03 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 28' ' ' ALA . 4.9 t80 -105.39 124.5 49.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.482 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.423 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 76.1 m-85 -94.05 108.06 19.92 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.112 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.752 ' HE2' HD12 ' A' ' 89' ' ' ILE . 60.6 m-85 -58.24 178.79 0.09 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.204 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.56 -62.07 0.87 Allowed Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.378 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 46.4 p -91.28 -21.23 21.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.571 0.224 . . . . 0.0 110.934 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.412 ' HB2' ' O ' ' A' ' 52' ' ' THR . 26.3 m170 64.92 33.39 9.96 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.91 0.386 . . . . 0.0 110.432 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -94.93 158.49 15.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.46 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -132.85 149.26 52.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.31 0.576 . . . . 0.0 111.74 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.55 171.5 19.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.44 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.437 ' C ' HD12 ' A' ' 58' ' ' LEU . 17.4 m-85 -107.78 124.52 50.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.923 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.658 HD22 ' HB1' ' A' ' 18' ' ' ALA . 5.9 mp -138.04 160.19 40.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.43 175.59 39.34 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.187 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.36 -24.92 49.54 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.405 2.07 . . . . 0.0 112.161 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -69.34 -25.74 64.35 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.086 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 30.0 m-20 -97.97 7.7 45.92 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.31 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.578 HD21 HG11 ' A' ' 47' ' ' VAL . 71.8 mt -115.15 139.4 49.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.748 0.308 . . . . 0.0 110.37 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.7 m-85 -137.58 159.61 68.43 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.965 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.55 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 13.2 Cg_exo -69.48 111.88 2.88 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.685 2.256 . . . . 0.0 111.717 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 70' ' ' LYS . 78.1 t80 -51.97 -58.38 6.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.79 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.96 -41.73 47.18 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.08 0.467 . . . . 0.0 111.639 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.61 -39.72 73.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.477 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.23 12.19 30.34 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' TYR . 3.6 ptpt -55.73 -46.38 77.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.857 0.361 . . . . 0.0 111.49 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.476 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -70.1 -25.69 63.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.931 -179.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -47.33 10.76 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 1.8 m-30 -101.02 -8.01 22.75 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.1 73.05 2.71 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.284 -0.96 . . . . 0.0 113.219 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 3.3 mtmt -149.09 158.19 39.05 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-O 120.592 0.234 . . . . 0.0 110.398 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.41 155.44 25.41 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.601 2.201 . . . . 0.0 112.555 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -136.36 168.74 18.88 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.545 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -89.42 -16.37 31.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.221 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.4 mmt180 -66.72 -14.51 62.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.004 0.431 . . . . 0.0 110.67 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt 63.6 143.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.124 -179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.67 -18.39 39.03 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.58 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 20.0 t80 -58.91 -56.08 26.86 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.976 0.417 . . . . 0.0 110.697 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.64 -45.33 66.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.999 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.82 -30.99 6.39 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.992 0.425 . . . . 0.0 110.52 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.88 -31.36 60.2 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.994 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.687 ' O ' HG22 ' A' ' 89' ' ' ILE . 61.5 mt -60.9 -43.65 98.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.973 0.416 . . . . 0.0 110.471 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 70.9 t90 -64.26 -44.21 92.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.177 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -62.47 -50.91 69.57 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.822 0.305 . . . . 0.0 111.822 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.752 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.09 -26.19 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -100.92 -44.89 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -79.62 -33.34 41.54 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -155.9 87.1 3.08 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.848 0.356 . . . . 0.0 111.1 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -76.18 -12.01 19.31 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.638 2.225 . . . . 0.0 112.646 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.649 HG22 HH12 ' A' ' 29' ' ' ARG . 24.3 p -104.32 11.97 34.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.546 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.622 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.8 p -62.18 148.35 10.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.836 0.351 . . . . 0.0 111.466 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -156.48 166.42 33.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.974 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.66 108.3 16.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.4 m -146.58 -51.45 0.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.942 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.01 -176.76 36.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.446 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -132.29 -47.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.862 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -134.76 105.8 6.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 m -119.13 156.97 28.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.989 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.4 p -157.57 164.77 36.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 60.86 99.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -137.15 138.3 40.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.807 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.95 -36.37 3.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.075 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.3 m -84.23 149.77 25.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.035 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.59 -57.34 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.927 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.36 30.74 0.38 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.1 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.815 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.819 0.342 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -168.17 -74.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.73 106.73 1.57 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.81 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -122.69 173.99 7.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.8 t30 60.74 19.72 9.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.184 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.15 156.46 0.13 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.838 0.351 . . . . 0.0 110.839 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -130.31 -58.24 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.682 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 9' ' ' GLU . 4.7 tttp 59.84 -153.18 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 8' ' ' LYS . 5.1 mt-10 83.8 136.83 0.06 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.551 ' CD2' HG11 ' A' ' 16' ' ' VAL . 9.0 m-85 -124.41 164.69 19.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.93 0.395 . . . . 0.0 111.529 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.97 164.49 28.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.8 m -52.83 127.56 23.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.091 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.09 -14.15 57.18 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.163 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.01 141.0 47.69 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.798 0.333 . . . . 0.0 111.277 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.802 HD23 ' HG3' ' A' ' 29' ' ' ARG . 84.1 mt -93.17 122.6 35.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.343 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.551 HG11 ' CD2' ' A' ' 10' ' ' TYR . 33.9 m -142.43 173.62 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.183 0.516 . . . . 0.0 111.93 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.45 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 9.4 m-85 -112.22 134.54 53.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.671 178.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.899 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -114.13 123.65 50.15 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.036 0.446 . . . . 0.0 111.659 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -91.72 127.39 37.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.787 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 ttm -127.02 152.29 47.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.582 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -67.14 126.93 30.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.92 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 91.54 -3.72 79.03 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.954 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.424 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 1.6 m-85 -148.72 149.7 31.41 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-N 116.808 0.304 . . . . 0.0 110.729 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.79 172.2 15.42 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.5 2.133 . . . . 0.0 112.508 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -49.15 114.52 1.03 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.772 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.446 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.8 t-105 -98.86 132.46 23.7 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.293 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.488 ' HD3' ' CE2' ' A' ' 82' ' ' PHE . 32.5 Cg_exo -54.48 120.52 8.18 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.069 1.846 . . . . 0.0 110.953 178.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -144.16 175.04 10.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.394 0.616 . . . . 0.0 112.412 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.802 ' HG3' HD23 ' A' ' 15' ' ' LEU . 9.5 ttp180 -142.74 155.27 44.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.551 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.402 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 30.8 mm -78.66 135.0 26.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.78 -20.1 4.34 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.2 159.76 17.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.034 0.445 . . . . 0.0 111.266 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.28 162.28 26.91 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.984 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.6 107.45 0.18 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.569 2.18 . . . . 0.0 112.153 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -87.79 -77.77 0.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.177 0.513 . . . . 0.0 111.21 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.9 -38.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.325 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -143.72 93.08 2.42 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.061 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.511 ' O ' HG12 ' A' ' 38' ' ' VAL . 11.1 t -142.41 7.29 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.528 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.7 mmtp 66.04 -73.35 0.07 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.677 0.275 . . . . 0.0 111.367 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.681 ' O ' HG23 ' A' ' 41' ' ' THR . 0.7 OUTLIER -68.63 102.34 1.47 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.785 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 40' ' ' SER . 0.9 OUTLIER -166.54 143.28 4.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.288 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB3' ' HD2' ' A' ' 44' ' ' LYS . . . -171.36 41.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.595 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.92 40.95 2.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.559 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -138.98 144.79 39.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.015 -179.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 88.3 m-85 -94.26 154.01 17.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.837 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.433 ' HG3' ' CE1' ' A' ' 57' ' ' PHE . 5.1 tt0 -100.39 106.09 17.65 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.3 m -101.95 150.91 5.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.499 0.666 . . . . 0.0 112.126 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 17.9 t80 -105.33 125.31 50.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.289 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -91.37 106.97 18.89 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.422 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.795 ' HE2' HD12 ' A' ' 89' ' ' ILE . 41.0 m-85 -59.43 175.17 0.35 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.692 0.282 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.39 -61.66 0.84 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.31 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 53' ' ' HIS . 71.7 p -90.33 -22.48 21.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.7 0.286 . . . . 0.0 110.986 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 44.3 m170 64.84 34.32 9.38 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.351 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -91.4 154.74 18.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.755 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.07 143.67 49.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.251 0.548 . . . . 0.0 111.617 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.35 172.18 18.64 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.511 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 46' ' ' GLN . 15.3 m-85 -116.66 126.16 52.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.482 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.899 HD13 ' HB1' ' A' ' 18' ' ' ALA . 3.0 mt -140.02 163.24 33.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.174 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.659 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -94.27 171.55 31.08 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.321 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.415 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 38.3 Cg_endo -66.52 -19.48 54.68 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.474 2.116 . . . . 0.0 112.517 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -68.62 -29.48 68.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.936 0.398 . . . . 0.0 110.569 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.59 10.91 40.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.891 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.659 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.4 mp -108.36 137.3 46.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.519 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.6 m-85 -137.03 157.03 75.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.461 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 6.7 Cg_exo -72.32 111.6 3.24 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.429 2.086 . . . . 0.0 111.327 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.497 ' O ' ' N ' ' A' ' 70' ' ' LYS . 91.2 t80 -48.46 -57.47 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.875 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.26 -40.52 48.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 111.348 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 17.3 mt-10 -71.24 -39.95 71.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.535 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.482 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -104.35 9.38 35.85 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' TYR . 0.2 OUTLIER -57.52 -46.43 83.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.758 0.314 . . . . 0.0 111.792 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -67.75 -35.56 78.94 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 69' ' ' SER . 13.4 ptpt -82.81 -41.52 18.98 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CZ ' ' HD2' ' A' ' 72' ' ' LYS . 15.8 m-30 -97.92 -13.11 21.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 70' ' ' LYS . . . -84.53 75.35 2.37 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.266 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -152.13 153.96 31.82 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.585 0.231 . . . . 0.0 110.586 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_exo -45.31 136.14 11.42 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.717 2.278 . . . . 0.0 112.727 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.473 ' HB2' ' CG ' ' A' ' 82' ' ' PHE . 31.5 t30 -108.79 174.45 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.676 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 -22.4 15.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.851 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 -12.94 61.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.962 0.411 . . . . 0.0 110.8 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp 64.66 145.15 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.952 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.1 -18.25 46.05 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.753 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.488 ' CE2' ' HD3' ' A' ' 27' ' ' PRO . 11.3 t80 -58.88 -51.87 68.18 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 121.005 0.431 . . . . 0.0 110.559 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -46.66 66.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.409 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -48.11 -31.25 5.35 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.85 -31.22 60.44 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.063 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.633 ' O ' HG22 ' A' ' 89' ' ' ILE . 56.3 mt -61.02 -43.8 98.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.971 0.415 . . . . 0.0 110.315 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -64.13 -45.15 89.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.097 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.417 ' OE1' HG11 ' A' ' 95' ' ' VAL . 60.9 mt-10 -63.09 -50.99 68.37 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.795 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -51.73 -27.4 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.758 0.313 . . . . 0.0 111.754 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' HG3' HG23 ' A' ' 89' ' ' ILE . 59.5 mt-10 -99.52 -44.73 6.06 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -80.98 -31.7 34.66 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.64 87.73 3.1 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.819 0.342 . . . . 0.0 111.132 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 75.4 Cg_endo -77.71 -12.93 16.44 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.58 2.187 . . . . 0.0 112.791 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.8 p -104.45 12.78 32.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.634 0.254 . . . . 0.0 111.577 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.579 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.4 p -61.65 146.98 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.845 0.355 . . . . 0.0 111.432 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -143.18 178.76 7.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.032 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -87.24 -172.42 3.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.097 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.1 p -152.82 165.79 34.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 154.78 118.31 0.64 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -128.48 37.7 4.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 110.877 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 61.24 98.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.879 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.3 m 63.17 -79.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.8 78.39 0.29 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.905 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -172.16 112.27 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.858 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.7 mttm 61.63 102.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.91 123.15 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.24 123.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.972 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 21.8 m -74.47 158.75 33.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.09 166.34 13.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.081 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.986 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.974 0.416 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 t -100.1 -33.15 10.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.58 93.1 8.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.3 155.03 44.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.818 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 63.6 t30 67.62 -69.92 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.077 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.3 120.62 24.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -139.12 -165.6 1.88 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.731 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 9' ' ' GLU . 8.2 ttmm -93.38 4.23 54.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.628 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 1.7 mm-40 82.57 -130.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.469 -179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' CD1' ' O ' ' A' ' 9' ' ' GLU . 0.6 OUTLIER 161.8 97.89 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.918 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -133.48 160.32 37.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.432 . . . . 0.0 111.265 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 7.6 t -52.3 135.82 31.95 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.372 -179.75 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.85 -11.27 69.89 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.003 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.33 142.93 47.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.928 0.394 . . . . 0.0 111.103 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.428 HD23 ' HG3' ' A' ' 29' ' ' ARG . 77.2 mt -90.77 118.53 30.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.205 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.28 167.44 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.834 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.452 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 8.2 m-85 -109.86 132.62 53.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.65 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.581 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -110.83 124.06 51.31 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 111.523 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.71 133.21 35.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.96 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -129.83 147.15 51.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.62 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 112.69 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.89 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' CD1' ' A' ' 23' ' ' TYR . . . 109.56 -5.79 31.41 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.911 179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.433 ' CD1' ' O ' ' A' ' 22' ' ' GLY . 1.4 m-85 -147.96 161.57 34.29 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.784 0.326 . . . . 0.0 110.886 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 95.1 Cg_endo -83.94 168.98 11.98 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.895 2.397 . . . . 0.0 112.503 -179.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.516 ' CE1' ' CZ ' ' A' ' 73' ' ' PHE . 67.9 m80 -47.53 116.68 1.52 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.544 179.026 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.471 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.2 t-105 -98.04 130.76 27.9 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.59 -179.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.43 120.5 8.13 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.084 1.856 . . . . 0.0 111.044 179.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.644 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -144.74 175.06 10.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.352 0.596 . . . . 0.0 112.533 -178.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.433 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 2.0 ttt180 -142.89 156.07 44.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.527 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 21.1 mm -77.67 135.05 27.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.32 -21.66 4.18 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -179.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -165.28 157.2 15.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.932 0.396 . . . . 0.0 111.272 -179.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.09 157.83 32.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.28 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.529 ' CB ' HG21 ' A' ' 38' ' ' VAL . 96.1 Cg_endo -80.59 97.78 1.04 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.866 2.377 . . . . 0.0 112.232 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -153.15 13.77 0.51 Allowed 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.031 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -171.1 -37.38 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.872 -179.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.06 106.45 3.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.333 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -154.07 -42.24 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.423 -179.967 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.05 -71.49 0.13 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.803 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -160.42 0.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.329 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.678 HG23 ' HD2' ' A' ' 44' ' ' LYS . 9.7 m 65.97 120.39 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.812 0.339 . . . . 0.0 110.815 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.11 -61.04 1.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.135 0.493 . . . . 0.0 110.056 179.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -155.68 47.07 0.49 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.151 179.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.678 ' HD2' HG23 ' A' ' 41' ' ' THR . 1.3 mttp -105.58 133.3 50.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.191 -178.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 34.0 m-85 -93.32 156.55 16.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.005 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.74 97.09 8.7 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.027 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.644 ' CG2' ' HB1' ' A' ' 28' ' ' ALA . 2.7 p -100.05 148.58 6.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.485 -177.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.526 ' HE2' HG13 ' A' ' 95' ' ' VAL . 33.0 t80 -106.33 125.6 51.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.293 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.597 ' HE2' ' HB3' ' A' ' 56' ' ' ALA . 79.2 m-85 -93.39 110.65 22.2 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.743 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.754 ' CE2' HD12 ' A' ' 89' ' ' ILE . 50.3 m-85 -60.96 175.91 0.46 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.065 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.55 -62.94 0.85 Allowed Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.132 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.5 p -90.63 -22.95 20.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 110.581 179.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 38.0 m80 63.93 37.05 9.73 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.013 0.435 . . . . 0.0 110.194 -179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -91.21 153.97 19.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.72 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.8 139.16 53.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.162 0.506 . . . . 0.0 111.137 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.597 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.35 169.6 23.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.634 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 9.9 m-85 -112.07 126.41 55.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.773 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mp -139.21 162.53 34.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.064 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.9 176.11 39.03 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.362 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.74 -24.56 40.77 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.442 2.095 . . . . 0.0 112.219 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -70.03 -25.1 63.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.795 179.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -99.96 4.73 45.07 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.364 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.1 mt -116.09 139.47 50.26 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.648 0.261 . . . . 0.0 110.483 179.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.481 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 m-85 -137.84 165.69 31.91 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.884 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.595 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 2.7 Cg_exo -75.35 115.73 4.32 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.69 2.26 . . . . 0.0 111.733 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.528 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -53.03 -57.83 9.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.825 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -48.85 -42.98 38.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.98 0.419 . . . . 0.0 111.797 -179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -70.82 -39.72 72.87 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.441 -179.486 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.456 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 2.5 m -105.94 13.57 29.17 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 66' ' ' TYR . 6.0 ptmm? -58.06 -45.93 86.24 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.884 0.373 . . . . 0.0 111.452 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -67.66 -37.28 82.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -179.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 73' ' ' PHE . 6.1 ptmt -83.39 -43.31 16.04 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.516 ' CZ ' ' CE1' ' A' ' 25' ' ' HIS . 20.5 m-30 -95.27 -13.22 25.05 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -89.42 74.65 1.94 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.843 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 7.7 mmtp -146.82 148.74 34.01 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.612 0.244 . . . . 0.0 110.41 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.03 155.37 2.77 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.51 2.14 . . . . 0.0 112.538 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.425 ' ND2' ' HG3' ' A' ' 24' ' ' PRO . 8.8 t-20 -137.15 166.95 22.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.591 -179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -15.52 35.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.268 -179.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.404 ' HG2' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -66.71 -13.75 61.71 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.038 0.446 . . . . 0.0 110.597 179.304 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm 64.18 142.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.337 -179.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.21 -16.84 56.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.585 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 38.6 t80 -59.08 -56.68 19.16 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 120.922 0.391 . . . . 0.0 110.74 179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.4 -46.18 69.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.189 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -48.93 -30.69 6.23 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.913 0.387 . . . . 0.0 110.5 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.28 -31.4 59.35 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.818 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.642 ' O ' HG22 ' A' ' 89' ' ' ILE . 84.2 mt -60.78 -43.72 97.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 110.233 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.8 t90 -63.68 -45.29 90.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.112 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.542 ' HG2' HG11 ' A' ' 95' ' ' VAL . 1.5 mp0 -62.94 -51.36 67.19 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.754 HD12 ' CE2' ' A' ' 50' ' ' PHE . 1.0 OUTLIER -52.25 -26.3 8.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.748 0.308 . . . . 0.0 111.818 -179.824 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -100.04 -44.68 5.92 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -82.64 -31.68 28.66 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -178.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -156.77 88.79 2.68 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.728 0.299 . . . . 0.0 111.092 -179.497 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.6 Cg_endo -76.4 -10.37 18.97 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.598 2.199 . . . . 0.0 112.764 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.49 11.6 38.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.496 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.562 HG12 ' HE1' ' A' ' 50' ' ' PHE . 10.6 p -62.51 142.11 17.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.78 0.324 . . . . 0.0 111.218 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.29 144.4 17.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.017 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -94.37 111.04 22.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.123 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 m 61.35 -179.04 0.11 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.86 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.7 -23.75 5.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.635 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -149.04 162.73 39.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.793 0.33 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 60.61 105.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.5 m -157.01 116.34 3.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.989 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 60.13 85.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.954 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -99.4 -46.44 5.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -157.23 35.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.91 87.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.23 171.93 13.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.4 t -122.17 -43.6 2.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -98.4 165.39 11.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.078 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptm . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.766 0.317 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 t -145.13 136.92 25.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -139.92 -70.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.89 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.36 -174.7 3.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.914 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.31 -73.53 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.75 143.43 38.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.772 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -138.23 82.01 1.89 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.014 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -113.57 118.99 35.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.767 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -96.57 141.57 29.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.779 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.513 ' CE1' HG11 ' A' ' 16' ' ' VAL . 91.5 m-85 -113.55 159.72 19.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.654 179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.72 154.71 47.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 111.025 -179.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.418 ' HA ' HG22 ' A' ' 30' ' ' ILE . 59.5 m -51.92 134.63 31.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.346 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.37 -10.32 74.45 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.952 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.38 142.5 48.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.359 . . . . 0.0 111.171 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.488 HD23 ' HG3' ' A' ' 29' ' ' ARG . 64.1 mt -93.21 118.35 31.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.934 0.397 . . . . 0.0 110.532 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.513 HG11 ' CE1' ' A' ' 10' ' ' TYR . 22.6 m -142.84 171.71 9.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.683 -179.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.546 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 33.2 m-85 -110.21 135.22 51.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.452 178.48 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.682 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -112.03 126.64 55.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.41 . . . . 0.0 111.583 -179.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.3 129.11 37.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.927 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 ttm -134.06 144.33 48.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.71 179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.9 pttt -65.03 122.96 18.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.651 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.73 -8.93 56.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.769 -179.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.66 146.13 21.55 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-O 120.604 0.24 . . . . 0.0 110.526 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 71.9 Cg_endo -75.39 175.17 11.62 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.414 2.076 . . . . 0.0 112.512 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -48.21 111.88 0.5 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.527 179.01 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.7 t-105 -98.43 130.68 27.61 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.448 -179.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -53.91 120.1 7.36 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.272 1.982 . . . . 0.0 110.909 178.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.39 174.36 10.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.359 0.6 . . . . 0.0 112.546 -178.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HG3' HD23 ' A' ' 15' ' ' LEU . 18.2 ttp180 -143.14 155.65 44.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.487 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.474 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 32.6 mm -78.82 136.52 23.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -126.46 -20.8 4.3 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -178.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.02 157.84 16.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.899 0.38 . . . . 0.0 111.18 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.49 ' HE1' ' O ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -155.94 154.27 27.38 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.378 179.834 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -88.87 175.66 3.53 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.087 2.525 . . . . 0.0 112.17 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.34 -48.08 0.53 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.112 0.482 . . . . 0.0 111.061 179.594 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.07 -41.06 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.883 179.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.63 90.41 1.01 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.19 179.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG23 ' HG2' ' A' ' 39' ' ' LYS . 3.0 m -148.6 -39.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.672 -179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.527 ' HG2' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -163.91 140.43 6.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.801 0.334 . . . . 0.0 110.95 179.781 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -62.26 111.24 1.9 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.805 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.478 HG22 ' CE2' ' A' ' 57' ' ' PHE . 2.3 p -136.33 9.52 3.2 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.749 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 37.61 42.02 0.34 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.935 0.398 . . . . 0.0 111.688 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' C ' ' HG2' ' A' ' 44' ' ' LYS . 3.3 t-20 64.47 47.44 2.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.991 -179.752 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HG2' ' C ' ' A' ' 43' ' ' ASN . 0.8 OUTLIER -140.01 158.42 44.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.245 -179.362 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -97.58 159.0 15.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.944 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -97.65 109.5 22.24 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.577 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 50.2 t -102.78 141.71 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 121.395 0.617 . . . . 0.0 112.421 -178.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 96' ' ' LYS . 47.9 t80 -105.25 121.25 43.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.693 179.044 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.682 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 76.8 m-85 -93.86 110.89 22.53 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.585 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.8 ' CE2' HD12 ' A' ' 89' ' ' ILE . 49.9 m-85 -60.69 178.11 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.06 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.428 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 70.26 -63.53 0.78 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 111.857 -179.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.3 p -91.38 -22.36 20.52 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.732 0.301 . . . . 0.0 110.528 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.7 m170 62.87 36.65 12.73 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.016 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -90.44 154.75 19.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.33 140.71 52.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.321 0.581 . . . . 0.0 111.6 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.528 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -154.99 167.59 29.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.038 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.478 ' CE2' HG22 ' A' ' 41' ' ' THR . 14.0 m-85 -111.92 126.91 55.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 29.3 mt -141.25 164.34 30.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.062 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -91.96 171.16 33.99 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.076 179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.61 -19.06 48.56 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.407 2.071 . . . . 0.0 112.223 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -67.77 -28.44 67.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.932 0.396 . . . . 0.0 110.398 179.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -100.22 16.5 24.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.657 179.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mp -114.23 137.24 52.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.54 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.4 m-85 -136.74 155.87 76.4 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.715 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.526 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 10.1 Cg_exo -69.71 112.7 3.14 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.219 1.946 . . . . 0.0 111.178 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.552 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.5 t80 -47.65 -58.78 3.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.323 -178.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -50.61 -39.7 50.87 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.967 0.413 . . . . 0.0 111.772 -179.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.5 mt-10 -71.05 -39.87 72.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.605 -179.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -102.66 8.09 39.71 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.24 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.552 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -55.61 -50.75 69.32 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.825 0.345 . . . . 0.0 111.384 179.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -70.95 -19.71 62.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.441 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HD3' ' CD1' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -85.01 -52.23 6.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.177 0.513 . . . . 0.0 111.939 -179.214 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.476 ' CD1' ' HD3' ' A' ' 72' ' ' LYS . 6.7 m-85 -100.72 -10.24 21.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.448 -0.797 . . . . 0.0 112.712 -178.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.02 72.31 2.29 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.297 -179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -150.64 152.15 31.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.681 0.24 . . . . 0.0 110.478 179.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.62 138.97 14.02 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.661 2.241 . . . . 0.0 112.72 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.457 ' HB3' ' CB ' ' A' ' 82' ' ' PHE . 9.4 t-20 -110.0 164.19 12.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.544 -179.338 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.54 -20.73 23.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.685 179.418 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -69.35 -12.37 61.6 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.973 0.416 . . . . 0.0 110.66 179.055 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.2 mmtt 65.33 146.52 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.386 -179.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.13 -18.81 42.5 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.855 -178.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.6 t80 -58.24 -54.94 41.26 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.017 0.437 . . . . 0.0 110.834 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.27 -47.05 66.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.294 -179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -48.3 -31.37 5.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.045 0.45 . . . . 0.0 110.494 179.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.32 -31.69 58.92 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.031 179.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.615 ' O ' HG22 ' A' ' 89' ' ' ILE . 41.9 mt -60.98 -43.54 98.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.986 0.422 . . . . 0.0 110.192 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -63.31 -45.46 91.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.053 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.445 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -62.73 -51.61 66.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.039 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.8 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.7 OUTLIER -52.32 -26.5 9.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.791 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.66 -44.86 5.97 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -80.47 -33.06 36.94 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -178.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -155.9 88.22 2.97 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 120.754 0.311 . . . . 0.0 111.136 -179.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.1 Cg_endo -76.23 -12.12 19.2 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.695 2.263 . . . . 0.0 112.838 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 p -104.05 12.71 33.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.406 -179.706 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.635 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.4 p -60.71 145.7 12.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.778 0.323 . . . . 0.0 111.348 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 48' ' ' PHE . 13.0 mmtp 62.78 99.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.916 -179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 61.83 151.8 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.939 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 37.9 t -168.5 178.39 4.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.97 0.414 . . . . 0.0 111.082 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.75 36.26 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.56 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -117.07 129.81 56.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.328 . . . . 0.0 110.843 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -157.82 115.47 3.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.93 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 93.7 p -123.47 177.06 5.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.823 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.7 t 60.51 159.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -56.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.95 -178.11 3.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.795 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.95 -54.9 5.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.83 176.79 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 33.7 m -122.25 -52.07 1.96 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.77 -56.21 17.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.105 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.862 179.961 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.842 0.353 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 m -147.89 87.08 1.6 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -127.88 94.74 4.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.908 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 61.67 95.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.038 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -102.86 119.64 39.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.806 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.36 144.02 44.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.995 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -73.98 -13.5 60.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.214 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.0 tptt 63.99 121.94 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.935 0.397 . . . . 0.0 111.075 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -96.49 144.57 26.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.757 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.563 ' CD2' HG11 ' A' ' 16' ' ' VAL . 59.6 m-85 -115.2 159.51 20.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.895 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.75 157.53 45.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 111.005 -179.6 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 49.6 t -51.95 130.86 30.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.388 -179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.85 -13.45 65.12 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.967 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.51 140.87 51.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.762 0.315 . . . . 0.0 111.022 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.832 HD23 ' HG3' ' A' ' 29' ' ' ARG . 60.4 mt -92.51 118.94 31.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.982 0.42 . . . . 0.0 110.427 179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.563 HG11 ' CD2' ' A' ' 10' ' ' TYR . 29.9 m -141.08 173.5 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.803 -179.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.541 ' HB3' ' HB3' ' A' ' 25' ' ' HIS . 16.1 m-85 -111.35 138.88 47.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.509 178.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB3' ' HE1' ' A' ' 49' ' ' PHE . . . -117.29 126.42 52.69 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.171 0.51 . . . . 0.0 112.133 -179.069 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.442 ' HB2' ' CD2' ' A' ' 25' ' ' HIS . 10.7 tptm -91.18 129.56 37.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.01 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.42 140.15 48.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.743 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.9 123.32 17.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.79 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.65 -7.88 46.44 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.685 -179.719 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.09 160.99 30.41 Favored Pre-proline 0 C--N 1.333 -0.142 0 CA-C-O 120.728 0.299 . . . . 0.0 110.626 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HG3' ' ND2' ' A' ' 77' ' ' ASN . 94.7 Cg_endo -81.67 171.16 13.58 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.635 2.224 . . . . 0.0 112.367 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 67.8 m80 -50.02 118.52 2.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.392 179.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.457 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.9 t-105 -99.49 133.05 22.2 Favored Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -179.014 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.429 ' HA ' ' CD1' ' A' ' 17' ' ' PHE . 11.7 Cg_endo -54.45 120.79 8.61 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.393 2.062 . . . . 0.0 110.819 178.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.612 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -145.01 176.35 9.55 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.832 ' HG3' HD23 ' A' ' 15' ' ' LEU . 11.7 ttp180 -142.61 155.57 44.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.47 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 mm -82.53 137.76 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -124.31 -14.99 6.84 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.461 ' C ' ' HG2' ' A' ' 33' ' ' MET . 0.9 OUTLIER -162.73 155.61 19.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.084 0.468 . . . . 0.0 111.519 -179.772 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.461 ' HG2' ' C ' ' A' ' 32' ' ' GLU . 0.2 OUTLIER -147.92 137.28 12.01 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.087 179.682 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.652 ' CB ' HG21 ' A' ' 38' ' ' VAL . 59.7 Cg_endo -72.02 98.79 0.93 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.438 2.092 . . . . 0.0 112.148 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.88 5.21 0.49 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.36 -40.69 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.788 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 38' ' ' VAL . . . -147.94 104.07 3.54 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.116 179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.652 HG21 ' CB ' ' A' ' 34' ' ' PRO . 3.3 m -156.83 98.47 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.117 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -76.25 -78.25 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.934 -179.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.82 84.57 0.08 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.866 0.365 . . . . 0.0 110.31 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.496 HG22 ' N ' ' A' ' 42' ' ' ALA . 56.7 m -144.16 165.4 27.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.222 0.534 . . . . 0.0 111.421 -179.274 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.496 ' N ' HG22 ' A' ' 41' ' ' THR . . . -169.86 50.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.474 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.5 m120 70.43 37.36 1.54 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.021 -178.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -138.71 142.61 38.91 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.499 -179.163 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.8 OUTLIER -95.48 163.19 13.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.663 179.439 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.03 110.26 22.57 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.612 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 99.3 t -104.74 143.61 15.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.304 -178.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 40.8 t80 -106.75 123.85 48.74 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.912 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.614 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 86.1 m-85 -95.81 113.77 25.44 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.948 -179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.723 ' HE2' HD12 ' A' ' 89' ' ' ILE . 60.9 m-85 -61.47 179.54 0.22 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.248 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 68.62 -63.56 0.45 Allowed Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.117 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 69.7 p -91.7 -21.56 20.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.746 0.307 . . . . 0.0 110.7 179.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 64.5 m170 62.0 37.46 14.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.181 -179.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -90.8 155.88 18.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.492 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.04 140.05 53.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.391 0.615 . . . . 0.0 111.655 -179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.18 166.92 32.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.262 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -106.2 124.76 50.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.655 179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 86.2 mt -139.78 162.69 34.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -95.25 167.19 26.13 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.495 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.17 -19.76 67.67 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.661 2.241 . . . . 0.0 112.615 -179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -69.12 -27.28 65.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.873 0.368 . . . . 0.0 110.856 179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 24.8 m-20 -97.95 8.81 44.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.231 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.558 HD22 HG21 ' A' ' 16' ' ' VAL . 95.6 mt -109.35 139.87 43.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.693 0.283 . . . . 0.0 110.539 179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.6 m-85 -134.06 156.67 78.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.09 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.458 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 15.4 Cg_exo -68.19 109.66 2.03 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.605 2.203 . . . . 0.0 111.43 179.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.543 ' O ' ' N ' ' A' ' 70' ' ' LYS . 83.4 t80 -54.9 -62.14 1.85 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.915 -179.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.468 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -49.01 -42.13 36.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.081 0.467 . . . . 0.0 111.474 -179.149 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 0.9 OUTLIER -70.88 -39.77 72.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.485 -179.373 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.418 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -104.93 9.75 34.5 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.522 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' N ' ' O ' ' A' ' 66' ' ' TYR . 4.2 ptpp? -55.21 -45.21 75.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.855 0.36 . . . . 0.0 111.401 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.3 mt-10 -70.09 -26.89 64.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.987 -179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.2 mtmm -84.57 -46.44 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 69' ' ' SER . 23.7 m-85 -105.07 -0.83 26.34 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -178.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -88.8 75.07 1.99 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.873 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -150.36 157.31 36.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.69 0.281 . . . . 0.0 110.861 179.924 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.82 149.89 10.25 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.704 2.269 . . . . 0.0 112.573 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.417 ' OD1' ' CD2' ' A' ' 82' ' ' PHE . 4.9 m120 -131.2 165.81 22.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.595 -179.253 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.32 -17.53 30.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.259 -179.741 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -66.25 -15.06 62.88 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.075 0.464 . . . . 0.0 110.61 179.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mmmt 63.98 142.6 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.097 -179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.33 -17.91 48.92 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.801 -178.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.457 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 18.4 t80 -58.66 -53.58 56.76 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.034 0.445 . . . . 0.0 110.505 179.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.61 -46.48 67.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.043 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.62 -32.66 8.53 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.019 0.438 . . . . 0.0 110.39 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.488 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.34 -31.83 60.74 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.814 179.388 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 89' ' ' ILE . 84.1 mt -60.84 -43.73 97.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.001 0.429 . . . . 0.0 110.268 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.452 ' CD1' ' ND2' ' A' ' 91' ' ' ASN . 61.1 t90 -65.46 -41.52 93.29 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.053 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.419 ' OE1' HG11 ' A' ' 95' ' ' VAL . 58.7 mm-40 -64.29 -53.67 45.21 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.036 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.723 HD12 ' HE2' ' A' ' 50' ' ' PHE . 1.2 tt -52.39 -25.38 7.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 87' ' ' TRP . 15.8 pt-20 -100.37 -44.65 5.84 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.452 ' ND2' ' CD1' ' A' ' 87' ' ' TRP . 35.3 m-80 -81.33 -33.91 32.19 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 62.7 t-20 -156.66 85.46 3.01 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.804 0.335 . . . . 0.0 111.017 -179.579 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 72.1 Cg_endo -74.97 -10.24 21.17 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.676 2.251 . . . . 0.0 112.685 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.1 p -104.18 11.78 34.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.538 -179.853 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.419 HG11 ' OE1' ' A' ' 88' ' ' GLU . 11.4 p -61.71 147.2 11.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.851 0.357 . . . . 0.0 111.441 -179.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -142.86 145.28 32.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.857 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -100.11 143.73 29.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.14 93.59 2.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 125.51 51.63 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.576 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -107.29 117.73 34.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.4 102.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.862 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.22 130.11 44.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.6 m -126.12 -174.47 3.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.878 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 61.96 110.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.945 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 15.6 mttt 63.01 121.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.985 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 7.9 mttt -139.25 -56.84 0.6 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.92 -30.37 13.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 61.52 172.59 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.837 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.73 173.93 6.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.011 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.834 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.879 0.371 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.7 t -133.67 -51.99 0.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.796 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.93 -172.72 2.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.08 -177.19 3.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.056 -179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -142.82 -65.04 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.739 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 -122.02 23.04 10.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.02 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -126.02 105.48 8.92 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.643 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 10' ' ' TYR . 2.5 pttp -140.73 176.39 8.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.102 -179.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -154.32 142.6 20.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.541 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.458 ' CE2' ' HD2' ' A' ' 8' ' ' LYS . 88.9 m-85 -116.81 159.55 22.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.74 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HA ' ' HE1' ' A' ' 33' ' ' MET . 5.8 mmtm -137.77 161.15 37.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.968 0.413 . . . . 0.0 110.997 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.2 t -52.2 124.68 13.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.77 -16.09 44.11 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.061 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.23 140.01 50.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.827 0.346 . . . . 0.0 111.126 -179.877 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.57 HD23 ' HG3' ' A' ' 29' ' ' ARG . 56.3 mt -92.8 118.68 31.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.301 179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.423 HG21 HD22 ' A' ' 63' ' ' LEU . 31.1 m -139.67 171.77 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.743 -179.484 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.494 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 11.4 m-85 -109.98 136.68 48.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.706 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.728 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -113.43 126.44 55.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.993 0.425 . . . . 0.0 111.779 -179.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 14.2 tptm -92.96 130.64 38.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.854 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.94 148.6 50.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.77 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -67.36 106.67 2.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.774 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.82 -7.08 27.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.611 -0.805 . . . . 0.0 112.749 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -141.07 156.61 68.11 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-O 120.713 0.292 . . . . 0.0 110.656 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -84.98 171.92 9.01 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.744 2.296 . . . . 0.0 112.206 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.48 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 74.8 m80 -47.79 111.88 0.49 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.42 179.032 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.432 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 1.6 t-105 -99.57 129.06 29.76 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.783 -0.19 . . . . 0.0 111.24 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HG3' HD22 ' A' ' 86' ' ' LEU . 12.4 Cg_endo -55.46 121.13 9.38 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.152 1.902 . . . . 0.0 110.968 179.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -143.68 175.77 9.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.29 0.566 . . . . 0.0 112.257 -178.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.57 ' HG3' HD23 ' A' ' 15' ' ' LEU . 6.3 ttp180 -141.67 154.83 45.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.75 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.408 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.1 mm -82.27 114.25 22.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 178.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -109.87 -13.84 14.38 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.26 152.48 14.79 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.943 0.402 . . . . 0.0 111.309 -179.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.44 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 6.3 ptp -154.75 156.35 31.35 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.168 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.82 160.76 24.46 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.678 2.252 . . . . 0.0 112.111 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -82.87 -37.85 23.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.167 0.508 . . . . 0.0 110.715 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.89 -39.69 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.052 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.693 ' O ' HG22 ' A' ' 38' ' ' VAL . . . -162.53 -47.54 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.12 179.354 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 37' ' ' ALA . 5.2 m 51.05 21.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.829 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 41.49 60.55 2.09 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.719 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.598 ' OG ' HG23 ' A' ' 38' ' ' VAL . 13.7 p 177.06 -45.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.4 p -79.55 102.88 9.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.922 179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . . . -73.7 52.76 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.021 179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.4 t30 56.08 50.8 12.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.047 0.451 . . . . 0.0 110.969 -179.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' HD3' ' HB3' ' A' ' 42' ' ' ALA . 1.6 mtmt -132.06 138.82 48.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.208 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 62.4 m-85 -94.42 153.22 18.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.843 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -99.0 105.78 17.96 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.623 HG11 HD21 ' A' ' 63' ' ' LEU . 29.5 m -101.47 150.34 6.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-O 121.542 0.687 . . . . 0.0 112.211 -178.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 32.9 t80 -105.81 124.38 49.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.076 179.651 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.466 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 32.5 m-85 -91.72 107.62 19.33 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.565 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.799 ' HE2' HD12 ' A' ' 89' ' ' ILE . 36.0 m-85 -58.56 175.11 0.27 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.794 0.33 . . . . 0.0 110.934 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.53 -62.05 0.86 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.386 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 65.4 p -90.49 -21.51 21.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.652 0.263 . . . . 0.0 111.097 179.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 48.4 m170 64.02 34.9 10.99 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.889 0.376 . . . . 0.0 110.29 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -90.32 153.68 20.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.704 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.54 141.51 51.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.166 0.507 . . . . 0.0 111.633 -179.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -155.41 177.53 11.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.406 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.441 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 9.0 m-85 -120.56 127.34 52.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.804 179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.728 HD13 ' HB1' ' A' ' 18' ' ' ALA . 5.3 mt -140.01 163.93 31.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.117 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.94 177.17 35.25 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.566 -179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.12 -25.26 51.07 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.665 2.243 . . . . 0.0 112.437 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -69.92 -25.43 63.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.352 . . . . 0.0 111.091 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' HA ' ' A' ' 18' ' ' ALA . 36.3 m-20 -98.39 4.79 48.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.388 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.623 HD21 HG11 ' A' ' 47' ' ' VAL . 20.8 mt -112.59 139.37 48.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.444 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.4 m-85 -136.01 159.93 69.18 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.067 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.452 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 12.2 Cg_exo -69.68 110.88 2.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.695 2.264 . . . . 0.0 111.64 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.531 ' O ' ' N ' ' A' ' 70' ' ' LYS . 84.5 t80 -51.82 -59.25 4.53 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.549 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.412 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.8 mt-10 -50.42 -41.41 52.38 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.701 -179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 2.2 tm-20 -69.55 -39.81 77.21 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.458 -179.386 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 m -108.15 13.77 25.62 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 71' ' ' GLU . 4.5 ptpp? -56.09 -47.67 77.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 0.0 111.125 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 5.3 mt-10 -71.13 -21.32 62.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.316 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HD3' ' CE1' ' A' ' 73' ' ' PHE . 4.2 tttt -85.59 -49.35 8.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -179.021 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' ' CD2' ' A' ' 25' ' ' HIS . 9.5 m-85 -103.01 -4.79 24.13 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -178.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.443 ' HA2' HD11 ' A' ' 86' ' ' LEU . . . -83.32 71.1 3.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.245 -0.979 . . . . 0.0 113.077 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 9.1 mtmt -149.33 153.54 37.54 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.74 158.19 14.16 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.574 2.182 . . . . 0.0 112.733 -179.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -137.15 167.27 21.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.469 -179.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.46 -15.45 46.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.112 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 -14.04 61.61 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.008 0.432 . . . . 0.0 110.792 179.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp 63.85 142.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.273 -179.367 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.05 -17.79 48.94 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.742 -178.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 75' ' ' LYS . 44.5 t80 -59.83 -54.19 49.09 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.998 0.428 . . . . 0.0 110.842 179.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.511 ' HA ' HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -53.1 -46.33 68.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.236 -179.823 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -48.39 -29.83 4.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.997 0.427 . . . . 0.0 110.601 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.458 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.97 -31.59 59.75 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.172 179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.575 ' O ' HG22 ' A' ' 89' ' ' ILE . 3.8 mm? -61.01 -44.16 97.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.959 0.409 . . . . 0.0 110.533 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' ASN . 64.2 t90 -65.12 -45.71 83.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.339 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.474 ' OE1' HG11 ' A' ' 95' ' ' VAL . 52.5 mt-10 -62.48 -51.02 69.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -178.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.799 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.6 OUTLIER -52.3 -27.18 10.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.711 0.291 . . . . 0.0 111.684 -179.64 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -99.6 -44.73 6.03 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 0.5 OUTLIER -80.33 -31.86 37.98 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.736 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -155.61 88.11 3.07 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.821 0.343 . . . . 0.0 111.188 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 73.3 Cg_endo -75.93 -13.39 19.54 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.676 2.25 . . . . 0.0 112.697 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.558 HG22 HH12 ' A' ' 29' ' ' ARG . 48.1 p -105.67 12.4 31.1 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.496 -179.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.567 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.8 p -63.14 149.76 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.977 0.418 . . . . 0.0 111.481 -179.674 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.14 143.23 25.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.456 ' HB2' ' ND1' ' A' ' 53' ' ' HIS . . . -91.56 104.0 16.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.054 179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 t -83.3 138.4 33.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.999 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.34 141.91 10.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.431 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -125.79 153.04 44.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.897 0.38 . . . . 0.0 110.99 -179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.01 -46.72 0.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.2 t -133.93 99.79 4.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -101.9 -62.93 1.2 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.22 113.5 1.87 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 -179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.29 157.68 44.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.72 124.58 29.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.5 m -150.5 138.94 20.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 67.5 m -142.89 -56.6 0.42 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.9 167.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.761 0.315 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -102.52 31.73 3.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -120.55 138.25 53.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.937 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 t -125.42 139.51 53.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.798 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -128.45 6.19 5.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.467 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -162.22 -67.0 0.05 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.72 0.295 . . . . 0.0 110.978 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -58.47 174.81 0.28 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 9' ' ' GLU . 13.3 tppt? -153.86 162.07 41.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -157.17 146.67 20.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.811 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.634 ' CD2' HG11 ' A' ' 16' ' ' VAL . 47.9 m-85 -117.74 160.78 20.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.694 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -134.22 160.47 37.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.867 0.365 . . . . 0.0 111.135 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -52.26 133.0 34.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.372 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.2 -10.97 72.75 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.915 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -72.03 142.8 49.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.768 0.318 . . . . 0.0 111.15 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.419 HD23 ' HG3' ' A' ' 29' ' ' ARG . 30.2 mt -90.81 116.79 28.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.927 0.394 . . . . 0.0 110.281 179.512 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.634 HG11 ' CD2' ' A' ' 10' ' ' TYR . 27.3 m -139.48 168.9 17.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.663 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 44.5 m-85 -110.56 137.06 48.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.506 178.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.705 ' HB1' ' CD1' ' A' ' 58' ' ' LEU . . . -112.29 124.22 51.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.881 0.372 . . . . 0.0 111.294 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -91.11 134.39 34.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.963 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 mmm -128.19 149.27 50.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.646 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.55 115.22 3.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 0.0 111.063 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.72 -31.69 6.99 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.574 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -103.02 153.0 38.61 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 110.915 -179.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.87 166.8 11.39 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.816 2.344 . . . . 0.0 112.43 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 17' ' ' PHE . 46.7 m80 -48.61 113.98 0.88 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.612 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.472 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 3.7 t-105 -98.65 131.33 26.04 Favored Pre-proline 0 N--CA 1.464 0.266 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -178.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.9 120.34 7.74 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.357 2.038 . . . . 0.0 110.857 178.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.624 ' HB1' ' CG2' ' A' ' 47' ' ' VAL . . . -145.49 175.03 10.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.692 HH12 HG22 ' A' ' 94' ' ' THR . 1.0 OUTLIER -143.07 155.93 44.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.336 179.619 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 17.0 mm -80.82 136.88 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -127.31 -18.1 4.57 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.005 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -164.42 153.62 13.46 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.899 0.381 . . . . 0.0 111.334 -179.674 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.544 ' HE1' ' O ' ' A' ' 10' ' ' TYR . 6.8 ptp -156.54 166.3 16.83 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.826 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.851 ' HA ' HG22 ' A' ' 38' ' ' VAL . 8.2 Cg_exo -72.4 56.06 2.64 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.877 2.385 . . . . 0.0 112.274 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -164.36 37.57 0.08 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.685 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -170.12 -36.8 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.15 -64.18 1.1 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.214 178.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.851 HG22 ' HA ' ' A' ' 34' ' ' PRO . 9.2 t 55.25 100.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.355 179.165 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.69 -67.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.7 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 m -96.66 42.09 1.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.448 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.01 174.08 6.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.275 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -171.1 56.5 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.403 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.481 ' C ' ' HG2' ' A' ' 44' ' ' LYS . 7.6 m120 68.46 28.68 5.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.04 -178.361 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HG2' ' C ' ' A' ' 43' ' ' ASN . 2.2 mtmt -138.38 151.91 47.92 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.057 -179.231 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -92.18 158.79 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.231 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -99.55 98.22 9.13 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.624 ' CG2' ' HB1' ' A' ' 28' ' ' ALA . 2.1 p -99.79 147.29 7.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.659 0.742 . . . . 0.0 112.408 -177.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CZ ' ' HA ' ' A' ' 53' ' ' HIS . 28.4 t80 -105.63 124.97 50.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.283 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.609 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 63.7 m-85 -91.85 108.15 19.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.548 179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.752 ' CE2' HD12 ' A' ' 89' ' ' ILE . 38.0 m-85 -59.79 175.78 0.34 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.729 0.3 . . . . 0.0 110.979 -179.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' N ' ' HA2' ' A' ' 85' ' ' GLY . . . 70.68 -62.77 0.88 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.229 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.2 p -90.78 -22.07 21.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.794 0.331 . . . . 0.0 110.656 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.457 ' HA ' ' CZ ' ' A' ' 48' ' ' PHE . 50.4 m170 63.51 36.04 11.48 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.388 -179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -90.41 153.52 20.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.589 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.25 139.55 53.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.113 0.483 . . . . 0.0 111.328 -179.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB3' ' HE2' ' A' ' 49' ' ' PHE . . . -155.7 167.84 29.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.64 -179.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -110.28 125.64 53.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.639 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.705 ' CD1' ' HB1' ' A' ' 18' ' ' ALA . 62.3 mt -138.39 161.49 36.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.043 -179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.81 171.8 33.41 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.311 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.416 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 40.1 Cg_endo -67.39 -20.85 47.93 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.351 2.034 . . . . 0.0 112.214 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -68.37 -28.9 67.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.958 0.409 . . . . 0.0 110.453 179.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -100.49 12.06 38.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.816 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 2.3 mp -109.51 136.59 48.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.386 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.5 m-85 -135.05 146.0 56.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.902 0.382 . . . . 0.0 111.048 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.477 ' HG2' ' HB3' ' A' ' 68' ' ' GLU . 17.8 Cg_endo -60.06 112.25 1.24 Allowed 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.43 2.087 . . . . 0.0 111.334 179.414 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 17' ' ' PHE . 78.6 t80 -49.71 -61.78 1.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.215 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -50.28 -40.8 49.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.125 0.488 . . . . 0.0 111.49 -179.258 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.477 ' HB3' ' HG2' ' A' ' 65' ' ' PRO . 6.0 tt0 -71.01 -39.74 72.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.198 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.452 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 5.3 m -101.04 8.14 43.07 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HD3' ' CE2' ' A' ' 66' ' ' TYR . 0.3 OUTLIER -53.17 -53.68 46.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.267 0.556 . . . . 0.0 111.426 179.64 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.85 -17.79 62.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.831 -179.312 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.8 tttt -85.26 -50.53 7.28 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.452 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 7.8 m-85 -107.29 -3.19 19.96 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.57 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.39 72.68 2.61 Favored Glycine 0 C--N 1.329 0.165 0 C-N-CA 120.172 -1.013 . . . . 0.0 112.976 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -149.81 153.23 35.9 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-O 120.607 0.241 . . . . 0.0 110.678 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -51.13 153.57 9.06 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.55 2.167 . . . . 0.0 112.626 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -137.05 167.35 21.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.684 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 -15.38 41.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.324 -179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 37.9 mmt-85 -66.03 -15.19 62.82 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 121.032 0.444 . . . . 0.0 110.595 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm 63.62 142.32 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.136 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 89.04 -17.2 52.81 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.608 -178.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.472 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 36.1 t80 -58.38 -56.08 26.68 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 120.986 0.422 . . . . 0.0 110.754 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.86 -46.28 67.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -48.58 -31.69 6.97 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.974 0.416 . . . . 0.0 110.426 179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -74.33 -32.2 58.28 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.026 179.459 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.557 ' O ' HG22 ' A' ' 89' ' ' ILE . 16.5 mt -60.68 -43.55 97.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.996 0.426 . . . . 0.0 110.123 179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . 0.441 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 63.8 t90 -64.9 -43.22 93.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.935 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 21.6 mm-40 -63.46 -52.41 61.53 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.752 HD12 ' CE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -53.04 -25.44 9.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.738 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 87' ' ' TRP . 12.5 pt-20 -99.92 -44.77 5.93 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.073 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 87' ' ' TRP . 1.2 m-80 -82.55 -29.37 30.39 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -155.86 86.88 3.12 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.79 0.328 . . . . 0.0 111.125 -179.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 71.9 Cg_endo -76.86 -14.29 17.3 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.667 2.245 . . . . 0.0 112.653 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.692 HG22 HH12 ' A' ' 29' ' ' ARG . 16.7 p -105.13 11.9 32.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.576 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG12 ' HE1' ' A' ' 50' ' ' PHE . 12.7 p -60.72 147.25 10.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.894 0.378 . . . . 0.0 111.403 -179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -152.94 21.57 0.58 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.287 -179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 51.6 28.85 5.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.291 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.46 47.83 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -118.15 68.51 0.33 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -144.92 32.75 1.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.894 0.378 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -83.01 166.29 18.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.1 t -141.9 -58.52 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.9 t 63.13 -79.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -73.1 170.2 15.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.929 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -177.1 149.61 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.946 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt 60.89 84.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.994 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.8 m 56.82 92.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.038 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.2 m -170.37 -66.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.76 158.11 36.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.074 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.852 179.968 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.778 0.323 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.84 159.7 36.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.856 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.71 -51.93 7.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.3 p -113.54 -176.25 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -116.71 162.54 17.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 -179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -171.68 143.31 1.69 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.966 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 61.46 153.17 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.002 179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.57 147.7 31.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.742 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -95.69 142.63 27.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.748 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.558 ' CE1' HG11 ' A' ' 16' ' ' VAL . 87.7 m-85 -112.1 157.51 20.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.714 179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmt -131.48 158.67 40.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.048 0.451 . . . . 0.0 111.169 -179.538 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.73 131.86 35.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.516 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.81 -11.45 68.04 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.932 -0.651 . . . . 0.0 113.14 179.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -70.86 138.4 50.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.875 0.369 . . . . 0.0 111.26 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.415 HD23 ' HG3' ' A' ' 29' ' ' ARG . 75.5 mt -91.89 118.09 30.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.386 179.472 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.558 HG11 ' CE1' ' A' ' 10' ' ' TYR . 25.5 m -139.88 171.95 13.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.832 -179.553 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.532 ' CZ ' ' CD1' ' A' ' 66' ' ' TYR . 30.3 m-85 -112.81 137.09 51.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.539 178.669 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HB1' HD13 ' A' ' 58' ' ' LEU . . . -114.4 126.5 55.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.883 0.373 . . . . 0.0 111.301 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.456 ' HD3' ' CE1' ' A' ' 25' ' ' HIS . 12.3 tptp -90.25 136.08 33.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.087 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -130.32 151.8 50.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.534 179.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -67.64 118.26 10.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.919 -179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.55 -8.57 74.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.981 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.411 ' CD1' ' HD3' ' A' ' 79' ' ' ARG . 1.9 m-85 -132.19 154.45 81.65 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 116.849 0.324 . . . . 0.0 111.071 -179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -84.27 167.16 12.29 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.86 2.373 . . . . 0.0 112.495 -179.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.456 ' CE1' ' HD3' ' A' ' 19' ' ' LYS . 80.2 m80 -47.09 115.23 1.02 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.629 179.16 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.458 ' CZ2' ' HA ' ' A' ' 82' ' ' PHE . 2.1 t-105 -99.03 130.02 28.34 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.536 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.78 119.48 6.31 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.374 2.049 . . . . 0.0 111.112 178.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.598 ' HB1' ' CG1' ' A' ' 47' ' ' VAL . . . -144.12 174.34 10.95 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.425 0.631 . . . . 0.0 112.69 -177.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 30' ' ' ILE . 0.4 OUTLIER -142.92 155.8 44.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.305 179.686 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 29' ' ' ARG . 28.5 mm -78.18 138.36 20.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.004 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.73 -20.33 5.5 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.055 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -162.51 150.78 14.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.069 0.461 . . . . 0.0 111.234 -179.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.401 ' HE2' ' HA ' ' A' ' 33' ' ' MET . 29.2 mmt -93.35 161.15 31.66 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.795 179.512 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.489 ' HD3' ' CE2' ' A' ' 45' ' ' TYR . 98.4 Cg_endo -87.15 111.24 0.84 Allowed 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.904 2.403 . . . . 0.0 112.356 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' HG3' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -51.46 -93.5 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.919 179.761 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -173.97 -52.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.262 0.553 . . . . 0.0 110.512 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.52 72.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.139 179.896 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.467 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 3.9 m -145.29 21.28 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.317 -179.422 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 38' ' ' VAL . 3.6 mmmp? -159.89 -79.67 0.05 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.499 179.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.7 t -179.8 41.47 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.46 179.865 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.48 HG21 ' CE2' ' A' ' 57' ' ' PHE . 38.6 p -138.08 122.0 17.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.125 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.61 -60.64 2.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.252 0.549 . . . . 0.0 109.788 178.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -155.66 50.33 0.55 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.889 179.004 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -114.16 139.75 49.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.709 -178.571 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.534 ' O ' ' HA ' ' A' ' 57' ' ' PHE . 80.1 m-85 -95.82 155.02 16.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.678 179.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.436 ' HG3' ' CE2' ' A' ' 57' ' ' PHE . 5.4 mt-30 -96.39 106.71 18.99 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.598 ' CG1' ' HB1' ' A' ' 28' ' ' ALA . 63.4 t -100.77 143.06 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.294 -178.297 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -105.89 122.02 45.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.156 179.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.646 ' HE1' ' HB3' ' A' ' 18' ' ' ALA . 75.0 m-85 -94.97 110.28 22.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.415 179.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.725 ' HE2' HD12 ' A' ' 89' ' ' ILE . 57.2 m-85 -58.86 -179.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.025 -179.513 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 69.52 -63.64 0.61 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.205 -179.552 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.9 p -91.11 -22.83 20.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.749 0.309 . . . . 0.0 110.734 179.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 23.4 m170 64.55 36.51 8.55 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.534 -179.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -94.21 157.0 16.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.517 179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.1 t -131.75 149.92 52.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.362 0.601 . . . . 0.0 112.009 -179.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.52 170.94 20.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.126 179.949 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 52.4 m-85 -105.96 86.59 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 0.0 110.849 179.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.813 HD13 ' HB1' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -98.08 156.84 16.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.195 -179.87 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.559 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -91.97 169.42 32.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.324 179.649 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.405 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 42.0 Cg_endo -67.48 -20.86 47.35 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.504 2.136 . . . . 0.0 112.359 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -27.83 67.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.95 0.405 . . . . 0.0 110.413 179.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -100.7 12.46 37.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.791 179.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.559 HD13 ' O ' ' A' ' 59' ' ' GLY . 5.8 mp -108.73 137.37 46.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.676 179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.49 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.7 m-85 -136.14 158.24 74.1 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.65 -179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.639 ' HB2' ' HB2' ' A' ' 68' ' ' GLU . 5.9 Cg_exo -71.79 111.51 3.16 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.391 2.061 . . . . 0.0 111.288 179.615 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.566 ' CZ ' ' HG3' ' A' ' 70' ' ' LYS . 89.2 t80 -45.63 -58.97 3.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.438 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -50.95 -39.43 54.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.949 -179.092 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.639 ' HB2' ' HB2' ' A' ' 65' ' ' PRO . 1.1 mm-40 -70.62 -39.76 73.55 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.465 ' HB3' ' CD2' ' A' ' 73' ' ' PHE . 49.5 m -105.49 11.03 32.99 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.566 ' HG3' ' CZ ' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -56.38 -49.47 74.37 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 111.554 179.977 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.51 -26.17 64.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.707 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -85.01 -46.93 10.73 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.465 ' CD2' ' HB3' ' A' ' 69' ' ' SER . 2.5 m-30 -99.87 -12.95 19.41 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' A' ' 75' ' ' LYS . . . -80.68 71.1 2.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.289 -0.957 . . . . 0.0 113.043 -179.523 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' O ' ' CE1' ' A' ' 82' ' ' PHE . 16.0 mttt -148.99 153.21 38.03 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.595 0.236 . . . . 0.0 110.384 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -51.27 153.31 9.91 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.463 2.109 . . . . 0.0 112.674 -179.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -136.48 163.44 30.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.545 -179.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -81.81 -16.54 50.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.153 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.411 ' HD3' ' CD1' ' A' ' 23' ' ' TYR . 17.9 mmm180 -64.52 -15.66 61.26 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 120.916 0.389 . . . . 0.0 110.823 179.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt 63.24 140.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.139 -179.38 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.88 -16.98 53.55 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.348 -0.93 . . . . 0.0 111.463 -178.196 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.458 ' HA ' ' CZ2' ' A' ' 26' ' ' TRP . 29.5 t80 -58.57 -55.49 34.39 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.943 0.401 . . . . 0.0 110.649 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.7 m -53.54 -45.66 69.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.121 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -48.91 -31.69 7.7 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.038 0.446 . . . . 0.0 110.464 179.689 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 50' ' ' PHE . . . -73.04 -31.75 61.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.921 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.667 ' O ' HG22 ' A' ' 89' ' ' ILE . 19.7 mt -61.12 -43.68 98.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.961 0.41 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -63.61 -45.46 90.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 50' ' ' PHE . 2.2 mp0 -62.38 -50.93 69.6 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.128 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.725 HD12 ' HE2' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -52.48 -25.99 8.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.723 0.297 . . . . 0.0 111.8 -179.708 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -44.81 5.89 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.095 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -80.49 -32.23 37.05 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.32 87.85 3.17 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.798 0.332 . . . . 0.0 110.978 -179.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 50' ' ' PHE . 96.3 Cg_endo -79.6 -12.52 13.75 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.636 2.224 . . . . 0.0 112.958 -179.597 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.419 HG22 ' NH1' ' A' ' 29' ' ' ARG . 21.1 p -103.8 12.8 34.11 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.551 HG12 ' HE1' ' A' ' 50' ' ' PHE . 13.2 p -65.62 149.37 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.837 0.351 . . . . 0.0 111.288 -179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.86 165.81 24.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.963 -179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.0 178.47 8.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.056 179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.8 m 60.05 162.62 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.36 90.76 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.531 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -122.14 99.1 6.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.81 0.338 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -68.52 -37.48 80.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -110.41 93.53 4.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.911 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.6 p -143.26 128.49 18.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.918 179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 61.42 113.56 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.62 101.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.8 154.54 33.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.918 179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.79 179.12 4.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 5.9 p -173.04 35.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.887 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 59.64 103.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.052 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.961 . . . . . . . . 0 0 . 1 stop_ save_